Citrus Sinensis ID: 018991
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | 2.2.26 [Sep-21-2011] | |||||||
| Q3EDL4 | 472 | Probable serine/threonine | yes | no | 0.910 | 0.671 | 0.861 | 1e-157 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.862 | 0.686 | 0.594 | 1e-91 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.899 | 0.633 | 0.512 | 3e-83 | |
| Q8LEB6 | 484 | Probable receptor-like pr | no | no | 0.830 | 0.597 | 0.5 | 5e-83 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.870 | 0.648 | 0.503 | 2e-79 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.778 | 0.377 | 0.39 | 1e-53 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.836 | 0.404 | 0.397 | 2e-53 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.589 | 0.288 | 0.497 | 2e-53 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.761 | 0.389 | 0.406 | 9e-53 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.531 | 0.283 | 0.515 | 2e-52 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 555 bits (1431), Expect = e-157, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 298/326 (91%), Gaps = 9/326 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 337 bits (863), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 185/311 (59%), Positives = 224/311 (72%), Gaps = 11/311 (3%)
Query: 14 SKRTSIFGLRLWVVIGIL-LGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPI 72
+ + S+FGL L++VI I + L++ L L +CL +R + ++ + S I P +
Sbjct: 13 TTKPSVFGLNLYLVIAICSVFILLISLLIFLFVCL-NRVSRARRMRVKHSSGSI---PLV 68
Query: 73 SKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEV 132
SKEI EI GKI + VV A+S E+ AS SG VG
Sbjct: 69 SKEISEI-KTVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVAS--SGDVGTSE 125
Query: 133 SHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK 192
+ +GWG+WY+L++LE AT G ++N+IGEGGYG+VYR SDG+ AVKNLLNN+GQAEK
Sbjct: 126 A-MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEK 184
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
EFKVEVE IG+VRHKNLV L+GYC + A RMLVYEY+DNGNL+QWLHGDVG VSPLTW
Sbjct: 185 EFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTW 244
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
DIRM I +GTAKGLAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE SY
Sbjct: 245 DIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSY 304
Query: 311 VTTRVMGTFGY 321
VTTRVMGTFGY
Sbjct: 305 VTTRVMGTFGY 315
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (790), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 183/357 (51%), Positives = 234/357 (65%), Gaps = 44/357 (12%)
Query: 3 MYDAAFVNTELSKRTSIFGLR---LWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQ 59
M + +N E+SK+ S FGL+ LWV + +++G IV+ L +LSL +T RRK ++
Sbjct: 1 MPPESSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKS----RR 56
Query: 60 QQQSKQILNTPPISKEIQ-EIVHHPAPVPE---IQVD---IGK--IEH--RVVFSDR--- 105
P +SK+I+ + P PE I+++ GK + H R SD
Sbjct: 57 SSSKFPFNQIPHVSKDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTL 116
Query: 106 --------------ASSGESRGTGSACETASFGSGSVG-------PEVSHLGWGRWYTLR 144
+ SGE G GSA +G G V PE+SHLGWG W+TLR
Sbjct: 117 SQCSSVNHHERACSSHSGEEGGFGSAGR--QYGGGPVTASPLVGLPEISHLGWGHWFTLR 174
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
+LE AT+ NV+GEGGYG+VYRG L +GT+VAVK LLNN GQAEKEF+VEVE IG V
Sbjct: 175 DLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHV 234
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
RHKNLVRLLGYC+EG +RMLVYEYV++GNL+QWLHG + LTW+ RM II GTA+ L
Sbjct: 235 RHKNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQAL 294
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
AYLHE +EPKVVHRD+K+SNIL+D ++NA++SDFGLAKLL S S++TTRVMGTFGY
Sbjct: 295 AYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 351
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 166/332 (50%), Positives = 215/332 (64%), Gaps = 43/332 (12%)
Query: 21 GLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIV 80
GL LW +I I+L ++ V+ L +SL LT RRK S+ N P+S++I V
Sbjct: 15 GLELWEIIVIVLSAIFVVVL-AISLWLTFRRK---------TSRSSSNLIPVSRQIPPSV 64
Query: 81 HHPAPVPEIQVD-----------------IGKIEHRVVFSDRASSGESRGTGSACETASF 123
P + EI+VD G E + +G+S +GS
Sbjct: 65 --PEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLEKK 122
Query: 124 GSGSVG--------------PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
SV PE SHLGWG W+TLR+L+ AT+ +N+IG+GGYG+VYR
Sbjct: 123 DGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYR 182
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229
G L +GT VAVK LLNN GQA+K+F+VEVE IG VRHKNLVRLLGYC+EG RMLVYEYV
Sbjct: 183 GNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYV 242
Query: 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+NGNL+QWL GD + LTW+ R+ I++GTAK LAYLHE +EPKVVHRD+KSSNIL+D
Sbjct: 243 NNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDD 302
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++N+++SDFGLAKLL +++S++TTRVMGTFGY
Sbjct: 303 KFNSKISDFGLAKLLGADKSFITTRVMGTFGY 334
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 296 bits (757), Expect = 2e-79, Method: Compositional matrix adjust.
Identities = 161/320 (50%), Positives = 221/320 (69%), Gaps = 17/320 (5%)
Query: 13 LSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPI 72
L+KR + L LW +I I L + ++ L +LS+ L+ R+K + + + +P
Sbjct: 9 LTKRYGV--LELWEIIVIALFAAFIVIL-VLSVWLSFRKKSK---RSNATTLPVTQSPRF 62
Query: 73 SKEIQEI-VHHPAP----VPEIQVD---IGKIEHRVVFSDRASSGESRGTGSACETASFG 124
++EI+EI V H + +D + IE+ FS G+ T S
Sbjct: 63 TEEIKEISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVGSHLPPSTPSTT 122
Query: 125 SGS--VG-PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVK 181
+ S +G PEVSH+GWG W+TLR+L+ AT+ +E++IG+GGYG+VY G L++ T VAVK
Sbjct: 123 APSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVK 182
Query: 182 NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD 241
LLNN GQA+K+F+VEVE IG VRHKNLVRLLGYCVEG +RMLVYEY++NGNL+QWLHGD
Sbjct: 183 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGD 242
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ LTW+ R+ +++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 302 KLLCSERSYVTTRVMGTFGY 321
KLL ++ +YV+TRVMGTFGY
Sbjct: 303 KLLGADSNYVSTRVMGTFGY 322
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 1e-53, Method: Compositional matrix adjust.
Identities = 117/300 (39%), Positives = 174/300 (58%), Gaps = 29/300 (9%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
VIGI + ++V+ LF+ + R++K +S Q L +S + +H
Sbjct: 262 TVIGIGIAGVLVI-LFIAGVFFVRRKQKKG--SSSPRSNQYLPPANVSVNTEGFIH---- 314
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG---PEVSHLGWGR-WY 141
+ + +G S S+ +T S G+ G P+ + +G + +
Sbjct: 315 ----------------YRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHF 358
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVI 201
T EL T G C+ V+GEGG+G VY+GIL +G VA+K L + + +EFK EVE+I
Sbjct: 359 TYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEII 418
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
RV H++LV L+GYC+ +R L+YE+V N LD LHG ++ L W R+ I +G A
Sbjct: 419 SRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAIGAA 476
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KGLAYLHE PK++HRD+KSSNILLD ++ A+V+DFGLA+L + +S+++TRVMGTFGY
Sbjct: 477 KGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGY 536
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 210 bits (534), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 118/297 (39%), Positives = 172/297 (57%), Gaps = 6/297 (2%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
++G+ + ++AL + + RRKK ++ S Q L P S + ++ P
Sbjct: 246 TMVGMAVAGFAIMAL--IGVVFLVRRKKKRNIDSYNHS-QYLPHPNFSVKSDGFLYGQDP 302
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRW-YTLR 144
+ ++S G S GT S P+ + LG G+ ++
Sbjct: 303 GKGYSSGPNGSMYNNSQQQQSSMGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYE 362
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
EL T G +N++GEGG+G VY+G L DG VAVK L GQ ++EFK EVE+I RV
Sbjct: 363 ELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRV 422
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H++LV L+GYC+ +R+L+YEYV N L+ LHG V L W R+ I +G+AKGL
Sbjct: 423 HHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLPV--LEWSKRVRIAIGSAKGL 480
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
AYLHE PK++HRD+KS+NILLD ++ A+V+DFGLA+L + +++V+TRVMGTFGY
Sbjct: 481 AYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGY 537
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (532), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 109/219 (49%), Positives = 146/219 (66%), Gaps = 14/219 (6%)
Query: 103 SDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEG 162
S R G +R +GSA ++A GSG +T EL T G + N++GEG
Sbjct: 315 SQRGGGGYTR-SGSAPDSAVMGSGQT-----------HFTYEELTDITEGFSKHNILGEG 362
Query: 163 GYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222
G+G VY+G L+DG VAVK L GQ ++EFK EVE+I RV H++LV L+GYC+ + R
Sbjct: 363 GFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADSER 422
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
+L+YEYV N L+ LHG V L W R+ I +G+AKGLAYLHE PK++HRD+KS
Sbjct: 423 LLIYEYVPNQTLEHHLHGKGRPV--LEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDIKS 480
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+NILLD ++ A+V+DFGLAKL S +++V+TRVMGTFGY
Sbjct: 481 ANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGY 519
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 207 bits (527), Expect = 9e-53, Method: Compositional matrix adjust.
Identities = 122/300 (40%), Positives = 174/300 (58%), Gaps = 35/300 (11%)
Query: 26 VVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQQQSKQILNTPPISKEIQEIVHHPAP 85
V IG+++G L+ L+LF++ + T +RK+ K+ V + P
Sbjct: 239 VAIGVIVG-LVFLSLFVMGVWFTRKRKR--------------------KDPGTFVGYTMP 277
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGES--RGTGSACETASFGSGSVGPEVSHLGWGRWYTL 143
G V+F+ R+S+ +GS AS SG V + S W++
Sbjct: 278 PSAYSSPQGS--DVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRS------WFSY 329
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
EL TSG E+N++GEGG+G VY+G+LSDG +VAVK L Q E+EFK EVE+I R
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
V H++LV L+GYC+ +R+LVY+YV N L LH V +TW+ R+ + G A+G
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGAARG 447
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTTRVMGTFGY 321
+AYLHE P+++HRD+KSSNILLD + A V+DFGLAK+ ++V+TRVMGTFGY
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGY 507
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 206 bits (524), Expect = 2e-52, Method: Compositional matrix adjust.
Identities = 97/188 (51%), Positives = 135/188 (71%), Gaps = 3/188 (1%)
Query: 135 LGWGR-WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE 193
LG+ + +T EL AT+G E N++G+GG+G V++GIL G +VAVK L GQ E+E
Sbjct: 261 LGFSKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGERE 320
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
F+ EVE+I RV H++LV L+GYC+ G R+LVYE+V N NL+ LHG + W R
Sbjct: 321 FQAEVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGKGRPT--MEWSTR 378
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ I LG+AKGL+YLHE PK++HRD+K+SNIL+D ++ A+V+DFGLAK+ ++V+T
Sbjct: 379 LKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVST 438
Query: 314 RVMGTFGY 321
RVMGTFGY
Sbjct: 439 RVMGTFGY 446
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| 255541684 | 492 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.908 | 0.642 | 0.873 | 1e-163 | |
| 15223428 | 472 | putative serine/threonine-protein kinase | 0.910 | 0.671 | 0.861 | 1e-156 | |
| 297848354 | 472 | kinase family protein [Arabidopsis lyrat | 0.910 | 0.671 | 0.861 | 1e-155 | |
| 14194119 | 479 | At1g01540/F22L4_6 [Arabidopsis thaliana] | 0.910 | 0.661 | 0.861 | 1e-155 | |
| 224130370 | 485 | predicted protein [Populus trichocarpa] | 0.896 | 0.643 | 0.854 | 1e-155 | |
| 30678150 | 386 | putative serine/threonine-protein kinase | 0.910 | 0.821 | 0.861 | 1e-155 | |
| 8920590 | 497 | Contains a strong similarity to an unkno | 0.910 | 0.637 | 0.800 | 1e-151 | |
| 297814211 | 481 | predicted protein [Arabidopsis lyrata su | 0.919 | 0.665 | 0.815 | 1e-150 | |
| 240255713 | 479 | protein kinase family protein [Arabidops | 0.913 | 0.663 | 0.809 | 1e-147 | |
| 334186273 | 480 | protein kinase family protein [Arabidops | 0.913 | 0.662 | 0.809 | 1e-147 |
| >gi|255541684|ref|XP_002511906.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223549086|gb|EEF50575.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1498), Expect = e-163, Method: Compositional matrix adjust.
Identities = 290/332 (87%), Positives = 298/332 (89%), Gaps = 16/332 (4%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAFVNTELSK TSIFGLRLWVVIGILLGSLIVLALFLLSLC+TSRRK L+
Sbjct: 1 MSVYDAAFVNTELSKPTSIFGLRLWVVIGILLGSLIVLALFLLSLCITSRRKNKKTLKLT 60
Query: 61 QQSKQILNTPPISKEIQEIVHHPAP-----------VPEIQVDIGKIEHRVVFSDRASSG 109
TPPISKEIQEIVH P VPEIQV+IGK EHRVVFSDR SSG
Sbjct: 61 DTI-----TPPISKEIQEIVHFPTQDNHHHHHHAVQVPEIQVEIGKTEHRVVFSDRPSSG 115
Query: 110 ESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYR 169
ESRGT SACETASFGSGSVGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY
Sbjct: 116 ESRGTASACETASFGSGSVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYS 175
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229
G+LSDGT+VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV
Sbjct: 176 GVLSDGTRVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 235
Query: 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR
Sbjct: 236 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 295
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
QWN +VSDFGLAKLLCSERSYVTTRVMGTFGY
Sbjct: 296 QWNPKVSDFGLAKLLCSERSYVTTRVMGTFGY 327
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15223428|ref|NP_171661.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|158564340|sp|Q3EDL4.2|Y1154_ARATH RecName: Full=Probable serine/threonine-protein kinase At1g01540 gi|12083266|gb|AAG48792.1|AF332429_1 putative protein serine/threonine kinase [Arabidopsis thaliana] gi|2505874|emb|CAA73303.1| putative kinase [Arabidopsis thaliana] gi|332189181|gb|AEE27302.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1431), Expect = e-156, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 298/326 (91%), Gaps = 9/326 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297848354|ref|XP_002892058.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297337900|gb|EFH68317.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1430), Expect = e-155, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 298/326 (91%), Gaps = 9/326 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQTQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|14194119|gb|AAK56254.1|AF367265_1 At1g01540/F22L4_6 [Arabidopsis thaliana] gi|20334728|gb|AAM16225.1| At1g01540/F22L4_6 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 555 bits (1429), Expect = e-155, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 298/326 (91%), Gaps = 9/326 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130370|ref|XP_002320820.1| predicted protein [Populus trichocarpa] gi|222861593|gb|EEE99135.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 281/329 (85%), Positives = 293/329 (89%), Gaps = 17/329 (5%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YD AFVNTELSK TSIFGLRLWVVIGILLGSLIVLALFLLSLC+TSRRK +Q
Sbjct: 1 MSVYDGAFVNTELSKPTSIFGLRLWVVIGILLGSLIVLALFLLSLCVTSRRK-----NRQ 55
Query: 61 QQSKQILNTPPISKEIQEIVH--------HPAPVPEIQVDIGKIEHRVVFSDRASSGESR 112
+ + TPPISKEIQEIVH H VPEIQV IGK+EHRVVFS SGESR
Sbjct: 56 FKLTKTDTTPPISKEIQEIVHLPVQDHNHHAIQVPEIQVGIGKVEHRVVFS----SGESR 111
Query: 113 GTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL 172
GT S ETASFGSGSVGPEVSHLGWGRWYTLRELEAAT GLCEENVIGEGGYGIVYRG+L
Sbjct: 112 GTASGGETASFGSGSVGPEVSHLGWGRWYTLRELEAATGGLCEENVIGEGGYGIVYRGVL 171
Query: 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232
SDGTKVAVKNLLNNRGQAE+EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG
Sbjct: 172 SDGTKVAVKNLLNNRGQAEREFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 231
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
NLDQWLHGDVG+VSPLTWDIR NIILGTAKGLAYLH+GLEPKVVHRDVKSSNILLDRQWN
Sbjct: 232 NLDQWLHGDVGEVSPLTWDIRRNIILGTAKGLAYLHDGLEPKVVHRDVKSSNILLDRQWN 291
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++VSDFGLAKLL SERSYVTTRVMGTFGY
Sbjct: 292 SKVSDFGLAKLLHSERSYVTTRVMGTFGY 320
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|30678150|ref|NP_849573.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] gi|332189180|gb|AEE27301.1| putative serine/threonine-protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 553 bits (1425), Expect = e-155, Method: Compositional matrix adjust.
Identities = 281/326 (86%), Positives = 298/326 (91%), Gaps = 9/326 (2%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|8920590|gb|AAF81312.1|AC061957_8 Contains a strong similarity to an unknown protein from Arabidopsis thaliana gi|2505874 and contains an eukaryotic protein kinase PF|00069 domain. ESTs gb|Z26473, gb|AI996016, gb|Z17558, gb|N97089, gb|BE039500, gb|AA712856, gb|Z26772 come from this gene [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1392), Expect = e-151, Method: Compositional matrix adjust.
Identities = 281/351 (80%), Positives = 298/351 (84%), Gaps = 34/351 (9%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+YDAAF+NTELSK TSIFGLRLWVVIGILLGSLIV+ALFLLSLCLTSRRK N +
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 QQSKQILNTPPISKEIQEIVHHPA---PVP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNR-------------------------GQAEKEFKVEVEVIGRVRHKNLV 210
TKVAVKNLLNNR GQAEKEFKVEVEVIGRVRHKNLV
Sbjct: 177 TKVAVKNLLNNRWLRVIVIRVLLLFNCIAFGVSLIARGQAEKEFKVEVEVIGRVRHKNLV 236
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RLLGYCVEGAYRMLVY++VDNGNL+QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEG
Sbjct: 237 RLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEG 296
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LEPKVVHRD+KSSNILLDRQWNA+VSDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 LEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGY 347
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297814211|ref|XP_002874989.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297320826|gb|EFH51248.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 536 bits (1380), Expect = e-150, Method: Compositional matrix adjust.
Identities = 270/331 (81%), Positives = 288/331 (87%), Gaps = 11/331 (3%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+++ +N ELSK+TSIFGL+LWVVIGILLGSLIV+ALF LSLCLTSRR+
Sbjct: 3 MSIFNPDSINNELSKQTSIFGLKLWVVIGILLGSLIVIALFFLSLCLTSRRRNRKPRHAD 62
Query: 61 QQSKQILNTPPISKEIQEIVHHPA--------PVP-EIQVDIGKIEHRVVFSDRASSGES 111
S + TPPISKEIQEIV PA PV EIQVDIGKIEHRVVFSDR SSGES
Sbjct: 63 FASAAVA-TPPISKEIQEIVRSPAQDHYHPTQPVAAEIQVDIGKIEHRVVFSDRVSSGES 121
Query: 112 RGTGSACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
RGT SA ETAS+ GSG VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY G
Sbjct: 122 RGTVSASETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSG 181
Query: 171 ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230
IL+DGTKVAVKNLLNNRGQAEKEF+VEVE IGRVRHKNLVRLLGYCVEGAYRMLVY+YVD
Sbjct: 182 ILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYDYVD 241
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
NGNL+QW+HGDVGD SPLTWDIRMNIIL AKGLAYLHEGLEPKVVHRD+KSSNILLDRQ
Sbjct: 242 NGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQ 301
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
WNA+VSDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 302 WNAKVSDFGLAKLLFSESSYVTTRVMGTFGY 332
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|240255713|ref|NP_192042.5| protein kinase family protein [Arabidopsis thaliana] gi|332656610|gb|AEE82010.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1353), Expect = e-147, Method: Compositional matrix adjust.
Identities = 268/331 (80%), Positives = 285/331 (86%), Gaps = 13/331 (3%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+++ +N ELSK TSIFGL+LWVVIGILLGSLIV+ALF LSLCLTSRR+
Sbjct: 3 MSIFNPDSINNELSKPTSIFGLKLWVVIGILLGSLIVIALFFLSLCLTSRRRNRKPRHAD 62
Query: 61 QQSKQILNTPPISKEIQEIVHHPA--------PVP-EIQVDIGKIEHRVVFSDRASSGES 111
S + TPPISKEIQEIV PA PV EIQVDIGK EHRVVFSDR SSGES
Sbjct: 63 FASAAVA-TPPISKEIQEIVRPPAQDHCHPTQPVAAEIQVDIGKTEHRVVFSDRVSSGES 121
Query: 112 RGTGSACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
RGT S ETAS+ GSG VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY G
Sbjct: 122 RGTVS--ETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSG 179
Query: 171 ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230
IL+DGTKVAVKNLLNNRGQAEKEF+VEVE IGRVRHKNLVRLLGYCVEGAYRMLVY+YVD
Sbjct: 180 ILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYDYVD 239
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
NGNL+QW+HGDVGD SPLTWDIRMNIIL AKGLAYLHEGLEPKVVHRD+KSSNILLDRQ
Sbjct: 240 NGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQ 299
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
WNA+VSDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 300 WNAKVSDFGLAKLLFSESSYVTTRVMGTFGY 330
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334186273|ref|NP_001190651.1| protein kinase family protein [Arabidopsis thaliana] gi|332656611|gb|AEE82011.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1353), Expect = e-147, Method: Compositional matrix adjust.
Identities = 268/331 (80%), Positives = 285/331 (86%), Gaps = 13/331 (3%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRLWVVIGILLGSLIVLALFLLSLCLTSRRKKHNHLQQQ 60
MS+++ +N ELSK TSIFGL+LWVVIGILLGSLIV+ALF LSLCLTSRR+
Sbjct: 3 MSIFNPDSINNELSKPTSIFGLKLWVVIGILLGSLIVIALFFLSLCLTSRRRNRKPRHAD 62
Query: 61 QQSKQILNTPPISKEIQEIVHHPA--------PVP-EIQVDIGKIEHRVVFSDRASSGES 111
S + TPPISKEIQEIV PA PV EIQVDIGK EHRVVFSDR SSGES
Sbjct: 63 FASAAVA-TPPISKEIQEIVRPPAQDHCHPTQPVAAEIQVDIGKTEHRVVFSDRVSSGES 121
Query: 112 RGTGSACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRG 170
RGT S ETAS+ GSG VGPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVY G
Sbjct: 122 RGTVS--ETASYSGSGCVGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYSG 179
Query: 171 ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230
IL+DGTKVAVKNLLNNRGQAEKEF+VEVE IGRVRHKNLVRLLGYCVEGAYRMLVY+YVD
Sbjct: 180 ILTDGTKVAVKNLLNNRGQAEKEFRVEVEAIGRVRHKNLVRLLGYCVEGAYRMLVYDYVD 239
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
NGNL+QW+HGDVGD SPLTWDIRMNIIL AKGLAYLHEGLEPKVVHRD+KSSNILLDRQ
Sbjct: 240 NGNLEQWIHGDVGDKSPLTWDIRMNIILCMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQ 299
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
WNA+VSDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 300 WNAKVSDFGLAKLLFSESSYVTTRVMGTFGY 330
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 348 | ||||||
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.910 | 0.671 | 0.785 | 1.7e-128 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.902 | 0.638 | 0.607 | 7.4e-98 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.712 | 0.567 | 0.665 | 1.2e-83 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.614 | 0.433 | 0.671 | 5.9e-78 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.655 | 0.463 | 0.609 | 4.1e-77 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.614 | 0.417 | 0.653 | 1.2e-74 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.666 | 0.497 | 0.582 | 1.8e-74 | |
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.551 | 0.396 | 0.682 | 2e-72 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.551 | 0.411 | 0.671 | 6.7e-72 | |
| TAIR|locus:2019938 | 718 | PERK11 "proline-rich extensin- | 0.669 | 0.324 | 0.441 | 6.5e-51 |
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1261 (449.0 bits), Expect = 1.7e-128, P = 1.7e-128
Identities = 256/326 (78%), Positives = 271/326 (83%)
Query: 1 MSMYDAAFVNTELSKRTSIFGLRXXXXXXXXXXXXXXXXXXXXXXXXXXRRKKHNHLXXX 60
MS+YDAAF+NTELSK TSIFGLR RRK N
Sbjct: 1 MSVYDAAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRK--NRKPRA 58
Query: 61 XXSKQILNTPPISKEIQEIVHHPAP---VP-EIQVDIGKIEHRVVFSDRASSGESRGTGS 116
+ + TPPISKEI+EIV PA VP EIQVDIGKIEHRVVFSDR SSGESRGT S
Sbjct: 59 DFASAAIATPPISKEIKEIV--PAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTAS 116
Query: 117 ACETASF-GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDG 175
A ETAS+ GSG+ GPEVSHLGWGRWYTLRELEAAT+GLCEENVIGEGGYGIVYRGIL+DG
Sbjct: 117 ASETASYSGSGNCGPEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDG 176
Query: 176 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235
TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY++VDNGNL+
Sbjct: 177 TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLE 236
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
QW+HGDVGDVSPLTWDIRMNIILG AKGLAYLHEGLEPKVVHRD+KSSNILLDRQWNA+V
Sbjct: 237 QWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKV 296
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
SDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 297 SDFGLAKLLGSESSYVTTRVMGTFGY 322
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 972 (347.2 bits), Expect = 7.4e-98, P = 7.4e-98
Identities = 204/336 (60%), Positives = 236/336 (70%)
Query: 3 MYDAAFVNTELSKRTSIFGLRXXXXXXXXXXXXXXXXXXXXXXXXXXRRK-KHNHLXXXX 61
M D+ VN +LS+ TSIFGLR RR K+ L
Sbjct: 1 MADSHSVNNQLSRHTSIFGLRLWVVLGVCVGAAIVLLLVLISLWFIYRRSNKNKSLESSS 60
Query: 62 XSKQILNTPPISKEIQEIVH--HPAPVPE------------IQVDIGKIEHRVVFSDRAS 107
S + P +SKEIQEI P P PE I ++IGK +HR+ + +R
Sbjct: 61 KSNHTI-VPVVSKEIQEIRPPIQPDPTPEPHQNQQREDDNKIHIEIGK-DHRIAYPERGG 118
Query: 108 -SGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGI 166
+G G+GS + SG PEVSHLGWG WYTLRELE +T+G +ENVIG+GGYGI
Sbjct: 119 WTGSGSGSGSGDQGLLMLSG---PEVSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGI 175
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226
VYRG+L D + VA+KNLLNNRGQAEKEFKVEVE IGRVRHKNLVRLLGYCVEGA+RMLVY
Sbjct: 176 VYRGVLEDKSMVAIKNLLNNRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVY 235
Query: 227 EYVDNGNLDQWLHGD-VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
EYVDNGNL+QW+HG +G SPLTW+IRMNI+LGTAKGL YLHEGLEPKVVHRD+KSSNI
Sbjct: 236 EYVDNGNLEQWIHGGGLGFKSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNI 295
Query: 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LLD+QWN++VSDFGLAKLL SE SYVTTRVMGTFGY
Sbjct: 296 LLDKQWNSKVSDFGLAKLLGSEMSYVTTRVMGTFGY 331
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 838 (300.0 bits), Expect = 1.2e-83, P = 1.2e-83
Identities = 169/254 (66%), Positives = 194/254 (76%)
Query: 70 PPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG 129
P +SKEI EI GKI + VV A+S E+ AS SG VG
Sbjct: 66 PLVSKEISEI-KTVGKFINSDDSKGKIGNEVVVVVSATSKEATSGFDTLSVAS--SGDVG 122
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
+ +GWG+WY+L++LE AT G ++N+IGEGGYG+VYR SDG+ AVKNLLNN+GQ
Sbjct: 123 TSEA-MGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQ 181
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEYVDNGNLDQWLHGDVGDVSP 247
AEKEFKVEVE IG+VRHKNLV L+GYC + A RMLVYEY+DNGNL+QWLHGDVG VSP
Sbjct: 182 AEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSP 241
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
LTWDIRM I +GTAKGLAYLHEGLEPKVVHRDVKSSNILLD++WNA+VSDFGLAKLL SE
Sbjct: 242 LTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNILLDKKWNAKVSDFGLAKLLGSE 301
Query: 308 RSYVTTRVMGTFGY 321
SYVTTRVMGTFGY
Sbjct: 302 TSYVTTRVMGTFGY 315
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 5.9e-78, Sum P(2) = 5.9e-78
Identities = 147/219 (67%), Positives = 174/219 (79%)
Query: 108 SGESRGTGSACETASFG----SGSVG-PEVSHLGWGRWYTLRELEAATSGLCEENVIGEG 162
SGE G GSA G S VG PE+SHLGWG W+TLR+LE AT+ NV+GEG
Sbjct: 133 SGEEGGFGSAGRQYGGGPVTASPLVGLPEISHLGWGHWFTLRDLELATNRFAPVNVLGEG 192
Query: 163 GYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222
GYG+VYRG L +GT+VAVK LLNN GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG +R
Sbjct: 193 GYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEGVHR 252
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
MLVYEYV++GNL+QWLHG + LTW+ RM II GTA+ LAYLHE +EPKVVHRD+K+
Sbjct: 253 MLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYLHEAIEPKVVHRDIKA 312
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
SNIL+D ++NA++SDFGLAKLL S S++TTRVMGTFGY
Sbjct: 313 SNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 351
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 4.1e-77, Sum P(2) = 4.1e-77
Identities = 139/228 (60%), Positives = 173/228 (75%)
Query: 94 GKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGL 153
G H + + S E S+ + S G SHLGWG W+TLR+LE AT+
Sbjct: 120 GSFHHLEIIDKHSDSAEEVSASSSLYNIATPSPLSGLPESHLGWGHWFTLRDLETATNRF 179
Query: 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ENVIGEGGYG+VYRG L +GT VAVK +LN GQAEKEF+VEV+ IG VRHKNLVRLL
Sbjct: 180 SKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVRHKNLVRLL 239
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
GYC+EG +R+LVYEYV+NGNL+QWLHG + LTW+ RM +++GT+K LAYLHE +EP
Sbjct: 240 GYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALAYLHEAIEP 299
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KVVHRD+KSSNIL++ ++NA+VSDFGLAKLL + +S+VTTRVMGTFGY
Sbjct: 300 KVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGY 347
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 145/222 (65%), Positives = 173/222 (77%)
Query: 108 SGESRGTGSACETASFGSGS-------VG-PEVSHLGWGRWYTLRELEAATSGLCEENVI 159
SGE G+A S G VG PE+SHLGWG W+TLR+L+ AT+ ENVI
Sbjct: 137 SGEDGSFGAAWRQNSLSQGGLVTASPLVGLPEISHLGWGHWFTLRDLQLATNRFAAENVI 196
Query: 160 GEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219
GEGGYG+VY+G L +G VAVK LLNN GQAEKEF+VEVE IG VRHKNLVRLLGYC+EG
Sbjct: 197 GEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGYCIEG 256
Query: 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279
RMLVYEYV++GNL+QWLHG +G S LTW+ RM I++GTA+ LAYLHE +EPKVVHRD
Sbjct: 257 VNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTAQALAYLHEAIEPKVVHRD 316
Query: 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+K+SNIL+D +NA++SDFGLAKLL S S++TTRVMGTFGY
Sbjct: 317 IKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 358
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 721 (258.9 bits), Expect = 1.8e-74, Sum P(2) = 1.8e-74
Identities = 141/242 (58%), Positives = 182/242 (75%)
Query: 89 IQVDIGKIEHRVVFSDRASSGE-------SRGTGSACETASFGSGSVG--PEVSHLGWGR 139
+ +++ K + S R+ SG+ +R T S E A+ + PE SHLGWG
Sbjct: 85 LNLEMEKNRENGLSSSRSGSGKEGYLCVANRSTSSLYEMATPSPSPLSGLPE-SHLGWGH 143
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W+TLR+LE AT+ +ENVIGEGGYG+VYRG L +G+ VAVK +LN+ GQAEKEF+VEV+
Sbjct: 144 WFTLRDLEIATNRFSKENVIGEGGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVD 203
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
IG VRHKNLVRLLGYC+EG R+LVYEY++NGNL++WLHG + LTW+ RM ++ G
Sbjct: 204 AIGHVRHKNLVRLLGYCIEGTNRILVYEYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTG 263
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
T+K LAYLHE +EPKVVHRD+KSSNIL+D ++NA++SDFGLAKLL +S+VTTRVMGTF
Sbjct: 264 TSKALAYLHEAIEPKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTF 323
Query: 320 GY 321
GY
Sbjct: 324 GY 325
|
|
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
Identities = 131/192 (68%), Positives = 164/192 (85%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PE SHLGWG W+TLR+L+ AT+ +N+IG+GGYG+VYRG L +GT VAVK LLNN GQ
Sbjct: 143 PEFSHLGWGHWFTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQ 202
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
A+K+F+VEVE IG VRHKNLVRLLGYC+EG RMLVYEYV+NGNL+QWL GD + LT
Sbjct: 203 ADKDFRVEVEAIGHVRHKNLVRLLGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLT 262
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
W+ R+ I++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++N+++SDFGLAKLL +++S
Sbjct: 263 WEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKS 322
Query: 310 YVTTRVMGTFGY 321
++TTRVMGTFGY
Sbjct: 323 FITTRVMGTFGY 334
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 727 (261.0 bits), Expect = 6.7e-72, P = 6.7e-72
Identities = 129/192 (67%), Positives = 165/192 (85%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEVSH+GWG W+TLR+L+ AT+ +E++IG+GGYG+VY G L++ T VAVK LLNN GQ
Sbjct: 131 PEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQ 190
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
A+K+F+VEVE IG VRHKNLVRLLGYCVEG +RMLVYEY++NGNL+QWLHGD+ LT
Sbjct: 191 ADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLT 250
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
W+ R+ +++GTAK LAYLHE +EPKVVHRD+KSSNIL+D ++A++SDFGLAKLL ++ +
Sbjct: 251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310
Query: 310 YVTTRVMGTFGY 321
YV+TRVMGTFGY
Sbjct: 311 YVSTRVMGTFGY 322
|
|
| TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 6.5e-51, P = 6.5e-51
Identities = 106/240 (44%), Positives = 154/240 (64%)
Query: 86 VPEIQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVG---PEVSHLGWGR-WY 141
+P V + E + + + +G S S+ +T S G+ G P+ + +G + +
Sbjct: 300 LPPANVSVNT-EGFIHYRQKPGNGNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHF 358
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVI 201
T EL T G C+ V+GEGG+G VY+GIL +G VA+K L + + +EFK EVE+I
Sbjct: 359 TYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEII 418
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
RV H++LV L+GYC+ +R L+YE+V N LD LHG ++ L W R+ I +G A
Sbjct: 419 SRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAIGAA 476
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KGLAYLHE PK++HRD+KSSNILLD ++ A+V+DFGLA+L + +S+++TRVMGTFGY
Sbjct: 477 KGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGY 536
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q3EDL4 | Y1154_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8619 | 0.9109 | 0.6716 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 348 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-39 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-36 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-36 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-26 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-23 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-23 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-21 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-21 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-21 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-21 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-20 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-18 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-17 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-17 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-16 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-16 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 7e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-16 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-15 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-15 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-15 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-14 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-14 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-14 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-14 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-14 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-14 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-14 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-13 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-13 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 7e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-12 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 9e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-11 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 5e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-10 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-10 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-10 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-10 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-10 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 7e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 9e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 9e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-08 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-08 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-08 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 8e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-07 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-06 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-06 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-06 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 9e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 6e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-05 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-04 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-04 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-04 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 0.001 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.002 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 0.003 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 0.003 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 0.004 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.004 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.004 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.004 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 4e-39
Identities = 60/167 (35%), Positives = 92/167 (55%), Gaps = 10/167 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEGG+G VY G KVA+K + + +E E+E++ ++ H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ + LV EY + G+L L + G L+ D + I+L +GL YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEG---KLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 277 HRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
HRD+K NILLD +++DFGL+KLL S++S + T V GT Y
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYM 160
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 51/167 (30%), Positives = 82/167 (49%), Gaps = 15/167 (8%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRH 206
L +GEG +G VY+G L +VAVK L + Q +EF E ++ ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+LLG C E M+V EY+ G+L +L + L+ ++ L A+G+
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE----LSLSDLLSFALQIARGM 116
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
YL +HRD+ + N L+ ++SDFGL++ L + Y
Sbjct: 117 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYK 160
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-37
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRH 206
L +GEG +G VY+G L +VAVK L + Q +EF E ++ ++ H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+LLG C E +V EY++ G+L +L + L+ ++ L A+G+
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-----LSLSDLLSFALQIARGM 115
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
YL +HRD+ + N L+ ++SDFGL++ L + Y
Sbjct: 116 EYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 13/168 (7%)
Query: 157 NVIGEGGYGIVYRGILSDG----TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L T+VAVK L + + K+F E V+ ++ H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDVSPLTWDIRMNIILGTAKGLAY 266
LLG C E LV EY++ G+L +L + S L+ ++ + AKG+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
L K VHRD+ + N L+ ++SDFGL++ + + Y
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-36
Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 158 VIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L TKVAVK L + E+ EF E ++ ++ H N+VR
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LLG C +G +V EY+ G+L +L LT + + L AKG+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE---KLTLKDLLQMALQIAKGMEYLESK- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
VHRD+ + N L+ ++SDFGL++ + + Y
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 60/169 (35%), Positives = 87/169 (51%), Gaps = 13/169 (7%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLL 213
+G G +G VY+ G VAVK +L R + K+ + E+ ++ R+ H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVK-ILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + LV EY + G+L +L PL+ D I L +GL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLSRGG----PLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
++HRD+K NILLD +++DFGLAK L S +TT V GT Y
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYM 165
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 1e-32
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 11/167 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG +G VY G VA+K + + + E++++ +++H N+VRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ LV EY + G+L L G +S + R + L YLH
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSE--DEAR-FYLRQILSALEYLHS---KG 117
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+VHRD+K NILLD + +++DFGLA+ L TT V GT Y
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-TTFV-GTPEY 162
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 54/144 (37%), Positives = 78/144 (54%), Gaps = 7/144 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V G G KVAVK L ++ A+ F E V+ +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
G +V EY+ G+L +L V +T ++ L +G+ YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAV--ITLAQQLGFALDVCEGMEYLE---EKNFVHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAK 302
D+ + N+L+ A+VSDFGLAK
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 1e-23
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 7/165 (4%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG+G +G VY SDG +K + L+N + E+E + EV+++ ++ H N+++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E +V EY D G+L Q + + P + ++ + L YLH
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
K++HRD+K NI L ++ DFG++K+L S T V GT
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-23
Identities = 55/173 (31%), Positives = 84/173 (48%), Gaps = 17/173 (9%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
++G G +G VY + D G +AVK L + + + + E+ ++ ++H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 214 GYCVEGAYRML-VY-EYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHE 269
G + L ++ EYV G+L L G + IR IL +GLAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--IRKYTRQIL---EGLAYLHS 119
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+VHRD+K +NIL+D +++DFG AK L E T V GT +
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 5e-23
Identities = 59/176 (33%), Positives = 95/176 (53%), Gaps = 17/176 (9%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVE 199
E S + ++ VIG G +G V+RGIL + VA+K L G EK+ F E
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEAS 58
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++G+ H N++RL G + M++ EY++NG LD++L G+ S + ++ G
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRG 115
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTT 313
A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 116 IAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 98.3 bits (243), Expect = 5e-23
Identities = 58/175 (33%), Positives = 88/175 (50%), Gaps = 16/175 (9%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
+GEG +G VY D VA+K L L ++ + + F E++++ + H N+V+L
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + LV EYVD G+L+ L +G PL+ + I+ L YLH
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSK--- 120
Query: 274 KVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERS-----YVTTRVMGTFGYA 322
++HRD+K NILLDR ++ DFGLAKLL S + + +GT GY
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
|
Length = 384 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 15/166 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKN 208
E VIG G +G V RG L K VA+K L G ++K+ F E ++G+ H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RL G + M++ EY++NG+LD++L + G + + ++ G A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQL---VGMLRGIASGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
E VHRD+ + NIL++ +VSDFGL++ L + TT+
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK 166
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 1e-21
Identities = 48/152 (31%), Positives = 86/152 (56%), Gaps = 11/152 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ G+ + +VA+K L ++ +++F+ EV+ + R+RHK+L+ L
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C G ++ E ++ G+L +L G V V+ L +++ A+G+AYL E
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL-----IDMACQVAEGMAYLE---E 122
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + NIL+ +V+DFGLA+L+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARLI 154
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 52/169 (30%), Positives = 93/169 (55%), Gaps = 19/169 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
++IG G +G+VY+G+ L G VA+K +L + +A K E++++ ++H N+V+ +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGD--VSPLTWDIRMNIILGTAKGLAYLHE 269
G ++ EY +NG+L Q + G + V+ + + +L +GLAYLHE
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-----VYVYQVL---QGLAYLHE 117
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
V+HRD+K++NIL + +++DFG+A L + V+GT
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 2e-21
Identities = 44/165 (26%), Positives = 81/165 (49%), Gaps = 9/165 (5%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+GG+G VY+ G +VA+K + + +++ E++++ + +H N+V+ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ +V E+ G+L L LT + KGL YLH ++
Sbjct: 67 LKKDELWIVMEFCSGGSLKDLLKSTNQ---TLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
HRD+K++NILL ++ DFGL+ L ++ ++GT +
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTMVGTPYW 163
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 6e-21
Identities = 54/174 (31%), Positives = 84/174 (48%), Gaps = 23/174 (13%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IGEG G VY+ + G +VA+K + R Q ++ E+ ++ +H N+V
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVD 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW-DIRMN------IILGTAKGL 264
+ G +V EY+D G+L D+ +T +RMN + +GL
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLT--------DI--ITQNFVRMNEPQIAYVCREVLQGL 129
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
YLH V+HRD+KS NILL + + +++DFG A L E+S + V GT
Sbjct: 130 EYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-21
Identities = 51/156 (32%), Positives = 85/156 (54%), Gaps = 19/156 (12%)
Query: 158 VIGEGGYGIVYRGI---LSDGTK--VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+G+ + K VA+K L +A KE E V+ V H ++VR
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + L+ + + G L ++ ++G L W +++ AKG++YL
Sbjct: 74 LLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHRD+ + N+L+ + +++DFGLAKLL
Sbjct: 127 E---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-20
Identities = 60/173 (34%), Positives = 88/173 (50%), Gaps = 33/173 (19%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IGEG YG VY+ G VA+K + R + EKE F + E++++ ++RH N+VRL
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 213 LGYCVE---GAYRMLVYEYVD---NGNLDQWLHGDVGDVSPLTWD-IR--MNIILGTAKG 263
G+ M V+EY+D G LD +V T I+ M +L +G
Sbjct: 64 KEIVTSKGKGSIYM-VFEYMDHDLTGLLD---SPEV----KFTESQIKCYMKQLL---EG 112
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRV 315
L YLH ++HRD+K SNIL++ +++DFGLA+ S T RV
Sbjct: 113 LQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRV 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 56/182 (30%), Positives = 94/182 (51%), Gaps = 27/182 (14%)
Query: 157 NVIGEGGYGIVYRG---ILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
+GEG +G V L D T +VAVK+L ++ Q +F+ E+E++ + H+N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWL--HGDVGDVSPL---TWDIRMNIILGTAKG 263
+ G C + R L+ EY+ +G+L +L H D ++ L + I KG
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI--------CKG 121
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFG 320
+ YL + +HRD+ + NIL++ + ++SDFGLAK+L ++ Y + G F
Sbjct: 122 MDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 321 YA 322
YA
Sbjct: 179 YA 180
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 6e-20
Identities = 50/165 (30%), Positives = 87/165 (52%), Gaps = 9/165 (5%)
Query: 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
N IG+G +G+V++ + +D A+K + L+ + E+E + E V+ ++ ++R
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++ +V EY +NG+L + L G PL D + GLA+LH
Sbjct: 66 ESFLDKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLHSK--- 120
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
K++HRD+KS N+ LD N ++ D G+AKLL ++ T ++GT
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 7e-20
Identities = 56/178 (31%), Positives = 90/178 (50%), Gaps = 25/178 (14%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G VY+G L T VA+K L N + ++EF+ E E++ ++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV-------SPLTWDIRMNIILG 259
LLG C + +++EY+ +G+L ++L H DVG S L ++I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
A G+ YL VHRD+ + N L+ ++SDFGL++ + S Y RV
Sbjct: 133 IAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY---RVQS 184
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 46/146 (31%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E +V+ ++ H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+ LV+E++++G L +L G S T + + L +G+AYL V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETL---LGMCLDVCEGMAYLESS---NVIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D+ + N L+ +VSDFG+ + +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFV 150
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 7e-19
Identities = 50/166 (30%), Positives = 77/166 (46%), Gaps = 17/166 (10%)
Query: 159 IGEGGYGIVYRGI--LSDGT--KVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V +G+ + G +VAVK L A +KEF E V+ ++ H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C MLV E G L ++L ++ A G+AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
VHRD+ + N+LL + A++SDFG+++ L + Y G
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 49/147 (33%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G V+ G + TKVAVK L G E F E +++ ++RH LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
E +V EY+ G+L +L G L + M + A+G+AYL +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AEGMAYLES---RNYIH 126
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLL 304
RD+ + NIL+ +++DFGLA+L+
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-18
Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 10/150 (6%)
Query: 158 VIGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG- 214
V+G+G G+VY+ G A+K + ++ + K+ E++ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG +V EY+D G+L L VG + + I KGL YLH
Sbjct: 68 FYKEGEIS-IVLEYMDGGSLAD-LLKKVGKIPE---PVLAYIARQILKGLDYLHTKR--H 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
++HRD+K SN+L++ + +++DFG++K+L
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVL 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-18
Identities = 54/161 (33%), Positives = 84/161 (52%), Gaps = 15/161 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKN 208
E VIG G +G V RG L K VA+K L G EK +F E ++G+ H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G + M++ E+++NG LD +L + G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
E VHRD+ + NIL++ +VSDFGL++ L + S
Sbjct: 124 ---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-18
Identities = 53/168 (31%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
N IG G +G VY + L G +AVK + +N + KE E++V+ ++H NLV+
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G V + EY G L++ L G + + L +GLAYLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQL--LEGLAYLHSH--- 118
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+VHRD+K +NI LD ++ DFG A L + T MG
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN-----NTTTMGEEVQ 161
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 50/165 (30%), Positives = 78/165 (47%), Gaps = 15/165 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAE-KEFKV-EVEVIGRVRHKNLVRLLG 214
V+GEG YG+V + G VA+K + + K+ + EV+V+ ++RH+N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+EYV+ L + L G + P +R I + +AY H
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDA--VRS-YIWQLLQAIAYCHSH---N 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSER----SYVTTR 314
++HRD+K NIL+ ++ DFG A+ L YV TR
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 9e-18
Identities = 49/155 (31%), Positives = 82/155 (52%), Gaps = 13/155 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLL---NNRGQAEKEFKV---EVEVIGRVRHKNLV 210
V+G+G YG VY G+ + G +AVK + +N AEKE++ EV+++ ++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ LG C++ + E+V G++ L+ P+ I+ G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL----DGVAYLHNN 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
VVHRD+K +N++L ++ DFG A+ L
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (200), Expect = 2e-17
Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 16/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ G VA+K + + E+ E+ ++ ++H N+V+LL
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKLL 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+EY D +L ++L G +SP I+ +I+ +GLAY H
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--IK-SIMYQLLRGLAYCHSH--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVM 316
+++HRD+K NIL++R +++DFGLA+ R+Y T V+
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV 160
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-17
Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRL 212
+G G +G VY G+ L DG AVK +L ++ + K+ + E+ ++ +++H N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
LG E + E V G+L + L + GL YLH+
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+K +NIL+D +++DFG+AK
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 6e-17
Identities = 59/171 (34%), Positives = 80/171 (46%), Gaps = 34/171 (19%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGY 215
VIGEG YG VY+ G VA+K +++ E+E K E ++ + H N+ Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATF--Y 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV--------SPLTWDIRMNIILGT 260
GA+ + GN DQ WL G V D+ L + I+ T
Sbjct: 70 ---GAF----IKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS--DFGLAKLLCSERS 309
+GLAYLHE KV+HRD+K NILL + NA V DFG++ L S
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTK--NAEVKLVDFGVSAQLDSTLG 168
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 50/169 (29%), Positives = 82/169 (48%), Gaps = 28/169 (16%)
Query: 159 IGEGGYGIVYR----GILS--DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
IG+G +G V++ G+L T VAVK L + +F+ E ++ H N+V+
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDV------GDVSPLTWDIR 253
LLG C G L++EY+ G+L+++L H + PL+ +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ I A G+AYL E K VHRD+ + N L+ +++DFGL++
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 158 VIGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
+GEG +G V+ G D VAVK L A K+F+ E E++ +H+N+V
Sbjct: 12 ELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG--------DVGDVSPLTWDIRMNIILGT 260
+ G C EG ++V+EY+++G+L+++L HG + LT + I +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A G+ YL VHRD+ + N L+ ++ DFG+++
Sbjct: 132 ASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 9e-17
Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 16/159 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G+ T+VA+K + N E+ EF E V+ ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHG------DVGDVSPLTWDIRMNIILGTAKGLA 265
LLG G ++V E + G+L +L + + P T + + A G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
YL K VHRD+ + N ++ ++ DFG+ + +
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-16
Identities = 57/147 (38%), Positives = 83/147 (56%), Gaps = 13/147 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+IGEG +G V +G + G KVAVKN+ + QA F E V+ ++ HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 217 V-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G Y +V E + GNL +L + + ++ + L A+G+ YL K+
Sbjct: 69 LHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYLES---KKL 121
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + NIL+ A+VSDFGLA+
Sbjct: 122 VHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-16
Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 157 NVIGEGGYGIVY----RGILSDGTK--VAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNL 209
+G G +G VY RG D + VAVK L + Q E +F +E ++ + H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAY 266
VRL+G E R ++ E + G+L +L + S LT + AKG Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAK 302
L E +HRD+ + N LL + RV +DFG+A+
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-16
Identities = 47/149 (31%), Positives = 72/149 (48%), Gaps = 7/149 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G YG VY+ ++ G VA+K + G + + E+ ++ RH N+V G
Sbjct: 9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ +V EY G+L G PL+ + T KGLAYLHE
Sbjct: 69 YLRRDKLWIVMEYCGGGSLQDIYQVTRG---PLSELQIAYVCRETLKGLAYLHE---TGK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+K +NILL + +++DFG++ L
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 3e-16
Identities = 48/146 (32%), Positives = 76/146 (52%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
IG+G +G VY+G+L T+VAVK + K F E E++ + H N+V+L+G CV
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
+ +V E V G+L +L LT + + L A G+ Y LE K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNR---LTVKKLLQMSLDAAAGMEY----LESKNCI 115
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+ + N L+ ++SDFG+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 53/198 (26%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG-Y 215
+GEG YG VY+ I G VA+K + + +E E+ ++ + +V+ G Y
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVE--EDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHE 269
+V EY G+ V D+ +T + + I+ T KGL YLH
Sbjct: 68 FKNTDL-WIVMEYCGAGS--------VSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHS 117
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
K +HRD+K+ NILL+ + A+++DFG++ L + T V+GT
Sbjct: 118 N---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGT----------- 162
Query: 330 PLFILLYILLSVRYNSST 347
P ++ ++ + YN+
Sbjct: 163 PFWMAPEVIQEIGYNNKA 180
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 5e-16
Identities = 52/169 (30%), Positives = 84/169 (49%), Gaps = 8/169 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG+G +G V + SDG + K + N + EK+ V EV ++ ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 214 GYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++ + + L V EY + G+L Q + + + + I+ L H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 272 EPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+P V+HRD+K +NI LD N ++ DFGLAK+L + S+ T V GT
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G+ ++ T VAVK L + +F E +++ ++RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E + G+L ++L G G L I M + A G+AYL +HR
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV--ASGMAYLE---AQNYIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D+ + N+L+ +V+DFGLA+++
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 5e-16
Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG +GIV++ G VA+K + R G + E++ + +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYLHEGLEPK 274
G+ +LV EY+ + L + D PL + + KG+AY+H
Sbjct: 68 FPHGSGFVLVMEYMPSD-----LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSY---VTTR 314
++HRD+K +N+L+ +++DFGLA+L E R Y V TR
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 7e-16
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 22/160 (13%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRV-RHKNLVRL 212
+IGEG + V + A+K L + + K K+E EV+ R+ H +++L
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67
Query: 213 LGYCV----EGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKGLAYL 267
Y E Y V EY NG L Q++ G + T I+L L YL
Sbjct: 68 --YYTFQDEENLY--FVLEYAPNGELLQYIR-KYGSLDEKCTRFYAAEILLA----LEYL 118
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
H ++HRD+K NILLD+ + +++DFG AK+L
Sbjct: 119 HS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 8e-16
Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKN 208
E VIG G +G V G L K VA+K L G EK+ F E ++G+ H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G + M+V EY++NG+LD +L G + + + ++ G A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQL---VGMLRGIASGMKYLS 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTT 313
+ VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 124 ---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 9e-16
Identities = 53/156 (33%), Positives = 88/156 (56%), Gaps = 19/156 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKV----AVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+GI + +G V A+K L G +A EF E ++ + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + LV + + +G L ++H ++G L W +++ AKG+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHRD+ + N+L+ + +++DFGLA+LL
Sbjct: 127 E---RRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 43/165 (26%), Positives = 78/165 (47%), Gaps = 18/165 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVRLL 213
IGEG YG+VY+ G VA+K + + E++++ + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIK--LRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E++D +L + + L + + + +GLA+ H
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----YVTTR 314
++HRD+K N+L++ + +++DFGLA+ S YV TR
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR 162
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-15
Identities = 50/164 (30%), Positives = 82/164 (50%), Gaps = 15/164 (9%)
Query: 151 SGLCEENVIGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQ-AEKEFKVEVEVIGR 203
S L E +G G +G V+ +GI +G + V VK L + + + EF+ E+++ +
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-----PLTWDIRMNIIL 258
+ HKN+VRLLG C E ++ EY D G+L Q+L PL+ ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A G+ +L + VHRD+ + N L+ Q +VS L+K
Sbjct: 125 QIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-15
Identities = 46/149 (30%), Positives = 76/149 (51%), Gaps = 6/149 (4%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
+G+G YG VY+ LSD A+K + L + Q E+E V E+ ++ V H N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G +V EY G+L + + + I + +GL LHE K+
Sbjct: 68 FLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KI 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+KS+NILL ++ D G++K+L
Sbjct: 125 LHRDLKSANILLVANDLVKIGDLGISKVL 153
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 2e-15
Identities = 52/165 (31%), Positives = 81/165 (49%), Gaps = 12/165 (7%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
E E E V+G+G YGIVY LS ++A+K + + + E+ +
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK- 262
++H+N+V+ LG E + + E V G+L L G PL D II T +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIIFYTKQI 117
Query: 263 --GLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
GL YLH+ ++VHRD+K N+L++ ++SDFG +K L
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 4e-15
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 28/170 (16%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRV-RHKN 208
+G+G +G VY G VA+K + +K+F EV+ + ++ H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V+L E V+EY++ GNL Q + G P + + +II +GLA++H
Sbjct: 60 IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIH 116
Query: 269 E-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER---SYVTTR 314
+ G HRD+K N+L+ +++DFGLA+ + S YV+TR
Sbjct: 117 KHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR 162
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-15
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 15/148 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V+ G VA+K ++ +E +F E +V+ ++ H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA----KGLAYLHEGLEPK 274
+V EY+ NG L +L G + +L + + YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKG-------KLGTEWLLDMCSDVCEAMEYLESN---G 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+ + N L+ +VSDFGLA+
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 16/163 (9%)
Query: 159 IGEGGYGIVYRG----ILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G+V RG VAVK L +++ +F E ++ + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT--WDIRMNIILGTAKGLAYLHEGL 271
G V M+V E G+L L D ++ D + I A G+ YL
Sbjct: 63 G-VVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLES-- 115
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERSYVTT 313
+ +HRD+ + NILL ++ DFGL + L +E YV
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 54/168 (32%), Positives = 84/168 (50%), Gaps = 21/168 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L N ++ + E E E++ ++ + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C E MLV E G L+++L G V +V L + M G+ YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSM--------GMKYLEG 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
VHRD+ + N+LL Q A++SDFGL+K L ++ SY R G
Sbjct: 114 ---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-15
Identities = 54/150 (36%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGV 67
Query: 216 CVE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
VE G Y +V EY+ G+L +L V L D + L + + YL
Sbjct: 68 IVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEAN-- 121
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 17/151 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV------EVEVIGRVRHKNLVR 211
IGEG YG+VY+ G VA+K + R + E E V E+ ++ + H N+VR
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI---RLETEDE-GVPSTAIREISLLKELNHPNIVR 62
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LL LV+E++D LD + D ++ L + + + +G+AY H
Sbjct: 63 LLDVVHSENKLYLVFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH- 118
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+V+HRD+K N+L+DR+ +++DFGLA+
Sbjct: 119 --RVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 1e-14
Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 29/176 (16%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G YG+V + G KVA+K + N + A++ + E++++ +RH+N++ L
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHENIIGL 64
Query: 213 L-------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
L Y +V E ++ +L + + PLT D + +GL
Sbjct: 65 LDILRPPSPEDFNDVY--IVTELMET-DLHKVIKSP----QPLTDDHIQYFLYQILRGLK 117
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
YLH V+HRD+K SNIL++ + ++ DFGLA+ + + YV TR
Sbjct: 118 YLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 1e-14
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F E E++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---------SPLTWDIRMNIILGTAKG 263
G CVEG ++V+EY+ +G+L+++L D + LT ++I A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ YL VHRD+ + N L+ ++ DFG+++ + S Y
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L + +EF E V+ ++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L + + + + + + + YL +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---N 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLM 154
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-14
Identities = 43/159 (27%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLL---NNRGQAEK---EFKVEVEVIGRVRHKNL 209
+G G + Y R + + GT +AVK + N + E+ + E+ ++ R+ H ++
Sbjct: 7 QLGTGAFSSCYQARDVKT-GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+R+LG E ++ L E++ G++ L + +N +GL+YLHE
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 270 GLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSE 307
+++HRDVK +N+L+D R++DFG A L ++
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 13/153 (8%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRL 212
+G G G+V + G +AVK + E K E++++ + +V
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVGF 64
Query: 213 LGYC-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G G + + EY+D G+LD+ L +V P I I + KGL YLHE
Sbjct: 65 YGAFYNNGDISICM-EYMDGGSLDKILK-EVQGRIPE--RILGKIAVAVLKGLTYLHEKH 120
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
K++HRDVK SNIL++ + ++ DFG++ L
Sbjct: 121 --KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 52/176 (29%), Positives = 87/176 (49%), Gaps = 21/176 (11%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDV---------SPLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG + LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVM 316
G+ YL L VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 133 SGMVYL-ASLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-14
Identities = 49/181 (27%), Positives = 84/181 (46%), Gaps = 30/181 (16%)
Query: 158 VIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLV 210
+GEG +G V + + T VAVK L N +E ++ E ++ +V H +++
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPLTW 250
+L G C + +L+ EY G+L +L + D D LT
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
++ ++G+ YL E K+VHRD+ + N+L+ ++SDFGL++ + E SY
Sbjct: 127 GDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 311 V 311
V
Sbjct: 184 V 184
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-14
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER---MNYVHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 4e-14
Identities = 49/168 (29%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVR---HK 207
E IGEG YG VY+ L+ G VA+K + L+ G + E+ ++ ++ H
Sbjct: 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHP 61
Query: 208 NLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPL---TWDIRMNIILG 259
N+VRLL C LV+E+VD Q L + I+ +++
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVD-----QDLATYLSKCPKPGLPPETIK-DLMRQ 115
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+G+ +LH ++VHRD+K NIL+ +++DFGLA++ E
Sbjct: 116 LLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-14
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 42/167 (25%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
+GEG +G VY+ + G VA+K +L EK+ F + E++++ +++H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP----------------LTW-DIRMN 255
+ + E D + G V V+P LT I+
Sbjct: 73 ID---------MAVERPDK---SKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIK-C 119
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+L +G+ YLHE ++HRD+K++NIL+D Q +++DFGLA+
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 21/168 (12%)
Query: 159 IGEGGYGIVYRGILS--DGTK-VAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V +G+ K VAVK L N N + E E V+ ++ + +VR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E MLV E + G L+++L H +++ L + M G+ YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSM--------GMKYLEE 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G
Sbjct: 114 T---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG 158
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 49/156 (31%), Positives = 81/156 (51%), Gaps = 19/156 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
++G G +G V++GI + +G VA+K + + G Q +E + +G + H +VR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLH 268
LLG C GA LV + G+L + + P L W +++ AKG+ YL
Sbjct: 74 LLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHR++ + NILL +++DFG+A LL
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 50/165 (30%), Positives = 82/165 (49%), Gaps = 17/165 (10%)
Query: 146 LEAATSGLCEENVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
+ S L EENVI G G Y+G + +G + VK + + E +G++
Sbjct: 685 INDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKL 740
Query: 205 RHKNLVRLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
+H N+V+L+G C +GAY L++EY++ NL + L L+W+ R I +G AK
Sbjct: 741 QHPNIVKLIGLCRSEKGAY--LIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAK 791
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
L +LH P VV ++ I++D + + L LLC++
Sbjct: 792 ALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD 835
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 6e-14
Identities = 48/150 (32%), Positives = 85/150 (56%), Gaps = 15/150 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G V+ G + TKVA+K+L +G E F E ++ +++H LVRL Y V
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 218 ---EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E Y ++ EY++NG+L +L G LT + +++ A+G+A++
Sbjct: 70 VTQEPIY--IITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIER---KN 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD++++NIL+ +++DFGLA+L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 9e-14
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 17/157 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---------FKVEVEVIGRVRHK 207
+IG G +G VY G+ S G +AVK + A + E+ ++ ++H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+ LG ++ + + EYV G++ L+ L +R N + KGL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL---VR-NFVRQILKGLNYL 122
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
H ++HRD+K +NIL+D + ++SDFG++K L
Sbjct: 123 HN---RGIIHRDIKGANILVDNKGGIKISDFGISKKL 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 9e-14
Identities = 53/172 (30%), Positives = 83/172 (48%), Gaps = 23/172 (13%)
Query: 157 NVIGEGGYGIVYRG----ILSDGT---KVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH 206
N +G G +G VY G IL G+ +VAVK L +G Q +KEF E ++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKG 263
N+V+LLG C+ + ++ E ++ G+L +L + LT ++I L AKG
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSY 310
YL + +HRD+ + N L+ D ++ DFGLA+ + Y
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY 167
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 28/170 (16%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV------EVEVIGRVRHKNLVR 211
IGEG YG+V++ + G VA+K + ++E + + E+ ++ +++H NLV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFV----ESEDDPVIKKIALREIRMLKQLKHPNLVN 64
Query: 212 LLGYCVEGAYRMLVYEYVDN---GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+ LV+EY D+ L++ G + + II T + + + H
Sbjct: 65 LIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-------VPEHLIKKIIWQTLQAVNFCH 117
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----YVTTR 314
+ +HRDVK NIL+ +Q ++ DFG A++L YV TR
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 41/149 (27%), Positives = 78/149 (52%), Gaps = 15/149 (10%)
Query: 178 VAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + A +F E++++ R+++ N++RLLG CV ++ EY++NG+L+Q
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 237 WLH--------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L ++ ++ + + + A G+ YL VHRD+ + N L+
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVG 163
Query: 289 RQWNARVSDFGLAKLLCSERSYVTTRVMG 317
+ +++DFG+++ L S Y R+ G
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYY---RIQG 189
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 158 VIGEGGYGIVYRGILS--DGT--KVAVKNL-LNNRGQAE-KEFKVEVEVIGRVRHKNLVR 211
++GEG +G V G LS DG+ KVAVK + L+ +E +EF E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 212 LLGYCVEGAYR------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM--NIILGTAKG 263
L+G C E + M++ ++ +G+L +L P ++ ++ A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+ YL +HRD+ + N +L V+DFGL+K + S Y R+
Sbjct: 126 MEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 1e-13
Identities = 58/188 (30%), Positives = 86/188 (45%), Gaps = 58/188 (30%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVR 211
+G+G YGIV++ I D VA+K + + N A++ F+ E+ + + H N+V+
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 212 LLGYCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI----------- 256
LL V A LV+EY++ D+ V IR NI
Sbjct: 72 LLN--VIKAENDKDIYLVFEYMET---------DLHAV------IRANILEDVHKRYIMY 114
Query: 257 -ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------ 309
+L K L Y+H G V+HRD+K SNILL+ +++DFGLA+ L
Sbjct: 115 QLL---KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPV 168
Query: 310 ---YVTTR 314
YV TR
Sbjct: 169 LTDYVATR 176
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 50/159 (31%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
N IGEG YGIVYR + G VA+K + R E++ + E+ ++ +RH N+V
Sbjct: 13 NRIGEGTYGIVYRARDTTSGEIVALKKV---RMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKG 263
L V LV EY + D+ + +P + ++L +G
Sbjct: 70 ELKEVVVGKHLDSIFLVMEYCEQ---------DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLHE ++HRD+K SN+LL + +++DFGLA+
Sbjct: 121 LQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 42/152 (27%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-GYC 216
+G+G +G VY+ G A K + + ++F VE++++ +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E +L+ E+ D G LD + + LT + + L +LH KV+
Sbjct: 73 YENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
HRD+K+ NILL + +++DFG++ S
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 54/163 (33%), Positives = 89/163 (54%), Gaps = 20/163 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+G+ + +G K VA+K L +A KE E V+ V + ++ R
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 74 LLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSY 310
E ++VHRD+ + N+L+ + +++DFGLAKLL E+ Y
Sbjct: 127 E---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY 166
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 38/130 (29%), Positives = 67/130 (51%), Gaps = 11/130 (8%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + A ++F EV+++ R+ N+ RLLG C ++ EY++NG+L+Q
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 237 WLH-------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+L G + L++ + + A G+ YL VHRD+ + N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGK 165
Query: 290 QWNARVSDFG 299
+ +++DFG
Sbjct: 166 NYTIKIADFG 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 19/166 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRVRHKNL 209
+GEG Y +VY+ G VA+K + KE K E++++ ++H N+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGE---RKEAKDGINFTALREIKLLQELKHPNI 64
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LL + LV+E+++ +L++ + ++P DI+ + +L T +GL YLH
Sbjct: 65 IGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPA--DIK-SYMLMTLRGLEYLHS 120
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
++HRD+K +N+L+ +++DFGLA+ S +T +V
Sbjct: 121 NW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQV 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 55/179 (30%), Positives = 89/179 (49%), Gaps = 24/179 (13%)
Query: 156 ENVIGEGGYGIVYRGILS-DGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
E+VIGEG +G V R ++ DG K+ A+K L + + ++F E+EV+ ++ H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIIL 258
LLG C Y + EY GNL +L + G S LT +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
A G+ YL E + +HRD+ + N+L+ ++++DFGL++ E YV + MG
Sbjct: 127 DVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV-KKTMG 178
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 3e-13
Identities = 49/178 (27%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V+ G KVA+K + N +E++F E +V+ ++ H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E+++NG L +L G +S D+ +++ +G+ YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSK---DMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLY 336
D+ + N L+ +VSDFG+ + + + Y + + G A F V+ SP + +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS-----SSG-AKFPVKWSPPEVFNF 175
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 56/176 (31%), Positives = 85/176 (48%), Gaps = 19/176 (10%)
Query: 158 VIGEGGYG--IVYR-GILSDGTK--VAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVR 211
V+GEG +G +Y +DGT VAVK L GQ +K E+ ++ + H+N+V+
Sbjct: 11 VLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 212 LLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E + L+ EYV G+L +L +++ L + +G+AYLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHS 125
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
+HRD+ + N+LLD ++ DFGLAK + Y R G F YA
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 3e-13
Identities = 41/148 (27%), Positives = 79/148 (53%), Gaps = 14/148 (9%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + + A +F E++++ R++ N++RLL C+ ++ EY++NG+L+Q
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 237 WL-------HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
+L + DV +++ + + A G+ YL VHRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGK 165
Query: 290 QWNARVSDFGLAKLLCSERSYVTTRVMG 317
+ +++DFG+++ L S Y R+ G
Sbjct: 166 NYTIKIADFGMSRNLYSGDYY---RIQG 190
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-13
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 22/158 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE----------FKVEVEVIGRVRH 206
+IG+G YG VY + ++ G +AVK + A + + E+E + + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
N+V+ LG+ Y + EYV G++ L +G + +GL
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG------RFEEQLVRFFTEQVLEGL 121
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AYLH ++HRD+K+ N+L+D ++SDFG++K
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISK 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 48/167 (28%), Positives = 75/167 (44%), Gaps = 35/167 (20%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRH-KNL 209
L + IG G +G V + + GT +AVK + + +K ++++V+ R +
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 210 VRLLG---------YCVE------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
V+ G C+E + VYE V + + +I
Sbjct: 66 VKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPE--------------EILG 110
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
I + T K L YL E L K++HRDVK SNILLDR N ++ DFG++
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 48/164 (29%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-13
Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 19/156 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTK----VAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVR 211
V+G G +G VY+GI + DG VA+K L N +A KE E V+ V + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ + LV + + G L ++ +G L W +++ AKG++YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHRD+ + N+L+ + +++DFGLA+LL
Sbjct: 127 E---VRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG V++ VA+K + L++ + + E+ ++ ++HKN+VRL
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY D +L ++ GD+ P M +L KGLA+ H V
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLL---KGLAFCHS---HNV 120
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L+++ +++DFGLA+
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 7e-13
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR--MLVYEYVD 230
+ G VAVK L ++ + ++F+ E+E++ ++H N+V+ G C R LV EY+
Sbjct: 31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLP 90
Query: 231 NGNLDQWL--HGDVGDVSPL---TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
G+L +L H + D L I KG+ YL + VHRD+ + NI
Sbjct: 91 YGSLRDYLQKHRERLDHRKLLLYASQI--------CKGMEYLGS---KRYVHRDLATRNI 139
Query: 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
L++ + ++ DFGL K+L ++ Y R G F YA
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 54/154 (35%), Positives = 87/154 (56%), Gaps = 16/154 (10%)
Query: 157 NVIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
VIG+G +G VY G L SDG K+ AVK+L + + + E+ F E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 211 RLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 60 SLLGICLPSEGS-PLVVLPYMKHGDLRNFIRSETHN--PTVKDL-IGFGLQVAKGMEYL- 114
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD + +V+DFGLA+
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 7e-13
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 14/164 (8%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNLVRLLG 214
++GEG YG+V + + G VA+K L + K E+ ++ ++RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+VD+ LD G I+ +G+ + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQIL----RGIEFCHSH---N 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE----RSYVTTR 314
++HRD+K NIL+ + ++ DFG A+ L + YV TR
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-13
Identities = 47/158 (29%), Positives = 80/158 (50%), Gaps = 31/158 (19%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV------------EVEVIGRVRH 206
+GEG Y VY+G +N A KE + E+ ++ ++H
Sbjct: 8 LGEGTYATVYKG----------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH 57
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGL 264
+N+VRL MLV+EY+D +L +++ HG G + P T +L KG+
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGI 113
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+ HE +V+HRD+K N+L++++ +++DFGLA+
Sbjct: 114 AFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 24/185 (12%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLN-NRGQAEKEFKVEV 198
EL + EE +GE +G +Y+G L VA+K L + N Q EF+ E
Sbjct: 1 ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDVSPLTWDIR 253
++ + H N+V LLG + +++EY++ G+L ++L H DVG S ++
Sbjct: 59 SLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVK 118
Query: 254 --------MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
++I + A G+ YL VH+D+ + NIL+ Q + ++SD GL++ +
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIY 175
Query: 306 SERSY 310
S Y
Sbjct: 176 SADYY 180
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVS--PLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKEFK---VEVEVIGRV-RHKN 208
+GEG +G V + + VAVK L ++ EK+ E+E++ + +HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKN 77
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD---------VGDVSP---LTWDIRMNI 256
++ LLG C + +V EY +GNL +L P LT ++
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ +L K +HRD+ + N+L+ +++DFGLA+
Sbjct: 138 AYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 53/178 (29%), Positives = 90/178 (50%), Gaps = 14/178 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ ++ H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ NG L +L P + + +G+AYL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL---LEMCKDVCEGMAYLES---KQFIHR 124
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLY 336
D+ + N L+D Q +VSDFGL++ + + Y ++ +G+ F V+ SP +LLY
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSS--VGS----KFPVRWSPPEVLLY 175
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 21/170 (12%)
Query: 159 IGEGGYGIVYRG------ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGD----VGDVSP------LTWDIRMNIILGT 260
G C +G ++V+EY+ +G+L+++L HG + D P L ++I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
A G+ YL VHRD+ + N L+ ++ DFG+++ + S Y
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 40/150 (26%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVR 211
IG+G +G VY+ I VA+K + + +AE E + E++ + + R + +
Sbjct: 6 LECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPYITK 63
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G ++G+ ++ EY G+ D+ L I+ GL YLHE
Sbjct: 64 YYGSFLKGSKLWIIMEYCGGGSC-----LDLLKPGKLDETYIAFILREVLLGLEYLHEE- 117
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+HRD+K++NILL + + +++DFG++
Sbjct: 118 --GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
++G+G +G V++G L D T VAVK + Q K +F E ++ + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + L + L A G+AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+ + N L+ ++SDFG+++
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + F E ++ ++H LVRL +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ EY+ G+L +L D G + P D I A+G+AY+ +
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIER---KNYI 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD++++N+L+ +++DFGLA+++
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI 153
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH 206
E L +G G +G V+ G + TKVAVK L E F E +++ ++RH
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRH 60
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
LV+L E +V EY+ G+L +L G+ L +++ A G+AY
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAY 117
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ +HRD++S+NIL+ +++DFGLA+L+
Sbjct: 118 IER---MNYIHRDLRSANILVGDGLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + ++ VA+K + + Q+ ++++ EV + ++RH N +
Sbjct: 23 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV--SPLTWDIRMNIILGTAKGLAYLHEGL 271
G + LV EY D+ +V PL I G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYCLGSA------SDILEVHKKPLQEVEIAAICHGALQGLAYLHS-- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ +HRD+K+ NILL +++DFG A L+ S+V T
Sbjct: 134 -HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 4e-12
Identities = 42/150 (28%), Positives = 74/150 (49%), Gaps = 13/150 (8%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLG 214
N IG G G VY+ I G A+K + N ++ E+E++ V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++ E++D G+L+ D ++ + I G+AYLH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQI--------LSGIAYLHR---RH 188
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+VHRD+K SN+L++ N +++DFG++++L
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 60/179 (33%), Positives = 92/179 (51%), Gaps = 31/179 (17%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG VY+ D G VA+K + R EKE F + E++++ ++ H+N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 211 RLLGYCVE-----------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
L + GA+ LV+EY+D+ +L L + S M +L
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAF-YLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLL- 126
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTTRVM 316
+GL Y H+ +HRD+K SNILL+ + +++DFGLA+L SE R Y T +V+
Sbjct: 127 --EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPY-TNKVI 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 44/165 (26%), Positives = 86/165 (52%), Gaps = 16/165 (9%)
Query: 159 IGEGGYGIVY------RGILSDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+GEG +G V G + G +VAVK+L + G + K E+E++ + H+N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 212 LLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C E L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQ---QLKYAVQICKGMDYLGS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
+ VHRD+ + N+L++ + ++ DFGL K + +++ Y T +
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 169
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 6e-12
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 24/178 (13%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLVR 211
+VIGEG +G V + + DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIILG 259
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ + YV + MG
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-KKTMG 171
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 29/175 (16%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G YG+V I G KVA+K + + A++ + E++++ +H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR 70
Query: 214 G-YCVEGAYRMLVYEYVD--NGNLDQWLHGDVGDVSPLTWD-IR--MNIILGTAKGLAYL 267
GA VY +D +L +H D PLT + IR + +L +GL Y+
Sbjct: 71 DILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQLL---RGLKYI 123
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER--------SYVTTR 314
H V+HRD+K SN+L++ R+ DFG+A+ L S YV TR
Sbjct: 124 HSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-12
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLG 214
V+G G +GIV+ K+ + + + E + E +V+ + H N++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLAYLHEGLE 272
+E M+V EY G L +++ + + I+L L ++H L
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA----LHHVHTKL- 121
Query: 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++HRD+K+ NILLD+ ++ DFG++K+L S+ T V+GT Y
Sbjct: 122 --ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCY 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 50/165 (30%), Positives = 86/165 (52%), Gaps = 17/165 (10%)
Query: 158 VIGEGGYG--IVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+GEG +G ++ + + SD K A+K + L A ++ + E ++ +++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSD-QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP----LTWDIRMNIILGTAKGLAYLHEG 270
+ +V EY D G+L Q + G + P L W ++M + G+ ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE- 118
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+V+HRD+KS NI L + ++ DFG A+LL S +Y T V
Sbjct: 119 --KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 1e-11
Identities = 50/177 (28%), Positives = 74/177 (41%), Gaps = 32/177 (18%)
Query: 159 IGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V R + KV K + R + E E ++ R+ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH-TLTERNILSRINHPFIVKLH 59
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK--------GL 264
Y + ++ LV EY G L + H A+ L
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGEL--FSH----------LSKEGRFSEERARFYAAEIVLAL 106
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
YLH +++RD+K NILLD + +++DFGLAK L SE S T GT Y
Sbjct: 107 EYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEY 159
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 20/172 (11%)
Query: 159 IGEGGYGIVYRGILSDGT---KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V G L+ KVAVK + + R + E +F E + H N++RL
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME-DFLSEAVCMKEFDHPNVMRL 65
Query: 213 LGYCVEGAYR------MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGT--AKG 263
+G C++ +++ ++ +G+L +L + +GD P +M + T A G
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD-CPQYLPTQMLVKFMTDIASG 124
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+ YL +HRD+ + N +L+ N V+DFGL+K + + Y R+
Sbjct: 125 MEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRI 173
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG GIV S G +VAVK + + R Q +E EV ++ +H N+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V E+++ G L D+ + + + + L K L++LH V+
Sbjct: 86 LVGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSE----RSYVTT 313
HRD+KS +ILL ++SDFG + E +S V T
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 14/166 (8%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRH---KNLVRL 212
+IG G YG VYRG + G VA+K + L+ + + EV ++ ++R N+ +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G ++G ++ EY + G++ + P+ II L Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV-- 120
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
V+HRD+K++NIL+ N ++ DFG+A LL S +T V GT
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 40/163 (24%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE-------------VIGRVR 205
IGEG YG+VY+ ++ + N A K+ ++E E ++ ++
Sbjct: 10 IGEGTYGVVYKA----------RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ 59
Query: 206 HKNLVRL--LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP-LTWDIRM--NIILGT 260
H N+VRL + + + Y LV+EY+D LD H D SP + R+ +
Sbjct: 60 HGNIVRLQDVVHSEKRLY--LVFEYLD---LDLKKHMDS---SPDFAKNPRLIKTYLYQI 111
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAK 302
+G+AY H +V+HRD+K N+L+DR+ NA +++DFGLA+
Sbjct: 112 LRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-11
Identities = 50/170 (29%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G YGIV S+ KVA+K N +NR A++ + E++++ + H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 215 YCVEGAYRM------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ +R +VYE +D LH + L+ D + +GL Y+H
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDTD-----LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER----SYVTTR 314
V+HRD+K SN+LL+ + ++ DFGLA+ + YV TR
Sbjct: 126 SA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTR 172
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 8/159 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVA---VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V G G A VK L + E+ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW-DIRMNIILGTAKGLAYLHEGLEP 273
C+E +LV E+ G+L +L + G V+ + D+ + A GL +LH+
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
+H D+ N L + ++ D+GLA E Y+T
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 49/175 (28%), Positives = 79/175 (45%), Gaps = 13/175 (7%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEKE-FKVEVE 199
EL+ + + E ++G G +G + RG L +K VA+ L ++ F E
Sbjct: 1 ELDNKSIKI--ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEAL 58
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
+G+ H N+VRL G G M+V EY+ NG LD +L G + M ++ G
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQL---MGMLPG 115
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
A G+ YL E VH+ + + +L++ ++S F + SE Y T
Sbjct: 116 LASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 3e-11
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 41/183 (22%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR------------GQAEKEFKV--EVEVI 201
+GEG YG V + G VA+K + G F E++++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------ 255
++H+N++ L+ VEG + LV + + D+ V + IR+
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDI---------MASDLKKV--VDRKIRLTESQVKC 123
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
I+L GL LH+ +HRD+ +NI ++ + +++DFGLA R Y
Sbjct: 124 ILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLA------RRYGYPPY 174
Query: 316 MGT 318
T
Sbjct: 175 SDT 177
|
Length = 335 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 43/169 (25%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 158 VIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRL 212
V+G+G +G +YR D + V K + N +EKE + E+ ++ ++H N++
Sbjct: 7 VLGKGAFGEATLYRRT-EDDSLVVWKEV-NLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ ++ ++ EY + G L + G + + + ++Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY--LFQIVSAVSYIHKA-- 120
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++HRD+K+ NI L + ++ DFG++K+L SE S T V+GT Y
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYY 167
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 27/192 (14%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGT------KVAVKNLLNN-RGQAEKEFKVE 197
E+ +T EE +GE +G VY+G L VA+K L + G +EFK E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV------- 245
+ R++H N+V LLG + +++ Y + +L ++L H DVG
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
S L ++I+ A G+ +L VVH+D+ + N+L+ + N ++SD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 306 SERSYVTTRVMG 317
+ Y ++MG
Sbjct: 176 AADYY---KLMG 184
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 5e-11
Identities = 51/162 (31%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY I ++ G +VA+K + N + Q +KE + E+ V+ +H N+V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L DV + + + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
HRD+KS NILL + +++DFG + E+S +T V GT
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-11
Identities = 52/175 (29%), Positives = 86/175 (49%), Gaps = 14/175 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLLGY 215
IG+G +G VY+GI + TK V + + +AE E + E+ V+ + + R G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 216 CVEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++G ++ EY+ G+ LD G PL I+ KGL YLH +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHS---ER 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
+HRD+K++N+LL Q + +++DFG+A L + T V F A +++ S
Sbjct: 122 KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 176
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 39/153 (25%), Positives = 70/153 (45%), Gaps = 9/153 (5%)
Query: 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNL 209
+ E + +GEG G V + L + + + + K+ E+E+ + +
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 210 VRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIILGTAKGLAY 266
V+ G ++ + + EY + G+LD ++ V + + I KGL+Y
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299
LH K++HRD+K SNILL R+ ++ DFG
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 47/162 (29%), Positives = 80/162 (49%), Gaps = 13/162 (8%)
Query: 158 VIGEGGYGIVYRG-----ILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V SD KVAVK L +E+E E++++ + H+N+
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V LLG C G +++ EY G+L +L + D+ ++ AKG+A+L
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDL-LSFSYQVAKGMAFLAS 159
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
+HRD+ + N+LL ++ DFGLA+ + ++ +YV
Sbjct: 160 ---KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-11
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 14/154 (9%)
Query: 159 IGEGGYGIVYRGIL----SDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IGEG +G + IL DG + +K N+ + +E + EV V+ ++H N+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
E +V +Y + G+L + ++ G D ++ + L ++H+
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRG--VLFPEDQILDWFVQICLALKHVHD--- 119
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
K++HRD+KS NI L + ++ DFG+A++L S
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 8e-11
Identities = 47/154 (30%), Positives = 81/154 (52%), Gaps = 23/154 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
IGEG YG+VY+ G VA+K + R E E E+ ++ + H N+V+L
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIVKL 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII----LGTAKGLAYLH 268
L LV+E++ + +L +++ D SPL+ I + +I +GLA+ H
Sbjct: 65 LDVIHTENKLYLVFEFL-HQDLKKFM-----DASPLS-GIPLPLIKSYLFQLLQGLAFCH 117
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+V+HRD+K N+L++ + +++DFGLA+
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 44/150 (29%), Positives = 78/150 (52%), Gaps = 9/150 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ + TKVAVK + E F E V+ ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 69
Query: 216 CV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E Y ++ E++ G+L +L D G PL I + + A+G+A++ +
Sbjct: 70 VTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQ---RN 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD++++NIL+ +++DFGLA+++
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI 152
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 52/172 (30%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG-- 214
IG+G YG VY+ DG+ AVK +L+ ++E + E ++ + H N+V+ G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 215 ----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
V G LV E + G++ + + G + L + I+ G GL +LH
Sbjct: 89 YKADKLV-GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN 147
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+++HRDVK +NILL + ++ DFG++ L S R T V F A
Sbjct: 148 ---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 47/155 (30%), Positives = 80/155 (51%), Gaps = 17/155 (10%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEF-KVEVEVIGRVRHKNLVRLLG 214
IGEG +G +Y SD +K + L EKE K EV ++ +++H N+V
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEG 270
E +V EY D G+L + ++ G + L+W +++++ GL ++H
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GLKHIH-- 118
Query: 271 LEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
+ K++HRD+KS NI L + A++ DFG+A+ L
Sbjct: 119 -DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 46/167 (27%), Positives = 83/167 (49%), Gaps = 42/167 (25%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
IG+G +G V+ R + VA+K +L EKE F + E++++ ++H+N+V
Sbjct: 20 IGQGTFGEVFKARHKKT-KQIVALKKVLMEN---EKEGFPITALREIKILQLLKHENVVN 75
Query: 212 LLGYCVEGA-----YR---MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK- 262
L+ C A Y+ LV+E+ ++ D++ L + + L K
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEFCEH------------DLAGLLSNKNVKFTLSEIKK 123
Query: 263 -------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL Y+H K++HRD+K++NIL+ + +++DFGLA+
Sbjct: 124 VMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 1e-10
Identities = 42/156 (26%), Positives = 79/156 (50%), Gaps = 22/156 (14%)
Query: 178 VAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
VAVK L + + A +F EV+++ R++ N++RLLG CV+ ++ EY++NG+L+Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 237 WLH---------------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281
+L + +++ +++ L A G+ YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLA 165
Query: 282 SSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
+ N L+ +++DFG+++ L + Y R+ G
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQG 198
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 44/146 (30%), Positives = 76/146 (52%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + TKVA+K L E F E +++ ++RH LV L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V E++ G+L +L GD L +++ A G+AY+ +HR
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +++DFGLA+L+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI 152
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 46/166 (27%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V R GI VAVK L +N + + E+E++ + +HKN
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVS--PLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V L++ ++
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + +HRD+ + N+L+ +++DFGLA+
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
VIG G +VY I L + KVA+K + L + E + EV+ + + H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 215 YCVEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLE 272
V G LV Y+ G+ LD I ++ KGL YLH G
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD--EAIIATVLKEVLKGLEYLHSNGQ- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+K+ NILL + +++DFG++ L
Sbjct: 124 ---IHRDIKAGNILLGEDGSVKIADFGVSASL 152
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-10
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 21/171 (12%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVK--NLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRL 212
+G+G +G VY D G ++AVK + + +KE + E++++ ++H+ +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G + + EY+ G++ L +G LT + +G+ YLH
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYG------ALTETVTRKYTRQILEGVEYLHSN 123
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSERSYVTTRVMGT 318
+VHRD+K +NIL D N ++ DFG +K L CS + + + V GT
Sbjct: 124 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 42/163 (25%), Positives = 81/163 (49%), Gaps = 18/163 (11%)
Query: 153 LCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVR 205
+ E +G+G +G+VY +G++ D T+VA+K + E+ EF E V+
Sbjct: 10 MSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILG 259
++VRLLG +G +++ E + G+L +L ++ +P + + +
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 45/165 (27%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G VY+G+ ++ VAVK N + +E F E ++ + H ++V+L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+G E +V E G L +L + D++ L + LAYL
Sbjct: 73 IGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLIL-----YSYQLSTALAYLES- 125
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+ VHRD+ + N+L+ ++ DFGL++ L E Y ++
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKG 168
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-10
Identities = 45/162 (27%), Positives = 84/162 (51%), Gaps = 15/162 (9%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLG-YC 216
+G+G +G VY+ + +A ++ + + E E + VE+E++ H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 217 VEGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+G +++ E+ G +D L D G P I++ I + L YLH K+
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKI 131
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTT 313
+HRD+K+ N+LL + +++DFG++ K L S++ T
Sbjct: 132 IHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGT 173
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 46/159 (28%), Positives = 83/159 (52%), Gaps = 11/159 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G V+ I ++ G +VA+K + N + Q +KE + E+ V+ +++ N+V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + + R + + L +LH +V+
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-----QALEFLHAN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
HRD+KS N+LL + +++DFG + E+S +T V
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 134 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 32/161 (19%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
N I EG YG+VYR G VA+K L + EKE F + E+ ++ +++H N+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEK---EKEGFPITSLREINILLKLQHPNIV 67
Query: 211 RL----LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTA 261
+ +G ++ Y +V EYV++ D+ + P ++L
Sbjct: 68 TVKEVVVGSNLDKIY--MVMEYVEH---------DLKSLMETMKQPFLQSEVKCLMLQLL 116
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
G+A+LH+ ++HRD+K+SN+LL+ + ++ DFGLA+
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 48/159 (30%), Positives = 81/159 (50%), Gaps = 11/159 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY I ++ G +VA+K + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALDFLHSN---QVI 137
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
HRD+KS NILL + +++DFG + E+S +T V
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 5e-10
Identities = 51/172 (29%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 159 IGEGGYGIVYRGILS--DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY 215
IG+G YG V++ +L+ +G+K AVK +L+ ++E + E ++ + H N+V+ G
Sbjct: 26 IGKGTYGKVFK-VLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83
Query: 216 -----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G LV E + G++ + G + + I I+ GL +LH
Sbjct: 84 YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
K +HRDVK +NILL + ++ DFG++ L S R T V F A
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 43/147 (29%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
+ +V E V G+ +L + P +++ ++ + A E LE K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTE----GP---RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+ + N L+ + ++SDFG+++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 7e-10
Identities = 40/145 (27%), Positives = 77/145 (53%), Gaps = 9/145 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL-GYC 216
+G+G +G VY+ + +A +++ + + E E + VE++++ H N+V+LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E +L+ E+ G +D + + PLT + T + L YLHE K++
Sbjct: 73 YENNLWILI-EFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN---KII 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA 301
HRD+K+ NIL + +++DFG++
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 16/154 (10%)
Query: 159 IGEGGYGIVYRGI---LSDG-----TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++GI + D T+V +K L + + F ++ ++ HK+LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G CV G ++V EYV G+LD +L + ++ ++W L AK LA+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWK------LEVAKQLAWALHF 115
Query: 271 LEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKL 303
LE K + H +V + N+LL R+ + + + KL
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKL 149
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 9e-10
Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 12/174 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + +V A+K + + E E + E+ V+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 217 VEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G ++ EY+ G+ LD G + T ++ KGL YLH K
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS---EKK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
+HRD+K++N+LL Q + +++DFG+A L + T V F A ++Q S
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 176
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 54/160 (33%), Positives = 82/160 (51%), Gaps = 24/160 (15%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVR---HKN 208
IGEG YG V+ R + + G VA+K + R Q +E EV V+ + H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEHPN 65
Query: 209 LVRLLGYC-VEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
+VRL C V R LV+E+VD +L +L V + T I+ +++ +G
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPTETIK-DMMFQLLRG 122
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
L +LH +VVHRD+K NIL+ +++DFGLA++
Sbjct: 123 LDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 47/165 (28%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + + VA+K + + Q+ ++++ EV + ++RH N ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLH 268
G + LV EY G D+ PL + G +GLAYLH
Sbjct: 82 GCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRDVK+ NILL ++ DFG A ++ +V T
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 45/147 (30%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 159 IGEGGYGIVYRG--ILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y V++G L++ VA+K + L + A EV ++ ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q++ D G++ + ++++ + +GLAY H KV
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMD-DCGNIMSMH-NVKI-FLYQILRGLAYCHR---RKV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 38/159 (23%), Positives = 86/159 (54%), Gaps = 14/159 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLV 210
+++ EG +G ++ GIL D +V VK + ++ + + + E ++ + H+N++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLA 265
+L C+E G ++Y Y++ GNL +L G+ + L+ +++ + A G++
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
YLH+ V+H+D+ + N ++D + +++D L++ L
Sbjct: 132 YLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDL 167
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 1e-09
Identities = 46/141 (32%), Positives = 71/141 (50%), Gaps = 17/141 (12%)
Query: 159 IGEGGYGIVYRGIL---SDGTKVA----VKNLLNNRGQAEK---EFKVEVEVIGRVRHKN 208
+G+G + +Y+G+L SD V V +L G + F ++ ++ HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
LV+L G CV M V EYV G LD +LH + +VS L W ++++ A L YL
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVFLHREKNNVS-LHW--KLDVAKQLASALHYLE 118
Query: 269 EGLEPKVVHRDVKSSNILLDR 289
+ K+VH +V NIL+ R
Sbjct: 119 DK---KLVHGNVCGKNILVAR 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 47/147 (31%), Positives = 80/147 (54%), Gaps = 11/147 (7%)
Query: 159 IGEGGYGIVYRG--ILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y VY+G L+D VA+K + L + A EV ++ ++H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q+L D G+ + ++++ + +GL Y H KV
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLD-DCGNSINMH-NVKL-FLFQLLRGLNYCHR---RKV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 2e-09
Identities = 47/162 (29%), Positives = 73/162 (45%), Gaps = 38/162 (23%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
+G G YG+V + + GT +AVK + +N++ Q K +++++ R V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ--KRLLMDLDISMRSVDCPYTVTFY 66
Query: 214 GYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVS-----PLTWDIRMNI---ILG----- 259
G EG D W+ +V D S +D + I ILG
Sbjct: 67 GALFREG---------------DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS 111
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
K L YLH L V+HRDVK SN+L++R ++ DFG++
Sbjct: 112 IVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 47/158 (29%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ + EV ++ R+ H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLA 265
+ C LV+E+VD Q L + V P L + +++ +GL
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+LH +VHRD+K NIL+ +++DFGLA++
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 9/157 (5%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
E IG+G + +VY+ I L DG VA+K + + + + K E++++ ++ H N++
Sbjct: 7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVI 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ L +E +V E D G+L + + + + L ++H
Sbjct: 66 KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS- 124
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+++HRD+K +N+ + ++ D GL + S+
Sbjct: 125 --KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 28/157 (17%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
IGEG YG+VY+G G VA+K + R ++E+E E+ ++ ++H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI---RLESEEEGVPSTAIREISLLKELQHPNIVCL 64
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ + L++E++ +D + D + + +YL++ L+
Sbjct: 65 QDVLMQESRLYLIFEFLS---MDLKKYLD---------SLPKGQYMDAELVKSYLYQILQ 112
Query: 273 P-------KVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+V+HRD+K N+L+D + +++DFGLA+
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 3e-09
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 22/176 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
I +G YG V+ S G A+K + + + Q + + E +++ + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD-QVLTERDILSQAQSPYVVKLY 59
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y +G + LV EY+ G+L L +V L D+ I L YLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN-- 112
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-------TTRVMGTFGY 321
++HRD+K NIL+D + +++DFGL+K+ R R++GT Y
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 56.7 bits (136), Expect = 4e-09
Identities = 44/153 (28%), Positives = 78/153 (50%), Gaps = 11/153 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
HRD+KS NILL + +++DFG + E+S
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 4e-09
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
++G G YG VY+G ++A +++ G E+E K E+ ++ + H+N+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 217 VEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ LV E+ G++ + G+ W I +GL++LH+
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQH 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
KV+HRD+K N+LL ++ DFG++ L
Sbjct: 131 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D VAVK L ++ + + E+E++ + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDV--SPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D + LT+ ++
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 5e-09
Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 14/162 (8%)
Query: 159 IGEGGYGIVYRGILSDG---TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V G ++ G +V VK L + Q + +F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLH----GDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
C E +LV E+ G+L +L ++ P T RM + A GL +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-RMACEI--ALGLLHLHKN 119
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
+H D+ N LL ++ D+GL+ E YVT
Sbjct: 120 ---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 6e-09
Identities = 44/166 (26%), Positives = 80/166 (48%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ + TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L L++ ++
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 7e-09
Identities = 42/154 (27%), Positives = 74/154 (48%), Gaps = 12/154 (7%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
V+G G YG VY+G ++A +++ E+E K+E+ ++ + H+N+ G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82
Query: 217 VEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ + LV E+ G++ + G+ L D I +GLA+LH
Sbjct: 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNA--LKEDWIAYICREILRGLAHLHAH 140
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
KV+HRD+K N+LL ++ DFG++ L
Sbjct: 141 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 7e-09
Identities = 53/170 (31%), Positives = 81/170 (47%), Gaps = 26/170 (15%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G GIV + G VAVK L N+ A++ ++ E+ ++ V HKN++ LL
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLN 87
Query: 215 YCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYL 267
E LV E +D NL Q +H ++ RM+ +L G+ +L
Sbjct: 88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIKHL 139
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
H ++HRD+K SNI++ ++ DFGLA+ C+ YV TR
Sbjct: 140 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTR 186
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 37/105 (35%), Positives = 51/105 (48%), Gaps = 10/105 (9%)
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
E RH LV L C + + V EY G+L +H DV P ++
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFS-EPRAVFYAACVV 111
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
LG L YLHE K+V+RD+K N+LLD + +++DFGL K
Sbjct: 112 LG----LQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 43/144 (29%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY+ L G AVK + G + E+ ++ +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ EY G+L H PL+ + T +GLAYLH + +H
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 278 RDVKSSNILLDRQWNARVSDFGLA 301
RD+K +NILL + +++DFG+A
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-09
Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEG Y V++G VA+K + L + A EV ++ ++H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
LV+EY+D+ +L Q+L +S I M +L +GL+Y H+ K++
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLL---RGLSYCHK---RKIL 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+K N+L++ + +++DFGLA+
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 29/157 (18%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV------------EVEVIGRVR 205
+GEG Y VY+G ++ L + A KE ++ E ++ ++
Sbjct: 12 KLGEGSYATVYKG----------RSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK 61
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H N+V L LV+EY+D +L Q++ G +S + + +L +GLA
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLL---RGLA 117
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
Y H+ +V+HRD+K N+L+ + +++DFGLA+
Sbjct: 118 YCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 1e-08
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVA---VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLG 214
IG G +G V + T VA VK L N E+ EF + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 215 YCVEGAYRMLVYEYVDNGNL------DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
CVE +LV+EY + G+L +QW + + L RM + A G+ ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN-SQLLLLQ---RMACEI--AAGVTHMH 116
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ +H D+ N L +V D+G+ E Y+ T
Sbjct: 117 ---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE-DYIET 157
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 45/173 (26%), Positives = 83/173 (47%), Gaps = 25/173 (14%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ IGEG YG+V G KVA+K + ++ ++ + E++++ R +H+N++ +L
Sbjct: 11 SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGIL 69
Query: 214 GYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ +V E ++ L+ + L+ D + +GL Y+H
Sbjct: 70 DIIRPPSFESFNDVYIVQELMETD-----LY-KLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-------SYVTTR 314
V+HRD+K SN+LL+ + ++ DFGLA++ E YV TR
Sbjct: 124 SA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 22/59 (37%), Positives = 33/59 (55%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
L YLH ++HRD+K NILLD Q + ++DF +A + + + T+ GT GY
Sbjct: 112 ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV-TPDTLTTSTS-GTPGY 165
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 23/165 (13%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
IG G +G VY R + ++ VA+K + + Q+ ++++ EV+ + R++H N +
Sbjct: 33 IGHGSFGAVYFARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLH 268
G + LV EY G D+ PL I G +GLAYLH
Sbjct: 92 GCYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRD+K+ NILL +++DFG A + S+V T
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 1e-08
Identities = 41/149 (27%), Positives = 74/149 (49%), Gaps = 12/149 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V++GI + KV +++ +AE E + E+ V+ + + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ + PL I+ KGL YLH K
Sbjct: 71 YLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHS---EKK 122
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+K++N+LL +++DFG+A L
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQL 151
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 15/153 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G G +G VY +D G ++AVK + + E +V E++++ +RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 212 LLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + + L EY+ G++ L LT ++ +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ +VHRD+K +NIL D N ++ DFG +K
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-08
Identities = 48/164 (29%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY S + VAVK + + Q ++++ EV+ + +++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHE 269
++ LV EY G D+ PL I G +GLAYLH
Sbjct: 89 CYLKEHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRD+K+ NILL +++DFG A S+V T
Sbjct: 140 H---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 15/155 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G+G +G VY D G ++A K + + E +V E++++ ++H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 212 LLGYCVEGAYRMLV--YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + A + L EY+ G++ L LT + +G++YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ +VHRD+K +NIL D N ++ DFG +K L
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L K L+ LH
Sbjct: 88 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLKALSVLHA-- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
V+HRD+KS +ILL ++SDFG + E
Sbjct: 135 -QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 41/146 (28%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG-Y 215
+G+G YG VY+ + G +A+K + +++ + +E++++ + +V G +
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+EGA M + EY+D G+LD+ L+ + D+ I KGL +L E E +
Sbjct: 69 FIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA 301
+HRDVK +N+L++ ++ DFG++
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 29/150 (19%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG---------------- 202
+G G +Y GIL+ + ++ EKE KV ++V+
Sbjct: 3 LGRGTRTQIYAGILNYK-----DDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASM 57
Query: 203 --RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT 260
+V HK++V L G CV ++V E+V+ G LD ++H LT + +
Sbjct: 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQL 114
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
A L+YL + +VH +V + NILL R+
Sbjct: 115 ASALSYLE---DKDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 4e-08
Identities = 49/158 (31%), Positives = 82/158 (51%), Gaps = 12/158 (7%)
Query: 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRV 204
AATS L E +GEG Y VY+GI +G VA+K +++ + + F E ++ +
Sbjct: 3 AATSYLNLEK-LGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGL 60
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+H N+V L V+EY+ +L Q++ G + P + M +L +GL
Sbjct: 61 KHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLL---RGL 116
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AY+H ++HRD+K N+L+ +++DFGLA+
Sbjct: 117 AYIHG---QHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 48/161 (29%), Positives = 71/161 (44%), Gaps = 20/161 (12%)
Query: 175 GTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGYCVEGAYRML-VYEYVD 230
G +VA+K L + + E + F+ E + R+ H N+V LL + V+EYV
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--- 287
L + L D G + M +L LA H +VHRD+K NI++
Sbjct: 63 GRTLREVLAAD-GALPAGETGRLMLQVL---DALACAHNQ---GIVHRDLKPQNIMVSQT 115
Query: 288 DRQWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYA 322
+ +A+V DFG+ LL R TT V+GT Y
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYC 156
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 42/155 (27%), Positives = 77/155 (49%), Gaps = 15/155 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLVR 211
++G+G +G VY +D G ++AVK + + E +V E++++ + H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 212 LLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G + R L E++ G++ L LT ++ +G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ +VHRD+K +NIL D N ++ DFG +K L
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 9/150 (6%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHN---QGVIH 141
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
RD+KS +ILL ++SDFG + E
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 26/179 (14%)
Query: 152 GLCEENVIGEGGYGIV----YRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVR 205
C V+G+G YG V +R +DG + +K NL N + K + E +++ +++
Sbjct: 1 AYCFVRVVGKGSYGEVSLVRHR---TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK 57
Query: 206 HKNLVRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSP----LTWDIRMNIILG 259
H N+V EG +L V + + G+L L G + P + W +++
Sbjct: 58 HPNIV-AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI----- 111
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A L YLHE ++HRD+K+ N+ L R +V D G+A++L ++ +T ++GT
Sbjct: 112 -AMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 17/177 (9%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKV-----EVEVIG-RVR 205
+G G +G VY+ + ++ V N + + E++ + EV +I ++R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H N+VR +E +V + ++ L + + T + NI + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
YLH+ E ++VHRD+ +NI+L ++DFGLAK S +T+ V+GT Y+
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK-QPESKLTS-VVGTILYS 180
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-08
Identities = 39/146 (26%), Positives = 73/146 (50%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGYC 216
+GEG Y VY+G K+ ++ + + F E ++ ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
LV+EYV + +L Q++ G + P + + +L +GL+Y+H+ ++
Sbjct: 73 HTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLL---RGLSYIHQRY---IL 125
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+K N+L+ +++DFGLA+
Sbjct: 126 HRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 6/90 (6%)
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +V H +L + G CV G+ ++V E+V++G LD L + G V P+ W ++ +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV-PVAW--KITVAQQ 125
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289
A L+YL + +VH +V + NILL R
Sbjct: 126 LASALSYLE---DKNLVHGNVCAKNILLAR 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 22/165 (13%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G+V R L+ G VA+K ++ A++ ++ E++++ +RH+N++ L
Sbjct: 18 VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLS 75
Query: 214 GYCV---EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ E Y V E + +L + L PL + +GL Y+H
Sbjct: 76 DIFISPLEDIY--FVTELLGT-DLHRLL-----TSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
VVHRD+K SNIL++ + ++ DFGLA++ + + YV+TR
Sbjct: 128 ---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTR 169
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-07
Identities = 23/75 (30%), Positives = 42/75 (56%), Gaps = 6/75 (8%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LD P+ +I I + +GL YL+ +++HRD+K SNIL
Sbjct: 83 EFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNIL 136
Query: 287 LDRQWNARVSDFGLA 301
++ + ++ DFG++
Sbjct: 137 VNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 47/173 (27%), Positives = 77/173 (44%), Gaps = 47/173 (27%)
Query: 159 IGEGGYGIVYRGIL---SDGTKVAVKNLLNNRGQAEKEFKV--------EVEVIGRVRHK 207
IG G YG VY+ DG + A+K + +KE E+ ++ ++H+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 208 NLVRLLGYCVEGAYRM--LVYEYVDNGNLDQW------LHGDVGDVSP-----LTWDIRM 254
N+V L+ +E A + L+++Y ++ D W + P L W I +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEH---DLWQIIKFHRQAKRVSIPPSMVKSLLWQI-L 118
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKL 303
N G+ YLH V+HRD+K +NIL+ + R + D GLA+L
Sbjct: 119 N-------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 49/186 (26%), Positives = 85/186 (45%), Gaps = 29/186 (15%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVE 197
T+ EL + L + +G G YG V I G KVA+K L + A++ ++ E
Sbjct: 9 TVWELPERYTSLKQ---VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-E 64
Query: 198 VEVIGRVRHKNLVRLLGYCVEGA--------YRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
+ ++ ++H+N++ LL Y ++ Y D L +G PL+
Sbjct: 65 LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-------LQKIMG--HPLS 115
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
D ++ GL Y+H ++HRD+K N+ ++ ++ DFGLA+ +E +
Sbjct: 116 EDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT 172
Query: 310 -YVTTR 314
YV TR
Sbjct: 173 GYVVTR 178
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 1e-07
Identities = 46/145 (31%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
IGEG GIV R S G +VAVK +++ R Q +E VI R +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHS-GRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G ++ E++ G L D+ + L + + + L YLH V
Sbjct: 87 YLVGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHS---QGV 138
Query: 276 VHRDVKSSNILLDRQWNARVSDFGL 300
+HRD+KS +ILL ++SDFG
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGF 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 1e-07
Identities = 53/172 (30%), Positives = 86/172 (50%), Gaps = 21/172 (12%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + + G A K L R + EK +E E++ +V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-IILGTAK---GLAYLHE 269
Y E + LV ++ G+L ++ +VG+ + M +I +A+ G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIY-NVGERG-----LEMERVIHYSAQITCGILHLHS 113
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+RD+K N+LLD Q N R+SD GLA L ++ T+ GT GY
Sbjct: 114 ---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGY 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 45/175 (25%), Positives = 81/175 (46%), Gaps = 29/175 (16%)
Query: 157 NVIGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
N+IG G +G+VY I D + KVA+K +L + +E + + + H N++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 216 CVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII----LGTAKG 263
++ +V E++ Q +H + + + + ++ +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIP-----QTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAK-LLCSER--SYVTTR 314
LAY+H + HRD+K N+L+D ++ DFG AK LL +R SY+ +R
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
|
Length = 440 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 25/160 (15%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKN-LVR 211
IGEG YG VY+ + G VA+K R + ++E E+ ++ + +VR
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKK---TRLEMDEEGIPPTALREISLLQMLSESIYIVR 65
Query: 212 LLGYCVEGAYR-------MLVYEYVDNGNLDQWLHGDV-GDVSPLTWDIRMNIILGTAKG 263
LL VE LV+EY+D+ +L +++ + G PL + + KG
Sbjct: 66 LL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAK 302
+A+ H+ V+HRD+K N+L+D+Q +++D GL +
Sbjct: 123 VAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IG G YG VY+ ++ G A+K + G+ + E+ ++ +H N+V G +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ E+ G+L H PL+ + T +GL YLH + +H
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 278 RDVKSSNILLDRQWNARVSDFG----LAKLLCSERSYVTT 313
RD+K +NILL + +++DFG + + +S++ T
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGT 169
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-07
Identities = 49/170 (28%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + K+ A K L R + E+ E +++ +V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y E + LV ++ G+L + G+ G II G L +LH+
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICG----LEHLHQ-- 113
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++V+RD+K N+LLD N R+SD GLA L + R GT GY
Sbjct: 114 -RRIVYRDLKPENVLLDDHGNVRISDLGLAVEL-KGGKKIKGRA-GTPGY 160
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 38/136 (27%), Positives = 57/136 (41%), Gaps = 29/136 (21%)
Query: 174 DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-GY------C-VEGAYRMLV 225
KV VK K E++++ + H+ ++ L+ Y C V Y+ +
Sbjct: 118 QRKKVIVK-----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172
Query: 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285
+ YVD PL + + I + LAYLH ++HRDVK+ NI
Sbjct: 173 FTYVDR-------------SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENI 216
Query: 286 LLDRQWNARVSDFGLA 301
LD NA + DFG A
Sbjct: 217 FLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+ VIG+G YG+V I G KVA+K ++ + A + + E++++ +RH ++V
Sbjct: 5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVE 63
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + + R YV ++ LH + LT + + + L Y+H
Sbjct: 64 IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA- 122
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-------RSYVTTR 314
V HRD+K NIL + ++ DFGLA++ ++ YV TR
Sbjct: 123 --NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ + + L L + + E++V+ +V G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 126
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVT-TRVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 182
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 36/110 (32%), Positives = 59/110 (53%), Gaps = 19/110 (17%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LDQ L + + +I + + +GLAYL E + +++HRDVK SNIL
Sbjct: 83 EHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNIL 136
Query: 287 LDRQWNARVSDFG--------LAKLLCSERSYVT-TRVMGTFGYAHFIVQ 327
++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 182
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 5e-07
Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 17/163 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ ++G G G VY+ L +AVK + L+ + +K+ E+E++ + ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 214 G-YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + VE + E++D G+LD + + + I + KGL YL L
Sbjct: 66 GAFFVENRISICT-EFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLW-SL- 114
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE--RSYVTT 313
K++HRDVK SN+L++ + ++ DFG++ L + ++YV T
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 84 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 139
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 140 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 181
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
E++D G+LDQ L + +I I + +GL YL E + K++HRDVK SNIL
Sbjct: 79 EHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 287 LDRQWNARVSDFGLAKLLCSE--RSYVTTR 314
++ + ++ DFG++ L S+V TR
Sbjct: 133 VNSRGEIKLCDFGVSGQLIDSMANSFVGTR 162
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 37/117 (31%), Positives = 53/117 (45%), Gaps = 14/117 (11%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-- 254
E ++ +RH LV L G + + LV EYV G L L P R
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL--RKSGRFPEPV-ARFYA 107
Query: 255 -NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
++L L YLH +V+RD+K N+LLD +++DFG AK + R+Y
Sbjct: 108 AQVVLA----LEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV-KGRTY 156
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 50/176 (28%), Positives = 81/176 (46%), Gaps = 30/176 (17%)
Query: 159 IGEGGYGIV----YRGILSDGTKVAVK---NLLNNRGQAEKEFKVEVEVIGRVR-HKNLV 210
+G+G YGIV S+ VA+K N+ + + A++ + E++++ R HKN+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNIT 65
Query: 211 RL--LGYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
L + G + L +YE + +L Q + PLT + I GL Y+
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLTDAHFQSFIYQILCGLKYI 121
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---------RSYVTTR 314
H V+HRD+K N+L++ ++ DFGLA+ SE YV TR
Sbjct: 122 HSA---NVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAGFMTEYVATR 173
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 44/173 (25%), Positives = 82/173 (47%), Gaps = 33/173 (19%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLD 81
Query: 215 YCVEGAYRMLVYEYVDNGNLDQW---------LHGDVGDV---SPLTWDIRMNIILGTAK 262
+ + +LD++ + D+G + L+ D ++ K
Sbjct: 82 V------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLK 129
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
GL Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR
Sbjct: 130 GLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR 179
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 43/177 (24%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G G+V+ + SD +VAVK ++ Q+ K E+++I R+ H N+V+
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT----------WDIRMNIILGTA------ 261
VYE + D L DVG ++ L D+ + G
Sbjct: 67 -------VYEVLGPSGSD--LTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHAR 117
Query: 262 -------KGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSY 310
+GL Y+H V+HRD+K +N+ ++ ++ DFGLA+++ S+
Sbjct: 118 LFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 33/160 (20%)
Query: 158 VIGEGGYGIVY--RGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G +G V+ R + KV K+ + R Q + E +++ +V+L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIVKL 66
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAK--------G 263
+ + LV EY+ G+L + IR ++ TA+
Sbjct: 67 YYSFQDEEHLYLVMEYMPGGDL-------------MNLLIRKDVFPEETARFYIAELVLA 113
Query: 264 LAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L +H+ G +HRD+K NIL+D + +++DFGL K
Sbjct: 114 LDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCK 149
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
+G+GG+G V + + G A K L R + K ++ VE ++ +V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 215 YCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEG 270
Y + + LV ++ G+L ++ +V + +P + R TA+ GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIY-NVDEENPGFPEPRA--CFYTAQIISGLEHLHQR 116
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
++++RD+K N+LLD N R+SD GLA
Sbjct: 117 ---RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 29/107 (27%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
+E ++ V H +++R+ V GA +V + + +L +L PL D +
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSR---PLPIDQALI 161
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
I +GL YLH +++HRDVK+ NI ++ + D G A+
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 46/151 (30%), Positives = 72/151 (47%), Gaps = 14/151 (9%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G V SDG+ AVK L + + + E V+ + ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + A ++ V +YV+ G L L + + P + A + YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV----ASAIGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+++RD+K NILLD Q + ++DFGL K
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 50/171 (29%), Positives = 85/171 (49%), Gaps = 27/171 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE-KEFKV-EVEVIGRVRHKNLVRLLG 214
V+GEG YG+V + + + VA+K ++ E KE + E++++ ++ +N+V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65
Query: 215 YCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ A+R LV+EYV+ N+ + L V P + + I K + + H+
Sbjct: 66 ---KEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPP---EKVRSYIYQLIKAIHWCHK 118
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------YVTTR 314
+VHRD+K N+L+ ++ DFG A+ L SE S YV TR
Sbjct: 119 N---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATR 165
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 5e-06
Identities = 45/169 (26%), Positives = 82/169 (48%), Gaps = 21/169 (12%)
Query: 158 VIGEGGYGIVYRGIL--SDGT--KVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
++G+G +G V L DG+ KVAVK L + + E EF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFDHPNVI 64
Query: 211 RLLGYCVEGAYR------MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIR--MNIILGTA 261
+L+G + + M++ ++ +G+L +L +G+ P T ++ + ++ A
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE-EPFTLPLQTLVRFMIDIA 123
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
G+ YL +HRD+ + N +L+ V+DFGL+K + S Y
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY 169
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 19/163 (11%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML--VYEYVDNGNLDQWLHGDVGD 244
R + E+ E V+ V H ++RL + E R L + EYV G L +L + G
Sbjct: 41 RLKQEQHVHNEKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR-NSGR 97
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-- 302
S T + I+ L YLH E +V+RD+K NILLD++ + +++DFG AK
Sbjct: 98 FSNSTGLFYASEIVC---ALEYLH-SKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKL 151
Query: 303 -----LLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLS 340
LC Y+ V+ + G+ V L IL+Y +L
Sbjct: 152 RDRTWTLCGTPEYLAPEVIQSKGHNK-AVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-06
Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 24/177 (13%)
Query: 158 VIGEGGYGIVY----RGILSDGT----KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ G G KV K + + + + + E +V+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +YV+ G +L Q H +V +I + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+LH+ +++RD+K NILLD + + ++DFGL+K +E GT Y
Sbjct: 119 DHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEY 172
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-06
Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 38/196 (19%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNL-------LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+GGYG V+ D G VA+K + LN + E +++ + + LV
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV----RHVLTERDILTTTKSEWLV 64
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LL + Y L EYV G+ L+ G + + + M + L Y
Sbjct: 65 KLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY-- 122
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQV 328
+HRD+K N L+D + +++DFGL+K G YA+ +V
Sbjct: 123 -------IHRDLKPENFLIDASGHIKLTDFGLSK--------------GIVTYANSVVG- 160
Query: 329 SPLFILLYILLSVRYN 344
SP ++ +L Y+
Sbjct: 161 SPDYMAPEVLRGKGYD 176
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 36/160 (22%), Positives = 72/160 (45%), Gaps = 11/160 (6%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
E IG G + VYR L DG VA+K +L++ +A + E++++ ++ H N+
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNHPNV 64
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ +E +V E D G+L + + + + L ++H
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+V+HRD+K +N+ + ++ D GL + S+ +
Sbjct: 125 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 52/206 (25%), Positives = 76/206 (36%), Gaps = 45/206 (21%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G GG+G V + S A+K + GQ ++ E E++ H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQ-QEHIFSEKEILEECNHPFIVKLY 59
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI-RMNIILGTAKG--------- 263
+ Y ++ EY G L W I R +
Sbjct: 60 RTFKDKKYIYMLMEYCLGGEL---------------WTILRDRGLFDEYTARFYIACVVL 104
Query: 264 -LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTT 313
YLH +++RD+K N+LLD ++ DFG AK L C YV
Sbjct: 105 AFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAP 161
Query: 314 RVMGTFGYAHFIVQVSPLFILLYILL 339
++ GY V L ILLY LL
Sbjct: 162 EIILNKGYDFS-VDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 42/160 (26%), Positives = 79/160 (49%), Gaps = 30/160 (18%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLV 210
IG G +G+V+ R DG +VA+K + N N ++ F+ E++++ +H N++
Sbjct: 8 IGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVL 62
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV----SPLTWD-IRMNI--ILGTAKG 263
L YV + + + D+ + PL+ D +++ + IL +G
Sbjct: 63 SALDILQPPHIDPFEEIYV----VTELMQSDLHKIIVSPQPLSSDHVKVFLYQIL---RG 115
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
L YLH ++HRD+K N+L++ ++ DFGLA++
Sbjct: 116 LKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 24/55 (43%), Positives = 33/55 (60%), Gaps = 2/55 (3%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
P+ DI + + K L YL E + V+HRDVK SNILLD N ++ DFG++
Sbjct: 110 PIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-06
Identities = 51/151 (33%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK---VEVEV-IGRVRHKNLVRL 212
VIG+G +G V +DG AVK L +KE K E V + V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + A ++ V +YV+ G L L + P I A L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEI----ASALGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+++RD+K NILLD Q + ++DFGL K
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 30/173 (17%)
Query: 158 VIGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG G GIV Y + G VA+K L N A++ ++ E+ ++ V HKN++
Sbjct: 23 PIGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIG 79
Query: 212 LLGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGL 264
LL E LV E +D NL Q + D L + RM+ +L G+
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHE-RMSYLLYQMLCGI 131
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 132 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 51/181 (28%), Positives = 76/181 (41%), Gaps = 34/181 (18%)
Query: 158 VIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V++ G KV K + + K E ++ V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAK------ 262
V L+ G L+ EY+ G L L R I + TA
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLE-------------REGIFMEDTACFYLSEI 109
Query: 263 --GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320
L +LH+ +++RD+K NILLD Q + +++DFGL K E + VT GT
Sbjct: 110 SLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIE 165
Query: 321 Y 321
Y
Sbjct: 166 Y 166
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 21/54 (38%), Positives = 32/54 (59%), Gaps = 4/54 (7%)
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
+GL Y+H ++HRD+K SNI ++ ++ DFGLA+ E + YV TR
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 82 LNVFTP---QKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 158 VIGEGGYGIVYRGILS-DGTKVAVKNL-----LNNRGQAEKEFKVEVEVIGR-VRHKNLV 210
VIG+G +G V DG AVK L LN + Q K E V+ + V+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59
Query: 211 RLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI-ILGTAKGLAYLH 268
L Y + ++ V ++V+ G L L + P R A L YLH
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP-----RARFYAAEIASALGYLH 113
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+V+RD+K NILLD Q + ++DFGL K ++ TT
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT 155
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 49/177 (27%), Positives = 79/177 (44%), Gaps = 24/177 (13%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ R + T KV K L + + + + E V+ VR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +YV G +L Q + +V + +I + L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIIL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+LH+ +V+RD+K NILLD + + ++DFGL+K SE T GT Y
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 25/81 (30%), Positives = 41/81 (50%), Gaps = 11/81 (13%)
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGT 318
YLH +++RD+K N+LLD + + +V+DFG AK LC Y+ V+ +
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQS 189
Query: 319 FGYAHFIVQVSPLFILLYILL 339
G+ V + +LLY +
Sbjct: 190 KGHGK-AVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 28/114 (24%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ +L Y LV EY++ G+ + + L D I G+ L
Sbjct: 58 YVAKLYYSFQSKDYLYLVMEYLNGGDCASL----IKTLGGLPEDWAKQYIAEVVLGVEDL 113
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
H+ ++HRD+K N+L+D+ + +++DFGL S + +GT Y
Sbjct: 114 HQR---GIIHRDIKPENLLIDQTGHLKLTDFGL-----SRNGLENKKFVGTPDY 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 14/151 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G V ++ AVK L + + EK E V+ + V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + A ++ V +Y++ G L L + + P I A L YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHS-- 114
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+V+RD+K NILLD Q + ++DFGL K
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 35/158 (22%), Positives = 70/158 (44%), Gaps = 7/158 (4%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
E IG G + VYR L D VA+K + +A ++ E++++ ++ H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +E +V E D G+L Q + + + + ++H
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-- 124
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+V+HRD+K +N+ + ++ D GL + S+ +
Sbjct: 125 -RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 6e-05
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 51/171 (29%), Positives = 80/171 (46%), Gaps = 17/171 (9%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLL 213
V+G+GG+G V + + G A K L R + K + E +++ +V + +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL- 65
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
Y E + LV ++ G+L ++ G+ G I G L LH+
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG----LEDLHQ- 120
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 121 --ERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGY 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 6/59 (10%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL ++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 7e-05
Identities = 23/59 (38%), Positives = 35/59 (59%), Gaps = 6/59 (10%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL ++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 161
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 8e-05
Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 9/107 (8%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
E V+ RH L L Y + R+ V EY + G L L +
Sbjct: 45 ESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAE 103
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
I+ L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 104 IVSA----LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 9e-05
Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V KVAVK L + A + ++ E+ ++ ++H+N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLD 81
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
E NL + D+ ++ L+ + +I +GL Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNL---MGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSA- 137
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR
Sbjct: 138 --GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR 179
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 43/183 (23%), Positives = 75/183 (40%), Gaps = 33/183 (18%)
Query: 159 IGEGGYGIVYRGILSDGT--KVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
+G G +G V + VA+K ++ +K+ E +++ + H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
G + +Y LV E+V G +L DVG A + +
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF--------------YAAQIVLI 143
Query: 268 HEGLEP-KVVHRDVKSSNILLDRQWNARVSDFGLAKL-------LCSERSYVTTRVMGTF 319
E L+ +V+RD+K N+LLD+ +++DFG AK+ LC Y+ ++
Sbjct: 144 FEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNV 203
Query: 320 GYA 322
G+
Sbjct: 204 GHG 206
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 2e-04
Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 9/107 (8%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
E V+ RH L L Y + R+ V EYV+ G L + H V + D
Sbjct: 45 ESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGEL--FFHLSRERV--FSEDRTRF 99
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH G K+V+RD+K N++LD+ + +++DFGL K
Sbjct: 100 YGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 2e-04
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 114 GLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEI-PEGETIRGRV-GTVGY 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 29/87 (33%), Positives = 41/87 (47%), Gaps = 14/87 (16%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL----------LCSERSYVTT 313
L LH+ V++RD+K NILLD Q + + DFGL KL C Y+
Sbjct: 106 LENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAP 162
Query: 314 RVMGTFGYAHFIVQVSPLFILLYILLS 340
++ GY V L +LLY +L+
Sbjct: 163 ELLLGHGYTK-AVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 16/40 (40%), Positives = 28/40 (70%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL +LHE +++RD+K N+LLD + + +++DFG+ K
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 31/137 (22%), Positives = 58/137 (42%), Gaps = 19/137 (13%)
Query: 180 VKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL--------LGYCVEGAYRMLVYEYVDN 231
+ + +A + + E+ +GR+ H+N++++ Y + Y +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291
D W PL R I+ + Y+H+ K++HRD+K NI L+
Sbjct: 256 EAFD-WKD------RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDG 304
Query: 292 NARVSDFGLAKLLCSER 308
+ DFG A ER
Sbjct: 305 KIVLGDFGTAMPFEKER 321
|
Length = 501 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 4e-04
Identities = 29/86 (33%), Positives = 43/86 (50%), Gaps = 19/86 (22%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK--LLCSERSYVTTRVMGTFG 320
GL +LH +V+RD+K NILLD + +++DFG+ K +L + T GT
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGT-- 159
Query: 321 YAHFIVQVSPLFILLYILLSVRYNSS 346
P +I ILL +YN+S
Sbjct: 160 ---------PDYIAPEILLGQKYNTS 176
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 24/177 (13%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G G YG V+ R + + KV K + + + + + E +V+ +R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNG----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+ L Y + ++ L+ +Y++ G +L Q +V + +I + L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL--------AL 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+LH+ +++RD+K NILLD + ++DFGL+K + GT Y
Sbjct: 119 EHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL L ++V+RD+K NILLD + + R+SD GLA + E V RV GT GY
Sbjct: 114 GLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQI-PEGETVRGRV-GTVGY 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 8e-04
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 21/155 (13%)
Query: 158 VIGEGGYGIVY---------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
+I G YG VY R + K+ +NL+ R Q ++ F VE +++ +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMK---KINKQNLIL-RNQIQQVF-VERDILTFAENPF 62
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + +V EYV+ G+ L ++ L D+ T L YLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARMYFAETVLALEYLH 118
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+VHRD+K N+L+ + +++DFGL+K+
Sbjct: 119 N---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 9e-04
Identities = 26/59 (44%), Positives = 32/59 (54%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL LH V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 114 GLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESIRGRV-GTVGY 167
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 9e-04
Identities = 15/41 (36%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
GL +LH+ +++RD+K N+LLD+ + +++DFG+ K
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 17/46 (36%), Positives = 28/46 (60%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
VHRD+K N+L+DR + +++DFG A L + + + +GT Y
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY 169
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 13/24 (54%), Positives = 19/24 (79%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFG 299
VHRD+K N+LLD+ + R++DFG
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.001
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 107 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.001
Identities = 16/35 (45%), Positives = 24/35 (68%), Gaps = 1/35 (2%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK-LLCSERS 309
+HRD+K N+LLD + + ++SDFGL L S R+
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.002
Identities = 31/160 (19%), Positives = 71/160 (44%), Gaps = 22/160 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-------EVEVIGRVRHKNLV 210
+I E +Y+GI + +V ++ + K KV E++ + R+ N++
Sbjct: 27 LIKENDQNSIYKGIF-NNKEVIIRTF----KKFHKGHKVLIDITENEIKNLRRIDSNNIL 81
Query: 211 RLLGY----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
++ G+ + L+ EY G L + L + L++ ++++ + KGL
Sbjct: 82 KIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYN 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
L++ ++++ S + L+ + ++ GL K+L S
Sbjct: 138 LYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175
|
Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 27/84 (32%), Positives = 44/84 (52%), Gaps = 15/84 (17%)
Query: 224 LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNI--ILGTAKGLAYLHEGLEPKVVHRD 279
LV EY+ G++ LH G +D M + I A L YLH ++HRD
Sbjct: 81 LVMEYLIGGDVKSLLHIYG--------YFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 280 VKSSNILLDRQWNARVSDFGLAKL 303
+K N+L+ + + +++DFGL+K+
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 14/26 (53%), Positives = 21/26 (80%)
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA 301
+HRD+K NIL+DR + ++SDFGL+
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.002
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 26/170 (15%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGY 215
IG G +G V+ + ++ RG E+E +EV V+ ++HKN+VR +
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 216 CVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE- 272
+ A + L + E+ D G+L + + + ++I LAY H +
Sbjct: 81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDG 140
Query: 273 ---PKVVHRDVKSSNILLDR----------QWN-------ARVSDFGLAK 302
+V+HRD+K NI L Q N A++ DFGL+K
Sbjct: 141 PNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
|
Length = 1021 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 19/154 (12%)
Query: 158 VIGEGGYGIVY--RGILSD------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V+ R I KV K L R + K+E +++ V H +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT--KMERDILAEVNHPFI 60
Query: 210 VRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
V+L + EG L+ +++ G+L L +V T + + A L +LH
Sbjct: 61 VKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEV----MFTEEDVKFYLAELALALDHLH 115
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L +++RD+K NILLD + + +++DFGL+K
Sbjct: 116 -SL--GIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.002
Identities = 22/68 (32%), Positives = 36/68 (52%), Gaps = 3/68 (4%)
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
D PL D + A+G+ +L +HRDV + N+LL A++ DFGLA+
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARD 261
Query: 304 LCSERSYV 311
+ ++ +YV
Sbjct: 262 IMNDSNYV 269
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 35/132 (26%), Positives = 61/132 (46%), Gaps = 19/132 (14%)
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDI 252
VE V+ + L C + R+ V EYV+ G+L + G + + +
Sbjct: 49 VEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 108
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-- 310
+++ GL +LH +++RD+K N++LD + + +++DFG +C E
Sbjct: 109 EISV------GLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFG----MCKEHMVDG 155
Query: 311 VTTRVM-GTFGY 321
VTTR GT Y
Sbjct: 156 VTTRTFCGTPDY 167
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 24/87 (27%), Positives = 41/87 (47%), Gaps = 14/87 (16%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVT 312
GL +LH +++RD+K N++LDR + +++DFG+ K C Y+
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIA 164
Query: 313 TRVMGTFGYAHFIVQVSPLFILLYILL 339
++ Y F V +LLY +L
Sbjct: 165 PEILQGLKYT-FSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.004
Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 36/174 (20%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-------------EVEVIGRVR 205
+G+G +G VY ++ D VA + L + KE V E +++ ++
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERL-----KVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH--GDVGDVSP----LTWDIRMNIILG 259
H +V+ +E ++ EY + +LD L G W I++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--- 117
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
G+ Y+H+ +++HRD+K+ NI L ++ DFG+++LL TT
Sbjct: 118 ---GVHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.004
Identities = 22/64 (34%), Positives = 36/64 (56%), Gaps = 10/64 (15%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVM-G 317
A GL +LH +++RD+K N++LD + + +++DFG +C E + TTR G
Sbjct: 111 AIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFG----MCKENIFGGKTTRTFCG 163
Query: 318 TFGY 321
T Y
Sbjct: 164 TPDY 167
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 175 GTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232
GT V V+ +L N + K + EV + RH N++ G++ ++ ++ G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ + L + ++ + NI+ G +GL YLH+ +HR++K+S+IL+ +
Sbjct: 85 SANSLLKTYFPE--GMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISG--D 137
Query: 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLF 332
VS GL+ L R+ +V+ + + F V P
Sbjct: 138 GLVSLSGLSHLYSLVRNGQKAKVV--YDFPQFSTSVLPWL 175
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 17/39 (43%), Positives = 26/39 (66%), Gaps = 3/39 (7%)
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 36/150 (24%), Positives = 66/150 (44%), Gaps = 12/150 (8%)
Query: 158 VIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLL 213
V+G+G +G V L G AVK L + + + + E ++ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V E+V+ G+L + I L +LH+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SALMFLHD--- 114
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+++RD+K N+LLD + + +++DFG+ K
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.004
Identities = 14/40 (35%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ + YLHE +++HRD+K+ NI ++ + + DFG A
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.95 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.82 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.8 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.8 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.64 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.61 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.51 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.43 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.22 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.21 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.05 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.04 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.86 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.74 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.69 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 98.67 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.65 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.46 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.39 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.3 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.22 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.21 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.14 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.12 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.08 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.99 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.89 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.85 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.73 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.71 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.5 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.42 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.12 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.09 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.87 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.78 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.71 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.71 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.7 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.58 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.29 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.24 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.8 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.69 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.66 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.59 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.39 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.04 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.96 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.94 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.86 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.04 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 93.99 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-48 Score=347.54 Aligned_cols=187 Identities=26% Similarity=0.447 Sum_probs=168.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.+|...+.||+|+||+||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||++++++++++.+|||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 45666777999999999999965 6899999999665 44456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC------CceEEecccCc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ------WNARVSDFGLA 301 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~------~~~kl~DFGla 301 (348)
||.||||.+|++.+ +.+++..+..++.|++.||++||++ +||||||||+||||+.. -.+||+|||+|
T Consensus 90 yC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred eCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999865 4699999999999999999999999 99999999999999764 45899999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|.+.. ......++|++.|||||+ |+||+|++||+|++|+.||.
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~ 215 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD 215 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence 99863 345566899999999995 99999999999999999997
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=334.88 Aligned_cols=189 Identities=26% Similarity=0.348 Sum_probs=168.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|++.++||+|+||+||.++.+ +++.+|+|.+.+.. ....+....|..+|.+++||+||+++..|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 456888999999999999999954 68999999996652 23345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
+||+.||.|...|.+. ..+++..+.-++.+|+.||.|||++ +||||||||+|||||.+|+++|+|||||+...
T Consensus 104 ld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 9999999999999754 5699999999999999999999999 99999999999999999999999999999654
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ..+..++||+.|||||+ |+||||+++|||++|.+||-
T Consensus 177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 433 24445899999999994 99999999999999999995
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-46 Score=348.54 Aligned_cols=189 Identities=26% Similarity=0.396 Sum_probs=172.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..|+..++||+|+|+.||.++. .+|..||+|++.+. +....+.+.+|+++.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4588889999999999999996 78999999999654 4456677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|+|..++|..+++++ .++++.++..++.||+.||.|||++ +|+|||||..|+|++++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999999854 6799999999999999999999999 999999999999999999999999999998865
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+.. .....+|||.|.|||+ ||||+||+||.|+.|++||.+
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 543 3445799999999995 999999999999999999964
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=340.97 Aligned_cols=208 Identities=54% Similarity=0.895 Sum_probs=182.1
Q ss_pred CccccchHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEE
Q 018991 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (348)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 216 (348)
..+.|++.++..++++|...+.||+|+||.||+|...+|..||||++........++|..|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34679999999999999999999999999999999998899999988655432155699999999999999999999999
Q ss_pred EECC-EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 217 VEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 217 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
.+.+ +.+||+||+++|+|.++|+..... +++|..+++|+.++|+||+|||+.+.+.|+||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999875432 8999999999999999999999987778999999999999999999999
Q ss_pred ecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 296 SDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+|||+|+..............||.+|++||. ||||||++|.||++|+.|..
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d 279 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVD 279 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccC
Confidence 9999997654311111111179999999993 99999999999999997754
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=335.96 Aligned_cols=189 Identities=26% Similarity=0.396 Sum_probs=165.4
Q ss_pred hcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcc-------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQ-------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.+.|.+.+.||+|+||.|-+|. .++|+.||||++.+.... ......+|+++|++|+|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 3456677899999999999999 457999999999655221 12345799999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CceEEecc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDF 298 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~---~~~kl~DF 298 (348)
.|+||||++||+|.+++-.+ +.+.++....++.|++.|+.|||++ ||+||||||+|||+..+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999999755 5678888899999999999999999 99999999999999766 78999999
Q ss_pred cCcccccCCCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|+... + ...+..+|||+.|.|||+ ||||+||+||-+++|.+||+.
T Consensus 324 GlAK~~g-~-~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 324 GLAKVSG-E-GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred chhhccc-c-ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 9999875 2 334556899999999995 999999999999999999984
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=326.09 Aligned_cols=183 Identities=27% Similarity=0.415 Sum_probs=166.3
Q ss_pred cCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-EEEEEEeecCC
Q 018991 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVYEYVDN 231 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e~~~~ 231 (348)
..+.||+|..|+||+++++ +++.+|+|.+..+ +....+++.+|+++++.++||+||++||.|..++ ...|+||||.+
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 3577999999999999976 6889999999544 5556788999999999999999999999999999 59999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
|+|.+++... +.+++...-.++.+|++||.|||+ + +||||||||+|||++..|++||||||.++.+.+.
T Consensus 163 GSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 163 GSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 9999999754 569999999999999999999996 5 9999999999999999999999999999988654
Q ss_pred cccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+..++||..||||| .||||||+.++||++|+|||..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 566789999999999 3999999999999999999974
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-46 Score=319.44 Aligned_cols=193 Identities=25% Similarity=0.361 Sum_probs=168.7
Q ss_pred CCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEee-EEEECCE-EEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLG-YCVEGAY-RMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~-~~~~~~~-~~lv~ 226 (348)
+|.+++.||+|+||.||++. ..+|..||.|.+.-. +.+..+++..|+.+|++|+|||||++++ .+.+++. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45567889999999999999 668999999988533 3455678999999999999999999999 5555555 89999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||.+|||.+.++........+++..+++++.|+|.||.++|.+. ++ |+||||||.||+|+.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999876666678999999999999999999999842 24 899999999999999999999999999998
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+... .+...+|||.||+||. ||||+||++|||+.-+.||.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~ 229 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFY 229 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcc
Confidence 76544 4556899999999994 99999999999999999995
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=306.69 Aligned_cols=184 Identities=26% Similarity=0.308 Sum_probs=165.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|+..+.||.|+||+|.+++.+ +|.-+|+|++.+..- +..+...+|..+|+.+.||+++++++.+.+...+|+|||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4566788999999999999965 688999999966532 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|++||.|..++++. +++++..+..++.||+.||+|||++ +|++|||||+|||+|.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred ccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999864 5799999999999999999999998 9999999999999999999999999999987543
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+-..||||.|+|||+ |+|||||++|||+.|.+||.
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~ 242 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFY 242 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCc
Confidence 445799999999994 99999999999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=326.13 Aligned_cols=193 Identities=24% Similarity=0.340 Sum_probs=170.3
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC---CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 221 (348)
....++|.+++.||+|+|++|++|+. .+++.||||++.+. +....+.+..|-+.|.+| .||.|++|+..|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 45667899999999999999999994 57899999988544 223345677889999999 89999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
+|+|+||+++|+|.++|++. +.|++.....++.+|+.||+|||++ |||||||||+|||||.++++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999854 6799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc----------c--cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERS----------Y--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~----------~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.+..... . ....++||..|.+||+ |||+|||+||.|+.|.+||+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr 288 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR 288 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence 98854221 1 1244899999999994 99999999999999999997
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=324.75 Aligned_cols=192 Identities=32% Similarity=0.528 Sum_probs=166.1
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc--hHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-EEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~e 227 (348)
..+...+.||+|+||+||+|.++....||+|.+...... ..++|.+|+.+|.+++|||||+++|++.+.. ..++|||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 334455679999999999999975444999999655322 2568999999999999999999999999887 7999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceecCCCCCCEEECCCC-ceEEecccCccccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQW-NARVSDFGLAKLLC 305 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~-ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~ 305 (348)
|+++|+|.++++.. ....+++..++.++.||++||.|||++ + ||||||||+|||++.++ ++||+|||+++...
T Consensus 121 y~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKV 195 (362)
T ss_pred eCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeec
Confidence 99999999999864 236799999999999999999999998 7 99999999999999997 99999999998765
Q ss_pred CCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
... ...+...||+.|||||+ ||||||++||||+||+.||..+
T Consensus 196 ~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~ 249 (362)
T KOG0192|consen 196 ISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDL 249 (362)
T ss_pred ccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCC
Confidence 432 23333789999999995 9999999999999999999864
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=320.93 Aligned_cols=193 Identities=24% Similarity=0.284 Sum_probs=167.3
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
....++|+..++||+|+||.||+|+.+ +|..+|+|++++..- ...+-++.|-.+|...++|+||++|..|++.+.+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345677889999999999999999954 699999999977643 2334577899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
||||||++|||+..+|... ..|+++.+..++.+++.|++-||.. |+|||||||+|+|||..|++||+|||||.
T Consensus 217 YLiMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~ 289 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLST 289 (550)
T ss_pred EEEEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccc
Confidence 9999999999999999754 6799999999999999999999998 99999999999999999999999999985
Q ss_pred cccC---------------------CCc-------------------------ccccccccCCCccccee----------
Q 018991 303 LLCS---------------------ERS-------------------------YVTTRVMGTFGYAHFIV---------- 326 (348)
Q Consensus 303 ~~~~---------------------~~~-------------------------~~~~~~~gt~~y~~pe~---------- 326 (348)
.+.. ... ..+...+|||.|+|||+
T Consensus 290 gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~c 369 (550)
T KOG0605|consen 290 GLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKEC 369 (550)
T ss_pred hhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccc
Confidence 4321 000 01123569999999996
Q ss_pred ccchHHHHHHHHHhccCCCC
Q 018991 327 QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 327 DiwSlG~il~el~~g~~Pf~ 346 (348)
|+||||||+|||+.|.+||.
T Consensus 370 DwWSLG~ImyEmLvGyPPF~ 389 (550)
T KOG0605|consen 370 DWWSLGCIMYEMLVGYPPFC 389 (550)
T ss_pred cHHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999996
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=325.07 Aligned_cols=187 Identities=28% Similarity=0.373 Sum_probs=168.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|.+.++||+|+||+||+|+. .+.+.||+|.+.+.. .+..+.+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4567778899999999999994 468899999986653 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+.| +|..+|..+ ..++++.+..++.++..||.|||++ +|+|||+||+|||++..+.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~~d----~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD----GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9986 999999755 5799999999999999999999999 9999999999999999999999999999987653
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
....+.+.|||.|||||. |+|||||+||||++|++||-
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence 445667899999999994 99999999999999999994
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=317.80 Aligned_cols=189 Identities=28% Similarity=0.343 Sum_probs=167.7
Q ss_pred cCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 225 (348)
+.|+..+.||+|.||.||+|+ ..+|+.||+|++.... .....-..+|+.+|++|+||||++|.+...+. ..+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 345566789999999999999 5689999999996554 34456678999999999999999999998876 689999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
+|||++ ||.-++.... -.|++.++..++.|++.||+|||++ +|+|||||.+|||||.+|.+||+|||||++..
T Consensus 197 FeYMdh-DL~GLl~~p~---vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG---VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred Eecccc-hhhhhhcCCC---cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeecc
Confidence 999986 9999886532 4699999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
.......+..+-|.+|.+|| +|+||.||||.||+.|++.|+
T Consensus 270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~ 321 (560)
T KOG0600|consen 270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQ 321 (560)
T ss_pred CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcC
Confidence 77766667778899999999 499999999999999999885
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=320.42 Aligned_cols=198 Identities=27% Similarity=0.414 Sum_probs=169.8
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+.+++.++.+...+.||+|.||.||.|.++....||+|.++... ...++|.+|+++|++|+|+|||++++++..++.+|
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 34445555566678899999999999999877799999987653 34578889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
||||||+.|+|.++|+.. ....+...+.+.++.|||+||+||+++ ++|||||.++||||+++..+||+||||||.
T Consensus 278 IVtE~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~ 352 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARL 352 (468)
T ss_pred EEEEecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccc
Confidence 999999999999999863 335688899999999999999999999 999999999999999999999999999996
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+.++.........-...|.|||+ |||||||+||||+| |+.|+..
T Consensus 353 ~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 353 IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 54444333333444567889995 99999999999998 8888865
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=316.32 Aligned_cols=191 Identities=29% Similarity=0.406 Sum_probs=166.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC----Cc-chHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN----RG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 221 (348)
...+|.+.+.||+|+||.|++|+. .++..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 345678889999999999999985 46899999966543 11 23456778999999999 9999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccC
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGL 300 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGl 300 (348)
.|+||||+.||+|.+++... .++.+..+..++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~----g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK----GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHHc----CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999763 5688999999999999999999999 99999999999999999 9999999999
Q ss_pred cccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+.... .........+||+.|+|||+ ||||+||+||.|++|++||..
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99874 22233455799999999994 999999999999999999963
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=300.01 Aligned_cols=187 Identities=23% Similarity=0.311 Sum_probs=161.8
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.|+....+|+|+||.||+|+.+ +|+.||||++.... +...+-..+|+++|++++|||+|.++.+|.....++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4556678999999999999965 69999999996653 33445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|+. ++.+-|.+.. ..++...+..++.|++.|+.|+|++ +++||||||+||||+.++.+||||||+|+.+....
T Consensus 83 ~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg 155 (396)
T KOG0593|consen 83 CDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG 155 (396)
T ss_pred cch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence 987 5555555432 3478899999999999999999999 99999999999999999999999999999987533
Q ss_pred cccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
...++.+.|.+|.||| +||||+||++.||++|++-|+
T Consensus 156 -d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 156 -DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred -chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 3445678899999999 499999999999999998775
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=319.82 Aligned_cols=190 Identities=25% Similarity=0.305 Sum_probs=166.5
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
...++|...++||+|+||+|+++..+ +++.+|||.+++.. ....+....|.+++... +||.++.++.+|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 44567889999999999999999965 68899999998763 23445677788887777 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|.||||+.||++..+.+. ..+++..+..++..|+.||.|||++ +||+||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~~~-----~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHT-----DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEec-----ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 999999999995544432 4699999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..-..+. .+..++|||.|||||+ |+|||||+||||+.|++||+
T Consensus 517 e~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~ 569 (694)
T KOG0694|consen 517 EGMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFP 569 (694)
T ss_pred ccCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCC
Confidence 8654433 5667999999999995 99999999999999999997
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=302.63 Aligned_cols=190 Identities=28% Similarity=0.388 Sum_probs=164.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC--EEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~e~ 228 (348)
++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3455688999999999999964 58999999986553333567899999999999999999999855444 68999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCcccccC-
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCS- 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~~~~- 306 (348)
+++|+|.+++.+..+ .+++..+..+..||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999986532 699999999999999999999999 9999999999999999 79999999999998763
Q ss_pred -CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 -ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 -~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..........||+.|||||+ |||||||++.||+||+.||+.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 22233445889999999995 999999999999999999875
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=282.10 Aligned_cols=187 Identities=25% Similarity=0.343 Sum_probs=163.2
Q ss_pred CCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.|...+.||+|.||.||+|+ .++|+.||||+++..+. .......+|+..|+.++|+||+.++++|...+.+.||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 45667889999999999999 56899999999976533 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++. +|...++.. ...++..++..++.++++||+|||.+ .|+||||||.|+|++.+|.+||+|||+|+......
T Consensus 83 m~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 985 999999754 35789999999999999999999999 99999999999999999999999999999987654
Q ss_pred cccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..... .+-|.+|.||| +||||.||++.||+-|.+=|+
T Consensus 156 ~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp 203 (318)
T KOG0659|consen 156 RIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP 203 (318)
T ss_pred ccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC
Confidence 43333 36789999999 499999999999998876553
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.48 Aligned_cols=196 Identities=29% Similarity=0.435 Sum_probs=171.7
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
+.++..+.+.+.||+|.||.|.+|....+..||+|+++..... .+.+|.+|+.+|.+|+||||++++|+|..++.++++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 4677888889999999999999999887899999999876544 458999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
+||+++|+|.+|+..+... ...-....+|+.||+.||+||.+. ++|||||.++|||++.++++||+|||++|.+.
T Consensus 614 ~EYmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccc
Confidence 9999999999999876332 234455678999999999999988 99999999999999999999999999999888
Q ss_pred CCCccccc-ccccCCCccccee----------ccchHHHHHHHHHh--ccCCCCC
Q 018991 306 SERSYVTT-RVMGTFGYAHFIV----------QVSPLFILLYILLS--VRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~-~~~gt~~y~~pe~----------DiwSlG~il~el~~--g~~Pf~~ 347 (348)
....|... ..+-...|||||+ |+|+||++|||+++ .+-||++
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~ 743 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQ 743 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhh
Confidence 77665443 4667789999995 99999999999764 6778875
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.83 Aligned_cols=187 Identities=25% Similarity=0.392 Sum_probs=164.2
Q ss_pred cCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcch---HHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..|++.+.||+|.||+|-++. ...|+.||||.++++.-+. .-.+.+|+++|..|+||||+.+|.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 456667889999999999999 4679999999997764443 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||..+|.|.+|+.++ ..+++.+...+++||.+|+.|+|.+ +++|||||.+|||+|.++.+||+||||+.....
T Consensus 133 EYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999866 5699999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ....++|++-|++|| +|-||||++||.|++|..||-
T Consensus 206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 32 334467777777665 599999999999999999994
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=308.06 Aligned_cols=188 Identities=26% Similarity=0.345 Sum_probs=170.1
Q ss_pred hcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
...|..-+.||+|+-|.||.++ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|.-.+.+|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3456666789999999999999 457889999999877766677788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++||+|.+.+... .+++.++..+++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||+|..+....
T Consensus 352 m~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred cCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 9999999998653 489999999999999999999999 99999999999999999999999999999887665
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. .....+|||+|||||+ ||||||++++||+.|++||-
T Consensus 424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 5 3444789999999995 99999999999999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=305.62 Aligned_cols=187 Identities=26% Similarity=0.320 Sum_probs=165.4
Q ss_pred cCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHH-HHHHHHHHHhcCC-CCCeeeEeeEEEECC-EEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVR-HKNLVRLLGYCVEGA-YRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-H~nIv~l~~~~~~~~-~~~lv~ 226 (348)
++|...+.||.|+||.||+|+ ..+|..||||++++......+ .-.+|+..|++|+ ||||+++.+++.+.+ .+|+||
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf 89 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF 89 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence 456667889999999999999 567899999999766443332 2357999999998 999999999999988 999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||+ .+|.++++.+ ...|++..+..|+.||++||+|+|.+ |++|||+||+|||+.....+||+|||+||.+.+
T Consensus 90 E~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 90 EFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred Hhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccccccc
Confidence 9997 4999999876 36899999999999999999999999 999999999999999888999999999999876
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...| ++.+-|.+|.|||+ ||||+||+++|+++=++-|+
T Consensus 163 kpPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 163 KPPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred CCCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 6544 66789999999995 99999999999999988875
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=321.97 Aligned_cols=198 Identities=29% Similarity=0.482 Sum_probs=172.5
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
.+..+.+....+.||+|+||+||+|+.. +...||||.++..... ..++|++|+++|..++|||||+++|+|..
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 3455666677788999999999999843 3467999999877555 78899999999999999999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------D----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
++.+++|+|||..|||.+||+.+.. . ..+++..+.+.|+.|||.||+||-++ .+|||||..+|+||.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVG 637 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceec
Confidence 9999999999999999999974321 1 23488999999999999999999998 999999999999999
Q ss_pred CCCceEEecccCcccccCCCccccc-ccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 289 RQWNARVSDFGLAKLLCSERSYVTT-RVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~~~~~~~~-~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
++..|||+||||+|.+.+.+.|... ...-...||+||+ ||||+||+|||+++ |+.|+-
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~ 707 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYY 707 (774)
T ss_pred cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccc
Confidence 9999999999999999888777655 3455678999995 99999999999998 888864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=303.28 Aligned_cols=189 Identities=22% Similarity=0.262 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|+..+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++.+++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 36788899999999999999954 68899999986532 223346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 999999999999753 4689999999999999999999998 999999999999999999999999999976532
Q ss_pred CCc----------------------------------ccccccccCCCccccee----------ccchHHHHHHHHHhcc
Q 018991 307 ERS----------------------------------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVR 342 (348)
Q Consensus 307 ~~~----------------------------------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~ 342 (348)
... ......+||+.|+|||+ |||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 00123579999999994 9999999999999999
Q ss_pred CCCC
Q 018991 343 YNSS 346 (348)
Q Consensus 343 ~Pf~ 346 (348)
+||.
T Consensus 234 ~Pf~ 237 (363)
T cd05628 234 PPFC 237 (363)
T ss_pred CCCC
Confidence 9996
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=296.59 Aligned_cols=194 Identities=25% Similarity=0.308 Sum_probs=161.8
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--------------chHHHHHHHHHHHhcCCCCCee
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--------------QAEKEFKVEVEVIGRVRHKNLV 210 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~H~nIv 210 (348)
-....+.|++.+.||+|.||.|-+|+. .+++.||||++.+... ...+...+|+.+|++|.|||||
T Consensus 92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV 171 (576)
T KOG0585|consen 92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV 171 (576)
T ss_pred cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence 345567899999999999999999995 4789999999854321 1124688999999999999999
Q ss_pred eEeeEEEEC--CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 211 RLLGYCVEG--AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 211 ~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
+|+.+..+. +.+|||+|||..|.+...-. +...+++.++..+++++..||+|||.+ +||||||||+|+||+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 999998764 67899999999988765321 212389999999999999999999999 999999999999999
Q ss_pred CCCceEEecccCcccccCC----CcccccccccCCCccccee--------------ccchHHHHHHHHHhccCCCC
Q 018991 289 RQWNARVSDFGLAKLLCSE----RSYVTTRVMGTFGYAHFIV--------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~~----~~~~~~~~~gt~~y~~pe~--------------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+|++||+|||.+...... .........|||.|+|||. ||||+||+||-|+.|++||-
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 9999999999999865221 1112233689999999994 99999999999999999994
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=303.65 Aligned_cols=195 Identities=20% Similarity=0.214 Sum_probs=168.2
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
++....++|++.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34445678899999999999999999965 58899999885421 223445778999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 999999999999999998642 478889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
++.+............||+.|+||| +|||||||+||+|++|++||..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~ 249 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCC
Confidence 9876544333334567999999998 4999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=304.03 Aligned_cols=197 Identities=28% Similarity=0.461 Sum_probs=170.7
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
...+++++..+.+.+.+.||+|+||+||+|+|.. .||||.+..... ...+.|++|+..+++-+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 4457888888889999999999999999999853 699999976643 345789999999999999999999999988
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
... .||+.+|+|.+|+.+++... ..|.....+.|++||++||.|||.+ +|||||||..||++.++++|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecc
Confidence 876 89999999999999998653 5688889999999999999999999 9999999999999999999999999
Q ss_pred cCcccccC-CCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCS-ERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~-~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~ 346 (348)
||+..-.. ..........|...|||||+ |||||||++|||++|.+||+
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 99864221 11122223468889999995 99999999999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=306.32 Aligned_cols=185 Identities=25% Similarity=0.350 Sum_probs=164.2
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|++++.||+|+-|.|.+|++ .+|+.+|||++.+.. ......+.+|+-+|+-+.|||++++|+++++..++|+|+||
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy 93 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY 93 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence 55678899999999999994 589999999996542 22235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|.|++++.+. +++++.++.+++.||+.|+.|+|.. +|+||||||+|+|||..+.+||+|||+|..-...
T Consensus 94 v~gGELFdylv~k----G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g- 165 (786)
T KOG0588|consen 94 VPGGELFDYLVRK----GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG- 165 (786)
T ss_pred cCCchhHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC-
Confidence 9999999999754 6799999999999999999999998 9999999999999999999999999999764332
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....-||+|.|++||+ ||||+|||||.|++|++||-
T Consensus 166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 23344699999999995 99999999999999999995
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=301.61 Aligned_cols=190 Identities=23% Similarity=0.296 Sum_probs=163.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36788899999999999999964 68999999986532 223356778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 999999999998753 4589999999999999999999998 999999999999999999999999999876532
Q ss_pred CCcc-------------------------------------cccccccCCCccccee----------ccchHHHHHHHHH
Q 018991 307 ERSY-------------------------------------VTTRVMGTFGYAHFIV----------QVSPLFILLYILL 339 (348)
Q Consensus 307 ~~~~-------------------------------------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~ 339 (348)
.... .....+||+.|+|||+ |||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 1112469999999993 9999999999999
Q ss_pred hccCCCCC
Q 018991 340 SVRYNSST 347 (348)
Q Consensus 340 ~g~~Pf~~ 347 (348)
+|++||..
T Consensus 234 ~G~~Pf~~ 241 (364)
T cd05599 234 VGYPPFCS 241 (364)
T ss_pred cCCCCCCC
Confidence 99999963
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=289.05 Aligned_cols=194 Identities=23% Similarity=0.273 Sum_probs=171.2
Q ss_pred HhcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..+.|++.++||.|.-+.||+|+ ...+..||||++.-.+. ...+.+.+|+..|+.++||||++++..|..+..+|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 34567888999999999999999 45689999999965433 33578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
.||.+|++.++++..... .+++..+..|++++++||.|||.+ |.||||+|+.||||+.+|.+||+|||.+..+..
T Consensus 104 pfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred hhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 999999999999865433 489999999999999999999999 999999999999999999999999999877765
Q ss_pred CCcccc---cccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVT---TRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~---~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ..+.||+.|||||+ ||||||++..||++|..||+.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k 234 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK 234 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence 442211 44789999999996 999999999999999999986
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=284.01 Aligned_cols=195 Identities=27% Similarity=0.349 Sum_probs=164.8
Q ss_pred CccccchHHHHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc--hHHHHHHHHHHHhcCCCCCeeeEe
Q 018991 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLL 213 (348)
Q Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~ 213 (348)
..++.+.++++ ..+.|++|+||.||+|+. ++++.||+|+++..... ..-.-.+|+.+|.+++|||||.+.
T Consensus 69 l~gCrsv~efe-------~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vk 141 (419)
T KOG0663|consen 69 LGGCRSVEEFE-------KLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVK 141 (419)
T ss_pred ccCcccHHHHH-------HHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeE
Confidence 34455565544 467799999999999995 57899999999765432 123457899999999999999999
Q ss_pred eEEEEC--CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 018991 214 GYCVEG--AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (348)
Q Consensus 214 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~ 291 (348)
.+.... +.+|+|||||+. ||..++..-. +++...++..++.|+++|++|||.+ .|+||||||+|+|++..|
T Consensus 142 EVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G 214 (419)
T KOG0663|consen 142 EVVVGSNMDKIYIVMEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKG 214 (419)
T ss_pred EEEeccccceeeeeHHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCC
Confidence 988754 579999999986 9999997542 5799999999999999999999999 899999999999999999
Q ss_pred ceEEecccCcccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 292 NARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 292 ~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
.+||+|||+||....... ..+..+-|.+|.||| +|+||+|||+.||+++++-|+
T Consensus 215 ~lKiaDFGLAR~ygsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~ 279 (419)
T KOG0663|consen 215 ILKIADFGLAREYGSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFP 279 (419)
T ss_pred cEEecccchhhhhcCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCC
Confidence 999999999998876533 344567899999999 399999999999999998775
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=301.29 Aligned_cols=188 Identities=19% Similarity=0.237 Sum_probs=161.0
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.|...+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 477788999999999999995 468899999986542 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 99999999998753 4588899999999999999999998 9999999999999999999999999998643210
Q ss_pred Cc----------------------------------------------ccccccccCCCccccee----------ccchH
Q 018991 308 RS----------------------------------------------YVTTRVMGTFGYAHFIV----------QVSPL 331 (348)
Q Consensus 308 ~~----------------------------------------------~~~~~~~gt~~y~~pe~----------DiwSl 331 (348)
.. .......||+.|+|||. |||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 00123579999999994 99999
Q ss_pred HHHHHHHHhccCCCC
Q 018991 332 FILLYILLSVRYNSS 346 (348)
Q Consensus 332 G~il~el~~g~~Pf~ 346 (348)
||++|||++|+.||.
T Consensus 235 G~il~elltG~~Pf~ 249 (381)
T cd05626 235 GVILFEMLVGQPPFL 249 (381)
T ss_pred hhHHHHHHhCCCCCc
Confidence 999999999999995
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=284.87 Aligned_cols=189 Identities=24% Similarity=0.340 Sum_probs=159.6
Q ss_pred CCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCC-eeeEeeEEEECC------EE
Q 018991 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGA------YR 222 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~------~~ 222 (348)
|...+.||+|+||+||+|+ ..+|+.||+|++.-... .......+|+.+|+.++|+| |+.+++++.+.+ .+
T Consensus 13 ~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l 92 (323)
T KOG0594|consen 13 YEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKL 92 (323)
T ss_pred HHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceE
Confidence 3344569999999999999 55789999999965533 24456788999999999999 999999998877 88
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++|+||+.. +|..++.........++...+..++.|++.||+|||++ +|+||||||+||||+++|.+||+|||+|+
T Consensus 93 ~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 93 YLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHH
Confidence 999999975 99999986532213466688999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...-+... .+...+|.+|.|||+ ||||+|||++||++++.-|+
T Consensus 169 a~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFp 222 (323)
T KOG0594|consen 169 AFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFP 222 (323)
T ss_pred HhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCC
Confidence 76533322 334578899999994 99999999999999998885
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=301.72 Aligned_cols=189 Identities=23% Similarity=0.290 Sum_probs=161.1
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3677889999999999999985 468999999886432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999998643 4588999999999999999999998 999999999999999999999999999964321
Q ss_pred CCc----------------------------------------------ccccccccCCCccccee----------ccch
Q 018991 307 ERS----------------------------------------------YVTTRVMGTFGYAHFIV----------QVSP 330 (348)
Q Consensus 307 ~~~----------------------------------------------~~~~~~~gt~~y~~pe~----------DiwS 330 (348)
... ......+||+.|+|||+ ||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 00012469999999994 9999
Q ss_pred HHHHHHHHHhccCCCC
Q 018991 331 LFILLYILLSVRYNSS 346 (348)
Q Consensus 331 lG~il~el~~g~~Pf~ 346 (348)
|||+||||++|++||.
T Consensus 234 lGvil~elltG~~Pf~ 249 (377)
T cd05629 234 LGAIMFECLIGWPPFC 249 (377)
T ss_pred cchhhhhhhcCCCCCC
Confidence 9999999999999995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.14 Aligned_cols=188 Identities=21% Similarity=0.263 Sum_probs=160.5
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.|...+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.++++++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 477788999999999999995 468899999986432 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998653 4588899999999999999999998 9999999999999999999999999997543100
Q ss_pred C----------------------------------------------cccccccccCCCccccee----------ccchH
Q 018991 308 R----------------------------------------------SYVTTRVMGTFGYAHFIV----------QVSPL 331 (348)
Q Consensus 308 ~----------------------------------------------~~~~~~~~gt~~y~~pe~----------DiwSl 331 (348)
. ........||+.|+|||+ |||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 000123579999999994 99999
Q ss_pred HHHHHHHHhccCCCC
Q 018991 332 FILLYILLSVRYNSS 346 (348)
Q Consensus 332 G~il~el~~g~~Pf~ 346 (348)
||+||||++|++||.
T Consensus 235 Gvil~elltG~~Pf~ 249 (382)
T cd05625 235 GVILYEMLVGQPPFL 249 (382)
T ss_pred hHHHHHHHhCCCCCC
Confidence 999999999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=299.85 Aligned_cols=196 Identities=21% Similarity=0.228 Sum_probs=169.6
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
+.+++...++|.+.+.||+|+||.||+++.. +++.+|+|.+.... ......+.+|+.++..++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 4455566788999999999999999999965 68899999885422 2233457789999999999999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
++..|+||||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 99999999999999999998642 478888999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
|+++.+............||+.|+||| +|||||||+||||++|++||.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 999877544433334567999999998 399999999999999999996
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=295.08 Aligned_cols=186 Identities=22% Similarity=0.274 Sum_probs=163.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..|++|
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 45777899999999999999965 68899999986532 223456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 999999999998753 4588899999999999999999998 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 217 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD 217 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCC
Confidence 22 23579999999994 999999999999999999963
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.19 Aligned_cols=183 Identities=25% Similarity=0.265 Sum_probs=158.6
Q ss_pred ceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
+.||+|+||.||+++. .+|+.||+|.+.... ......+..|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999995 468999999986542 223346778999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~ 152 (323)
T cd05571 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cc
Confidence 999998653 4689999999999999999999998 999999999999999999999999999986432221 22
Q ss_pred cccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 313 TRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCC
Confidence 34679999999994 999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=273.68 Aligned_cols=189 Identities=27% Similarity=0.367 Sum_probs=166.5
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++++.||+|-||.||+|+. +++..||+|.+.+.. ....+++.+|+++-+.|+||||.++|++|.++...||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 4567788999999999999995 468899999996652 334568899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||.+.|.|...|.... ...+++.....++.|+|.||.|+|.+ +|+||||||+|+|++.++.+||+|||.+-.-.
T Consensus 102 Eya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999997543 35688888899999999999999998 99999999999999999999999999987543
Q ss_pred CCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......+||..|.+|| +|+|++|++.||++.|.+||..
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes 224 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFES 224 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhh
Confidence 22344579999999999 3999999999999999999963
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=286.51 Aligned_cols=191 Identities=23% Similarity=0.210 Sum_probs=163.4
Q ss_pred cCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
+.|+..+.||+|.-|+||+++.++ +..+|+|.+.+... +...+.+.|.+||+.++||.++.||+.|+.++..|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345556789999999999999764 68999999966532 23346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||+||+|..+++++. ...+++..+..++.+|+.||+|||.. |||.|||||+||||-++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999987653 46799999999999999999999998 999999999999999999999999988743210
Q ss_pred ---------------------------------C-C---------------------cccccccccCCCccccee-----
Q 018991 307 ---------------------------------E-R---------------------SYVTTRVMGTFGYAHFIV----- 326 (348)
Q Consensus 307 ---------------------------------~-~---------------------~~~~~~~~gt~~y~~pe~----- 326 (348)
. . ......++||..|.|||+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 0 012223789999999995
Q ss_pred -----ccchHHHHHHHHHhccCCCC
Q 018991 327 -----QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 327 -----DiwSlG~il~el~~g~~Pf~ 346 (348)
|||+|||+||||++|..||+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFK 336 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFK 336 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcC
Confidence 99999999999999999997
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=299.61 Aligned_cols=191 Identities=20% Similarity=0.213 Sum_probs=165.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
...++|.+.+.||+|+||.||+++.. ++..||+|.+.... ......+..|+.+++.++||||+++++++.+++..|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34567888899999999999999964 68899999986432 223345778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 999999999999998642 478888999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+............||+.|+||| +|||||||+||||++|++||.
T Consensus 192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 6544333334467999999998 399999999999999999996
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=290.11 Aligned_cols=185 Identities=26% Similarity=0.296 Sum_probs=162.9
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|++.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5778899999999999999965 68999999986432 2234568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 82 YVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998754 4588999999999999999999998 9999999999999999999999999999876432
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 155 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~ 200 (291)
T cd05612 155 T----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD 200 (291)
T ss_pred c----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 23578999999993 999999999999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=293.76 Aligned_cols=185 Identities=26% Similarity=0.333 Sum_probs=163.6
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|++++..++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5778899999999999999965 58899999986542 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 82 YVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999643 4588999999999999999999998 999999999999999999999999999986543
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......||+.|+|||. |||||||++|||++|++||..
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 200 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCC
Confidence 2334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=301.09 Aligned_cols=187 Identities=26% Similarity=0.445 Sum_probs=164.0
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.|+++.+....++-||.|+-|.||+|+++ ++.||||+++.-+ ..++..|++|+||||+.+.|+|.....+||
T Consensus 118 ~WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCI 189 (904)
T KOG4721|consen 118 LWEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCI 189 (904)
T ss_pred hccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEE
Confidence 34555556666788999999999999986 5789999774322 246788999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||||..|.|...|+.. .+++......+..+||.||+|||.+ .|||||||.-||||..+..+||+|||.++.+
T Consensus 190 iMEfCa~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~ 262 (904)
T KOG4721|consen 190 IMEFCAQGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKEL 262 (904)
T ss_pred eeeccccccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhh
Confidence 99999999999999865 4678888899999999999999999 9999999999999999999999999999987
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
... .....++||..|||||+ |||||||+||||+||+.|+++|
T Consensus 263 ~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 263 SDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred hhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 554 23345899999999995 9999999999999999999875
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=300.59 Aligned_cols=188 Identities=21% Similarity=0.256 Sum_probs=160.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+++|..++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5788899999999999999954 68899999885432 1233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 82 YIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 99999999999653 4588899999999999999999998 9999999999999999999999999998533100
Q ss_pred C------------------------------------------cccccccccCCCccccee----------ccchHHHHH
Q 018991 308 R------------------------------------------SYVTTRVMGTFGYAHFIV----------QVSPLFILL 335 (348)
Q Consensus 308 ~------------------------------------------~~~~~~~~gt~~y~~pe~----------DiwSlG~il 335 (348)
. ........||+.|+|||+ |||||||+|
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 001123579999999994 999999999
Q ss_pred HHHHhccCCCC
Q 018991 336 YILLSVRYNSS 346 (348)
Q Consensus 336 ~el~~g~~Pf~ 346 (348)
|||++|++||.
T Consensus 235 yell~G~~Pf~ 245 (376)
T cd05598 235 YEMLVGQPPFL 245 (376)
T ss_pred eehhhCCCCCC
Confidence 99999999996
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=294.37 Aligned_cols=187 Identities=23% Similarity=0.295 Sum_probs=162.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECC--CcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD--GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+.||+|+||.||+|.++. +..||+|.+.... ....+.+..|+.++..++||||+++++++.+++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3457788999999999999998543 3689999885432 2334567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 109 v~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 99999999999999754 4588999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... .....||+.|+|||+ |||||||++|||++|++||..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 230 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYA 230 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCC
Confidence 432 223579999999994 999999999999999999964
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=284.30 Aligned_cols=187 Identities=25% Similarity=0.268 Sum_probs=161.3
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|+..+.||+|+||.||++.. .+++.||+|.+..... .....+.+|+.++.+++|+||+++++++.+++..+++|||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66678999999999999995 5789999998864421 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMG--NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999998875432 23588999999999999999999998 99999999999999999999999999998754322
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. .....||..|+|||+ |||||||++|+|++|+.||.
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 202 (285)
T cd05631 157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202 (285)
T ss_pred e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCC
Confidence 2 233578999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=289.44 Aligned_cols=183 Identities=25% Similarity=0.264 Sum_probs=158.0
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
+.||+|+||.||+++.. +|..||+|.+.... ......+..|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999986542 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 152 (323)
T cd05595 81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-TM 152 (323)
T ss_pred cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-cc
Confidence 999888643 4689999999999999999999998 999999999999999999999999999876432221 22
Q ss_pred cccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 313 TRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....||+.|+|||. |||||||++|||++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 33579999999994 999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=291.03 Aligned_cols=191 Identities=23% Similarity=0.212 Sum_probs=164.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ......+..|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36788899999999999999964 67889999886432 222345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 Ey~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 9999999999997532 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
..........||+.|+||| +|||||||+||+|++|++||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 4433333467999999998 3999999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=293.24 Aligned_cols=198 Identities=27% Similarity=0.394 Sum_probs=162.3
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+++.++|++.+.||+|+||.||+|.+ .++..||+|.+..... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 34567788899999999999999974 2356799999865432 3345788999999999 89999999998876
Q ss_pred C-CEEEEEEeecCCCCHHHHHhcCCCC-----------------------------------------------------
Q 018991 219 G-AYRMLVYEYVDNGNLDQWLHGDVGD----------------------------------------------------- 244 (348)
Q Consensus 219 ~-~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 244 (348)
. +..+++|||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999998753210
Q ss_pred -----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc-ccccccC
Q 018991 245 -----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGT 318 (348)
Q Consensus 245 -----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt 318 (348)
..++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+....... .....++
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~ 239 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCC
Confidence 13578888999999999999999998 99999999999999999999999999998764433222 2234566
Q ss_pred CCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 319 FGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 319 ~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..|+|||+ |||||||+||||++ |..||..
T Consensus 240 ~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~ 279 (338)
T cd05102 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 279 (338)
T ss_pred ccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCC
Confidence 78999993 99999999999997 9999963
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-39 Score=284.92 Aligned_cols=184 Identities=25% Similarity=0.354 Sum_probs=152.1
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-----EEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRMLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~lv~ 226 (348)
|...+++|.|+||.||+|.. ++++.||||++..+..- -.+|+++|++++|||||++..+|.... ...+||
T Consensus 26 ~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 26 YEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 44568899999999999995 46789999998665432 235899999999999999998886432 235799
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla~~~~ 305 (348)
||++. +|.++++........++.-.+.-+..|+++||.|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+.
T Consensus 102 eymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 99986 99999985333335677777888999999999999998 99999999999999966 899999999999986
Q ss_pred CCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..... .....|..|.||| +||||.||++.||+-|++=|+
T Consensus 178 ~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFp 227 (364)
T KOG0658|consen 178 KGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFP 227 (364)
T ss_pred cCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccC
Confidence 54432 3346778899999 399999999999999998885
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.34 Aligned_cols=190 Identities=23% Similarity=0.228 Sum_probs=164.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+..|..++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 36788899999999999999954 6889999998642 1223355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 9999999999996432 4588999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..........||+.|+||| +|||||||++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 4333333357999999997 399999999999999999995
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=289.41 Aligned_cols=183 Identities=26% Similarity=0.284 Sum_probs=158.6
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999954 68999999986542 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 999888643 4689999999999999999999998 99999999999999999999999999998643222 122
Q ss_pred cccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 313 TRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCC
Confidence 34679999999994 999999999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.46 Aligned_cols=188 Identities=27% Similarity=0.266 Sum_probs=162.4
Q ss_pred CCCcCceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
+|++.+.||+|+||.||+++. .+++.||+|.+.... ....+.+..|+.++..+ +||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999985 257899999886432 22335677899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 9999999999999998653 4588999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..............||+.|+|||. |||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~ 208 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFT 208 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCC
Confidence 754443333445679999999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=294.97 Aligned_cols=188 Identities=22% Similarity=0.267 Sum_probs=162.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|+..+.||+|+||.||+++.. +++.||+|.+.... ......+..|+.++..++||||+++++.+.+.+..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5777899999999999999964 68899999986432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 82 ~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 82 FLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred CCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998653 4588999999999999999999998 9999999999999999999999999998755321
Q ss_pred Cc----------------------------------ccccccccCCCccccee----------ccchHHHHHHHHHhccC
Q 018991 308 RS----------------------------------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRY 343 (348)
Q Consensus 308 ~~----------------------------------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~ 343 (348)
.. ......+||+.|+|||+ |||||||++|||++|++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 01123579999999994 99999999999999999
Q ss_pred CCC
Q 018991 344 NSS 346 (348)
Q Consensus 344 Pf~ 346 (348)
||.
T Consensus 235 Pf~ 237 (360)
T cd05627 235 PFC 237 (360)
T ss_pred CCC
Confidence 995
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=286.59 Aligned_cols=181 Identities=25% Similarity=0.233 Sum_probs=157.4
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999965 58899999986432 23345677899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 9998653 4588999999999999999999998 99999999999999999999999999998643322 22334
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..||+.|+|||. |||||||++|+|++|+.||..
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCC
Confidence 679999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=288.55 Aligned_cols=191 Identities=23% Similarity=0.210 Sum_probs=164.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+++.+ +++.+|+|.+.+.. ......+..|..++..++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36778899999999999999965 57889999885421 122345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 ey~~~g~L~~~l~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKFE---DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 9999999999997532 3588999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
..........||+.|+||| +|||||||+||||++|+.||..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 4333334467999999998 3999999999999999999963
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=293.82 Aligned_cols=190 Identities=23% Similarity=0.344 Sum_probs=169.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE-EEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY-RMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~-~~lv~ 226 (348)
++|...+++|+|+||.+++++++ ++..+++|.+.... ...++....|+.++++++|||||.+.+.|..++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 45777889999999999999954 67899999986543 3344567889999999999999999999998887 99999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
+||+||+|.+.+...+ ...++++.+..++.|++.|+.|||++ +|+|||||+.|||++.++.+||.|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998764 35689999999999999999999988 999999999999999999999999999999876
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.. .+..+.||+.||.||. |||||||++|||++-+.+|+
T Consensus 159 ~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 159 EDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred chh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC
Confidence 653 4556899999999994 99999999999999999996
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=292.56 Aligned_cols=190 Identities=23% Similarity=0.269 Sum_probs=165.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+..|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 35778899999999999999965 68999999986542 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999754 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CC----------------------------cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ER----------------------------SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~----------------------------~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ........||+.|+|||. |||||||+||||++|++||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 33 112233579999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=291.76 Aligned_cols=188 Identities=26% Similarity=0.343 Sum_probs=166.9
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|...+.||+|+||.||+|.. ++++.||+|++.-.. ....+++++|+.+|.+++++||.++|+.+..+..+|++||||.
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~ 94 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCG 94 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhc
Confidence 45557899999999999995 468899999996543 3445789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
||++.+.|+.. ..+.+..+.-++++++.||.|||.+ +.+|||||+.|||+..+|.+|++|||++..+......
T Consensus 95 gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 95 GGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred CcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999754 3447778888999999999999999 9999999999999999999999999999988765544
Q ss_pred cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
. ..++||+.|||||+ ||||||++.|||++|.+|++.+
T Consensus 168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~ 214 (467)
T KOG0201|consen 168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKL 214 (467)
T ss_pred c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCccc
Confidence 3 66899999999995 9999999999999999999864
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=290.95 Aligned_cols=190 Identities=21% Similarity=0.221 Sum_probs=166.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+++.. +++.||+|.+..... ...+.+..|+.++..++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36788899999999999999954 688999999865422 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRYE---DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 9999999999997542 4689999999999999999999998 999999999999999999999999999987755
Q ss_pred CCcccccccccCCCcccce----------------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..........||+.|+||| +|||||||++|||++|++||.
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCC
Confidence 4433333457899999998 399999999999999999996
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=318.05 Aligned_cols=197 Identities=23% Similarity=0.238 Sum_probs=179.2
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEec---CCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
..+++...++|.+.++||+|+||.|..++++ +++.||+|++.+ -+.....-|..|-.+|...+.+.|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 5677788899999999999999999999964 688999998854 233344568899999999999999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
+.++|+||||++||||..++... .+++++.+..++..|..||+-||+. |+|||||||+|||||.+|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999754 3699999999999999999999988 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~ 346 (348)
|.|-.+..++.-.....+|||.|.+||+ |+||+||++|||++|..||.
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 9999998888777777899999999995 99999999999999999995
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=300.76 Aligned_cols=192 Identities=21% Similarity=0.257 Sum_probs=165.7
Q ss_pred CCcCceEeecCceEEEEEEEC-C-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-D-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|.+.+.||+|+||.||++... + +..||+|.+..........+..|+.+|+.++||||+++++++...+..|+||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 667789999999999999843 4 67889997755554555677889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc-
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS- 309 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~- 309 (348)
+|+|.+++........++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999998865433445789999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......+||+.|+|||. |||||||++|+|++|+.||..
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~ 273 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 12334679999999994 999999999999999999963
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=285.59 Aligned_cols=183 Identities=28% Similarity=0.373 Sum_probs=157.4
Q ss_pred ceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+++|+.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999985 257889999986432 22334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++... ..+.+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 9999999998654 4578888999999999999999998 99999999999999999999999999997543322
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||. |||||||+||||++|++||..
T Consensus 155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 155 T-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred C-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 2 2233579999999993 999999999999999999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=287.29 Aligned_cols=182 Identities=25% Similarity=0.259 Sum_probs=156.9
Q ss_pred ceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|++++..++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3699999999999995 468999999986542 223356678999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
+|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 999988643 468999999999999999999997 6 899999999999999999999999999876432222 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||. |||||||+||+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCC
Confidence 233579999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=279.59 Aligned_cols=190 Identities=25% Similarity=0.244 Sum_probs=165.8
Q ss_pred hcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHH---HHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~---~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|...++||+|.||+|-+|+ ..+++.+|+|++++..-....+ -..|-++|+..+||.+..+...|+.++++|.|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3457778999999999999999 4579999999997664333333 45688999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||..||.|.-.|.+. ..++++....+-.+|..||.|||++ +||.||||.+|+|+|.+|++||+|||+++.-.
T Consensus 247 MeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 9999999998887654 4688999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ..+..++|||.|.|||+ |+|.+|+++|||++|++||.+
T Consensus 320 ~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 320 KYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred ccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 332 34556899999999995 999999999999999999975
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=288.94 Aligned_cols=187 Identities=27% Similarity=0.345 Sum_probs=166.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc---hHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~l 224 (348)
...|.+.+.||+|.||.||+|+.+ +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 445777788999999999999965 5999999999766443 3468899999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC----CCceEEecccC
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGL 300 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~----~~~~kl~DFGl 300 (348)
|||+|.||.|.+.+... .+++..+..++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999754 289999999999999999999998 9999999999999953 35799999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+..... .......+||+.|+|||+ ||||+|+++|.|++|..||.
T Consensus 186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~ 239 (382)
T KOG0032|consen 186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFW 239 (382)
T ss_pred ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCc
Confidence 998765 445666899999999995 99999999999999999995
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=280.71 Aligned_cols=190 Identities=21% Similarity=0.264 Sum_probs=162.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+.+|++++..++||||+++++++..++..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 35788899999999999999975 57899999986542 2334567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|++++.+..+.... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEMP----NGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 99987666554322 4588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.........|++.|+|||+ |||||||++|||++|++||..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~ 203 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPG 203 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCC
Confidence 3333334678999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=281.40 Aligned_cols=190 Identities=22% Similarity=0.300 Sum_probs=161.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 356888899999999999999965 688999999864432 223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+. ++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKHP---GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 996 68888876432 4578889999999999999999998 9999999999999999999999999999765332
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 157 SH-TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred Cc-cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 21 2233568899999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=280.08 Aligned_cols=189 Identities=24% Similarity=0.348 Sum_probs=161.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|.+.+.||+|+||.||+|+.+ ++..||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 45778899999999999999964 68899999886443 22345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNCG---NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 985 9999886432 3578899999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+++.|+|||. ||||+||++|+|++|++||..
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2233468899999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=283.43 Aligned_cols=183 Identities=23% Similarity=0.284 Sum_probs=154.9
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhc-CCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
++||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++.. .+||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 57899999986542 2223445566666665 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 9999998653 4588999999999999999999998 99999999999999999999999999998653322 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~ 198 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCC
Confidence 334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=283.22 Aligned_cols=187 Identities=22% Similarity=0.229 Sum_probs=159.2
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCC-CeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHK-NLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~ 226 (348)
+|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..++|+ +|+++++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4677889999999999999965 57899999986542 23345677899999999765 5889999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 999999999998643 4588999999999999999999998 999999999999999999999999999875322
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .......||+.|+|||+ ||||+||++|+|++|+.||.
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~ 202 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 21 12234679999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=284.27 Aligned_cols=182 Identities=23% Similarity=0.266 Sum_probs=157.3
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
++||+|+||.||+++.. +++.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999964 68899999997542 22334577899999888 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 9999888643 4689999999999999999999998 99999999999999999999999999997532222 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 197 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcc
Confidence 334679999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=300.75 Aligned_cols=193 Identities=29% Similarity=0.453 Sum_probs=166.0
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
++..+...++++||.|.||.|++|+++- ...||||.++.. ..+.+.+|+.|+.||.+++||||++|.|+......
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKP 704 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCce
Confidence 3455667788999999999999999752 357999999876 34567789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
..||+|||++|+|..||+.+. +.|++.+...++++|+.||.||-+. ++|||||.++|||+|.+..+|++||||+
T Consensus 705 vMIiTEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999998765 3488899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCccccccccc--CCCccccee----------ccchHHHHHHHHHh-ccCCC
Q 018991 302 KLLCSERSYVTTRVMG--TFGYAHFIV----------QVSPLFILLYILLS-VRYNS 345 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~g--t~~y~~pe~----------DiwSlG~il~el~~-g~~Pf 345 (348)
|.+.++.....+..-| ...|.|||+ |+||+||+|||.++ |+-|+
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 9886654222222222 357999995 99999999999665 88876
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=273.82 Aligned_cols=188 Identities=25% Similarity=0.339 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.|++.++||+|.|+.||++.. .+|+.+|+|++... .....+++.+|+.+...|+||||+++.+.+...+..|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3455667899999999999985 46899999988443 23356789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGla~~~ 304 (348)
++.|++|..-+-.+ ..+++..+-.+++||+.+|.|+|.+ +|||||+||+|+|+. ...-+||+|||+|..+
T Consensus 91 ~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 91 LVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred cccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 99999997655433 4578888999999999999999999 999999999999995 3446999999999988
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .........|||+||+||+ |||+.|++||.|+.|++||..
T Consensus 164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 7 4455667899999999995 999999999999999999963
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=298.44 Aligned_cols=186 Identities=27% Similarity=0.392 Sum_probs=160.1
Q ss_pred CceEeecCceEEEEEE-ECCCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------EEEEEEe
Q 018991 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------YRMLVYE 227 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~lv~e 227 (348)
.+.||+|+||.||+|+ ..+|+.||||..... .....+...+|+++|++++|||||+++++-.+.. ...++||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 3569999999999999 557999999988654 3345567788999999999999999998865433 4579999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCC--ceEEecccCccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQW--NARVSDFGLAKL 303 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~--~~~--~~kl~DFGla~~ 303 (348)
||.+|||...|.+..+ ...+++.+++.++.+++.||.|||++ +|+||||||.||++- .+| --||+|||.||.
T Consensus 98 yC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are 173 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE 173 (732)
T ss_pred ecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence 9999999999986543 35699999999999999999999999 999999999999983 334 379999999999
Q ss_pred ccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..+. ....+.||+.|.+|| +|.|||||++|+++||.+||..
T Consensus 174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 87655 455689999999999 4999999999999999999964
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=282.90 Aligned_cols=187 Identities=22% Similarity=0.240 Sum_probs=159.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
+|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +|++|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4677889999999999999965 57899999986542 12234566677887777 5899999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 999999999988643 4588999999999999999999998 999999999999999999999999999976432
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .......||+.|+|||+ |||||||++|||++|+.||.
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~ 202 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCC
Confidence 22 22334679999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.52 Aligned_cols=197 Identities=26% Similarity=0.363 Sum_probs=167.0
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECCC-cEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeE-EEE-----
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSDG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY-CVE----- 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~-~~~----- 218 (348)
.+...+++++++|.+|+|+.||+++...+ .+||+|++...+....+.+.+|+++|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34567788889999999999999997655 999999998888888899999999999997 9999999993 321
Q ss_pred -CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 219 -GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
.-+.+|+||||.||.|-|++..+.. ..|++.++++|+.|+|+|+.+||.. .++|||||||.+||||+.++..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence 1367899999999999999986543 3499999999999999999999997 77899999999999999999999999
Q ss_pred ccCcccccCCC-c-----c--cccccccCCCccccee-------------ccchHHHHHHHHHhccCCCC
Q 018991 298 FGLAKLLCSER-S-----Y--VTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 298 FGla~~~~~~~-~-----~--~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~ 346 (348)
||.|.-..... . + .......|+-|.+||. |||||||+||-|+....||-
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe 259 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFE 259 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcC
Confidence 99986432211 0 0 1112457899999994 99999999999999999995
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.89 Aligned_cols=186 Identities=26% Similarity=0.301 Sum_probs=157.1
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHH---hcCCCCCeeeEeeEEEECCEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVI---GRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+..|.+++ ..++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 456788999999999999954 68999999986442 22234566666554 567899999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|..++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988753 3589999999999999999999998 99999999999999999999999999987543
Q ss_pred CCCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......|++.|+||| +|||||||++|+|++|++||..
T Consensus 153 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 153 GFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred CCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 2222 233467999999999 3999999999999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=282.05 Aligned_cols=188 Identities=24% Similarity=0.318 Sum_probs=164.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467888899999999999999965 68889999886542 2345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++... ..+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 99999999999754 35889999999999999999999851 5999999999999999999999999999865432
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......|++.|+|||. |||||||++|||++|++||.
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~ 203 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP 203 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 2233578999999994 99999999999999999995
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.72 Aligned_cols=184 Identities=26% Similarity=0.298 Sum_probs=158.1
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||++... +++.||+|.+..... ...+.+..|+++++.++||||+++.+++..++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 689999999999954 688999999864422 1234567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++.........+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988754333345689999999999999999999998 999999999999999999999999999987644322 2234
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 198 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFR 198 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 578999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=282.83 Aligned_cols=182 Identities=24% Similarity=0.288 Sum_probs=156.4
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+++.. +++.||+|.+.... ......+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 68899999986542 22334577888888776 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~ 152 (329)
T cd05618 81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-T 152 (329)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-c
Confidence 9999888643 4689999999999999999999998 999999999999999999999999999976432221 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 334679999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=282.23 Aligned_cols=183 Identities=23% Similarity=0.288 Sum_probs=156.5
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 68899999986432 23345567788888776 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 9999988654 4588999999999999999999998 99999999999999999999999999987643222 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEA 198 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 334679999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=282.50 Aligned_cols=183 Identities=23% Similarity=0.272 Sum_probs=156.4
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|.+++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999965 57899999986542 22334567788888866 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (321)
T cd05591 81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-T 152 (321)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-c
Confidence 9999988643 4588999999999999999999998 999999999999999999999999999976433222 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~ 198 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCC
Confidence 334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=281.40 Aligned_cols=182 Identities=24% Similarity=0.276 Sum_probs=156.8
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +++.||+|.+..... ...+.+..|..++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999964 578999999975422 2334577899998888 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (327)
T cd05617 81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD-T 152 (327)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-c
Confidence 9999888643 4589999999999999999999998 999999999999999999999999999975332221 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||. |||||||+||+|++|++||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~ 197 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCC
Confidence 234679999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.80 Aligned_cols=183 Identities=29% Similarity=0.299 Sum_probs=154.3
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHH-HHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +|+.||+|.+.... ......+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999964 68999999986432 122234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 9999988643 4688999999999999999999998 99999999999999999999999999987643222 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|+|++|++||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCC
Confidence 334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=283.47 Aligned_cols=182 Identities=25% Similarity=0.394 Sum_probs=156.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445678999999999999964 689999999865432 334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+.. ...+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 156 ~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 156 GGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 99986532 356777889999999999999998 999999999999999999999999999987643221
Q ss_pred cccccccCCCcccce---------------eccchHHHHHHHHHhccCCCC
Q 018991 311 VTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
......||..|++|| +|||||||++|||++|+.||.
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 274 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFG 274 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 223357899999999 399999999999999999995
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=268.08 Aligned_cols=188 Identities=26% Similarity=0.364 Sum_probs=164.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-----c---chHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-----G---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 219 (348)
.+.|...+.||.|..+.|.+|.. .+|..+|+|++.... . ...+.-..|+.+|+++ -||+|+++.++|+.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 45677778899999999999985 478899999885431 1 1223456799999998 599999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
...++|+|.|+.|.|.|+|... -.++++....|+.|+..|+.|||.+ +||||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts~----VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSK----VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhhh----eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccc
Confidence 9999999999999999999754 4689999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------------DiwSlG~il~el~~g~~Pf~ 346 (348)
+|..+.. .....+.+|||+|.|||. |+||+|++||.|+.|.+||-
T Consensus 169 Fa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 169 FACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred eeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9998754 335567899999999994 99999999999999999993
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=281.61 Aligned_cols=183 Identities=27% Similarity=0.285 Sum_probs=153.8
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHH-HHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
++||+|+||.||+|+.. +++.||+|.+.... ......+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999964 68899999986432 122334555544 67889999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+.+... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 9999888643 4588889999999999999999998 99999999999999999999999999987542222 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|||++|++||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=281.16 Aligned_cols=187 Identities=22% Similarity=0.237 Sum_probs=159.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEe
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 227 (348)
|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+. |++|+++++++.+.+..|+|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566789999999999999954 68899999986542 223345777888888885 5778889999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 82 YVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999998643 4589999999999999999999998 9999999999999999999999999999864332
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~ 203 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCC
Confidence 21 2234579999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=274.61 Aligned_cols=187 Identities=28% Similarity=0.378 Sum_probs=160.7
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-----CCEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-----GAYRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-----~~~~~ 223 (348)
.|...+.||+|+||.|..+.. .+|..||||++.+. .....++..+|+.+|+.++|+||+.+++.+.. -+..|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 344467899999999999995 47899999999643 33345678889999999999999999999875 24689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|+|+|+ .+|...++.. ..++...+..++.|+++||.|+|+. +|+||||||.|+|++.+..+||+|||+|+.
T Consensus 103 iV~elMe-tDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 103 LVFELME-TDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EehhHHh-hHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceee
Confidence 9999996 5999999754 4599999999999999999999998 999999999999999999999999999998
Q ss_pred ccCC-CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSE-RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~-~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... .....++.+-|.+|.|||. ||||+||||.||++|++=|+
T Consensus 175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFp 229 (359)
T KOG0660|consen 175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFP 229 (359)
T ss_pred ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCC
Confidence 7542 1223466788999999994 99999999999999998774
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=276.93 Aligned_cols=195 Identities=26% Similarity=0.441 Sum_probs=160.4
Q ss_pred hcCCCcCceEeecCceEEEEEEECC-----------------CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD-----------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVR 211 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 211 (348)
...|.+.+.||+|+||.||+|.+++ +..||+|.+.... .....++.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3567788999999999999998532 3369999886543 234567899999999999999999
Q ss_pred EeeEEEECCEEEEEEeecCCCCHHHHHhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 018991 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG---------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276 (348)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iv 276 (348)
+++++.+.+..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999864321 113478888999999999999999998 999
Q ss_pred ecCCCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh--ccC
Q 018991 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS--VRY 343 (348)
Q Consensus 277 Hrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~--g~~ 343 (348)
||||||+|||++.++.+||+|||+++.+...... ......++..|+|||. |||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443322 1223455778999993 99999999999986 567
Q ss_pred CCCC
Q 018991 344 NSST 347 (348)
Q Consensus 344 Pf~~ 347 (348)
||..
T Consensus 241 p~~~ 244 (304)
T cd05096 241 PYGE 244 (304)
T ss_pred CCCc
Confidence 8753
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.10 Aligned_cols=184 Identities=17% Similarity=0.252 Sum_probs=158.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
...+|++.+.||+|+||.||+|.. .+++.||+|... ...+.+|++++++++||||+++++++......++++|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346799999999999999999995 468899999642 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
++. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 996 6898888643 3588999999999999999999998 9999999999999999999999999999764333
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.........||+.|+|||+ |||||||+||||++|+.||.
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 2223334679999999994 99999999999999998763
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.16 Aligned_cols=187 Identities=23% Similarity=0.348 Sum_probs=157.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~~ 223 (348)
.|++.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|++++++++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 3667789999999999999954 68999999886432 22345688899999999999999999988643 2479
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999996 6999988643 4589999999999999999999998 999999999999999999999999999986
Q ss_pred ccCCCc--ccccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERS--YVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... .......||+.|+|||+ |||||||++|+|++|++||.
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~ 209 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFP 209 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCC
Confidence 533221 11234578999999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=280.53 Aligned_cols=183 Identities=28% Similarity=0.274 Sum_probs=153.2
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHH-HHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEV-EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999965 57889999986432 12223344444 456778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+.+..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~ 152 (325)
T cd05602 81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-T 152 (325)
T ss_pred CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-C
Confidence 9999998653 4578888899999999999999998 999999999999999999999999999976432222 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||+ |||||||++|+|++|++||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCC
Confidence 334679999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=279.17 Aligned_cols=182 Identities=23% Similarity=0.295 Sum_probs=155.0
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +|..||+|.+.... ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999965 68899999986542 22334566677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 152 (316)
T cd05620 81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence 9999988653 4588999999999999999999998 9999999999999999999999999998753221 122
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||+ |||||||++|||++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~ 197 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFH 197 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCC
Confidence 344679999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=282.00 Aligned_cols=182 Identities=30% Similarity=0.288 Sum_probs=154.0
Q ss_pred ceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHH-HHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+. .+|+.||+|.+.... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3699999999999995 468999999986432 122334555554 56778999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|..++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 9999888643 4689999999999999999999998 99999999999999999999999999987543222 12
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||. |||||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~ 197 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCC
Confidence 334679999999994 99999999999999999995
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=282.45 Aligned_cols=183 Identities=23% Similarity=0.287 Sum_probs=158.4
Q ss_pred ceEeecCceEEEEEEE----CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
+.||+|+||.||+++. .+|+.||+|.+..... .....+..|++++.+++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999884 3578999999865422 233456789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 99999998643 4589999999999999999999998 999999999999999999999999999986543321
Q ss_pred cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......||+.|++||. |||||||++|||++|+.||..
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCC
Confidence 2334679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=275.71 Aligned_cols=182 Identities=28% Similarity=0.432 Sum_probs=151.0
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc--CCCCCeeeEeeEEEEC----CEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEG----AYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 223 (348)
.....+.+.||+|.||.||+|+|+ |+.||||++... .++.+.+|.++... |+|+||..+++.-..+ .++|
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 345566789999999999999996 789999998543 34556667776654 6999999999887544 3689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCCEEECCCCceEEecc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-----~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
||++|.+.|+|.|||.+. .++....++++..++.||.|||.. .+|.|.|||||..|||+..++.+.|+|+
T Consensus 286 LvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 999999999999999753 588899999999999999999953 4688999999999999999999999999
Q ss_pred cCcccccCCCcc---cccccccCCCccccee----------------ccchHHHHHHHHHh
Q 018991 299 GLAKLLCSERSY---VTTRVMGTFGYAHFIV----------------QVSPLFILLYILLS 340 (348)
Q Consensus 299 Gla~~~~~~~~~---~~~~~~gt~~y~~pe~----------------DiwSlG~il~el~~ 340 (348)
|||-........ .....+||..|||||+ ||||||.++||++.
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 999765443221 1223689999999995 99999999999884
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=278.03 Aligned_cols=183 Identities=24% Similarity=0.280 Sum_probs=155.2
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhc-CCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. +++.||+|.+.... ......+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999965 57899999986542 2233456667777776 4899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05619 81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK 152 (316)
T ss_pred CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence 9999998643 3588899999999999999999998 99999999999999999999999999987542221 12
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. ||||+||++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence 234679999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=307.78 Aligned_cols=196 Identities=29% Similarity=0.462 Sum_probs=169.4
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC--Cc----EEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD--GT----KVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.+.+.+..+.||+|.||.||.|...+ +. .||+|.+... +.+...+|.+|..+|++++|||||+++|++.+...
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 35566677899999999999999653 43 4999998765 44556789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
.+|++|||++|||..||++.+. ....++....+.++.|||+|++||+++ ++|||||..+||||+....+||+||
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 9999999999999999986522 234688899999999999999999999 9999999999999999999999999
Q ss_pred cCcccccCCCccccccc-ccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRV-MGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~-~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+|+.+.....|....- .-...|||||+ |||||||+|||++| |..||+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 99998777666554433 44578999995 99999999999999 8889875
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=272.36 Aligned_cols=192 Identities=26% Similarity=0.371 Sum_probs=161.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.+.||+|+||.||+|.++ .+..||+|.+..... .....+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456788899999999999999853 356899998865532 334578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +++||||||+|||++.++.+|++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE---GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999987532 4688999999999999999999998 9999999999999999999999999987654
Q ss_pred cCCCcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
............++..|+||| +|||||||++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 332222222334567899999 399999999999775 9999963
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=272.80 Aligned_cols=189 Identities=25% Similarity=0.270 Sum_probs=161.8
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|+..+.||+|+||.||++... +++.||+|.+..... .....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3667789999999999999954 688999999865322 223456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++.... ...+++..+..++.|++.||.|||++ +++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNMG--NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999998886432 24589999999999999999999998 9999999999999999999999999999876433
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....|++.|++||. ||||+||++|||++|+.||..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~ 203 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCC
Confidence 22 123478999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=279.80 Aligned_cols=188 Identities=24% Similarity=0.330 Sum_probs=163.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|++.+.||+|+||.||++... ++..+|+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 467888899999999999999965 68889999886542 2344678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++... ..+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||++..+...
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 99999999999753 4588899999999999999999974 16999999999999999999999999999765332
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......|+..|+|||. |||||||++|+|++|+.||.
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 203 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIP 203 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1223568999999994 99999999999999999996
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=285.95 Aligned_cols=198 Identities=26% Similarity=0.365 Sum_probs=163.3
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
....++|.+.+.||+|+||.||+|++ .++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++.+
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 34556788889999999999999973 235689999886443 23445788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------------------------------------------------- 243 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 243 (348)
.+..++||||+++|+|.++++....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 9999999999999999999864321
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 244 ----------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 244 ----------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 267 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRND 267 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence 012478888999999999999999998 9999999999999999999999999999876543
Q ss_pred Ccccc-cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 308 RSYVT-TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 308 ~~~~~-~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..... ....++..|+|||. |||||||++|||++ |..||..
T Consensus 268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 32211 12345567999994 99999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=295.08 Aligned_cols=197 Identities=23% Similarity=0.265 Sum_probs=166.0
Q ss_pred HHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA---- 220 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 220 (348)
...++|.+.+.||+|+||.||+++. .+++.||+|.+.... ......+.+|+.++..++|+||++++..+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3456788899999999999999984 478999999986542 233456788999999999999999988775432
Q ss_pred ----EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEe
Q 018991 221 ----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 221 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
..++||||+++|+|.+++.........+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36899999999999999976544446789999999999999999999998 99999999999999999999999
Q ss_pred cccCcccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||+++.+..... .......||+.|+|||. |||||||+||||++|+.||..
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~ 247 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999987643322 12234679999999994 999999999999999999963
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=286.72 Aligned_cols=197 Identities=26% Similarity=0.400 Sum_probs=162.2
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 219 (348)
...++|++.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+++++.+ +||||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 44567888899999999999998842 23579999986543 23345688999999999 899999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCC--------------------------------------------------------
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVG-------------------------------------------------------- 243 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 243 (348)
+..++||||+++|+|.+++.....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999999854210
Q ss_pred ----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc-c
Q 018991 244 ----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-T 312 (348)
Q Consensus 244 ----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~ 312 (348)
...++++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+....... .
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 113578889999999999999999998 99999999999999999999999999998764433221 1
Q ss_pred cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 313 TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....++..|+|||+ |||||||++|+|++ |+.||..
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~ 317 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 12335567999993 99999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-36 Score=271.69 Aligned_cols=180 Identities=17% Similarity=0.347 Sum_probs=154.9
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcch---HHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEEEEEeec
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYV 229 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~ 229 (348)
..||+|++|.||+|.+ +|+.||+|.+....... .+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 58899999986543322 4667899999999999999999999977 35789999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++... ..+++.....++.|++.||.|||+. .+++||||||+|||+++++.+||+|||+++.+....
T Consensus 105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 999999999754 4588899999999999999999973 178899999999999999999999999998654322
Q ss_pred ccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....|+..|+|||. |||||||++|||++|+.||..
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~ 224 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCC
Confidence 22467888999884 999999999999999999974
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=289.97 Aligned_cols=196 Identities=28% Similarity=0.418 Sum_probs=165.2
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECC--C---cEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEee
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSD--G---TKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLG 214 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~--~---~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~ 214 (348)
...|+...++....+.||+|+||.||+|+++. + ..||+|..+.. ......+|.+|+++|++++|||||++||
T Consensus 149 r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 149 RQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred ccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 44556667777778999999999999999642 2 23899988752 2445678999999999999999999999
Q ss_pred EEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
++..+..+++|||+|.||+|.++|+... ..++..+.+.++.+.+.||+|||++ +++||||.++|||++.++.+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vK 302 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVK 302 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEE
Confidence 9999999999999999999999998653 2589999999999999999999999 999999999999999999999
Q ss_pred EecccCcccccCCCcccccc--cccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTR--VMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~--~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+|||+++.-. .+.... -.-...|+|||+ |||||||++||+++ |.-||..
T Consensus 303 ISDFGLs~~~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 303 ISDFGLSRAGS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred eCccccccCCc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 99999998643 222221 123467899995 99999999999999 7878864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=283.38 Aligned_cols=187 Identities=24% Similarity=0.324 Sum_probs=160.0
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-----EEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 223 (348)
+|++.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++..++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 467788999999999999995 478999999885432 233457888999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|+||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999997 5888887543 4689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.............+++.|+|||. ||||+||++|||++|++||.
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 206 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQ 206 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCC
Confidence 64433333344567889999983 99999999999999999995
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=273.93 Aligned_cols=187 Identities=28% Similarity=0.377 Sum_probs=166.8
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
|.+.+.||+|+||.||++.++ .|+.+|||.+... .+.+++..|+.+|.+++.|++|++||.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 445567999999999999964 6999999988543 4577899999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+..+.++.++ .+++++++..++...++||+|||.. .-+|||||+.|||++.+|.+||+|||.|..+.+.- ..
T Consensus 113 GSiSDI~R~R~---K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRARR---KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHHhc---CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 99999997653 6899999999999999999999987 88999999999999999999999999998875432 22
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
...+.|||.|||||+ ||||||++..||..|++|++.|
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI 232 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI 232 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc
Confidence 344899999999995 9999999999999999999876
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=275.67 Aligned_cols=183 Identities=25% Similarity=0.300 Sum_probs=156.7
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+++.. ++..||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999965 57899999986542 22344567788888887 799999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 9999988643 4689999999999999999999998 999999999999999999999999999875322221 2
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~ 198 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCC
Confidence 234579999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=273.78 Aligned_cols=180 Identities=30% Similarity=0.465 Sum_probs=153.0
Q ss_pred CcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc--CCCCCeeeEeeEEEECC----EEEEEEe
Q 018991 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEGA----YRMLVYE 227 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~----~~~lv~e 227 (348)
+..++||+|.||.||+|.+. ++.||||++. ....+.|+.|-+|... ++|+||+++++.-.... .+|||+|
T Consensus 213 ~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 34567999999999999985 5899999884 3445678888777665 58999999999877655 8899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG------LEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~------~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
|.+.|+|.++|+.+ ..+|....+++..+++||+|||+. .+|.|+|||||.+|||+..|+++.|+|||+|
T Consensus 289 fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999865 589999999999999999999964 3678999999999999999999999999999
Q ss_pred ccccCCCcc-cccccccCCCccccee----------------ccchHHHHHHHHHhcc
Q 018991 302 KLLCSERSY-VTTRVMGTFGYAHFIV----------------QVSPLFILLYILLSVR 342 (348)
Q Consensus 302 ~~~~~~~~~-~~~~~~gt~~y~~pe~----------------DiwSlG~il~el~~g~ 342 (348)
..+...... .+...+||..|||||+ ||||+|.+||||++..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 887643322 2233689999999995 9999999999999753
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=289.04 Aligned_cols=182 Identities=23% Similarity=0.400 Sum_probs=158.0
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecC----CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE--EEEEEeec
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNN----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY--RMLVYEYV 229 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~--~~lv~e~~ 229 (348)
.+||+|+|-+||+|.+. +|..||.-.++.. .+...++|..|+.+|+.|+||||+++|.++.+... .-+|+|++
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 56999999999999954 5888886655322 23445789999999999999999999999987665 77899999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~~~~~~ 308 (348)
..|+|..|+++. ..++...+..|++||++||.|||++ .|+|+|||||-+||+|+. .|.|||+|+|||..+...
T Consensus 126 TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s- 199 (632)
T KOG0584|consen 126 TSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS- 199 (632)
T ss_pred cCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence 999999999865 4588889999999999999999998 788999999999999975 589999999999987533
Q ss_pred cccccccccCCCccccee---------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+..+.|||.|||||. ||||||++|.||+|+.||++
T Consensus 200 --~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYs 244 (632)
T KOG0584|consen 200 --HAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYS 244 (632)
T ss_pred --ccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChh
Confidence 2344899999999994 99999999999999999997
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.84 Aligned_cols=188 Identities=27% Similarity=0.352 Sum_probs=154.8
Q ss_pred CCCcCceEeecCceEEEEEEEC--CCcEEEEEEEecCC--cchHHHHHHHHHHHhcC---CCCCeeeEeeEEEE-----C
Q 018991 152 GLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE-----G 219 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~ 219 (348)
+|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5778899999999999999863 46789999886442 22234556677776665 69999999998852 4
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
...++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEcccc
Confidence 56899999997 59999986532 23588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++..... .......||+.|+|||. |||||||++|||++|++||..
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 211 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCC
Confidence 99876433 22334578999999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=265.36 Aligned_cols=190 Identities=23% Similarity=0.390 Sum_probs=162.2
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
++|++.+.||+|+||.||++.++++..+|+|.+.... .....+..|++++++++||||+++++++...+..+++|||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3467778899999999999998888889999875433 334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQRQ---GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 999999987532 3588999999999999999999998 9999999999999999999999999999876443322
Q ss_pred cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 311 VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
......++..|+||| +||||||+++|+|++ |++||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 222234556799998 399999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=287.49 Aligned_cols=188 Identities=22% Similarity=0.322 Sum_probs=155.1
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--------
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-------- 219 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-------- 219 (348)
...+|.+.+.||+|+||.||+|... +++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3457889999999999999999964 68899999885432 2234699999999999999999887542
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDF 298 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DF 298 (348)
...++||||+++ +|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 78777754333345789999999999999999999998 999999999999998664 7999999
Q ss_pred cCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+|+.+..... .....||+.|+|||+ |||||||+||||++|++||.
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 272 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFS 272 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 99987643322 233578999999993 99999999999999999996
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=267.56 Aligned_cols=193 Identities=23% Similarity=0.374 Sum_probs=164.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+..|+.++++++|+||+++++.+.+.+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 345678889999999999999998788889999875433 2356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSDE--GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999997542 24578889999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........++..|++|| .|||||||++|+|++ |+.||..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 207 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPG 207 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence 22222334567799998 399999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=283.28 Aligned_cols=189 Identities=25% Similarity=0.353 Sum_probs=166.1
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
....|.+.+.||+|.|+.|.++++. ++..||||.+.+... ...+.+.+|+++|+.++|||||+++.+...+..+|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3556778899999999999999954 689999999976633 3334588999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+.+|.+++++..+ ....+..+..++.|+.+|++|||++ .|+|||||++||||+.+..+||+|||++..+.
T Consensus 134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence 9999999999999865 3456678889999999999999999 99999999999999999999999999999875
Q ss_pred CCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
. .......+|++.|+||| +|+||+|++||.|++|.+||-
T Consensus 207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFD 256 (596)
T KOG0586|consen 207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFD 256 (596)
T ss_pred c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccC
Confidence 3 23344578999999888 499999999999999999994
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=265.45 Aligned_cols=194 Identities=24% Similarity=0.380 Sum_probs=165.1
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
..+++|.+.+.||+|+||.||+|..++++.||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 3456688889999999999999998777889999886543 335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 82 LMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred cccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999997542 24689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..........+..|++||. ||||||+++|||++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 207 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207 (261)
T ss_pred cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 2221222223457999983 99999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=265.70 Aligned_cols=183 Identities=25% Similarity=0.357 Sum_probs=160.3
Q ss_pred ceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
+.||+|+|+.|-.|. ..+|..+|||++.+.....+.+..+|++++.+++ |+||++++++|+++...|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999998 6789999999998877777888999999999995 99999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---ceEEecccCccccc--CCCc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLLC--SERS 309 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl~DFGla~~~~--~~~~ 309 (348)
...+.++ ..+++.++..+..+|+.||.|||.+ +|.||||||+|||-.... -+|||||.|..-+. ++-+
T Consensus 164 LshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 9999765 5699999999999999999999999 999999999999986443 48999998865432 1111
Q ss_pred ----ccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCC
Q 018991 310 ----YVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ----~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~ 346 (348)
......+|+..|||||+ |.||||++||.|++|.+||.
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFv 292 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFV 292 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCcc
Confidence 11223679999999995 99999999999999999995
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=266.88 Aligned_cols=181 Identities=27% Similarity=0.306 Sum_probs=154.9
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||+++.+ +|+.||+|.+..... .....+..|++++.+++||||+++++++.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 689999999999954 689999998854321 1233456799999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~ 153 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQ 153 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eec
Confidence 98886432 23588899999999999999999998 999999999999999999999999999987644322 223
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..|+..|+|||+ ||||+||++|||++|+.||.
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~ 195 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK 195 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 568999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=298.13 Aligned_cols=194 Identities=22% Similarity=0.319 Sum_probs=162.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+++.+|++++++++||||+++++++.+++..|++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 45778899999999999999964 58999999986542 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 227 EYVDNGNLDQWLHGDVG-------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 113456778899999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCc-----------------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERS-----------------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~-----------------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++....... .......||+.|+|||. |||||||++|||++|++||..
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9987621110 01123579999999994 999999999999999999963
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=282.02 Aligned_cols=198 Identities=26% Similarity=0.382 Sum_probs=163.7
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 218 (348)
+...++|.+.+.||+|+||.||+|... .+..||+|.+.... ....+.+.+|++++.++. ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 445778888999999999999999852 13469999886543 233467889999999996 9999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC-------------------------------------------------------
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------------------------------------------------- 243 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 243 (348)
.+..|+|||||++|+|.+++.....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999999864311
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 244 -------------------------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 244 -------------------------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
....+++..+..++.|++.||.|||++ +|+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEE
Confidence 012477888899999999999999998 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++.+....... .....++..|++||. |||||||++|||++ |..||..
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~ 342 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence 9999999999999998764433221 223456788999993 99999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=263.62 Aligned_cols=190 Identities=24% Similarity=0.307 Sum_probs=164.5
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.++.+++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 44688889999999999999995 46889999988655444556688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.++++.. .++++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999998643 4688999999999999999999998 99999999999999999999999999998764322
Q ss_pred cccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......|+..|++|| +|+||+||++|||++|+.||..
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 1 122356888899988 3999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=283.45 Aligned_cols=184 Identities=24% Similarity=0.318 Sum_probs=156.6
Q ss_pred CCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-C-----CCeeeEeeEEEECCEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-H-----KNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~l~~~~~~~~~~~l 224 (348)
.|.+.++||+|+||.|.+|. ..+++.||||++++.. .-..+-..|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 56788999999999999999 4579999999887654 33456677999999997 4 379999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CceEEecccCcc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAK 302 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~--~~~kl~DFGla~ 302 (348)
|+|.+. -+|.++++.+. ...++...+..++.||+.||.+||+. +|||+||||+||||.+- ..+||+|||.|.
T Consensus 266 VfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEeccccc
Confidence 999997 59999998764 45689999999999999999999988 99999999999999743 369999999998
Q ss_pred cccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....- + ..+-+..|.|||+ ||||||||+.||++|.+-|+
T Consensus 340 ~~~q~v-y---tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 340 FESQRV-Y---TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred ccCCcc-e---eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 753321 1 3456778999995 99999999999999977664
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=270.59 Aligned_cols=189 Identities=24% Similarity=0.332 Sum_probs=159.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 45777889999999999999964 67889999886443 22334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 985 8888876432 3578889999999999999999998 99999999999999999999999999997653322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+++.|+|||. |||||||++|+|++|+.||..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 1223467889999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=261.49 Aligned_cols=190 Identities=24% Similarity=0.351 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc-----chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG-----QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++|...+.||+|++|.||++.. .+++.||+|.+..... .....+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688889999999999999995 4689999998864421 123468889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.+
T Consensus 82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 99999999999998754 4588899999999999999999998 9999999999999999999999999999865
Q ss_pred cCCCcccc--cccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVT--TRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~--~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
........ ....|+..|+|||. ||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 43222111 23567889999994 999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=267.49 Aligned_cols=195 Identities=27% Similarity=0.457 Sum_probs=164.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 456888899999999999999842 34568999886655555667899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 224 LVYEYVDNGNLDQWLHGDV---------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
+++||+++++|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999986432 1223589999999999999999999998 999999999999999999999
Q ss_pred EecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 295 VSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+|||+++........ ......++..|+|||. |||||||++|+|++ |..||..
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~ 225 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999866433221 1223445778999993 99999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=275.90 Aligned_cols=193 Identities=25% Similarity=0.265 Sum_probs=167.2
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
...+.|..-++||+|+||.||-|+.+ +|+.+|.|.+.+..- +......+|-.+|.+++.+.||.+-..|++.+.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34566788899999999999999954 699999998854422 23345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||..|.||||.-.|.... ...+++..+..++.+|+.||++||.+ +||.|||||+|||+|+.|+++|+|+|||..
T Consensus 262 lVLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 9999999999988776442 25799999999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+...... ...+||.+|||||+ |+|||||+||||+.|+-||++
T Consensus 337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 7654332 23389999999995 999999999999999999985
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=263.16 Aligned_cols=189 Identities=25% Similarity=0.370 Sum_probs=161.0
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+|.+.+.||+|+||.||++.+.++..+|+|.+.... ....++.+|+.++.+++||||+++++++......+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 466778899999999999998777779999886443 3346788999999999999999999999988889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 84 GCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999987532 3589999999999999999999998 99999999999999999999999999998764433222
Q ss_pred ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 312 TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....++..|++|| .|||||||++|+|++ |+.||..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 22234556788888 399999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=265.70 Aligned_cols=188 Identities=26% Similarity=0.285 Sum_probs=160.7
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|+..+.||+|+||.||++... +++.||+|.+..... .....+..|+.++++++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999954 688999998864422 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999999886432 24588999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....|+..|+|||+ ||||+||++|+|++|++||..
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~ 203 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 203 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 2 123478999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=277.72 Aligned_cols=180 Identities=25% Similarity=0.237 Sum_probs=151.5
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcC---CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
||+|+||.||+|+.. +++.||+|.+..... .....+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999964 689999999854321 1223344566666655 699999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~ 152 (330)
T cd05586 81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-T 152 (330)
T ss_pred ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-C
Confidence 9999988643 4588999999999999999999998 999999999999999999999999999976433222 2
Q ss_pred ccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....||+.|+|||. |||||||++|+|++|+.||.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~ 198 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCC
Confidence 334679999999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=275.40 Aligned_cols=186 Identities=27% Similarity=0.308 Sum_probs=157.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
.++|+..+.||+|+||.||++... +|..||+|.+... .......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 467888899999999999999954 6899999998543 2233456788999999999999999999986543
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999975 67766642 378888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++...... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 98653322 2234578999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=265.11 Aligned_cols=188 Identities=26% Similarity=0.266 Sum_probs=160.7
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|+..+.||+|+||.||++.. .+++.||+|.+..... .....+..|++++..++|+||+.+.+.+..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 45567899999999999995 4688999998865422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMG--NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 99999998886432 24689999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....|+..|++||. |+|||||++|+|++|++||..
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~ 203 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 2 123578999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=286.79 Aligned_cols=183 Identities=28% Similarity=0.418 Sum_probs=162.4
Q ss_pred eEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHH
Q 018991 158 VIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (348)
+||+|.||+||-|+.. +...+|||.+........+-+..|+.+-+.|+|.|||+++|.+..++..-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999954 466799999987776777778899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceEEecccCcccccCCCccccc
Q 018991 237 WLHGDVGDVSPL--TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTT 313 (348)
Q Consensus 237 ~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~ 313 (348)
+|+..- +|+ ++..+-.+..||++||.|||++ .|||||||-+|+|++ -.|.+||+|||.++.+..-.. .+.
T Consensus 662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TE 734 (1226)
T KOG4279|consen 662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTE 734 (1226)
T ss_pred HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccc
Confidence 997543 455 7788889999999999999999 999999999999996 578999999999998765432 344
Q ss_pred ccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 314 RVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 314 ~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+.||..|||||+ |||||||++.||.||++||-.
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 5899999999995 999999999999999999954
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=263.61 Aligned_cols=188 Identities=23% Similarity=0.314 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
++|...+.||+|+||.||+++. .+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..|++|||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 3556667899999999999995 468899999887655444556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++... ..+++.+++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+....
T Consensus 89 ~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 999999998643 4689999999999999999999998 99999999999999999999999999987654321
Q ss_pred ccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~ 346 (348)
.......|+..|+|||. |+|||||++|+|++|+.||.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~ 210 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF 210 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcc
Confidence 22234578899999983 99999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=264.48 Aligned_cols=193 Identities=26% Similarity=0.437 Sum_probs=166.6
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+..+|+..+.||+|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+....+++|||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567778899999999999999877899999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999997542 24689999999999999999999998 99999999999999999999999999998764332
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
. ......++..|++|| +||||||+++|+|++ |++||..
T Consensus 159 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~ 207 (261)
T cd05148 159 Y-LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207 (261)
T ss_pred c-cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCc
Confidence 2 122334566788888 399999999999998 8999964
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=264.59 Aligned_cols=194 Identities=26% Similarity=0.475 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.+|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|++++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 44667788999999999999853 2478999988655433 4568999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 224 LVYEYVDNGNLDQWLHGDV----------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
++|||+++++|.+++.... .....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997542 1224578899999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||+++.+...... ......+++.|+||| +|||||||++|||++ |..||..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~ 227 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999865433221 122234577899999 499999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=269.68 Aligned_cols=190 Identities=26% Similarity=0.419 Sum_probs=158.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.+|+..+.||+|+||.||+|++. ++. .||+|.+.... ....+++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45788899999999999999853 333 48999886443 34456788999999999999999999998765 4679
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 999999999999997542 3578889999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....... .....++..|++||. |||||||++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~ 214 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 5433221 222334668999993 99999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.05 Aligned_cols=192 Identities=21% Similarity=0.325 Sum_probs=164.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+. .+++.||+|.+... .......+..|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688889999999999999995 47899999987542 2233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.........+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999998864333334588899999999999999999998 999999999999999999999999999987644
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......|++.|++||. |+||+|+++|||++|+.||.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 322 2233568889999994 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=260.41 Aligned_cols=189 Identities=24% Similarity=0.370 Sum_probs=159.6
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+|.+.+.||+|+||.||++.++++..+|+|.+.... .....+..|++++++++||||+++++++...+..+++|||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466778899999999999998777789999875433 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999987542 3588999999999999999999998 99999999999999999999999999998764332221
Q ss_pred ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 312 TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....++..|++|| +||||||+++|+|++ |++||..
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 11222345799998 499999999999999 8999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=262.43 Aligned_cols=187 Identities=24% Similarity=0.362 Sum_probs=152.3
Q ss_pred eEeecCceEEEEEEECC---CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
.||+|+||.||+|...+ ...+++|.+.... ......+.+|+++++.++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997433 3468888775443 2334568889999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 234 LDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 234 L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
|.+++...... ....++...+.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......+..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999764321 23356788899999999999999998 999999999999999999999999999876433322211
Q ss_pred -cccccCCCcccce-----------------eccchHHHHHHHHHh-ccCCCCC
Q 018991 313 -TRVMGTFGYAHFI-----------------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 313 -~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....++..|+||| +|||||||++|||++ |+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCc
Confidence 2234566788888 399999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=254.18 Aligned_cols=200 Identities=24% Similarity=0.236 Sum_probs=171.3
Q ss_pred HHHhcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----C
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----A 220 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~ 220 (348)
.+..+.|.+.+.||+|+|+.||+++ ..+++.+|+|++.....+..+...+|++..++++|||+++++++...+ +
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3456778889999999999999999 678899999999877777778899999999999999999999876533 4
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..||++.|...|+|.+.+.....+...+++.+++.|+.++++||++||+. .+++.||||||.|||+.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999987766667899999999999999999999998 45699999999999999999999999999
Q ss_pred cccccCC----Cc----ccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSE----RS----YVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~----~~----~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+....-. .. ..-.+-..|..|.|||. |||||||+||+|+.|.-||-.
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~ 243 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFER 243 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchH
Confidence 8764321 10 11112457889999993 999999999999999999954
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=268.93 Aligned_cols=185 Identities=22% Similarity=0.317 Sum_probs=151.7
Q ss_pred CceEeecCceEEEEEEEC---CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEEEeecC
Q 018991 156 ENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVD 230 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 230 (348)
++.||+|+||.||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...|+++||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999864 46789999885432 23457789999999999999999999864 456899999986
Q ss_pred CCCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCceEEecccCc
Q 018991 231 NGNLDQWLHGDV-----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLA 301 (348)
Q Consensus 231 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill----~~~~~~kl~DFGla 301 (348)
++|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875321 1223588999999999999999999998 99999999999999 45678999999999
Q ss_pred ccccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+....... .......||+.|+|||+ ||||+||++|+|++|++||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 87654322 12234678999999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=264.41 Aligned_cols=196 Identities=22% Similarity=0.404 Sum_probs=161.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
..++|++.+.||+|+||.||+|... ++..||+|.+.... .....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999753 24679999875432 2334568899999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGD------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
.++||||+++++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 99999999999999998653211 23467888999999999999999998 9999999999999999999999
Q ss_pred ecccCcccccCCCcccc-cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 296 SDFGLAKLLCSERSYVT-TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~~-~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+|||+++.+.....+.. ....++..|+|||. |||||||++|||++ |..||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~ 224 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 224 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99999986644332211 12345778999994 99999999999999 7889864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=272.47 Aligned_cols=187 Identities=24% Similarity=0.332 Sum_probs=160.4
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc--hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|.+++.||+|.|..|-++++ -+|..||||++.+.+.. ....+.+|++.|+.++|||||++|.+...+..+|||+|+-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 45567899999999999984 48999999999766433 3356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~~~~~~ 308 (348)
.+|+|.+|+-++. ..+.++...+++.||+.|+.|+|+. .+|||||||+|+++- .-|-+||+|||++..+....
T Consensus 100 D~GDl~DyImKHe---~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 100 DGGDLFDYIMKHE---EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred CCchHHHHHHhhh---ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 9999999997653 4589999999999999999999987 999999999999875 56889999999997664332
Q ss_pred cccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....+|+..|-||| +||||||||||-|++|++||..
T Consensus 174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqe 221 (864)
T KOG4717|consen 174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQE 221 (864)
T ss_pred --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccc
Confidence 234467777777777 4999999999999999999964
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=266.26 Aligned_cols=186 Identities=25% Similarity=0.339 Sum_probs=161.0
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|++++.+++||||+++++++.+++..+++|||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 5788899999999999999954 6788999987644 2233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++... ..+++..+..++.|++.||.|||++ .+++|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 82 DGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred CCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 999999999754 4588999999999999999999973 18999999999999999999999999998765332
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......|+..|++||. |+||||+++|+|++|++||.
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~ 199 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIP 199 (308)
T ss_pred -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 1233578889999993 99999999999999999985
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=262.40 Aligned_cols=192 Identities=23% Similarity=0.377 Sum_probs=162.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|.+.+.||+|+||.||+|..+ +++.||+|.+.... ....++.+|++++..++||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345777789999999999999954 58899999876443 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 84 ~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 84 MTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred CCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 99999999986542 24588999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........++..|++|| +|||||||++|||++ |..||..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 208 (263)
T cd05052 159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208 (263)
T ss_pred eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 22222233456799998 399999999999998 9999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=261.42 Aligned_cols=181 Identities=24% Similarity=0.360 Sum_probs=158.1
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|+..+.||+|+||.||+|.. .+++.||+|.+.... ....+.+..|++++++++||||+++++++...+..+++|||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 567778999999999999995 468899999886542 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|..+. .+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999997652 367888899999999999999998 9999999999999999999999999999865432
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......|+..|++||. |+||||+++|+|++|+.||.
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 194 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYP 194 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCch
Confidence 1233578999999994 99999999999999999995
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=260.64 Aligned_cols=192 Identities=24% Similarity=0.375 Sum_probs=163.0
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+..++|++.+.||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++||||+++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 44567888899999999999999988889999998865443 3467889999999999999999999874 456899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTPE--GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 999999999986542 24688999999999999999999998 9999999999999999999999999999876533
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
.........++..|++|| +||||||+++|||++ |++||.
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 222222344567899988 399999999999999 999996
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=263.56 Aligned_cols=186 Identities=27% Similarity=0.298 Sum_probs=163.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..+++|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 35778899999999999999964 68999999886532 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+|||++.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998754 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....+++.|++|| +||||||+++|+|++|+.||..
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 200 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFD 200 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 3 23457889999999 3999999999999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=262.01 Aligned_cols=191 Identities=28% Similarity=0.398 Sum_probs=160.5
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
..+|.+.+.||+|+||.||+|+..+...||+|.+.... ...+.+..|++++.+++||||+++++.+.. +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45688889999999999999997766789999886533 234578899999999999999999998754 5579999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++.+.....
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999997532 23578999999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......++..|++||. |||||||++|+|++ |+.||..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~ 206 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 22223446678999993 99999999999999 8989864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=260.34 Aligned_cols=187 Identities=25% Similarity=0.335 Sum_probs=155.0
Q ss_pred eEeecCceEEEEEEECC---CcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
.||+|+||.||+|...+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 45799998865432 334578889999999999999999999999889999999999999
Q ss_pred HHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 234 LDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 234 L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
|.+++..... .....++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.......+..
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999975322 223466778889999999999999998 999999999999999999999999999976544332222
Q ss_pred -cccccCCCcccce-----------------eccchHHHHHHHHHh-ccCCCCC
Q 018991 313 -TRVMGTFGYAHFI-----------------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 313 -~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....++..|++|| +||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 212 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH 212 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 2345677899998 399999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=279.95 Aligned_cols=190 Identities=22% Similarity=0.304 Sum_probs=154.3
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC------CCeeeEeeEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH------KNLVRLLGYC 216 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~l~~~~ 216 (348)
+++.....+|.+.+.||+|+||.||+|... +++.||||++.... ....++..|++++..++| ++++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999954 57889999985432 233445667777776654 4588999988
Q ss_pred EEC-CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCC---
Q 018991 217 VEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQW--- 291 (348)
Q Consensus 217 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~--- 291 (348)
... ...|+|||++ +++|.+++... ..+++..+..++.|++.||.|||+ . +|+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5788999988 67898888643 468999999999999999999997 5 899999999999998765
Q ss_pred -------------ceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 292 -------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 292 -------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+||+|||++..... ......||+.|+|||+ |||||||+||||++|++||.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998864321 2334689999999995 99999999999999999995
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=281.36 Aligned_cols=183 Identities=28% Similarity=0.348 Sum_probs=160.2
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc---hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|...+.||.|+||.||.++. ++...||||++.-...+ ...++..|+.+|.+++|||++.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44456799999999999994 56789999998544322 345789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|- |+-.|++.-.. +++.+..+..|+.+.+.||.|||+. +.||||||+.|||+++.|.|||+|||.|....
T Consensus 108 Cl-GSAsDlleVhk---KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--- 177 (948)
T KOG0577|consen 108 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA--- 177 (948)
T ss_pred Hh-ccHHHHHHHHh---ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC---
Confidence 97 58888876543 5789999999999999999999999 99999999999999999999999999998754
Q ss_pred cccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..++|||.|||||+ |||||||+..||...++|.-+
T Consensus 178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn 227 (948)
T KOG0577|consen 178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 227 (948)
T ss_pred --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence 3345799999999995 999999999999999999754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=259.73 Aligned_cols=191 Identities=26% Similarity=0.366 Sum_probs=160.8
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||+|..+++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 446777889999999999999988888899998865433 3467889999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||++..+.....
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDGE--GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999987532 24588999999999999999999998 999999999999999999999999999987644332
Q ss_pred ccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......++..|+||| +||||||+++|+|++ |++||..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 206 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 2222234556799998 499999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=272.19 Aligned_cols=197 Identities=26% Similarity=0.390 Sum_probs=160.8
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEEE-
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE- 218 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 218 (348)
.+.++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+..|++++.++ +||||+++++++..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 44567888999999999999999732 247899998864432 2335677899999999 89999999998865
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCC------------------------------------------------------
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGD------------------------------------------------------ 244 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 244 (348)
+...++++||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 45688999999999999998643210
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc-cccccCCC
Q 018991 245 ---VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TRVMGTFG 320 (348)
Q Consensus 245 ---~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~~~gt~~ 320 (348)
..++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+........ ....++..
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 12688999999999999999999998 999999999999999999999999999987654333222 22456678
Q ss_pred cccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 321 YAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 321 y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+||| +|||||||+||||++ |+.||..
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 99999 499999999999998 9999963
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=258.96 Aligned_cols=192 Identities=30% Similarity=0.450 Sum_probs=162.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.+.||+|+||.||+|.+.. ...||+|.+.... .....++..|+.++.+++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3567888999999999999999642 4579999886543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+|||+++++.+||+|||+++..
T Consensus 83 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLREND---GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999997542 3689999999999999999999998 9999999999999999999999999999887
Q ss_pred cCCC-cccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSER-SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~-~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.... ........++..|++||. ||||||+++|+|++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 5222 222222345677999983 99999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=262.74 Aligned_cols=191 Identities=24% Similarity=0.287 Sum_probs=165.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|++.+.||+|+||.||++... ++..+|+|.+........+.+..|++++++++||||+++++.+..+...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 455777788999999999999964 6889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 99999999986532 4589999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+++.|++|| +|+||||+++|+|++|++||..
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 2 222356888898887 4999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.90 Aligned_cols=191 Identities=22% Similarity=0.286 Sum_probs=164.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.+.|++.+.||+|+||.||+|+.. ++..+++|.+........+.+..|+.+++.++||||+++++.+..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 456778889999999999999965 5889999998766555667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|..++.+.. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 164 (292)
T cd06644 91 CPGGAVDAIMLELD---RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL 164 (292)
T ss_pred CCCCcHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence 99999988875432 3588999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......++..|++|| +|||||||++|+|++|++||..
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 1223356788899988 3999999999999999999853
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=276.68 Aligned_cols=184 Identities=22% Similarity=0.245 Sum_probs=158.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC---CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
...|.+.+.||+|+||.||+|... ++..|++|.+... ....+|+++|++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 456888999999999999999853 3578999987543 23457999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|++. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 166 e~~~-~~l~~~l~~~----~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVDRS----GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9996 6898888432 5689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... ......||+.|+|||. |||||||+||||++|+.||.
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~ 288 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLF 288 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 3322 2224679999999994 99999999999999999995
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=256.67 Aligned_cols=190 Identities=27% Similarity=0.388 Sum_probs=164.6
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|.+.+.||+|+||.||++... ++..|++|.+... .......+..|+++++.++||||+++++++.+.+..+++|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 3667788999999999999964 6889999988643 234456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999997542 24688999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....|++.|++|| +|+||||+++|+|++|+.||..
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 22 23356888999999 4999999999999999999964
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=295.72 Aligned_cols=198 Identities=23% Similarity=0.299 Sum_probs=162.7
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYR 222 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 222 (348)
...++|.+.+.||+|+||.||+++.. ++..||+|.+... .......+..|+.++.+++||||++++++|.+ ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34567888999999999999999964 5778999988643 22334678899999999999999999998865 3578
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----CCCceecCCCCCCEEECC---------
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL----EPKVVHRDVKSSNILLDR--------- 289 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~----~~~ivHrdlkp~Nill~~--------- 289 (348)
||||||+++|+|.++|.........+++..++.|+.||+.||.|||+.. ..+|+||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 9999999999999999754333357999999999999999999999841 025999999999999964
Q ss_pred --------CCceEEecccCcccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 290 --------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 290 --------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+.+||+|||+++.+.... ......||+.|+|||+ |||||||+||+|++|++||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 2348999999998764332 2234579999999993 999999999999999999963
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=262.21 Aligned_cols=193 Identities=25% Similarity=0.380 Sum_probs=160.1
Q ss_pred cCCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++|++.+.||+|+||.||+|.. .++..|++|.+.... ......+.+|++++++++||||+++++++...+..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999984 245789999886433 2334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 018991 225 VYEYVDNGNLDQWLHGDVG-------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~ 291 (348)
+|||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999853211 113478889999999999999999998 999999999999999999
Q ss_pred ceEEecccCcccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 292 NARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 292 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
.+||+|||+++....... .......++..|++||. |||||||++|||++ |.+||.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~ 228 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999999999987643322 12233445677999983 99999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=260.66 Aligned_cols=188 Identities=23% Similarity=0.318 Sum_probs=161.9
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
|++.+.||+|+||.||++... ++..+++|.+........+.+.+|+++++.++||||+++++++..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345677999999999999965 5778899988655555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|..++.... .++++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 99998876422 4689999999999999999999998 99999999999999999999999999987653322 12
Q ss_pred ccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....++..|++|| +||||+||++|+|++|++||..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 23356888999998 4999999999999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=258.23 Aligned_cols=190 Identities=22% Similarity=0.311 Sum_probs=159.6
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 222 (348)
++|++.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688889999999999999995 468999999875321 12235688899999999999999999998763 567
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
+++|||+++++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998643 3478888999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+..... .......|+..|++||. |||||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 6543211 11223568889999994 999999999999999999853
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=255.87 Aligned_cols=185 Identities=25% Similarity=0.367 Sum_probs=156.4
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
++||+|+||.||+|...++..+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999987888999998765432 23456889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccccccc
Q 018991 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315 (348)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 315 (348)
+++.... ..+.+..++.++.|++.||.|+|++ +++|+||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKKK---DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 9986432 3578999999999999999999998 999999999999999999999999999976433222111122
Q ss_pred ccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 316 MGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 316 ~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.++..|++|| .||||||+++|+|++ |..||..
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 3456799998 399999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=262.83 Aligned_cols=188 Identities=23% Similarity=0.329 Sum_probs=163.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.+|+..+.||+|+||.||++.. .+++.|++|.+........+.+..|+.+++.++||||+++++.+..+...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 4677788999999999999995 468899999987665555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.. ..+++.++..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999863 3478899999999999999999998 999999999999999999999999999886543322
Q ss_pred ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....|++.|++|| +|||||||++|+|++|+.||..
T Consensus 172 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 172 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred c-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 1 22346888999999 3999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=261.64 Aligned_cols=193 Identities=27% Similarity=0.456 Sum_probs=161.3
Q ss_pred cCCCcCceEeecCceEEEEEEECC-C-----cEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSD-G-----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++|++.+.||+|+||.||+|.... + ..|++|.+.... .....++.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998542 2 579999886543 234467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 018991 224 LVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~ 291 (348)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999975321 114578889999999999999999998 999999999999999999
Q ss_pred ceEEecccCcccccCCCc-ccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 292 NARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 292 ~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
.+||+|||+++....... .......+++.|+||| +|||||||++|||++ |..||.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~ 228 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999999986543322 1223345678899999 399999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=275.19 Aligned_cols=199 Identities=24% Similarity=0.386 Sum_probs=163.3
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCC-CCCeeeEeeEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCV 217 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~ 217 (348)
++...++|.+.+.||+|+||.||+|++. .+..||+|.+..... ...+.+..|+.+|.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3455667778899999999999999853 246799999965432 23456889999999997 999999999999
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCC------------------------------------------------------
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVG------------------------------------------------------ 243 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 243 (348)
.++..++||||+++|+|.++++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999965321
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018991 244 ----------------------------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283 (348)
Q Consensus 244 ----------------------------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~ 283 (348)
....+++..+..++.|++.||.|||++ +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 112467778899999999999999998 9999999999
Q ss_pred CEEECCCCceEEecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 284 NILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 284 Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+++++.+||+|||+++.+...... ......++..|++|| +||||||+++|||++ |+.||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999865432221 112245678899998 399999999999998 8999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=258.22 Aligned_cols=194 Identities=27% Similarity=0.399 Sum_probs=165.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
...++|.+.+.||+|+||.||++..+++..+|+|.+.... ...+++..|+.++++++||||+++++++.+....+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 4566788899999999999999998777889999886543 334678899999999999999999999998889999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.+...
T Consensus 82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 999999999997542 24689999999999999999999998 9999999999999999999999999999876532
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.........++..|++|| +||||||+++|+|++ |+.||..
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 207 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 222222233456788888 399999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=272.35 Aligned_cols=186 Identities=24% Similarity=0.244 Sum_probs=156.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------C
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 220 (348)
.++|...+.||+|+||.||++... +++.||||.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 457888899999999999999954 68899999886432 23345678899999999999999999987543 3
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 57999999975 78777742 377888999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++...... ......||..|+|||+ |||||||++|+|++|++||..
T Consensus 173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 98654322 2233578999999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=263.83 Aligned_cols=189 Identities=24% Similarity=0.336 Sum_probs=160.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.|...+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 45777889999999999999964 68899999886442 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++ ++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 59998886532 3578899999999999999999998 99999999999999999999999999997653322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+++.|++||. |||||||++|+|++|++||+.
T Consensus 159 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 159 K-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred C-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223456888999983 999999999999999999963
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.09 Aligned_cols=186 Identities=23% Similarity=0.298 Sum_probs=158.0
Q ss_pred HHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG----- 219 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----- 219 (348)
...++|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3456788999999999999999995 4688999998864322 2335677899999999999999999987643
Q ss_pred -CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 220 -AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
...|+++|++ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999988 6799888753 3589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+++..... .....||+.|+|||+ |||||||++|+|++|+.||+
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 217 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFP 217 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 999875432 223568999999993 99999999999999999996
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=259.47 Aligned_cols=188 Identities=33% Similarity=0.567 Sum_probs=156.1
Q ss_pred cCceEeecCceEEEEEEEC-----CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 155 EENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+.||.|.||.||+|.+. .+..|+||.+..... ...+.+.+|++.+.+++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3478999999999999976 256899999855432 3467899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|+|.++|... ....+++..+..++.|++.||.|||++ +++|+||+++|||++.++.+||+|||+++......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999865 235689999999999999999999998 99999999999999999999999999998773322
Q ss_pred c-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 309 S-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
. .......+...|++||. ||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2 22233456778999994 99999999999999 7899875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=271.70 Aligned_cols=186 Identities=24% Similarity=0.273 Sum_probs=157.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------ 219 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 219 (348)
..++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 3467888899999999999999854 68899999886432 23345677899999999999999999988643
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
...|++|||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCc
Confidence 357999999975 77777642 378888999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+++..... .......||..|+|||. |||||||++|+|++|+.||.
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 219 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99865432 22234578999999994 99999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=256.54 Aligned_cols=189 Identities=25% Similarity=0.407 Sum_probs=161.6
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
+|+..+.||+|+||.||+|...+++.+|+|.+..... .....+.+|++++++++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667789999999999999987889999998854321 1224588899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
+||+++++|.+++... .++++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999999653 3578999999999999999999998 99999999999999999999999999987653
Q ss_pred CCC-----cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SER-----SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~-----~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ........|+..|++||. |+||||+++|+|++|++||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 211 111223568889999993 999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=256.13 Aligned_cols=192 Identities=21% Similarity=0.354 Sum_probs=165.6
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46888899999999999999965 7899999988532 2233567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999865433345689999999999999999999998 999999999999999999999999999886643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......++..|++||. |+||||+++|+|++|+.||.
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 322 1223568889999993 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=257.85 Aligned_cols=191 Identities=25% Similarity=0.356 Sum_probs=159.6
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|.+.+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 34577788999999999999998777789999875443 33467888999999999999999998875 45678999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 9999999997542 24578999999999999999999998 999999999999999999999999999987643322
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......++..|++||. ||||||+++|+|++ |++||..
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 206 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 22222345678999983 99999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=262.03 Aligned_cols=194 Identities=25% Similarity=0.424 Sum_probs=163.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 34667789999999999999842 345689998866655556778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 018991 225 VYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999965321 123488999999999999999999998 9999999999999999999
Q ss_pred eEEecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 293 ARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+||+|||+++........ ......++..|++|| +|||||||++|||++ |+.||..
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999865433221 122345678899999 499999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=258.53 Aligned_cols=187 Identities=33% Similarity=0.499 Sum_probs=161.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchH--HHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE--KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|+..+.||+|+||.||+++.. +++.+|+|.+........ ....+|+.++..++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 345688999999999999965 567899999976644332 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||.+.... ...
T Consensus 81 ~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN----KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENN 152 (260)
T ss_dssp TTEBHHHHHHHH----SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STT
T ss_pred cccccccccccc----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence 999999999722 4689999999999999999999998 99999999999999999999999999997642 222
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......++..|+|||. ||||||+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 23344678899999994 999999999999999999974
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=261.55 Aligned_cols=202 Identities=27% Similarity=0.324 Sum_probs=168.4
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+++.++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.++.++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44555666788899999999999999999996 468899999885432 2345677899999998 89999999999875
Q ss_pred C-----CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 219 G-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 219 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
. +..++|+||+++++|.++++........+++..++.++.|++.||+|||++ +++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 3 358999999999999998865333345689999999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+|||+++.+..... ......|+..|++|| +|||||||++|||++|++||..
T Consensus 168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~ 235 (291)
T cd06639 168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFD 235 (291)
T ss_pred EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCC
Confidence 9999999987643221 122346788899988 4999999999999999999964
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=255.22 Aligned_cols=191 Identities=27% Similarity=0.337 Sum_probs=165.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|+..+.||+|+||.||++... ++..+++|.+........+.+.+|++++++++||||+++++++.+.+..|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 456788899999999999999964 5788999998766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999986532 4588999999999999999999998 99999999999999999999999999988654322
Q ss_pred cccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......++..|++|| +|+||||+++|+|++|++||..
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 1 122346777888888 3999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=262.50 Aligned_cols=198 Identities=25% Similarity=0.380 Sum_probs=163.9
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECC------CcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+...++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|++++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4456678888999999999999998532 3679999886542 23345688899999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
++..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999996431 2235688999999999999999999998 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++.+....... .....++..|++||. |||||||++|||++ |..||..
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 9999999999999998765433221 112334567999994 99999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=260.23 Aligned_cols=187 Identities=27% Similarity=0.367 Sum_probs=153.4
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcC---CCCCeeeEeeEEEE-----CC
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE-----GA 220 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~-----~~ 220 (348)
+|.+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3677789999999999999965 688999998864321 2223455677776655 79999999998864 34
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..++++||+++ +|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999984 8988886532 24589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++...... ......||..|+|||+ |||||||++|+|++|++||.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~ 208 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFC 208 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcC
Confidence 98764322 2233568899999993 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=259.01 Aligned_cols=191 Identities=23% Similarity=0.318 Sum_probs=160.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC------C
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG------A 220 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~------~ 220 (348)
+.+.|+..+.||+|+||.||+|... +++.||+|.+.... .....+..|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4456777788999999999999954 58899999886543 3445788899999998 699999999998753 4
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|++|||+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 6899999999999999987532 24688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+..+..... ......|+..|++|| +||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~ 217 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC 217 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 986543221 223356888899988 499999999999999999995
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=261.73 Aligned_cols=197 Identities=23% Similarity=0.376 Sum_probs=160.9
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
...++|++.+.||+|+||.||+|..+ .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45667888999999999999999753 24579999875443 223446788999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVG------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
..+++|||+++|+|.+++..... .....++..+..++.|++.||.|||++ +|+||||||+||+++.++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964321 123456778899999999999999998 999999999999999999999
Q ss_pred EecccCcccccCCCcccc-cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVT-TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~-~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+|||+++.+........ ....++..|++||. |+|||||++|||++ |++||..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999986543322111 12345677999994 99999999999998 7889864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=283.16 Aligned_cols=187 Identities=23% Similarity=0.307 Sum_probs=161.8
Q ss_pred CcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 154 CEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.+...||.|+||.||++..++ +-..|.|.+........+++..|++||..++||+||++++.|.-++.+|+++|||.||
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 344569999999999999654 4456778776666667788999999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
-....+-.- ..++.+.++..++.|++.||.|||++ +|||||||+.|||++.+|.++|+|||.+....... ...
T Consensus 115 AVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~-qkR 187 (1187)
T KOG0579|consen 115 AVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTR-QKR 187 (1187)
T ss_pred hHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHH-hhh
Confidence 988877542 25799999999999999999999999 99999999999999999999999999987643322 233
Q ss_pred cccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 313 TRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..+.|||+|||||+ ||||||++|.||..+.+|...
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe 237 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE 237 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence 45899999999995 999999999999999999764
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=261.55 Aligned_cols=202 Identities=26% Similarity=0.320 Sum_probs=167.6
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEE-
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCV- 217 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~- 217 (348)
..++.+..+.++|++.+.||+|+||.||++... +++.+|+|.+.... .....+..|+.++..+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 344555667888999999999999999999964 57899999875432 2345678899999999 6999999999884
Q ss_pred ----ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 218 ----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 218 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
+++..+++|||+++++|.+++.........+++..+..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34578999999999999998864333335688999999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+|||+++.+..... ......|++.|+||| +||||+||++|||++|+.||..
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~ 231 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCC
Confidence 9999999987643322 223346889999998 3999999999999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=281.76 Aligned_cols=193 Identities=18% Similarity=0.235 Sum_probs=152.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC--CcEEEEEEE--------------e---cCCcchHHHHHHHHHHHhcCCCCCe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD--GTKVAVKNL--------------L---NNRGQAEKEFKVEVEVIGRVRHKNL 209 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~H~nI 209 (348)
..++|.+.+.||+|+||.||+|..+. +...+.|.+ . .........+.+|+.+|.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 35679999999999999999987532 222222211 0 0111233567899999999999999
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
+++++++.+.+..|+++|++. ++|.+++..... .........+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEC
Confidence 999999999999999999996 578777653321 112234566788999999999999998 999999999999999
Q ss_pred CCCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
.++.+||+|||+++.+............||..|++||+ |||||||+||||++|++|+
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999998776544434445689999999995 9999999999999998754
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=263.52 Aligned_cols=184 Identities=22% Similarity=0.323 Sum_probs=150.8
Q ss_pred ceEeecCceEEEEEEEC---CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~ 231 (348)
..||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999964 35789999885432 23457789999999999999999998854 5678999999874
Q ss_pred CCHHHHHhcCC-----CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCceEEecccCcc
Q 018991 232 GNLDQWLHGDV-----GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (348)
Q Consensus 232 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill----~~~~~~kl~DFGla~ 302 (348)
+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 8888775321 1223588999999999999999999998 99999999999999 566789999999998
Q ss_pred cccCCCcc--cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......||+.|+|||. |||||||++|||++|++||.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 76543221 2233578999999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=254.99 Aligned_cols=185 Identities=25% Similarity=0.366 Sum_probs=154.3
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
+.||+|+||.||+|... +++.+|+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 35999999999999964 68899999875443 23446788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccccc-
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT- 313 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~- 313 (348)
.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++...........
T Consensus 81 ~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTEG---PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99986432 4588999999999999999999998 9999999999999999999999999999865432111111
Q ss_pred ccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 314 RVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 314 ~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....+..|++||. ||||||+++|||++ |.+||..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 1122456899983 99999999999998 8899853
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=258.49 Aligned_cols=192 Identities=21% Similarity=0.336 Sum_probs=163.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||++.. .++..+++|.+.... .....++.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3566778899999999999995 578999999875432 223457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.........+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999864333335689999999999999999999998 999999999999999999999999999887643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......|+..|++||. |+||||+++|+|++|..||.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 322 1223568889999993 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=261.01 Aligned_cols=188 Identities=24% Similarity=0.329 Sum_probs=164.7
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|.+.+.||+|+||.||++.. .+++.||+|.+........+.+..|+.+++.++||||+++++++..++..|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 35678889999999999999995 47899999998766555566788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999864 3478899999999999999999998 99999999999999999999999999998754332
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .....+++.|++||. |+|||||++|+|++|+.||.
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~ 216 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 21 223468888999983 99999999999999999995
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=256.44 Aligned_cols=195 Identities=25% Similarity=0.370 Sum_probs=164.4
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++.+++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455666666778999999999999954 678899998876655566788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPL--TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLA 301 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla 301 (348)
++||+++++|.+++.... .++ ++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 83 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 999999999999987532 234 7788889999999999999998 9999999999999976 679999999998
Q ss_pred ccccCCCcccccccccCCCcccce------------eccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
..+..... ......|++.|++|| +|+||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 157 KRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred eecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 76543222 122245788899988 3999999999999999999963
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=260.65 Aligned_cols=195 Identities=23% Similarity=0.398 Sum_probs=162.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC------CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 45678888999999999999998642 3689999886443 2334578889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVG------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
.+++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999999865321 123478889999999999999999998 9999999999999999999999
Q ss_pred ecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 296 SDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 296 ~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
+|||+++.+...... ......++..|++|| +|||||||++|||++ |+.||.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 223 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCc
Confidence 999999876443322 122345678899999 399999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=256.94 Aligned_cols=191 Identities=22% Similarity=0.371 Sum_probs=153.7
Q ss_pred CcCceEeecCceEEEEEEECC-Cc--EEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------CEE
Q 018991 154 CEENVIGEGGYGIVYRGILSD-GT--KVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AYR 222 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~ 222 (348)
.+.+.||+|+||.||+|...+ +. .+|+|.+.... ....+.+..|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456789999999999999654 32 68999876542 23346788899999999999999999987532 246
Q ss_pred EEEEeecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 223 MLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999999874322 1234588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCccccc-ccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 301 AKLLCSERSYVTT-RVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~-~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++........... ...+++.|++||. |||||||++|||++ |++||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 9876543322211 2345667888874 99999999999999 8999964
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=259.93 Aligned_cols=195 Identities=25% Similarity=0.424 Sum_probs=163.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
..++...++||+|+||.||++... ++..+++|.+..........+.+|++++..++||||+++++++.+.+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 345677889999999999999732 35679999887666566678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 018991 224 LVYEYVDNGNLDQWLHGDVG-----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||+++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999875321 113578999999999999999999998 9999999999999999999
Q ss_pred eEEecccCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+||+|||+++.......+. .....+++.|++|| +|||||||++|||++ |.+||..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999997654332221 12234567899999 499999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=272.99 Aligned_cols=183 Identities=20% Similarity=0.249 Sum_probs=156.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|.+.+.||+|+||.||++.+. +++.||+|... ...+.+|+++|++++||||+++++++...+..+++||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 346888899999999999999965 57889999532 22356799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+. ++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 242 ~~-~~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGARL---RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 68988886432 3689999999999999999999998 99999999999999999999999999998764332
Q ss_pred cc-cccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 309 SY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 309 ~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
.. ......||..|++||. |||||||+||||++|..|+
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 21 1223579999999994 9999999999999987654
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=254.13 Aligned_cols=190 Identities=25% Similarity=0.327 Sum_probs=163.6
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+..|+.+++.++||||+++++.+.+++..|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 3667789999999999999954 6889999988543 2334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ...+++..++.++.|++.||.|||++ +|+|+||||+||++++++.++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 81 DGGDLMQKIKLQR--GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999886432 24578999999999999999999998 999999999999999999999999999987654322
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......|++.|+|||+ |+||||+++|+|++|+.||..
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCC
Confidence 2233568889999994 999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-34 Score=258.09 Aligned_cols=189 Identities=22% Similarity=0.344 Sum_probs=159.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++..++||||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3667788999999999999964 68899999885432 22345788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++ ++|.+++.... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 68988886432 224689999999999999999999998 99999999999999999999999999997654322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......+++.|+|||. |||||||++|+|++|++||.
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 1122356788999983 99999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=255.78 Aligned_cols=193 Identities=23% Similarity=0.349 Sum_probs=162.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+..++|.+.+.||+|+||.||++...++..+++|.+.... ...+.+.+|++++++++|+||+++++.+.. ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 3456788889999999999999997777889999876432 334678889999999999999999999887 67899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhCC--ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 999999999997542 24578889999999999999999998 9999999999999999999999999999876433
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.........++..|++|| +|+|||||++|+|++ |+.||+.
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~ 206 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 206 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCC
Confidence 222222234566788988 399999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=254.85 Aligned_cols=188 Identities=25% Similarity=0.396 Sum_probs=160.4
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc---------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+..|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 556788999999999999854 6789999988544221 124678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++++||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||+|+||++++++.+||+|||+++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999653 4588889999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc-----ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERS-----YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~-----~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+..... .......|+..|++|| +|+|||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 214 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPD 214 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 7753221 1112346888999998 4999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=258.18 Aligned_cols=194 Identities=26% Similarity=0.414 Sum_probs=163.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++|...+.||+|+||.||+|+.+ +...+++|.+...... ....+..|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56778889999999999999954 2457999987654433 4567899999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGD-----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
+||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754321 12689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+++..............++..|++|| +||||||+++|+|++ |.+||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 998765443333333345677799888 399999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=259.66 Aligned_cols=188 Identities=23% Similarity=0.342 Sum_probs=164.8
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.+|+..+.||.|+||.||++.. .+++.|++|.+........+.+.+|+.+++.++||||+++++++...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4577788999999999999985 578999999987655555677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.. ..+++.++..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+.....
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998863 3488999999999999999999998 999999999999999999999999999887644322
Q ss_pred ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
......++..|++|| +|||||||++|+|++|+.||..
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 223356888999999 3999999999999999999963
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=259.08 Aligned_cols=193 Identities=26% Similarity=0.417 Sum_probs=159.6
Q ss_pred CCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667788999999999999853 235688888765432 334678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 225 VYEYVDNGNLDQWLHGDVG--------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
++||+.+++|.+++..... ...++++..++.++.|++.||.|||++ +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864211 123578999999999999999999998 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+++++.+||+|||+++.......+. .....++..|++||. ||||||+++|||++ |+.||..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999998764433322 222345678999993 99999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=257.79 Aligned_cols=190 Identities=27% Similarity=0.409 Sum_probs=156.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.+|++.+.||+|+||.||+|.+. ++. .+++|.+..... ....++..|+..+.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 35667789999999999999964 344 477887754322 234567788889999999999999998754 45788
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.+
T Consensus 86 i~e~~~~gsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR---DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999997532 4589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCC-cccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSER-SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~-~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.... ........++..|++||. |||||||++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~ 214 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 4332 222334567778999993 99999999999998 9999863
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=255.20 Aligned_cols=192 Identities=26% Similarity=0.413 Sum_probs=156.5
Q ss_pred CCcCceEeecCceEEEEEEEC-C---CcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE-----
Q 018991 153 LCEENVIGEGGYGIVYRGILS-D---GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----- 221 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 221 (348)
|++.+.||+|+||.||+|... + +..||+|.+..... .....+..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456788999999999999854 2 36799998865432 234578899999999999999999998865543
Q ss_pred -EEEEEeecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 222 -RMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
.++++||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 789999999999999885432 1224689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcccccc-cccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 299 GLAKLLCSERSYVTTR-VMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~-~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+++.......+.... ..++..|++|| +|||||||++|||++ |.+||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9998765443322221 23456788888 499999999999999 8899853
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=257.73 Aligned_cols=190 Identities=23% Similarity=0.294 Sum_probs=159.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+++++.++|+||+++++++.+++..|+|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 467888899999999999999854 68899999886443 2233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+. ++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQHP---GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 996 68877765432 3477888899999999999999998 9999999999999999999999999999865432
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... .....+++.|++||. ||||||+++|+|++|+.||..
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 221 223457888999993 999999999999999999953
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=271.21 Aligned_cols=183 Identities=25% Similarity=0.394 Sum_probs=158.2
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.++||+|.||+||-|+++ +|+.||||.+.+.+ .+...++.+|+.+|.++.||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 478999999999999964 79999999996553 34456789999999999999999999999999999999999965
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCcccccCCCc
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla~~~~~~~~ 309 (348)
++.+.+-.. +.+.+++.....++.||+.||.|||.+ +|+|+||||+|||+.. .-++||||||+||++....
T Consensus 648 DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 665555432 235799998899999999999999998 9999999999999964 3579999999999986543
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
....++|||.|.|||+ |+||.|+|+|--++|.+||-
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN 767 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN 767 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence 3345899999999996 99999999999999999995
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.00 Aligned_cols=190 Identities=23% Similarity=0.335 Sum_probs=159.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~ 222 (348)
.+|...+.||+|+||.||++.. .++..|++|.+.... ......+.+|+.++++++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688889999999999999995 468899999885432 1223468889999999999999999999876 3678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++++||+++++|.+++... ..+++...+.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 8999999999999998643 3578899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+..... .......++..|+|||. ||||+||++|||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~ 211 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccc
Confidence 6543211 11123468889999983 999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=269.94 Aligned_cols=192 Identities=22% Similarity=0.328 Sum_probs=162.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEec--CCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 225 (348)
....|++.+.||+|+.+.||++...+.+.+|+|++.. .+.+....+..|+.+|.+|+ |.+|+++++|-..++.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3445788899999999999999988878888887733 34556678999999999995 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||=+ .||..+|+..... ...| .++.+..|++.++.++|++ ||||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 439 mE~Gd-~DL~kiL~k~~~~--~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSI--DPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eeccc-ccHHHHHHhccCC--CchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99865 6999999865322 2223 6788999999999999999 9999999999999865 689999999999887
Q ss_pred CCCccc-ccccccCCCccccee---------------------ccchHHHHHHHHHhccCCCCCC
Q 018991 306 SERSYV-TTRVMGTFGYAHFIV---------------------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 306 ~~~~~~-~~~~~gt~~y~~pe~---------------------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
.+.... ....+||+.||+||+ ||||||||||+|++|+.||.+|
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~ 575 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI 575 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH
Confidence 654432 234689999999995 9999999999999999999764
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=256.45 Aligned_cols=187 Identities=22% Similarity=0.319 Sum_probs=151.2
Q ss_pred eEeecCceEEEEEEECCC---cEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 158 VIGEGGYGIVYRGILSDG---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.++..++||||+++++.+.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 499999999999985433 346677665433 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc-ccc
Q 018991 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVT 312 (348)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~ 312 (348)
|.+++..........++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++........ ...
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999976433334567778889999999999999998 999999999999999999999999999865322211 112
Q ss_pred cccccCCCcccce-----------------eccchHHHHHHHHHh-ccCCCCC
Q 018991 313 TRVMGTFGYAHFI-----------------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....++..|++|| +|||||||++|||++ |.+||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 2345777888887 499999999999997 5778853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.41 Aligned_cols=188 Identities=26% Similarity=0.349 Sum_probs=160.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|+..+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++|||++++++++......+++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5777889999999999999965 58999999886442 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++++.|..++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 82 CDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred cCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9998888776532 3589999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......++..|++|| +||||||+++|+|++|++||..
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 2 112245677888887 3999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=274.67 Aligned_cols=190 Identities=22% Similarity=0.264 Sum_probs=160.6
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchH---HHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
..-|...+.||-|+||+|.+++. ++...+|+|.+.+.+...+ .-.+.|-.||...+.+.||+||..|++.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 34466778899999999999984 4567899999865543222 3467799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||++||++..+|.+- +.|.+..+..++.++..|+++.|.. |+|||||||+|||||.+|++||+|||||.-+.
T Consensus 708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence 9999999999988643 5689999999999999999999987 99999999999999999999999999995431
Q ss_pred C--------C---------------------------------CcccccccccCCCccccee----------ccchHHHH
Q 018991 306 S--------E---------------------------------RSYVTTRVMGTFGYAHFIV----------QVSPLFIL 334 (348)
Q Consensus 306 ~--------~---------------------------------~~~~~~~~~gt~~y~~pe~----------DiwSlG~i 334 (348)
- + ....+...+||+.|+|||+ |+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 0 0 0011223679999999996 99999999
Q ss_pred HHHHHhccCCCC
Q 018991 335 LYILLSVRYNSS 346 (348)
Q Consensus 335 l~el~~g~~Pf~ 346 (348)
||||+.|++||-
T Consensus 861 l~em~~g~~pf~ 872 (1034)
T KOG0608|consen 861 LYEMLVGQPPFL 872 (1034)
T ss_pred HHHHhhCCCCcc
Confidence 999999999994
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=262.92 Aligned_cols=187 Identities=17% Similarity=0.156 Sum_probs=154.6
Q ss_pred CceEeec--CceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 156 ENVIGEG--GYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 156 ~~~lG~G--~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
.++||+| +|++||++.. .+|+.||+|.+.... ....+.+..|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 7889999985 478999999986542 2334567789999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+|+|.+++..+. ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.++++||+.+..+......
T Consensus 83 ~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 83 YGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999986542 23588999999999999999999998 9999999999999999999999999875443221110
Q ss_pred ------cccccccCCCcccce------------eccchHHHHHHHHHhccCCCCC
Q 018991 311 ------VTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ------~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
......++..|+||| +|||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 011134567788887 3999999999999999999963
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=255.27 Aligned_cols=180 Identities=25% Similarity=0.343 Sum_probs=150.9
Q ss_pred ceEeecCceEEEEEEECC-------------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 157 NVIGEGGYGIVYRGILSD-------------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+.||+|+||.||+|+..+ ...|++|.+..........+..|+.++..++||||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358889876554445567888999999999999999999999998999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-------eEEe
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-------ARVS 296 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~-------~kl~ 296 (348)
++|||+++++|..++.... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS---DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 9999999999999886432 4589999999999999999999998 9999999999999987654 8999
Q ss_pred cccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHH-hccCCCCC
Q 018991 297 DFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILL-SVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~-~g~~Pf~~ 347 (348)
|||++...... ....++..|+|||. |||||||++|||+ .|+.||..
T Consensus 155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99998765322 22457788999993 9999999999998 58888863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=262.61 Aligned_cols=195 Identities=26% Similarity=0.376 Sum_probs=160.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
..++|.+.+.||+|+||.||+++.. +...+|+|.+.... .....++..|+.++.++ +||||+++++++..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 3456888899999999999999852 23469999886542 23445688899999999 79999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence 9999999999999999999975421 113588999999999999999999998 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
++.++.+||+|||+++......... .....++..|++|| +|||||||++|+|++ |..||.
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999998654322111 11123456799998 399999999999998 888885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.27 Aligned_cols=192 Identities=28% Similarity=0.423 Sum_probs=156.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc--EEEEEEEecC-CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT--KVAVKNLLNN-RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|++.++||+|+||.||+|..+ ++. .+++|.+... .....+.+..|++++.++ +||||+++++++...+..|++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788899999999999999865 333 4788877643 233446788999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 226 YEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
+||+++++|.+++..... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999965321 113588999999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||++...... ........+..|++||. |||||||++|||++ |+.||..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~ 221 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG 221 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999998643211 11111223456888883 99999999999997 9999953
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=261.60 Aligned_cols=192 Identities=27% Similarity=0.423 Sum_probs=156.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCc--EEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGT--KVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.+.||+|+||.||+|.++ ++. .+++|.+.... ......+.+|++++.++ +||||+++++++..++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 356778899999999999999964 454 45777765432 23445788899999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 018991 225 VYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 9999999999999975421 123578999999999999999999998 9999999999999999999
Q ss_pred eEEecccCcccccCCCcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
+||+|||+++...... ......++..|++|| +|||||||++|||++ |..||.
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 225 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 225 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcc
Confidence 9999999986432111 111123356688888 399999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=259.58 Aligned_cols=189 Identities=24% Similarity=0.313 Sum_probs=160.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|...+.||+|+||.||++... +++.|++|.+..... .....+..|+++++.++||||+++++.+..++..+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36778899999999999999965 578999998865432 23456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 999999999999653 4588999999999999999999998 999999999999999999999999999874211
Q ss_pred C--------------CcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCC
Q 018991 307 E--------------RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~--------------~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
. .........++..|++|| +|||||||++|||++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~ 217 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 217 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 0 011112246788899998 499999999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=258.45 Aligned_cols=188 Identities=23% Similarity=0.258 Sum_probs=161.4
Q ss_pred CCCcCceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
+|++.+.||+|+||.||+++. .+|..||+|.+.... ....+.+..|++++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 466778999999999999985 368899999986532 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++|+||+++++|.+++... .++++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 9999999999999998653 4588899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCcccce------------eccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..............|+..|++|| .||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~ 209 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCC
Confidence 76443333333466888999998 399999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=258.34 Aligned_cols=190 Identities=23% Similarity=0.384 Sum_probs=161.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|++.+.||+|+||.||++... ++..||+|.+... .......+.+|++++++++||||+++++.+..++..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 4667788999999999999965 6899999988654 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ....+++..+..++.|++.||.|||++ .+|+|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 82 DAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred CCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999987532 124689999999999999999999963 289999999999999999999999999997653321
Q ss_pred ccccccccCCCcccce----------------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....++..|++|| +|||||||++|+|++|++||..
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 12245777888887 3999999999999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=261.31 Aligned_cols=194 Identities=26% Similarity=0.380 Sum_probs=162.4
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECC
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 220 (348)
..++|.+.+.||+|+||.||++... ++..||+|.+.... ....+.+..|+.+++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3456888899999999999999741 34579999886543 33346788999999999 7999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..+++|||+++|+|.++++... ...+++.+++.++.|++.||.|||++ +|+|+||||+|||++.++.+|++|||+
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999997532 13489999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 301 AKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.+...... ......++..|++||. ||||+||++|+|++ |..||+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~ 246 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPG 246 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCC
Confidence 9876543321 1122345678999994 99999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=258.07 Aligned_cols=196 Identities=21% Similarity=0.355 Sum_probs=162.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC-----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 221 (348)
..++|.+.+.||+|+||.||+|.+.+ +..|++|.+.... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45678888999999999999999654 6789999886543 3345678899999999999999999998766 467
Q ss_pred EEEEEeecCCCCHHHHHhcCCCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGD----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
.++++||+++++|.+++...... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654221 14689999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 298 FGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 298 FGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+++.+...... ......++..|+|||. |||||||++|||++ |+.||..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 222 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCc
Confidence 9999866433221 1222345677999983 99999999999999 9999964
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.03 Aligned_cols=182 Identities=28% Similarity=0.442 Sum_probs=151.2
Q ss_pred EeecCceEEEEEEEC---CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS---DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||+|.++ ++..||+|.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999854 355799998865532 334678899999999999999999998854 567999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.+..........
T Consensus 82 ~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSGKK---DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 99986432 4689999999999999999999998 99999999999999999999999999998654433221111
Q ss_pred --cccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 315 --VMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 315 --~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..++..|++|| +|||||||++|+|++ |+.||..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 201 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKK 201 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCc
Confidence 22356799998 399999999999996 9999964
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=252.75 Aligned_cols=187 Identities=32% Similarity=0.448 Sum_probs=161.6
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||+|... ++.||+|.+..... ..+.+..|+.++..++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 456778899999999999999875 78899999865543 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999997542 13689999999999999999999998 999999999999999999999999999987632221
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...++..|++||. ||||||+++|+|++ |+.||..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 2234567888883 99999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=260.61 Aligned_cols=195 Identities=25% Similarity=0.428 Sum_probs=159.4
Q ss_pred hcCCCcCceEeecCceEEEEEEECC---------------CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD---------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLL 213 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~---------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~ 213 (348)
.++|++.+.||+|+||.||+|+... ...||+|.+.... ......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3567888999999999999997532 2358999886542 23345788999999999999999999
Q ss_pred eEEEECCEEEEEEeecCCCCHHHHHhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 018991 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVG--------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (348)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Ni 285 (348)
+++...+..++||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999864311 112478889999999999999999998 999999999999
Q ss_pred EECCCCceEEecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh--ccCCCCC
Q 018991 286 LLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS--VRYNSST 347 (348)
Q Consensus 286 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~--g~~Pf~~ 347 (348)
+++.++.+||+|||+++.+...... ......++..|++|| +|||||||++|+|++ |..||..
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999999865433221 122234567899998 399999999999998 6778853
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.91 Aligned_cols=195 Identities=25% Similarity=0.436 Sum_probs=159.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-----------------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-----------------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVR 211 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 211 (348)
.++|++.+.||+|+||.||++... +...+|+|.+.... .....++.+|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 456888899999999999998632 23468999886543 334567899999999999999999
Q ss_pred EeeEEEECCEEEEEEeecCCCCHHHHHhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD-------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
+++++...+..+++|||+++++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 999999999999999999999999998753211 13477888999999999999999998 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh--ccCCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS--VRYNSST 347 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~--g~~Pf~~ 347 (348)
||++.++.+||+|||+++.+....... .....++..|++|| +|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~ 236 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence 999999999999999998664332211 12233456788887 499999999999998 7788853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=260.56 Aligned_cols=190 Identities=27% Similarity=0.272 Sum_probs=162.8
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc---hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|+..+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++..++||||+++++.+.+....|++||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999965 5899999998655322 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+.+++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 82 YCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred ecCCCCHHHHHHhCC--CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999987432 24689999999999999999999998 9999999999999999999999999998765322
Q ss_pred Cc----------------------------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RS----------------------------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~----------------------------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .......|+..|++||. ||||||+++|+|++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 233 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFK 233 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCC
Confidence 11 11123468889999984 99999999999999999996
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.54 Aligned_cols=188 Identities=26% Similarity=0.356 Sum_probs=163.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|+||.||+|... ++..|++|.+.... ......+.+|+.++++++||||+++++++.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3677789999999999999964 68999999986543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+ +++|.+++.... .++++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986532 4689999999999999999999998 99999999999999999999999999998765443
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........|+..|++||. ||||+|+++|+|++|++||.
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 222334568889999984 99999999999999988884
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=252.95 Aligned_cols=182 Identities=28% Similarity=0.426 Sum_probs=152.6
Q ss_pred eEeecCceEEEEEEEC---CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 158 VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.||+|+||.||+|.++ ++..+|+|.+.... ....+++..|+.+++.++||||+++++++.. +..+++|||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 4899999999999753 57889999885443 2345678899999999999999999998854 4578999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc-
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV- 311 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~- 311 (348)
+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||.||+++.++.+||+|||+++.+.......
T Consensus 81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 999999643 3588999999999999999999998 99999999999999999999999999998765443221
Q ss_pred -ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 312 -TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 312 -~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....++..|++|| +|||||||++|||++ |+.||..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 11223457899998 499999999999998 9999964
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=252.88 Aligned_cols=190 Identities=23% Similarity=0.340 Sum_probs=160.1
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC-----CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 222 (348)
.+|.+.+.||+|+||.||++.. .++..||+|.+... .......+.+|++++++++||||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4678889999999999999995 46899999987432 122345788899999999999999999998764 468
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++++||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 8999999999999998643 3578899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCC--cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSER--SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~--~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ........++..|++||. |+|||||++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 654311 111223568889999993 999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=251.15 Aligned_cols=186 Identities=25% Similarity=0.356 Sum_probs=161.3
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
|+..+.||+|+||.||+|... ++..|++|.+.... ....+.+..|+++++.++||||+++++++.+....++++
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999965 78999999885433 123467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 82 ELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999998643 3588999999999999999999998 999999999999999999999999999887644
Q ss_pred CCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......|+..|++|| +|+||||+++|+|++|+.||..
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~ 204 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 32 223356788888887 4999999999999999999964
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=250.87 Aligned_cols=190 Identities=22% Similarity=0.336 Sum_probs=164.3
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|+..+.||+|+||.||.++. ++++.+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 467788999999999999984 468899999885442 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997542 24688999999999999999999998 99999999999999999999999999998764443
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+++.|++|| +|+||||+++|+|++|+.||..
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 2 223456889999999 3999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=263.54 Aligned_cols=183 Identities=23% Similarity=0.299 Sum_probs=154.5
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
....+|.+.+.||+|+||.||+|+.. ++..||+|..... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34567999999999999999999965 5778999964322 2345899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+. ++|.+++... ..++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 9996 6898888643 24689999999999999999999998 999999999999999999999999999975432
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
.. ......||+.|+|||. |||||||++|||+++..|+
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 AP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred Cc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 21 2233579999999994 9999999999999865443
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.07 Aligned_cols=191 Identities=28% Similarity=0.413 Sum_probs=158.0
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCc----EEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGT----KVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|+..+.||+|+||.||+|++ .++. .||+|.+.... ....+++.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 34577788999999999999985 3444 48999886543 33456788999999999999999999998754 467
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK---DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 9999999999999987532 4588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+...... ......++..|++||. |||||||++|||++ |..||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 214 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 6533221 1122334678999994 99999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=255.47 Aligned_cols=190 Identities=26% Similarity=0.407 Sum_probs=157.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-----CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 223 (348)
.+|++.+.||+|+||.||++... ++..||+|.+........+.+.+|++++.+++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46777889999999999999742 578899999876655556788999999999999999999998754 34689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR---ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 9999999999999986432 3588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCccccc--ccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTT--RVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~--~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+......... ...++..|++||. ||||||+++|||++|..|+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 6543322111 1223345888883 99999999999999876643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=250.93 Aligned_cols=188 Identities=30% Similarity=0.456 Sum_probs=161.3
Q ss_pred ceEeecCceEEEEEEECC----CcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|.... +..|++|.+...... ..+.+..|++++..++|+||+++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 369999999999999653 788999998665433 357788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 232 GNLDQWLHGDVGD-----VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 232 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
++|.+++...... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999764211 35689999999999999999999998 999999999999999999999999999987755
Q ss_pred CCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 307 ERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 307 ~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
... .......++..|++||. ||||||+++|+|++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 210 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG 210 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCC
Confidence 432 12233567888999993 99999999999999 6999964
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=257.41 Aligned_cols=196 Identities=28% Similarity=0.414 Sum_probs=160.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
..++|.+.+.||+|+||.||+|.+. .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456888899999999999999964 35678999875443 2334568899999999999999999999999889
Q ss_pred EEEEEeecCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---ceEE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARV 295 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl 295 (348)
.+++|||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence 9999999999999999875421 123589999999999999999999998 999999999999998654 5999
Q ss_pred ecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 296 SDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+|||+++.+....... ......+..|++||. |||||||++|||++ |+.||..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~ 224 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPG 224 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 9999998764322211 112233567899993 99999999999997 9999964
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=239.79 Aligned_cols=197 Identities=24% Similarity=0.350 Sum_probs=164.1
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
++.+.+.+.....||+|++|.|-+-++. +|...|+|.+... ..+..+++..|+.+..+. ..|.+|.+||...++...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4455556666678999999999888854 7899999999655 334556788888876654 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+.||.|. -+|..+-++-.......++..+-+|+..+..||.|||++ ..++|||+||.|||+|.+|++|+||||++.
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccce
Confidence 99999997 488877665444556789999999999999999999997 489999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+.+.-. .+-..|...||||| +||||||+++.||.++++|+.+
T Consensus 198 ~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 8754321 22246899999999 3999999999999999999864
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=260.81 Aligned_cols=198 Identities=25% Similarity=0.381 Sum_probs=161.4
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 216 (348)
.....+|.+.+.||+|+||.||+++.. +...+|+|.+.... ......+..|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 344566788899999999999999742 24568999876443 23345688899999999 699999999999
Q ss_pred EECCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 217 VEGAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
.+++..|++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 164 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN 164 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence 999999999999999999999965321 124588999999999999999999998 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||++.++.+||+|||+++.......+. .....++..|++||. ||||||+++|+|++ |..||..
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999998764322211 111234467999993 99999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=258.25 Aligned_cols=192 Identities=23% Similarity=0.346 Sum_probs=157.7
Q ss_pred CCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+..|+.++.+++||||+++++++.+.+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 445577999999999999853 247899999865432 2345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
+||+.+++|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCce
Confidence 99999999999985321 1123578888999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||+++.+...... ......+++.|+|||. |||||||++|||++ |..||..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 229 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 229 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC
Confidence 99999999876433221 1222446778999983 99999999999998 8888863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=254.54 Aligned_cols=186 Identities=30% Similarity=0.426 Sum_probs=154.9
Q ss_pred CCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 224 (348)
|+..+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 36678899999999988753 3577899998865432 3456788999999999999999999988653 46899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|||+++++|.+++... .+++.++..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+
T Consensus 86 v~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeeccccccc
Confidence 99999999999998642 489999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCccc--ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYV--TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~--~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
....... .....++..|++||. ||||||+++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~ 211 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCC
Confidence 5432211 112345566888883 99999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.08 Aligned_cols=196 Identities=24% Similarity=0.373 Sum_probs=161.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
...+|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 4556778899999999999999741 24579999876442 23446788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
.+..|++|||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 9999999999999999999975421 123578888999999999999999998 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++.+....... .....++..|+||| +||||||+++|+|++ |..||..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999998765433221 22234567899998 399999999999998 7888853
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=252.24 Aligned_cols=184 Identities=26% Similarity=0.387 Sum_probs=157.6
Q ss_pred ceEeecCceEEEEEEECC--C--cEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|++|.||+|.+.+ + ..||+|.+..... ...+.+..|+.++++++||||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999999643 2 3699999876655 556789999999999999999999999988 889999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc-
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 310 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~- 310 (348)
++|.+++..... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999976432 4689999999999999999999998 9999999999999999999999999999877543221
Q ss_pred -cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 311 -VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 311 -~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
......++..|++|| .|||||||++|+|++ |+.||.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 202 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA 202 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 111245778899999 499999999999998 999984
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=254.14 Aligned_cols=191 Identities=28% Similarity=0.406 Sum_probs=159.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-C---CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-D---GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.+|++.+.||+|+||.||+|... + +..+|+|.+.... ....+.+..|+.++.+++||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 45777899999999999999853 2 3379999886543 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKHD---GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 99999999999997542 4588999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcccc--cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYVT--TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~~--~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....... ....++..|++||. |+||||+++|+|++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~ 212 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWE 212 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCccc
Confidence 4332211 11233567888883 99999999999886 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.83 Aligned_cols=189 Identities=23% Similarity=0.407 Sum_probs=161.3
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
+|+.++.||+|+||.||++.. .+++.||+|.+..... ...+.+..|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 467788999999999999994 5789999998864321 134578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~ 303 (348)
++||+++++|.+++... .++++..+..++.|++.||.|||++ +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999998753 4688999999999999999999998 999999999999998775 599999999987
Q ss_pred ccCCCc---ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERS---YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~---~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... .......++..|++|| +|+||+|+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 210 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNA 210 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 654321 1122356888999999 3999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=255.57 Aligned_cols=191 Identities=24% Similarity=0.324 Sum_probs=159.8
Q ss_pred hcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+.||+|+||.||+|...+ ...|++|...... ....+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4457778899999999999998543 2468999876554 3445678999999999999999999998875 45789
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQVNK---YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeec
Confidence 999999999999997532 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....+......++..|++||. ||||||+++|||++ |+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 5543333333445567999993 99999999999986 9999964
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=254.85 Aligned_cols=192 Identities=26% Similarity=0.342 Sum_probs=157.6
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHH-HhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEV-IGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+++.. +|+.||+|.+.... ......+..|..+ ++.++||||+++++++..++..|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 35778889999999999999965 68999999886543 2233455556665 566789999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|++ |+|.+++.........+++..+..++.|++.||.|||++ .+++||||||+||+++.++.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 689888865433335789999999999999999999974 27999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......++..|++|| +|+|||||++|+|++|++||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 1 112246788888888 3999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=256.19 Aligned_cols=188 Identities=25% Similarity=0.350 Sum_probs=158.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|+..+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 46777889999999999999965 688999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 985 9999886542 3578999999999999999999998 99999999999999999999999999987643221
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......++..|++||. ||||+|+++|+|++|+.||.
T Consensus 158 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 205 (291)
T cd07844 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFP 205 (291)
T ss_pred c-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 1122346777888883 99999999999999999995
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.33 Aligned_cols=179 Identities=29% Similarity=0.510 Sum_probs=151.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
..+...++||+|+||.||+|+. .++..||+|.+....... ..|++.+++++||||+++++++.+++..|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999996 578999999885433222 24688899999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.++++ .++|..+..++.|++.||+|||....++|+||||||+||+++.++..++. ||........
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-- 835 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-- 835 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence 9999999985 27899999999999999999996555699999999999999999888876 6665543221
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
....+|+.|+|||. |||||||++|||++|+.||.
T Consensus 836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 12367899999994 99999999999999999984
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=256.37 Aligned_cols=195 Identities=27% Similarity=0.439 Sum_probs=162.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECC-----------------CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD-----------------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVR 211 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~ 211 (348)
..+|.+.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4567888999999999999998532 2458999886553 234567889999999999999999
Q ss_pred EeeEEEECCEEEEEEeecCCCCHHHHHhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 212 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
+++++..++..++++||+++++|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999975431 123689999999999999999999998 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCcc-cccccccCCCcccce----------eccchHHHHHHHHHh--ccCCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS--VRYNSST 347 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~--g~~Pf~~ 347 (348)
|+++.++.++|+|||+++.+...... ......++..|++|| +|||||||++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999876443221 122345677899998 499999999999998 7778753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=250.50 Aligned_cols=189 Identities=26% Similarity=0.364 Sum_probs=164.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|+..+.||+|+||.||+|...+ +..+++|.+..... .+++.+|++++++++||||+++++++.+....|+++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 3567788899999999999999764 78999998864432 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++..+....
T Consensus 80 ~~~~~L~~~l~~~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 80 CGAGSVSDIMKITN---KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred CCCCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999986432 4689999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......++..|++|| +||||||+++|+|++|+.||..
T Consensus 154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 1 223356888999999 4999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=253.65 Aligned_cols=187 Identities=25% Similarity=0.325 Sum_probs=163.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+..|+++++.++||||+++++++.++...|+|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 4667788999999999999965 68899999886543 334457889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++... ++++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||+++.+.....
T Consensus 82 ~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 82 GGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998643 689999999999999999999998 999999999999999999999999999988754321
Q ss_pred ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
......+++.|++|| +||||||+++|+|++|+.||..
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 223356888999999 3999999999999999999953
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=264.58 Aligned_cols=197 Identities=25% Similarity=0.380 Sum_probs=158.9
Q ss_pred HHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG 219 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~ 219 (348)
.+.++|.+.+.||+|+||.||+|.+ .+++.||||.+..... .....+.+|+.++.++ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 3456788899999999999999973 2467899999865432 2345688899999999 689999999988654
Q ss_pred -CEEEEEEeecCCCCHHHHHhcCCCC------------------------------------------------------
Q 018991 220 -AYRMLVYEYVDNGNLDQWLHGDVGD------------------------------------------------------ 244 (348)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 244 (348)
...+++|||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 5678999999999999998643210
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc-ccc
Q 018991 245 ---------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TTR 314 (348)
Q Consensus 245 ---------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~-~~~ 314 (348)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......... ...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 12467888899999999999999998 99999999999999999999999999998754332221 122
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..++..|++||. ||||||+++|+|++ |..||..
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 345667999994 99999999999997 9999853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=254.18 Aligned_cols=194 Identities=29% Similarity=0.355 Sum_probs=164.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECC------
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~------ 220 (348)
++++|++.+.||+|+||.||+|..+ +++.+++|.+..... ..+.+..|+++++++ +||||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4577888999999999999999964 578999998765443 346788999999999 7999999999997644
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|++|||+++++|.+++.........+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999999865432235689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
+........ ......|+..|+||| +||||||++||+|++|++||..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 876543322 222346888899988 4999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=251.10 Aligned_cols=189 Identities=26% Similarity=0.462 Sum_probs=160.5
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
.+|++.+.||+|+||.||++.+.++..+|+|.+.... ....++..|++++++++|||++++++++......++++||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3566778899999999999997767889999876443 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++.... .++++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQR---GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhCc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 999999986532 3578999999999999999999998 9999999999999999999999999999866433221
Q ss_pred cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 311 VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
......++..|++|| +||||||+++|||++ |+.||.
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~ 203 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYE 203 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCC
Confidence 122233556899998 499999999999998 999985
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=253.54 Aligned_cols=191 Identities=28% Similarity=0.470 Sum_probs=159.1
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CC---cEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DG---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|+..+.||+|+||.||+|+.. ++ ..+++|.+.... ....+.+..|++++.+++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 346777889999999999999964 33 369999886542 3345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDHD---GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999986532 4588999999999999999999998 9999999999999999999999999999866
Q ss_pred cCCCcccc--cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 305 CSERSYVT--TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~--~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
........ .....+..|++||. |||||||++|||++ |+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~ 212 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW 212 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCC
Confidence 43222111 11223456899983 99999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=250.21 Aligned_cols=186 Identities=32% Similarity=0.413 Sum_probs=157.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEE-ECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~ 228 (348)
..+|.+.+.||+|+||.||++... +..+++|.+.... ..+.+..|+.++++++|+|++++++++. ..+..++++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 346777899999999999999864 7789999875432 3457889999999999999999999765 45678999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999987542 23588999999999999999999998 99999999999999999999999999988653322
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....++..|++|| .|||||||++|+|++ |++||..
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 2234456799998 399999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=249.11 Aligned_cols=189 Identities=24% Similarity=0.360 Sum_probs=160.9
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e 227 (348)
+|++.+.||+|++|.||++... +++.||+|.+.... ....+.+..|++++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4777899999999999999954 57899999986432 2334568889999999999999999998764 456899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ...+++.++..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQK--GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 999999999987532 24589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ......+++.|+|||. ||||||+++|+|++|+.||.
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 22 2234568899999994 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=255.84 Aligned_cols=188 Identities=24% Similarity=0.326 Sum_probs=161.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++..++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 34666788999999999999954 68899999876543 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++... ..+++..+..++.+++.||.|||+. .+++|+||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 9999999988653 4589999999999999999999963 189999999999999999999999999987653221
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....|+..|++||. |||||||++|+|++|+.||..
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 223578899999994 999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=256.71 Aligned_cols=186 Identities=24% Similarity=0.330 Sum_probs=157.0
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|+..+.||+|+||.||+|+.. +|..||+|.+.... ......+.+|++++++++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3667788999999999999964 68899999886432 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++ ++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSCN---GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 97 58888776432 4589999999999999999999998 99999999999999999999999999998654322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf 345 (348)
.. .....++..|+|||. |||||||++|+|++|+.||
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~ 200 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCC
Confidence 11 122457788999993 9999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=261.35 Aligned_cols=196 Identities=25% Similarity=0.375 Sum_probs=160.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
....|.+.+.||+|+||.||+++.. .+..||+|.+.... ....+++..|++++.++ +||||+++++++..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3456788899999999999999742 12368999876432 23356788999999999 79999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
.+..++++||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +++||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 166 (334)
T cd05100 90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVL 166 (334)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEE
Confidence 9999999999999999999975321 123578899999999999999999998 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++......... .....++..|++||+ ||||||+++|||++ |..||..
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999999999999998764432221 122334567999983 99999999999998 8899864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=258.71 Aligned_cols=182 Identities=26% Similarity=0.347 Sum_probs=158.8
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
...||+|+||.||++... ++..||+|.+........+.+.+|+.++..++||||+++++.+...+..+++|||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 356999999999999954 6889999988665555566788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||++++++.+||+|||++........ ....
T Consensus 107 ~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 177 (292)
T cd06658 107 TDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS 177 (292)
T ss_pred HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence 998853 3478999999999999999999998 999999999999999999999999999876543322 1223
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..|+..|+|||. |+||||+++|||++|+.||.
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~ 219 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 219 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 568899999993 99999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=257.39 Aligned_cols=191 Identities=23% Similarity=0.335 Sum_probs=159.4
Q ss_pred CCcCceEeecCceEEEEEEEC---CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 224 (348)
|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 667788999999999999964 47899999987633 33345678899999999999999999999988 88999
Q ss_pred EEeecCCCCHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC----CCceEEeccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSDFG 299 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~----~~~~kl~DFG 299 (348)
||||+++ +|.+++...... ...+++..+..++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 777776543222 23688999999999999999999998 9999999999999999 9999999999
Q ss_pred CcccccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++.+..... .......++..|+|||+ |||||||++|+|++|++||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 9987644322 11223567888999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=255.59 Aligned_cols=186 Identities=25% Similarity=0.316 Sum_probs=158.5
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc-----hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
|...+.||+|+||.||+|... +++.||+|.+...... ....+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 666788999999999999964 6899999998655322 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 82 e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 82 EFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred ccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 999 889999997542 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......+++.|++|| .|||||||++|+|++|.+||.
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~ 204 (298)
T cd07841 155 PNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLP 204 (298)
T ss_pred CCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCcccc
Confidence 322 122234677788887 399999999999999988774
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=261.39 Aligned_cols=192 Identities=22% Similarity=0.241 Sum_probs=161.2
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc---hHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~ 221 (348)
++...+|....+||+|+||+|.++.-+ +.+.+|||+++++.-- +.+--..|-++|... +-|.+++++.+|+.-++
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 344567888899999999999999854 5678999998766321 122233566777655 68899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
+|.||||+.||+|...+++- +.+.+..+..++.+|+-||-|||++ +|+.||||.+|||+|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 99999999999998888643 5677888899999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.---.. ..+..++|||.|+|||+ |+||+|++||||+.|++||-
T Consensus 498 KEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 498 KENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred cccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 8643322 33445899999999995 99999999999999999994
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=252.26 Aligned_cols=189 Identities=29% Similarity=0.445 Sum_probs=157.0
Q ss_pred CCCcCceEeecCceEEEEEEEC-CC---cEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DG---TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.|.+.+.||+|+||.||+|... ++ ..||+|.+... ......++..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667889999999999999964 33 36999988654 2334567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++....
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCcccccccc
Confidence 9999999999987532 3588999999999999999999998 999999999999999999999999999886643
Q ss_pred CCccc--ccccc--cCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 307 ERSYV--TTRVM--GTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 307 ~~~~~--~~~~~--gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
..... ..... .+..|++||. |||||||++|||++ |..||.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~ 213 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 213 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCC
Confidence 32211 11111 1346889983 99999999999886 999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=248.62 Aligned_cols=189 Identities=28% Similarity=0.373 Sum_probs=163.2
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc--hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|...+.||+|+||.||+|... +++.|++|.+...... ..+.+..|+++++.++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3667789999999999999954 6889999998765443 566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 9999999998743 3478889999999999999999998 99999999999999999999999999998765433
Q ss_pred ccccc---ccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTT---RVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~---~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ...++..|++|| +||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~ 208 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccC
Confidence 22111 246778898888 3999999999999999999963
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=253.42 Aligned_cols=198 Identities=25% Similarity=0.338 Sum_probs=165.0
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE-
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE- 218 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~- 218 (348)
++.++..+...|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 4555556777888899999999999999996 468899999875443 3345678899999998 79999999999853
Q ss_pred -----CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 219 -----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 219 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
....|++|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 457899999999999999987532 24578888999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+|+|||++........ ......|++.|+||| +|+|||||++|||++|++||.
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~ 227 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcc
Confidence 9999999876543221 122356888999998 399999999999999999995
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=258.33 Aligned_cols=182 Identities=25% Similarity=0.319 Sum_probs=158.6
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
...||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++..++..++++||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 346999999999999954 6889999998655444556788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++.. ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+..... ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 998753 3478999999999999999999998 999999999999999999999999999876543322 2233
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..|+..|++||. |||||||++|||++|+.||.
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 218 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF 218 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 578899999994 99999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=253.60 Aligned_cols=179 Identities=22% Similarity=0.287 Sum_probs=147.7
Q ss_pred eEeecCceEEEEEEECC-------------------------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeE
Q 018991 158 VIGEGGYGIVYRGILSD-------------------------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l 212 (348)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 48999999999997421 13588998865444445678889999999999999999
Q ss_pred eeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-
Q 018991 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW- 291 (348)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~- 291 (348)
++++.++...++||||+++|+|..++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK---GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 999999999999999999999999986432 4578999999999999999999998 999999999999997643
Q ss_pred ------ceEEecccCcccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHH-hccCCCCC
Q 018991 292 ------NARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILL-SVRYNSST 347 (348)
Q Consensus 292 ------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~-~g~~Pf~~ 347 (348)
.+|++|||++...... ....++..|++|| +|||||||++|||+ +|+.||..
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 224 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE 224 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence 3899999998654222 1234667788888 39999999999985 69999853
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=296.96 Aligned_cols=189 Identities=29% Similarity=0.349 Sum_probs=163.6
Q ss_pred CCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++.....||.|.||.||.|. .++|...|+|.++-.. ....+...+|+.++..++|||+|++||+-.+++..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45567789999999999999 5679999999885442 33445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|++|+|.+++... .-.++.....+..|++.|+.|||++ |||||||||.||+++.+|.+|++|||.|..+.++.
T Consensus 1316 C~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred hccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 9999999999743 2356666677889999999999999 99999999999999999999999999999887653
Q ss_pred ccccc---ccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTT---RVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~---~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ...||+.|||||+ |||||||++.||+||+-||.+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~ 1443 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAE 1443 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhh
Confidence 22222 3689999999995 999999999999999999976
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=253.82 Aligned_cols=188 Identities=26% Similarity=0.439 Sum_probs=157.1
Q ss_pred CCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~ 223 (348)
.|++.+.||+|+||.||++++ .++..||+|.+.... ......+.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 466778899999999999984 247889999886443 33446789999999999999999999998775 5689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 9999999999999986432 3588999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCcc--cccccccCCCcccce----------eccchHHHHHHHHHhccCCC
Q 018991 304 LCSERSY--VTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf 345 (348)
+...... ......++..|++|| +|||||||++|||++++.|+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6543321 112245667788888 49999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=247.61 Aligned_cols=187 Identities=27% Similarity=0.381 Sum_probs=155.7
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
++....||.|+.|.|++++++ +|...|||.+.... ....++++..+.++.+.. .|.||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 334566999999999999965 68999999997654 344567888888877664 899999999999999999999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
.. -+..++++-. .++++..+-++...+.+||.||.+++ +|+|||+||+|||+|+.|.+|+||||++..+.....
T Consensus 174 s~-C~ekLlkrik---~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLKRIK---GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHHhc---CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 53 4455554322 56888888899999999999998764 899999999999999999999999999988755433
Q ss_pred ccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+...|.+.||+|| +||||||++|+||+||+|||..
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 34457999999999 3999999999999999999973
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=256.49 Aligned_cols=187 Identities=26% Similarity=0.363 Sum_probs=160.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|+..+.||+|+||.||+|..+ +++.||+|.+..... ...+.+.+|++++..++||||+++++++.++...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777889999999999999975 588999998754322 2345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.++.... ..+++..++.++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++..+....
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 82 VDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred CCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9998888876532 3489999999999999999999998 99999999999999999999999999998764433
Q ss_pred cccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......++..|++|| +||||||+++|||++|++||.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~ 202 (286)
T cd07846 155 E-VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFP 202 (286)
T ss_pred c-ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCC
Confidence 2 222345788899888 399999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=252.24 Aligned_cols=179 Identities=26% Similarity=0.275 Sum_probs=148.7
Q ss_pred eEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHH---HHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 158 VIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVE---VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
.||+|+||.||++... +++.+|+|.+..... .....+..|.. ++...+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999964 688999998865421 11223334443 3334579999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 99999988643 4689999999999999999999998 99999999999999999999999999997653322
Q ss_pred cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 311 VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....|+..|++||. ||||+||++|+|++|+.||.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 123468899999983 99999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=248.38 Aligned_cols=193 Identities=26% Similarity=0.348 Sum_probs=165.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||.|+||.||+|... ++..+++|.+.... ......+.+|+.+++.++|+||+++++.+...+..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 36788899999999999999954 67899999886443 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++..... ...+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999975321 14588999999999999999999998 99999999999999999999999999998765443
Q ss_pred cc---cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SY---VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~---~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......|+..|++||. |+||||+++|+|++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 209 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSK 209 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccc
Confidence 22 2233568889999983 999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=251.18 Aligned_cols=187 Identities=27% Similarity=0.415 Sum_probs=161.2
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC-CcchHHHHHHHHHHHhcCC---CCCeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|+.+++.++ |||++++++++.+....+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 356678899999999999995 46899999988644 2334567888999999986 999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ++++..++.++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999998542 588999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......|+..|++|| +|+||||+++|+|++|+.||..
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 432 223346888899888 3999999999999999999964
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=255.37 Aligned_cols=194 Identities=27% Similarity=0.411 Sum_probs=160.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.++|+..+.||+|+||.||++... ++..||+|.+.... .....++.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999853 46789999886543 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 223 MLVYEYVDNGNLDQWLHGDV------------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
++++||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 99999999999999996421 1123578889999999999999999998 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
|+++.++.+||+|||+++.+....... ......+..|++|| +|||||||++|||++ |..||.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999988654332211 11223456799999 399999999999998 888884
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=269.56 Aligned_cols=200 Identities=24% Similarity=0.377 Sum_probs=171.4
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.++|+..+.+....+.||-|.||.||.|.|+. ...||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|..+..
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence 46777788888888999999999999999864 5679999887554 456789999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|||+|||.+|+|.+||++... ..++.-..+.++.||..||+||..+ ++|||||..+|||+.++..+||+||||+
T Consensus 338 FYIiTEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLs 412 (1157)
T KOG4278|consen 338 FYIITEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLS 412 (1157)
T ss_pred eEEEEecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchh
Confidence 9999999999999999987532 4566677889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSSTI 348 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~~ 348 (348)
+++..+.........-...|.|||. |||+|||+|||+.| |--|++-|
T Consensus 413 RlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi 470 (1157)
T KOG4278|consen 413 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI 470 (1157)
T ss_pred hhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc
Confidence 9987654332223444567889994 99999999999987 66676543
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=251.38 Aligned_cols=190 Identities=27% Similarity=0.435 Sum_probs=158.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
..|++.+.||+|+||.||+|... +|. .+|+|.+..... ....++.+|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999854 333 589998765543 344678899999999999999999999987 77899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK---DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 999999999999997542 3589999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcccc-cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYVT-TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~-~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........ ....++..|++||. ||||||+++|||++ |++||..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 214 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCC
Confidence 54332211 11234567999983 99999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=250.58 Aligned_cols=185 Identities=28% Similarity=0.449 Sum_probs=151.0
Q ss_pred ceEeecCceEEEEEEEC-CCc--EEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGT--KVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|+.. ++. .+++|.+.... ....+.+..|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 35899999999999964 343 46888776432 33446788999999999 799999999999999999999999999
Q ss_pred CCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 232 GNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 232 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
|+|.+++..... ....+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 123578999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
+++..... ........+..|++||. |||||||++|||++ |+.||.
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~ 213 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 213 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 98642211 11111233556888883 99999999999997 999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=231.42 Aligned_cols=186 Identities=25% Similarity=0.334 Sum_probs=156.8
Q ss_pred CCcCceEeecCceEEEEEE-ECCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|...+.||+|.||+||+++ .++++.||+|.+.-+ +........+|+.+|+.++|.|||+++++...+..+.+|+|||
T Consensus 4 ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c 83 (292)
T KOG0662|consen 4 YDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_pred hHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh
Confidence 3344679999999999999 557899999998544 3334456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
.. +|..+...-. +.+....+..++.|+++||.|+|++ ++.|||+||.|.||+.+|++|++|||+++.+.-.-.
T Consensus 84 dq-dlkkyfdsln---g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 84 DQ-DLKKYFDSLN---GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hH-HHHHHHHhcC---CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 75 9988886543 4578888999999999999999999 999999999999999999999999999998765433
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHh-ccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
.... .+-|.+|.+|.+ |+||.||++.|+.. |++-|+
T Consensus 157 cysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp 204 (292)
T KOG0662|consen 157 CYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_pred eeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence 2222 356889988885 99999999999986 666554
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=250.55 Aligned_cols=188 Identities=26% Similarity=0.375 Sum_probs=158.9
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---c-------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---Q-------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~-------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
+|...+.||+|+||.||+|.. .+++.+|+|.+..... . ..+.+..|+.++.+++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 356678899999999999985 4688999998753211 1 1245778999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..++||||+++++|.+++... .++++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999998754 4688999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCc-ccccccccCCCcccce------------eccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERS-YVTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~-~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
++....... .......|+..|++|| +|+||||+++|+|++|..||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 986543221 1123356788888887 399999999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=250.74 Aligned_cols=186 Identities=25% Similarity=0.358 Sum_probs=160.9
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3555678999999999999964 58899999886443 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.. .++++.++..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 99999999863 3578899999999999999999998 999999999999999999999999999987654332
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......++..|++||. |+|||||++|||++|.+||.
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 202 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNS 202 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCC
Confidence 2223467888999994 99999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=249.29 Aligned_cols=178 Identities=26% Similarity=0.378 Sum_probs=148.7
Q ss_pred ceEeecCceEEEEEEECC-C----------cEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 157 NVIGEGGYGIVYRGILSD-G----------TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 358999999999999653 3 25788876544332 5778899999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-------ceEEecc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-------NARVSDF 298 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-------~~kl~DF 298 (348)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999997542 2588999999999999999999998 999999999999999887 7999999
Q ss_pred cCcccccCCCcccccccccCCCcccce------------eccchHHHHHHHHHh-ccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFI------------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|++...... ....++..|++|| .||||||+++|+|++ |..||..
T Consensus 153 g~a~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 153 GIPITVLSR-----EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred Ccccccccc-----cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 999875431 1234556677777 499999999999999 5888754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=246.72 Aligned_cols=185 Identities=28% Similarity=0.394 Sum_probs=156.0
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
+.||+|+||.||++...+++.|++|.+...... ....+..|++++++++||||+++++++.+....++++||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 358999999999999766899999988655433 4567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccc-cc
Q 018991 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT-TR 314 (348)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~-~~ 314 (348)
+++.... ..+++..++.++.+++.||.|||++ +++||||||+|||++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~~---~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKKK---NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9986532 3578899999999999999999998 999999999999999999999999999986542211111 11
Q ss_pred cccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 315 VMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..++..|++|| +||||||+++|+|++ |..||..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 22355688888 399999999999999 8889864
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=253.92 Aligned_cols=188 Identities=24% Similarity=0.337 Sum_probs=163.2
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.+|...+.||+|+||.||++.. .++..|++|.+........+.+..|+.++++++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 4677788999999999999985 468899999886554445567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++... .+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998642 478889999999999999999998 999999999999999999999999999876543322
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......+++.|++||. |+||||+++|+|++|++||..
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2233468888999993 999999999999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=247.19 Aligned_cols=188 Identities=24% Similarity=0.366 Sum_probs=165.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+..|+..+.+++||||+++++++...+..++++||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777899999999999999965 589999998866543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++++|.+++... .++++..+..++.|++.||.|||+ . +++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 82 DGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999754 468999999999999999999999 8 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....++..|++|| .|+||||+++|+|++|++||..
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 202 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP 202 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 22 22356788899999 3999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=254.71 Aligned_cols=186 Identities=26% Similarity=0.387 Sum_probs=159.2
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+..|+.++++++||||+++++++..++..|+|+||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 344567999999999999854 57889999876442 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++.. .++++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++..+.....
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998853 3588999999999999999999998 999999999999999999999999999987654322
Q ss_pred cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......|+..|++||. |+|||||++|||++|+.||..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 1222467888999983 999999999999999999863
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=250.16 Aligned_cols=180 Identities=26% Similarity=0.271 Sum_probs=149.3
Q ss_pred eEeecCceEEEEEEE-CCCcEEEEEEEecCCcc---hHHHHHHHH---HHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 158 VIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ---AEKEFKVEV---EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
.||+|+||.||+++. .+++.||+|.+...... ....+..|. .++....||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999995 46889999988654211 112233333 34455689999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 99999988643 4689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....|+..|++||. ||||+|+++|+|++|+.||..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~ 198 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 123468899999883 999999999999999999963
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=247.38 Aligned_cols=183 Identities=27% Similarity=0.387 Sum_probs=152.7
Q ss_pred ceEeecCceEEEEEEEC-C---CcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-D---GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|.+. . +..+|+|.+..... ...+++..|+++++.++||||+++++++.. +..+++|||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCC
Confidence 35999999999999853 2 26899998865543 345678899999999999999999998764 457999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+++... ..+++..++.++.|++.||.|||++ +++|+||||+|||++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999754 3588999999999999999999998 99999999999999999999999999998764433221
Q ss_pred cc--ccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 312 TT--RVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 312 ~~--~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.. ...++..|++|| +||||||+++|+|++ |++||..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~ 201 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCccc
Confidence 11 122346799999 499999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=251.39 Aligned_cols=187 Identities=25% Similarity=0.277 Sum_probs=163.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|++++++++||||+++++.+.+.+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999965 68899999886543 2345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+.+++|.+++... .++++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998654 4688999999999999999999998 9999999999999999999999999998876443
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......|+..|++||. |+||||+++|+|++|+.||..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 201 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCC
Confidence 2 2233567888999993 999999999999999999864
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=252.97 Aligned_cols=188 Identities=27% Similarity=0.324 Sum_probs=161.4
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|+||.||+|... +++.|++|.+... .....+.+..|++++++++|+||+++++++.+++..++++||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5777889999999999999965 5889999988543 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++++.+..+.... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 82 VERTLLELLEASP----GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 9987776655432 4588999999999999999999998 99999999999999999999999999998776544
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........++..|++||. ||||||+++|+|++|++||.
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 323344578888999983 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=253.06 Aligned_cols=180 Identities=22% Similarity=0.350 Sum_probs=150.8
Q ss_pred ceEeecCceEEEEEEECC--------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.||+|+||.||+|.... ...+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 359999999999998532 234888877555444556788899999999999999999999998999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------eEEecccC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGL 300 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~--------~kl~DFGl 300 (348)
+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKNK---NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 99999999997542 3588999999999999999999998 9999999999999987765 69999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhc-cCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSV-RYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g-~~Pf~~ 347 (348)
+...... ....++..|++||. ||||||+++|+|++| ..||..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 8754322 22467888999983 999999999999998 566653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=246.80 Aligned_cols=188 Identities=28% Similarity=0.468 Sum_probs=160.4
Q ss_pred CcCceEeecCceEEEEEEECC-----CcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 154 CEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++.+.||+|+||.||++...+ +..||+|.+...... ..+.+..|+.++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999653 378999998655433 56688899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++..... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccc
Confidence 9999999999875321 1289999999999999999999998 9999999999999999999999999999877654
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
..+......+++.|++|| +||||||+++|+|++ |++||.
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~ 206 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYP 206 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 333322234678899998 399999999999998 888885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=248.29 Aligned_cols=192 Identities=26% Similarity=0.369 Sum_probs=162.7
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~ 226 (348)
+|++.+.||+|+||.||++.. .++..+|+|.+.... ....+.+..|++++++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 366778999999999999985 468899999886432 2334568889999999999999999998764 45689999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-----EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-----~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
||+++++|.+++........++++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999764434467899999999999999999999 66 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......... .....+++.|++||. |+||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 877544321 233568999999994 999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=251.94 Aligned_cols=190 Identities=26% Similarity=0.346 Sum_probs=160.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 227 (348)
+|...+.||.|++|.||++... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+. +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 5667789999999999999964 688999998865432 3456788999999999999999999988653 47899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 82 YCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred ecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999998764333345688999999999999999999998 9999999999999999999999999998765432
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....++..|++|| .|||||||++|+|++|++||..
T Consensus 159 ~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (287)
T cd06621 159 L---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205 (287)
T ss_pred c---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 1 12345778899998 3999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=252.44 Aligned_cols=188 Identities=23% Similarity=0.383 Sum_probs=159.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|+..+.||+|+||.||+|+.. ++..||+|.+.... ......+..|++++++++||||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4677889999999999999964 68899999885432 22335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+. ++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||+++.++.+||+|||+++.+....
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 96 68988886432 24689999999999999999999998 99999999999999999999999999987654322
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......++..|++||. ||||||+++|+|++|+.||.
T Consensus 155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~ 202 (284)
T cd07860 155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 202 (284)
T ss_pred c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 1 1222356788999983 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=246.77 Aligned_cols=189 Identities=23% Similarity=0.363 Sum_probs=162.6
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|+||.||+++. .+++.||+|.+... .....+++.+|+.++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 367788999999999999995 46889999988643 223445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++.+++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999986532 23578999999999999999999998 99999999999999999999999999998764432
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......|++.|++||. |+|||||++|+|++|+.||.
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~ 202 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCcc
Confidence 2 2233568889999994 99999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=250.20 Aligned_cols=182 Identities=26% Similarity=0.290 Sum_probs=155.3
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||+|... +|+.||+|.+.... ......+..|+++++.++||||+++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999854 68899999886432 12234567899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++..... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++....... ....
T Consensus 81 ~~~l~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNVGE--PGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHcCc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 999875422 3689999999999999999999998 99999999999999999999999999988654321 1223
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..++..|++||. ||||||+++|+|++|+.||..
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 196 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCC
Confidence 457788999994 999999999999999999953
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=248.49 Aligned_cols=186 Identities=24% Similarity=0.253 Sum_probs=153.5
Q ss_pred hcCCCcC-ceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE----CCEE
Q 018991 150 TSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE----GAYR 222 (348)
Q Consensus 150 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~----~~~~ 222 (348)
+++|.+. ++||-|-.|.|..|..+ +++++|+|.+... ....+|+++-... .|||||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4445443 57999999999999954 7899999987432 2344577765555 59999999998864 4567
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEeccc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFG 299 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFG 299 (348)
.+|||.++||.|+..+..+. ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|.. .+..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~g--~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRG--DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHcc--cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccc
Confidence 89999999999999998653 35799999999999999999999998 999999999999996 45679999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+|+.-... ......+-||.|.|||+ |+||+||++|.|++|.+||-.
T Consensus 210 FAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS 265 (400)
T KOG0604|consen 210 FAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_pred cccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccc
Confidence 99975433 23344688999999996 999999999999999999953
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=248.74 Aligned_cols=191 Identities=25% Similarity=0.362 Sum_probs=159.6
Q ss_pred CCCcCceEeecCceEEEEEEECC--CcEEEEEEEecCC----------cchHHHHHHHHHHHhc-CCCCCeeeEeeEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILSD--GTKVAVKNLLNNR----------GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVE 218 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~ 218 (348)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999999654 6789999875321 1223456778888765 799999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEec
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999885432233568999999999999999999996 5 799999999999999999999999
Q ss_pred ccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
||++....... ......|+..|++||. |+||||+++|+|++|++||..
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 99998765433 2334568889999984 999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=250.13 Aligned_cols=189 Identities=24% Similarity=0.372 Sum_probs=160.0
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|+..+.||+|++|.||+|+.. +|..||+|.+..... .....+..|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4677889999999999999965 688999998865432 23456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++ +|.+++..... ..++++..+..++.|++.||.|||++ +++|+||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 85 89888865422 24689999999999999999999998 999999999999999999999999999976543221
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......++..|++||. ||||||+++|+|++|++||.
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1122456788988883 99999999999999999996
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=247.07 Aligned_cols=184 Identities=28% Similarity=0.451 Sum_probs=149.0
Q ss_pred ceEeecCceEEEEEEEC----CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEE-ECCEEEEEEeecC
Q 018991 157 NVIGEGGYGIVYRGILS----DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEYVD 230 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~lv~e~~~ 230 (348)
+.||+|+||.||+|... +...||+|.+... .....+.+..|+.+++.++||||+++++++. .++..++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999853 2357999987543 2334567888999999999999999999775 4556789999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+|+|.+++.... ..+++..++.++.|++.||.|||+. +++||||||+|||+++++.+||+|||+++.+......
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSET---HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999997532 3467778889999999999999998 9999999999999999999999999999865432211
Q ss_pred ---cccccccCCCccccee----------ccchHHHHHHHHHhc-cCCCC
Q 018991 311 ---VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSV-RYNSS 346 (348)
Q Consensus 311 ---~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g-~~Pf~ 346 (348)
......++..|++||. |||||||++|||++| .+||.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 1112345678999993 999999999999995 56665
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=246.81 Aligned_cols=180 Identities=27% Similarity=0.310 Sum_probs=157.4
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||.|+||.||+++.. +++.+++|.+..... ...+.+.+|+.+++.++||||+++++.+.++...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999965 588999999865432 2346788999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 9999754 3488999999999999999999998 99999999999999999999999999998765432 2233
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..+++.|++||. |+||+|+++|+|++|.+||..
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 194 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGE 194 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCC
Confidence 568889999983 999999999999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=247.27 Aligned_cols=186 Identities=25% Similarity=0.357 Sum_probs=160.2
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 556788999999999999854 68899999875432 2334578889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++.. ..+++..+..++.|++.|+.|||++ +++|+||||+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999863 3578999999999999999999998 999999999999999999999999999987644321
Q ss_pred cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......++..|++||. |+|||||++|+|++|..||..
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 1223467888999983 999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=251.70 Aligned_cols=188 Identities=26% Similarity=0.328 Sum_probs=159.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 225 (348)
++|+..+.||+|+||.||+|..+ +++.+++|.+..... .....+.+|+.++.+++||||+++++++... +..|++
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35777788999999999999965 588999999865432 2234567899999999999999999999877 889999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
+||++ ++|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99997 49999886532 3589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... ......+++.|++||. ||||||+++|+|++|+.||.
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 4321 1223457788999983 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=249.66 Aligned_cols=186 Identities=27% Similarity=0.385 Sum_probs=161.8
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|+..+.||+|+||.||++..+ +++.+++|.+.... ....+++.+|+++++.++||||+++++.+..++..++++||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4566678999999999999965 68899999886653 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++++|.+++.... .++++..+..++.|++.||.|||+ . +++|+||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 82 DGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred CCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 9999999997542 468899999999999999999998 7 99999999999999999999999999987654322
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
. ....++..|++|| +||||||+++|+|++|++||.
T Consensus 156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 200 (265)
T cd06605 156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP 200 (265)
T ss_pred h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 1 1267888999999 399999999999999999985
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=251.07 Aligned_cols=191 Identities=23% Similarity=0.282 Sum_probs=157.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCE-----
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAY----- 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~----- 221 (348)
++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 35778899999999999999964 689999998754422 23356788999999995 6999999999987665
Q ss_pred EEEEEeecCCCCHHHHHhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEeccc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFG 299 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFG 299 (348)
.|++|||+++ +|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999985 898888653322 35689999999999999999999998 9999999999999998 8899999999
Q ss_pred CcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+++........ .....+++.|+|||. ||||||+++|+|++|..||.
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 213 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP 213 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC
Confidence 99865432211 122356778888883 99999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=258.46 Aligned_cols=190 Identities=26% Similarity=0.379 Sum_probs=159.8
Q ss_pred CCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcc--h-----HHHHHHHHHHHhcCCCCCeeeEeeEEE-ECCEEE
Q 018991 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQ--A-----EKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRM 223 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~ 223 (348)
|-...+||+|+|+.||++. +...+.||+|+-..++.. . .+...+|.++-+.|+||.||++|++|. +.+..|
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 3455789999999999999 455788999975433221 1 123557999999999999999999986 567788
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccC
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGL 300 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGl 300 (348)
-|+|||+|.+|.-+|+.+ ..+++.++..|+.||..||.||.+. +++|||-||||.|||+- ..|.+||+||||
T Consensus 545 TVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred eeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 999999999999999865 4589999999999999999999987 78899999999999994 568899999999
Q ss_pred cccccCCCc------ccccccccCCCccccee--------------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERS------YVTTRVMGTFGYAHFIV--------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~------~~~~~~~gt~~y~~pe~--------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++++..+.. ..+....||.+|.+||. ||||+|||+|.+++|+-||.+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh 686 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH 686 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence 999876533 23445789999999994 999999999999999999964
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=249.43 Aligned_cols=187 Identities=27% Similarity=0.444 Sum_probs=154.2
Q ss_pred eEeecCceEEEEEEECC-------CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 158 VIGEGGYGIVYRGILSD-------GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+++++.++||||+++++++.+.+..+++|||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999998642 2578999875443 234567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-----ceEEecccCc
Q 018991 230 DNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-----NARVSDFGLA 301 (348)
Q Consensus 230 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-----~~kl~DFGla 301 (348)
++++|.+++..... ....+++..++.++.|++.||.|||++ +++|+||||+||+++.++ .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999964321 123478899999999999999999998 999999999999999877 8999999999
Q ss_pred ccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 302 KLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+.+....... .....++..|++|| +|||||||++|+|++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 8664332211 11234567899999 399999999999998 9999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=250.24 Aligned_cols=185 Identities=28% Similarity=0.334 Sum_probs=157.6
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..|...+.||+|+||.||+|... +++.||+|.+..... ...+++.+|+++++.++||||+++++++.+.+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 44777789999999999999964 688999998854322 23356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+. |++.+++.... .++++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~---~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVHK---KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9997 57877775332 3589999999999999999999998 999999999999999999999999999876532
Q ss_pred CCcccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....++..|++|| +||||||+++|||++|+.||..
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 2 2246778888888 3999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=252.62 Aligned_cols=190 Identities=28% Similarity=0.464 Sum_probs=155.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++|+..+.||+|+||.||+|.+. ++. .||+|.+..... ....++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45667788999999999999853 444 578888765432 2344688899999999999999999998764 4678
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.+
T Consensus 86 v~e~~~~g~l~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK---DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 999999999999986542 3578899999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... ......++..|++||. ||||||+++|||++ |+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~ 214 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 433221 1222345678999993 99999999999997 8999864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=251.37 Aligned_cols=192 Identities=28% Similarity=0.347 Sum_probs=159.7
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA---- 220 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~---- 220 (348)
...++|++.+.||+|+||.||+|... +++.||+|.+.... ......+..|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567888899999999999999965 58899999986442 223356778999999999999999999987654
Q ss_pred ------EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 221 ------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 221 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
..++++||+++ ++.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||++++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence 78999999986 777777543 24689999999999999999999998 999999999999999999999
Q ss_pred EecccCcccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
|+|||++..+............++..|++|| .|||||||++|+|++|++||.
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~ 219 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ 219 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 9999999876543322222234567788887 399999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=240.55 Aligned_cols=187 Identities=26% Similarity=0.391 Sum_probs=165.1
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
|...+.||+|++|.||++... ++..+++|.+..........+.+|++++++++|||++++++++......++++||+++
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 566788999999999999965 6889999998766554567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 82 GSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 99999986542 4689999999999999999999998 999999999999999999999999999987654432
Q ss_pred ccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....++..|++|| .|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 199 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 23456888899998 4999999999999999999974
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=248.10 Aligned_cols=186 Identities=26% Similarity=0.341 Sum_probs=160.5
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
|...+.||+|++|.||++.. .+++.+++|.+........+.+.+|+.++..++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 33456899999999999995 46889999988655444556688999999999999999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+++.. .++++..+..++.|++.||.|||++ +++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~ 171 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R 171 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence 999999864 3588899999999999999999998 999999999999999999999999999876543322 1
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....|++.|++||. |+||||+++|+|++|+.||..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 223568899999993 999999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=247.71 Aligned_cols=191 Identities=26% Similarity=0.353 Sum_probs=165.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.+++|...+.||+|+||.||++... ++..+++|.+..... ..+.+..|++++..++|+|++++++.+...+..|+++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 3455677788999999999999975 688999999865543 45678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999997642 3689999999999999999999998 9999999999999999999999999998765433
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......++..|++|| .|+||||+++|+|++|+.||..
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 22 222345788899998 3999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=256.27 Aligned_cols=188 Identities=26% Similarity=0.368 Sum_probs=157.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 222 (348)
.++|++.+.||+|+||.||+|.. .+|+.||+|.+... .......+..|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 35688889999999999999995 46899999988543 223445678899999999999999999987654 357
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+++||+.+ +|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECccccee
Confidence 999999974 88887753 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......|+..|+|||. ||||+||++|+|++|+.||.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~ 211 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 76433221 1223578899999993 99999999999999999995
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=266.45 Aligned_cols=188 Identities=26% Similarity=0.285 Sum_probs=164.0
Q ss_pred cCCCcCceEeecCceEEEEEEECCC-cEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDG-TKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.+++....||-|+||.|-+++.+.. ..+|+|++++. +.+..+.+..|-++|..++.|.||++|..|.++...|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 3455567799999999999996543 34899988654 2334455778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|-|-||.|...|+.+ +.+.......++..+..|++|||.+ +||.|||||+|++++.+|.+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrdR----g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhhc----CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 999999999999765 5688888889999999999999999 999999999999999999999999999999865
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .+-.++|||.|.|||+ |.||||+++|||++|.+||+-
T Consensus 573 g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 573 GR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred CC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 44 3445899999999995 999999999999999999984
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=248.57 Aligned_cols=190 Identities=27% Similarity=0.412 Sum_probs=158.7
Q ss_pred CCCcCceEeecCceEEEEEEEC-----CCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~ 223 (348)
.|+..+.||+|+||.||++.+. ++..+|+|.+...... ..+.+..|+++++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566688999999999999853 3678999988655433 45689999999999999999999999877 55789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
++|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999997542 3589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCccccc--ccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTT--RVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~--~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......... ...++..|++|| .||||||+++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 214 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccc
Confidence 7533221111 123445678888 4999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=251.86 Aligned_cols=189 Identities=29% Similarity=0.373 Sum_probs=158.1
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 224 (348)
.++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 456888899999999999999964 689999998864432 2233466799999999999999999998765 56899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMP---TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999974 8988886432 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
....... ....++..|++||. |||||||++|+|++|++||.
T Consensus 159 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~ 210 (309)
T cd07845 159 GLPAKPM-TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLP 210 (309)
T ss_pred CCccCCC-CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCC
Confidence 5432221 22345778999983 99999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=248.72 Aligned_cols=189 Identities=23% Similarity=0.333 Sum_probs=156.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|+..+.||+|++|.||+|... +++.||+|.+.... ....+.+..|++++++++||||+++++++.+....|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 45778889999999999999964 68899999885432 2234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCcccccC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCS 306 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~~~~ 306 (348)
|++ ++|.+++.... ...+++..+..++.|++.||+|||++ +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 58888875432 23467888889999999999999998 9999999999999985 56799999999976543
Q ss_pred CCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......+++.|++|| +||||+|+++|+|++|++||.
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~ 205 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP 205 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 211 112235678888888 399999999999999999995
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=244.72 Aligned_cols=184 Identities=32% Similarity=0.437 Sum_probs=154.5
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+|+.++.+++|||++++++++..+. .+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCC
Confidence 4577789999999999999975 57789999885432 3457888999999999999999999987654 799999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++.... ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 999999997542 24578999999999999999999998 99999999999999999999999999987643211
Q ss_pred cccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 311 VTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....+..|++|| .|+||||+++|+|++ |++||..
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 200 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPK 200 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1223456788888 399999999999998 9999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=242.27 Aligned_cols=189 Identities=26% Similarity=0.380 Sum_probs=161.1
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|...+.||+|+||.||++.. .++..+|+|.+.... ....+.+..|+++++.++||||+++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 466778999999999999995 468899999886542 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCcccccCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSE 307 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla~~~~~~ 307 (348)
+++++|.+++.... ...+++..++.++.|++.||.|||++ +++|+||||+||+++++ +.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999997542 24588999999999999999999998 99999999999999855 46899999999876443
Q ss_pred CcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....++..|++|| +|+||||+++|+|++|+.||..
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 203 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA 203 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCccc
Confidence 21 22356888999999 3999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=262.20 Aligned_cols=195 Identities=26% Similarity=0.403 Sum_probs=169.7
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECC---C--cEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSD---G--TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
+.+..++.....+.||.|.||.||.|.+.+ | -.||||.-+.+ .....+.|..|+.+|++++||||++++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344556666777899999999999999643 2 35899988764 44556789999999999999999999999976
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
. ..|||||+++-|.|..||+.+. ..++......++.||+.||.|||+. ++|||||..+|||+....-+||+||
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeeccc
Confidence 4 5899999999999999998664 4588888899999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
|++|.+..+..|.++...-...||+||+ |||=||+++||++. |.-||.
T Consensus 536 GLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfq 594 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQ 594 (974)
T ss_pred chhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccc
Confidence 9999998888888887777788999995 99999999999876 888985
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=243.85 Aligned_cols=181 Identities=21% Similarity=0.206 Sum_probs=149.8
Q ss_pred HhcCCCcCceE--eecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhc-CCCCCeeeEeeEEEECCEEEE
Q 018991 149 ATSGLCEENVI--GEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 149 ~~~~~~~~~~l--G~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~l 224 (348)
-.++|.+.+.+ |+|+||.||++.. .++..+|+|.+........ |...... .+||||+++++.+...+..|+
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34556666665 9999999999995 4688899998754322111 2222221 279999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~ 303 (348)
||||+++++|.+++... .++++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 99999999999999754 3689999999999999999999998 999999999999999988 999999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..... ...++..|+|||+ ||||+|+++|+|++|++||.
T Consensus 160 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~ 207 (267)
T PHA03390 160 IGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207 (267)
T ss_pred cCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 64332 2367888999984 99999999999999999996
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=256.37 Aligned_cols=186 Identities=25% Similarity=0.274 Sum_probs=157.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------ 219 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 219 (348)
..+.|+..+.||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3567888899999999999999954 7899999988543 223345677899999999999999999988644
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
...|+||||+. ++|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCc
Confidence 35699999996 588888753 278888999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+++...... ......++..|++|| +|||||||++|+|++|+.||.
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~ 218 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFP 218 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCC
Confidence 998764332 223346788999999 399999999999999999996
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=245.00 Aligned_cols=192 Identities=21% Similarity=0.357 Sum_probs=154.2
Q ss_pred CCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 153 LCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
|.+.++||+|+||.||+|.+. ++..||+|.+.... ....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456678999999999999853 36789999886542 234567888999999999999999999886532
Q ss_pred EEEEEEeecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
..++++||+.+|+|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875321 1223578899999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCccc-ccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 299 GLAKLLCSERSYV-TTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~-~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|+++.......+. .....+++.|++|| +|||||||++|+|++ |++||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 9998764332221 12234556788888 499999999999999 8899863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=248.80 Aligned_cols=188 Identities=27% Similarity=0.273 Sum_probs=159.9
Q ss_pred CCCcCceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 152 GLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
+|++.+.||+|+||.||+++. .++..||+|.+.... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778899999999999984 256889999886432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 9999999999999998643 3588899999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+............|+..|++||. |+||||+++|+|++|..||.
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~ 209 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFT 209 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcc
Confidence 765443333334568888988883 99999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=246.06 Aligned_cols=187 Identities=27% Similarity=0.331 Sum_probs=159.7
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEEEe
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYE 227 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~e 227 (348)
|++.+.||+|+||.||+|... +++.+|+|.+.... ......+..|+++++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999965 58899999997653 33345688899999999999999999999988 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++ +|.+++.... ..+++..++.++.|++.||.|||++ +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSPE---VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 8988886432 4689999999999999999999998 9999999999999999999999999999876554
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.........++..|++||. ||||||+++|+|++|+.||.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~ 203 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ 203 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 3222233456788999993 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=239.83 Aligned_cols=188 Identities=27% Similarity=0.412 Sum_probs=164.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+.+|++++.+++|||++++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3667789999999999999865 578999999866543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998754 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....++..|++|| .||||+|+++|+|++|+.||..
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 22 23356788899998 4999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=245.12 Aligned_cols=182 Identities=26% Similarity=0.343 Sum_probs=157.1
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||+++.. +++.+++|.+..... ...+.+.+|++++.+++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999976 489999998865432 3445788899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc-----
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS----- 309 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~----- 309 (348)
.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999753 3689999999999999999999998 999999999999999999999999999876543321
Q ss_pred --ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 310 --YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 --~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......++..|++|| .|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 203 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 1223356788999998 4999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=242.93 Aligned_cols=179 Identities=22% Similarity=0.285 Sum_probs=149.9
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc---hHHHHHHHHHHH-hcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ---AEKEFKVEVEVI-GRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|... +++.||+|.+...... ....+..|..++ ...+|||++++++++..++..|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999964 6889999988644321 122344455444 445899999999999999999999999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
++|.+++... .++++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 9999999653 4588999999999999999999998 999999999999999999999999999876433
Q ss_pred ccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 312 TTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 312 ~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....++..|++|| +||||||+++|+|++|.+||..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 195 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCC
Confidence 22346788898888 3999999999999999999963
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=246.35 Aligned_cols=187 Identities=25% Similarity=0.370 Sum_probs=158.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|+..+.||+|++|.||+|... +|..||+|.+.... ......+.+|+++++.++|||++++++++.+.+..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456688999999999999954 78999999886543 223356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
+ ++|.+++..... ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSSPL--TGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhCCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 699999865421 3689999999999999999999998 999999999999999999999999999976543221
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. .....++..|++||. ||||||+++|+|++|++||.
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 201 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP 201 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 1 122356788999983 99999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=246.55 Aligned_cols=193 Identities=21% Similarity=0.313 Sum_probs=159.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CC----CcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SD----GTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~ 221 (348)
...|+....||+|.||.||++.- ++ ...+|||+++..+. .......+|+.+++.++|||++.+..++.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 34577778899999999999963 22 23789999865532 233566789999999999999999999887 778
Q ss_pred EEEEEeecCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CceEEe
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVS 296 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~----~~~kl~ 296 (348)
.|+++||.+. +|.+.++-++. ....++...+..|+.||+.|++|||++ -|+||||||.|||+..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEee
Confidence 9999999986 99999875432 234688889999999999999999999 79999999999999877 899999
Q ss_pred cccCcccccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 297 DFGLAKLLCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 297 DFGla~~~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|||++|.+.+.-. +....++-|.+|.|||. |+||+|||+.||++-++-|.
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 9999998865432 23334788999999993 99999999999999888764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=250.32 Aligned_cols=192 Identities=28% Similarity=0.372 Sum_probs=156.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhc-CCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++++.+..||.|+||.|++-.++ .|+..|||++.... .+..+++..|.+...+ =+.||||++||....++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 33444567999999999999865 69999999997654 3566778888876544 479999999999999999999999
Q ss_pred ecCCCCHHHHHhc-CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 228 YVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 228 ~~~~g~L~~~l~~-~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
+|. -+|..+.+. .......+++..+-.|......||.||-.. ..|+|||+||+|||++..|.+||||||++..+.+
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 996 477655432 111224588888888888889999999875 3899999999999999999999999999987743
Q ss_pred CCcccccccccCCCcccce------------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
+...+.-.|...||||| +|+||||++|||++||+||++.
T Consensus 221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~ 271 (361)
T KOG1006|consen 221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRK 271 (361)
T ss_pred --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcch
Confidence 33444567999999999 3999999999999999999874
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=240.47 Aligned_cols=192 Identities=25% Similarity=0.360 Sum_probs=166.5
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|...+.||+|+||.||++... ++..+++|.+..... .....+..|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3667788999999999999964 688999999865533 4556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.........+++..+..++.+++.||.|||++ +++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976543346789999999999999999999998 99999999999999999999999999998765443
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......|++.|++|| +|+||+|+++|+|++|+.||..
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 2233356888899999 4999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=248.13 Aligned_cols=191 Identities=18% Similarity=0.216 Sum_probs=144.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCCcchH-----------HHHHHHHHHHhcCCCCCeeeEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAE-----------KEFKVEVEVIGRVRHKNLVRLL 213 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~l~ 213 (348)
..+.|++.+.||+|+||.||+|...+ +..+++|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 34578889999999999999999653 34566665432221111 0112233445667899999999
Q ss_pred eEEEECC----EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 018991 214 GYCVEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (348)
Q Consensus 214 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~ 289 (348)
+++.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence 8776543 4478888875 4777766532 2357788899999999999999998 9999999999999999
Q ss_pred CCceEEecccCcccccCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 290 QWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 290 ~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++.+||+|||+|+.+...... ......||+.|+|||+ |||||||+||||++|++||+.
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~ 235 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999876432211 1122469999999994 999999999999999999964
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=248.57 Aligned_cols=184 Identities=27% Similarity=0.343 Sum_probs=156.3
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.|...+.||+|+||.||+++. .++..+|+|.+..... .....+..|++++++++|||++++++++.+++..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366678899999999999995 4688999998864422 233568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+. |+|.+.+.... .++++..+..++.|++.||.|||++ +|+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 106 YCL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred CCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 997 48887775432 4589999999999999999999998 9999999999999999999999999998754322
Q ss_pred CcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....|+..|++||. |||||||++|+|++|++||..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 226 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 226 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 23467788888883 999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=245.33 Aligned_cols=184 Identities=23% Similarity=0.309 Sum_probs=153.5
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEEC--CEEEEEEe
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEG--AYRMLVYE 227 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~e 227 (348)
|++.+.||+|+||.||+|.. .++..||+|.+.... .........|+.++.++. |||++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 45567899999999999995 468899999886542 222334457888888885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|++ ++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++. +.+||+|||+++.+...
T Consensus 81 ~~~-~~l~~~l~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGRK---RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 997 58888876432 4689999999999999999999998 9999999999999999 99999999999876443
Q ss_pred CcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
... ....++..|++|| +|||||||++|||++|.+||.
T Consensus 153 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 153 PPY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred CCc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 221 2345788888888 399999999999999999995
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=248.38 Aligned_cols=181 Identities=26% Similarity=0.346 Sum_probs=157.7
Q ss_pred ceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 157 NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
..||+|+||.||++.. .++..||+|.+..........+.+|+.+++.++|+||+++++.+...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 4599999999999986 468999999886555455567889999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccccccc
Q 018991 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315 (348)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 315 (348)
+++.. ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++..+..... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 176 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSL 176 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-ccccc
Confidence 98753 3478999999999999999999998 999999999999999999999999999876643322 12235
Q ss_pred ccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 316 MGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 316 ~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.|+..|++||. |+||+|+++|+|++|+.||.
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~ 217 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF 217 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 68888999993 99999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-32 Score=252.65 Aligned_cols=195 Identities=25% Similarity=0.303 Sum_probs=163.1
Q ss_pred cccchHHHHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeE
Q 018991 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (348)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~ 215 (348)
+.....++...+++|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|++++.+++||||++++++
T Consensus 5 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~ 84 (345)
T cd07877 5 RQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84 (345)
T ss_pred hhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeee
Confidence 3345666777889999999999999999999985 578899999886432 2234567789999999999999999998
Q ss_pred EEEC------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 018991 216 CVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (348)
Q Consensus 216 ~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~ 289 (348)
+... ...|++++++ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.
T Consensus 85 ~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~ 155 (345)
T cd07877 85 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNE 155 (345)
T ss_pred eeecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcC
Confidence 8643 3467888877 6799888753 2488999999999999999999998 9999999999999999
Q ss_pred CCceEEecccCcccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 290 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
++.+||+|||+++..... .....++..|++|| +|||||||++|+|++|++||.
T Consensus 156 ~~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~ 219 (345)
T cd07877 156 DCELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 219 (345)
T ss_pred CCCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999998865322 22346788899998 399999999999999999995
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-32 Score=242.81 Aligned_cols=190 Identities=25% Similarity=0.377 Sum_probs=161.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|...+.||+|+||.||++..+ +|..+|+|.+.... ....+.+.+|++++++++|+||+++++.+.+....++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4667789999999999999965 58899999885542 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCcccccCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 307 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~~~ 307 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +++|+||||+||++++++ .+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQR--GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 99999999986542 23578999999999999999999998 999999999999999875 4699999999876543
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......|++.|++||. |+||||+++|+|++|+.||..
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 22 2223468889999993 999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=246.90 Aligned_cols=190 Identities=26% Similarity=0.352 Sum_probs=163.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 225 (348)
++|.+.+.||+|+||.||++... ++..|++|.+.... ....+.+..|.+++.+++ ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36778889999999999999964 68999999886532 233456788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++++|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999754 3699999999999999999999998 99999999999999999999999999988764
Q ss_pred CCCc-------------------ccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 306 SERS-------------------YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~-------------------~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .......++..|++|| .|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 4321 1122356788999998 3999999999999999999974
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=266.42 Aligned_cols=197 Identities=26% Similarity=0.359 Sum_probs=170.3
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE--
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE-- 218 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~-- 218 (348)
++.+..++..|.+.++||+|.+|.||+++ .++++.+|+|++.... ...++++.|.++|+.. .|||++.++++|..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 33344456778888999999999999999 5578899999775443 4456788889998887 69999999999863
Q ss_pred ---CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 219 ---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 219 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
++.+|||||||.+|+..|+++... ...+.|..+..|++.++.||.+||.+ .++|||+|-.|||++.++.+|+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEE
Confidence 578999999999999999998765 46799999999999999999999998 9999999999999999999999
Q ss_pred ecccCcccccCCCcccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCC
Q 018991 296 SDFGLAKLLCSERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~ 346 (348)
+|||++..++.... ......||+.|||||+ |+||||++..||.-|.+|+-
T Consensus 165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~ 229 (953)
T KOG0587|consen 165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC 229 (953)
T ss_pred eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc
Confidence 99999998865443 3344789999999996 99999999999999999984
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=252.94 Aligned_cols=188 Identities=27% Similarity=0.362 Sum_probs=157.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC--CEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG--AYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~--~~~~ 223 (348)
.++|++.+.||+|+||.||+|... ++..+|+|.+... .......+..|+.++.++ +||||+++++++... ...|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 455777788999999999999965 6889999988543 222334577899999999 999999999998653 4689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||++ ++|.+++... .+.+.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999997 5999888642 578888999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCc----ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERS----YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~----~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+..... .......|+..|++||. ||||||+++|+|++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~ 214 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFP 214 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCC
Confidence 654332 12233568899999993 99999999999999999985
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=253.56 Aligned_cols=188 Identities=26% Similarity=0.394 Sum_probs=158.3
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 223 (348)
.+|++.+.||+|+||.||+|.. .++..||+|.+.... ......+..|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 5678888999999999999995 468999999886542 2334567789999999999999999998763 35689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|+||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 85 lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 85 VVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 9999996 6899988643 4589999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCc---ccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERS---YVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~---~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
...... .......|+..|++|| +|||||||++|+|++|+.||.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~ 213 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccC
Confidence 643221 1223357888899998 399999999999999999994
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=247.17 Aligned_cols=190 Identities=23% Similarity=0.316 Sum_probs=156.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
.++|+..+.||+|+||.||+|... +++.||+|.+..... .....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 346888899999999999999964 688999998854322 22345667999999999999999999987654
Q ss_pred --EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 221 --YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 221 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
..++||||+. ++|.+++.... ..+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN---VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999997 48888876432 3589999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcc---cccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSY---VTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~---~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
|++......... ......++..|+||| +||||||+++|+|++|+.||.
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 999876433221 112245778899999 399999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=236.70 Aligned_cols=189 Identities=26% Similarity=0.336 Sum_probs=164.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv~ 226 (348)
+|...+.||+|++|.||+|... ++..|++|.+..... ...+.+.+|+.++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3666789999999999999965 688999998865542 3456788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999998754 3689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcc-cccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSY-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......++..|++|| +|+||||+++|+|++|+.||..
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 205 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSE 205 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4321 123356888999999 3999999999999999999964
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=252.19 Aligned_cols=187 Identities=26% Similarity=0.362 Sum_probs=157.5
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 222 (348)
+.|.+.+.||+|+||.||+++. .+++.||+|.+... .......+..|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4678889999999999999995 46899999988643 223345677899999999999999999988654 347
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+++||+. ++|.+++... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 99999996 6898888643 4689999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
....... ......++..|++|| +|||||||++|+|++|+.||.
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 210 (337)
T cd07858 157 TTSEKGD-FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFP 210 (337)
T ss_pred ccCCCcc-cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCC
Confidence 7644322 223346788899998 399999999999999999995
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=246.02 Aligned_cols=191 Identities=29% Similarity=0.382 Sum_probs=153.7
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|...+.||+|+||.||++... +++.+|+|.+.... ......+..|+.++.++. ||||+++++++..++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3444567999999999999954 68999999886443 234557888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 229 VDNGNLDQWLHGD-VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 229 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
+.. ++.++.... ......+++..+..++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.+...
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 665543210 11225689999999999999999999963 28999999999999999999999999999865433
Q ss_pred CcccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....|+..|++|| +|||||||++|+|++|++||..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 12235777888887 4999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=241.07 Aligned_cols=190 Identities=24% Similarity=0.326 Sum_probs=162.9
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+|++.+.||+|+||.||+++.. ++..+++|.+.... ......+..|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3667788999999999999854 68899999886542 23345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999876433335688999999999999999999998 9999999999999999999999999999876544
Q ss_pred cccccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
......++..|++|| +|+||||+++|+|++|+.||..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 203 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 122245788899888 4999999999999999999963
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-32 Score=262.28 Aligned_cols=186 Identities=27% Similarity=0.441 Sum_probs=155.9
Q ss_pred cCceEeecCceEEEEEEE-CC----CcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 155 EENVIGEGGYGIVYRGIL-SD----GTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~-~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..++||+|+||+||+|.+ .. .-+||+|.+... ..+...++..|+..|.+++|||++++++++.... +-||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 457899999999999985 23 347999988654 3455788999999999999999999999998776 7799999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++.|.|.++++.++ .++.....+.|..||++||.|||.+ +++||||.++|+|+..-..+||+|||+++.+..+.
T Consensus 779 mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999998765 4577788899999999999999999 99999999999999999999999999999987654
Q ss_pred c-ccccccccCCCcccce----------eccchHHHHHHHHHh-ccCCCCC
Q 018991 309 S-YVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~-~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~-g~~Pf~~ 347 (348)
. +.+....-.+.||+-| .|||||||++||++| |.-|+-.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 3 3333333345566655 499999999999998 7777643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=250.27 Aligned_cols=185 Identities=24% Similarity=0.331 Sum_probs=156.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-----
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----- 220 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----- 220 (348)
..++|++.+.||+|+||.||++.. .++..||+|.+.... ......+..|++++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 456788889999999999999984 478999999885432 223456788999999999999999999987553
Q ss_pred -EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 221 -YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 221 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecc
Confidence 458999999 6799888753 3588999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
++....... ....+++.|++|| +|+||||+++|+|++|++||.
T Consensus 164 ~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~ 217 (343)
T cd07880 164 LARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK 217 (343)
T ss_pred cccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 998654321 2345678888888 399999999999999999996
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=247.22 Aligned_cols=184 Identities=15% Similarity=0.111 Sum_probs=150.3
Q ss_pred eEeecCceEEEEEEECCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
.+|.|+++.|+++.. +++.||+|.+... .....+.+..|+++++.++||||+++++++.+.+..+++|||+++++|.
T Consensus 9 ~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 9 CFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred hhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 344445544554444 6899999998654 2334567899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc------
Q 018991 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS------ 309 (348)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~------ 309 (348)
+++..... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||.+..+.....
T Consensus 88 ~~l~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~ 162 (314)
T cd08216 88 DLLKTHFP--EGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162 (314)
T ss_pred HHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccc
Confidence 99975422 3588899999999999999999998 999999999999999999999999999876543221
Q ss_pred ccccccccCCCcccce------------eccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFI------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......++..|++|| +||||+||++|||++|+.||..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~ 212 (314)
T cd08216 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKD 212 (314)
T ss_pred cccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1112245667788887 3999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=248.47 Aligned_cols=183 Identities=23% Similarity=0.293 Sum_probs=153.5
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCcch--------------HHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA--------------EKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
.+.||+|+||.||+|... +++.||+|.+....... ...+.+|++++..++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 467999999999999954 68999999885442211 124678999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..+++|||+. |+|.+++... ..+++.....++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccc
Confidence 9999999997 6999988643 4588999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-------------cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSER-------------SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~-------------~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++...... ........++..|++||. |||||||++|+|++|++||.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~ 235 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP 235 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 98654111 111122346778999983 99999999999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=241.70 Aligned_cols=190 Identities=22% Similarity=0.245 Sum_probs=163.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
..++|....+||+|+|.+|.++++ ++.+.+|+|++++.- .....-.+.|-.+..+. +||.+|.+..+|+.+.+++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 456788889999999999999995 467889999886542 22333455676666665 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|.||++||+|.-.+++. .++++..+..+..+|+.||.|||++ ||+.||||.+|+|+|..|++||+|+|+++.
T Consensus 328 fvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence 999999999997766544 4699999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
--.+. ..+..++|||.|.|||+ |+|+||++++||+.|+-||-
T Consensus 401 ~l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 401 GLGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred CCCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 54433 34556899999999994 99999999999999999995
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=248.19 Aligned_cols=185 Identities=20% Similarity=0.234 Sum_probs=151.0
Q ss_pred eEeec--CceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 158 VIGEG--GYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 158 ~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.||+| +||.||+++.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++++||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999964 78999999886443 223467888999999999999999999999999999999999999
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc--
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-- 310 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-- 310 (348)
+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++||+.+.........
T Consensus 85 ~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 85 SANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999987542 23588999999999999999999998 9999999999999999999999999865433221110
Q ss_pred ---ccc-ccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 311 ---VTT-RVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ---~~~-~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..+ ...++..|++||. |||||||++|+|++|++||..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~ 212 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 001 1224556888873 999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=251.03 Aligned_cols=187 Identities=23% Similarity=0.343 Sum_probs=155.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC----------
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG---------- 219 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~---------- 219 (348)
.+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 4677889999999999999995 46889999998766555667788999999999999999999876543
Q ss_pred ----CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceE
Q 018991 220 ----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNAR 294 (348)
Q Consensus 220 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~k 294 (348)
...|+++||++ ++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEE
Confidence 35789999997 599888853 3588999999999999999999998 999999999999997 456789
Q ss_pred EecccCcccccCCCcc--cccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 295 VSDFGLAKLLCSERSY--VTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 295 l~DFGla~~~~~~~~~--~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
|+|||+++.+...... ......++..|+||| +|||||||++|+|++|+.||.
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 220 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA 220 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999865432211 112235778888888 399999999999999999995
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=249.56 Aligned_cols=187 Identities=27% Similarity=0.362 Sum_probs=160.3
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-----EEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRM 223 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~ 223 (348)
+|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+..|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 3667789999999999999965 58899999886543 334567889999999999999999999998775 789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
++|||++ ++|.+++... .++++..++.++.|++.||.|||++ +|+|+||||+|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999998 5899888643 3689999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... .......++..|++||. |+||||+++|+|++|++||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~ 208 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcC
Confidence 654321 12234567888999983 99999999999999999996
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-33 Score=258.04 Aligned_cols=188 Identities=25% Similarity=0.347 Sum_probs=161.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcch--------HHHHHHHHHHHhcCC---CCCeeeEeeEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA--------EKEFKVEVEVIGRVR---HKNLVRLLGYCVE 218 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 218 (348)
.+|...+.||+|+||.|++|.++ +...|+||.+.+.+--. .-..-.|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45777889999999999999965 46789999886553211 112446999999998 9999999999999
Q ss_pred CCEEEEEEeec-CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 219 GAYRMLVYEYV-DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 219 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
++.+||+||-. ++-+|++++... +.+.+.++..|+.||+.|+++||++ +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999974 456999999754 5689999999999999999999999 999999999999999999999999
Q ss_pred ccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
||.|....+. .-..+.||.+|+|||+ |||+||++||.+++.+-||-+|
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyni 772 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYNI 772 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcCC
Confidence 9998765332 2234789999999996 9999999999999999999887
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=261.33 Aligned_cols=189 Identities=24% Similarity=0.365 Sum_probs=160.5
Q ss_pred CCCcCceEeecCceEEEEEEECC--C--cEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILSD--G--TKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..+..++||+|+||.|++|.|.. | ..||||.+...... ...+|.+|+.+|.+|+|||+++|||+..+ ....+|+
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34456789999999999999753 3 46899999776544 56789999999999999999999999988 6678999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|+++.|+|.+.|+.. ....|.......++.||+.||.||.++ ++|||||..+|+|+.....+||+||||.+.+..
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999872 335688888999999999999999999 999999999999999999999999999999876
Q ss_pred CCccc-cc-ccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 307 ERSYV-TT-RVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 307 ~~~~~-~~-~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
.+.+. .. ...-...|++||+ |+|++||+||||++ |+-||.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~ 317 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWV 317 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCC
Confidence 55432 22 2334467899995 99999999999998 677764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=257.26 Aligned_cols=195 Identities=20% Similarity=0.339 Sum_probs=149.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-----------------CCCcEEEEEEEecCCcchHHH--------------HHHH
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-----------------SDGTKVAVKNLLNNRGQAEKE--------------FKVE 197 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 197 (348)
..++|.+.++||+|+||.||+|.. .+++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 577899999999999999999963 235679999986543322223 3346
Q ss_pred HHHHhcCCCCCe-----eeEeeEEEE--------CCEEEEEEeecCCCCHHHHHhcCCCC--------------------
Q 018991 198 VEVIGRVRHKNL-----VRLLGYCVE--------GAYRMLVYEYVDNGNLDQWLHGDVGD-------------------- 244 (348)
Q Consensus 198 ~~~l~~l~H~nI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------- 244 (348)
+..+.+++|.++ ++++++|.. .+..|||+||+++++|.++++.....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766654 667777643 35689999999999999998743211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCcccc
Q 018991 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHF 324 (348)
Q Consensus 245 ~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~p 324 (348)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..............+|+.|++|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12346778889999999999999998 999999999999999999999999999976543322222223457889988
Q ss_pred ee--------------------------------ccchHHHHHHHHHhccC-CCC
Q 018991 325 IV--------------------------------QVSPLFILLYILLSVRY-NSS 346 (348)
Q Consensus 325 e~--------------------------------DiwSlG~il~el~~g~~-Pf~ 346 (348)
|. ||||+||+||+|++|.+ ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 82 99999999999999986 764
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=246.08 Aligned_cols=190 Identities=26% Similarity=0.343 Sum_probs=156.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------- 219 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------- 219 (348)
.++|.+.+.||+|+||.||+|... +++.+|+|.+..... .....+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 457888899999999999999964 688999998854422 2234567899999999999999999987543
Q ss_pred -CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 220 -AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 220 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
...++++||+.+ +|...+... ...+++..+..++.|++.||.|||++ +|+|+||||+||++++++.+||+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 777777543 24689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCcc----------cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSY----------VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~----------~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+++........ ......+++.|+|||. |||||||++|+|++|++||.
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~ 228 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQ 228 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCC
Confidence 999865432211 1123456788999983 99999999999999999985
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=241.61 Aligned_cols=183 Identities=28% Similarity=0.344 Sum_probs=155.1
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|...+.||+|+||.||+|+.. ++..|++|.+..... .....+..|++++..++|||++++++++.+....|++|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445577999999999999954 688999998864322 2335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+. |++.+++.... .++++..++.++.|++.||.|||++ +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~---~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 96 58888775432 4688999999999999999999998 999999999999999999999999999864322
Q ss_pred cccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....|+..|++||. |||||||++|+|++|++||..
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~ 222 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 222 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 123567888888883 999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=241.83 Aligned_cols=190 Identities=28% Similarity=0.398 Sum_probs=156.1
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv 225 (348)
..++|.+.+.||+|+||.||+|.+++ ++.||+|.+.... ......+..|+.++.+.. ||||+++++++.+....|++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34567778999999999999999764 8899999986543 223455666777676664 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||+. ++|.+++.... .++++..+..++.|++.||.|||+ . +|+||||+|+||++++++.+||+|||++..+
T Consensus 93 ~e~~~-~~l~~l~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELMS-TCLDKLLKRIQ---GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eeccC-cCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 99986 47777765422 368999999999999999999996 4 8999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCcccce--------------eccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFI--------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe--------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ....++..|++|| +||||||+++|+|++|++||..
T Consensus 166 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 166 VDSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred cCCCcc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 433221 2235677888887 3999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=248.20 Aligned_cols=183 Identities=25% Similarity=0.345 Sum_probs=153.7
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------C
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 220 (348)
.++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36788889999999999999995 468999999886432 22335678899999999999999999998754 3
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..++|+||+.. +|..++. ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46899999974 7877652 2488899999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++..... .....++..|++||. |||||||++|||++|+.||.
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~ 216 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK 216 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9865322 123457788888883 99999999999999999996
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=240.53 Aligned_cols=186 Identities=27% Similarity=0.349 Sum_probs=157.4
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|.+.+.||+|+||.||+|... +++.|++|.+..... .......+|+..+.+++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456688999999999999975 578899998865432 22234556899999999 999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
+|+|.+++.... ...+++..++.++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 789999887542 24689999999999999999999998 999999999999999999999999999987644322
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ....++..|++||. |+||||+++|+|++|++||+
T Consensus 155 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~ 200 (283)
T cd07830 155 Y--TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFP 200 (283)
T ss_pred c--CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccC
Confidence 1 23457888999983 99999999999999999995
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=243.27 Aligned_cols=183 Identities=27% Similarity=0.359 Sum_probs=155.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|+..+.||+|+||.||+|+.. ++..+++|.+... .....+++..|+++++.++|+|++++++++...+..++|+||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 445577999999999999964 5788999988543 222345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+. |++.+++.... .++++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~-~~l~~~~~~~~---~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 97 CL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred cC-CCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 97 58887775432 4588999999999999999999998 9999999999999999999999999998765432
Q ss_pred cccccccccCCCcccce-------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI-------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe-------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
....++..|++|| +|||||||++|+|++|+.||..
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2346778888888 3999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=273.36 Aligned_cols=189 Identities=28% Similarity=0.400 Sum_probs=150.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE---------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------- 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------- 218 (348)
.++|+..+.||+|+||.||+++.+ ||+.||||++.-.. ......+.+|+.+|++|+|||||+++..+..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 345666788999999999999965 89999999996543 2334568889999999999999999853310
Q ss_pred ----------------------------------------------C---------------------------------
Q 018991 219 ----------------------------------------------G--------------------------------- 219 (348)
Q Consensus 219 ----------------------------------------------~--------------------------------- 219 (348)
.
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence 0
Q ss_pred -------------------------------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018991 220 -------------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268 (348)
Q Consensus 220 -------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH 268 (348)
..+||-||||+...|.++++++.-. -..+..++++++|+.||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHHHHH
Confidence 1237889999987777777654211 035678899999999999999
Q ss_pred hCCCCCceecCCCCCCEEECCCCceEEecccCccccc-----------------CCCcccccccccCCCccccee-----
Q 018991 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC-----------------SERSYVTTRVMGTFGYAHFIV----- 326 (348)
Q Consensus 269 ~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~-----------------~~~~~~~~~~~gt~~y~~pe~----- 326 (348)
++ +||||||||.||+++++..+||+|||+|.... .......+..+||.-|+|||.
T Consensus 715 ~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 99 99999999999999999999999999998721 011123445789999999994
Q ss_pred --------ccchHHHHHHHHHhccCCCCC
Q 018991 327 --------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 327 --------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||||||+|+||+ +||.+
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~T 817 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGT 817 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCc
Confidence 9999999999999 67764
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=245.61 Aligned_cols=187 Identities=24% Similarity=0.343 Sum_probs=157.1
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYR 222 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~ 222 (348)
....++|+..+.||+|+||.||++... +++.||+|.+.... ....+.+..|++++..++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 345678999999999999999999954 78999999875432 2334667889999999999999999999875 5678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++++||+ +++|.++++. .++++..+..++.|++.||.|||++ +|+||||+|+||++++++.+||+|||++.
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 9999998 4689888853 3478888889999999999999998 99999999999999999999999999987
Q ss_pred cccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... ....++..|++||. |||||||++|+|++|+.||.
T Consensus 157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~ 207 (328)
T cd07856 157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207 (328)
T ss_pred ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 643221 22356777888883 99999999999999999995
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=245.69 Aligned_cols=187 Identities=25% Similarity=0.298 Sum_probs=154.2
Q ss_pred CCCcCceEeecCceEEEEEEEC-C--CcEEEEEEEecCC--cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEEC----CE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-D--GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEG----AY 221 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~----~~ 221 (348)
+|.+.+.||+|+||.||+++.. + +..||+|.+.... ....+.+.+|++++.++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667788999999999999964 4 7789999886432 22345678899999999 599999999875432 45
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.++++||+. ++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG----QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 788999986 6899988643 4688999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcc---cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSY---VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~---~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.+...... ......|+..|++||. ||||+|+++|+|++|+.||.
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 876432221 1223578999999993 99999999999999999986
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=240.39 Aligned_cols=203 Identities=23% Similarity=0.306 Sum_probs=164.8
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECC------CcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGY 215 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~ 215 (348)
..++...+..++...++-+|.||.||+|.|++ .+.|-+|.++....+ ....+..|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666667778888899999999999997643 355778877665433 34567889999999999999999998
Q ss_pred EEEC-CEEEEEEeecCCCCHHHHHhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 216 CVEG-AYRMLVYEYVDNGNLDQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 216 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~----~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
+..+ ...++++.++.-|+|..||...++ ....++..+...++.|++.|++|||.+ ++||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence 8654 567888999999999999973222 234577788889999999999999999 99999999999999999
Q ss_pred CceEEecccCcccccCCCcccccc-cccCCCccccee----------ccchHHHHHHHHHh-ccCCCCCC
Q 018991 291 WNARVSDFGLAKLLCSERSYVTTR-VMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSSTI 348 (348)
Q Consensus 291 ~~~kl~DFGla~~~~~~~~~~~~~-~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~~ 348 (348)
.++||+|=.++|.+...+...... ......||++|+ |+||||++||||+| |+.|+-.|
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeI 502 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEI 502 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCcccc
Confidence 999999999999887655443332 234567999995 99999999999998 89988654
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=237.54 Aligned_cols=186 Identities=28% Similarity=0.377 Sum_probs=153.9
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcC---CCCCeeeEeeEEEECCE-----
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAY----- 221 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~----- 221 (348)
|++.+.||+|+||.||+|+.+ +++.||+|.+..... .....+..|+.++.++ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456678999999999999976 489999999864322 2234566777776655 69999999999988776
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.+++|||+.+ +|.+++..... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK--PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999974 89988865322 3589999999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
........ .....++..|++|| .|||||||++|+|++|++||.
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~ 207 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFR 207 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCccc
Confidence 87644322 12335788899998 399999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=239.49 Aligned_cols=186 Identities=26% Similarity=0.344 Sum_probs=158.3
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|...+.||+|++|.||++... +++.+++|.+..... .....+..|++++++++||||+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 345678999999999999964 688999998865432 24567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++ +|.+++.... ..+++..++.++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ---RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred CC-CHHHHHHhhc---ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 75 8888886532 4689999999999999999999998 999999999999999999999999999987654431
Q ss_pred ccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
......++..|++|| +|+||||+++|+|++|+.||.
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~ 200 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 122245777888888 399999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=233.39 Aligned_cols=181 Identities=28% Similarity=0.315 Sum_probs=157.1
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
||+|+||.||++... +++.+++|.+..... .....+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999965 588999998865432 2345788899999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
.+++... ..+++..+..++.|++.||.|||++ +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999754 3588999999999999999999998 99999999999999999999999999998764432 12234
Q ss_pred cccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 315 VMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 315 ~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
..++..|++|| .|+||||+++|+|++|+.||..
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 56788899998 4999999999999999999964
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=263.58 Aligned_cols=200 Identities=27% Similarity=0.407 Sum_probs=170.3
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEEC----C----CcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEee
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILS----D----GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLG 214 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~ 214 (348)
.++...+++.+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 56777888888889999999999999843 1 35699999876533 4567899999999998 6999999999
Q ss_pred EEEECCEEEEEEeecCCCCHHHHHhcCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 018991 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDV---G-------DV--SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282 (348)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp 282 (348)
++...+..++|+||+..|+|.++|+..+ . .. ..++....+.++.|||.||+||++. +++||||.+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence 9999999999999999999999998765 0 01 1388899999999999999999998 999999999
Q ss_pred CCEEECCCCceEEecccCcccccCCCcccccccccC--CCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT--FGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 283 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt--~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+|||+.++..+||+|||+|+.......+....-.|+ ..|||||+ ||||+|++|||+++ |..|++.
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~ 524 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG 524 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence 999999999999999999998777666654433433 34999995 99999999999998 7888875
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=236.94 Aligned_cols=186 Identities=26% Similarity=0.396 Sum_probs=157.9
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
|+..+.||+|.||.||+|+.. +++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 345577999999999999965 58999999886543 333456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
+ ++|.+++.... ..+++..+..++.|++.||.|||++ +|+|+||+|+||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 8 59999997542 3589999999999999999999998 999999999999999999999999999987644322
Q ss_pred ccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
. .....++..|++|| .|+|||||++|||++|++||.
T Consensus 154 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~ 200 (282)
T cd07829 154 T-YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFP 200 (282)
T ss_pred c-cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 1 12234567788887 399999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-31 Score=235.13 Aligned_cols=189 Identities=21% Similarity=0.294 Sum_probs=155.1
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-----CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
|.+.+.||+|+||.||++... .+..+++|.++.. .......+..|+.++++++||||+++++++.+....++++
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 667788999999999999864 3445556655332 1223345677899999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++. +.+||+|||+++....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998865333345789999999999999999999998 9999999999999975 5699999999987644
Q ss_pred CCcccccccccCCCcccce----------eccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......|++.|++|| +|+||||+++|+|++|+.||.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~ 206 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 322 222356788899988 499999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=246.48 Aligned_cols=184 Identities=24% Similarity=0.333 Sum_probs=156.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE-----
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----- 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 221 (348)
.++|...+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567888899999999999999965 57899999875432 2233567789999999999999999998876554
Q ss_pred -EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 222 -RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 222 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
.++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5699998864 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+...... .....++..|++|| +|||||||++|+|++|+.||.
T Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~ 217 (343)
T cd07851 165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP 217 (343)
T ss_pred ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 9865432 22345777888888 399999999999999999995
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=258.61 Aligned_cols=191 Identities=19% Similarity=0.207 Sum_probs=140.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-C----CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeE------EE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-D----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY------CV 217 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~------~~ 217 (348)
..++|.+.+.||+|+||.||+|++. + +..||+|++..... .+....| .+....+.++..+... ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678899999999999999999964 4 68999998754321 1111111 1112222222222221 23
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVGD----------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK 281 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlk 281 (348)
.+...++|+||+.+++|.+++...... ........+..++.|++.||.|||++ +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999998643210 00112344567999999999999998 99999999
Q ss_pred CCCEEECC-CCceEEecccCcccccCCCcccccccccCCCccccee--------------------------------cc
Q 018991 282 SSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV--------------------------------QV 328 (348)
Q Consensus 282 p~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~--------------------------------Di 328 (348)
|+|||++. ++.+||+|||+|+.+.....+......+++.|+|||. ||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 5799999999998776555555667889999999992 99
Q ss_pred chHHHHHHHHHhccCCCC
Q 018991 329 SPLFILLYILLSVRYNSS 346 (348)
Q Consensus 329 wSlG~il~el~~g~~Pf~ 346 (348)
|||||+||||+++.+|+.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999887764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=230.27 Aligned_cols=169 Identities=20% Similarity=0.112 Sum_probs=142.5
Q ss_pred cCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhc
Q 018991 162 GGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240 (348)
Q Consensus 162 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (348)
|.||.||+++. .+++.+|+|.+.... .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 78999999995 468899999986442 233445555566799999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCC
Q 018991 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320 (348)
Q Consensus 241 ~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 320 (348)
. ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.++++|||++..+.... ....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcc
Confidence 3 3589999999999999999999998 99999999999999999999999999887654321 22345667
Q ss_pred cccce----------eccchHHHHHHHHHhccCCCC
Q 018991 321 YAHFI----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 321 y~~pe----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
|++|| .|+||+|+++|||++|+.||.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 88888 399999999999999998765
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=247.57 Aligned_cols=182 Identities=26% Similarity=0.274 Sum_probs=150.5
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++.|.....+|.|+|+.|-.|.. .+++..++|++..... +..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 55677777899999999999995 4688899999865522 233466555554 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-CCCCceEEecccCcccccC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill-~~~~~~kl~DFGla~~~~~ 306 (348)
++.++-+.+.+... +....++..|+.+++.|+.|||++ ++|||||||+|||+ +..++++|+|||.++.+..
T Consensus 397 ~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999888877543 122266778999999999999998 99999999999999 6899999999999998755
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....+-|..|.|||+ ||||||++||+|++|+.||..
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~ 515 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAA 515 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcccc
Confidence 4 222356788889985 999999999999999999963
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-32 Score=231.84 Aligned_cols=186 Identities=23% Similarity=0.320 Sum_probs=157.2
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-----EEEE
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-----YRML 224 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-----~~~l 224 (348)
.+..+.||-|+||.||.+.+ ++|+.||+|++.+-. ....+.+.+|+.+|..++|.|+...++..+..+ ++|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 44567899999999999984 579999999886542 234567888999999999999999998877654 4578
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++|++.. +|...+-. ..+++.+.+.-++.||++||+|||+. +|.||||||.|.|++.+..+||||||+++..
T Consensus 135 ~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEeccccccccc
Confidence 8999874 88877753 36788999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..+.....+..+-|..|.+||. ||||.||++.||+-.+.-|.
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 7666666666677889999994 99999999999998776653
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=217.73 Aligned_cols=189 Identities=31% Similarity=0.414 Sum_probs=161.1
Q ss_pred CCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+..++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 3456789999999999999764 889999998765544 56788899999999999999999999999899999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+++|.+++..... .+++..+..++.+++.++.|||++ +++|+|++|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 9999999975421 178899999999999999999998 9999999999999999999999999999876544211
Q ss_pred cccccccCCCcccce-----------eccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
......++..|++|| .|+|+||+++|+|++|++||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122345667777777 5999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-32 Score=228.81 Aligned_cols=187 Identities=22% Similarity=0.376 Sum_probs=151.9
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--------CCE
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------GAY 221 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~~~ 221 (348)
|.....||+|.||.||+++. ++|+.||+|++... +........+|+.+|..++|+|++.++..|.. ...
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 33346799999999999995 46888999876432 23334566789999999999999999887742 345
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+|+++|+. +|.-+|.... ..++...+.+++.++..||.|+|.. .|+|||+||+|+||+.++.+||+|||++
T Consensus 99 ~ylVf~~ceh-DLaGlLsn~~---vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSNRK---VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeHHHhhh-hHHHHhcCcc---ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 8999999986 9999986542 4688899999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcc---cccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSY---VTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~---~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
+.+...... ..+..+-|.+|.+|| +|||+.||++.||.++.+=|+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 876433221 122345588999988 499999999999999987654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=226.29 Aligned_cols=187 Identities=22% Similarity=0.259 Sum_probs=157.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-C-CC----eeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-H-KN----LVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H-~n----Iv~l~~~~~~~~~~ 222 (348)
.+.|.+.+.+|+|.||.|-.|..+ .+..||+|+++.- ....+....|+++|.++. + |+ +|.+.++|.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 778899999999999999999954 5789999987543 344566777999999994 2 22 78888999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------------
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR------------- 289 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~------------- 289 (348)
|||+|.+ |-++.++|..+ +..+++.+++..++.|++.++.|||+. +++|-||||+|||+.+
T Consensus 167 Civfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred EEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 9999998 46999999865 457899999999999999999999998 9999999999999832
Q ss_pred -------CCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 290 -------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 290 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..+||+|||.|..-.... +.++-|..|.|||+ ||||+||||+||.+|..-|.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2348999999998754332 45788999999996 999999999999999987764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=212.15 Aligned_cols=182 Identities=24% Similarity=0.362 Sum_probs=151.8
Q ss_pred hcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECC--EEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA--YRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~~lv 225 (348)
.++|++.+.+|+|.++.||.|. ..++++++||.++. ...+.+.+|+.+|..|. ||||+++++...+.. ...|+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4457777889999999999999 55788999998853 34567889999999997 999999999998753 55799
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCcccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLL 304 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla~~~ 304 (348)
+||+.+-+...+. +.++...+..++.+++.||.|+|+. ||.|||+||.|++||.. .+++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998887765 4577788899999999999999999 99999999999999854 57999999999886
Q ss_pred cCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....+.- .+.+..|-.||. |+|||||+|..|+-.+-||-
T Consensus 184 Hp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 184 HPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred CCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 55444322 234556677883 99999999999999999985
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=239.50 Aligned_cols=187 Identities=27% Similarity=0.376 Sum_probs=150.6
Q ss_pred CCcCceEeecCceE-EEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 153 LCEENVIGEGGYGI-VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 153 ~~~~~~lG~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
|...+++|.|+.|+ ||+|.++ |+.||||++.... ..-..+|+..|..- +|||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45557799999874 8999984 7899999885432 23456799998887 69999999999999999999999997
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---C--CceEEecccCccccc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---Q--WNARVSDFGLAKLLC 305 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~--~~~kl~DFGla~~~~ 305 (348)
.+|.+++.....+............+.|+++||++||+. +||||||||.||||+. + .+++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 599999986411111112133467889999999999997 9999999999999965 2 468999999999987
Q ss_pred CCCcc--cccccccCCCccccee----------ccchHHHHHHHHHhc-cCCCCC
Q 018991 306 SERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSV-RYNSST 347 (348)
Q Consensus 306 ~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g-~~Pf~~ 347 (348)
...+. ......||.+|+|||. ||+||||++|+.++| .-||..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd 717 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGD 717 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCc
Confidence 65543 2345789999999994 999999999999886 889853
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=241.99 Aligned_cols=175 Identities=23% Similarity=0.310 Sum_probs=150.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ......+..|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46778899999999999999965 68899999986542 223467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+.+++|.+++... ..+++..++.++.||+.||.|||.+ +|+||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 999999999998643 3578889999999999999999998 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee-----------ccchHHH
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFI 333 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~ 333 (348)
.. .......+|+.|++||. ++|++|.
T Consensus 157 ~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~ 193 (669)
T cd05610 157 RE-LNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF 193 (669)
T ss_pred Cc-ccccccccCccccCccccccCCCCceeeeeeecCc
Confidence 32 23345689999999984 6777774
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=209.44 Aligned_cols=176 Identities=30% Similarity=0.415 Sum_probs=153.7
Q ss_pred CceEEEEEEEC-CCcEEEEEEEecCCcch-HHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhc
Q 018991 163 GYGIVYRGILS-DGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240 (348)
Q Consensus 163 ~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 240 (348)
+||.||+|... +++.+++|.+....... .+.+..|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999975 58999999986654443 67899999999999999999999999999999999999999999999865
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCC
Q 018991 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320 (348)
Q Consensus 241 ~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~ 320 (348)
. ..+++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++|+|||.+....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 3 2278899999999999999999998 99999999999999999999999999998765432 2234567888
Q ss_pred cccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 321 YAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 321 y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
|++|| +||||||+++|+|++|..||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 88888 4999999999999999999964
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-29 Score=239.38 Aligned_cols=189 Identities=25% Similarity=0.323 Sum_probs=166.4
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.++|.....+|.|+||.||+++. ++++..|+|.++-.......-++.|+-+++.++|||||.+++.+...+..|+.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 456777888999999999999994 5789999999977766666778889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
||.+|+|.+.-+.. .++++.++....+..++||+|||++ +-+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 93 ycgggslQdiy~~T----gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceeeec----ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999876533 6899999999999999999999998 8899999999999999999999999998876542
Q ss_pred CcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf 345 (348)
- .....+.||+.||+||+ |||++|+...|+-.-++|-
T Consensus 166 i-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 166 I-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred h-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 2 23345899999999995 9999999999998877763
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-28 Score=209.24 Aligned_cols=183 Identities=16% Similarity=0.284 Sum_probs=144.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeE-EEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGY-CVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~-~~~~~~~~lv~e 227 (348)
+.|.+.+.||+|.||.+-+++++ +...+++|-+.... ...++|.+|..---.| .|.||+.-|++ |+..+....++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45777789999999999999976 46789999775432 3457888887654455 48999987764 667788889999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCceEEecccCccccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLC 305 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~--~~~~~kl~DFGla~~~~ 305 (348)
|++.|+|.+-+.. ..+.+.....++.|+++|+.|+|++ ++||||||.+||||- +..++||||||+.+..+
T Consensus 103 ~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999987643 3467788899999999999999999 999999999999993 44589999999988654
Q ss_pred CCCcccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
..-.+ .--+..|.+|| .|||.||+++|.+++|.+|+.
T Consensus 175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 32111 12234455555 399999999999999999986
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=212.06 Aligned_cols=160 Identities=21% Similarity=0.213 Sum_probs=125.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--CCcEEEEEEEecC-----CcchHHHHHHHHHHHhcCCCCCeee-EeeEEEECC
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVR-LLGYCVEGA 220 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~-l~~~~~~~~ 220 (348)
...+|.+.+.||+|+||.||+|++. +++.+|||++... .....+.+.+|+++|++++|+|++. +++ .+
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~ 91 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TG 91 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cC
Confidence 4566888899999999999999864 5777899987532 1223456899999999999999985 443 24
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCceEEeccc
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl-kp~Nill~~~~~~kl~DFG 299 (348)
..|+||||++|++|... . . .. ...++.|++.+|.|||++ +|+|||| ||+|||++.++.+||+|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~-~------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-R-P------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CcEEEEEccCCCCHHHh-C-c------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECc
Confidence 57999999999999632 1 1 11 145788999999999998 9999999 9999999999999999999
Q ss_pred CcccccCCCcc-------cccccccCCCccccee
Q 018991 300 LAKLLCSERSY-------VTTRVMGTFGYAHFIV 326 (348)
Q Consensus 300 la~~~~~~~~~-------~~~~~~gt~~y~~pe~ 326 (348)
+|+.+...... ......+++.|++||.
T Consensus 158 lA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~ 191 (365)
T PRK09188 158 LASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDA 191 (365)
T ss_pred cceecccCcchhhhhhhhhhhhhhccCccCCccc
Confidence 99976543211 1134678888999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=207.27 Aligned_cols=181 Identities=26% Similarity=0.287 Sum_probs=145.7
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------EEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------YRM 223 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~ 223 (348)
|.....+|.|.- .|..+... .+++||+|++.... ....++..+|..++..++|+||++++.+|.... ..|
T Consensus 19 y~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y 97 (369)
T KOG0665|consen 19 YVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVY 97 (369)
T ss_pred eeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHH
Confidence 333455777766 45555432 57899999884432 223456778999999999999999999997543 469
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|||||. .+|.+.+.. .+.-..+..+..|++.|+.|||+. +|+||||||+||+++.+..+||.|||+|+.
T Consensus 98 ~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 98 LVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 9999997 599988863 366677889999999999999998 999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
-... ...+..+.|..|.|||+ ||||+||++.||++|..-|+
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~ 218 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFP 218 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEec
Confidence 5433 45566778888999995 99999999999999987664
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-27 Score=220.49 Aligned_cols=197 Identities=22% Similarity=0.201 Sum_probs=159.6
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC------CCCeeeEe
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR------HKNLVRLL 213 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~l~ 213 (348)
|.+.-.+.--..|.+....|+|-|+.|.+|... .|..||||++.++. ...+.=+.|+++|++|+ --|+++|+
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 333334455667777888999999999999954 47899999997654 33455667999999996 34789999
Q ss_pred eEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-Cc
Q 018991 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WN 292 (348)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~ 292 (348)
-.|...+++|||+|-+. -+|.+.|+....+ ..|....+..++.|+..||..|-.. +|+|.||||+|||+++. ..
T Consensus 501 r~F~hknHLClVFE~Ls-lNLRevLKKyG~n-vGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPLS-LNLREVLKKYGRN-VGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhhh-chHHHHHHHhCcc-cceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcce
Confidence 99999999999999885 5999999865433 4578888999999999999999987 99999999999999865 56
Q ss_pred eEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+||||||.|.....+.- ++ ..-+..|.|||+ |+||.||+||||.||+.-|+
T Consensus 576 LKLCDfGSA~~~~enei--tP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFp 636 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI--TP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFP 636 (752)
T ss_pred eeeccCccccccccccc--cH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecC
Confidence 89999999987654432 12 234556888885 99999999999999998876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1e-24 Score=187.38 Aligned_cols=173 Identities=35% Similarity=0.588 Sum_probs=145.6
Q ss_pred EeecCceEEEEEEEC-CCcEEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHH
Q 018991 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (348)
Q Consensus 159 lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (348)
||+|.+|.||++... +++.+++|.+...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999975 4889999988655432 34678899999999999999999999999999999999999999999
Q ss_pred HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCcccccCCCccccccc
Q 018991 237 WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERSYVTTRV 315 (348)
Q Consensus 237 ~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~~~~~~~~~~~~~ 315 (348)
++.... ..+++..+..++.+++.++.+||++ +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 987532 3588899999999999999999998 9999999999999999 89999999999986644321 11223
Q ss_pred ccCCCcccce-----------eccchHHHHHHHH
Q 018991 316 MGTFGYAHFI-----------VQVSPLFILLYIL 338 (348)
Q Consensus 316 ~gt~~y~~pe-----------~DiwSlG~il~el 338 (348)
.+...|++|| .|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 4566666665 4999999999987
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.5e-26 Score=204.72 Aligned_cols=190 Identities=26% Similarity=0.347 Sum_probs=156.6
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECC
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 220 (348)
+....+.|...+.||+|+|+.||++.+. ..+.||+|.+.... ....+..|+++|..+ -+.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445667888899999999999999843 46789999885443 234588899999998 5999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEeccc
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFG 299 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFG 299 (348)
...+|+||+++-+..++.. .++...+..+++.++.||.++|.+ ||||||+||.|+|.+. .++-.|.|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence 9999999999999999874 366788999999999999999999 9999999999999984 5678899999
Q ss_pred CcccccC---------------------------------CCcccc----------cccccCCCccccee----------
Q 018991 300 LAKLLCS---------------------------------ERSYVT----------TRVMGTFGYAHFIV---------- 326 (348)
Q Consensus 300 la~~~~~---------------------------------~~~~~~----------~~~~gt~~y~~pe~---------- 326 (348)
+|..... ...+.. ....||++|.|||+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 9962110 000000 11459999999995
Q ss_pred -ccchHHHHHHHHHhccCCCCC
Q 018991 327 -QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 327 -DiwSlG~il~el~~g~~Pf~~ 347 (348)
||||.|+++..+++++|||-+
T Consensus 259 iDiws~GVI~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFK 280 (418)
T ss_pred cceeeccceeehhhcccccccc
Confidence 999999999999999999953
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-24 Score=198.76 Aligned_cols=190 Identities=22% Similarity=0.331 Sum_probs=153.7
Q ss_pred CCCcCceEeecCceEEEEEEECCC--cEEEEEEEecCCcchHHHHHHHHHHHhcCCC----CCeeeEeeEE-EECCEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDG--TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH----KNLVRLLGYC-VEGAYRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~l~~~~-~~~~~~~l 224 (348)
.|.+.+.||+|+||.||.+..... ..+|+|............+..|..++..+.. +++..+++.. ..+...|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 688899999999999999996543 4788887755433322267788899888873 6889999988 47778899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CceEEeccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-----WNARVSDFG 299 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-----~~~kl~DFG 299 (348)
||+.+ |.+|.++..... ...++....+.++.|++.+|++||+. |++||||||.|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99988 679999876543 46799999999999999999999999 99999999999999754 469999999
Q ss_pred Ccc--cccCCCc-----cc--ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAK--LLCSERS-----YV--TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~--~~~~~~~-----~~--~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++ ....... .. ...+.||..|+++.+ |+||++.++.+|+.|.+|++.
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~ 239 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEA 239 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcc
Confidence 998 3322211 11 123569999998875 999999999999999999865
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=195.82 Aligned_cols=133 Identities=23% Similarity=0.303 Sum_probs=109.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-----CC---CeeeEeeEEEE--
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----HK---NLVRLLGYCVE-- 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~---nIv~l~~~~~~-- 218 (348)
...|.+.+.||-|.|++||+|... +.+.||+|+.+. .....+....|+.+|++++ |+ +||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 356778899999999999999954 567899997753 3344566778999999984 33 59999999974
Q ss_pred --CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 219 --GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 219 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
+.++|+|+|++ |-+|..++... ...-++...+..|++||+.||.|||..+ +|||-||||+|||+.
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 45889999998 56898888754 3355888999999999999999999875 999999999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-24 Score=180.95 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=108.7
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcc--h------------------------HHHHHHHHHHHhcCCCCCe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--A------------------------EKEFKVEVEVIGRVRHKNL 209 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~H~nI 209 (348)
...||+|+||.||+|...+|+.||+|.++..... . ......|.+.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999778999999998654211 0 0122358999999988776
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecCCCCCCEEEC
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL-HEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL-H~~~~~~ivHrdlkp~Nill~ 288 (348)
.....+... ..++||||++++++....... .+++...+..++.|++.+|.|+ |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~----~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD----APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 443333222 238999999987776543221 3588899999999999999999 687 999999999999998
Q ss_pred CCCceEEecccCcccccC
Q 018991 289 RQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~ 306 (348)
++.++|+|||+|.....
T Consensus 153 -~~~v~LiDFG~a~~~~~ 169 (190)
T cd05147 153 -DGKLYIIDVSQSVEHDH 169 (190)
T ss_pred -CCcEEEEEccccccCCC
Confidence 47899999999976533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=183.37 Aligned_cols=187 Identities=21% Similarity=0.304 Sum_probs=152.8
Q ss_pred CCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeec
Q 018991 152 GLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+|.+++.||+|+||..+.|+ +-+++.||||.-. ......++..|.+..+.| ..++|..+|-+...+.+..||+|++
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 57888999999999999999 5678999999542 222234567788887777 4789999998888888889999998
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-----CceEEecccCcccc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-----WNARVSDFGLAKLL 304 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-----~~~kl~DFGla~~~ 304 (348)
|.+|.|+..-.. ..|+...++.++.|++.-++|+|++ .+|.|||||+|+||..- ..+.|+|||+|+..
T Consensus 107 -GPSLEDLFD~Cg---R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG---RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred -CcCHHHHHHHhc---CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 679998876432 4689999999999999999999999 99999999999999643 35899999999987
Q ss_pred cCCCc-----c-cccccccCCCcccce----------eccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERS-----Y-VTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~-----~-~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+... | ......||..||+-- .|+-|||-++++.+-|.+||.-
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG 238 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 238 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence 55432 1 122378999999754 3999999999999999999963
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.1e-24 Score=179.95 Aligned_cols=191 Identities=21% Similarity=0.281 Sum_probs=154.9
Q ss_pred HhcCCCcCceEeecCceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC-CCeeeEeeEEEECCEEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~ 226 (348)
...+|.+.+.||+|+||.+|.|. ..+|..||||.-.... ...++..|..+...|+| ..|..+..+..+.+...+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34568888999999999999999 5679999999654332 23456778888888874 67888888888888899999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla~~ 303 (348)
|++ |.+|.+++.-.. ..++...++.++-|++.-++|+|.+ +++||||||+|.|..- ..++.++|||+|+.
T Consensus 91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhh
Confidence 998 679999875432 3588889999999999999999999 9999999999999863 45689999999987
Q ss_pred ccCCCc------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCCC
Q 018991 304 LCSERS------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 304 ~~~~~~------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
..+... .......||..|++--+ |+-|+|.+|.++.-|.+||.-|
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 654322 12234789999986543 9999999999999999999743
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.6e-23 Score=174.71 Aligned_cols=141 Identities=19% Similarity=0.173 Sum_probs=111.5
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcc----------------------h----HHHHHHHHHHHhcCCCCCe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----------------------A----EKEFKVEVEVIGRVRHKNL 209 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~----~~~~~~E~~~l~~l~H~nI 209 (348)
...||+|+||.||+|...+|+.||||.+...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998654211 0 1124578999999999987
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCHHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEE
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQW-LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILL 287 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill 287 (348)
.....+.... .++||||++++++... +.. ..++......++.|++.+|.++|+ + +|+||||||+|||+
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence 5544443332 4899999998755433 321 346778889999999999999999 8 99999999999999
Q ss_pred CCCCceEEecccCcccccCC
Q 018991 288 DRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 288 ~~~~~~kl~DFGla~~~~~~ 307 (348)
+ ++.++|+|||++..+...
T Consensus 152 ~-~~~~~liDFG~a~~~~~~ 170 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDHP 170 (190)
T ss_pred E-CCCEEEEEcccceecCCC
Confidence 9 789999999999877543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=180.31 Aligned_cols=172 Identities=15% Similarity=0.147 Sum_probs=131.9
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHH---------HHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---------FKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
...++|...++||+|+||.||+... ++..+|+|.+.......... +.+|++.+.+++||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4577899999999999999999655 56789999986553332222 6789999999999999999988764
Q ss_pred C--------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 219 G--------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 219 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
. +..+++|||++|.+|.++.. ++. ....+++.+|..+|.. +++|||+||.||+++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 35789999999999988732 222 2455889999999999 99999999999999998
Q ss_pred CceEEecccCcccccCCCcccccccccCCCcccceeccchHHHHHHHHH
Q 018991 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILL 339 (348)
Q Consensus 291 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~DiwSlG~il~el~ 339 (348)
+ ++|+|||.......+... ....--..|. -.+||||||+++..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~--d~~vler~y~-~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAK--DRIDLERHYG-IKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhH--HHHHHHhHhc-ccccccceeEeehHHH
Confidence 8 999999988765332211 1122222344 4679999999887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4e-22 Score=182.05 Aligned_cols=188 Identities=32% Similarity=0.441 Sum_probs=158.1
Q ss_pred CCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc---hHHHHHHHHHHHhcCCCC-CeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ---AEKEFKVEVEVIGRVRHK-NLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~H~-nIv~l~~~~~~~~~~~lv~e~ 228 (348)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +++++++.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 78899988655332 367789999999999988 799999999888888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCcccccCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSE 307 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~~~ 307 (348)
+.++++.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777643211 2688899999999999999999998 999999999999999988 7999999999865543
Q ss_pred Ccc-----cccccccCCCcccce-------e------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSY-----VTTRVMGTFGYAHFI-------V------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~-----~~~~~~gt~~y~~pe-------~------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......||..|++|| . |+||+|++++++++|..||.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~ 212 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFE 212 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 322 234567888898888 2 99999999999999999975
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=169.88 Aligned_cols=172 Identities=17% Similarity=0.087 Sum_probs=131.3
Q ss_pred cCceEeecCceEEEEEEECCCcEEEEEEEecCCc----chHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeec
Q 018991 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG----QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+...|++|+||+||.+.- ++.+++.+.+..... .....+.+|+++|++|. |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346799999999997665 677888776644322 11235789999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC-CCCCEEECCCCceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV-KSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl-kp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
.|.+|.+.+.. . ...++.|++.+|.++|++ ||+|||| ||.|||++.++.++|+|||+|.......
T Consensus 81 ~G~~L~~~~~~----------~-~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR----------G-DLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh----------h-hHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998754321 1 134678899999999999 9999999 7999999999999999999998544322
Q ss_pred cc----c--------ccccccCCCccccee------------ccchHHHHHHHHHhccCCC
Q 018991 309 SY----V--------TTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 309 ~~----~--------~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf 345 (348)
.. . ..-...++.|++|+- ++++.|+-+|.++|++.|+
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 10 0 011236788887772 7889999999999999886
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=216.25 Aligned_cols=136 Identities=15% Similarity=0.142 Sum_probs=103.2
Q ss_pred CCC-CCeeeEeeEE-------EECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 018991 204 VRH-KNLVRLLGYC-------VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275 (348)
Q Consensus 204 l~H-~nIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~i 275 (348)
++| +||.++++++ ......+.++||+ +++|.++|... ...+++..++.++.||+.||.|||++ +|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---gI 101 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---GI 101 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 455 5777788877 2334567788987 46999999643 24589999999999999999999998 99
Q ss_pred eecCCCCCCEEECC-------------------CCceEEecccCcccccCCC---------------cccccccccCCCc
Q 018991 276 VHRDVKSSNILLDR-------------------QWNARVSDFGLAKLLCSER---------------SYVTTRVMGTFGY 321 (348)
Q Consensus 276 vHrdlkp~Nill~~-------------------~~~~kl~DFGla~~~~~~~---------------~~~~~~~~gt~~y 321 (348)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666677665421100 0001124588999
Q ss_pred cccee----------ccchHHHHHHHHHhccCCCC
Q 018991 322 AHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 322 ~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+|||. |||||||+||||++|.+||.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99994 99999999999999998875
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.5e-21 Score=167.44 Aligned_cols=138 Identities=20% Similarity=0.315 Sum_probs=106.7
Q ss_pred CcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-----CCCCeeeEeeEEEECC---EEE-E
Q 018991 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-----RHKNLVRLLGYCVEGA---YRM-L 224 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~l~~~~~~~~---~~~-l 224 (348)
...+.||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+ +||||+++++++.++. ..+ +
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 2223444 69988665444567899999999999 5799999999998873 434 7
Q ss_pred EEee--cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCceecCCCCCCEEECC----CCceEEec
Q 018991 225 VYEY--VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL-AYLHEGLEPKVVHRDVKSSNILLDR----QWNARVSD 297 (348)
Q Consensus 225 v~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL-~yLH~~~~~~ivHrdlkp~Nill~~----~~~~kl~D 297 (348)
|+|| +.+|+|.+++.+. .+++. ..++.|++.++ +|||++ +|+||||||+|||++. ++.++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999642 25544 35677888787 999999 9999999999999974 34799999
Q ss_pred -ccCccc
Q 018991 298 -FGLAKL 303 (348)
Q Consensus 298 -FGla~~ 303 (348)
||....
T Consensus 153 g~G~~~~ 159 (210)
T PRK10345 153 NIGESTF 159 (210)
T ss_pred CCCCcce
Confidence 554443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-22 Score=191.95 Aligned_cols=178 Identities=24% Similarity=0.234 Sum_probs=148.9
Q ss_pred eEeecCceEEEEEEE----CCCcEEEEEEEecCCcc--hHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecC
Q 018991 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
++|+|+||.|++++. ..|..+|+|.+++.... .......|..++..++ ||.++++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998873 23677888877554221 1123445777888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~ 310 (348)
+|+|...+... ..+.+.....+...++-+++++|.. +|+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99998877643 4567777788888899999999998 9999999999999999999999999999986544332
Q ss_pred cccccccCCCccccee--------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV--------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~--------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+||..||+||+ |+||+|++++||++|-.||..
T Consensus 154 -----cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 154 -----CGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred -----ccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 89999999995 999999999999999999964
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-22 Score=196.43 Aligned_cols=185 Identities=21% Similarity=0.214 Sum_probs=145.7
Q ss_pred cCceEeecCceEEEEEEEC-CCcEEEEEEEec---CCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLN---NRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~---~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
...++|.|++|.|+..... .....+.|.... ... .....+..|..+-..+.|||++..+..+.+....+-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4578999999988777633 333344443221 111 111225567777888999999888887776666666699
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
||++ +|..++... ..+....+..++.|++.|+.|+|+. +|.|||+|++|+++..+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 999998753 3577788889999999999999998 9999999999999999999999999998765443
Q ss_pred Cc---ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RS---YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~---~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....++|+.+|+|||+ ||||.|++++.|.+|++||+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~ 527 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKV 527 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccc
Confidence 32 45556899999999995 999999999999999999973
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.1e-20 Score=162.87 Aligned_cols=148 Identities=16% Similarity=0.128 Sum_probs=113.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEE--ECCCcEEEEEEEecCCcc------------------------hHHHHHHHHHHH
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQ------------------------AEKEFKVEVEVI 201 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l 201 (348)
.....|.+.+.||+|+||.||+|. ..+|+.||+|.+...... ....+..|.+++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333457788999999999999998 457999999998644210 112356899999
Q ss_pred hcCCCCC--eeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-ceec
Q 018991 202 GRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVHR 278 (348)
Q Consensus 202 ~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~-ivHr 278 (348)
.++.+.+ ++++++. ...++||||+++.+|....... ..+.......++.|++.++.+||++ + |+||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~ 173 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD----VEPEEEEEFELYDDILEEMRKLYKE---GELVHG 173 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc----CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeC
Confidence 9997533 4444443 2348999999998887654221 2355566788999999999999998 8 9999
Q ss_pred CCCCCCEEECCCCceEEecccCcccccCC
Q 018991 279 DVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 279 dlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
||||+||+++ +++++|+|||.+......
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~~~~ 201 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVELDHP 201 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence 9999999999 889999999999865443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=157.25 Aligned_cols=135 Identities=21% Similarity=0.360 Sum_probs=113.0
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcc--------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.||+|++|.||+|.+ +|..+++|........ ....+.+|+.++..++|++++....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999987 5778999976433211 123577899999999999988777777777888999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++|++|.+++... .. ....++.+++.+|.++|+. +++|+|++|.|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998532 11 6788999999999999998 999999999999999 789999999998763
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.7e-20 Score=155.12 Aligned_cols=95 Identities=23% Similarity=0.143 Sum_probs=83.2
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++..+. .++++..+..++.|++.||.|||++ + ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVRG---RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 68999997532 4699999999999999999999987 5 999999999999999 99998764322
Q ss_pred ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 312 TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..||+.|+|||+ |||||||++|||++|++||.
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~ 105 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN 105 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcc
Confidence 268899999994 99999999999999999995
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.8e-19 Score=154.25 Aligned_cols=146 Identities=18% Similarity=0.133 Sum_probs=112.3
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc----------------------hHHHHHHHHHHH
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----------------------AEKEFKVEVEVI 201 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l 201 (348)
.++......|...+.||+|+||.||++...+|+.||||.+...... .......|..++
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444447778999999999999999878999999987543210 112356788889
Q ss_pred hcCCCCC--eeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 202 GRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 202 ~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
.++.|++ ++..++ ....+++|||+++++|...... .....++.+++.++.++|+. +|+|+|
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 8888874 444443 2445899999999998765320 23456888999999999998 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||+||++++++.++|+|||++.....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCCC
Confidence 999999999999999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.5e-19 Score=174.56 Aligned_cols=138 Identities=21% Similarity=0.325 Sum_probs=111.5
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEe-cC-Cc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLL-NN-RG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~-~~-~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
..|...+.||+|+||.||++.+.+. .+++|... .. .. ...+.+.+|++++..++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445678999999999999987543 34444332 11 11 1224678899999999999999888887777778
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ .++.++|+|||+++
T Consensus 412 ~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred EEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 99999999999999874 2467889999999999998 99999999999999 57799999999998
Q ss_pred ccc
Q 018991 303 LLC 305 (348)
Q Consensus 303 ~~~ 305 (348)
...
T Consensus 476 ~~~ 478 (535)
T PRK09605 476 YSD 478 (535)
T ss_pred cCC
Confidence 753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-19 Score=152.84 Aligned_cols=131 Identities=23% Similarity=0.384 Sum_probs=106.5
Q ss_pred eEeecCceEEEEEEECCCcEEEEEEEecCCc---c-----hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRG---Q-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~---~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.||+|+||.||+|.+ ++..+++|....... . ....+.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999996 567899998643211 1 1245778999999999887665555556667779999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|++|.+++.... . .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999999875321 0 6888999999999998 999999999999999 789999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.1e-20 Score=158.81 Aligned_cols=182 Identities=20% Similarity=0.303 Sum_probs=144.3
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
..|.+...|..|+|++.. ..+++|++... .....++|..|.-.|+-+.||||..+++.|....++.++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 347888899999999964 45666776443 233456899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
+..|++.. .......++.+++.++++|+.|||+. .+-|.---|....+++|++.+.+|.- +-++ .++....
T Consensus 275 ynvlhe~t--~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~k-----fsfqe~g 345 (448)
T KOG0195|consen 275 YNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTK-----FSFQEVG 345 (448)
T ss_pred HHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-ccce-----eeeeccc
Confidence 99998653 24567788999999999999999986 54455567899999999998887641 1111 1222222
Q ss_pred cccCCCccccee-------------ccchHHHHHHHHHhccCCCCCC
Q 018991 315 VMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSSTI 348 (348)
Q Consensus 315 ~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~~ 348 (348)
..-.|.||+||+ |+|||.++||||.|.+.||..+
T Consensus 346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl 392 (448)
T KOG0195|consen 346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL 392 (448)
T ss_pred cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence 345678999994 9999999999999999999753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=175.60 Aligned_cols=189 Identities=23% Similarity=0.246 Sum_probs=140.1
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC---CCCeeeEeeEEEECCE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAY 221 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~ 221 (348)
+++.....|++.+.||+|+||.||+|...+|+.||+|.-+...... |-.=.+++.+|+ -+-|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3455566788889999999999999998889999999765544321 111122333443 2344555555556666
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-------CCCceE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-------RQWNAR 294 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-------~~~~~k 294 (348)
-+||+||.+.|+|.+++.. .+..+|..++.++.|++.-+++||.. +|||+||||+|+||. +..-++
T Consensus 769 S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 7899999999999999963 35688999999999999999999998 999999999999994 234599
Q ss_pred EecccCcccccCCC-cccccccccCCCcccce----------eccchHHHHHHHHHhccC
Q 018991 295 VSDFGLAKLLCSER-SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLSVRY 343 (348)
Q Consensus 295 l~DFGla~~~~~~~-~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~g~~ 343 (348)
|+|||-+-.+.--. ...-..+++|-.+-.+| +|.|.|..++|-|+-|+|
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986543211 11222344555554444 699999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.4e-18 Score=150.88 Aligned_cols=185 Identities=23% Similarity=0.290 Sum_probs=116.4
Q ss_pred CcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCC----------CCeeeEeeEE---
Q 018991 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH----------KNLVRLLGYC--- 216 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H----------~nIv~l~~~~--- 216 (348)
...+.||.|+++.||.+++. +++++|+|....... ...+++++|.-....+.+ -.++.-++..
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 44678999999999999965 589999998744321 233556666544444322 1222222222
Q ss_pred ------EEC---C-----EEEEEEeecCCCCHHHHHhc---CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 217 ------VEG---A-----YRMLVYEYVDNGNLDQWLHG---DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 217 ------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
... . +.+++|+-+. +||.+++.. .......+.....+.+..|+++.+++||.+ |++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST
T ss_pred CCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecc
Confidence 111 1 1256777775 688887542 211112344445567778999999999999 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCccccee------------------ccchHHHHHHHHHhc
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV------------------QVSPLFILLYILLSV 341 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~------------------DiwSlG~il~el~~g 341 (348)
|||+|++++++|.++|+||+.....+.. ... ...+..|.+||. |.|+||+++|.|.||
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999876543221 111 233456666652 999999999999999
Q ss_pred cCCCC
Q 018991 342 RYNSS 346 (348)
Q Consensus 342 ~~Pf~ 346 (348)
++||-
T Consensus 247 ~lPf~ 251 (288)
T PF14531_consen 247 RLPFG 251 (288)
T ss_dssp S-STC
T ss_pred cCCCC
Confidence 99995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.1e-17 Score=140.99 Aligned_cols=137 Identities=22% Similarity=0.221 Sum_probs=98.0
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcch--HHH----------------------HHHHHHHHhcCCCCC--e
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA--EKE----------------------FKVEVEVIGRVRHKN--L 209 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~H~n--I 209 (348)
.+.||+|+||.||+|...+++.||||.+....... ... ...|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 36799999999999998789999999886532111 111 134556666654432 4
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCHHHH-HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEE
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQW-LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILL 287 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill 287 (348)
.+.++. ...+++|||++++.+... +.... .. .....++.+++.++.++|. + +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 235899999998543221 11110 11 5567889999999999998 7 99999999999999
Q ss_pred CCCCceEEecccCcccccC
Q 018991 288 DRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 288 ~~~~~~kl~DFGla~~~~~ 306 (348)
+ ++.++|+|||.+.....
T Consensus 149 ~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 149 D-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred E-CCcEEEEECcccccccC
Confidence 9 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.7e-17 Score=132.39 Aligned_cols=134 Identities=19% Similarity=0.185 Sum_probs=111.6
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC--CCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
.+.||+|.++.||++...+ ..+++|....... ...+..|..++..++| +++++++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999754 7899998755433 4578889999999976 589999998888888999999999876
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+..+ +......++.+++.+|.++|.....+++|+|++|.||++++.+.+++.|||.++.
T Consensus 80 ~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 6543 4455677889999999999985334799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-18 Score=172.49 Aligned_cols=184 Identities=21% Similarity=0.145 Sum_probs=136.1
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc-chHHHHH---HHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++...+.||++.|=+|.+|+++.|. |+||.+.+..+ -..+.+. .|++ ...++|||.+.+.-+-..+.-.|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4566788999999999999988776 88998865542 2233333 3444 455689999998877666667789999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|..+ +|.|.+.-+ +-+...+.+-|+.|++.||.-+|.. +|+|+|||.+||||+.-.-+.|+||..-+...-.
T Consensus 102 yvkh-nLyDRlSTR----PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTR----PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhccc----hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9975 999988643 3456667788999999999999998 9999999999999999989999999766543211
Q ss_pred C------cccccccccCCCcccce---------------------eccchHHHHHHHHHh-ccCCC
Q 018991 308 R------SYVTTRVMGTFGYAHFI---------------------VQVSPLFILLYILLS-VRYNS 345 (348)
Q Consensus 308 ~------~~~~~~~~gt~~y~~pe---------------------~DiwSlG~il~el~~-g~~Pf 345 (348)
. .+.-..-.-...|.||| .||+|+||++.||++ |++||
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 1 00000001112344444 599999999999988 68888
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.6e-16 Score=139.41 Aligned_cols=136 Identities=21% Similarity=0.279 Sum_probs=104.9
Q ss_pred ceEe-ecCceEEEEEEECCCcEEEEEEEecCC-------------cchHHHHHHHHHHHhcCCCCCe--eeEeeEEEEC-
Q 018991 157 NVIG-EGGYGIVYRGILSDGTKVAVKNLLNNR-------------GQAEKEFKVEVEVIGRVRHKNL--VRLLGYCVEG- 219 (348)
Q Consensus 157 ~~lG-~G~fg~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~H~nI--v~l~~~~~~~- 219 (348)
..|| .|+.|.||.+... +..+++|...... ......+.+|++++..++|++| ++.+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 7889999998874 6789999774321 1123457789999999998875 6677664432
Q ss_pred C---EEEEEEeecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 220 A---YRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 220 ~---~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
. ..++|||++++ .+|.+++... +++.. .+.+++.+|.+||++ ||+||||||.|||++.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6999888532 34443 356889999999999 9999999999999999899999
Q ss_pred ecccCccccc
Q 018991 296 SDFGLAKLLC 305 (348)
Q Consensus 296 ~DFGla~~~~ 305 (348)
+|||.+....
T Consensus 184 IDfg~~~~~~ 193 (239)
T PRK01723 184 IDFDRGELRT 193 (239)
T ss_pred EECCCcccCC
Confidence 9999987643
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.8e-18 Score=167.31 Aligned_cols=153 Identities=25% Similarity=0.330 Sum_probs=110.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|...+.|..|+||.||..+++ +.+.+|+| +.+.+. +.+ .++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilR--nilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILR--NILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhh--ccccccCCccee------------------
Confidence 345667789999999999999976 46778885 322211 110 033333445444
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC--
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-- 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~-- 306 (348)
||-...++.- ++++.+. +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++...-
T Consensus 136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 5555555422 3444322 5689999998 999999999999999999999999999875311
Q ss_pred ------------CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ------------ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ------------~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........++||+.|.|||+ |||++|+++||.+.|++||-
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpff 259 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 259 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeecc
Confidence 01223345799999999995 99999999999999999984
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=5.5e-16 Score=147.43 Aligned_cols=142 Identities=27% Similarity=0.431 Sum_probs=114.4
Q ss_pred HhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018991 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (348)
Q Consensus 201 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl 280 (348)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+... ...+.+.....++.+++.||.|||.. +--.|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 45689999999999999999999999999999999999753 35688888999999999999999986 22389999
Q ss_pred CCCCEEECCCCceEEecccCcccccCCCc-ccccccccCCCcccce-----------------eccchHHHHHHHHHhcc
Q 018991 281 KSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFI-----------------VQVSPLFILLYILLSVR 342 (348)
Q Consensus 281 kp~Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~g~ 342 (348)
++.|+++|..+.+||+|||+......... .......-..-|.+|| .||||+|+++||+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 99999999999999999999887642100 0001111222344444 49999999999999999
Q ss_pred CCCCC
Q 018991 343 YNSST 347 (348)
Q Consensus 343 ~Pf~~ 347 (348)
-||..
T Consensus 156 ~~~~~ 160 (484)
T KOG1023|consen 156 GPFDL 160 (484)
T ss_pred Ccccc
Confidence 99974
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=137.95 Aligned_cols=134 Identities=22% Similarity=0.251 Sum_probs=102.1
Q ss_pred CCCCeeeEeeEEEEC---------------------------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHH
Q 018991 205 RHKNLVRLLGYCVEG---------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257 (348)
Q Consensus 205 ~H~nIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 257 (348)
+|||||++.++|.++ ..+|+||.-.+. +|.+++..+ ..+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-----~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-----HRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-----CCchHHHHHHH
Confidence 599999999887541 245899998874 999999654 34556667788
Q ss_pred HHHHHHHHHHHhCCCCCceecCCCCCCEEE--CCCC--ceEEecccCcccccCCC---ccccc--ccccCCCccccee--
Q 018991 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQW--NARVSDFGLAKLLCSER---SYVTT--RVMGTFGYAHFIV-- 326 (348)
Q Consensus 258 ~~i~~aL~yLH~~~~~~ivHrdlkp~Nill--~~~~--~~kl~DFGla~~~~~~~---~~~~~--~~~gt~~y~~pe~-- 326 (348)
.|+++|+.|||.+ +|.|||+|.+|||+ |+|+ .+.|+|||.+-.-.... .|.+. ..-|...-|+||+
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999998 3333 47899999875322211 11111 2345566788884
Q ss_pred --------------ccchHHHHHHHHHhccCCCCC
Q 018991 327 --------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 327 --------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|.|+.|.+.||++...-||-.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 999999999999999999953
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.61 E-value=7.1e-15 Score=141.19 Aligned_cols=142 Identities=22% Similarity=0.227 Sum_probs=98.0
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchH----------------------------------------HHHH
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------------------------------------KEFK 195 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~ 195 (348)
.+.||.|++|.||+|++++|+.||||+......... -++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 367999999999999999999999998855421100 0234
Q ss_pred HHHHHHhcC----CCCCeeeEeeEEE-ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q 018991 196 VEVEVIGRV----RHKNLVRLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-GLAYLHE 269 (348)
Q Consensus 196 ~E~~~l~~l----~H~nIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-aL~yLH~ 269 (348)
+|+..+.++ +|.+-+.+-.++. .....+|||||++|++|.++...... ... ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CCC---HHHHHHHHHHHHHHHHHh
Confidence 455555544 2332233322332 23456899999999999887643211 122 2345555554 4677888
Q ss_pred CCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 270 ~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
. |++|+|++|.||+++.+++++++|||++..+..
T Consensus 276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 7 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.7e-16 Score=155.75 Aligned_cols=189 Identities=24% Similarity=0.276 Sum_probs=147.6
Q ss_pred CCcCceEeecCceEEEEEEEC--CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEe
Q 018991 153 LCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 227 (348)
|.+.+.||+|+|+.|-..... ....+|.|.+.... .........|..+-+.+. |+|++.+++...+.+..++.+|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 444556999999999888753 34556777654332 222334445777767776 9999999999999999999999
Q ss_pred ecCCCCHHHHH-hcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCceecCCCCCCEEECCCC-ceEEecccCcccc
Q 018991 228 YVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~ 304 (348)
|..++++.+.+ .... ...+....-.++.|+..++.|+| .. ++.|+|+||+|.+++..+ ..|++|||+|...
T Consensus 102 ~s~g~~~f~~i~~~~~---~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDS---TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccccccccccCCc---cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999887 3321 13444556778999999999999 77 999999999999999999 9999999999877
Q ss_pred cC-CC-ccccccccc-CCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CS-ER-SYVTTRVMG-TFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~-~~-~~~~~~~~g-t~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .. .......+| ++.|++||. |+||.|+++..|++|..|+-.
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 65 22 233334677 899999884 999999999999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.56 E-value=9.1e-16 Score=143.79 Aligned_cols=113 Identities=24% Similarity=0.384 Sum_probs=96.6
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
.+|+.|++|.-.+|.++|.++.. ....++...+.++.|++.|++| + +.+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 57899999999999999975432 2456777889999999999999 5 899999999999999999999999999
Q ss_pred cccccCCC-----cccccccccCCCcccce----------eccchHHHHHHHHHh
Q 018991 301 AKLLCSER-----SYVTTRVMGTFGYAHFI----------VQVSPLFILLYILLS 340 (348)
Q Consensus 301 a~~~~~~~-----~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~~ 340 (348)
........ ....+.-.||..||+|| +||||||++|+||++
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 87765544 23445578999999999 499999999999997
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.8e-14 Score=140.22 Aligned_cols=146 Identities=17% Similarity=0.131 Sum_probs=95.0
Q ss_pred hcCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcch----------------------------------HH--
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQA----------------------------------EK-- 192 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 192 (348)
-..|+. +.||+|++|.||+|++++ |+.||||......... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 344555 689999999999999876 9999999986542100 01
Q ss_pred ----HHHHHHHHHhcCC----CCCeeeEeeEEEE-CCEEEEEEeecCCCCHHHH--HhcCCCCCCCCCHHHHHHHHHHHH
Q 018991 193 ----EFKVEVEVIGRVR----HKNLVRLLGYCVE-GAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMNIILGTA 261 (348)
Q Consensus 193 ----~~~~E~~~l~~l~----H~nIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~i~ 261 (348)
++.+|+..+.+++ +.+.+.+-.++.+ ....+|||||+.|+++.++ +.....+...+....+..++.|+.
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 1334444444432 3333433333332 3456899999999999875 222211111233333344444443
Q ss_pred HHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEecccCcccccC
Q 018991 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFGLAKLLCS 306 (348)
Q Consensus 262 ~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DFGla~~~~~ 306 (348)
.. |++|+|+||.||+++.++ +++++|||+...+..
T Consensus 278 -------~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -------RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34 999999999999999888 999999999987653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.43 E-value=5.5e-13 Score=111.67 Aligned_cols=130 Identities=19% Similarity=0.145 Sum_probs=94.2
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++ ++++.+. ....++||||++|.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 46889999999999875 67899997644321 22346778888888865554 4555443 33357999999998775
Q ss_pred HHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 236 ~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+.- .. ...++.+++.+|..||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 80 ~~~---------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 420 10 1235678899999999871 11259999999999999 66899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.5e-12 Score=124.21 Aligned_cols=159 Identities=18% Similarity=0.167 Sum_probs=120.3
Q ss_pred ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHH
Q 018991 172 LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251 (348)
Q Consensus 172 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~ 251 (348)
..++.+|.|...............+-+..|+.++||||+++++.+..++..|||+|-+. .|..++++ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 44678888888766655334456677888999999999999999999999999999985 67777754 3355
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCcccce------
Q 018991 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI------ 325 (348)
Q Consensus 252 ~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe------ 325 (348)
.+.--+.||+.||.|||+.+ +++|++|.-..|+++..|+-||++|-++........ .......-..|..|+
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 56667899999999999653 899999999999999999999999987754322111 001111112233333
Q ss_pred --eccchHHHHHHHHHhcc
Q 018991 326 --VQVSPLFILLYILLSVR 342 (348)
Q Consensus 326 --~DiwSlG~il~el~~g~ 342 (348)
.|.|-|||+++|++.|.
T Consensus 182 ~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cchhhhhHHHHHHHHhCcc
Confidence 49999999999999983
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.9e-11 Score=104.19 Aligned_cols=137 Identities=16% Similarity=0.158 Sum_probs=98.4
Q ss_pred ceEeecCceEEEEEEECC-------CcEEEEEEEecCCc----------------------chHHHHH----HHHHHHhc
Q 018991 157 NVIGEGGYGIVYRGILSD-------GTKVAVKNLLNNRG----------------------QAEKEFK----VEVEVIGR 203 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~~----~E~~~l~~ 203 (348)
..||.|--+.||.|...+ +..+|||+.+.... ...+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899997743210 0112222 79999998
Q ss_pred CC--CCCeeeEeeEEEECCEEEEEEeecCCCCHHH-HHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCceecC
Q 018991 204 VR--HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYL-HEGLEPKVVHRD 279 (348)
Q Consensus 204 l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL-H~~~~~~ivHrd 279 (348)
+. .-++++.+++ ...+|||||+.+..+.. .++. ..++......+..+++.+|..+ |.. +++|+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 85 3566677764 44689999998654422 2221 2344556677788999999998 777 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|++.|||+++ +.+.|+|||.+-....
T Consensus 151 Ls~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 151 LSEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCHHHEEEEC-CcEEEEECCCceeCCC
Confidence 9999999974 6899999998876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=3.8e-11 Score=104.76 Aligned_cols=142 Identities=22% Similarity=0.268 Sum_probs=105.8
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCC--CCeeeEeeEEEEC---CEEEEEEeecC
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEG---AYRMLVYEYVD 230 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~---~~~~lv~e~~~ 230 (348)
+.|+.|..+.||++...+|..+++|....... .....+..|.+++..+.+ .++.+++.+.... +..+++|||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 46899999999999986678899998754332 134567889999999875 4467777776553 25689999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--------------------------------------- 271 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--------------------------------------- 271 (348)
|.++.+.+.. ..++......++.+++..|..||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9887665421 23566666777777888887777420
Q ss_pred --------------CCCceecCCCCCCEEECC--CCceEEecccCccc
Q 018991 272 --------------EPKVVHRDVKSSNILLDR--QWNARVSDFGLAKL 303 (348)
Q Consensus 272 --------------~~~ivHrdlkp~Nill~~--~~~~kl~DFGla~~ 303 (348)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999988764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.2e-11 Score=118.27 Aligned_cols=187 Identities=20% Similarity=0.185 Sum_probs=142.5
Q ss_pred CCCcCceEee--cCceEEEEEEE---CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 152 GLCEENVIGE--GGYGIVYRGIL---SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 152 ~~~~~~~lG~--G~fg~V~~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
.+.....+|. |.+|.||.+.. +++..+|+|.-+.. .+.....-.+|..-.+++ .|+|.++.+..+...+..|
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3445577999 99999999885 35788999874322 222223334455555556 4999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK----GLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDF 298 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DF 298 (348)
+-+|+|. .+|..+.+... .-++.........+... ||.++|+. +++|-|+||.||+...+ ..++++||
T Consensus 195 iqtE~~~-~sl~~~~~~~~---~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeecccc-chhHHhhhccc---ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCc
Confidence 9999996 68888876542 23566667777777777 99999998 99999999999999999 88999999
Q ss_pred cCcccccCCCc----ccccccccCCCccccee---------ccchHHHHHHHHHhccCCC
Q 018991 299 GLAKLLCSERS----YVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 299 Gla~~~~~~~~----~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf 345 (348)
|+...+....- .......|..-|++||+ ||+|+|.++.+-.++--++
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence 99988765431 11122357788999995 9999999999988775544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-10 Score=95.64 Aligned_cols=131 Identities=24% Similarity=0.393 Sum_probs=96.6
Q ss_pred eEeecCceEEEEEEECCCcEEEEEEEecCC---cc-----hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR---GQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.+++|+-+.+|.+.+. |.++++|.-.... +. ......+|+.++.+++--.|....=+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999764 4456677432221 11 1235667999999987555544444555677778999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+|-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++..+. +.++||||+..-
T Consensus 82 ~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 998899888643 134566666678889998 999999999999998764 999999999853
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-10 Score=94.60 Aligned_cols=142 Identities=20% Similarity=0.302 Sum_probs=103.6
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCc--------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
...+-||+-+.|+++.+. |+.+.||.-..... -..++..+|+++|.++.--.|.-..-++.+...-.|+||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 467899999999999984 77777885432211 123467789999999875555555555666666789999
Q ss_pred ecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---ceEEecccCccc
Q 018991 228 YVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKL 303 (348)
Q Consensus 228 ~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl~DFGla~~ 303 (348)
|++| .++.+++...... .........++..+-..+.-||.+ +|+|+||..+||++..++ .+.++|||++..
T Consensus 91 ~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9986 4788888654321 112222267788888889999999 999999999999996554 358999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.7e-11 Score=109.21 Aligned_cols=143 Identities=15% Similarity=0.238 Sum_probs=108.3
Q ss_pred HHhcCCCCCeeeEeeEEEECC-----EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018991 200 VIGRVRHKNLVRLLGYCVEGA-----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274 (348)
Q Consensus 200 ~l~~l~H~nIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ 274 (348)
-|.++.|.|||+++.++.+.. +..+++||+..|++.++|++-......+......+|+.||+.||.|||+. .|.
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 355567999999999986543 46789999999999999987555556677778889999999999999996 788
Q ss_pred ceecCCCCCCEEECCCCceEEecccCccc---ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhc
Q 018991 275 VVHRDVKSSNILLDRQWNARVSDFGLAKL---LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSV 341 (348)
Q Consensus 275 ivHrdlkp~Nill~~~~~~kl~DFGla~~---~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g 341 (348)
|+|+++..+-|++..++-+|+.--.-... ...-.........+-++|.+|+. |||++|.+..||..+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888753111100 00001111112345678888884 999999999999887
Q ss_pred cC
Q 018991 342 RY 343 (348)
Q Consensus 342 ~~ 343 (348)
+.
T Consensus 279 Ei 280 (458)
T KOG1266|consen 279 EI 280 (458)
T ss_pred ee
Confidence 65
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.2e-09 Score=102.95 Aligned_cols=169 Identities=18% Similarity=0.190 Sum_probs=126.0
Q ss_pred ceEEEEEE-ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEEEEEeecCC-CCHHHH
Q 018991 164 YGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYVDN-GNLDQW 237 (348)
Q Consensus 164 fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~ 237 (348)
-.+.|++. ..||..|++|++...+.........-++.++++.|+|+|++..++.. +..+++|++|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35788998 45899999999944433332223334678899999999999998873 4567899999886 577776
Q ss_pred HhcCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 238 LHGDV-----------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 238 l~~~~-----------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
--... ......++..++.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 43211 1223567899999999999999999998 999999999999999999999998887766544
Q ss_pred CCcccccccccCCCcccceeccchHHHHHHHHHhccC
Q 018991 307 ERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRY 343 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~DiwSlG~il~el~~g~~ 343 (348)
+. +++--.--..|.=.||.++..|.||.-
T Consensus 446 d~--------~~~le~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------TEPLESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------CcchhHHhhhhHHHHHHHHHHHhhccc
Confidence 43 111111122488899999999999953
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.5e-09 Score=92.18 Aligned_cols=126 Identities=26% Similarity=0.322 Sum_probs=81.8
Q ss_pred EEEEEEECCCcEEEEEEEecCC-------------cc-------------hHHHHHHHHHHHhcCCCC--CeeeEeeEEE
Q 018991 166 IVYRGILSDGTKVAVKNLLNNR-------------GQ-------------AEKEFKVEVEVIGRVRHK--NLVRLLGYCV 217 (348)
Q Consensus 166 ~V~~~~~~~~~~vavK~~~~~~-------------~~-------------~~~~~~~E~~~l~~l~H~--nIv~l~~~~~ 217 (348)
.||.|...+|..+|+|..+... .. ......+|.+.|.++..- ++++++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999774421 00 012456799999999765 56677654
Q ss_pred ECCEEEEEEeecC--CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 218 EGAYRMLVYEYVD--NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY-LHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 218 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~y-LH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
.. ..|||||++ |..+..+.... ++......++.+++..+.. +|.. +|+|+||.+.|||++++ .+.
T Consensus 79 ~~--~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 79 NR--NVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ET--TEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred eC--CEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 23 369999998 65555443221 1123345566777775655 4676 99999999999999988 999
Q ss_pred EecccCccccc
Q 018991 295 VSDFGLAKLLC 305 (348)
Q Consensus 295 l~DFGla~~~~ 305 (348)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.05 E-value=7.9e-11 Score=112.67 Aligned_cols=185 Identities=18% Similarity=0.137 Sum_probs=136.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC--CCcEEEEEEEecCCcchHHH--HHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNRGQAEKE--FKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
....+|.....||.|.|+.|+.+..+ ++..+++|.+.+.......+ -..|+.+...+ .|.++++++..+......
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 34556777889999999999998744 67889999887664333322 23355555555 599999988888777778
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLA 301 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla 301 (348)
|+-.|||.++++..... -...+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||+.
T Consensus 342 ~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~ 414 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCW 414 (524)
T ss_pred cCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccc
Confidence 89999999998876652 124567778889999999999999987 99999999999999876 88899999988
Q ss_pred ccccCCCcccccccccCCCcc--cce----------eccchHHHHHHHHHhccC
Q 018991 302 KLLCSERSYVTTRVMGTFGYA--HFI----------VQVSPLFILLYILLSVRY 343 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~--~pe----------~DiwSlG~il~el~~g~~ 343 (348)
..+.-.. .....+.++. ++. +|++|||.-+++.+++..
T Consensus 415 t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 415 TRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred cccceec----ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 6432111 1112222222 222 499999999999988743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.5e-11 Score=122.25 Aligned_cols=188 Identities=18% Similarity=0.146 Sum_probs=131.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.+.+-+-+|+++.++.+.-. .|...++|..... .....+....+-.++-...||.++.....+......+|+++|
T Consensus 806 ~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~ 885 (1205)
T KOG0606|consen 806 FEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHY 885 (1205)
T ss_pred ceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHH
Confidence 344455778888888877633 3433344432111 111122233344444444567777766666677788999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC--
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-- 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~-- 306 (348)
+.+++|...|+.. .+.+..-....+..+..+++|||.. .+.|+|++|.|+|...++..+++|||+.....-
T Consensus 886 ~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 886 LNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred hccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999998754 3455555566677788899999987 689999999999999999999999984332110
Q ss_pred ----C---------------C---------cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ----E---------------R---------SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ----~---------------~---------~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. . ......+.||+.|.+||. |+|++|++++|.++|.+||..
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0 011223679999999994 999999999999999999963
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.04 E-value=6.9e-09 Score=93.21 Aligned_cols=141 Identities=16% Similarity=0.097 Sum_probs=98.9
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcc-hH----------HHHHHHHHHHhcCCCCC--eeeEeeEEEE-----
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-AE----------KEFKVEVEVIGRVRHKN--LVRLLGYCVE----- 218 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~H~n--Iv~l~~~~~~----- 218 (348)
+.+-+.....|++..+ +|+.+.||......-. .. ..+.+|...+.+|..-+ .+...++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455445555777666 5778999966332210 11 13678888887774333 3344445443
Q ss_pred CCEEEEEEeecCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-------C
Q 018991 219 GAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-------Q 290 (348)
Q Consensus 219 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-------~ 290 (348)
....++|+|++++. +|.+++..... .+........++.+++..+.-||.. ||+|+|+++.|||++. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~--~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT--NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence 23578999999986 89998853211 2345666778999999999999999 9999999999999975 4
Q ss_pred CceEEecccCccc
Q 018991 291 WNARVSDFGLAKL 303 (348)
Q Consensus 291 ~~~kl~DFGla~~ 303 (348)
..+.++||+.++.
T Consensus 182 ~~~~LIDl~r~~~ 194 (268)
T PRK15123 182 LKLSVIDLHRAQI 194 (268)
T ss_pred ceEEEEECCcccc
Confidence 6899999998864
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.5e-08 Score=87.65 Aligned_cols=146 Identities=23% Similarity=0.208 Sum_probs=98.4
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc----------------------hHHHHHHHHHH
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ----------------------AEKEFKVEVEV 200 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~ 200 (348)
+..+.....-..+++.||-|--+.||.|....|.++|||.=+..... .....++|.+.
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 34443333334566889999999999999888999999954222100 11245679999
Q ss_pred HhcCCCC--CeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceec
Q 018991 201 IGRVRHK--NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278 (348)
Q Consensus 201 l~~l~H~--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHr 278 (348)
|.+|... .+++.+++ +...+||||++|-.|...- +.....-.++..|+.-+.-+-.. ||||+
T Consensus 163 L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHG 226 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHG 226 (304)
T ss_pred HHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---Ccccc
Confidence 9988654 67776654 5567999999986665431 11112223333333434433344 99999
Q ss_pred CCCCCCEEECCCCceEEecccCcccc
Q 018991 279 DVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 279 dlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|+.+-||+++++|.+.++||--+...
T Consensus 227 DlSefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 227 DLSEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred CCchheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999999766544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.9e-07 Score=80.95 Aligned_cols=107 Identities=21% Similarity=0.203 Sum_probs=81.4
Q ss_pred HHHHHHHHHHhcCC--CCCeeeEeeEEEEC----CEEEEEEeecCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHH
Q 018991 192 KEFKVEVEVIGRVR--HKNLVRLLGYCVEG----AYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264 (348)
Q Consensus 192 ~~~~~E~~~l~~l~--H~nIv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL 264 (348)
....+|...+..|. .-..++.+++.... ...++|+|++++. +|.+++.... ..+......++.+++..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARLI 131 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHHH
Confidence 35667777776664 23345556665542 2458999999874 7999986531 145566778899999999
Q ss_pred HHHHhCCCCCceecCCCCCCEEECCCC---ceEEecccCccccc
Q 018991 265 AYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLLC 305 (348)
Q Consensus 265 ~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl~DFGla~~~~ 305 (348)
.-||.. +|+|+|+++.|||++.+. .+.++||+-++...
T Consensus 132 ~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 132 AKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999 999999999999999887 89999999887643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.69 E-value=4.5e-07 Score=77.80 Aligned_cols=139 Identities=17% Similarity=0.152 Sum_probs=101.3
Q ss_pred EeecCceEEEEEEECCCcEEEEEEEecCC------cchHHHHHHHHHHHhcCCCC--CeeeEeeEEEE----CCEEEEEE
Q 018991 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR------GQAEKEFKVEVEVIGRVRHK--NLVRLLGYCVE----GAYRMLVY 226 (348)
Q Consensus 159 lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~----~~~~~lv~ 226 (348)
-|+|+.+-|++-.+. |..+-+|.-.+.. +.....|.+|...|.++..- .+++....... .-..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467888889987764 4468888764221 23456789999999888533 24444422211 12468999
Q ss_pred eecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--eEEecccCccc
Q 018991 227 EYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~--~kl~DFGla~~ 303 (348)
|-+++ -+|.+++... ...+.+......++.+++..+.-||+. ++.|+|+.+.||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 5898888543 123567777788999999999999999 9999999999999986666 99999977664
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=98.67 E-value=1.3e-08 Score=103.38 Aligned_cols=71 Identities=13% Similarity=0.052 Sum_probs=55.1
Q ss_pred eecCCCCC-CEEECCCCceEEecccCcccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHhccC
Q 018991 276 VHRDVKSS-NILLDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRY 343 (348)
Q Consensus 276 vHrdlkp~-Nill~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~ 343 (348)
.|++.+|. |++++.+...++.|||.++....... .......||+.|++||+ |||||||+||||++|++
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~ 578 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIP 578 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 35566666 66777777789999999887643221 22334689999999994 99999999999999999
Q ss_pred CCC
Q 018991 344 NSS 346 (348)
Q Consensus 344 Pf~ 346 (348)
||.
T Consensus 579 pf~ 581 (669)
T cd05610 579 PFN 581 (669)
T ss_pred CCC
Confidence 995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.1e-07 Score=92.56 Aligned_cols=141 Identities=18% Similarity=0.194 Sum_probs=90.4
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchH------------------------------H----------HHHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE------------------------------K----------EFKV 196 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 196 (348)
+.|+.++-|.||+|++++|+.||||+...+-.... + ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999998865421100 0 1233
Q ss_pred HHHHHhcCC-----CCCeeeEeeEEE-ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018991 197 EVEVIGRVR-----HKNLVRLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270 (348)
Q Consensus 197 E~~~l~~l~-----H~nIv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~ 270 (348)
|+.-+.+++ .|++ ++=.+++ -.+...|+|||++|-.+.+...-.. ...+.+.+.....++..-.-+-|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHHhc--
Confidence 444444432 3332 2222232 2455689999999988887742111 12333333333332222222223
Q ss_pred CCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 271 ~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
+++|.|..|.||+++.++++-+.|||+...+..
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 899999999999999999999999999877654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=6.1e-07 Score=83.17 Aligned_cols=183 Identities=15% Similarity=0.098 Sum_probs=118.7
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEE------EEC-CEEEEEEe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC------VEG-AYRMLVYE 227 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~------~~~-~~~~lv~e 227 (348)
...||+|+-+.+|-.-.- +. .+.|+..........+.. ..|.+. .||-+..=+.+= -++ ...-+.|.
T Consensus 16 gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 16 GRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQAQKV---AELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CccccCCccceeeecchh-hc-hhheeecCCCchHHHHHH---HHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 456999999999954321 12 344766554433322222 223333 566543311110 112 22567777
Q ss_pred ecCCC-CHHHHHhc--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 228 YVDNG-NLDQWLHG--DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
.+.+- ....++.- ++.......|...++.++.++.+..-||.. |-+-+|+.++|+|+.+++.+.|.|=..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceeec
Confidence 77653 23333321 222345678999999999999999999998 9999999999999999999999874332222
Q ss_pred cCCCcccccccccCCCccccee---------------ccchHHHHHHHHHhc-cCCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSV-RYNSSTI 348 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g-~~Pf~~~ 348 (348)
.+...+.. .+|...|.+||. |-|.||+++++|+-| +-||+-|
T Consensus 168 ~ng~~~~c--pVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 168 ANGTLHLC--PVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred cCCceEec--ccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 22222222 368888888883 999999999998887 9999865
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-06 Score=76.05 Aligned_cols=140 Identities=19% Similarity=0.186 Sum_probs=84.9
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC--eeeEeeEEEECCEEEEEEeecCCCC-
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGN- 233 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~g~- 233 (348)
..||+|..+.||+. .+..+++|...... ......+|.+++..+..-. +.+.+++..+.+...++||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 45899999999984 24567788765422 3345788999998886433 4677888877888889999999853
Q ss_pred HHHH---------------------HhcCCCCCCCCCHHHHHHHHHH----------HHH-HHHHHHhC-CCCCceecCC
Q 018991 234 LDQW---------------------LHGDVGDVSPLTWDIRMNIILG----------TAK-GLAYLHEG-LEPKVVHRDV 280 (348)
Q Consensus 234 L~~~---------------------l~~~~~~~~~l~~~~~~~i~~~----------i~~-aL~yLH~~-~~~~ivHrdl 280 (348)
+... ++.-......++.. ...+..+ +.. ...+|... ..+.++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 1111 11100011111100 0001000 001 12222211 1235789999
Q ss_pred CCCCEEECCCCceEEecccCccc
Q 018991 281 KSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 281 kp~Nill~~~~~~kl~DFGla~~ 303 (348)
.|.||++++++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999988763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.5e-06 Score=72.61 Aligned_cols=139 Identities=15% Similarity=0.179 Sum_probs=90.2
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHH---------HHHHHHHhcCCC---CCeeeEeeE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF---------KVEVEVIGRVRH---KNLVRLLGY 215 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~H---~nIv~l~~~ 215 (348)
....+|...+++-......|.+-.. +|..+.+|...+......+.| .+++..+.+++. ...+.++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4566777777887777777776665 468899998765543333222 233333333322 222232333
Q ss_pred EEE-----CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 216 CVE-----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 216 ~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
... ....+++|||++|-.|.++.. +++ .+...+..++.-||.. |+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 222 234568999999988876532 222 2345566788999998 99999999999999865
Q ss_pred CceEEecccCccc
Q 018991 291 WNARVSDFGLAKL 303 (348)
Q Consensus 291 ~~~kl~DFGla~~ 303 (348)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 599999987654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.39 E-value=4.8e-06 Score=72.83 Aligned_cols=144 Identities=23% Similarity=0.269 Sum_probs=83.7
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC--CeeeEeeEEEE---CCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGYCVE---GAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~~~~---~~~~~lv~e~~~~ 231 (348)
+.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++..... ....+++|+++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999876 58999976433 3456777888888887533 35667764433 3457899999999
Q ss_pred CCHHH----------------HH---hcCCCCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHhC
Q 018991 232 GNLDQ----------------WL---HGDVGDVSPLTWDI---------RMNI------------ILGTAK-GLAYLHEG 270 (348)
Q Consensus 232 g~L~~----------------~l---~~~~~~~~~l~~~~---------~~~i------------~~~i~~-aL~yLH~~ 270 (348)
..+.. .+ +.......++.... .... ...+.. .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 87777 11 11100111111110 0000 011122 23333321
Q ss_pred ----CCCCceecCCCCCCEEEC-CCCceEEecccCccc
Q 018991 271 ----LEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKL 303 (348)
Q Consensus 271 ----~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~ 303 (348)
....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 234799999999999999 666678999987753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.8e-06 Score=82.69 Aligned_cols=139 Identities=20% Similarity=0.242 Sum_probs=89.4
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcch-------------------------------HH------HHHHHHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQA-------------------------------EK------EFKVEVE 199 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~E~~ 199 (348)
+.||.-+.|.||+|++++|+.||||.-+..-... .+ +|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999765442110 00 1333433
Q ss_pred HHhc----CCCCC------eeeEeeEEEECCEEEEEEeecCCCCHHHH--HhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018991 200 VIGR----VRHKN------LVRLLGYCVEGAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267 (348)
Q Consensus 200 ~l~~----l~H~n------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL 267 (348)
-..+ +.|-+ |++++-.+ .....|+||||+|..+.|. +.+. .++...+..-+.+...-+-+.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-----gi~~~~i~~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-----GISPHDILNKLVEAYLEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-----CCCHHHHHHHHHHHHHHHHHh
Confidence 3222 33544 44443322 2346899999999876554 3332 244444444444433333333
Q ss_pred HhCCCCCceecCCCCCCEEECC----CCceEEecccCcccccCC
Q 018991 268 HEGLEPKVVHRDVKSSNILLDR----QWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 268 H~~~~~~ivHrdlkp~Nill~~----~~~~kl~DFGla~~~~~~ 307 (348)
| |++|+|-.|.||++.. ++.+.+-|||+...+...
T Consensus 320 ~-----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 320 T-----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred c-----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 3 8999999999999984 678999999999876543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.30 E-value=2.3e-05 Score=68.47 Aligned_cols=155 Identities=20% Similarity=0.209 Sum_probs=99.7
Q ss_pred cchHHHHHHhcCCCcCceEe---ecCceEEEEEEECCCcEEEEEEEecCCcch-------------------HH-----H
Q 018991 141 YTLRELEAATSGLCEENVIG---EGGYGIVYRGILSDGTKVAVKNLLNNRGQA-------------------EK-----E 193 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG---~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~ 193 (348)
.++..+....+...+.+..| .|.-+.||+|...++..+|+|+........ .+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45566666666666555555 455668999987788999999885542110 00 1
Q ss_pred HHHHHHHHhcCC--CCCeeeEeeEEEECCEEEEEEeecCCCC-HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018991 194 FKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270 (348)
Q Consensus 194 ~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~ 270 (348)
..+|..-|.++. +-.+++-+++. ...|||||+.... -.-.|+ ..++.......+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 234666666653 44455555443 2369999986531 111111 11223335667777888888877652
Q ss_pred CCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 271 ~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
.++||+||..-|||+. ++.+.|+|||-|-...++
T Consensus 186 --a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 186 --AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred --cCcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 2999999999999999 789999999988766543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.1e-05 Score=71.78 Aligned_cols=141 Identities=18% Similarity=0.119 Sum_probs=84.2
Q ss_pred EeecCc-eEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecCCCCHHH
Q 018991 159 IGEGGY-GIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236 (348)
Q Consensus 159 lG~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 236 (348)
|-.|.. ..||+.... +..+.+|...... ...+..|++++..+. +--+.+++++....+..++|||+++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444555 778988754 4678888764332 334667888888773 4556788888777677899999999877654
Q ss_pred HH-------------------hcCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHHhC----C
Q 018991 237 WL-------------------HGDVGDVSPLTWD--IRMNIIL--------------------GTAKGLAYLHEG----L 271 (348)
Q Consensus 237 ~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~aL~yLH~~----~ 271 (348)
.. +.-.....++... ....... .+...+..|-.. .
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 31 1110000111100 0000000 011112222111 1
Q ss_pred CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 272 ~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
.+.++|+|+.|.|||++++....|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34689999999999999987788999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.22 E-value=5.4e-05 Score=64.91 Aligned_cols=134 Identities=21% Similarity=0.311 Sum_probs=90.3
Q ss_pred cCceEeecCceEEEEEEECCCcEEEEEEEecCC----------------cchHHHHHHHHHHHhcCC------CCCeeeE
Q 018991 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----------------GQAEKEFKVEVEVIGRVR------HKNLVRL 212 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------H~nIv~l 212 (348)
....||+|+.-.||.- .+.....||++.... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3467999999999864 334557788876554 112345555655544444 8899999
Q ss_pred eeEEEECCEEEEEEeecCC------CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 213 LGYCVEGAYRMLVYEYVDN------GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
+|+.+++...-+|+|.+.+ .+|.+++... .++. .....+. .-..||-+. +|+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L~---~f~~~l~~~---~Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQALD---EFKRYLLDH---HIVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHHH---HHHHHHHHc---CCeecCCCcccEE
Confidence 9999999889999998643 3688888543 2444 3333333 334566666 8999999999999
Q ss_pred ECCC--C--ceEEec-ccCcc
Q 018991 287 LDRQ--W--NARVSD-FGLAK 302 (348)
Q Consensus 287 l~~~--~--~~kl~D-FGla~ 302 (348)
+... + .+.|+| ||-..
T Consensus 151 ~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred EEecCCCceEEEEEeCCCCcc
Confidence 9532 2 577777 44433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.7e-05 Score=82.62 Aligned_cols=78 Identities=13% Similarity=0.293 Sum_probs=56.3
Q ss_pred CceEeecCceEEEEEEECCC---cEEEEEEEecCC-cchHHHHHHHHHHHhcCC-CCCe--eeEeeEEEEC---CEEEEE
Q 018991 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVR-HKNL--VRLLGYCVEG---AYRMLV 225 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-H~nI--v~l~~~~~~~---~~~~lv 225 (348)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.++|+.+. |+++ ++++.++.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 45688999999999886553 467777653322 123356889999999995 6665 7888887664 467899
Q ss_pred EeecCCCC
Q 018991 226 YEYVDNGN 233 (348)
Q Consensus 226 ~e~~~~g~ 233 (348)
|||++|..
T Consensus 123 ME~v~G~~ 130 (822)
T PLN02876 123 MEYLEGRI 130 (822)
T ss_pred EEecCCcc
Confidence 99998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.14 E-value=3.5e-07 Score=88.67 Aligned_cols=171 Identities=16% Similarity=0.091 Sum_probs=119.5
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEEeecCCC-CH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEYVDNG-NL 234 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~~~g-~L 234 (348)
+.+++|+++++++.+-...+....+.+... .....++++|.+++||| .+..++-+..+...+++++++.++ +-
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~ 322 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSS 322 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccc
Confidence 457889999999887433333345544322 34455788999999999 777788888888899999999877 22
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 314 (348)
..... .....+..-+...+.+.-.++++++|+- .-+|+| ||+..+ +..|..||+....+.... ....
T Consensus 323 ~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 323 ALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred cccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 21110 0111233344455666677899999975 458998 777765 688999999988775432 2334
Q ss_pred cccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 315 VMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 315 ~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
..+++.+++||+ |.|+++.--.+|.-|-+|-
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 679999999995 9999998777777666553
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.6e-05 Score=63.84 Aligned_cols=129 Identities=18% Similarity=0.279 Sum_probs=86.1
Q ss_pred cCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCee-eEeeEEEECCEEEEEEeecCCCC
Q 018991 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV-RLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
..+.|++|.+|.||+|.+. |..+|+|.-..+ .....++.|+++|..++-.++. ++|.+.. .++.|||+.|-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 3467999999999999996 458899865433 3456788999999998866654 4444432 245699999988
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCC-CCCEEECCCCceEEecccCcccc
Q 018991 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVK-SSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlk-p~Nill~~~~~~kl~DFGla~~~ 304 (348)
|.+.-.. ....++..++ .. .|.-+. .||-|+.|. |...++..++.+-|+||..|..-
T Consensus 99 L~~~~~~-------~~rk~l~~vl----E~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG-------GDRKHLLRVL----EK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc-------ccHHHHHHHH----HH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8776432 1223333333 23 222222 278888774 55555555669999999988754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.7e-05 Score=67.48 Aligned_cols=104 Identities=22% Similarity=0.255 Sum_probs=78.2
Q ss_pred HHHHHHhcCCC-CCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 018991 196 VEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274 (348)
Q Consensus 196 ~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ 274 (348)
.|.-+|..+++ +++++++|+|- .+++.||...+++...- .........+|..+.+++.+++..++++++...-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 46777888875 69999999982 25789999877554210 00001123689999999999999999999853335
Q ss_pred ceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 275 ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+.-.|++++|+-+++++++|++|....-..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 667999999999999999999999766443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00017 Score=68.44 Aligned_cols=75 Identities=20% Similarity=0.305 Sum_probs=53.7
Q ss_pred ceEeecCceEEEEEEECCC-cEEEEEEEecC-----C--cchHHHHHHHHHHHhcCC---CCCeeeEeeEEEECCEEEEE
Q 018991 157 NVIGEGGYGIVYRGILSDG-TKVAVKNLLNN-----R--GQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv 225 (348)
+.||.|.+..||++...+| +.++||.-... . +...+....|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 4689999999999998776 48999975311 1 223456677888887762 3567788777 44557899
Q ss_pred EeecCCCC
Q 018991 226 YEYVDNGN 233 (348)
Q Consensus 226 ~e~~~~g~ 233 (348)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00018 Score=65.90 Aligned_cols=76 Identities=12% Similarity=0.048 Sum_probs=55.1
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC---CCeeeEeeEEEE---CCEEEEEEeec
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH---KNLVRLLGYCVE---GAYRMLVYEYV 229 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H---~nIv~l~~~~~~---~~~~~lv~e~~ 229 (348)
.+.||.|..+.||+....++ .+.+|..+. ......+..|.+.|+.+.- ..++++++++.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 35699999999999876555 466676432 1123578889999988842 468888887754 36689999999
Q ss_pred CCCCH
Q 018991 230 DNGNL 234 (348)
Q Consensus 230 ~~g~L 234 (348)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98654
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00015 Score=61.97 Aligned_cols=125 Identities=26% Similarity=0.398 Sum_probs=86.5
Q ss_pred cCCCcCceEeecCc-eEEEEEEECCCcEEEEEEEec---CCc------------------chHHHHHHHHHHHhcCC---
Q 018991 151 SGLCEENVIGEGGY-GIVYRGILSDGTKVAVKNLLN---NRG------------------QAEKEFKVEVEVIGRVR--- 205 (348)
Q Consensus 151 ~~~~~~~~lG~G~f-g~V~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 205 (348)
.+++..+.||.|.- |.||+++.. |+.+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 56777889999999 999999984 77999998311 000 01124777888777764
Q ss_pred CCCe--eeEeeEEEEC------------------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH
Q 018991 206 HKNL--VRLLGYCVEG------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265 (348)
Q Consensus 206 H~nI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~ 265 (348)
+.++ |+.+||..-. ....||-||++... .+.. .-+.++.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 4455 8888887422 01246777766532 1222 23456667788
Q ss_pred HHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 266 yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89988 9999999999986 4589999864
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00012 Score=64.77 Aligned_cols=72 Identities=17% Similarity=0.278 Sum_probs=43.8
Q ss_pred ceEeecCce-EEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC---CeeeEeeEEEEC---CEEEEEEeec
Q 018991 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK---NLVRLLGYCVEG---AYRMLVYEYV 229 (348)
Q Consensus 157 ~~lG~G~fg-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~~~---~~~~lv~e~~ 229 (348)
+.|+.|+.. .||+. +..+++|.... ......+..|.+++..+... .+.++++..... ...+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 356766665 58875 23567775433 22345788899988877531 344445443332 2358899999
Q ss_pred CCCCH
Q 018991 230 DNGNL 234 (348)
Q Consensus 230 ~~g~L 234 (348)
+|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 88655
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00035 Score=61.56 Aligned_cols=73 Identities=15% Similarity=0.112 Sum_probs=46.1
Q ss_pred ceEeecCceEEEEEEECC--CcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 157 NVIGEGGYGIVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
+.|..|-...+|+....+ +..|++|....... ...+..+|..++..+. +...+++++... + .++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 457777788999988654 57888996543321 1123346888888774 333445554432 2 48999998865
Q ss_pred H
Q 018991 234 L 234 (348)
Q Consensus 234 L 234 (348)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 4
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00019 Score=64.25 Aligned_cols=139 Identities=14% Similarity=0.104 Sum_probs=76.1
Q ss_pred EeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeecCCCCHHH-
Q 018991 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNGNLDQ- 236 (348)
Q Consensus 159 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~L~~- 236 (348)
+..|-...+|+... ++..+++|..........-....|.++++.+....+ .+++... . -++|+||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccc
Confidence 44567778898874 566788886543322111234678888888754333 3444432 2 368999999865431
Q ss_pred -------------H---HhcCCCCCCCCCHH-HHHHHHHHH---------HHHHHHHHhC-----CCCCceecCCCCCCE
Q 018991 237 -------------W---LHGDVGDVSPLTWD-IRMNIILGT---------AKGLAYLHEG-----LEPKVVHRDVKSSNI 285 (348)
Q Consensus 237 -------------~---l~~~~~~~~~l~~~-~~~~i~~~i---------~~aL~yLH~~-----~~~~ivHrdlkp~Ni 285 (348)
. ++.......++... .+..+..++ ..-+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 11111111122221 111211111 1112222111 123589999999999
Q ss_pred EECCCCceEEecccCccc
Q 018991 286 LLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 286 ll~~~~~~kl~DFGla~~ 303 (348)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.71 E-value=7.1e-06 Score=80.47 Aligned_cols=82 Identities=21% Similarity=0.343 Sum_probs=61.2
Q ss_pred HHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccccc--------ccccCCCcccce-----
Q 018991 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--------RVMGTFGYAHFI----- 325 (348)
Q Consensus 259 ~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~--------~~~gt~~y~~pe----- 325 (348)
+++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+........+... -......|.+||
T Consensus 107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 445899999986 48999999999999999999999999987655442111111 122345677777
Q ss_pred -----eccchHHHHHHHHHhcc
Q 018991 326 -----VQVSPLFILLYILLSVR 342 (348)
Q Consensus 326 -----~DiwSlG~il~el~~g~ 342 (348)
.|++|+|+++|.+..|.
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~g 206 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGG 206 (700)
T ss_pred cccccccceeeeeEEEEEecCC
Confidence 39999999999888443
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0011 Score=60.53 Aligned_cols=143 Identities=17% Similarity=0.176 Sum_probs=82.4
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC--CeeeEee------EEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLG------YCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~------~~~~~~~~~lv~e~ 228 (348)
+.|..|....+|+....+ ..+++|.... .....+..|++++..+.+. .+++++. +....+..++++++
T Consensus 20 ~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 20 EGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred ecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 457777778899887644 4688887643 2334566677777777432 2444443 12334567899999
Q ss_pred cCCCCHHH-----------H---HhcCC---C-C---CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCCC
Q 018991 229 VDNGNLDQ-----------W---LHGDV---G-D---VSPLTWDIRM----------NIILGTAKGLAYLHE----GLEP 273 (348)
Q Consensus 229 ~~~g~L~~-----------~---l~~~~---~-~---~~~l~~~~~~----------~i~~~i~~aL~yLH~----~~~~ 273 (348)
++|..+.. . ++... . . .....|.... .....+..++.++.. ....
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 98865421 0 11100 0 0 0011111110 011112334444443 1234
Q ss_pred CceecCCCCCCEEECCCCceEEecccCccc
Q 018991 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 274 ~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+++|+|+.|.|+++++++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 799999999999999987778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0065 Score=56.14 Aligned_cols=143 Identities=15% Similarity=0.166 Sum_probs=75.5
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC--CCeeeEee------EEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH--KNLVRLLG------YCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~------~~~~~~~~~lv~e~ 228 (348)
+.|+.|....+|+....+| .+++|... . .....+..|..++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4466777778999886555 68888764 2 122333445555555421 12333332 12335667899999
Q ss_pred cCCCCHH-----------HHH---hcCCCC-------CCCCCH-HHHHH------------HHHH-HHHHHHHHHh----
Q 018991 229 VDNGNLD-----------QWL---HGDVGD-------VSPLTW-DIRMN------------IILG-TAKGLAYLHE---- 269 (348)
Q Consensus 229 ~~~g~L~-----------~~l---~~~~~~-------~~~l~~-~~~~~------------i~~~-i~~aL~yLH~---- 269 (348)
++|..+. +.+ +..... ...+.| ..... .+.+ +...++.+..
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9886321 111 111000 001111 11111 1111 1111222221
Q ss_pred CCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 270 ~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
....+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 1245899999999999999765568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0039 Score=57.38 Aligned_cols=144 Identities=17% Similarity=0.180 Sum_probs=80.1
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC--CeeeEeeE------EEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRLLGY------CVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l~~~------~~~~~~~~lv~e~ 228 (348)
+.++.|....+|+....+| .+++|...... ....+..|.+++..|... .+++++.. ....+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4567777778998876544 57788764322 123445566666666322 23444332 1234567899999
Q ss_pred cCCCCHH-----------HH---HhcCCCCC---C-----CCCHHHHH------------HHHHHHHHHHHHHHh----C
Q 018991 229 VDNGNLD-----------QW---LHGDVGDV---S-----PLTWDIRM------------NIILGTAKGLAYLHE----G 270 (348)
Q Consensus 229 ~~~g~L~-----------~~---l~~~~~~~---~-----~l~~~~~~------------~i~~~i~~aL~yLH~----~ 270 (348)
++|..+. .. ++...... . .-.|.... .....+...++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 9874321 11 11110000 0 00111100 001122334555532 1
Q ss_pred CCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 271 ~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
...+++|+|+.+.|+++++++...|+||+.+..
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 245899999999999999887778999998743
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0022 Score=58.83 Aligned_cols=141 Identities=26% Similarity=0.299 Sum_probs=79.5
Q ss_pred eEeecCceEEEEEEECC-------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEEeec
Q 018991 158 VIGEGGYGIVYRGILSD-------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~ 229 (348)
.|..|--..+|+....+ ++.+++|...... ....+...|..++..+.... ..++++++.+ .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 45556667889887654 4789999764432 22234566777777774322 3455555432 3689998
Q ss_pred CCCCHHHH-----------------HhcCCCCC-------CCCCHHHHHHH--------------------------HHH
Q 018991 230 DNGNLDQW-----------------LHGDVGDV-------SPLTWDIRMNI--------------------------ILG 259 (348)
Q Consensus 230 ~~g~L~~~-----------------l~~~~~~~-------~~l~~~~~~~i--------------------------~~~ 259 (348)
+|..+... ++...... .+.-+.....+ ...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 87655321 11111110 01111111111 112
Q ss_pred HHHHHHHHHh------CCCCCceecCCCCCCEEECCC----CceEEecccCccc
Q 018991 260 TAKGLAYLHE------GLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (348)
Q Consensus 260 i~~aL~yLH~------~~~~~ivHrdlkp~Nill~~~----~~~kl~DFGla~~ 303 (348)
+..-+.++-. .....++|+|+.+.|||++++ +.+.++||..|..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334432 123478999999999999985 8899999988864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.00057 Score=62.18 Aligned_cols=143 Identities=19% Similarity=0.118 Sum_probs=92.1
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC---------c-------c------hHHHHHHHHH
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR---------G-------Q------AEKEFKVEVE 199 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---------~-------~------~~~~~~~E~~ 199 (348)
.+..+..-..-+..++.||-|.-+.+|.+-...|.+.++|.-.-.. . . .+-...+|..
T Consensus 83 AlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfa 162 (465)
T KOG2268|consen 83 ALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFA 162 (465)
T ss_pred HHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHH
Confidence 3333333333456788999999999999998889999888421110 0 0 0113456888
Q ss_pred HHhcCC-CCC-eeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCcee
Q 018991 200 VIGRVR-HKN-LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277 (348)
Q Consensus 200 ~l~~l~-H~n-Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivH 277 (348)
.|+.|. |-. +++.+ +.++.++|||++.+-.|.+.-+- .....+..- +..-+.-|-.+ |+||
T Consensus 163 fmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v-------~d~~~ly~~---lm~~Iv~la~~---GlIH 225 (465)
T KOG2268|consen 163 FMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV-------EDPPTLYDD---LMGLIVRLANH---GLIH 225 (465)
T ss_pred HHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec-------CChHHHHHH---HHHHHHHHHHc---Ccee
Confidence 888884 322 33444 34567899999999888765321 111222221 22223334445 9999
Q ss_pred cCCCCCCEEECCCCceEEecccCc
Q 018991 278 RDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 278 rdlkp~Nill~~~~~~kl~DFGla 301 (348)
+|..-=||++++++.++++||--.
T Consensus 226 gDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred cccchheeEEecCCCEEEeechHh
Confidence 999999999999999999999643
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0001 Score=78.46 Aligned_cols=152 Identities=11% Similarity=-0.029 Sum_probs=106.6
Q ss_pred HHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 018991 194 FKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271 (348)
Q Consensus 194 ~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~ 271 (348)
...|...++...|+++.....-..+ ....|..++|+.+|++.+.+-+...+.+++....+.....+...+..-+|++.
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3345556666789998877665543 34568999999999999998765555555554443333333355555555442
Q ss_pred --CCCceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCcccce----------eccchHHHHHHHHH
Q 018991 272 --EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI----------VQVSPLFILLYILL 339 (348)
Q Consensus 272 --~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe----------~DiwSlG~il~el~ 339 (348)
..-.+|+++|+-|.+|..+..+|+.++|+.+....... ......+++.|+.++ .|||..|+-+|++.
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 12368999999999999999999999999995433322 233356677777666 39999999999998
Q ss_pred hccCCCC
Q 018991 340 SVRYNSS 346 (348)
Q Consensus 340 ~g~~Pf~ 346 (348)
-|..||.
T Consensus 1435 ~~n~~fi 1441 (2724)
T KOG1826|consen 1435 DGNAYFI 1441 (2724)
T ss_pred cccHHHH
Confidence 8877763
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.015 Score=52.95 Aligned_cols=73 Identities=18% Similarity=0.228 Sum_probs=46.2
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC---CCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.+.++.|....+|+.. .+++.+.+|.-. ......|..|.+-|+.| .--.+++++++...++..+|+|||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999877 567889999764 22234567787777777 3456788999888777789999998765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0097 Score=53.93 Aligned_cols=32 Identities=28% Similarity=0.399 Sum_probs=26.4
Q ss_pred CCceecCCCCCCEEECCCCc-eEEecccCcccc
Q 018991 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304 (348)
Q Consensus 273 ~~ivHrdlkp~Nill~~~~~-~kl~DFGla~~~ 304 (348)
+.++|+|+.|.|||++++++ .-|.||+.+..-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 35899999999999997555 469999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.014 Score=54.63 Aligned_cols=141 Identities=19% Similarity=0.200 Sum_probs=77.1
Q ss_pred eEeecCceEEEEEEECC-----CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeecCC
Q 018991 158 VIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~ 231 (348)
.|-.|-.-.+|++...+ ++.|++|......... -+...|..++..+..-++ .++++.+.. + .|.||+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~g 117 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIHA 117 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeCC
Confidence 34446667889887532 3678899765433221 123567777777753333 355565532 2 57999877
Q ss_pred CCHHHH-----------------HhcCCCC--CCCCCHHHHHHHHHHH-----------------HHHHHHHH----h-C
Q 018991 232 GNLDQW-----------------LHGDVGD--VSPLTWDIRMNIILGT-----------------AKGLAYLH----E-G 270 (348)
Q Consensus 232 g~L~~~-----------------l~~~~~~--~~~l~~~~~~~i~~~i-----------------~~aL~yLH----~-~ 270 (348)
.+|... ++.-... ..+..+..+..+..++ ...+..|. . .
T Consensus 118 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~ 197 (344)
T PLN02236 118 RTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDD 197 (344)
T ss_pred CCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccC
Confidence 655311 1111100 0112233333332221 11122221 1 1
Q ss_pred CCCCceecCCCCCCEEECC-CCceEEecccCccc
Q 018991 271 LEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKL 303 (348)
Q Consensus 271 ~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~ 303 (348)
....++|+|+++.|||+++ ++.+.++||..+..
T Consensus 198 ~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 198 QEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1236899999999999986 46899999988764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.78 E-value=0.019 Score=53.60 Aligned_cols=79 Identities=16% Similarity=0.225 Sum_probs=50.4
Q ss_pred eEeecCceEEEEEEECCC-cEEEEEEEec-------CCcchHHHHHHHHHHHhcCC--CC-CeeeEeeEEEECCEEEEEE
Q 018991 158 VIGEGGYGIVYRGILSDG-TKVAVKNLLN-------NRGQAEKEFKVEVEVIGRVR--HK-NLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lv~ 226 (348)
.||.|....||++...+| +.|+||.-.. ..+....+...|.+.|.... -| .+++++.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999997654 6899996532 11333445556777776653 23 45666554 455567999
Q ss_pred eecCCC-CHHHHH
Q 018991 227 EYVDNG-NLDQWL 238 (348)
Q Consensus 227 e~~~~g-~L~~~l 238 (348)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998643 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.041 Score=50.48 Aligned_cols=29 Identities=31% Similarity=0.373 Sum_probs=25.5
Q ss_pred CCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 273 ~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.0056 Score=64.12 Aligned_cols=143 Identities=20% Similarity=0.180 Sum_probs=97.8
Q ss_pred HHHHHHHHHhcCCCCCeeeEeeEEEECCEE----EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 018991 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268 (348)
Q Consensus 193 ~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH 268 (348)
....|...+.++.|+|++.++.+...+... .+..|+|..-++...+..- ...+....+.+..++..||.|+|
T Consensus 228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v----~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV----GSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc----cccCHHHHHHHHHHHhhhHHHHH
Confidence 344577788899999999999887654332 2455788888888777532 56778888889999999999999
Q ss_pred hCCCCCceecCCCCC---CEEECCCCceEEe--cccCcccccCCCcccccccccCCCcccce------------eccchH
Q 018991 269 EGLEPKVVHRDVKSS---NILLDRQWNARVS--DFGLAKLLCSERSYVTTRVMGTFGYAHFI------------VQVSPL 331 (348)
Q Consensus 269 ~~~~~~ivHrdlkp~---Nill~~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~y~~pe------------~DiwSl 331 (348)
+. ...|.-+... +--.+.++...++ ||+..+.+......... ..+..+.+++ .|+|.+
T Consensus 304 ~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 304 SL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred Hh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHHH
Confidence 87 5555544444 3444556666666 88888776544322111 1122222333 299999
Q ss_pred HHHHHHHHhccCC
Q 018991 332 FILLYILLSVRYN 344 (348)
Q Consensus 332 G~il~el~~g~~P 344 (348)
|..+..+..|..+
T Consensus 379 gll~~~~~~~~~i 391 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDI 391 (1351)
T ss_pred HHHHhhhhhcCcc
Confidence 9999999888654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.019 Score=53.40 Aligned_cols=140 Identities=16% Similarity=0.172 Sum_probs=93.1
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCC------c----------------chHH----HHHHHHHHHhcCCCCCe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR------G----------------QAEK----EFKVEVEVIGRVRHKNL 209 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~------~----------------~~~~----~~~~E~~~l~~l~H~nI 209 (348)
...|..|--+.||.+...+|..+|||+.+.+- . ..++ -...|++-|++++...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 35677788889999998899999999874321 0 0011 13457778888776554
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCH-HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
...--..... ..|||+|+..... .-.|+ ...++...+..+-.|++.-|.-|.+.+ ++||.||.--|+|+.
T Consensus 229 P~PePIlLk~--hVLVM~FlGrdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 229 PCPEPILLKN--HVLVMEFLGRDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCceeeec--ceEeeeeccCCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 4332222222 3689999964222 11221 134666667777778888888776653 899999999999986
Q ss_pred CCCceEEecccCccccc
Q 018991 289 RQWNARVSDFGLAKLLC 305 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~ 305 (348)
+ |.+.|+|-+-+-...
T Consensus 300 d-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEHD 315 (520)
T ss_pred C-CEEEEEEccccccCC
Confidence 5 689999987665443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.024 Score=52.16 Aligned_cols=32 Identities=34% Similarity=0.524 Sum_probs=28.7
Q ss_pred CCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 273 ~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+.++|+|+.+.|+++++++.+=|.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 46999999999999999988999999998753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.29 E-value=0.072 Score=50.74 Aligned_cols=79 Identities=14% Similarity=0.202 Sum_probs=50.5
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecC-----C--cchHHHHHHHHHHHhcCC---CCCeeeEeeEEEECCEEEEEE
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNN-----R--GQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~ 226 (348)
+.||.|....||+.... +..++||.-... . +....+-..|.+.|..+. ..++++++.++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 56899999999998864 457889976421 1 112233334566665543 3578888888763 457899
Q ss_pred eecCC--CCHHHHH
Q 018991 227 EYVDN--GNLDQWL 238 (348)
Q Consensus 227 e~~~~--g~L~~~l 238 (348)
|++++ ..+.+-+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99976 2344443
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.05 Score=50.50 Aligned_cols=141 Identities=21% Similarity=0.253 Sum_probs=79.9
Q ss_pred EeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC---CCC---eeeEeeEE--EECC--EEEEEEee
Q 018991 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKN---LVRLLGYC--VEGA--YRMLVYEY 228 (348)
Q Consensus 159 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~n---Iv~l~~~~--~~~~--~~~lv~e~ 228 (348)
|.+ .-..+|+...++|+. ++|..... ....++.-|...|..|. .+- +..+=|-. .-.+ +.+-+.+|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 345689888777665 88876544 34556666777777663 221 22221211 1123 67889999
Q ss_pred cCCCCHHH-H--------------Hhc----C----CCCCCCCCHHH----H---------HHHHHHHHHHHHHHHhCC-
Q 018991 229 VDNGNLDQ-W--------------LHG----D----VGDVSPLTWDI----R---------MNIILGTAKGLAYLHEGL- 271 (348)
Q Consensus 229 ~~~g~L~~-~--------------l~~----~----~~~~~~l~~~~----~---------~~i~~~i~~aL~yLH~~~- 271 (348)
++|..+.. . |+. . ........|.. . .....++...+..+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877762 1 111 0 00111223331 0 012233444455554432
Q ss_pred ---CCC---ceecCCCCCCEEECCCCc-eEEecccCccc
Q 018991 272 ---EPK---VVHRDVKSSNILLDRQWN-ARVSDFGLAKL 303 (348)
Q Consensus 272 ---~~~---ivHrdlkp~Nill~~~~~-~kl~DFGla~~ 303 (348)
... +||+|+.|.||+++.+.. +.+.||+-+..
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 123 899999999999998875 89999998753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.064 Score=50.84 Aligned_cols=73 Identities=16% Similarity=0.237 Sum_probs=49.1
Q ss_pred ceEeecCceEEEEEEECC-CcEEEEEEEec------CCcchHHHHHHHHHHHhcCC--CC-CeeeEeeEEEECCEEEEEE
Q 018991 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLN------NRGQAEKEFKVEVEVIGRVR--HK-NLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--H~-nIv~l~~~~~~~~~~~lv~ 226 (348)
+.||-|.-..||++...+ ++.|+||.-.. +.+...++...|.+.|+... -| .+++++.+ ++....+||
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~vM 112 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCVM 112 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHHH
Confidence 468999999999999743 56799996532 12334456666777777653 23 56666655 444557889
Q ss_pred eecCC
Q 018991 227 EYVDN 231 (348)
Q Consensus 227 e~~~~ 231 (348)
|+++.
T Consensus 113 EdL~~ 117 (409)
T PRK12396 113 EDLSD 117 (409)
T ss_pred HhCcc
Confidence 98854
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.18 Score=54.10 Aligned_cols=32 Identities=34% Similarity=0.460 Sum_probs=26.4
Q ss_pred CCCceecCCCCCCEEECCCC--ceE-EecccCccc
Q 018991 272 EPKVVHRDVKSSNILLDRQW--NAR-VSDFGLAKL 303 (348)
Q Consensus 272 ~~~ivHrdlkp~Nill~~~~--~~k-l~DFGla~~ 303 (348)
...+||+|+.+.|||++.++ ++. |+|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 44799999999999999875 555 999998753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.66 E-value=0.11 Score=48.38 Aligned_cols=141 Identities=16% Similarity=0.207 Sum_probs=74.4
Q ss_pred eEeecCceEEEEEEECC----CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeecCCC
Q 018991 158 VIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.|..|=--.+|+....+ +..|.+|........ .-+-.+|..+++.+..-++ +++++++. .+ ++.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCC
Confidence 34445556788886432 237888876443221 1223457777777754444 35565552 22 588888765
Q ss_pred CHHH--------------H---HhcCCCC--CCCCCHHHHHHHHHHH----------------------HHHHHHH---H
Q 018991 233 NLDQ--------------W---LHGDVGD--VSPLTWDIRMNIILGT----------------------AKGLAYL---H 268 (348)
Q Consensus 233 ~L~~--------------~---l~~~~~~--~~~l~~~~~~~i~~~i----------------------~~aL~yL---H 268 (348)
.|.. . ++..... ..+-.+..+..+..++ ..-+..+ .
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 4421 1 1111100 0111233333332221 1111111 1
Q ss_pred -hC-CCCCceecCCCCCCEEECC-CCceEEecccCccc
Q 018991 269 -EG-LEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKL 303 (348)
Q Consensus 269 -~~-~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~ 303 (348)
.. ...-+.|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11 1123689999999999974 57899999988754
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.49 Score=43.94 Aligned_cols=70 Identities=16% Similarity=0.106 Sum_probs=42.3
Q ss_pred CceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC--CeeeE---ee--EEEECCEEEEEEeecCCCC
Q 018991 163 GYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK--NLVRL---LG--YCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 163 ~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~--nIv~l---~~--~~~~~~~~~lv~e~~~~g~ 233 (348)
.-..||+....++..+++|...... ....++..|.+++..|... .++.. -| ....++..+.++++++|..
T Consensus 37 ~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 37 YENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred ccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 3457999887778889999764322 3445666777777666321 12221 11 2233466788999988753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.29 Score=44.98 Aligned_cols=32 Identities=22% Similarity=0.308 Sum_probs=28.3
Q ss_pred CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 272 ~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
..+++|+|+.+.|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.04 E-value=0.08 Score=49.32 Aligned_cols=72 Identities=21% Similarity=0.279 Sum_probs=53.4
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|++|++- |+++.- + .--.+.+...++.+.+.-++-+..+ ...-|||+.-.||||+ +|.+.|+||-+
T Consensus 300 y~yl~~kdh-gt~is~-i-------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 300 YLYLHFKDH-GTPISI-I-------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred EEEEEEecC-Cceeee-e-------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeee
Confidence 456777764 345432 2 1245788888888877666666654 3688999999999999 99999999999
Q ss_pred cccc
Q 018991 301 AKLL 304 (348)
Q Consensus 301 a~~~ 304 (348)
+|.-
T Consensus 368 sRl~ 371 (488)
T COG5072 368 SRLS 371 (488)
T ss_pred eecc
Confidence 9853
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.18 Score=44.99 Aligned_cols=78 Identities=18% Similarity=0.116 Sum_probs=52.6
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec-CCCCHH
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV-DNGNLD 235 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~-~~g~L~ 235 (348)
..+..|..+.|+.++..+|.++++|......... .+.. ....|...+-...|++++.-. ..-.+++|.+ ++.+|.
T Consensus 8 ~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~-~E~~-g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE-HEAR-GEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCCcceEEEEEEcCCCCeEEEEecCCcccch-hhhh-HHhHhheeCCCCceeeecccc--ccchhhhhhccCCCchh
Confidence 4466788999999998899999999765433211 1111 114477777778899988753 3446888988 445676
Q ss_pred HHH
Q 018991 236 QWL 238 (348)
Q Consensus 236 ~~l 238 (348)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.94 E-value=0.37 Score=42.17 Aligned_cols=73 Identities=18% Similarity=0.212 Sum_probs=46.7
Q ss_pred EeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC---CCCCeeeEeeEEEECCEEEEEEeecCCCCHH
Q 018991 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLD 235 (348)
Q Consensus 159 lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~ 235 (348)
+.-|..-..|.... +..++-+|.- .......|..|+.-|..+ +--++.+++.+..+.+..|+||||++-+.+.
T Consensus 24 v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 24 VSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred cCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 43333333444333 3467888743 223345677777655555 4466888899988999999999999875443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.18 Score=43.87 Aligned_cols=102 Identities=17% Similarity=0.152 Sum_probs=64.7
Q ss_pred EEEEEEEecCCcc-hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHH
Q 018991 177 KVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255 (348)
Q Consensus 177 ~vavK~~~~~~~~-~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~ 255 (348)
+..+|++...... ...-+..+.+++.++. .|+++..- +....-+++|+|-.... .. ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hH
Confidence 3456666433322 3445667777777653 46666521 33455689999854211 11 11
Q ss_pred HHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 256 i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
++..=+.+|.-.|+. ..+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 146 ~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 146 FITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhh
Confidence 121114677888965 45899999999999999999999999764
|
The function of this family is unknown. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.04 E-value=0.67 Score=44.05 Aligned_cols=73 Identities=16% Similarity=0.297 Sum_probs=41.6
Q ss_pred eEeecCceEEEEEEECCC--cE-----EEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEEeec
Q 018991 158 VIGEGGYGIVYRGILSDG--TK-----VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 158 ~lG~G~fg~V~~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~~ 229 (348)
.|..|-...+|++...++ .. |.++..- ......-+-.+|.++++.+...+ -.++++.+.. +++.||+
T Consensus 57 ~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efI 131 (383)
T PTZ00384 57 KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWV 131 (383)
T ss_pred EeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEe
Confidence 454577788999875432 22 4443321 11111122355788888885444 4556666532 6899999
Q ss_pred CCCCHH
Q 018991 230 DNGNLD 235 (348)
Q Consensus 230 ~~g~L~ 235 (348)
+|..|.
T Consensus 132 eGr~l~ 137 (383)
T PTZ00384 132 EGNTMG 137 (383)
T ss_pred ccccCC
Confidence 986553
|
|
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=93.99 E-value=0.024 Score=44.40 Aligned_cols=44 Identities=25% Similarity=0.382 Sum_probs=33.4
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~ 203 (348)
+.|+.|+.|.||+|++++|+.||||..+.. ..+.+...+.+|..
T Consensus 17 ~PlasASiaQVh~a~l~~g~~VaVKV~rP~---i~~~i~~Dl~~l~~ 60 (119)
T PF03109_consen 17 EPLASASIAQVHRARLKDGEEVAVKVQRPG---IEEQIEADLRILRR 60 (119)
T ss_pred chhhheehhhheeeeecccchhhhhhcchH---HHHHHHHHHHHHHH
Confidence 579999999999999999999999987443 34445555555543
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 348 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-28 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-27 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-27 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-20 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 9e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-13 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-13 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-13 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-13 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-13 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-13 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-13 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-13 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-13 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-13 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-13 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-13 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-13 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-13 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-13 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-13 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-13 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-12 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-12 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-12 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-12 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-12 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-12 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-12 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-12 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 6e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-12 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-12 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-12 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-12 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 8e-12 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-11 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-11 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-11 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-11 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-11 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-11 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 8e-11 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 9e-11 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-10 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-10 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-10 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-10 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-10 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-10 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-10 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 5e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-10 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-10 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-10 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-10 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-10 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-10 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-10 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-10 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 8e-10 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-10 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-10 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 8e-10 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 8e-10 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 9e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 9e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-09 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-09 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-09 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-09 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 3e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-09 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-09 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 9e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-08 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-08 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-08 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 6e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-08 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-08 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-08 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-08 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-08 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-08 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-08 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-08 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-08 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-08 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-07 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-07 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-07 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-07 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 6e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 6e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-07 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 7e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 8e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 8e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 8e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 9e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 9e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-06 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-06 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 8e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-05 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-05 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-05 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-05 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-05 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-05 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-05 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-05 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-05 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-05 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-05 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-05 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-05 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-05 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-05 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-05 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-05 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-05 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-05 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-05 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-05 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-05 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-05 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-05 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-05 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-05 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-04 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-04 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-120
Identities = 93/193 (48%), Positives = 130/193 (67%), Gaps = 2/193 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DGT VAVK L R Q
Sbjct: 10 PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ 68
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 309 SYVTTRVMGTFGY 321
++VTT V GT G+
Sbjct: 189 THVTTAVRGTIGH 201
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 323 bits (829), Expect = e-110
Identities = 76/217 (35%), Positives = 122/217 (56%), Gaps = 11/217 (5%)
Query: 107 SSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGI 166
S S+ T S + ++ L +LE AT+ + +IG G +G
Sbjct: 2 GSKYSKATNSI-------NDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGK 54
Query: 167 VYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226
VY+G+L DG KVA+K Q +EF+ E+E + RH +LV L+G+C E +L+Y
Sbjct: 55 VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114
Query: 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286
+Y++NGNL + L+G ++W+ R+ I +G A+GL YLH ++HRDVKS NIL
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINIL 171
Query: 287 LDRQWNARVSDFGLAKL-LCSERSYVTTRVMGTFGYA 322
LD + +++DFG++K ++++++T V GT GY
Sbjct: 172 LDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYI 208
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 2e-92
Identities = 71/195 (36%), Positives = 112/195 (57%), Gaps = 16/195 (8%)
Query: 139 RWYTLRELEAATSG------LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----G 188
++ EL+ T+ N +GEGG+G+VY+G + + T VAVK L
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+ +++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPL 130
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE- 307
+W +R I G A G+ +LH E +HRD+KS+NILLD + A++SDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 308 RSYVTTRVMGTFGYA 322
++ +T+R++GT Y
Sbjct: 188 QTVMTSRIVGTTAYM 202
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-66
Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 19/206 (9%)
Query: 128 VGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR 187
+G H G L + L V G +G V++ L VAVK + +
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVK-IFPIQ 58
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----RMLVYEYVDNGNLDQWLHGDVG 243
+ + + EV + ++H+N+++ +G G L+ + + G+L +L
Sbjct: 59 DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--- 115
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHE-------GLEPKVVHRDVKSSNILLDRQWNARVS 296
+ ++W+ +I A+GLAYLHE G +P + HRD+KS N+LL A ++
Sbjct: 116 --NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 297 DFGLAKLLCSERSYV-TTRVMGTFGY 321
DFGLA + +S T +GT Y
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRY 199
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-51
Identities = 53/197 (26%), Positives = 75/197 (38%), Gaps = 29/197 (14%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IG 202
E L +IG G YG VY+G L D VAVK + F E + +
Sbjct: 7 EPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVP 62
Query: 203 RVRHKNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
+ H N+ R + +LV EY NG+L ++L W +
Sbjct: 63 LMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLA 117
Query: 258 LGTAKGLAYLHE------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS----- 306
+GLAYLH +P + HRD+ S N+L+ +SDFGL+ L
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177
Query: 307 --ERSYVTTRVMGTFGY 321
E +GT Y
Sbjct: 178 PGEEDNAAISEVGTIRY 194
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-50
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 6/194 (3%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR-- 187
P +L + +++ L + IG G +G V+R G+ VAVK L+
Sbjct: 16 PTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFH 74
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
+ EF EV ++ R+RH N+V +G + +V EY+ G+L + LH G
Sbjct: 75 AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQ 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
L R+++ AKG+ YLH P +VHR++KS N+L+D+++ +V DFGL++L +
Sbjct: 134 LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-AS 191
Query: 308 RSYVTTRVMGTFGY 321
+ GT +
Sbjct: 192 TFLSSKSAAGTPEW 205
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-47
Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 14/173 (8%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLV 210
L + E G +++G G + VK L + ++F E + H N++
Sbjct: 12 LNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVL 70
Query: 211 RLLGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LG C + L+ ++ G+L LH + + L A+G+A+LH
Sbjct: 71 PVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN--FVVDQSQAVKFALDMARGMAFLH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LEP + + S ++++D AR+S + S+ + M +
Sbjct: 129 -TLEPLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAW 174
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 11/170 (6%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+ E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L
Sbjct: 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKL 66
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G C+ LV EY + G+L LHG + T M+ L ++G+AYLH
Sbjct: 67 YGACLNPVC--LVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123
Query: 273 PKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++HRD+K N+LL ++ DFG A + + T G+ +
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAW 169
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-46
Identities = 52/182 (28%), Positives = 95/182 (52%), Gaps = 23/182 (12%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-------KEFKVEVEVIGRV 204
+ E IG+GG+G+V++G + D + VA+K+L+ + E +EF+ EV ++ +
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H N+V+L G +V E+V G+L L P+ W +++ ++L A G+
Sbjct: 81 NHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDIALGI 135
Query: 265 AYLHEGLEPKVVHRDVKSSNILLD-----RQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
Y+ P +VHRD++S NI L A+V+DFGL++ + + + ++G F
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNF 190
Query: 320 GY 321
+
Sbjct: 191 QW 192
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 53/181 (29%), Positives = 89/181 (49%), Gaps = 21/181 (11%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLL----NNRGQAEKEFKVEVEVIGRVRHKN 208
L E +IG GG+G VYR G +VAVK + Q + + E ++ ++H N
Sbjct: 9 LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++ L G C++ LV E+ G L++ L G + DI +N + A+G+ YLH
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLH 122
Query: 269 EGLEPKVVHRDVKSSNILLDR--------QWNARVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ ++HRD+KSSNIL+ + +++DFGLA+ R+ + G +
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYA 179
Query: 321 Y 321
+
Sbjct: 180 W 180
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 5e-45
Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 7/165 (4%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G+G +G + G + +K L+ + ++ F EV+V+ + H N+++ +G
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + EY+ G L + W R++ A G+AYLH
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDS---QYPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
++HRD+ S N L+ N V+DFGLA+L+ E++
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 4e-44
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 23/183 (12%)
Query: 153 LCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLV 210
+ +G+G YG V+RG G VAVK + EK + E E+ +RH+N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENIL 65
Query: 211 RLLGYCVEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ + + L+ Y + G+L +L ++ L + I+L A GLA+
Sbjct: 66 GFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAH 120
Query: 267 LHEGLE-----PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM---GT 318
LH + P + HRD+KS NIL+ + ++D GLA + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 319 FGY 321
Y
Sbjct: 181 KRY 183
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 54/217 (24%), Positives = 92/217 (42%), Gaps = 35/217 (16%)
Query: 119 ETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKV 178
++ S GSGS P + ++++ IG+G YG V+ G G KV
Sbjct: 17 QSQSSGSGSGLPLLVQ-----RTIAKQIQ-------MVKQIGKGRYGEVWMGKW-RGEKV 63
Query: 179 AVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVEGAYR----MLVYEYVDNG 232
AVK E + E E+ +RH+N++ + ++G L+ +Y +NG
Sbjct: 64 AVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-----GLEPKVVHRDVKSSNILL 287
+L +L + L + + + GL +LH +P + HRD+KS NIL+
Sbjct: 121 SLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 288 DRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGY 321
+ ++D GLA S+ + +GT Y
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-42
Identities = 57/228 (25%), Positives = 96/228 (42%), Gaps = 35/228 (15%)
Query: 108 SGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIV 167
S + + + GSGS P + R + + IG+G +G V
Sbjct: 11 SEGTTLKDLIYDMTTSGSGSGLPLLVQ-----RTIARTIV-------LQESIGKGRFGEV 58
Query: 168 YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVEGAYR--- 222
+RG G +VAVK + E+ + E E+ +RH+N++ + +
Sbjct: 59 WRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114
Query: 223 -MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE-----PKVV 276
LV +Y ++G+L +L+ +T + + + L TA GLA+LH + P +
Sbjct: 115 LWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGY 321
HRD+KS NIL+ + ++D GLA S +GT Y
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-41
Identities = 47/209 (22%), Positives = 78/209 (37%), Gaps = 20/209 (9%)
Query: 124 GSGSVGPEVSHLGWGRW-----YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKV 178
G +S + R L+E + L +IG+G +G VY G +V
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EV 58
Query: 179 AVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQ 236
A++ + R K FK EV + RH+N+V +G C+ + ++ L
Sbjct: 59 AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 237 WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296
+ L + I KG+ YLH ++H+D+KS N+ D ++
Sbjct: 119 VVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVIT 171
Query: 297 DFGLAKL----LCSERSYVTTRVMGTFGY 321
DFGL + R G +
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCH 200
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 18/200 (9%)
Query: 125 SGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLL 184
S W E + IG G +G VY+G VAVK L
Sbjct: 4 GHHHHHHGSRDAADDW------EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLN 55
Query: 185 NNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDV 242
Q + FK EV V+ + RH N++ +GY +V ++ + +L LH
Sbjct: 56 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASE 114
Query: 243 GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++I TA+G+ YLH ++HRD+KS+NI L ++ DFGLA
Sbjct: 115 T---KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 303 LLCS-ERSYVTTRVMGTFGY 321
S+ ++ G+ +
Sbjct: 169 EKSRWSGSHQFEQLSGSILW 188
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-31
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 9/166 (5%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G +G V+ G L +D T VAVK+ + +F E ++ + H N+VRL+
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G C + +V E V G+ +L + L + ++ A G+ YL
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+HRD+ + N L+ + ++SDFG+++ ++ Y + +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREE-ADGVYAASGGLRQV 277
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 9e-31
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 43/171 (25%), Positives = 80/171 (46%), Gaps = 13/171 (7%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ +G+G +G V + G VAVK L ++ +++F+ E++++ + +V
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G + LV EY+ +G L +L + + KG+ YL
Sbjct: 88 KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL---LLYSSQICKGMEYLG 144
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G
Sbjct: 145 ---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 48/149 (32%), Positives = 80/149 (53%), Gaps = 7/149 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
C+E A LV E++++G L +L G + T + + L +G+AYL E V
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLE---EACV 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +VSDFG+ + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV 154
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 44/175 (25%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 153 LCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRH 206
L +GEG +G V + G +VAVK+L G + K E+E++ + H
Sbjct: 23 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82
Query: 207 KNLVRLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
+N+V+ G C E L+ E++ +G+L ++L + ++ ++ + KG+
Sbjct: 83 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ---QLKYAVQICKGM 139
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
YL + VHRD+ + N+L++ + ++ DFGL K + +++ Y T +
Sbjct: 140 DYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G V++G+ V +K + + G Q+ + + IG + H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VRLLG C + LV +Y+ G+L + G + P +N + AKG+ YL E
Sbjct: 78 VRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGPQL---LLNWGVQIAKGMYYLEE 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
+VHR++ + N+LL +V+DFG+A LL + +
Sbjct: 134 ---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 13/175 (7%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
P + LG+G W E++ L +G G +G+V G VA+K +
Sbjct: 9 PSTAGLGYGSW----EIDP--KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSM 61
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L
Sbjct: 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQ 121
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ + + + YL + +HRD+ + N L++ Q +VSDFGL++ +
Sbjct: 122 ---LLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-30
Identities = 42/171 (24%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G +G V + G VAVK L ++ + ++F+ E+E++ ++H N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLG 131
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + + G
Sbjct: 132 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-30
Identities = 49/170 (28%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 154 CEENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +G G +G V +G+ VA+K L +E E +++ ++ + +
Sbjct: 13 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VRL+G C A MLV E G L ++L G ++ ++ + G+ YL E
Sbjct: 73 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLEE 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
VHRD+ + N+LL + A++SDFGL+K L ++ SY T R G +
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-30
Identities = 51/169 (30%), Positives = 83/169 (49%), Gaps = 11/169 (6%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E +IG G G V G L VA+K L + ++ +F E ++G+ H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G G M+V EY++NG+LD +L G + + + ++ G G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQ---LVGMLRGVGAGMRYLS-- 168
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ VHRD+ + N+L+D +VSDFGL+++L + T G
Sbjct: 169 -DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 13/171 (7%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G +G V + G VAVK L ++ + ++F+ E+E++ ++H N+V
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 211 RLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK---LLQYTSQICKGMEYLG 162
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ +HRD+ + NIL++ + ++ DFGL K+L ++ Y + G
Sbjct: 163 ---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 14/171 (8%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKN 208
+G+G +G+V RG VAVK L + ++ +A +F EV + + H+N
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+RL G + +V E G+L L G T + A+G+ YL
Sbjct: 83 LIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGT---LSRYAVQVAEGMGYLE 138
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ +HRD+ + N+LL + ++ DFGL + L + +
Sbjct: 139 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 13/170 (7%)
Query: 155 EENVIGEGGYGIVYRGIL---SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G VAVK L N + E E V+ ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VR++G C ++ MLV E + G L+++L + + + ++ + G+ YL E
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYL-E 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 135 --ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 8/159 (5%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G+V G VAVK + +E EF E + + ++ H LV+ G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
C + +V EY+ NG L +L + P + + +G+A+L +
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQ---LLEMCYDVCEGMAFLE---SHQF 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
+HRD+ + N L+DR +VSDFG+ + + + YV++
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYV-LDDQYVSSV 163
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-29
Identities = 51/169 (30%), Positives = 84/169 (49%), Gaps = 11/169 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
+ V+G G +G V G L +K VA+K L + ++ +F E ++G+ H N++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G + M+V EY++NG+LD +L T + ++ G A G+ YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ---FTVIQLVGMLRGIASGMKYLS-- 164
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+ VHRD+ + NIL++ +VSDFGL ++L + T G
Sbjct: 165 -DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 7/150 (4%)
Query: 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L +EF E V+ ++H NLV+LLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HR++ + N L+ +V+DFGL++L+
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLM 368
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-29
Identities = 46/165 (27%), Positives = 79/165 (47%), Gaps = 13/165 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 80 CRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQY---LLNWCVQIAKGMNYLED 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 136 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 51/148 (34%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 26 LQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 216 CVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 137
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 20/163 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +GEG +G V+ + VAVK L A ++F+ E E++ ++H+++
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------HGDVGDVSPLTWDIRMNIIL 258
VR G C EG ++V+EY+ +G+L+++L G+ PL + +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
A G+ YL VHRD+ + N L+ + ++ DFG++
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 11/171 (6%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKN 208
L + +G G +G V +G+ VA+K L +E E +++ ++ +
Sbjct: 338 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPY 397
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+VRL+G C A MLV E G L ++L G ++ ++ + G+ YL
Sbjct: 398 IVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSN---VAELLHQVSMGMKYLE 453
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHR++ + N+LL + A++SDFGL+K L ++ SY T R G +
Sbjct: 454 E---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 48/172 (27%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 156 ENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNL 209
+GEG +G V G VAVK L + G Q +K E++++ + H+++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 210 VRLLGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
++ G C + LV EYV G+L +L ++ L + +G+AYL
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYL 150
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
H +HRD+ + N+LLD ++ DFGLAK + Y R G
Sbjct: 151 HA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS 199
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 51/148 (34%), Positives = 71/148 (47%), Gaps = 9/148 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 198 LQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGV 254
Query: 216 CVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGR--SVLGGDCLLKFSLDVCEAMEYLEG---NN 309
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 310 FVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 9/164 (5%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEF-KVEVEVIGRVRHKNLVRLLG 214
IGEG +G DG + +K + ++ E+E + EV V+ ++H N+V+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E +V +Y + G+L + ++ G D ++ + L ++H+ K
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRINAQKG--VLFQEDQILDWFVQICLALKHVHD---RK 145
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
++HRD+KS NI L + ++ DFG+A++L S + GT
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GT 188
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-28
Identities = 53/170 (31%), Positives = 89/170 (52%), Gaps = 12/170 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNL 209
+ VIG G +G VY+G+L + VA+K L + ++ +F E ++G+ H N+
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+RL G + M++ EY++NG LD++L G+ S L + ++ G A G+ YL
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQ---LVGMLRGIAAGMKYLA- 164
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
VHRD+ + NIL++ +VSDFGL+++L + T G
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-28
Identities = 44/149 (29%), Positives = 83/149 (55%), Gaps = 7/149 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+ G + TKVAVK+ L + F E ++ +++H+ LVRL
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKVAVKS-LKQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ ++ EY++NG+L +L G LT + +++ A+G+A++ E
Sbjct: 77 VTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD++++NIL+ + +++DFGLA+L+
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI 159
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-28
Identities = 36/165 (21%), Positives = 72/165 (43%), Gaps = 8/165 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
IG G + VYR L DG VA+K + + + + E++++ ++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+E +V E D G+L + + + + L ++H
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---R 155
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+V+HRD+K +N+ + ++ D GL + S+ + + V GT
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GT 199
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+G G +G VY G +S +VAVK L + ++ +F +E +I + H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLA 265
+VR +G ++ R ++ E + G+L +L S L +++ A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAK 302
YL E +HRD+ + N LL RV DFG+A+
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-28
Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 7/150 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++ +G G YG VY G+ VAVK L +EF E V+ ++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
C ++ E++ GNL +L ++ + + + + + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNR--QEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM 161
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-28
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + + A+K + + + +F E+EV+ ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNIIL 258
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 9e-28
Identities = 38/171 (22%), Positives = 77/171 (45%), Gaps = 22/171 (12%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK 207
+G+G + +++G+ T+V +K L + F ++ ++ HK
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+LV G CV G +LV E+V G+LD +L + ++ L ++ + A + +L
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW---KLEVAKQLAAAMHFL 129
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNAR--------VSDFGLAKLLCSERSY 310
E ++H +V + NILL R+ + + +SD G++ + +
Sbjct: 130 E---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL 177
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 16/159 (10%)
Query: 157 NVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNL 209
+G+G +G+VY G+ T+VA+K + E+ EF E V+ ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL------HGDVGDVSPLTWDIRMNIILGTAKG 263
VRLLG +G +++ E + G+L +L + ++P + + + A G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 16/160 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+G G +G VY G +S +VAVK L + ++ +F +E +I + H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLA 265
+VR +G ++ R ++ E + G+L +L S L +++ A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARV---SDFGLAK 302
YL E +HRD+ + N LL RV DFG+A+
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-27
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 331 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVERM---NY 384
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 422
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-27
Identities = 47/158 (29%), Positives = 81/158 (51%), Gaps = 7/158 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 248 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 339
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 8/166 (4%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEGG+ V L DG A+K +L + Q +E + E ++ H N++RL+
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVA 93
Query: 215 YCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
YC+ L+ + G L + + LT D + ++LG +GL +H
Sbjct: 94 YCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA- 152
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM 316
HRD+K +NILL + + D G C +
Sbjct: 153 --KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALT 196
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 39/149 (26%), Positives = 76/149 (51%), Gaps = 7/149 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G G +G V+ + TKVAVK + + + F E V+ ++H LV+L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ ++ E++ G+L +L D G S ++ A+G+A++ +
Sbjct: 252 VTKEPI-YIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQ---RNY 305
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD++++NIL+ +++DFGLA+++
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI 334
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 21/164 (12%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+ +GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNII 257
V+ G C +G ++V+EY+ +G+L+++L L ++I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
A G+ YL VHRD+ + N L+ ++ DFG++
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 5e-27
Identities = 41/164 (25%), Positives = 72/164 (43%), Gaps = 13/164 (7%)
Query: 156 ENVIGEGGYGIVYRGIL----SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
++GEG +G VY G+ + VAVK + +++F E ++ + H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + LT + L K +AYL
Sbjct: 77 KLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLT---LVLYSLQICKAMAYLES- 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
VHRD+ NIL+ ++ DFGL++ + + Y
Sbjct: 132 --INCVHRDIAVRNILVASPECVKLGDFGLSRYI-EDEDYYKAS 172
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 6e-27
Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + + + + L AKG+ YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKYLAS 146
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 12/163 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K ++F E + + H ++V
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + + + LAYL
Sbjct: 80 KLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLAS---LILYAYQLSTALAYLES- 134
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ VHRD+ + N+L+ ++ DFGL++ + Y +
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 175
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 8/172 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE--G 270
++ L V EY + G+L + + L + + ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ T V GT Y
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYM 183
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-26
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 16/168 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEK-EFKVEVEVIGRVRHKNL 209
++GEG +G V G L KVAVK + L+N Q E EF E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 210 VRLLGYCVEG-----AYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK 262
+RLLG C+E M++ ++ G+L +L + + ++ A
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
G+ YL +HRD+ + N +L V+DFGL+K + S Y
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY 203
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKN 208
+GE +G VY+G L VA+K L + G +EF+ E + R++H N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMNI 256
+V LLG + +++ Y +G+L ++L D S L +++
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ A G+ YL VVH+D+ + N+L+ + N ++SD GL + + + Y
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLL 187
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-26
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 13/165 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + + + + L AKG+ +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD---LIGFGLQVAKGMKFLAS 210
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
K VHRD+ + N +LD ++ +V+DFGLA+ + ++ + +
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM-YDKEFDSVH 251
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 45/191 (23%), Positives = 72/191 (37%), Gaps = 32/191 (16%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEF 194
GR+ IG G + VY+G+ +VA + F
Sbjct: 25 GRFLKFDIE------------IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRF 72
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRM----LVYEYVDNGNLDQWL--HGDVGDVSPL 248
K E E++ ++H N+VR LV E + +G L +L +
Sbjct: 73 KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------VM 126
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSE 307
+ + KGL +LH P ++HRD+K NI + + ++ D GLA L
Sbjct: 127 KIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--R 183
Query: 308 RSYVTTRVMGT 318
S+ V+GT
Sbjct: 184 ASFAKA-VIGT 193
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 42/180 (23%), Positives = 76/180 (42%), Gaps = 18/180 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 216 CVEG---------AYRMLVY---EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
+E + ++ +Y + NL W++G + + ++I L A+
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEA 130
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+ +LH ++HRD+K SNI +V DFGL + + T H
Sbjct: 131 VEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 44/168 (26%), Positives = 83/168 (49%), Gaps = 13/168 (7%)
Query: 153 LCEENVIGEGGYGIVYRGILSDG----TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHK 207
+ VIG+G +G+VY G D + A+K+L + F E ++ + H
Sbjct: 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHP 82
Query: 208 NLVRLLGYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L+G + ++ Y+ +G+L Q++ + + ++ L A+G+ Y
Sbjct: 83 NVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL---ISFGLQVARGMEY 139
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
L E K VHRD+ + N +LD + +V+DFGLA+ + +R Y + +
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDI-LDREYYSVQ 183
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 8e-26
Identities = 49/182 (26%), Positives = 78/182 (42%), Gaps = 28/182 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+IG GG+G V++ DG +K + N +AE+E V+ + ++ H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYNGC 72
Query: 216 CVEGAYRM----------------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
Y + E+ D G L+QW+ G L + + +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--EKLDKVLALELFEQ 130
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
KG+ Y+H K+++RD+K SNI L ++ DFGL L + TR GT
Sbjct: 131 ITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL--KNDGKRTRSKGTL 185
Query: 320 GY 321
Y
Sbjct: 186 RY 187
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 36/161 (22%), Positives = 68/161 (42%), Gaps = 17/161 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKE-FKVEVEVIGRVRHKNL 209
++G+G +G V L KVAVK L + ++ E F E + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 210 VRLLGYCVEG------AYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTA 261
+L+G + M++ ++ +G+L +L + L + ++ A
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
G+ YL +HRD+ + N +L V+DFGL++
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 37/163 (22%), Positives = 67/163 (41%), Gaps = 12/163 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDG----TKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K ++F E + + H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L + + + + LAYL
Sbjct: 455 KLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLAS---LILYAYQLSTALAYLES- 509
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+ VHRD+ + N+L+ ++ DFGL++ + Y +
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 550
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-25
Identities = 47/174 (27%), Positives = 77/174 (44%), Gaps = 30/174 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
IGEG +G V++ T VAVK L + +F+ E ++ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPL 248
+V+LLG C G L++EY+ G+L+++L PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ ++ I A G+AYL E K VHRD+ + N L+ +++DFGL++
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-25
Identities = 42/181 (23%), Positives = 78/181 (43%), Gaps = 25/181 (13%)
Query: 156 ENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-R 205
+GEG +G V VAVK L ++ + + + E+E++ + +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNL------------DQWLHGDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL + + +T+
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + + Y T
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216
Query: 314 R 314
Sbjct: 217 T 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-25
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 7/163 (4%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E + + E V G+L L G + +GL YLH+ ++V
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPL-KDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 277 HRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
HRD+K N+L++ ++SDFG +K L T GT
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGT 186
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 30/186 (16%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKN 208
+GEG +G V + T VAVK L N +E + E V+ +V H +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------------HGDVGDVSPL 248
+++L G C + +L+ EY G+L +L D D L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
T ++ ++G+ YL E K+VHRD+ + NIL+ ++SDFGL++ + E
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 309 SYVTTR 314
SYV
Sbjct: 205 SYVKRS 210
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 56/259 (21%), Positives = 103/259 (39%), Gaps = 28/259 (10%)
Query: 81 HHPAPVPEIQVDIGK---IEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGW 137
HH + P + K + +V S +SS + T T S + P ++ +
Sbjct: 8 HHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSE 67
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQ 189
+ E L +GEG +G V VAVK L ++ +
Sbjct: 68 YELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATE 127
Query: 190 AEK-EFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL------------D 235
+ + E+E++ + +HKN++ LLG C + ++ EY GNL +
Sbjct: 128 KDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 187
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
+ +T+ ++ A+G+ YL K +HRD+ + N+L+ ++
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKI 244
Query: 296 SDFGLAKLLCSERSYVTTR 314
+DFGLA+ + + Y T
Sbjct: 245 ADFGLARDINNIDYYKKTT 263
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 6e-24
Identities = 43/185 (23%), Positives = 70/185 (37%), Gaps = 30/185 (16%)
Query: 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVE 197
W T + +G G +G V+R G + AVK + + E E
Sbjct: 58 HWMTHQPR------------VGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEE 100
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN 255
+ + +V L G EG + + E ++ G+L Q + G L D +
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG------CLPEDRALY 154
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTR 314
+ +GL YLH +++H DVK+ N+LL A + DFG A L + +
Sbjct: 155 YLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211
Query: 315 VMGTF 319
Sbjct: 212 TGDYI 216
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-24
Identities = 45/161 (27%), Positives = 71/161 (44%), Gaps = 10/161 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ +H N+V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G ++ E++ G L D+ L + + + LAYLH V+H
Sbjct: 113 VGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIH 164
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
RD+KS +ILL ++SDFG + + + V GT
Sbjct: 165 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GT 204
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-23
Identities = 45/174 (25%), Positives = 78/174 (44%), Gaps = 21/174 (12%)
Query: 156 ENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
+G G +G V KVAVK L + EK E++++ + +H+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL----------HGDVGDVSPLTWDIRMNII 257
N+V LLG C G +++ EY G+L +L S + ++
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
A+G+A+L +HRDV + N+LL A++ DFGLA+ + ++ +Y+
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-23
Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IG+G G VY + ++ G +VA++ + + ++ E+ V+ ++ N+V L +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V EY+ G+L DV + + + + L +LH +V+H
Sbjct: 88 VGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
RD+KS NILL + +++DFG + E+S +T V GT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-23
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 25/178 (14%)
Query: 156 ENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
+G G +G V VAVK L + E+ E++V+ + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--------------HGDVGDVSPLTWDIR 253
N+V LLG C G +++ EY G+L +L D L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
++ AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 148 LSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 23/162 (14%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G +G V + D A+K + + + EV ++ + H+ +VR
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIK-KIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 217 VEGAYRM-------------LVYEYVDNGNLDQWLH-GDVGDVSPLTWDIRMNIILGTAK 262
+E + + EY +NG L +H ++ W + I+
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA--- 128
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
L+Y+H ++HRD+K NI +D N ++ DFGLAK +
Sbjct: 129 -LSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-23
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 15/169 (8%)
Query: 159 IGEGGYGIVYRG---ILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG VY IL KVA+K + + + K F+ EV ++ H+N+V +
Sbjct: 19 LGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ E LV EY++ L +++ PL+ D +N G+ + H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++VHRD+K NIL+D ++ DFG+AK L T V+GT Y
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-23
Identities = 46/179 (25%), Positives = 74/179 (41%), Gaps = 24/179 (13%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHKN 208
+G G +G V + VAVK L +E E++++ + H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 209 LVRLLGYC-VEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIRMN 255
+V LLG C G M++ E+ GNL +L + LT + +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 153 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 45/181 (24%), Positives = 81/181 (44%), Gaps = 25/181 (13%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-R 205
+GEG +G V + TKVAVK L ++ + + + E+E++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL ++L + L+
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y T
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250
Query: 314 R 314
Sbjct: 251 T 251
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 46/183 (25%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 156 ENVIGEGGYGIVYRGILSDG------TKVAVKNLLNNRGQAEK-EFKVEVEVIGRV-RHK 207
V+G G +G V +VAVK L +E+ E++++ ++ H+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-------------------HGDVGDVSPL 248
N+V LLG C L++EY G+L +L + D++ L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
T++ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 309 SYV 311
+YV
Sbjct: 227 NYV 229
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 36/163 (22%), Positives = 73/163 (44%), Gaps = 8/163 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G +G VY+ G A K + + +++ VE+E++ H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGA 84
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ E+ G +D + LT + + L +LH ++
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+HRD+K+ N+L+ + + R++DFG++ + +GT
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGT 180
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 3e-22
Identities = 38/180 (21%), Positives = 72/180 (40%), Gaps = 26/180 (14%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRV-RHKNLV 210
E IG G +G V++ + DG A+K G +++ + EV + +H ++V
Sbjct: 15 ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVV 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
R E + ++ EY + G+L + + +S +++L +GL Y+H
Sbjct: 75 RYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-- 132
Query: 271 LEPKVVHRDVKSSNILLDR-------------------QWNARVSDFGLAKLLCSERSYV 311
+VH D+K SNI + R + ++ D G + S +
Sbjct: 133 -SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 27/174 (15%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL 213
I GG G +Y + +G V +K L+++ + E + + V H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 214 GYCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ +V EYV +L + L + +L L+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199
Query: 269 E-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL V+ D+K NI+L + ++ D G + S + GT G+
Sbjct: 200 SIGL----VYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGF 243
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G V+RG G A+K N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 215 Y--CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 273 PKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+VHR++K NI+ D Q +++DFG A+ L + + GT Y H
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEEYLH 183
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 6e-22
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 11/167 (6%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
V+ EGG+ VY + G + A+K LL+N + + EV + ++ H N+V+
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFC 92
Query: 214 GYCV-------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G L+ + G L ++L + PL+ D + I T + + +
Sbjct: 93 SAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+H +P ++HRD+K N+LL Q ++ DFG A + Y +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWS 197
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 21/171 (12%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLR 113
Query: 214 GY------CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ + Y LV +YV + + L + + LAY+
Sbjct: 114 YFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTR 314
H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 173 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 6e-22
Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 11/163 (6%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G V++GI VA+K + + E E + E+ V+ + + + G
Sbjct: 29 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 88
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ + PL I+ KGL YLH K
Sbjct: 89 YLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE---KK 140
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+HRD+K++N+LL +++DFG+A L + T +GT
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGT 182
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-22
Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G V+RG G A+K N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLFA 74
Query: 215 Y--CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN-- 131
Query: 273 PKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+VHR++K NI+ D Q +++DFG A+ L + + GT Y H
Sbjct: 132 -GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY-GTEEYLH 183
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 20/170 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL- 213
VIG G +G+V++ L + +VA+K +L +K FK E++++ V+H N+V L
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 214 -----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G + + LV EYV + + + + + + LAY+H
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSER---SYVTTR 314
+ HRD+K N+LLD ++ DFG AK+L + SY+ +R
Sbjct: 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSR 205
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 38/171 (22%), Positives = 70/171 (40%), Gaps = 14/171 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 146
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYA 322
+VH D+K +N L+ ++ DFG+A + S V +GT Y
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-21
Identities = 38/171 (22%), Positives = 70/171 (40%), Gaps = 14/171 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 75 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYA 322
+VH D+K +N L+ ++ DFG+A + S V +GT Y
Sbjct: 128 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-21
Identities = 39/175 (22%), Positives = 65/175 (37%), Gaps = 19/175 (10%)
Query: 156 ENVIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
++G GG G VY + VA+K L++ ++ + E GR++ +
Sbjct: 39 RRLVGRGGMGDVYEAEDTVR--ERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + + ++ +L L PL + I+ L H
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 269 E-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
G HRDVK NIL+ A + DFG+A E+ +GT Y
Sbjct: 152 AAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYM 202
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 46/169 (27%), Positives = 81/169 (47%), Gaps = 15/169 (8%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG- 214
++G G YG VY+G + G A+K +++ G E+E K E+ ++ + H+N+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 215 YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ + M LV E+ G++ + G+ L + I +GL++LH+
Sbjct: 90 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN--TLKEEWIAYICREILRGLSHLHQ 147
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
KV+HRD+K N+LL ++ DFG++ L T +GT
Sbjct: 148 ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGT 192
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-21
Identities = 48/164 (29%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG VY+ I G VA+K + +E E+ ++ + ++V+ G
Sbjct: 34 LEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ +V EY G++ + LT D I+ T KGL YLH +
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLHFM---R 145
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+HRD+K+ NILL+ + +A+++DFG+A L + T + GT
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GT 188
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 5e-21
Identities = 37/171 (21%), Positives = 69/171 (40%), Gaps = 14/171 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNL--VRL 212
IG GG V++ + A+K NL Q ++ E+ + +++ + +RL
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + Y +V E N +L+ WL + R + + + +H+
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGYA 322
+VH D+K +N L+ ++ DFG+A + S V +G Y
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 8e-21
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 17/177 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLL-- 213
+G GG+G V R I G +VA+K +E + +E++++ ++ H N+V
Sbjct: 21 RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+L EY + G+L ++L+ + L ++ + L YLHE
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNAR---VSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+++HRD+K NI+L + D G AK L + T V GT Y
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYLA 191
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 8e-21
Identities = 47/165 (28%), Positives = 65/165 (39%), Gaps = 13/165 (7%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRV-RHKNLVRLL 213
+G G YG V++ DG AVK RG ++ K+ EV +V +H VRL
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
EG L E +L Q G + L + T LA+LH
Sbjct: 124 QAWEEGGILYLQTELCG-PSLQQHCE-AWG--ASLPEAQVWGYLRDTLLALAHLHS---Q 176
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+VH DVK +NI L + ++ DFGL L + G
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE-GD 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 38/172 (22%), Positives = 69/172 (40%), Gaps = 17/172 (9%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
E + G+G +G V G G VA+K ++ + +E + ++ + + H N+V+L
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQ- 85
Query: 215 YCV--------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
Y +V EYV + L + + + + +
Sbjct: 86 SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSER---SYVTTR 314
LH V HRD+K N+L++ ++ DFG AK L +Y+ +R
Sbjct: 145 LHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 48/174 (27%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLL-NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++V+G G G + + D VAVK +L A++E ++ E H N++R
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIRYFC 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ ++ + E L +++ D + L + ++ T GLA+LH
Sbjct: 86 TEKDRQFQYIAIELCA-ATLQEYVEQ--KDFAHLGLEPI-TLLQQTTSGLAHLH---SLN 138
Query: 275 VVHRDVKSSNILL-----DRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGY 321
+VHRD+K NIL+ + A +SDFGL K L R + R V GT G+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 46/161 (28%), Positives = 71/161 (44%), Gaps = 11/161 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVRL 212
IG G +G VY + + VA+K + + Q+ ++ EV + ++RH N ++
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + LV EY D PL + G +GLAYLH
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH-- 173
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRDVK+ NILL ++ DFG A ++ S+V T
Sbjct: 174 -NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 213
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-20
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ + A K +LL Q EK +E+ + + H+++V
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + LT + G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHRN- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+V+HRD+K N+ L+ ++ DFGLA + +
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-20
Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 13/157 (8%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY +A+K L L G + + EVE+ +RH N++R
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G + + ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHS-- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
+V+HRD+K N+LL +++DFG + S R
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 90.1 bits (223), Expect = 2e-20
Identities = 29/195 (14%), Positives = 54/195 (27%), Gaps = 38/195 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVR-------- 205
V+G+ G V A K+ K EV + +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 206 -----------------HKNLVRLLG----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGD 244
K ++R+ V + + + + L
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
L R+ + L + LA LH G +VH ++ +I+LD++ ++ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 304 LCSERSYVTTRVMGT 318
+ R
Sbjct: 261 DGASAVSPIGRGFAP 275
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 26/262 (9%), Positives = 54/262 (20%), Gaps = 49/262 (18%)
Query: 89 IQVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWG-RWYTLRELE 147
++ + + E + + + E A + + S L G R L E
Sbjct: 11 MRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVE-- 68
Query: 148 AATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGR 203
+ G +V+ + A+K N + R
Sbjct: 69 ----------PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAAR 118
Query: 204 VRHKNLVRLLGYC--------------------------VEGAYRMLVYEYV--DNGNLD 235
+ ++ A +L+ D L
Sbjct: 119 LLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLF 178
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
L + + A L +VH N+ + +
Sbjct: 179 STLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLML 235
Query: 296 SDFGLAKLLCSERS-YVTTRVM 316
D + +
Sbjct: 236 GDVSALWKVGTRGPASSVPVTY 257
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 4e-20
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 8/172 (4%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L +G G YG+V + + G +AVK + Q +K +++++ R V
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V G + E +D +LD++ + + DI I + K L +LH
Sbjct: 69 VTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ V+HRDVK SN+L++ ++ DFG++ L G Y
Sbjct: 128 --KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDIDAGCKPY 175
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 41/168 (24%), Positives = 69/168 (41%), Gaps = 9/168 (5%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
VIG G +V KVA+K + + Q + E++ + + H N+V
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 216 CVEGAYRMLVYEYVDNGNL----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
V LV + + G++ + L I+ +GL YLH+
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
+HRDVK+ NILL + +++DFG++ L + +V TF
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 4e-20
Identities = 46/168 (27%), Positives = 73/168 (43%), Gaps = 20/168 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG+V++ G VA+K + K E+ ++ +++H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKF---LESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL LV+EY D+ + L V ++ +I T + + + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHL--VK-SITWQTLQAVNFCHKH 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER----SYVTTR 314
+HRDVK NIL+ + ++ DFG A+LL V TR
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 89.5 bits (222), Expect = 4e-20
Identities = 46/186 (24%), Positives = 75/186 (40%), Gaps = 27/186 (14%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG 214
E ++G G G V G VAVK +L + +E++++ H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYC 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM-NIILGTAKGLAYLHEGL 271
+ + E N NL + + L + +++ A G+A+LH
Sbjct: 77 SETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH--- 132
Query: 272 EPKVVHRDVKSSNILLD-------------RQWNARVSDFGLAKLLCSERSYVTTRVM-- 316
K++HRD+K NIL+ +SDFGL K L S +S T +
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 317 -GTFGY 321
GT G+
Sbjct: 193 SGTSGW 198
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-20
Identities = 35/162 (21%), Positives = 63/162 (38%), Gaps = 17/162 (10%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ + A K +LL Q EK +E+ + + H+++V
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVGFH 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + LT + G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRK------ALTEPEARYYLRQIVLGCQYLHR-- 159
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+V+HRD+K N+ L+ ++ DFGLA + +
Sbjct: 160 -NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 44/168 (26%), Positives = 78/168 (46%), Gaps = 20/168 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
++GEG YG+V + G VA+K + + K E++++ ++RH+NLV
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKF---LESDDDKMVKKIAMREIKLLKQLRHENLV 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL C + LV+E+VD+ + L + ++ + G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQV--VQ-KYLFQIINGIGFCHSH 143
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSY---VTTR 314
++HRD+K NIL+ + ++ DFG A+ L + Y V TR
Sbjct: 144 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-20
Identities = 42/167 (25%), Positives = 84/167 (50%), Gaps = 16/167 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVR 211
+G G Y VY+G+ + G VA+K + + +E+ E+ ++ ++H+N+VR
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L LV+E++DN +L +++ L ++ +GLA+ HE
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
K++HRD+K N+L++++ ++ DFGLA+ ++ ++ V
Sbjct: 127 N---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF-SSEV 169
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-20
Identities = 46/166 (27%), Positives = 83/166 (50%), Gaps = 17/166 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG+VY+ G VA+K + R E E E+ ++ + H N+V
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKI---RLDTETEGVPSTAIREISLLKELNHPNIV 65
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+LL LV+E++ +L +++ D ++ + + + + +GLA+ H
Sbjct: 66 KLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
+V+HRD+K N+L++ + +++DFGLA+ R+Y T V
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY-THEV 164
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 8e-20
Identities = 45/175 (25%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 159 IGEGGYGIVYRG---ILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG V+ VAVK L L F+ E + + H +V +
Sbjct: 20 LGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 213 LGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G +V EYVD L +H P+T + +I + L + H
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFSH 133
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT--RVMGTFGY 321
+ ++HRDVK +NI++ +V DFG+A+ + + VT V+GT Y
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 8e-20
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 11/171 (6%)
Query: 153 LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ + +G G G+V++ G +A K + L + + E++V+ +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G + E++D G+LDQ L + I + + KGL YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE- 149
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ K++HRDVK SNIL++ + ++ DFG++ L S + V GT Y
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV-GTRSY 196
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 9e-20
Identities = 44/160 (27%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G + VYR + G +VA+K + G ++ + EV++ +++H +++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQR-VQNEVKIHCQLKHPSILELY 77
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
Y + Y LV E NG ++++L V P + + + + G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMHQIITGMLYLHS---H 131
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRD+ SN+LL R N +++DFGLA L T
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 2e-19
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 17/165 (10%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V
Sbjct: 27 EKVGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVS 83
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L+ LV+E+++ +L + L + + I + +L +G+A+ H+
Sbjct: 84 LIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH- 138
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
+++HRD+K N+L++ +++DFGLA+ RSY T V
Sbjct: 139 --RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEV 180
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-19
Identities = 48/176 (27%), Positives = 76/176 (43%), Gaps = 27/176 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEV------EV-----IGRV 204
IG G YG VY+ G VA+K++ R + EV +
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSV---RVPNGGGGGGGLPISTVREVALLRRLEAF 71
Query: 205 RHKNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
H N+VRL+ C LV+E+VD +L +L D L + +++
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQ 128
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+GL +LH +VHRD+K NIL+ +++DFGLA++ + + T V
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 33/172 (19%), Positives = 70/172 (40%), Gaps = 24/172 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVK-----------------NLLNNRGQAEKEFKVEVEV 200
+ +G + + D A+K N + +FK E+++
Sbjct: 38 TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNI 256
I ++++ + G ++YEY++N ++ ++ D + + I
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCI 156
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
I +Y+H + HRDVK SNIL+D+ ++SDFG ++ + ++
Sbjct: 157 IKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK 206
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 6e-19
Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 18/166 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IGEG YG V++ VA+K + R + E E+ ++ ++HKN+V
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRV---RLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL LV+E+ D +L ++ GD+ P + +L KGL + H
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHSR 120
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
V+HRD+K N+L++R ++++FGLA+ R Y + V
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEV 162
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 7e-19
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 7/172 (4%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L + IG G YG V + + G +AVK + + +K+ ++++V+ R +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+ G + E + + + + +I I L T K L +L E
Sbjct: 84 VQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
K++HRD+K SNILLDR N ++ DFG++ L S TR G Y
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 191
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-19
Identities = 47/168 (27%), Positives = 90/168 (53%), Gaps = 19/168 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKV----EVEVIGRVRHKNLV 210
+ +GEG + VY+ + VA+K + L +R +A+ E++++ + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLH 268
LL + LV+++++ +L+ + + ++P I+ M + L +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPS--HIKAYMLMTL---QGLEYLH 129
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
+ ++HRD+K +N+LLD +++DFGLAK S R+Y T +V
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQV 173
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-18
Identities = 48/165 (29%), Positives = 85/165 (51%), Gaps = 17/165 (10%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVR 211
IGEG YG+VY+ + G A+K + R + E E E+ ++ ++H N+V+
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKI---RLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +LV+E++D +L + L G + +T + +L G+AY H+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR- 119
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
+V+HRD+K N+L++R+ +++DFGLA+ R Y T +
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEI 161
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 40/171 (23%), Positives = 76/171 (44%), Gaps = 24/171 (14%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
+GEG YG VY+ I VA+K + R + E+E EV ++ ++H+N++
Sbjct: 40 TKLGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNII 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L L++EY +N +L +++ ++ + + + G+ + H
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYMD----KNPDVSMRVIKSFLYQLINGVNFCHS- 150
Query: 271 LEPKVVHRDVKSSNILLDRQWNAR-----VSDFGLAKLLCSE-RSYVTTRV 315
+ +HRD+K N+LL + + DFGLA+ R + T +
Sbjct: 151 --RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF-THEI 198
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (208), Expect = 2e-18
Identities = 34/163 (20%), Positives = 54/163 (33%), Gaps = 10/163 (6%)
Query: 157 NVIGEG--GYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG+G V G V V+ NL + + E+ V H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ +V ++ G+ + D + I+ G K L Y+H
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMD--GMNELAIAYILQGVLKALDYIHHM- 147
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
VHR VK+S+IL+ +S + S
Sbjct: 148 --GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVV 188
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 44/162 (27%), Positives = 80/162 (49%), Gaps = 30/162 (18%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLV 210
IG+G +G V++ G KVA+K + + EKE F + E++++ ++H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79
Query: 211 RLLGYCVEGAYRM--------LVYEYVDN---GNLDQWLHGDVGDVSPLTWDIRMNIILG 259
L+ C A LV+++ ++ G L + V T ++
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS---NVLV----KFTLSEIKRVMQM 132
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
GL Y+H K++HRD+K++N+L+ R +++DFGLA
Sbjct: 133 LLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-18
Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 51/216 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG+G + +V R I G + AVK ++ G + ++ K E + ++H ++V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 212 LLGYCVEGAYRMLVYEYVDNGNL-DQWL-HGDVG------DVSPLTWDIRMNIILGTAKG 263
LL +V+E++D +L + + D G S M IL +
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY-----MRQIL---EA 142
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFG 320
L Y H+ ++HRDVK +LL ++ +A V FG+A L RV GT
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPH 198
Query: 321 YAHFIVQVSP----------------LFILLYILLS 340
+ ++P ++L+ILLS
Sbjct: 199 F------MAPEVVKREPYGKPVDVWGCGVILFILLS 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 7e-18
Identities = 43/158 (27%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G+G +G VY + +A+K L L G E + + E+E+ +RH N++R+
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGV-EHQLRREIEIQSHLRHPNILRM 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
Y + L+ E+ G L + L HG + A L Y HE
Sbjct: 80 YNYFHDRKRIYLMLEFAPRGELYKELQKHG------RFDEQRSATFMEELADALHYCHE- 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
KV+HRD+K N+L+ + +++DFG + S R
Sbjct: 133 --RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 9e-18
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 50/211 (23%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLG 214
IG G Y + R I + + AVK + ++ ++ E+E++ R +H N++ L
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKD 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHE 269
+G Y +V E + G L + + S + + I K + YLH
Sbjct: 84 VYDDGKYVYVVTELMKGGELLDKIL-RQKFFSEREASAVLFTI--------TKTVEYLHA 134
Query: 270 GLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
VVHRD+K SNIL D N R+ DFG AK L +E + T T +
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANF---- 186
Query: 326 VQVSP----------------LFILLYILLS 340
V+P L +LLY +L+
Sbjct: 187 --VAPEVLERQGYDAACDIWSLGVLLYTMLT 215
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 1e-17
Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 11/172 (6%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGR-VRHKNL 209
L +G G G V++ G +AVK + + + K ++++V+ + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+ G + + E + P+ I + + K L YL E
Sbjct: 87 VQCFGTFITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE 142
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+ V+HRDVK SNILLD + ++ DFG++ L R G Y
Sbjct: 143 --KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAY 190
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 43/174 (24%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
++GEG YG V + + AVK L E K E++++ R+RHKN+++L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 213 LGYCV----EGAYRMLVYEYVDNGN---LDQWLHGDVGDVSPLTWDIRMN---------- 255
V E +V EY G LD R
Sbjct: 72 --VDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK------------RFPVCQAHGYFCQ 117
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+I GL YLH +VH+D+K N+LL ++S G+A+ L +
Sbjct: 118 LID----GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-17
Identities = 51/174 (29%), Positives = 83/174 (47%), Gaps = 25/174 (14%)
Query: 157 NVIGEGGYGIVYRG--ILSDGTKVAVKNLLNNRGQAEKE-FKV----EVEV---IGRVRH 206
IGEG YG V++ + + G VA+K + R Q +E + EV V + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLETFEH 73
Query: 207 KNLVRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
N+VRL C LV+E+VD +L +L D + + +++
Sbjct: 74 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVPEPGVPTETIKDMMFQLL 130
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+GL +LH +VVHRD+K NIL+ +++DFGLA++ + + T+ V
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVV 180
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 52/211 (24%), Positives = 92/211 (43%), Gaps = 41/211 (19%)
Query: 153 LCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+ + ++G G +G V++ + G K+A K ++ RG +KE K E+ V+ ++ H NL+
Sbjct: 91 VSKTEILGGGRFGQVHKCEETATGLKLAAK-IIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT-WDIR--MNIILGTAKGLAYL 267
+L +LV EYVD G L + + + LT D M I G+ ++
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYNLTELDTILFMKQICE---GIRHM 203
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
H+ ++H D+K NIL + ++ DFGLA+ GT +
Sbjct: 204 HQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEF---- 254
Query: 326 VQVSP----------------LFILLYILLS 340
++P + ++ Y+LLS
Sbjct: 255 --LAPEVVNYDFVSFPTDMWSVGVIAYMLLS 283
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 2e-17
Identities = 46/210 (21%), Positives = 85/210 (40%), Gaps = 44/210 (20%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V + A+K + + + EV V+ + H N+++L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL----HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ + LV E G L + + D + + + +L G+ YLH
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-----IKQVLS---GVTYLH 153
Query: 269 EGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
+ +VHRD+K N+LL ++ +A ++ DFGL+ + E +GT Y
Sbjct: 154 KH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYY---- 204
Query: 326 VQVSP---------------LFILLYILLS 340
++P + ++L+ILL+
Sbjct: 205 --IAPEVLRKKYDEKCDVWSIGVILFILLA 232
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-17
Identities = 44/207 (21%), Positives = 79/207 (38%), Gaps = 43/207 (20%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + + G K + + K E+ ++ ++ H L+ L
Sbjct: 58 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ +L+ E++ G L D+ D +V M GL ++HE
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY-----MRQACE---GLKHMHEH- 168
Query: 272 EPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
+VH D+K NI+ + + + V DFGLA L + T + +
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEF------AA 218
Query: 330 P----------------LFILLYILLS 340
P + +L Y+LLS
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLS 245
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 29/201 (14%), Positives = 69/201 (34%), Gaps = 30/201 (14%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKEFKVE 197
E + + + +++GEG + VY D K +K + EF +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIG 114
Query: 198 VEVIGRVR---HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIR 253
+++ R++ ++ + +LV E G L + + +
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-----------DRQWNARVSDFGLAK 302
++ + + +H+ +++H D+K N +L D + D G +
Sbjct: 175 ISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
Query: 303 LL--CSERSYVTTRVMGTFGY 321
+ + + T + T G+
Sbjct: 232 DMKLFPKGTIFTAKC-ETSGF 251
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-17
Identities = 35/207 (16%), Positives = 81/207 (39%), Gaps = 44/207 (21%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +GIV+R + S K + +G + K E+ ++ RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 217 VEGAYRMLVYEYVDNGNL-DQWLHGDVG----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++++E++ ++ ++ ++ ++ + + L +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVC---EALQFLHSH- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
+ H D++ NI+ + ++ + +FG A+ L ++ + Y +
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEY------YA 171
Query: 330 P----------------LFILLYILLS 340
P L L+Y+LLS
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLS 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 5e-17
Identities = 47/165 (28%), Positives = 81/165 (49%), Gaps = 17/165 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNLVR 211
+ +GEG Y VY+G VA+K + R + E+ EV ++ ++H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L LV+EY+D +L Q+L ++ + + +L +GLAY H
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL---RGLAYCHR-- 118
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRV 315
KV+HRD+K N+L++ + +++DFGLA+ ++Y V
Sbjct: 119 -QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-DNEV 161
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 48/212 (22%), Positives = 84/212 (39%), Gaps = 50/212 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A + + ++ + E + ++H N+VRL
Sbjct: 18 ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYL 267
E + L+++ V G L + + D + IL + +
Sbjct: 78 SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC--------IQQILE---AVLHC 126
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHF 324
H+ VVHR++K N+LL + A V +DFGLA + E+ GT GY
Sbjct: 127 HQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGY--- 179
Query: 325 IVQVSP----------------LFILLYILLS 340
+SP ++LYILL
Sbjct: 180 ---LSPEVLRKDPYGKPVDLWACGVILYILLV 208
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 80.1 bits (197), Expect = 6e-17
Identities = 28/194 (14%), Positives = 54/194 (27%), Gaps = 36/194 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLL---NNRGQAEKEFKVEVEVIGRVR-------- 205
V+G+ G V A K+ K EV + +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 206 -----------------HKNLVRLLG----YCVEGAYRMLVYEYVDNGNLDQWLHGDVGD 244
K ++R+ V + + + + L
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
L R+ + L + LA LH +VH ++ +I+LD++ ++ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 305 CSERSYVTTRVMGT 318
+ +R
Sbjct: 257 GARVVSSVSRGFEP 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 46/210 (21%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G G + V+ G A+K + + + + E+ V+ +++H+N+V L
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LV + V G L + + G D S + + + YLHE
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRIL-ERGVYTEKDASLVIQQV--------LSAVKYLHE 124
Query: 270 GLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
+VHRD+K N+L + N+++ +DFGL+K+ + ++T GT GY
Sbjct: 125 N---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGY----- 173
Query: 327 QVSP----------------LFILLYILLS 340
V+P + ++ YILL
Sbjct: 174 -VAPEVLAQKPYSKAVDCWSIGVITYILLC 202
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 7e-17
Identities = 49/224 (21%), Positives = 87/224 (38%), Gaps = 61/224 (27%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-------------NLLNNRGQAEKEFKVEVEVI 201
+G G YG V + ++ A+K + N + +E E+ ++
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRM 254
+ H N+++L + Y LV E+ + G L + + D ++ M
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI--------M 152
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYV 311
IL G+ YLH+ +VHRD+K NILL ++ ++ DFGL+ + Y
Sbjct: 153 KQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYK 204
Query: 312 TTRVMGTFGYAHFIVQVSP---------------LFILLYILLS 340
+GT Y ++P +++YILL
Sbjct: 205 LRDRLGTAYY------IAPEVLKKKYNEKCDVWSCGVIMYILLC 242
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 38/181 (20%), Positives = 73/181 (40%), Gaps = 30/181 (16%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
+G G G V KVA++ E + + E+E++ ++ H
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG--DVSPLTWDIRMNIILGTAKGL 264
++++ + Y +V E ++ G L + + + + + +
Sbjct: 202 IIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM--------LLAV 252
Query: 265 AYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
YLHE ++HRD+K N+LL + +++DFG +K+L E S + T GT Y
Sbjct: 253 QYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTY 307
Query: 322 A 322
Sbjct: 308 L 308
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 53/215 (24%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ V+G+G +G V G + AVK + + E EV+++ ++ H N++
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKES-LLREVQLLKQLDHPNIM 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKG 263
+L + + Y LV E G L + D + + +L G
Sbjct: 90 KLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI--------IRQVLS---G 138
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ Y+H+ K+VHRD+K N+LL + +A R+ DFGL+ E S +GT
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAY 193
Query: 321 YAHFIVQVSP---------------LFILLYILLS 340
Y ++P ++LYILLS
Sbjct: 194 Y------IAPEVLHGTYDEKCDVWSTGVILYILLS 222
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 45/213 (21%), Positives = 87/213 (40%), Gaps = 50/213 (23%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
++G+G +G V + + AVK N + + + EVE++ ++ H N+++L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLA 265
+ + +V E G L + D + + + G+
Sbjct: 87 FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQVFS---GIT 135
Query: 266 YLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
Y+H+ +VHRD+K NILL ++ + ++ DFGL+ +++ +GT Y
Sbjct: 136 YMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF--QQNTKMKDRIGTAYY- 189
Query: 323 HFIVQVSP---------------LFILLYILLS 340
++P ++LYILLS
Sbjct: 190 -----IAPEVLRGTYDEKCDVWSAGVILYILLS 217
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 45/204 (22%), Positives = 85/204 (41%), Gaps = 33/204 (16%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 221
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ +++YE++ G L + + + + ++ D + + KGL ++HE
Sbjct: 222 AFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---N 275
Query: 275 VVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP-- 330
VH D+K NI+ + + + DFGL L + V GT + +P
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTT-GTAEF------AAPEV 327
Query: 331 --------------LFILLYILLS 340
+ +L YILLS
Sbjct: 328 AEGKPVGYYTDMWSVGVLSYILLS 351
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 34/164 (20%), Positives = 65/164 (39%), Gaps = 30/164 (18%)
Query: 159 IGEGGYGIVYRGI---LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV------RHKNL 209
+G G YG VY+ D A+K + + + + + +H N+
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKHPNV 80
Query: 210 VRLLGYCVEGAYR--MLVYEYVDN---GNLDQWLHGDVGDVS-PLTWDIRMNIILGTAKG 263
+ L + A R L+++Y ++ + L + +++ G
Sbjct: 81 ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKL 303
+ YLH V+HRD+K +NIL+ + R ++D G A+L
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-16
Identities = 36/203 (17%), Positives = 76/203 (37%), Gaps = 53/203 (26%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLL 213
+G G +GIV + G + A+K +L + +K E++++ + H N+++L+
Sbjct: 12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHVNIIKLV 66
Query: 214 GYCVEGAYRM--------------------------------------LVYEYVDNGNLD 235
Y ++ EYV + L
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 236 QWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNAR 294
+ L + + ++ I + + ++H + HRD+K N+L++ + +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLK 182
Query: 295 VSDFGLAKLLCSER---SYVTTR 314
+ DFG AK L +Y+ +R
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSR 205
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 4e-16
Identities = 50/214 (23%), Positives = 82/214 (38%), Gaps = 50/214 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + S G + A K +R +E + EV ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L D + + + + IL G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNY 130
Query: 267 LHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
LH K+ H D+K NI+L D+ ++ DFGLA + + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIF-GTPEF- 184
Query: 323 HFIVQVSP----------------LFILLYILLS 340
V+P + ++ YILLS
Sbjct: 185 -----VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 5e-16
Identities = 44/212 (20%), Positives = 80/212 (37%), Gaps = 50/212 (23%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
+ +GEG + I + + AVK + E + E+ + H N+V+L
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLH 72
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYL 267
+ + LV E ++ G L ++ + S + + ++++
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIK--KKKHFSETEASYIMRKL--------VSAVSHM 122
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYAHF 324
H+ VVHRD+K N+L D N ++ DFG A+L + + T T Y
Sbjct: 123 HDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHY--- 175
Query: 325 IVQVSP----------------LFILLYILLS 340
+P L ++LY +LS
Sbjct: 176 ---AAPELLNQNGYDESCDLWSLGVILYTMLS 204
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 47/203 (23%), Positives = 84/203 (41%), Gaps = 31/203 (15%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+ S G + +K + +R Q E + E+EV+ + H N++++
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ +V E + G L + + L+ ++ LAY H V
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 276 VHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP-- 330
VH+D+K NIL D ++ ++ DFGLA+ L + T GT Y ++P
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHSTNAA-GTALY------MAPEV 197
Query: 331 -------------LFILLYILLS 340
+++Y LL+
Sbjct: 198 FKRDVTFKCDIWSAGVVMYFLLT 220
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 8e-16
Identities = 43/178 (24%), Positives = 71/178 (39%), Gaps = 24/178 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKE----FKVEVEVIGRVRHKN 208
+G G G V KVA+K E + + E+E++ ++ H
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
++++ + Y +V E ++ G L D V L + YL
Sbjct: 77 IIKIKNFFDAEDY-YIVLELMEGGELFD-----KVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 268 HEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
HE ++HRD+K N+LL Q +++DFG +K+L E S + T GT Y
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTPTYL 183
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-16
Identities = 42/176 (23%), Positives = 72/176 (40%), Gaps = 22/176 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-------NLLNNRGQAEKEFKV--EVEVIGRV-RH 206
++G G +V R I + AVK + E EV+++ +V H
Sbjct: 24 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
N+++L + LV++ + G L D + + L+ I+ + +
Sbjct: 84 PNIIQLKDTYETNTFFFLVFDLMKKGELFD-----YLTEKVTLSEKETRKIMRALLEVIC 138
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LH+ +VHRD+K NILLD N +++DFG + L + GT Y
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLREVC-GTPSY 189
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-16
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 47/208 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G IVYR A+K L + +K + E+ V+ R+ H N+++L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV E V G L + + G D + I + +AYLHE
Sbjct: 118 ETPTEISLVLELVTGGELFDRIV-EKGYYSERDAADAVKQI--------LEAVAYLHEN- 167
Query: 272 EPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQV 328
+VHRD+K N+L +A + +DFGL+K++ E + V GT GY
Sbjct: 168 --GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGY------C 217
Query: 329 SP----------------LFILLYILLS 340
+P + I+ YILL
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLC 245
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-16
Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K + + A K+ E + +++H N+VRL
Sbjct: 13 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE-----DIVAREFYSEADASHCIQQILESIAYCHSN--- 124
Query: 274 KVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP 330
+VHR++K N+LL + A V +DFGLA ++ GT GY +SP
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFA-GTPGY------LSP 176
Query: 331 ----------------LFILLYILLS 340
++LYILL
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLV 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-15
Identities = 50/214 (23%), Positives = 83/214 (38%), Gaps = 50/214 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + S G + A K +R +E + EV ++ +V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDV----GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L +L + + + IL G+ Y
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF-----IKQILD---GVNY 130
Query: 267 LHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
LH K+ H D+K NI+L D+ ++ DFGLA + + + GT +
Sbjct: 131 LHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF- 184
Query: 323 HFIVQVSP----------------LFILLYILLS 340
V+P + ++ YILLS
Sbjct: 185 -----VAPEIVNYEPLGLEADMWSIGVITYILLS 213
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 39/206 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K + + + ++ + E + +++H N+VRL
Sbjct: 36 ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE-----DIVAREFYSEADASHCIQQILESIAYCHSN--- 147
Query: 274 KVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP 330
+VHR++K N+LL + A V +DFGLA + ++ GT GY +SP
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGY------LSP 199
Query: 331 ----------------LFILLYILLS 340
++LYILL
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLV 225
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 1e-15
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 33/159 (20%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
+GEG YG V + VAVK +++ + + + E+ + + H+N+V+ G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 216 CVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN----------IILGTAKGL 264
EG + L EY G L D+ + DI M ++ G +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPDAQRFFHQLMAG----V 118
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
YLH + HRD+K N+LLD + N ++SDFGLA +
Sbjct: 119 VYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 74.9 bits (185), Expect = 2e-15
Identities = 47/214 (21%), Positives = 84/214 (39%), Gaps = 50/214 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
+G G + IV + G + A K L ++R +E + EV ++ +RH N++
Sbjct: 12 ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGLAY 266
L +L+ E V G L D + + + + IL G+ Y
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILD---GVHY 123
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA----RVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
LH ++ H D+K NI+L + ++ DFG+A + + + + GT +
Sbjct: 124 LHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEF- 177
Query: 323 HFIVQVSP----------------LFILLYILLS 340
V+P + ++ YILLS
Sbjct: 178 -----VAPEIVNYEPLGLEADMWSIGVITYILLS 206
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 49/209 (23%), Positives = 76/209 (36%), Gaps = 48/209 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V + + A K + + FK E+E++ + H N++RL
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 217 VEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ LV E G L + + D + M +L +AY H+
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI--------MKDVL---SAVAYCHK 124
Query: 270 GLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
V HRD+K N L ++ DFGLA + T+V GT Y
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMMRTKV-GTPYY----- 174
Query: 327 QVSP---------------LFILLYILLS 340
VSP +++Y+LL
Sbjct: 175 -VSPQVLEGLYGPECDEWSAGVMMYVLLC 202
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-15
Identities = 52/279 (18%), Positives = 101/279 (36%), Gaps = 48/279 (17%)
Query: 59 QQQQSKQILNTPPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTGSAC 118
+++ ++I + P +++E + Q E + + + E+ S
Sbjct: 19 RRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMG 78
Query: 119 ETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTK 177
+ E Y ++ VIG G +V R + + G +
Sbjct: 79 PEDELPDWAAAKEFYQK-----YDPKD------------VIGRGVSSVVRRCVHRATGHE 121
Query: 178 VAVK--------NLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEY 228
AVK + + + E ++ +V H +++ L+ ++ LV++
Sbjct: 122 FAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDL 181
Query: 229 VDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
+ G L D + + + M +L + +++LH +VHRD+K
Sbjct: 182 MRKGELFDYLT--EKVALSEKETRSI-----MRSLL---EAVSFLHAN---NIVHRDLKP 228
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
NILLD R+SDFG + L + GT GY
Sbjct: 229 ENILLDDNMQIRLSDFGFSCHL-EPGEKLRELC-GTPGY 265
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 48/167 (28%), Positives = 79/167 (47%), Gaps = 27/167 (16%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYC 216
+G G Y V+ I +++ KV VK L + +K+ K E++++ +R N++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLADIV 100
Query: 217 VEGAYRMLVY--EYVDNGNLDQWLHGDVGDVSPLT-WDIR--MNIILGTAKGLAYLHEGL 271
+ R E+V+N + Q LT +DIR M IL K L Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEIL---KALDYCHSM- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSY---VTTR 314
++HRDVK N+++D + R+ D+GLA+ + Y V +R
Sbjct: 150 --GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASR 194
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 46/160 (28%), Positives = 72/160 (45%), Gaps = 35/160 (21%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEK-EFKV--EVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + + +A + E+ + + H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ EG + L EY G L D+ + DI M ++ G
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDR-----------IEPDIGMPEPDAQRFFHQLMAG---- 117
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+ YLH + HRD+K N+LLD + N ++SDFGLA +
Sbjct: 118 VVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATV 154
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 3e-15
Identities = 45/178 (25%), Positives = 68/178 (38%), Gaps = 30/178 (16%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE--FKV---------EVEVIGRVRH 206
I G YG V G+ S+G VA+K + N E+ ++ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 207 KNLVRLL-------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
N++ L + Y LV E + +L Q +H ++ +
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLY--LVTELMRT-DLAQVIHDQR---IVISPQHIQYFMYH 142
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTR 314
GL LHE VVHRD+ NILL + + DF LA+ ++ + YVT R
Sbjct: 143 ILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR 197
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 45/211 (21%), Positives = 86/211 (40%), Gaps = 50/211 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + + AVK + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWL--HG-----DVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ + +V E G L + D + + + G+ Y+
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI--------IKQVFS---GITYM 137
Query: 268 HEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHF 324
H+ +VHRD+K NILL ++ + ++ DFGL+ + + + R+ GT Y
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRI-GTAYY--- 189
Query: 325 IVQVSP---------------LFILLYILLS 340
++P ++LYILLS
Sbjct: 190 ---IAPEVLRGTYDEKCDVWSAGVILYILLS 217
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 40/158 (25%), Positives = 68/158 (43%), Gaps = 34/158 (21%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
IG+G + V + G +VA+K + + K+ EV ++ + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 216 CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILGTAKG 263
L+ EY G + +L HG RM I+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG------------RMKEKEARSKFRQIVS----A 126
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ Y H+ ++VHRD+K+ N+LLD N +++DFG +
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFS 161
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 75.3 bits (185), Expect = 4e-15
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 30/184 (16%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LG-YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L + + LV E +D NL Q + L + ++ G+ +
Sbjct: 127 LNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKH 179
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTR------VMG 317
LH ++HRD+K SNI++ ++ DFGLA+ + YV TR V+
Sbjct: 180 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 236
Query: 318 TFGY 321
GY
Sbjct: 237 GMGY 240
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 41/164 (25%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V G G KVAVK + + K + E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK-IRREIQNLKLFRHPHIIKL- 81
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EYV G L ++ +G R++ I+
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICKNG------------RLDEKESRRLFQQIL-- 126
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
G+ Y H VVHRD+K N+LLD NA+++DFGL+ +
Sbjct: 127 --SGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNM 165
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-15
Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 41/162 (25%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G G +G V G G KVAVK + + K K E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGK-IKREIQNLKLFRHPHIIKL- 76
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EYV G L ++ HG R+ I+
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYICKHG------------RVEEMEARRLFQQIL-- 121
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ Y H VVHRD+K N+LLD NA+++DFGL+
Sbjct: 122 --SAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLS 158
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 73.7 bits (181), Expect = 6e-15
Identities = 47/245 (19%), Positives = 74/245 (30%), Gaps = 68/245 (27%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG+G YG+V I A+K + + + K EV ++ ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 212 LLGYCVEGAYRMLVYEYVDNGNL-----------DQWLHGDVGDVSPLTWDIRMNIILGT 260
L + Y LV E G+L DV +
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 261 AK-------------------------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
+ L YLH + HRD+K N L + +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 296 --SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP------------------LFILL 335
DFGL+K + + G +F V+P +LL
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF---VAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 336 YILLS 340
++LL
Sbjct: 267 HLLLM 271
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 7e-15
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 48/212 (22%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRH-KNLVRLL 213
+G G + +V + I S G + A K L R + ++ E+ V+ + ++ L
Sbjct: 36 ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYL 267
+ +L+ EY G + L DV L + IL G+ YL
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRL-----IKQILE---GVYYL 147
Query: 268 HEGLEPKVVHRDVKSSNILL-DRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHF 324
H+ +VH D+K NILL + DFG+++ + +MGT Y
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEY--- 199
Query: 325 IVQVSP----------------LFILLYILLS 340
++P + I+ Y+LL+
Sbjct: 200 ---LAPEILNYDPITTATDMWNIGIIAYMLLT 228
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-15
Identities = 53/216 (24%), Positives = 90/216 (41%), Gaps = 43/216 (19%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
E+V+GEG + V I L + AVK + G EVE++ + + H+N++ L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVG-----DVSPLTWDIRMNIILGTAKGLAYLH 268
+ E LV+E + G++ +H + S + D+ A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHIH-KRRHFNELEASVVVQDV--------ASALDFLH 128
Query: 269 EGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLL--CSERSYVTTRVM----GTF 319
+ HRD+K NIL + ++ DF L + + S ++T + G+
Sbjct: 129 ---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 320 GYA------HFIVQVSP---------LFILLYILLS 340
Y F + S L ++LYILLS
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 7e-15
Identities = 18/151 (11%), Positives = 44/151 (29%), Gaps = 19/151 (12%)
Query: 158 VIGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVR 211
G ++ + D +VA+ + + +E + R+ + R
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-G 270
+L A ++V E++ G+L + + + + A H G
Sbjct: 96 VLDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
V S + + + ++
Sbjct: 150 ----VALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 30/184 (16%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 213 LG-YCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
L + + + +V E +D NL Q + L + ++ G+ +
Sbjct: 90 LNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKH 142
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTR------VMG 317
LH ++HRD+K SNI++ ++ DFGLA+ + YV TR V+
Sbjct: 143 LHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 199
Query: 318 TFGY 321
GY
Sbjct: 200 GMGY 203
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 48/216 (22%), Positives = 84/216 (38%), Gaps = 50/216 (23%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKE-FKVEVEVIGRVRHKN 208
+G G + +V + S G + A K ++R +E + EV ++ ++H N
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDV---GDVSPLTWDIRMNIILGTAKGL 264
++ L +L+ E V G L D + + + + IL G+
Sbjct: 76 VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILN---GV 127
Query: 265 AYLHEGLEPKVVHRDVKSSNILL-DRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFG 320
YLH ++ H D+K NI+L DR ++ DFGLA + + + GT
Sbjct: 128 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPE 182
Query: 321 YAHFIVQVSP----------------LFILLYILLS 340
+ V+P + ++ YILLS
Sbjct: 183 F------VAPEIVNYEPLGLEADMWSIGVITYILLS 212
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.0 bits (178), Expect = 1e-14
Identities = 36/226 (15%), Positives = 69/226 (30%), Gaps = 58/226 (25%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVK--------NLLNNRGQAEKEFKVEVEV---------I 201
IGEG +G V++ I D T VA+K + + + +E E+ +
Sbjct: 28 IGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 202 GRVRHKNLVRLLG-YCVEGAY-----------------------------RMLVYEYVDN 231
R + + L +CV+G+Y +V E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 232 GN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
G L+Q + +I+ LA + HRD+ N+LL +
Sbjct: 147 GIDLEQMRT------KLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKT 198
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLY 336
++ K + + + + +F +
Sbjct: 199 SLKKLHYTLNGKSSTIPSCGLQVS-IIDYTLSRLERDGIVVFCDVS 243
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 2e-14
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 26/171 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGL 88
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV ++ +L + + + + ++ KGL
Sbjct: 89 LDVFTPASSLRNFYDFY--LVMPFMQT-DLQKIMG------LKFSEEKIQYLVYQMLKGL 139
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
Y+H VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR
Sbjct: 140 KYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 43/200 (21%), Positives = 79/200 (39%), Gaps = 52/200 (26%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK------------------------NLLNNRGQAEKE 193
IG+G YG+V +D T A+K
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 194 FKV--EVEVIGRVRHKNLVRLLGYCV-EGAYR---MLVYEYVDNGNL-DQWLHGDVGDVS 246
+V E+ ++ ++ H N+V+L V + +V+E V+ G + +
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLK------ 132
Query: 247 PLTWDIRMN----IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
PL+ D +I G+ YLH K++HRD+K SN+L+ + +++DFG++
Sbjct: 133 PLSEDQARFYFQDLIK----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN 185
Query: 303 LLCSERSYVTTRVMGTFGYA 322
+ ++ V GT +
Sbjct: 186 EFKGSDALLSNTV-GTPAFM 204
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 18/153 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+IG G YG V + VA+K +L + ++ + E+ ++ R+ H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 214 G-YCVEGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ + +V E D D LT ++ G+ Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIAD---SD--FKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
++HRD+K +N L+++ + +V DFGLA
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 45/185 (24%), Positives = 82/185 (44%), Gaps = 39/185 (21%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKV--EVEVIGRVRHK--N 208
++G GG+G VY GI +SD VA+K + +++ G+ +V EV ++ +V
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IIL 258
++RLL + +L+ E + D+ D +T + ++
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV-------QDLFDF--ITERGALQEELARSFFWQVL- 159
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMG 317
+ + + H V+HRD+K NIL+D + ++ DFG LL + + T G
Sbjct: 160 ---EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD-G 210
Query: 318 TFGYA 322
T Y+
Sbjct: 211 TRVYS 215
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V + G KVA+K L + A++ ++ E+ ++ +RH+N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGL 89
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV ++ +L + + + L D ++ KGL
Sbjct: 90 LDVFTPDETLDDFTDFY--LVMPFMGT-DLGKLMKHE-----KLGEDRIQFLVYQMLKGL 141
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
Y+H ++HRD+K N+ ++ ++ DFGLA+ SE + YV TR
Sbjct: 142 RYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR 189
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 71.4 bits (175), Expect = 7e-14
Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 20/174 (11%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
V+G GG+G V+ + K+ A K L R + K + VE +++ +V + +V L
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-----IILGTAKGLAYL 267
Y E + LV ++ G++ ++ D R I+ G L +L
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEP-RAIFYTAQIVSG----LEHL 305
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
H+ +++RD+K N+LLD N R+SD GLA L + ++ GT G+
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGF 355
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 40/162 (24%), Positives = 63/162 (38%), Gaps = 39/162 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVRHKNLVRLLGY 215
IG G +G+ VAVK + RG A E V E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKEV 84
Query: 216 CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ + ++ EY G L + + G R + ++ G
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAG------------RFSEDEARFFFQQLLS----G 128
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKL 303
++Y H ++ HRD+K N LLD ++ DFG +K
Sbjct: 129 VSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 54/218 (24%), Positives = 82/218 (37%), Gaps = 59/218 (27%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRV-RHKNLVR 211
V+G G G V + K A+K L + K EVE+ R + ++VR
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 119
Query: 212 LLGYCVEGAYRM----LVYEYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTA 261
++ +V E +D G L + GD + S + I
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--------G 171
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGT 318
+ + YLH + HRDVK N+L ++ NA +++DFG AK S S T T
Sbjct: 172 EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYT 226
Query: 319 FGYAHFIVQVSP----------------LFILLYILLS 340
Y V+P L +++YILL
Sbjct: 227 PYY------VAPEVLGPEKYDKSCDMWSLGVIMYILLC 258
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 22/115 (19%), Positives = 39/115 (33%), Gaps = 13/115 (11%)
Query: 215 YCVEGAYRMLVY---EYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLH 268
+ ++ +Y + NL W++ + I + I + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH 181
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
++HRD+K SNI +V DFGL + + T H
Sbjct: 182 S---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 6e-05
Identities = 19/76 (25%), Positives = 33/76 (43%), Gaps = 2/76 (2%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 213 LGYCVEGAYRMLVYEY 228
+E E
Sbjct: 70 FNAWLETPPEKWQEEM 85
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 56/216 (25%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLL 213
+ V+G G G V G K A+K LL + + + EV+ + ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALK-LLYDS----PKARQEVDHHWQASGGPHIVCIL 88
Query: 214 GYCVEGAYRM----LVYEYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTAKG 263
+ ++ E ++ G L + GD + + + DI
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI--------GTA 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAKLLCSERSYVTTRVMGTFG 320
+ +LH + HRDVK N+L ++ +A +++DFG AK ++ + T T
Sbjct: 141 IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPY 194
Query: 321 YAHFIVQVSP----------------LFILLYILLS 340
Y V+P L +++YILL
Sbjct: 195 Y------VAPEVLGPEKYDKSCDMWSLGVIMYILLC 224
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 3e-13
Identities = 46/187 (24%), Positives = 74/187 (39%), Gaps = 41/187 (21%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKV--EVEVIGRVR----H 206
++G+GG+G V+ G L+D +VA+K N + EV ++ +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------I 256
++RLL + MLV E D+ D +T + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA-------QDLFDY--ITEKGPLGEGPSRCFFGQV 148
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTTRV 315
+ + + H VVHRD+K NIL+D + ++ DFG LL T
Sbjct: 149 VA----AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFD 199
Query: 316 MGTFGYA 322
GT Y+
Sbjct: 200 -GTRVYS 205
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 4e-13
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 25/171 (14%)
Query: 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+ +G G YG V + G +VAVK L + A++ ++ E+ ++ ++H+N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGL 93
Query: 213 L--------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
L Y LV + +L+ + LT D +I +GL
Sbjct: 94 LDVFTPARSLEEFNDVY--LVTHLMGA-DLNNIVKC-----QKLTDDHVQFLIYQILRGL 145
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
Y+H ++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 31/162 (19%), Positives = 62/162 (38%), Gaps = 35/162 (21%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--------NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
+G G +G V+ + +V VK + +E+ ++ RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILG 259
+++L + LV E +G D+ + R++ ++
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-------LDLFAF--IDRHPRLDEPLASYIFRQLVSA 142
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ YL ++HRD+K NI++ + ++ DFG A
Sbjct: 143 ----VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-13
Identities = 43/164 (26%), Positives = 67/164 (40%), Gaps = 42/164 (25%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK----NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+GEG +G V KVA+K LL + + E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMR-VEREISYLKLLRHPHIIKL- 74
Query: 214 GYCVEGAYRM--LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMN----------IILG 259
Y V +V EY G L ++ RM II
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIVEKK------------RMTEDEGRRFFQQII-- 118
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+ Y H K+VHRD+K N+LLD N +++DFGL+ +
Sbjct: 119 --CAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNI 157
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 7e-13
Identities = 40/163 (24%), Positives = 76/163 (46%), Gaps = 22/163 (13%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+IG G YG VY + VA+K + + ++ + E+ ++ R++ ++RL
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLY 91
Query: 214 -------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y +V E D+ +L + + LT + I+ G +
Sbjct: 92 DLIIPDDLLKFDELY--IVLEIADS-DLKKLFKTPI----FLTEEHIKTILYNLLLGENF 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+HE ++HRD+K +N LL++ + +V DFGLA+ + SE+
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 40/181 (22%), Positives = 82/181 (45%), Gaps = 34/181 (18%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL-- 213
+G GG G+V+ + +D +VA+K + L + + + E+++I R+ H N+V++
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 214 -----GYCVEGAYRM-------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
+ + +V EY++ +L L PL + +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ-----GPLLEEHARLFMYQLL 130
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSERS-------YVTT 313
+GL Y+H V+HRD+K +N+ ++ + ++ DFGLA+++ S + T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 314 R 314
+
Sbjct: 188 K 188
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 42/173 (24%), Positives = 81/173 (46%), Gaps = 25/173 (14%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ IGEG YG+V + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 91
Query: 214 GYCVEGAYRM-----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + ++ +L + L L+ D + +GL Y+H
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQILRGLKYIH 145
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
V+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 146 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 23/174 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
V+G+GG+G V + K+ A K L R + K E +++ +V + +V L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-----NIILGTAKGLAYL 267
Y E + LV ++ G+L ++ P R I G L L
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA---RAVFYAAEICCG----LEDL 302
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
H ++V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 303 HRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIKGRV-GTVGY 351
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 3e-12
Identities = 40/181 (22%), Positives = 77/181 (42%), Gaps = 36/181 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL- 213
++GEG YG+V G VA+K + A + + E++++ +H+N++ +
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 214 ------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
Y ++ E + +L + + L+ D I T + + L
Sbjct: 77 IQRPDSFENFNEVY--IIQELMQT-DLHRVISTQ-----MLSDDHIQYFIYQTLRAVKVL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS--------------YVTT 313
H V+HRD+K SN+L++ + +V DFGLA+++ + +V T
Sbjct: 129 HGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 314 R 314
R
Sbjct: 186 R 186
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-11
Identities = 47/167 (28%), Positives = 84/167 (50%), Gaps = 21/167 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVR 211
+G+G YGIV++ I G VAVK + + N A++ F+ E+ ++ + H+N+V
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 212 LLGYCV----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
LL Y LV++Y++ +L + + L + ++ K + YL
Sbjct: 74 LLNVLRADNDRDVY--LVFDYMET-DLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYL 125
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
H G ++HRD+K SNILL+ + + +V+DFGL++ + R
Sbjct: 126 HSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 7e-11
Identities = 47/172 (27%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKN---LV 210
+IG GG+G VY +D K+ A+K L R + ++ E ++ V + +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 211 RLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+ Y ++ + + ++ G+L L IILG L ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILG----LEHMHN 310
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
VV+RD+K +NILLD + R+SD GLA ++ + V GT GY
Sbjct: 311 ---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGY 356
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 9e-11
Identities = 40/179 (22%), Positives = 67/179 (37%), Gaps = 38/179 (21%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++GEG + V ++ A+K L E + E +V+ R+ H V+L
Sbjct: 37 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN-------------IILGT 260
+ Y NG L +++ ++ I+
Sbjct: 97 FTFQDDEKLYFGLSYAKNGELLKYIR-------------KIGSFDETCTRFYTAEIVSA- 142
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVM-GT 318
L YLH ++HRD+K NILL+ + +++DFG AK+L E GT
Sbjct: 143 ---LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 31/160 (19%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLG- 214
V+G G G V + K A+K L + + + EVE+ R + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 215 YCVEGAYRMLVY---EYVDNGNL-DQWL-HGDVG----DVSPLTWDIRMNIILGTAKGLA 265
Y A R + E +D G L + GD + S + I + +
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI--------GEAIQ 131
Query: 266 YLHEGLEPKVVHRDVKSSNILL-DRQWNA--RVSDFGLAK 302
YLH + HRDVK N+L ++ NA +++DFG AK
Sbjct: 132 YLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 20/170 (11%)
Query: 158 VIGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G + V + + K+ K + RG+ F+ E +V+ + + +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM---NIILGTAKGLAYLH 268
+ + + LV EY G+L L G+ P R I++ + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEM-ARFYLAEIVMA----IDSVH 179
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
VHRD+K NILLDR + R++DFG L ++ + + +GT
Sbjct: 180 RL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 9/103 (8%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEV-IGRVRHK 207
+G G +G V + VAVK L +E + E+++ I H
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 208 NLVRLLGYC-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
N+V LLG C G M++ E+ GNL +L + P
Sbjct: 87 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 3e-09
Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 24/155 (15%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G + G L VA+K + + Q E++ ++ + ++ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS---GDGIPQVYYF 73
Query: 216 CVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLE 272
G Y +V E + G +L+ D+ D+ T+ ++ +++ + Y+H
Sbjct: 74 GPCGKYNAMVLELL--GPSLE-----DLFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVS-----DFGLAK 302
+++RDVK N L+ R N DF LAK
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 7e-09
Identities = 21/59 (35%), Positives = 31/59 (52%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
L YL +++HRD+K NILLD + ++DF +A +L E T + GT Y
Sbjct: 127 ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPY 180
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 32/175 (18%)
Query: 158 VIGEGGYGIVY--RGILSDGT---KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G +G V R + K+ K + R + F E +++ +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL 134
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK--------G 263
Y + + +V EY+ G+L + ++ A+
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLMS-------------NYDVPEKWARFYTAEVVLA 180
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
L +H +HRDVK N+LLD+ + +++DFG + E +GT
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 34/177 (19%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNL----LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
VIG G +G V L + KV A+K L + R + F+ E +V+ K + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTL 139
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL--GTAK------- 262
Y + + LV +Y G+L LT + L A+
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDL-------------LTLLSKFEDRLPEEMARFYLAEMV 185
Query: 263 -GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
+ +H+ VHRD+K NIL+D + R++DFG L + + ++ +GT
Sbjct: 186 IAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 41/150 (27%), Positives = 63/150 (42%), Gaps = 12/150 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++G+G +G V + A+K L A+ E E V+ RH L L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
Y + R+ V EY + G L L + I+ L YLH
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSA----LDYLHSEKN 269
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VV+RD+K N++LD+ + +++DFGL K
Sbjct: 270 --VVYRDLKLENLMLDKDGHIKITDFGLCK 297
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 34/154 (22%), Positives = 69/154 (44%), Gaps = 22/154 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKN--LLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG +G+++ G L + +VA+K ++ Q E++ + G + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLEP 273
EG + +LV + + +L+ D+ D+ + ++ + + +HE
Sbjct: 75 GQEGLHNVLVIDLLGP-SLE-----DLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 125
Query: 274 KVVHRDVKSSNILLDRQWNAR-----VSDFGLAK 302
+V+RD+K N L+ R + V DFG+ K
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 7e-08
Identities = 40/165 (24%), Positives = 73/165 (44%), Gaps = 39/165 (23%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V+ + I KV K L R + K+E +++ V H +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPFI 88
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IIL 258
V+L Y + ++ L+ +++ G+L L +V + L
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEV----------MFTEEDVKFYLAELAL 137
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
L +LH +++RD+K NILLD + + +++DFGL+K
Sbjct: 138 A----LDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKE 175
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 42/160 (26%), Positives = 66/160 (41%), Gaps = 33/160 (20%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
++G+G +G V + A+K L A+ E E V+ RH L L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 214 GYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILGTAK 262
Y + R+ V EY + G L + H L+ + I+
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH--------LSRERVFTEERARFYGAEIVSA--- 117
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 118 -LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 1e-07
Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 39/165 (23%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM-----------NII 257
V L+ Y + ++ L+ EY+ G L L + + I
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLERE-----------GIFMEDTACFYLAEIS 131
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ L +LH+ +++RD+K NI+L+ Q + +++DFGL K
Sbjct: 132 MA----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 46/259 (17%), Positives = 89/259 (34%), Gaps = 24/259 (9%)
Query: 56 HLQQQQQSKQILNTPPISKEIQEIVHHPAPVPEIQVDIGKIEHRVVFSDRASSGESRGTG 115
+ + + +S I E+ + + E+ F+ S G
Sbjct: 244 EIWDWDLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEY---FNVPVPPEGSEGNE 300
Query: 116 SACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEEN-----VIGEGGYGIVYRG 170
+ G + + + + + V+G+G +G V
Sbjct: 301 ELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLS 360
Query: 171 ILSDGTKV-AVKNL----LNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM- 223
++ AVK L + E VE V+ + L +L C + R+
Sbjct: 361 ERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALPGKPPFLTQLH-SCFQTMDRLY 418
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
V EYV+ G+L + P I +G L +L +++RD+K
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIG----LFFLQSK---GIIYRDLKLD 471
Query: 284 NILLDRQWNARVSDFGLAK 302
N++LD + + +++DFG+ K
Sbjct: 472 NVMLDSEGHIKIADFGMCK 490
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 5e-07
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 20/152 (13%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G +Y G ++ G +VA+K + Q E K+ + G V + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV---GIPTIRWC 73
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLEP 273
EG Y ++V E + +L+ D+ + + ++ ++L + Y+H
Sbjct: 74 GAEGDYNVMVMELLGP-SLE-----DLFNFCSRKFSLKTVLLLADQMISRIEYIHS---K 124
Query: 274 KVVHRDVKSSNILLDRQWNA---RVSDFGLAK 302
+HRDVK N L+ + DFGLAK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 31/159 (19%)
Query: 158 VIGEGGYGIVYRGILSDGTKV-AVKNLLNNRGQAEKEF---KVEVEVIGRVRHKNLVRLL 213
+G G +G V + A+K L + K+ E ++ V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN----------IILGTAKG 263
+ + +V EYV G + + H L R + I+L
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEM--FSH--------LRRIGRFSEPHARFYAAQIVLT---- 153
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YLH +++RD+K N+L+D+Q +V+DFG AK
Sbjct: 154 FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK 189
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 19/40 (47%), Positives = 25/40 (62%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH +V+RD+K NILLD Q + ++DFGL K
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK 187
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 18/56 (32%), Positives = 31/56 (55%), Gaps = 3/56 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
L +LH+ +++RD+K NILLD + ++DFGL+K ++ + GT
Sbjct: 171 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 38/153 (24%), Positives = 67/153 (43%), Gaps = 22/153 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G +Y G + +VA+K N+ Q E K+ + G + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQG---GTGIPNVRWF 71
Query: 216 CVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGT--AKGLAYLHEGLE 272
VEG Y +LV + + G +L+ D+ + ++ ++L + ++H
Sbjct: 72 GVEGDYNVLVMDLL--GPSLE-----DLFNFCSRKLSLKTVLMLADQMINRVEFVH---S 121
Query: 273 PKVVHRDVKSSNILLDRQWNAR---VSDFGLAK 302
+HRD+K N L+ A + DFGLAK
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH +++RD+K NILLD+ + +++DFG AK
Sbjct: 118 ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAK 154
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 14/40 (35%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L +LH+ +++RD+K N+LLD + + +++DFG+ K
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 172
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 41/167 (24%), Positives = 69/167 (41%), Gaps = 33/167 (19%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVA---VKNLLNNRGQAEKEFKVE-----VEVIGRVRHKNL 209
IG GG+G++Y + K A VK G E K + I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 210 VRLLG-----YC-----VEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLT-WDIRMNII 257
+ LG +YR +V E + G +L Q + G G T + + ++
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDL-QKISGQNGTFKKSTVLQLGIRML 161
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 302
L Y+HE + VH D+K++N+LL + +V +D+GL+
Sbjct: 162 ----DVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 3e-06
Identities = 18/51 (35%), Positives = 29/51 (56%), Gaps = 3/51 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
GL +LH +V+RD+K NILLD+ + +++DFG+ K + T
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 30/175 (17%), Positives = 56/175 (32%), Gaps = 46/175 (26%)
Query: 159 IGEGGYGIVYRGI---------LSDGTKVAVKNLLNNRGQAEKEFKV--------EVEVI 201
GI+Y K ++K L G+ E +V
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNKW 108
Query: 202 GRVRHKNLV---RLLGY-CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
++ L+ +G+ + YR LV L + L + +
Sbjct: 109 KKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS---------LGRSLQSA--LDVSPKHVLS 157
Query: 258 LGTAKGLA--------YLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAK 302
+ +A +LHE + VH +V + NI +D + ++V + +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 15/40 (37%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLHE +++RD+K N+LLD + + +++D+G+ K
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 158
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 38/178 (21%), Positives = 69/178 (38%), Gaps = 34/178 (19%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHK 207
IG+GG+G +Y ++ VK ++ G E K + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 208 NLVRLLG----------YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
++ LG +YR ++ + L + + + + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR-----FGSDLQ-KIYEANAKRFSRKTVLQ 156
Query: 258 LGT--AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYV 311
L L Y+HE + VH D+K+SN+LL+ + +V D+GLA C E +
Sbjct: 157 LSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHK 211
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 5e-06
Identities = 13/40 (32%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL +L +++RD+K N++LD + + +++DFG+ K
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 169
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 5e-06
Identities = 15/40 (37%), Positives = 27/40 (67%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLHE +++RD+K N+LLD + + +++D+G+ K
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK 201
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 36/179 (20%), Positives = 71/179 (39%), Gaps = 33/179 (18%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKV-------EVEVIGRVRH 206
+G G + V+ + + T VA+K + + AE E K+ + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85
Query: 207 KNLVRLLGY----CVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGT 260
++++LL + G + ++V+E V NL + + G I ++LG
Sbjct: 86 NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQISKQLLLG- 143
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDR------QWNARVSDFGLAKLLCSERSYVTT 313
L Y+H ++H D+K N+L++ +++D G A C + T
Sbjct: 144 ---LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTN 194
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 39/176 (22%), Positives = 66/176 (37%), Gaps = 41/176 (23%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHK------ 207
VIG+G +G V + VA+K + N QA E+ ++ +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTM 159
Query: 208 NLVRLLGY-------C-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
N++ +L C M +YE + + +
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF-----------QGFSLPLVRKFAHS 208
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA--RVSDFGLAKLLCSERSYVTT 313
+ L LH+ +++H D+K NILL +Q + +V DFG + C E V T
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYEHQRVYT 258
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.17 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.17 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.83 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.69 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.44 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.22 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.14 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.04 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.92 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.46 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.43 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.17 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.01 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.96 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.77 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.62 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 96.41 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.24 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.0 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 95.79 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.38 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 92.0 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 91.61 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 91.46 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 90.84 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.22 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 89.78 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 88.71 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 88.01 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 86.21 | |
| 2l34_A | 33 | TYRO protein tyrosine kinase-binding protein; immu | 86.2 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 80.49 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=376.01 Aligned_cols=189 Identities=22% Similarity=0.295 Sum_probs=169.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.++||+|+||+||+|+.. +|+.||||.+.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45888999999999999999964 6899999999653 2234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||+||+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 999999999999754 4699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCc-ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......+||+.|||||+ |||||||+||||++|++||.
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 332 33456799999999995 99999999999999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=378.21 Aligned_cols=189 Identities=25% Similarity=0.317 Sum_probs=170.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
...|+..+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+++|++++|||||++++++.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 345888899999999999999965 6999999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|++|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999974 3589999999999999999999999 99999999999999999999999999999875543
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....+||+.|||||+ |||||||+||||++|++||..
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 272 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 272 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3 3345789999999995 999999999999999999963
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=378.87 Aligned_cols=190 Identities=24% Similarity=0.366 Sum_probs=163.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57888999999999999999964 69999999996553 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
||+||+|.+++.... ...+++..++.++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~~--~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQK--GVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 999999999997542 24678999999999999999999999 9999999999999999999999999999976432
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......+||+.|||||+ |||||||+||||++|++||.
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 2 23345789999999995 99999999999999999996
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=372.87 Aligned_cols=196 Identities=26% Similarity=0.445 Sum_probs=170.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.+++|.+.+.||+|+||.||+|++. ++..||||.+........++|.+|+++|++++|||||++++++.+++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 3466778899999999999999864 4678999999876666678899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCC---------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 223 MLVYEYVDNGNLDQWLHGDV---------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
|||||||++|+|.++|+... .....++|.+++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence 99999999999999997532 2335799999999999999999999998 99999999999999999999
Q ss_pred EEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||+|+......... .....||+.|||||+ |||||||+||||+| |+.||..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~ 233 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 233 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999775544332 334679999999995 99999999999998 8999974
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-51 Score=376.11 Aligned_cols=195 Identities=26% Similarity=0.441 Sum_probs=163.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|.+.+.||+|+||.||+|+++ ++..||||.+........++|.+|+++|++++|||||++++++.+.+..|
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 456777889999999999999864 47889999998766666788999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 018991 224 LVYEYVDNGNLDQWLHGDVG-----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
||||||++|+|.++++.... ...+++|.+++.++.|++.||.|||++ +|+||||||+||||++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 99999999999999976432 224699999999999999999999998 9999999999999999999
Q ss_pred eEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 293 ARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+||+|||+|+.+...... ......||+.|||||+ |||||||+||||+| |+.||..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~ 263 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQ 263 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCC
Confidence 999999999977544332 3345789999999994 99999999999999 8999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=380.20 Aligned_cols=189 Identities=25% Similarity=0.317 Sum_probs=171.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.+.|+..+.||+|+||.||+|+.+ +|+.||||++........+.+.+|+.+|++++|||||++++++.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 356888999999999999999965 6999999999766555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|+||+|.+++.. ..+++.++..++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999964 3589999999999999999999999 99999999999999999999999999999875543
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....+||+.|||||+ |||||||+||||++|++||..
T Consensus 302 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 349 (423)
T 4fie_A 302 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 349 (423)
T ss_dssp C-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 3 3445789999999995 999999999999999999963
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=367.10 Aligned_cols=192 Identities=29% Similarity=0.428 Sum_probs=162.1
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++..+++.+.+.||+|+||.||+|++++ .||||.++... ....+.|.+|+.+|++++|||||++++++.+ +..||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4556788889999999999999998753 69999886443 3345689999999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||||++|+|.++|+... .++++.+++.++.||+.||+|||++ +|+||||||+||||++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~~~---~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQE---TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 999999999999997542 4699999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCC-cccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSER-SYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~-~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .......+||+.|||||+ |||||||+||||+||+.||..
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~ 239 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSH 239 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCC
Confidence 5432 223445789999999993 999999999999999999964
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.52 Aligned_cols=186 Identities=25% Similarity=0.387 Sum_probs=160.1
Q ss_pred CcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEEEEE
Q 018991 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVY 226 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 226 (348)
.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.|.+|+++|++++|||||++++++.+ ++.+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 34567999999999999965 68899999996542 3345679999999999999999999999875 34689999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~~~ 305 (348)
|||++|+|.+++.+. .++++..+..++.||+.||+|||++ .++|+||||||+||||+ .++.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 999999999999754 4689999999999999999999998 22399999999999997 47999999999998643
Q ss_pred CCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....+||+.|||||+ |||||||+||||+||++||..
T Consensus 184 ~~---~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 184 AS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 3345789999999995 999999999999999999963
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=357.38 Aligned_cols=187 Identities=24% Similarity=0.387 Sum_probs=153.5
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 4788999999999999999995 469999999996542 233567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||| +|+|.+++... .++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 67999999754 4699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....+||+.|||||+ |||||||+||+|++|++||..
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~ 214 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDD 214 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCC
Confidence 32 2344789999999994 999999999999999999963
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=367.44 Aligned_cols=185 Identities=23% Similarity=0.263 Sum_probs=160.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+.|...+.||+|+||.||+|+++ +|+.||||++...... .+|+.+|++++|||||++++++.+++..|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 45667788999999999999965 6899999999654322 35999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~~~~ 308 (348)
+||+|.++++.. .++++..+..++.||+.||+|||++ +|+||||||+||||+.++ ++||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999754 4699999999999999999999998 999999999999999987 69999999999875432
Q ss_pred cc----cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SY----VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~----~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ....++||+.|||||+ |||||||+||||++|++||..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 258 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCC
Confidence 21 1233689999999995 999999999999999999963
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=367.69 Aligned_cols=188 Identities=23% Similarity=0.250 Sum_probs=159.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+++|++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 45888899999999999999852 46889999986542 2233467889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||||+||+|.+++.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999999754 4699999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..... .....+||+.|||||+ |||||||+||||++|++||.
T Consensus 177 ~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 177 IDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp ----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 44322 3345789999999994 99999999999999999996
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=362.79 Aligned_cols=194 Identities=24% Similarity=0.372 Sum_probs=166.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+++++.+.||+|+||.||+|++. +++.||||.+.... ....++|.+|+.+|++++|||||+++|++.+++..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34556788999999999999863 46789999986543 344678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 018991 224 LVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~ 291 (348)
||||||++|+|.++|..+.. ....+++..++.++.||+.||+|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999965321 124689999999999999999999998 999999999999999999
Q ss_pred ceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 292 NARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 292 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.+||+|||+|+.+...... ......||+.|||||+ |||||||+||||+| |+.||..
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~ 250 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG 250 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCC
Confidence 9999999999987544332 3345689999999994 99999999999998 8999974
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=361.44 Aligned_cols=204 Identities=25% Similarity=0.347 Sum_probs=174.8
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEECC------CcEEEEEEEecCCc-chHHHHHHHHHHHhcCCC-CCeeeE
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRH-KNLVRL 212 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H-~nIv~l 212 (348)
+...+++++.++|++.+.||+|+||.||+|++.. ++.||||.+..... ...++|.+|+.+|.+++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4556788889999999999999999999998542 35799999976543 345679999999999965 899999
Q ss_pred eeEEEEC-CEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 213 LGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 213 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
+++|.+. +..|||||||++|+|.++|+.... ....+++..++.++.||+.||+|||++ +|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCc
Confidence 9999764 568999999999999999975321 124589999999999999999999999 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+|||+++++.+||+|||+|+.+.....+ ......||+.|||||+ |||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999987655443 3345789999999994 99999999999998 9999974
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=348.10 Aligned_cols=188 Identities=24% Similarity=0.412 Sum_probs=151.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC---------
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--------- 220 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--------- 220 (348)
+|++.+.||+|+||.||+|+.+ +|+.||||.+.... ....+.+.+|+++|++++|||||++++++.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4788899999999999999965 68999999986543 334567899999999999999999999987644
Q ss_pred ---EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 221 ---YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 221 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
..|+|||||++|+|.+++.... ......+..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 3699999999999999997542 223456777899999999999999999 999999999999999999999999
Q ss_pred ccCcccccCCCcc-----------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 298 FGLAKLLCSERSY-----------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 298 FGla~~~~~~~~~-----------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
||+|+.+...... .....+||+.|||||+ |||||||+||||++ ||.
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~ 228 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS 228 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCC
Confidence 9999987543221 1234679999999994 99999999999995 775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=348.16 Aligned_cols=188 Identities=26% Similarity=0.342 Sum_probs=154.6
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----EEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e 227 (348)
+|.+.+.||+|+||.||+|++ +|+.||||++.... .....++.|+..+.+++|||||++++++.+++ .+|||||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 456678999999999999998 58899999985432 12223345666677899999999999998654 6799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-----LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-----~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
||++|+|.++++.. ++++..+..++.|++.||.|||++ ..++|+||||||+||||+.++.+||+|||+|+
T Consensus 82 y~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999753 589999999999999999999975 24589999999999999999999999999999
Q ss_pred cccCCCcc---cccccccCCCcccce----------------eccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY---VTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~---~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
........ .....+||+.||||| +|||||||+||||+||++||.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~ 219 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCC
Confidence 87554332 223468999999999 399999999999999987764
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=353.81 Aligned_cols=188 Identities=24% Similarity=0.395 Sum_probs=162.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE------CCE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAY 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 221 (348)
++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 46888999999999999999964 79999999996543 2334678899999999999999999999764 357
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
+|||||||+ |+|.+++... .++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeeccee
Confidence 899999996 6899999754 5799999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCC---cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSER---SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~---~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.+.... .......+||+.|+|||+ ||||+||+||||++|++||.
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCC
Confidence 8765432 223445789999999994 99999999999999999995
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=344.14 Aligned_cols=186 Identities=24% Similarity=0.307 Sum_probs=160.6
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
..+.|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+|+++|..+ +||||+++++++.+++..|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 3567999999999999999999853 46789999886543 345678899999998 6999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCcc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAK 302 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla~ 302 (348)
+|||||++|+|.+++. .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 97 lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 9999999999999983 488999999999999999999999 99999999999999876 799999999998
Q ss_pred cccCCCc---------------------------ccccccccCCCccccee-----------ccchHHHHHHHHHhccCC
Q 018991 303 LLCSERS---------------------------YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYN 344 (348)
Q Consensus 303 ~~~~~~~---------------------------~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~P 344 (348)
....... ......+||++|+|||+ ||||+||++|||++|++|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 11223579999999994 999999999999999999
Q ss_pred CC
Q 018991 345 SS 346 (348)
Q Consensus 345 f~ 346 (348)
|.
T Consensus 247 f~ 248 (361)
T 4f9c_A 247 FY 248 (361)
T ss_dssp SS
T ss_pred CC
Confidence 94
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=364.74 Aligned_cols=187 Identities=25% Similarity=0.286 Sum_probs=163.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHH---HHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEF---KVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.++|.+.++||+|+||.||+|+.+ +|+.||||.+.+.. ....... ..++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 356888999999999999999965 69999999996432 1112223 3346777888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+|||||+||+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+||||+.+|.+||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 9999999999999999754 4699999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.+.... ....+||+.|||||+ |||||||+||||++|++||.
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~ 392 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 392 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 875432 334689999999994 99999999999999999995
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=357.15 Aligned_cols=188 Identities=24% Similarity=0.362 Sum_probs=169.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
++|.+.+.||+|+||.||+|+.+ +|+.||+|.+........+.+.+|+++|+.++|||||++++++.+++.+|||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57888999999999999999965 69999999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC--CceEEecccCcccccCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--WNARVSDFGLAKLLCSE 307 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~--~~~kl~DFGla~~~~~~ 307 (348)
+||+|.+++.... ..+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+...
T Consensus 237 ~gg~L~~~i~~~~---~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTCTT---SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 9999999996432 4699999999999999999999999 99999999999999854 89999999999987544
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ....+||+.|||||+ |||||||+||||++|++||.
T Consensus 311 ~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 311 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp SE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred Cc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 334689999999995 99999999999999999996
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=314.63 Aligned_cols=208 Identities=43% Similarity=0.713 Sum_probs=184.6
Q ss_pred cccchHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEE
Q 018991 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217 (348)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 217 (348)
..++..++....++|...+.||+|+||.||+|+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 55889999999999999999999999999999987899999999865432 22236889999999999999999999999
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
+.+..++||||+++|+|.+++........++++..+..++.|++.||.|||++..++|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987655556799999999999999999999997666899999999999999999999999
Q ss_pred ccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
||+++..............||+.|+|||. |||||||++|+|++|+.||.
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 99999876555555555679999999994 99999999999999999994
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=328.06 Aligned_cols=200 Identities=22% Similarity=0.212 Sum_probs=174.6
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEE
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 217 (348)
.+.+++...++|++.++||+|+||.||+|+.+ +++.||+|++..... .....+..|..++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34556667788999999999999999999976 578999999864321 12234788999999999999999999999
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
+.+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~---~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFE---DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 9999999999999999999997532 4689999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCcccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+|+.+...........+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~ 283 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence 99998876655555555789999999983 999999999999999999963
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=303.88 Aligned_cols=189 Identities=23% Similarity=0.325 Sum_probs=169.5
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 45688899999999999999995 57899999999766555667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 9999999999753 488999999999999999999999 99999999999999999999999999998765443
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3 2334679999999994 999999999999999999963
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=324.68 Aligned_cols=196 Identities=22% Similarity=0.234 Sum_probs=172.1
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
+.+++...++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455666788999999999999999999975 58899999986431 1122347789999999999999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
.+..|+||||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 99999999999999999999643 488999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCccccee--------------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV--------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~--------------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+++.+...........+||+.|+|||+ |||||||+||||++|+.||.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 9998876554444456789999999993 99999999999999999996
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=309.90 Aligned_cols=189 Identities=23% Similarity=0.323 Sum_probs=167.9
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..+|.+.+.||+|+||.||+|++ .+|+.||+|++.... ....+.+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45688889999999999999996 579999999986542 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp CCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred ECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 999999999999654 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....+||+.|+|||+ |||||||++|+|++|++||..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 32 2345689999999994 999999999999999999963
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.83 Aligned_cols=203 Identities=37% Similarity=0.645 Sum_probs=177.7
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
+.+.++....++|...+.||+|+||.||+|++++++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33445556788999999999999999999998889999999887666666778999999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..++||||+++|+|.+++.........+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976544445689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++....... .......||+.|+|||. |||||||++|||++|+.||.
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~ 242 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCS
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccc
Confidence 987543222 22334568999999994 99999999999999999985
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=311.26 Aligned_cols=189 Identities=24% Similarity=0.240 Sum_probs=166.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 56788899999999999999965 68999999986542 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 999999999998753 4589999999999999999999999 999999999999999999999999999986433
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 22 23345689999999994 999999999999999999963
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=313.92 Aligned_cols=191 Identities=21% Similarity=0.266 Sum_probs=162.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
..++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 4567888999999999999999965 68999999986542 23345678899999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 101 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence 999999999999999754 4589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......+||+.|+|||+ |||||||++|||++|++||..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 226 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCC
Confidence 43322 23445789999999994 999999999999999999963
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.88 Aligned_cols=201 Identities=22% Similarity=0.208 Sum_probs=174.7
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEE
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 216 (348)
+.+.+.+...++|.+.+.||+|+||.||+++.+ +++.||+|.+.+... ...+.+..|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 345566667788999999999999999999975 689999999864321 1223478899999999999999999999
Q ss_pred EECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEe
Q 018991 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
.+.+..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSKFG---ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHHS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEe
Confidence 99999999999999999999997532 3589999999999999999999998 99999999999999999999999
Q ss_pred cccCcccccCCCcccccccccCCCcccce-----------------eccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERSYVTTRVMGTFGYAHFI-----------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||+++.+...........+||+.|+||| +|||||||++|||++|+.||..
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 272 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence 99999887655444444578999999999 2999999999999999999963
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.61 Aligned_cols=191 Identities=27% Similarity=0.398 Sum_probs=161.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|++.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++.+++||||+++++++.+++..|+|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 356788899999999999999964 68899999985442 23346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 90 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998775
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...........||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 544444445679999999994 999999999999999999963
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.87 Aligned_cols=189 Identities=23% Similarity=0.252 Sum_probs=164.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.++||+|+||.||+|+.+ +++.||+|.+..... ...+.+..|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 456788899999999999999965 578999999975432 2224577899998876 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999998754 4689999999999999999999999 9999999999999999999999999999864
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... ......+||+.|+|||+ |||||||++|||++|+.||.
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~ 254 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSST
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCc
Confidence 3322 23445789999999995 99999999999999999994
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=304.96 Aligned_cols=186 Identities=23% Similarity=0.296 Sum_probs=165.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|..+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 46778899999999999999965 68999999986542 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 999999999999754 4689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 205 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 2 234689999999994 999999999999999999963
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=300.69 Aligned_cols=192 Identities=26% Similarity=0.424 Sum_probs=167.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+........+.+.+|++++.+++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 345777899999999999999965 6899999998766666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKSMD---SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHHCC---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999997642 4689999999999999999999999 99999999999999999999999999998764432
Q ss_pred ccc-------------ccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYV-------------TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~-------------~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... .....||+.|+|||+ ||||||+++|+|++|..||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~ 224 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcc
Confidence 211 114579999999994 999999999999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.46 Aligned_cols=192 Identities=22% Similarity=0.276 Sum_probs=166.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~ 222 (348)
...++|.+.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 45677888999999999999999975 68899999986542 22345677889998876 999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999753 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ......+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCC
Confidence 653322 22345789999999994 999999999999999999963
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=307.49 Aligned_cols=188 Identities=23% Similarity=0.263 Sum_probs=165.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|++.+.||+|+||.||+|+.+ +++.||+|.+.... ....+.+..|..++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 45778899999999999999975 58899999997542 23345678899999988 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999754 4589999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......+||+.|+|||+ |||||||++|||++|+.||.
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 211 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcC
Confidence 322 23345689999999994 99999999999999999995
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.12 Aligned_cols=198 Identities=25% Similarity=0.297 Sum_probs=173.8
Q ss_pred cchHHHHHHhcC----------CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe
Q 018991 141 YTLRELEAATSG----------LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209 (348)
Q Consensus 141 ~~~~~~~~~~~~----------~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI 209 (348)
++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.++++++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 556666666554 556678999999999999976 799999999977666667789999999999999999
Q ss_pred eeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC
Q 018991 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR 289 (348)
Q Consensus 210 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~ 289 (348)
+++++++...+..++||||+++++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999863 3589999999999999999999998 9999999999999999
Q ss_pred CCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 290 QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 290 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++.+||+|||+++.+..... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999987654332 2334679999999994 999999999999999999953
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=307.24 Aligned_cols=188 Identities=24% Similarity=0.320 Sum_probs=166.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.+.|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.+|.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 456788899999999999999965 6899999999654321 356789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEecc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDF 298 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DF 298 (348)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999999643 4689999999999999999999999 999999999999998776 7999999
Q ss_pred cCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+++.+.... ......||+.|+|||+ |||||||++|+|++|++||.
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 9998765432 2334679999999994 99999999999999999995
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=312.82 Aligned_cols=196 Identities=24% Similarity=0.376 Sum_probs=167.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
..++|.+.+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+++++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 3567888899999999999999852 34579999986553 23456789999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence 9999999999999999999976431 123588999999999999999999999 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++.+...... ......+|+.|+|||+ |||||||++|||++ |+.||..
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~ 308 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 308 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999999999999999876544332 2233567889999994 99999999999999 9999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=311.23 Aligned_cols=187 Identities=23% Similarity=0.279 Sum_probs=166.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+++|..++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45778899999999999999965 58899999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 95 e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999999754 4689999999999999999999999 999999999999999999999999999987653
Q ss_pred CCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .....+||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 32 2345689999999993 99999999999999999995
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=306.63 Aligned_cols=191 Identities=22% Similarity=0.227 Sum_probs=166.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
..++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4567888999999999999999976 47899999986542 23345678899999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 999999999999999753 3589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 43322 23345689999999994 999999999999999999963
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=303.21 Aligned_cols=190 Identities=27% Similarity=0.360 Sum_probs=164.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 56888899999999999999965 789999999865432 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+....
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 9999999998643 4689999999999999999999998 99999999999999999999999999998764332
Q ss_pred c-ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 S-YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~-~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 210 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 2 22334689999999994 999999999999999999963
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=306.27 Aligned_cols=186 Identities=22% Similarity=0.204 Sum_probs=165.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.++..++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 45778899999999999999965 68999999986542 233467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999754 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 240 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCC
Confidence 2 234689999999994 999999999999999999963
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.17 Aligned_cols=188 Identities=18% Similarity=0.242 Sum_probs=165.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 356788899999999999999965 58899999886443 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCceEEecccCcccccC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCS 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~--~~~~kl~DFGla~~~~~ 306 (348)
+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 83 ~~g~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 99999999996432 4689999999999999999999999 9999999999999987 78999999999987754
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... .....||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 157 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 204 (321)
T 1tki_A 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 332 234679999999994 99999999999999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=306.27 Aligned_cols=192 Identities=24% Similarity=0.308 Sum_probs=165.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
+.|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 45788899999999999999964 68999999985431 1245678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---eEEecccCc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLA 301 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~---~kl~DFGla 301 (348)
||||+++++|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988764332334689999999999999999999999 9999999999999986554 999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+....... ......||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 234 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFY 234 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCC
Confidence 87754332 2344679999999994 99999999999999999996
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=308.15 Aligned_cols=193 Identities=15% Similarity=0.197 Sum_probs=163.7
Q ss_pred HHhcCCCcCceEeecCceEEEEEE------ECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC---CCCeeeEeeEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVE 218 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~ 218 (348)
...++|.+.+.||+|+||.||+|. ..+++.||+|.+... ...++..|++++..++ |+||+++++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 345678888999999999999994 346889999998643 3456777888888876 9999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--------
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG-DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-------- 289 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-------- 289 (348)
.+..|+||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999974211 235699999999999999999999998 9999999999999998
Q ss_pred ---CCceEEecccCcccccCC-CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 290 ---QWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 290 ---~~~~kl~DFGla~~~~~~-~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++.+||+|||+|+.+... .........||+.|+|||+ |||||||++|||++|++||.
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~ 286 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV 286 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence 899999999999765422 2223345689999999994 99999999999999999984
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=302.34 Aligned_cols=190 Identities=26% Similarity=0.338 Sum_probs=156.5
Q ss_pred hcCCCcCceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.++|++.+.||+|+||.||+++. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35677889999999999999996 468999999986542 2234567889999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999753 4588999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+....... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 169 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 169 KESIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 86543322 2334679999999994 999999999999999999963
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=301.11 Aligned_cols=197 Identities=30% Similarity=0.475 Sum_probs=159.6
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
++.....+|.+.+.||+|+||.||+|+. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 3344566788889999999999999987 578999999865532 3346788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCceEEecccC
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
++||||+++|+|.+++.... ....+++..++.++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred EEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 99999999999999997542 112489999999999999999999998 8 99999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++...... .......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 186 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~ 241 (309)
T 3p86_A 186 SRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241 (309)
T ss_dssp -----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTT
T ss_pred Cccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 98654322 22334679999999994 999999999999999999974
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=304.13 Aligned_cols=189 Identities=24% Similarity=0.333 Sum_probs=165.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 456888999999999999999965 689999999965532 33467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~---~~~kl~DFGla~~ 303 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 108 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999998643 4689999999999999999999999 99999999999999865 4599999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~ 232 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 65332 2234679999999994 999999999999999999953
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=318.40 Aligned_cols=194 Identities=24% Similarity=0.305 Sum_probs=169.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.++||+|+||.||+|+.+ +|+.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 356778899999999999999975 68999999986542 22345788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++|+|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976543345799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....+||+.|+|||+ |||||||++|||++|++||..
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~ 391 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCC
Confidence 4332 2334689999999994 999999999999999999963
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.21 Aligned_cols=186 Identities=25% Similarity=0.382 Sum_probs=163.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4678889999999999999996 578999999986432 122357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+ +|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 89 E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred ECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 999 68999988654 4689999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .....+||+.|+|||+ |||||||++|+|++|++||.
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 209 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSB
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCC
Confidence 32 2234579999999994 99999999999999999996
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=297.19 Aligned_cols=190 Identities=22% Similarity=0.308 Sum_probs=162.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|++.+.||+|+||.||+|+..+++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 35677789999999999999999889999999986442 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 100 FMEK-DLKKVLDENK---TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CCSE-EHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CCCC-CHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9985 8888886542 4589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 22 2233578999999994 999999999999999999963
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.66 Aligned_cols=190 Identities=28% Similarity=0.255 Sum_probs=157.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHH-HhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEV-IGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+..... .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 346788899999999999999975 588999999965532 223456667766 567899999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999754 4588999999999999999999999 9999999999999999999999999999864
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 3322 23445789999999994 999999999999999999963
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.96 Aligned_cols=191 Identities=28% Similarity=0.455 Sum_probs=168.0
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||+|++.++..||+|.+.... ...+++.+|++++++++||||+++++++.+++..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 45677889999999999999998888899999987544 33467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~L~~~l~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHhcC---cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 9999999997542 4589999999999999999999999 999999999999999999999999999987654433
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~ 210 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 210 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCC
Confidence 33334567788999994 99999999999999 9999964
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=304.14 Aligned_cols=189 Identities=21% Similarity=0.291 Sum_probs=167.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+.|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+|..++||||+++++++.+.+..++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 46888899999999999999965 68899999987665555667899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCceEEecccCcccccCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~--~~~~kl~DFGla~~~~~~ 307 (348)
++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++.+...
T Consensus 131 ~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999998643 24689999999999999999999999 9999999999999974 578999999999877543
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 32 233579999999994 999999999999999999963
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-39 Score=297.15 Aligned_cols=187 Identities=22% Similarity=0.317 Sum_probs=165.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 34778899999999999999965 689999999865432 23577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEeccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DFG 299 (348)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 999999999999999643 4689999999999999999999998 999999999999999887 89999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+++.+..... .....||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 164 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 164 LAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp TCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9987653322 234679999999994 99999999999999999995
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=298.44 Aligned_cols=192 Identities=29% Similarity=0.458 Sum_probs=162.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+.||+|+||.||+|++. .+..||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 455778899999999999999974 3456999998755 33445679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 128 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHD---GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 999999999999996542 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
..... .......+|+.|+|||. |||||||++|+|++ |+.||..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 257 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWN 257 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCccc
Confidence 54322 22233456788999994 99999999999999 9999964
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=310.79 Aligned_cols=189 Identities=23% Similarity=0.273 Sum_probs=164.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|.+.+.||+|+||.||+|... +|+.+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 456888899999999999999964 689999999865532 33457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGla~~ 303 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 90 E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998754 4589999999999999999999999 999999999999998 567899999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... ......||+.|+|||+ |||||||++|+|++|++||.
T Consensus 163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 654332 2334689999999994 99999999999999999995
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=316.55 Aligned_cols=190 Identities=24% Similarity=0.237 Sum_probs=156.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 456888899999999999999964 6899999998653 222335677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999998754 468999999999999999999998 7 9999999999999999999999999999864
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||+ |||||||+||||++|+.||..
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 351 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCC
Confidence 43322 2344789999999994 999999999999999999964
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=293.15 Aligned_cols=189 Identities=24% Similarity=0.337 Sum_probs=161.3
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|.+.+.||+|+||.||+|+..+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 45778899999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 985 9999987542 4588999999999999999999999 99999999999999999999999999998764332
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2233578999999994 999999999999999999964
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=288.94 Aligned_cols=192 Identities=24% Similarity=0.373 Sum_probs=168.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..++|++.+.||+|+||.||+|..+++..||+|.+..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3456788899999999999999988888999999865443 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG---KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999997532 3589999999999999999999999 99999999999999999999999999998776554
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........+|+.|+|||. ||||||+++|+|++ |++||..
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccc
Confidence 443444566778999994 99999999999999 9999963
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=316.65 Aligned_cols=192 Identities=25% Similarity=0.284 Sum_probs=168.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
..++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ......+.+|+++|..++||||+++++++.+.+..|+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3566888899999999999999975 68999999986432 2334568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 262 VmEy~~gg~L~~~l~~~~--~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMG--QAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSSS--SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceec
Confidence 999999999999997542 23589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ....+||+.|+|||+ |||||||++|||++|+.||..
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 54332 233589999999994 999999999999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=307.64 Aligned_cols=190 Identities=24% Similarity=0.274 Sum_probs=166.7
Q ss_pred hcCCCcCceEeecCceEEEEEEE----CCCcEEEEEEEecCC----cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECC
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGA 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~ 220 (348)
.++|.+.+.||+|+||.||+++. .+++.||||.+.... ....+.+.+|++++..+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 35688889999999999999997 368999999985432 22334567799999999 6999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..++||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 999999999999999999754 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
++..............||+.|+|||+ |||||||+||||++|+.||.
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 98765544444555789999999994 99999999999999999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=290.68 Aligned_cols=204 Identities=35% Similarity=0.617 Sum_probs=177.2
Q ss_pred cccchHHHHHHhcCCCcC------ceEeecCceEEEEEEECCCcEEEEEEEecC----CcchHHHHHHHHHHHhcCCCCC
Q 018991 139 RWYTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLNN----RGQAEKEFKVEVEVIGRVRHKN 208 (348)
Q Consensus 139 ~~~~~~~~~~~~~~~~~~------~~lG~G~fg~V~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~H~n 208 (348)
..++..++...+++|... +.||+|+||.||+|.. +++.||+|.+... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 347889999999999877 8999999999999987 5789999998643 2234567899999999999999
Q ss_pred eeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 209 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
|+++++++.+.+..++||||+++++|.+++.... ...++++..++.++.|++.||.|||++ +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997432 225689999999999999999999998 999999999999999
Q ss_pred CCCceEEecccCcccccCCCc-ccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 289 RQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.++.+||+|||+++....... .......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 236 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCT
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCccc
Confidence 999999999999987654322 22334679999999994 999999999999999999963
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=293.58 Aligned_cols=189 Identities=23% Similarity=0.354 Sum_probs=159.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc--------------------------hHHHHHHHHHHHh
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--------------------------AEKEFKVEVEVIG 202 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~ 202 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+...... ..+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 356788899999999999999964 6889999998654211 1246889999999
Q ss_pred cCCCCCeeeEeeEEEE--CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018991 203 RVRHKNLVRLLGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (348)
Q Consensus 203 ~l~H~nIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl 280 (348)
+++||||+++++++.+ .+..++||||+++++|.+++. ..++++..+..++.|++.||.|||++ +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 568999999999999987653 24689999999999999999999999 9999999
Q ss_pred CCCCEEECCCCceEEecccCcccccCCCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 281 KSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 281 kp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+|||++.++.+||+|||+++....... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 2334679999999993 999999999999999999963
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=299.18 Aligned_cols=191 Identities=25% Similarity=0.338 Sum_probs=156.5
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----E
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----Y 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~ 221 (348)
.++|++.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.++.+++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35677889999999999999996 5789999999965432 33457889999999999999999999987654 3
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+++++|.+++... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 49999999999999999754 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+.+..... .......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 87654322 22234679999999994 999999999999999999963
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=295.72 Aligned_cols=193 Identities=23% Similarity=0.365 Sum_probs=152.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 356788899999999999999954 68999999986543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 228 YVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|++ |+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999886431 1224589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 3322 2233578999999994 999999999999999999963
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=295.81 Aligned_cols=191 Identities=23% Similarity=0.390 Sum_probs=160.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC--------
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-------- 220 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-------- 220 (348)
++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+|++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 45778899999999999999976 78999999986543 345678999999999999999999999986543
Q ss_pred -------------------------------------------------EEEEEEeecCCCCHHHHHhcCCCCCCCCCHH
Q 018991 221 -------------------------------------------------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251 (348)
Q Consensus 221 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~ 251 (348)
..++||||+++++|.+++.... ......+.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3799999999999999998653 23456777
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc-----------ccccccccCCC
Q 018991 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-----------YVTTRVMGTFG 320 (348)
Q Consensus 252 ~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~ 320 (348)
.++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 8899999999999999999 999999999999999999999999999988755421 12233579999
Q ss_pred ccccee----------ccchHHHHHHHHHhccCCC
Q 018991 321 YAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 321 y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
|+|||. |||||||++|+|++|..|+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~ 276 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ 276 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh
Confidence 999994 9999999999999998775
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=300.68 Aligned_cols=188 Identities=23% Similarity=0.282 Sum_probs=156.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|.+.+.||+|+||.||+++.. +++.||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 456778899999999999999975 789999999865432 335688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--eEEecccCcccccC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKLLCS 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~--~kl~DFGla~~~~~ 306 (348)
+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 9999999998653 4589999999999999999999999 9999999999999987765 99999999985432
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCC
Confidence 22 2234579999999993 999999999999999999963
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=315.33 Aligned_cols=197 Identities=23% Similarity=0.344 Sum_probs=169.1
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++++..++|.+.+.||+|+||.||+|.++++..||||.+.... ...+.+.+|+.+|++++||||+++++++. .+..+
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~ 258 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY 258 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence 34456677888999999999999999999888899999987544 34678999999999999999999999986 56789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 9999999999999997431 13578899999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.............++..|+|||+ |||||||+||||++ |+.||..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~ 388 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCC
Confidence 65432222233456788999994 99999999999999 9999964
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=301.65 Aligned_cols=188 Identities=27% Similarity=0.330 Sum_probs=149.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
..+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3566888899999999999999975 57899999986543 34568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla~~~ 304 (348)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 129 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 99999999999653 4589999999999999999999999 9999999999999975 889999999999876
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|+|||. |||||||++|||++|+.||..
T Consensus 202 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 202 EHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 4322 2334679999999994 999999999999999999953
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=296.42 Aligned_cols=191 Identities=28% Similarity=0.412 Sum_probs=162.5
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----EEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRML 224 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~l 224 (348)
..++|++.+.||+|+||.||+|++. ++.||||.+.... ........|+.++.+++||||+++++++.+.. ..++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3567888899999999999999975 7899999985443 33445667899999999999999999998743 4799
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCCceecCCCCCCEEECCCCceEEec
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-------LEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-------~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
||||+++|+|.++++.. .+++..+..++.|++.||.|||++ ..++|+||||||+|||++.++.+||+|
T Consensus 100 v~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~D 174 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174 (322)
T ss_dssp EEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECC
T ss_pred EEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEcc
Confidence 99999999999999753 489999999999999999999974 123899999999999999999999999
Q ss_pred ccCcccccCCCcc-cccccccCCCccccee---------------ccchHHHHHHHHHhccCCCC
Q 018991 298 FGLAKLLCSERSY-VTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 298 FGla~~~~~~~~~-~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~ 346 (348)
||+++.+...... ......||+.|+|||+ |||||||++|||++|+.||.
T Consensus 175 Fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp CTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred CCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9999877554332 2233679999999994 99999999999999999995
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=300.54 Aligned_cols=193 Identities=18% Similarity=0.144 Sum_probs=166.3
Q ss_pred hcCCCcCceEeec--CceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEG--GYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G--~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|++.+.||+| +||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3457788999999 99999999975 68999999996543 2334678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999997642 24589999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCCc------ccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERS------YVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~------~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... .......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 33221 11122478999999994 999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=290.37 Aligned_cols=192 Identities=22% Similarity=0.343 Sum_probs=165.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..++|.+.+.||+|+||.||++.+.++..||+|.+..... ..+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4566788899999999999999998888999999875543 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 101 ~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 99999999997532 3589999999999999999999999 99999999999999999999999999998765433
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~ 224 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 333333557788999994 99999999999998 9999974
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.01 Aligned_cols=188 Identities=27% Similarity=0.394 Sum_probs=166.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45778899999999999999975 78999999986442 123457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 96 E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 96 EYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp ECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999643 4689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....+||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 218 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCC
Confidence 32 2234579999999994 999999999999999999963
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=289.14 Aligned_cols=187 Identities=24% Similarity=0.324 Sum_probs=161.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 45778899999999999999965 68999999996543 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++ ++.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9985 6666665432 4689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf 345 (348)
.. ......||+.|+|||+ |||||||++|+|++|..||
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~ 202 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCS
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCC
Confidence 22 2334578999999994 9999999999999998886
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=301.71 Aligned_cols=192 Identities=28% Similarity=0.426 Sum_probs=153.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+.||+|+||.||+|+.. ++..||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457888999999999999999864 46789999986543 3445679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD---AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999997542 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... ......+++.|+|||. |||||||+||||++ |+.||..
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~ 253 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTT
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 543321 1222345778999994 99999999999998 9999963
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-39 Score=301.75 Aligned_cols=184 Identities=25% Similarity=0.315 Sum_probs=157.9
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
.+.||+|+||.||+|+.. +|+.||+|.+........+.+.+|++++.+++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 567999999999999964 6899999999776656667899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE--CCCCceEEecccCcccccCCCcccc
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVT 312 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill--~~~~~~kl~DFGla~~~~~~~~~~~ 312 (348)
.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDES---YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 99886432 4589999999999999999999999 99999999999999 6678999999999987654332 2
Q ss_pred cccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 313 TRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 313 ~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 33579999999993 999999999999999999963
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=303.19 Aligned_cols=204 Identities=24% Similarity=0.344 Sum_probs=171.6
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeE
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRL 212 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l 212 (348)
+...+++...++|.+.+.||+|+||.||+|++. +++.||||.+..... ...+.+.+|++++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 445667778889999999999999999999842 357899999976433 3446789999999999 79999999
Q ss_pred eeEEEECC-EEEEEEeecCCCCHHHHHhcCCCC-----------------------------------------------
Q 018991 213 LGYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGD----------------------------------------------- 244 (348)
Q Consensus 213 ~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------- 244 (348)
++++.+.+ ..++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 99998754 489999999999999999764321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 245 ---------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 245 ---------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 12288999999999999999999999 999999999999999999999999999987644332
Q ss_pred -ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 -YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 -~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......||+.|+|||+ |||||||++|||++ |+.||..
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 298 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCc
Confidence 23344678999999994 99999999999998 9999964
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=299.58 Aligned_cols=201 Identities=27% Similarity=0.398 Sum_probs=169.8
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 216 (348)
..+....++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 334556788999999999999999999964 34789999987553 33456789999999999999999999999
Q ss_pred EECCEEEEEEeecCCCCHHHHHhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 018991 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGD--------------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iv 276 (348)
.+.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~iv 196 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFV 196 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence 9999999999999999999999764211 15689999999999999999999999 999
Q ss_pred ecCCCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCC
Q 018991 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYN 344 (348)
Q Consensus 277 Hrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~P 344 (348)
||||||+|||++.++.+||+|||+++........ ......+|+.|+|||. ||||||+++|+|++ |+.|
T Consensus 197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p 276 (343)
T 1luf_A 197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276 (343)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence 9999999999999999999999999876443221 2233568899999994 99999999999999 9999
Q ss_pred CCC
Q 018991 345 SST 347 (348)
Q Consensus 345 f~~ 347 (348)
|..
T Consensus 277 ~~~ 279 (343)
T 1luf_A 277 YYG 279 (343)
T ss_dssp TTT
T ss_pred CCC
Confidence 964
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=294.05 Aligned_cols=190 Identities=24% Similarity=0.306 Sum_probs=163.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC--EEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 226 (348)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 45777889999999999999965 58999999986543 234567889999999999999999999998765 789999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCceEEecccCcc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill----~~~~~~kl~DFGla~ 302 (348)
||+++++|.+++..... ...+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp ECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred eCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999976422 23489999999999999999999999 99999999999999 788889999999998
Q ss_pred cccCCCcccccccccCCCcccce------------------eccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFI------------------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe------------------~DiwSlG~il~el~~g~~Pf~ 346 (348)
....... .....||+.|+||| +|||||||++|||++|+.||.
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 224 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEE
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 7754432 23357999999998 399999999999999999996
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=295.92 Aligned_cols=189 Identities=19% Similarity=0.239 Sum_probs=163.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+. .+++.||||.+..... .+.+..|+++++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 35678889999999999999996 5789999998865432 23578899999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----eEEecccCcc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAK 302 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~-----~kl~DFGla~ 302 (348)
|+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD---RTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 899999997542 4689999999999999999999999 9999999999999998887 9999999998
Q ss_pred cccCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+...... ......||+.|+|||+ |||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~ 219 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccc
Confidence 76543321 1235689999999994 999999999999999999964
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=295.08 Aligned_cols=198 Identities=27% Similarity=0.402 Sum_probs=168.0
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 219 (348)
+...++|.+.+.||+|+||.||+|.. .++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 34466788889999999999999985 235789999986543 33456788999999999999999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVG--------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
+..++||||+++++|.+++..... ....+++..+..++.|++.||.|||++ +|+|||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~d 175 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRD 175 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccc
Confidence 999999999999999999976432 123488999999999999999999999 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+|||++.++.+||+|||+++........ ......+|+.|+|||. |||||||++|+|++ |+.||..
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 255 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 2233567888999993 99999999999999 9999964
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=285.59 Aligned_cols=189 Identities=24% Similarity=0.297 Sum_probs=167.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.+.|.+.+.||+|+||.||+|... ++..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 345778899999999999999965 5778999999776556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCccccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~~~ 305 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++....
T Consensus 88 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 88 CTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999988654 4589999999999999999999999 99999999999999 788999999999998765
Q ss_pred CCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc--chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCC
Confidence 433 2234579999999994 999999999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.11 Aligned_cols=196 Identities=19% Similarity=0.228 Sum_probs=168.0
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-----CCCeeeEee
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----HKNLVRLLG 214 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~~ 214 (348)
+++.+.....++|.+.+.||+|+||.||+|+. .+++.||+|.+... ....+.+..|+.++..++ ||||+++++
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~ 103 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHG 103 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEE
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccc
Confidence 34444445567899999999999999999996 46889999988643 234456778999999986 999999999
Q ss_pred EEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----
Q 018991 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR----- 289 (348)
Q Consensus 215 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~----- 289 (348)
++...+..++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 104 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 104 KFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp EEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCE
T ss_pred eeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccc
Confidence 999999999999999 889999997643 23589999999999999999999999 9999999999999975
Q ss_pred --------------------CCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHH
Q 018991 290 --------------------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILL 339 (348)
Q Consensus 290 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~ 339 (348)
++.+||+|||+++..... .....||+.|+|||+ |||||||++|+|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 253 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY 253 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence 789999999999865432 234679999999994 9999999999999
Q ss_pred hccCCCCC
Q 018991 340 SVRYNSST 347 (348)
Q Consensus 340 ~g~~Pf~~ 347 (348)
+|++||..
T Consensus 254 ~g~~pf~~ 261 (360)
T 3llt_A 254 TGSLLFRT 261 (360)
T ss_dssp HSSCSCCC
T ss_pred HCCCCCCC
Confidence 99999964
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=304.33 Aligned_cols=195 Identities=24% Similarity=0.340 Sum_probs=165.8
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
+...++|.+.+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+++|++++||||+++++++.+++..++
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEE
Confidence 345567888899999999999999976 689999998865432 234568899999999999999999999999899999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 190 v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~ 263 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEG---ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREE 263 (377)
T ss_dssp EEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence 999999999999997532 3588999999999999999999999 9999999999999999999999999999865
Q ss_pred cCCCcccc-cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYVT-TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~-~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........ ....+++.|+|||+ |||||||+||||++ |+.||..
T Consensus 264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~ 318 (377)
T 3cbl_A 264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN 318 (377)
T ss_dssp TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 43221111 11235678999994 99999999999998 9999974
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=291.93 Aligned_cols=181 Identities=23% Similarity=0.327 Sum_probs=145.0
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecCCCC
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
.+.||+|+||.||+|+.. +++.||+|.+... ....+.+|+.++..+. ||||+++++++.++...|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999975 6899999998543 3466788999999997 9999999999999999999999999999
Q ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---ceEEecccCcccccCCCcc
Q 018991 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVSDFGLAKLLCSERSY 310 (348)
Q Consensus 234 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl~DFGla~~~~~~~~~ 310 (348)
|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 99999764 4689999999999999999999999 999999999999997665 899999999986644322
Q ss_pred cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 311 VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 311 ~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 2334578999999995 999999999999999999963
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=289.47 Aligned_cols=192 Identities=23% Similarity=0.328 Sum_probs=161.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.|.+.+.||+|+||.||+++.. ++..||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45777899999999999999964 68899999986553 33457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCccccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~~~ 305 (348)
+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999998864322235689999999999999999999999 99999999999999 456789999999998764
Q ss_pred CCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred Ccc--cCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 432 2334679999999994 999999999999999999964
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=289.13 Aligned_cols=189 Identities=25% Similarity=0.291 Sum_probs=158.9
Q ss_pred CCCc-CceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEee
Q 018991 152 GLCE-ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 152 ~~~~-~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.|.+ ++.||+|+||.||+|+. .+++.||+|.+........+.+.+|++++.++ +||||+++++++.+.+..|+||||
T Consensus 13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 92 (316)
T 2ac3_A 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92 (316)
T ss_dssp SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEc
Confidence 4555 36799999999999995 47899999999776656677899999999985 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---eEEecccCccccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLC 305 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~---~kl~DFGla~~~~ 305 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++...
T Consensus 93 ~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 93 MRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred CCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999754 4589999999999999999999999 9999999999999988766 9999999998654
Q ss_pred CCCc------ccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERS------YVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~------~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 3221 11223569999999993 999999999999999999963
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=300.88 Aligned_cols=190 Identities=25% Similarity=0.371 Sum_probs=153.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECC--EE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGA--YR 222 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~--~~ 222 (348)
..++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4567889999999999999999964 6899999998544 2334456788999999997 999999999998654 68
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||++ ++|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999998 5999998753 588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCC--------------------CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSE--------------------RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~--------------------~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+... ........+||++|+|||+ |||||||+||||++|++||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 75431 1122334689999999994 999999999999999999963
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=291.28 Aligned_cols=191 Identities=25% Similarity=0.404 Sum_probs=160.2
Q ss_pred hcCCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 222 (348)
.++|++.+.||+|+||.||+|++ .+++.||+|.+........+.+.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45677889999999999999984 25889999999766666667899999999999999999999998643 558
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 99999999999999997642 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......++..|+|||. ||||||+++|+|++|..||.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~ 218 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 218 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTC
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccC
Confidence 76543322 1223457778999994 99999999999999999885
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=297.66 Aligned_cols=198 Identities=26% Similarity=0.301 Sum_probs=162.4
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-----CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-----RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
....++|.+.+.||+|+||.||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 445667889999999999999999964 6889999998643 2344567899999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCC------------------------------------CCCCCHHHHHHHHHHHHHHH
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGD------------------------------------VSPLTWDIRMNIILGTAKGL 264 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~~aL 264 (348)
..++||||+++|+|.+++...... ...+++..+..++.|++.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 999999999999999998521000 11245777889999999999
Q ss_pred HHHHhCCCCCceecCCCCCCEEECCCC--ceEEecccCcccccCC---CcccccccccCCCccccee------------c
Q 018991 265 AYLHEGLEPKVVHRDVKSSNILLDRQW--NARVSDFGLAKLLCSE---RSYVTTRVMGTFGYAHFIV------------Q 327 (348)
Q Consensus 265 ~yLH~~~~~~ivHrdlkp~Nill~~~~--~~kl~DFGla~~~~~~---~~~~~~~~~gt~~y~~pe~------------D 327 (348)
.|||++ +|+||||||+|||++.++ .+||+|||+++.+... .........||+.|+|||. |
T Consensus 182 ~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 182 HYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999 999999999999998776 8999999999876432 2223345679999999993 9
Q ss_pred cchHHHHHHHHHhccCCCCC
Q 018991 328 VSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 328 iwSlG~il~el~~g~~Pf~~ 347 (348)
||||||++|+|++|+.||..
T Consensus 259 iwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCC
T ss_pred HHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999964
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.85 Aligned_cols=185 Identities=28% Similarity=0.364 Sum_probs=159.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|++.+.||+|+||.||+|+.+ +++.||+|.+...... ..+|++++.++ +||||+++++++.+.+..|+|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 446888899999999999999965 6889999999765432 34577788777 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC----CceEEecccCccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~----~~~kl~DFGla~~ 303 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+..+ +.+||+|||+++.
T Consensus 97 ~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 99999999999754 4689999999999999999999999 99999999999998533 3599999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... .....+||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 221 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFA 221 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCC
Confidence 654432 2334679999999994 99999999999999999996
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=302.55 Aligned_cols=195 Identities=25% Similarity=0.357 Sum_probs=164.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.++|.+.+.||+|+||.||+|++. ++..||||.+... .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456788899999999999999953 4678999998654 334455788999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---ceEEe
Q 018991 223 MLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---NARVS 296 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~~kl~ 296 (348)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999975421 224589999999999999999999999 999999999999999554 59999
Q ss_pred cccCcccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 297 DFGLAKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+++.+..... .......||+.|+|||+ |||||||++|||++ |+.||..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~ 289 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 289 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999986543322 22233568999999994 99999999999998 9999964
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=286.41 Aligned_cols=191 Identities=28% Similarity=0.439 Sum_probs=167.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|.+.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 456778899999999999999988888999999875543 3467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhhCc---ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 9999999997542 4588999999999999999999999 999999999999999999999999999987644322
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......+++.|+|||+ ||||||+++|+|++ |++||..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 22333567788999994 99999999999999 8999964
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=307.41 Aligned_cols=182 Identities=23% Similarity=0.309 Sum_probs=145.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 222 (348)
++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 56888899999999999999965 68999999986542 23456788999999999999999999998543 568
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||+. ++|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 133 ~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEECCCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEeccc-cchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccch
Confidence 99999985 6999998754 4699999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc--------------------------ccccccccCCCccccee-----------ccchHHHHHHHHHh
Q 018991 303 LLCSERS--------------------------YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLS 340 (348)
Q Consensus 303 ~~~~~~~--------------------------~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~ 340 (348)
....... ......+||++|+|||+ |||||||+||||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7643211 12334678999999994 99999999999999
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-38 Score=285.31 Aligned_cols=186 Identities=27% Similarity=0.400 Sum_probs=156.8
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc--CCCCCeeeEeeEEEEC----CEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEG----AYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~~~ 223 (348)
.++|.+.+.||+|+||.||+|++ +++.||+|.+... ....+..|.+++.. ++||||+++++++... ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 45688889999999999999998 6889999988543 34455566666666 7999999999987643 4579
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEEECCCCceEE
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--------EGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--------~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
+||||+++|+|.++++. ..+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||
T Consensus 83 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEE
T ss_pred EehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEE
Confidence 99999999999999953 35899999999999999999999 77 9999999999999999999999
Q ss_pred ecccCcccccCCCccc---ccccccCCCcccce----------------eccchHHHHHHHHHhc----------cCCCC
Q 018991 296 SDFGLAKLLCSERSYV---TTRVMGTFGYAHFI----------------VQVSPLFILLYILLSV----------RYNSS 346 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~---~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g----------~~Pf~ 346 (348)
+|||+++......... .....||+.|+||| +|||||||++|||++| +.||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765443321 22347999999998 3999999999999999 88885
Q ss_pred C
Q 018991 347 T 347 (348)
Q Consensus 347 ~ 347 (348)
.
T Consensus 235 ~ 235 (301)
T 3q4u_A 235 D 235 (301)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=296.84 Aligned_cols=198 Identities=26% Similarity=0.378 Sum_probs=166.0
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+...++|.+.+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.++.++ +||||+++++++..
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 44567888899999999999999995 235689999986542 23346788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGD-------------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 99999999999999999999764321 13478999999999999999999999 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+|||++.++.+||+|||+++.+...... ......||+.|+|||. |||||||++|+|++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999876544332 2334567889999994 99999999999998 9999964
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=297.98 Aligned_cols=196 Identities=25% Similarity=0.350 Sum_probs=167.3
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
..++|.+.+.||+|+||.||+|+.. ++..||+|++.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 4567888899999999999999852 23579999986553 33446788999999999 99999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
++..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEE
Confidence 9999999999999999999976431 124589999999999999999999999 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++....... .......+|+.|+|||. |||||||++|+|++ |+.||..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999987654332 22333567889999994 99999999999999 9999964
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=311.17 Aligned_cols=196 Identities=23% Similarity=0.376 Sum_probs=170.4
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEECC-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++...++|.+.+.||+|+||.||+|++.. +..||||.+.... ...+++.+|+.+|++++||||+++++++.+.+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456678888999999999999999764 8899999986543 346789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 294 v~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp EEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred EEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence 999999999999997542 24589999999999999999999999 9999999999999999999999999999987
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
............++..|+|||+ |||||||+||||++ |+.||..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~ 422 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 422 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCC
Confidence 5443333334556788999994 99999999999999 9999964
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=287.86 Aligned_cols=189 Identities=26% Similarity=0.327 Sum_probs=159.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 46788899999999999999975 589999998865432 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 99999999988643 4589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 32 2234578999999993 999999999999999999964
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=294.02 Aligned_cols=189 Identities=21% Similarity=0.309 Sum_probs=159.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCC--CCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRH--KNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H--~nIv~l~~~~~~~~~~~lv 225 (348)
.+.|.+.+.||+|+||.||++...+++.||+|.+.... ....+.+.+|+.+|.+++| |||+++++++.+++..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 45577889999999999999998889999999986543 2344678899999999986 9999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+.
T Consensus 88 ~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred Ee-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 99 5578999999764 4689999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCcc-cccccccCCCccccee---------------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSY-VTTRVMGTFGYAHFIV---------------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~-~~~~~~gt~~y~~pe~---------------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 43322 2334679999999993 999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=320.07 Aligned_cols=191 Identities=22% Similarity=0.227 Sum_probs=166.5
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~ 223 (348)
..++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4567888899999999999999965 68899999986532 22345677899999987 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999754 4589999999999999999999999 999999999999999999999999999986
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......+||+.|+|||+ |||||||+||||++|++||..
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~ 544 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCC
Confidence 43332 23445789999999994 999999999999999999963
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=286.85 Aligned_cols=195 Identities=26% Similarity=0.397 Sum_probs=167.7
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
++...++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++||||+++++++.+ +..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEE
Confidence 444567788899999999999999998888899999886543 345678999999999999999999999864 458999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 86 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 99999999999986431 12589999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...........++..|+|||. ||||||+++|+|++ |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 213 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcc
Confidence 544333334567889999994 99999999999999 9999964
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=292.48 Aligned_cols=199 Identities=20% Similarity=0.339 Sum_probs=151.5
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEECC-C---cEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILSD-G---TKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG 219 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~ 219 (348)
+....++|.+.+.||+|+||.||+|+... + ..||+|.+... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34456778999999999999999999543 3 27999988654 334457799999999999999999999999877
Q ss_pred CEE------EEEEeecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC
Q 018991 220 AYR------MLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW 291 (348)
Q Consensus 220 ~~~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~ 291 (348)
... +++|||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCC
Confidence 655 99999999999999986432 1223689999999999999999999999 999999999999999999
Q ss_pred ceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 292 NARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 292 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.+||+|||+++........ ......+++.|+|||. |||||||++|+|++ |++||..
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 242 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAG 242 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 9999999999876543322 2223457788999994 99999999999999 9999964
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=294.60 Aligned_cols=185 Identities=27% Similarity=0.345 Sum_probs=162.0
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
+.|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 4477889999999999999996 5789999999865432 23357889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+. |+|.+++.... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 134 e~~~-g~l~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 68888875432 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 255 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 23579999999993 999999999999999999964
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-38 Score=289.16 Aligned_cols=187 Identities=24% Similarity=0.321 Sum_probs=165.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+.|.+.+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 45778899999999999999965 689999999865432 13577999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEeccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DFG 299 (348)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999753 4689999999999999999999999 999999999999999887 79999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+++....... .....||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 165 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp TCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred cceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 9987654322 234579999999994 99999999999999999995
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=286.19 Aligned_cols=192 Identities=21% Similarity=0.282 Sum_probs=151.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
..++|++.+.||+|+||.||+|++.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 35567888999999999999999642 4579999886543 334567899999999999999999999984 55689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccc
Confidence 9999999999999997542 4589999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.............+|+.|+|||+ ||||||+++|||++ |+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~ 220 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCc
Confidence 76544444444567889999994 99999999999996 9999964
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=310.30 Aligned_cols=195 Identities=28% Similarity=0.391 Sum_probs=161.7
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
++...++|.+.+.||+|+||.||+|.++++..||||.+.... ...+++.+|+.+|++++||||+++++++.+ +..++|
T Consensus 179 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 179 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 445667788899999999999999999888889999987544 345679999999999999999999999866 668999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 257 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 99999999999996421 13588999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...........++..|+|||+ |||||||+||||++ |+.||..
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 384 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 384 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCC
Confidence 433322333567789999994 99999999999999 9999964
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=288.20 Aligned_cols=191 Identities=21% Similarity=0.245 Sum_probs=159.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..|++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 457888899999999999999965 688999999865422 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...........|++.|+|||. ||||||+++|+|++|+.||..
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 237 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCS
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCC
Confidence 544333445679999999994 999999999999999999963
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=292.12 Aligned_cols=190 Identities=21% Similarity=0.307 Sum_probs=166.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
..+|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 456778899999999999999965 57899999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 9999999999998753 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|++||. ||||||+++|+|++|+.||..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 3322 2334679999999994 999999999999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=296.26 Aligned_cols=189 Identities=22% Similarity=0.360 Sum_probs=165.1
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
.++|.+.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45688889999999999999995 4688999999865431 12235677999999999999999999999999
Q ss_pred EEEEEEeecCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 221 YRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 221 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
..++||||+.+| +|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999999777 999999754 4689999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++.+..... .....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 9987654332 234679999999994 999999999999999999964
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=281.85 Aligned_cols=190 Identities=28% Similarity=0.447 Sum_probs=153.3
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 4578889999999999999996 478999999985432 123467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.... .++++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHTCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 9999999999997542 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 322 2233578999999994 999999999999999999963
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=302.57 Aligned_cols=188 Identities=24% Similarity=0.328 Sum_probs=157.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 221 (348)
.++|.+.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+|+.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 456888899999999999999965 68899999996542 23456788999999999999999999999776 57
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+. ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999987 5999999754 4689999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcc---------------------cccccccCCCccccee-----------ccchHHHHHHHHHhccCCC
Q 018991 302 KLLCSERSY---------------------VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 302 ~~~~~~~~~---------------------~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf 345 (348)
+........ .....+||++|+|||+ |||||||+||||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876543211 2345789999999994 9999999999999865554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=297.75 Aligned_cols=188 Identities=20% Similarity=0.305 Sum_probs=160.1
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCC--CCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..|.+.+.||+|+||.||+|...+++.||||.+.... ....+.+.+|+.+|.+++ ||||+++++++..++..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3477889999999999999998789999999986543 334567899999999996 599999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 5678999999764 3688899999999999999999998 999999999999996 57999999999987654
Q ss_pred CCcc-cccccccCCCcccce---------------------eccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSY-VTTRVMGTFGYAHFI---------------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~-~~~~~~gt~~y~~pe---------------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|+||| +|||||||+||||++|+.||..
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 3322 233467999999999 2999999999999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=304.86 Aligned_cols=186 Identities=24% Similarity=0.278 Sum_probs=155.1
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------C
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 220 (348)
.++|++.+.||+|+||.||+|+.. +++.||||++... .....+.+.+|+.+|+.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 456888899999999999999964 6899999999754 233456788999999999999999999999654 4
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+++ +|.+.+.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEe
Confidence 67999999985 67777642 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .......||+.|+|||+ |||||||+||||++|++||..
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g 265 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876433 22345689999999994 999999999999999999963
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=297.42 Aligned_cols=183 Identities=25% Similarity=0.256 Sum_probs=149.1
Q ss_pred CCCcC-ceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHh-cCCCCCeeeEeeEEEE----CCEEEE
Q 018991 152 GLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIG-RVRHKNLVRLLGYCVE----GAYRML 224 (348)
Q Consensus 152 ~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~----~~~~~l 224 (348)
+|.+. +.||+|+||.||+|+.. +++.||||.+... ..+.+|+.++. ..+||||+++++++.. ....|+
T Consensus 62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 45444 68999999999999965 6889999998532 34667887764 4589999999999876 567899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLA 301 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla 301 (348)
||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 137 v~E~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeCCCCcHHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999997542 24689999999999999999999998 9999999999999987 789999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+...... .....+||+.|+|||+ |||||||+||+|++|+.||.
T Consensus 212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 264 (400)
T 1nxk_A 212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCC
Confidence 8764332 2234679999999995 99999999999999999995
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=280.88 Aligned_cols=190 Identities=27% Similarity=0.353 Sum_probs=166.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 45788899999999999999975 68999999986543 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 9999999988643 4689999999999999999999999 99999999999999999999999999998764332
Q ss_pred c-ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 S-YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~-~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 210 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 210 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSC
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 2 12334678999999994 999999999999999999963
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=290.09 Aligned_cols=198 Identities=26% Similarity=0.368 Sum_probs=168.9
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+...++|.+.+.||+|+||.||+|+. .+++.||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 34556788889999999999999985 2467899999875533 3456789999999999 99999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
.+..++||||+++|+|.+++...... ...+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N 175 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN 175 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence 99999999999999999999764321 23589999999999999999999999 99999999999
Q ss_pred EEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 285 ILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 285 ill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||++.++.+||+|||+++........ ......+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999877554332 2233567889999993 99999999999999 9999964
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=289.18 Aligned_cols=195 Identities=24% Similarity=0.378 Sum_probs=171.5
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
+...++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 345677888899999999999999976 48899999886543 3456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHCC--TTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhcc--cCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999997642 25689999999999999999999999 99999999999999999999999999998876
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...........+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~ 215 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 555444445677889999994 99999999999999 9999964
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=292.26 Aligned_cols=189 Identities=20% Similarity=0.322 Sum_probs=154.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 456888899999999999999954 689999999865432 22456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE-----CCCCceEEecccCc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLA 301 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill-----~~~~~~kl~DFGla 301 (348)
||++ |+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 113 e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 9998 5999999754 4589999999999999999999999 99999999999999 45556999999999
Q ss_pred ccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+....... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 87643322 2334578999999994 999999999999999999963
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=301.48 Aligned_cols=188 Identities=32% Similarity=0.403 Sum_probs=162.0
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC-EEEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA-YRMLVY 226 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~-~~~lv~ 226 (348)
...++|.+.+.||+|+||.||+|.+. ++.||||.+.... ..+.+.+|+.+|++++||||+++++++.+.. ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44567888899999999999999985 7799999986543 4567899999999999999999999987765 789999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 267 e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp ECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999997542 23478999999999999999999999 999999999999999999999999999986432
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
. .....++..|+|||+ |||||||+||||++ |+.||..
T Consensus 342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~ 389 (450)
T 1k9a_A 342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 389 (450)
T ss_dssp ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 122367889999994 99999999999998 9999974
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=295.10 Aligned_cols=191 Identities=20% Similarity=0.283 Sum_probs=157.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEECC------CcEEEEEEEecCCcchH-----------HHHHHHHHHHhcCCCCCeee
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAE-----------KEFKVEVEVIGRVRHKNLVR 211 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~H~nIv~ 211 (348)
..++|.+.+.||+|+||.||+|.+.+ ++.||+|.+........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 35578888999999999999999754 47899999865542211 12344666778889999999
Q ss_pred EeeEEEEC----CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 018991 212 LLGYCVEG----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (348)
Q Consensus 212 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill 287 (348)
+++++... ...|+||||+ +++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA---KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998764 4589999999 999999997542 4699999999999999999999999 99999999999999
Q ss_pred C--CCCceEEecccCcccccCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 288 D--RQWNARVSDFGLAKLLCSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 288 ~--~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+ .++.+||+|||+++.+...... ......||+.|+|||+ |||||||+||||++|+.||.
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~ 262 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 8 8899999999999876543221 1123569999999995 99999999999999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=304.71 Aligned_cols=188 Identities=27% Similarity=0.375 Sum_probs=166.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 45778899999999999999975 78999999986542 334677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~ 303 (348)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 106 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999998754 4689999999999999999999999 99999999999999 5678999999999987
Q ss_pred ccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 179 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 179 FEASK--KMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp BCCCC--SHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccc--ccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 65433 2334579999999995 999999999999999999963
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=280.65 Aligned_cols=189 Identities=24% Similarity=0.345 Sum_probs=164.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 456888899999999999999965 58899999986543 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---eEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~---~kl~DFGla~~ 303 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999888654 4589999999999999999999999 9999999999999986655 99999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... .....||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 158 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 654332 234679999999994 999999999999999999953
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=286.19 Aligned_cols=187 Identities=25% Similarity=0.214 Sum_probs=155.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|+..+.||+|+||.||+|+.. +++.||||++..... ........|+..+.++ +||||+++++++.+.+..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 46888899999999999999976 789999998865432 2333455555555554 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 137 e~~-~~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG---ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 579999886542 4699999999999999999999998 999999999999999999999999999987644
Q ss_pred CCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ......||+.|+|||+ |||||||++|||++|..||.
T Consensus 210 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~ 256 (311)
T 3p1a_A 210 AG--AGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPH 256 (311)
T ss_dssp -------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCS
T ss_pred CC--CCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 32 2233569999999995 99999999999999966553
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=290.24 Aligned_cols=204 Identities=23% Similarity=0.407 Sum_probs=170.8
Q ss_pred cchHHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEe
Q 018991 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLL 213 (348)
Q Consensus 141 ~~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~ 213 (348)
+..++++...++|.+.+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.++++++||||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 334455566778899999999999999999854 367899999865432 3445788999999999999999999
Q ss_pred eEEEECCEEEEEEeecCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE
Q 018991 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDV------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287 (348)
Q Consensus 214 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill 287 (348)
+++.+.+..++||||+++|+|.+++.... ....++++..++.++.|++.||.|||++ +|+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEE
Confidence 99999999999999999999999986421 1124578999999999999999999999 99999999999999
Q ss_pred CCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 288 DRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 288 ~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+.++.+||+|||+++........ ......+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 243 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 243 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCcccc
Confidence 99999999999999876543322 2223467889999994 99999999999999 8999964
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=281.54 Aligned_cols=190 Identities=21% Similarity=0.307 Sum_probs=166.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 345777899999999999999975 57899999986542 23456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 9999999999998653 4689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3322 2334679999999994 999999999999999999964
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=288.41 Aligned_cols=196 Identities=24% Similarity=0.380 Sum_probs=165.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC--------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
..++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4567888899999999999999863 46789999986543 23456788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGD------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNIL 286 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nil 286 (348)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||++ +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 99999999999999999999764321 13488999999999999999999999 9999999999999
Q ss_pred ECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 287 LDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 287 l~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
++.++.+||+|||+++........ ......+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 999999999999999876554332 2233567889999993 99999999999999 9999964
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-38 Score=299.61 Aligned_cols=190 Identities=23% Similarity=0.329 Sum_probs=155.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--------chHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
...++|.+.+.||+|+||.||+|... +++.||+|.+..... .....+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 34678999999999999999999964 689999999865421 11224788999999999999999999975
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CceEE
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARV 295 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~---~~~kl 295 (348)
.+..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence 45689999999999999988643 4689999999999999999999999 99999999999999754 45999
Q ss_pred ecccCcccccCCCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 296 SDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+|||+++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 284 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 284 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 9999998765332 2334689999999993 999999999999999999964
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=282.52 Aligned_cols=188 Identities=27% Similarity=0.377 Sum_probs=161.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 456788899999999999999965 57799999985432 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999998754 4589999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 209 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 209 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCC
Confidence 32 2234578999999994 999999999999999999964
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=290.90 Aligned_cols=191 Identities=26% Similarity=0.419 Sum_probs=156.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|+..+.||+|+||.||+|++. +++ +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 345777899999999999999964 444 4688877543 2344578999999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+++||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHST---TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 9999999999999997643 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+...... ......+|+.|+|||. |||||||++|||++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 222 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccC
Confidence 7544322 2233567889999994 99999999999999 9999964
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=285.19 Aligned_cols=190 Identities=26% Similarity=0.416 Sum_probs=161.2
Q ss_pred cCCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~ 222 (348)
+.|++.+.||+|+||.||+|++ .+++.||+|.+.... ....+.+.+|++++.+++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3467778999999999999984 358899999986442 33457789999999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK---NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 99999999999999996432 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......||..|+|||. ||||||+++|+|++|+.||.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 87654332 2334568888999994 99999999999999998864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-38 Score=285.53 Aligned_cols=188 Identities=24% Similarity=0.330 Sum_probs=162.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|.+.+.||+|+||.||+++.. +|+.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 345778899999999999999965 6899999999765544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCccccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~~~ 305 (348)
+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999998653 3589999999999999999999999 99999999999999 788999999999997643
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 32 2234579999999994 999999999999999999963
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-38 Score=288.23 Aligned_cols=195 Identities=24% Similarity=0.280 Sum_probs=164.6
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRM 223 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 223 (348)
..++|.+.+.||+|+||.||+++. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456788899999999999999996 5789999999876665666789999999999999999999999873 34789
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999875333346799999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCCcc--------cccccccCCCccccee-------------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSY--------VTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~--------~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~ 346 (348)
....... ......||+.|+|||. ||||||+++|+|++|+.||.
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 247 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTH
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChh
Confidence 5321110 1123457999999983 99999999999999999984
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.26 Aligned_cols=186 Identities=19% Similarity=0.267 Sum_probs=162.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~lv 225 (348)
.++|.+.+.||+|+||.||+|+++ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. +..++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 456778899999999999999985 7899999986553 23456789999999999999999999999877 778999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCceEEecccCccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
|||+++|+|.+++.... ...+++..+..++.|++.||.|||++ + |+||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGT--NFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSCS--SCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhcc--cCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 99999999999997642 23689999999999999999999998 7 99999999999999999999999988764
Q ss_pred ccCCCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 213 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTT
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 322 23468999999993 999999999999999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=284.06 Aligned_cols=191 Identities=28% Similarity=0.375 Sum_probs=159.2
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-----cchHHHHHHHHHHHhcC---CCCCeeeEeeEEEEC
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-----GQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVEG 219 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~~ 219 (348)
..++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356789999999999999999995 468999999986432 11234566777777666 499999999999876
Q ss_pred C-----EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceE
Q 018991 220 A-----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNAR 294 (348)
Q Consensus 220 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~k 294 (348)
. ..+++|||+. ++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEE
Confidence 5 5799999997 59999997643 23489999999999999999999999 999999999999999999999
Q ss_pred EecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|||+++...... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999998764332 2344689999999994 999999999999999999963
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.40 Aligned_cols=189 Identities=22% Similarity=0.305 Sum_probs=162.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 356888899999999999999975 78999999987542 33456788899999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---------------
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ--------------- 290 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~--------------- 290 (348)
|||+++++|.+++.........+++..+..++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999975422224689999999999999999999999 99999999999999844
Q ss_pred ----CceEEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 291 ----WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 291 ----~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..+||+|||++........ ..||+.|+|||. |||||||++|+|++|++||.
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 232 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred cCCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 4799999999987654322 358999999994 99999999999999988764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=297.85 Aligned_cols=190 Identities=24% Similarity=0.303 Sum_probs=163.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC--EEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~~lv~ 226 (348)
+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 45777889999999999999975 58999999986543 234567889999999999999999999998765 779999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCceEEecccCcc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLAK 302 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill----~~~~~~kl~DFGla~ 302 (348)
||+++|+|.+++..... ...+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++
T Consensus 89 e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp CCCTTEEHHHHTTSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred ecCCCCCHHHHHHhhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999975422 23489999999999999999999999 99999999999999 778889999999998
Q ss_pred cccCCCcccccccccCCCccccee------------------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV------------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~------------------DiwSlG~il~el~~g~~Pf~ 346 (348)
....... .....||+.|+|||+ |||||||++|||++|+.||.
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~ 224 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEE
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 7654332 234579999999982 99999999999999999995
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=284.42 Aligned_cols=186 Identities=23% Similarity=0.334 Sum_probs=161.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CC-------cEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DG-------TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.++|.+.+.||+|+||.||+|+.. ++ ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 456778899999999999999854 33 4799999876666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--------e
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------A 293 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~--------~ 293 (348)
.++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK---NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG---GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 999999999999999997542 3489999999999999999999999 9999999999999998887 9
Q ss_pred EEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhc-cCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSV-RYNSS 346 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g-~~Pf~ 346 (348)
||+|||++...... ....||+.|+|||. |||||||++|+|++| .+||.
T Consensus 161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 220 (289)
T 4fvq_A 161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS 220 (289)
T ss_dssp EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence 99999999765322 23568889999993 999999999999995 55554
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=282.14 Aligned_cols=189 Identities=19% Similarity=0.227 Sum_probs=163.6
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+. .+++.||+|.+.... ..+.+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 45688889999999999999995 578999999886443 234577899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-----eEEecccCcc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-----ARVSDFGLAK 302 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~-----~kl~DFGla~ 302 (348)
|+ +++|.+++.... .++++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++
T Consensus 87 ~~-~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 899999997542 3589999999999999999999998 9999999999999987776 9999999998
Q ss_pred cccCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
........ ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 220 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcch
Confidence 77543321 2334679999999994 999999999999999999964
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=303.18 Aligned_cols=189 Identities=25% Similarity=0.361 Sum_probs=163.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-------------chHHHHHHHHHHHhcCCCCCeeeEeeE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-------------QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 215 (348)
.+.|.+.+.||+|+||.||+|+.. ++..||+|.+..... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467888899999999999999965 588999999865421 234678899999999999999999999
Q ss_pred EEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC---c
Q 018991 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW---N 292 (348)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~---~ 292 (348)
+.+....|+|||||++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999988654 4589999999999999999999999 999999999999998775 6
Q ss_pred eEEecccCcccccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+||+|||+++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765432 2334579999999995 999999999999999999964
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=304.32 Aligned_cols=189 Identities=24% Similarity=0.328 Sum_probs=163.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.+.|.+.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|++++++++||||+++++++.+....|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 345888899999999999999965 6899999998543 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGla~~ 303 (348)
||+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 101 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 999999999988654 4589999999999999999999999 999999999999995 556799999999987
Q ss_pred ccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 224 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 64432 2334579999999995 999999999999999999963
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.45 Aligned_cols=186 Identities=31% Similarity=0.504 Sum_probs=151.6
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc----chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG----QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|++.+.||+|+||.||+|++. +..||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 456788899999999999999975 78999998854422 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---ceecCCCCCCEEECC--------CCceE
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK---VVHRDVKSSNILLDR--------QWNAR 294 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~---ivHrdlkp~Nill~~--------~~~~k 294 (348)
|||+++++|.+++.. ..+++..+..++.|++.||.|||++ + |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence 999999999999853 3589999999999999999999998 6 999999999999986 67899
Q ss_pred EecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|||+++...... .....||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999998664332 223579999999994 999999999999999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=290.28 Aligned_cols=192 Identities=24% Similarity=0.368 Sum_probs=167.6
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--------chHHHHHHHHHHHhcC-CCCCeeeEeeEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~H~nIv~l~~~~ 216 (348)
....++|.+.+.||+|+||.||+|+.. +|+.||||.+..... ...+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 344567888999999999999999975 799999999865431 1134678899999999 799999999999
Q ss_pred EECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEe
Q 018991 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
......++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEE
Confidence 9999999999999999999999753 4689999999999999999999998 99999999999999999999999
Q ss_pred cccCcccccCCCcccccccccCCCcccce----------------eccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERSYVTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||++..+..... .....||+.|+||| +|||||||++|+|++|+.||..
T Consensus 243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 9999987654322 23467999999998 3999999999999999999963
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=296.17 Aligned_cols=191 Identities=20% Similarity=0.319 Sum_probs=157.6
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------ 219 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------ 219 (348)
+...++|.+.+.||+|+||.||+|+. .+|+.||+|++...... ..+|+++|+.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 44567889999999999999999996 57899999998654322 23689999999999999999998543
Q ss_pred --------------------------------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 018991 220 --------------------------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267 (348)
Q Consensus 220 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yL 267 (348)
...++||||++ |+|.+.+.........+++..+..++.|++.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 588877754222335799999999999999999999
Q ss_pred HhCCCCCceecCCCCCCEEEC-CCCceEEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHH
Q 018991 268 HEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILL 335 (348)
Q Consensus 268 H~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il 335 (348)
|++ +|+||||||+|||++ .++.+||+|||+++.+..... .....||+.|+|||+ ||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999997 688999999999987644332 234578999999994 999999999
Q ss_pred HHHHhccCCCCC
Q 018991 336 YILLSVRYNSST 347 (348)
Q Consensus 336 ~el~~g~~Pf~~ 347 (348)
|||++|+.||..
T Consensus 233 ~ell~g~~pf~~ 244 (383)
T 3eb0_A 233 GELILGKPLFSG 244 (383)
T ss_dssp HHHHHSSCSSCC
T ss_pred HHHHhCCCCCCC
Confidence 999999999963
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=279.48 Aligned_cols=190 Identities=26% Similarity=0.382 Sum_probs=161.8
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecC
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVD 230 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~ 230 (348)
.+.....||+|+||.||+|+. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 344556899999999999996 4688999999977665666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEecccCcccccCCCc
Q 018991 231 NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 231 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFGla~~~~~~~~ 309 (348)
+++|.+++..... ...+++..+..++.|++.||.|||++ +|+|+||||+||+++. ++.+||+|||+++.......
T Consensus 103 ~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKWG-PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTTC-CCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhcc-CCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999976432 24567889999999999999999999 9999999999999987 89999999999987644322
Q ss_pred ccccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
......||+.|+|||. ||||||+++|+|++|+.||.
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 2234578999999983 99999999999999999995
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.31 Aligned_cols=188 Identities=24% Similarity=0.306 Sum_probs=160.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 45778899999999999999975 68899999986543 2335678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla~~~ 304 (348)
|+++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+++..
T Consensus 117 ~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 99999999988654 4589999999999999999999999 9999999999999976 455999999999876
Q ss_pred cCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... ......||+.|+|||+ |||||||++|+|++|++||..
T Consensus 190 ~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 190 ENQK--KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp BTTB--CBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCc--cccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 5432 2334679999999994 999999999999999999963
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=288.60 Aligned_cols=191 Identities=26% Similarity=0.368 Sum_probs=165.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEE--ECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV--EGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 222 (348)
.++|++.+.||+|+||.||+|++ .+++.||+|.+........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 35677889999999999999984 357899999997766666678999999999999999999999987 45678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 99999999999999997532 3589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......||+.|+|||. ||||||+++|+|++|+.||.
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 77544322 2233568888999994 99999999999999999984
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-39 Score=314.34 Aligned_cols=197 Identities=27% Similarity=0.386 Sum_probs=167.9
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
..+++..++|.+.+.||+|+||.||+|.+.++..||||.+.... ...+++.+|+++|++++||||+++++++.+ +..|
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~ 337 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 337 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence 33445667788889999999999999999888889999987544 345679999999999999999999999866 6689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++.... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 9999999999999996431 13588999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+............++..|+|||+ |||||||+||||++ |+.||..
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~ 467 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 467 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTT
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 65332222223456788999994 99999999999999 9999964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=290.43 Aligned_cols=189 Identities=24% Similarity=0.337 Sum_probs=155.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcch-HHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 46778899999999999999975 68999999885443211 12355799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
++ |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG---NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 98 59999887542 4589999999999999999999999 99999999999999999999999999998654332
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 155 K-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred c-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 2 2233578999999994 999999999999999999963
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-38 Score=292.23 Aligned_cols=188 Identities=24% Similarity=0.334 Sum_probs=164.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 356788899999999999999975 68999999987653 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|+++++|.+++... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++....
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 99999999999754 358999999999999999999998 4 799999999999999999999999999976532
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 185 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 185 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp H---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred c---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 2 2234579999999994 999999999999999999964
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=279.38 Aligned_cols=185 Identities=25% Similarity=0.384 Sum_probs=159.9
Q ss_pred CCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLV 225 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv 225 (348)
|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 455678999999999999964 67899999986543 3345678899999999999999999999875 4568999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEEC-CCCceEEecccCcc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLD-RQWNARVSDFGLAK 302 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~-~~~~~kl~DFGla~ 302 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ + |+||||||+|||++ .++.+||+|||++.
T Consensus 108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 9999999999999753 4588999999999999999999998 7 99999999999997 78999999999997
Q ss_pred cccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccc---ccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 64332 2234579999999995 999999999999999999964
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=288.24 Aligned_cols=190 Identities=25% Similarity=0.382 Sum_probs=159.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 345777899999999999999975 589999999865533 23456789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999999998887543 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 322 2234578999999993 999999999999999999963
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.00 Aligned_cols=186 Identities=29% Similarity=0.547 Sum_probs=159.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc--h-----HHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--A-----EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~-----~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+...... . .+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 356777899999999999999964 7899999988544221 1 157889999999999999999999986655
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCc-----eE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWN-----AR 294 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~~~~~-----~k 294 (348)
++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA---HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhccc---CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 79999999999999886542 4689999999999999999999998 8 999999999999988776 99
Q ss_pred EecccCcccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|||+++.... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 230 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 999999985433 2234679999999994 999999999999999999964
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=278.54 Aligned_cols=188 Identities=24% Similarity=0.344 Sum_probs=162.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 35778899999999999999976 689999999865421 23678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEeccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DFG 299 (348)
+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 999999999999999653 4689999999999999999999998 999999999999998877 89999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++........ .....||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 158 IAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 9987644322 234578999999994 999999999999999999963
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=289.82 Aligned_cols=191 Identities=25% Similarity=0.391 Sum_probs=157.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcE----EEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTK----VAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|.+.+.||+|+||.||+|++. ++.. ||+|.+.... ....+.+.+|+.++.+++||||+++++++.+ +..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccE
Confidence 346777899999999999999964 4443 7888774432 2233457789999999999999999999864 5588
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG---GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHHcc---ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999997542 4688899999999999999999999 999999999999999999999999999998
Q ss_pred ccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+..... .......||..|+|||. |||||||++|+|++ |+.||..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 220 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAG 220 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccc
Confidence 754432 22344678889999994 99999999999999 9999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=290.38 Aligned_cols=197 Identities=24% Similarity=0.275 Sum_probs=161.3
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc-----------chHHHHHHHHHHHhcCCCCCee
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG-----------QAEKEFKVEVEVIGRVRHKNLV 210 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~H~nIv 210 (348)
.+.++....++|.+.+.||+|+||.||+|...+|..||+|.+..... ...+.+.+|++++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 45677888999999999999999999999988899999998854321 1236789999999999999999
Q ss_pred eEeeEEEEC-----CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 018991 211 RLLGYCVEG-----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (348)
Q Consensus 211 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Ni 285 (348)
++++++... ...|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR---IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998643 36899999998 68888887432 4689999999999999999999999 999999999999
Q ss_pred EECCCCceEEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 286 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|++.++.+||+|||+++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 99999999999999998654332 2234578999999993 999999999999999999964
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=279.12 Aligned_cols=190 Identities=26% Similarity=0.399 Sum_probs=161.6
Q ss_pred cCCCcCc-eEeecCceEEEEEEEC---CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|.+.+ .||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4455555 8999999999999853 57789999987653 33456789999999999999999999999 55668999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999643 24689999999999999999999999 99999999999999999999999999998875
Q ss_pred CCCccc--ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYV--TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~--~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... .....+|+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 216 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 443322 222456889999994 99999999999998 9999964
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-38 Score=281.80 Aligned_cols=193 Identities=24% Similarity=0.347 Sum_probs=163.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv 225 (348)
++|++.+.||+|+||.||+++.. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 46778899999999999999965 68999999986543 2345678899999999999999999998865 5689999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----ceecCCCCCCEEECCCCceEEecccC
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-----VVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~-----ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
|||+++++|.+++.........+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999975433335689999999999999999999998 7 99999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++....... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 163 ARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp HHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred heeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 987654322 2234579999999994 999999999999999999964
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=280.12 Aligned_cols=187 Identities=24% Similarity=0.351 Sum_probs=164.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 45778899999999999999965 57889999985432 223467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999754 3589999999999999999999998 999999999999999999999999999976543
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....|++.|+|||. ||||||+++|+|++|+.||..
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 22 234578999999994 999999999999999999963
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=284.63 Aligned_cols=193 Identities=21% Similarity=0.330 Sum_probs=155.0
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 34688889999999999999996 47899999998653 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++.........+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999864322235689999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... ......|++.|+|||. ||||||+++|+|++|+.||.
T Consensus 188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 237 (310)
T 2wqm_A 188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 237 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 4322 2234578999999994 99999999999999999995
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=287.44 Aligned_cols=203 Identities=24% Similarity=0.354 Sum_probs=170.3
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEe
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLL 213 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~ 213 (348)
...++....++|.+.+.||+|+||.||+|++ .+++.||+|.+..... ...+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3455666778899999999999999999984 2467899999865533 3446788999999999 799999999
Q ss_pred eEEEECC-EEEEEEeecCCCCHHHHHhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018991 214 GYCVEGA-YRMLVYEYVDNGNLDQWLHGDVGD------------VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (348)
Q Consensus 214 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl 280 (348)
+++...+ ..++||||+++++|.+++...... ...+++..+..++.|++.||.|||++ +|+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccC
Confidence 9987754 589999999999999999765321 12388999999999999999999999 9999999
Q ss_pred CCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 281 KSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 281 kp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||++.++.+||+|||+++........ ......||+.|+|||. |||||||++|+|++ |+.||..
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 999999999999999999999876544332 2334678899999994 99999999999998 9999964
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=282.92 Aligned_cols=191 Identities=29% Similarity=0.442 Sum_probs=152.4
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
+..++|++.+.||+|+||.||+|+.. ..||+|.+.... ....+.+.+|+.++++++||||++++++. .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 34567888899999999999999864 359999986543 23456789999999999999999999965 45568999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 98 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHASE---TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 99999999999996442 4689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-cccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SER-SYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~-~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ........||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 227 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSN 227 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccc
Confidence 322 222334679999999993 999999999999999999964
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=293.91 Aligned_cols=185 Identities=24% Similarity=0.329 Sum_probs=155.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
.+.|.+.+.||+|+||.||+|... +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 456788899999999999999964 68999999985442 233467889999999999999999999997653
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 7899999875 3588999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 228 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 228 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 234578999999994 999999999999999999963
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=276.93 Aligned_cols=189 Identities=26% Similarity=0.366 Sum_probs=158.0
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 356788899999999999999975 68999999986432 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 9999999999999754 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 432 1233568899999984 999999999999999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=288.17 Aligned_cols=190 Identities=23% Similarity=0.340 Sum_probs=160.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEE--------C
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------G 219 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 219 (348)
++|.+.+.||+|+||.||+|+. .+|+.||+|.+..... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 4577889999999999999997 4789999998855432 234567889999999999999999999987 4
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
+..++||||+++ +|.+.+.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCC-CHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccch
Confidence 568999999985 8888776542 4589999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCC---cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSER---SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~---~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++.+.... ........||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 998764322 122234678999999994 999999999999999999963
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.54 Aligned_cols=191 Identities=24% Similarity=0.305 Sum_probs=158.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc-----hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
..++|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3567889999999999999999964 6899999998643221 124678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++ +|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHhcC---cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999986 8998886532 4588889999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+..... ......||+.|+|||. |||||||++|+|++|.+||..
T Consensus 161 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 161 SFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp TTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 7654322 2334578999999994 999999999999999999863
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=278.92 Aligned_cols=188 Identities=24% Similarity=0.346 Sum_probs=166.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
+.|...+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 45777889999999999999964 68899999986553 34457889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.. .++++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999863 3589999999999999999999999 99999999999999999999999999998765432
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 2 2334678999999994 999999999999999999964
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-37 Score=281.99 Aligned_cols=186 Identities=28% Similarity=0.412 Sum_probs=160.5
Q ss_pred CCcCceEeecCceEEEEEEEC-----CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC--CEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-----DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRML 224 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~--~~~~l 224 (348)
|++.+.||+|+||.||++.+. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 366789999999999998753 57899999997553 23456789999999999999999999999884 67899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccc
Confidence 99999999999999753 389999999999999999999999 9999999999999999999999999999887
Q ss_pred cCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 305 CSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 305 ~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... ......+|..|+|||. ||||||+++|+|++|+.||.
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~ 238 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQ 238 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccc
Confidence 554332 2233568888999994 99999999999999999985
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=282.95 Aligned_cols=185 Identities=27% Similarity=0.447 Sum_probs=153.2
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc--CCCCCeeeEeeEEEEC----CE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEG----AY 221 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~----~~ 221 (348)
...++|++.+.||+|+||.||+|+.. ++.||+|.+.... ...+..|.+++.. ++||||+++++++... ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34567899999999999999999985 8899999985432 3344455555555 4899999999999987 78
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCceEEe
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-----EPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~-----~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
.++||||+++|+|.++++.. .+++..++.++.|++.||.|||++. .++|+||||||+|||++.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 99999999999999999653 5899999999999999999999751 2389999999999999999999999
Q ss_pred cccCcccccCCCccc---ccccccCCCcccce----------------eccchHHHHHHHHHhc
Q 018991 297 DFGLAKLLCSERSYV---TTRVMGTFGYAHFI----------------VQVSPLFILLYILLSV 341 (348)
Q Consensus 297 DFGla~~~~~~~~~~---~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g 341 (348)
|||+++.+....... .....||+.|+||| +|||||||++|||++|
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 999998765433221 22457999999999 4999999999999999
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=283.98 Aligned_cols=192 Identities=27% Similarity=0.437 Sum_probs=159.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcE--EEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTK--VAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~--vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|.+.+.||+|+||.||+|+.. ++.. +|+|.+.... ....+.+.+|++++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 56778899999999999999954 5664 4999886532 23445788999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
|||+++++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2234689999999999999999999999 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
||+|||+++...... ......+++.|+|||. |||||||++|+|++ |+.||..
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 244 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 244 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCC
Confidence 999999997533211 1223457889999994 99999999999998 9999964
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=280.49 Aligned_cols=190 Identities=23% Similarity=0.346 Sum_probs=158.4
Q ss_pred hcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+.||+|+||.||+|++.+ +..||+|.+.... ....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4567788999999999999998542 3469999886553 33456789999999999999999999998654 5689
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 90 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK---NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHHT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhcc---ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 999999999999997532 4589999999999999999999999 9999999999999999999999999999877
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
............+++.|+|||. ||||||+++|+|++ |+.||.
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 5544433444567889999994 99999999999998 999995
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.37 Aligned_cols=189 Identities=19% Similarity=0.285 Sum_probs=154.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCCcch-----------HHHHHHHHHHHhcCCCCCeeeEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNRGQA-----------EKEFKVEVEVIGRVRHKNLVRLLG 214 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~H~nIv~l~~ 214 (348)
.++|.+.+.||+|+||.||+|+.. ++..+|+|.+....... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 456788899999999999999975 57789999987653221 123567888999999999999999
Q ss_pred EEEE----CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 215 YCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 215 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
++.. ....|+||||+ +++|.+++... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 77899999999 89999998754 3689999999999999999999999 99999999999999887
Q ss_pred C--ceEEecccCcccccCCCc------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 291 W--NARVSDFGLAKLLCSERS------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 291 ~--~~kl~DFGla~~~~~~~~------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+ .+||+|||+++.+..... .......||+.|+|||+ |||||||++|||++|+.||.
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 7 999999999987643321 11234679999999994 99999999999999999994
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=284.98 Aligned_cols=192 Identities=28% Similarity=0.450 Sum_probs=156.8
Q ss_pred hcCCCcCceEeecCceEEEEEEECC-----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.+.|...+.||+|+||.||+|.... +..||+|.+.... ......+.+|+.++.+++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 4556677899999999999998542 2359999986543 234557889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 9999999999999997542 4689999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... .......+|+.|+|||+ |||||||++|+|++ |+.||..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~ 253 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCccc
Confidence 654322 12222456788999994 99999999999999 9999964
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=288.91 Aligned_cols=186 Identities=24% Similarity=0.244 Sum_probs=151.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
.++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 356888899999999999999964 68899999986542 234467889999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 78999999974 88888853 388999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 228 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 98764322 2334679999999994 999999999999999999963
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=307.55 Aligned_cols=189 Identities=26% Similarity=0.392 Sum_probs=156.2
Q ss_pred CCCcCc-eEeecCceEEEEEEEC---CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 152 GLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 152 ~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++.+.+ .||+|+||.||+|.++ ++..||||.+.... ....+++.+|+++|++++||||+++++++.+ +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333344 7999999999999864 45679999987643 3456789999999999999999999999976 5589999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 999999999999653 24689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCccccc--ccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 307 ERSYVTT--RVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 307 ~~~~~~~--~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....... ...+++.|+|||+ |||||||+||||++ |+.||..
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 542 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542 (613)
T ss_dssp -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 4332222 2345689999994 99999999999998 9999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=291.69 Aligned_cols=198 Identities=26% Similarity=0.384 Sum_probs=166.9
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECC-C-----cEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSD-G-----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
+...++|.+.+.||+|+||.||+|.... + ..||+|.+..... ...+.+.+|+.++.++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 3456778889999999999999999642 2 4799999865532 3456788999999999 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG----------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~ 288 (348)
.+..++||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEEC
Confidence 9999999999999999999864210 124579999999999999999999999 999999999999999
Q ss_pred CCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 289 RQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 289 ~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.++.+||+|||+++........ ......+|+.|+|||. |||||||++|+|++ |..||..
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 269 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPG 269 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999999999876544332 2233567889999993 99999999999998 9999964
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=296.94 Aligned_cols=186 Identities=26% Similarity=0.331 Sum_probs=153.2
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC----C--EEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG----A--YRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~----~--~~~l 224 (348)
.|...+.||+|+||.||+|++. +++.||||++..... ...+|+++|+.++||||+++++++... + ..++
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 4677889999999999999975 689999999865432 233689999999999999999998642 2 3678
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-CceEEecccCccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKL 303 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-~~~kl~DFGla~~ 303 (348)
||||+++ +|.+.+.........+++..+..++.|++.||.|||++ +|+||||||+|||++.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999985 67666543212235689999999999999999999998 99999999999999965 6789999999987
Q ss_pred ccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... .....||+.|+|||+ |||||||+||||++|+.||..
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~ 259 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 259 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 644322 234578999999994 999999999999999999963
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=284.37 Aligned_cols=201 Identities=23% Similarity=0.365 Sum_probs=155.7
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~ 217 (348)
.++....++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 344455677888899999999999999853 34589999986543 233467889999999999999999999998
Q ss_pred ECCE-----EEEEEeecCCCCHHHHHhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 218 EGAY-----RMLVYEYVDNGNLDQWLHGDV--GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 218 ~~~~-----~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
+.+. .++||||+++++|.+++.... .....+++..++.++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCC
Confidence 6543 499999999999999985322 2335689999999999999999999998 99999999999999999
Q ss_pred CceEEecccCcccccCCCccc-ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 291 WNARVSDFGLAKLLCSERSYV-TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 291 ~~~kl~DFGla~~~~~~~~~~-~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+.+||+|||+++......... .....+++.|+|||. ||||||+++|+|++ |+.||..
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 252 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPG 252 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 999999999998765433222 223467888999994 99999999999999 9999864
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=289.15 Aligned_cols=194 Identities=26% Similarity=0.367 Sum_probs=151.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEE--------E
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCV--------E 218 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~--------~ 218 (348)
...+|.+.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3456888899999999999999964 68999999987666666678899999999996 999999999995 3
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--ceecCCCCCCEEECCCCceEEe
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK--VVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~--ivHrdlkp~Nill~~~~~~kl~ 296 (348)
....+++|||+. |+|.+++.... ...++++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345799999996 69999886421 124699999999999999999999998 7 9999999999999999999999
Q ss_pred cccCcccccCCCccc-----------ccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERSYV-----------TTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~-----------~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||+++......... .....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 999998765432211 113468999999993 999999999999999999963
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=283.10 Aligned_cols=198 Identities=22% Similarity=0.273 Sum_probs=149.6
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
....++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+++.+|+.++.+++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 45567899999999999999999995 468899999885442 2344678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 225 VYEYVDNGNLDQWLHGD----VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
||||+++++|.+++... ......+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998631 11235689999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCc----ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERS----YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~----~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+........ .......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 987643321 12233579999999994 999999999999999999964
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-37 Score=282.63 Aligned_cols=181 Identities=23% Similarity=0.299 Sum_probs=158.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEE--CCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVE--GAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~--~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+. .+++.||+|.+... ..+.+.+|+.++.+++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 5678889999999999999995 46899999998533 3567889999999997 9999999999988 66789999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~ 305 (348)
||+++++|.+++. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus 113 e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp ECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999884 378899999999999999999999 999999999999999776 89999999998765
Q ss_pred CCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... .....||..|+|||. |||||||++|+|++|+.||.
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~ 232 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 232 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 4332 233578999999984 99999999999999999994
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=277.03 Aligned_cols=189 Identities=24% Similarity=0.323 Sum_probs=164.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---------cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---------GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVE 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~ 218 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 456788899999999999999975 68899999986543 122356788999999995 9999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|+||||+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999753 4689999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccCCCcccccccccCCCccccee----------------ccchHHHHHHHHHhccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV----------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~----------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|++....... ......|++.|+|||. ||||||+++|+|++|+.||..
T Consensus 169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 9998765432 2234578999999982 999999999999999999953
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=284.55 Aligned_cols=191 Identities=27% Similarity=0.444 Sum_probs=154.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcE----EEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTK----VAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.++|++.+.||+|+||.||+|++. +++. ||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 456888899999999999999964 4443 577777443 3345678999999999999999999999998765 78
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+++||+.+|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 9999999999999997643 4589999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCCc-ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... .......+|+.|+|||. |||||||++|+|++ |+.||..
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~ 222 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 654332 22233457788999994 99999999999999 9999964
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=293.04 Aligned_cols=187 Identities=22% Similarity=0.311 Sum_probs=153.5
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------EEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------YRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------~~~l 224 (348)
.+|.+.+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+ ..++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 347778999999999999999877777999988654322 235899999999999999999996543 3789
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceEEecccCccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKL 303 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~ 303 (348)
||||++++ +.+.+.........+++..+..++.|++.||.|||++ +|+||||||+|||++ .++.+||+|||+++.
T Consensus 116 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 116 VLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999864 4443332111225689999999999999999999999 999999999999999 799999999999987
Q ss_pred ccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... .....||+.|+|||+ |||||||++|||++|++||..
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 244 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 644322 234578999999994 999999999999999999963
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-37 Score=283.39 Aligned_cols=188 Identities=23% Similarity=0.335 Sum_probs=158.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc--------chHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG--------QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
.++|.+.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|++++++++||||+++++++..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 456888899999999999999965 588999999854321 12235788999999999999999999987665
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---eEEec
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSD 297 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~---~kl~D 297 (348)
.|+||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred -eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEcc
Confidence 89999999999999998643 4689999999999999999999999 9999999999999987654 99999
Q ss_pred ccCcccccCCCcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 99998764322 2234679999999993 999999999999999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=295.09 Aligned_cols=188 Identities=16% Similarity=0.201 Sum_probs=152.8
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC---CcchHHHHHHHH---HHHhcCCCCCeeeEe-------eE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN---RGQAEKEFKVEV---EVIGRVRHKNLVRLL-------GY 215 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~ 215 (348)
.++|.+.+.||+|+||.||+|+. .+|+.||||.+... .....+.+.+|+ +++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35577788999999999999995 57999999998643 334557788999 555666899999998 66
Q ss_pred EEECC-----------------EEEEEEeecCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 018991 216 CVEGA-----------------YRMLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275 (348)
Q Consensus 216 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~i 275 (348)
+.+.+ ..|++|||+ +|+|.+++..... ....+++..++.++.|++.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 5799999975311 112344688889999999999999999 99
Q ss_pred eecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCccccee---------------------ccchHHHH
Q 018991 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV---------------------QVSPLFIL 334 (348)
Q Consensus 276 vHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~---------------------DiwSlG~i 334 (348)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||+ |||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2334567 89999883 99999999
Q ss_pred HHHHHhccCCCC
Q 018991 335 LYILLSVRYNSS 346 (348)
Q Consensus 335 l~el~~g~~Pf~ 346 (348)
||||++|+.||.
T Consensus 303 l~elltg~~Pf~ 314 (377)
T 3byv_A 303 IYWIWCADLPIT 314 (377)
T ss_dssp HHHHHHSSCCC-
T ss_pred HHHHHHCCCCCc
Confidence 999999999995
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-37 Score=287.20 Aligned_cols=189 Identities=24% Similarity=0.335 Sum_probs=162.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 222 (348)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ....+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 346888899999999999999965 68899999986543 23346788999999999999999999999765 368
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||+. |+|.+++... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 5999998643 589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
........ ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 76543222 1234689999999994 999999999999999999963
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=280.03 Aligned_cols=191 Identities=28% Similarity=0.407 Sum_probs=160.2
Q ss_pred HhcCCCcCc-eEeecCceEEEEEEEC---CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 149 ATSGLCEEN-VIGEGGYGIVYRGILS---DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 149 ~~~~~~~~~-~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
..++|.+.+ .||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+++++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345666667 8999999999999642 46789999986542 23356799999999999999999999999 56678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 9999999999999999754 4589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcccc--cccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 303 LLCSERSYVT--TRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~--~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......... ....+++.|+|||. ||||||+++|+|++ |+.||..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 223 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 223 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCC
Confidence 7755443222 22446788999994 99999999999999 9999964
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=282.55 Aligned_cols=188 Identities=30% Similarity=0.447 Sum_probs=152.6
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||++++. ++.||+|.+... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 345777899999999999999985 788999988533 345678999999999999999999998763 478999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc-eEEecccCcccccCCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN-ARVSDFGLAKLLCSER 308 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~-~kl~DFGla~~~~~~~ 308 (348)
++|+|.+++.... ....+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH- 159 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence 9999999997542 2235788999999999999999999931128999999999999998886 799999999865432
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.....||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 205 (307)
T 2eva_A 160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTT
T ss_pred ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchh
Confidence 223469999999994 999999999999999999964
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=277.21 Aligned_cols=192 Identities=24% Similarity=0.323 Sum_probs=160.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC----cchHHHHHHHHHHHhcCCCCCeeeEeeEEE--ECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKNLVRLLGYCV--EGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~--~~~~~ 222 (348)
.++|.+.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|++++++++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 357889999999999999999964 68899999986432 234567899999999999999999999985 44578
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||++++ |.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999876 777776532 24689999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCc-ccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERS-YVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~-~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....... .......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 7643221 22234568999999983 999999999999999999963
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=280.00 Aligned_cols=189 Identities=26% Similarity=0.385 Sum_probs=163.1
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhc--CCCCCeeeEeeEEEECC----
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLGYCVEGA---- 220 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~l~~~~~~~~---- 220 (348)
....++|.+.+.||+|+||.||+|+. +++.||+|.+... ....+..|.+++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 44567799999999999999999998 4889999998532 34567788888887 78999999999998876
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCceecCCCCCCEEECCCCc
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--------EGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--------~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
..++||||+++|+|.+++... .+++..++.++.|++.||.||| ++ +|+||||||+|||++.++.
T Consensus 114 ~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~ 185 (342)
T 1b6c_B 114 QLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGT 185 (342)
T ss_dssp CEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSC
T ss_pred eeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCC
Confidence 789999999999999999753 5899999999999999999999 77 9999999999999999999
Q ss_pred eEEecccCcccccCCCcc---cccccccCCCcccce----------------eccchHHHHHHHHHhc----------cC
Q 018991 293 ARVSDFGLAKLLCSERSY---VTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSV----------RY 343 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~---~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g----------~~ 343 (348)
+||+|||+++........ ......||+.|+||| +|||||||++|||++| +.
T Consensus 186 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~ 265 (342)
T 1b6c_B 186 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 265 (342)
T ss_dssp EEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccccc
Confidence 999999999876544322 223457999999998 3999999999999999 78
Q ss_pred CCCC
Q 018991 344 NSST 347 (348)
Q Consensus 344 Pf~~ 347 (348)
||..
T Consensus 266 p~~~ 269 (342)
T 1b6c_B 266 PYYD 269 (342)
T ss_dssp TTTT
T ss_pred Cccc
Confidence 8853
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=286.53 Aligned_cols=189 Identities=21% Similarity=0.317 Sum_probs=164.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcc-----------------hHHHHHHHHHHHhcCCCCCeeeE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ-----------------AEKEFKVEVEVIGRVRHKNLVRL 212 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~H~nIv~l 212 (348)
.++|.+.+.||+|+||.||+|.. +++.||+|.+...... ..+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 45688889999999999999999 8999999998643211 11788999999999999999999
Q ss_pred eeEEEECCEEEEEEeecCCCCHHHH------HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCE
Q 018991 213 LGYCVEGAYRMLVYEYVDNGNLDQW------LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNI 285 (348)
Q Consensus 213 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Ni 285 (348)
++++.+.+..++||||+++++|.++ +... ....+++..+..++.|++.||.|||+ + +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 5432 23579999999999999999999998 8 999999999999
Q ss_pred EECCCCceEEecccCcccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCCC
Q 018991 286 LLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 286 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|++.++.+||+|||++...... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999876433 2334578899999884 999999999999999999963
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=279.38 Aligned_cols=190 Identities=27% Similarity=0.360 Sum_probs=161.1
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
..+.|.+.+.||+|+||.||+|... +|+.||+|.+.... ..+.+.+|+.++..++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4567888899999999999999975 58999999986543 34578889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++++|.+++... ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999998632 24689999999999999999999998 9999999999999999999999999999876443
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 22 2234578999999994 999999999999999999964
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-37 Score=282.52 Aligned_cols=191 Identities=25% Similarity=0.403 Sum_probs=163.7
Q ss_pred hcCCCcCceEeecCceEEEEEEE-----CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC--EE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA--YR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~--~~ 222 (348)
.++|++.+.||+|+||.||+|++ .+++.||+|.+........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 34577788999999999999984 358899999997766666678999999999999999999999986543 67
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+++++|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST---TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 99999999999999997642 4589999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCccc--ccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSYV--TTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~~--~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
......... .....++..|+|||. ||||||+++|+|++|+.||.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~ 249 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSK 249 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGG
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 875543321 222457778999994 99999999999999998875
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=282.12 Aligned_cols=191 Identities=20% Similarity=0.291 Sum_probs=160.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.+.|++.+.||+|+||.||+|+.. +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 456888899999999999999975 5889999998766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 98 CPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CTTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred CCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 99999999886532 4589999999999999999999999 99999999999999999999999999976432211
Q ss_pred cccccccccCCCcccce---------------eccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFI---------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe---------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......||+.|+||| +||||||+++|+|++|+.||..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 1122357899999998 3999999999999999999964
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=290.58 Aligned_cols=189 Identities=28% Similarity=0.425 Sum_probs=148.9
Q ss_pred CCcCceEeecCceEEEEEEEC--CC--cEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCEEEEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS--DG--TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~ 226 (348)
|.+.+.||+|+||.||+|++. ++ ..||+|.+.... ....+.+.+|+.++++++||||+++++++.. ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 556688999999999999853 22 368999886543 3445789999999999999999999998754 56789999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 171 e~~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccc
Confidence 9999999999997542 4578999999999999999999999 999999999999999999999999999987644
Q ss_pred CCcc---cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 307 ERSY---VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 307 ~~~~---~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.... ......+|+.|+|||+ |||||||++|||++ |.+||..
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~ 299 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD 299 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCC
Confidence 3221 1233567788999994 99999999999999 7888863
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-37 Score=282.26 Aligned_cols=194 Identities=22% Similarity=0.311 Sum_probs=162.2
Q ss_pred HHHhcCCCcC-ceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCE
Q 018991 147 EAATSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAY 221 (348)
Q Consensus 147 ~~~~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~ 221 (348)
+.-.+.|.+. +.||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++..+. ||||+++++++.+.+.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3344456665 78999999999999965 68999999986542 334678889999999994 6999999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDF 298 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DF 298 (348)
.++||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPEL--AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EEEEEEecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 999999999999999986432 25689999999999999999999999 9999999999999987 789999999
Q ss_pred cCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 299 GLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+++...... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 179 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 179 GMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp GGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9998764332 2234679999999994 999999999999999999963
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=291.09 Aligned_cols=187 Identities=20% Similarity=0.222 Sum_probs=160.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC------CCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV------RHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~l~~~~~~~~~~ 222 (348)
..+|++.+.||+|+||.||+|+.. +++.||||.+.... ...+.+..|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 446888899999999999999965 58899999986432 3345677788887776 578999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc--eEEecccC
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--ARVSDFGL 300 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~--~kl~DFGl 300 (348)
++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999996 69999987643 24589999999999999999999999 9999999999999999887 99999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .....||+.|+|||+ |||||||+||||++|++||..
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 9765332 223579999999994 999999999999999999963
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=283.28 Aligned_cols=196 Identities=23% Similarity=0.326 Sum_probs=162.0
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE----
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE---- 218 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~---- 218 (348)
++....+.|.+.+.||+|+||.||+|+.. +++.||+|.+.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 33445677888999999999999999964 68999999986543 3346788999999998 79999999999987
Q ss_pred --CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEe
Q 018991 219 --GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 219 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
.+..++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+|+||||+|||++.++.+||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEEC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEe
Confidence 468899999999999999997542 24688999999999999999999999 99999999999999999999999
Q ss_pred cccCcccccCCCcccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||++........ ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 172 Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp CCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999987643221 2233578999999983 999999999999999999964
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=278.88 Aligned_cols=188 Identities=23% Similarity=0.345 Sum_probs=155.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEE------------
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV------------ 217 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~------------ 217 (348)
++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 56778899999999999999976 58999999997766666678999999999999999999999873
Q ss_pred --ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceE
Q 018991 218 --EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNAR 294 (348)
Q Consensus 218 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~k 294 (348)
+....++||||++ |+|.+++.. .++++..+..++.|++.||.|||++ +|+||||||+|||++ +++.+|
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3467899999998 699999853 3588999999999999999999999 999999999999997 567999
Q ss_pred EecccCcccccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 295 VSDFGLAKLLCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|||+++....... .......+|..|+|||. |||||||++|+|++|+.||..
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 999999987643221 12233567899999993 999999999999999999964
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=276.95 Aligned_cols=186 Identities=27% Similarity=0.445 Sum_probs=160.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---------- 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 218 (348)
..+|++.+.||+|+||.||+|+.. +++.||+|.+.... +.+.+|++++.+++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 345788899999999999999975 78999999986544 346679999999999999999998864
Q ss_pred ------CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc
Q 018991 219 ------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292 (348)
Q Consensus 219 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~ 292 (348)
....++||||+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCC
Confidence 345799999999999999997532 24689999999999999999999999 9999999999999999999
Q ss_pred eEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+||+|||+++....... .....||+.|+|||. ||||||+++|+|++|..||.
T Consensus 161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~ 222 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF 222 (284)
T ss_dssp EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch
Confidence 99999999987654332 233579999999994 99999999999999998863
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=276.83 Aligned_cols=190 Identities=28% Similarity=0.423 Sum_probs=156.8
Q ss_pred cCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEE-ECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~-~~~~~~l 224 (348)
..|.+.+.||+|+||.||+|+..+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 346677899999999999998542 2358999886543 334567889999999999999999999865 4567899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHCTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 999999999999997532 4588999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCcc---cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 305 CSERSY---VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 305 ~~~~~~---~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
...... ......+|+.|+|||. ||||||+++|+|++ |.+||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 234 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCc
Confidence 543321 2233567888999994 99999999999999 666664
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.96 Aligned_cols=185 Identities=25% Similarity=0.330 Sum_probs=143.6
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------C
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------A 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~ 220 (348)
.++|.+.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 35788889999999999999995 468999999986542 23456788999999999999999999999754 5
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+++||+ +++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 6799988853 3589999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .....||+.|+|||+ |||||||++|||++|++||..
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 232 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 232 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9875432 234679999999993 999999999999999999963
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=277.79 Aligned_cols=194 Identities=23% Similarity=0.271 Sum_probs=151.0
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc-chH-HHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG-QAE-KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
..++|++.+.||+|+||.||+|+. .+++.||+|.+..... ... +.+..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 346688889999999999999996 4789999999865432 222 3344455568888999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||++ |+|.+++.........+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99998 588887754222335799999999999999999999984 289999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee--------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV--------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~--------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 4322 233479999999995 999999999999999999963
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.45 Aligned_cols=185 Identities=22% Similarity=0.317 Sum_probs=142.5
Q ss_pred CceEeecCceEEEEEEEC---CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEEEeecC
Q 018991 156 ENVIGEGGYGIVYRGILS---DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLVYEYVD 230 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv~e~~~ 230 (348)
+++||+|+||.||+|+.. +++.||+|.+.... ....+.+|+.+|++++||||+++++++.. ....|+||||+.
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 457999999999999965 47889999886443 23467889999999999999999999965 678999999997
Q ss_pred CCCHHHHHhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE----CCCCceEEecccCc
Q 018991 231 NGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL----DRQWNARVSDFGLA 301 (348)
Q Consensus 231 ~g~L~~~l~~~-----~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill----~~~~~~kl~DFGla 301 (348)
++|.+++... ......+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp -EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred -CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 5888877521 11223589999999999999999999999 99999999999999 67789999999999
Q ss_pred ccccCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+....... .......||+.|+|||+ |||||||+||+|++|++||.
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCC
Confidence 87654321 22334689999999994 99999999999999999995
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=275.28 Aligned_cols=187 Identities=26% Similarity=0.382 Sum_probs=156.0
Q ss_pred CCcCceEeecCceEEEEEEEC-CC---cEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE-EEEE
Q 018991 153 LCEENVIGEGGYGIVYRGILS-DG---TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR-MLVY 226 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~-~lv~ 226 (348)
|...+.||+|+||.||+|++. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. +++|
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~ 102 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL 102 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEE
Confidence 445688999999999999853 22 3799998865433 3456788999999999999999999999876555 9999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+.+|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 103 e~~~~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 103 PYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp CCCTTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred ecccCCCHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 9999999999997532 4688999999999999999999999 999999999999999999999999999987644
Q ss_pred CCc---ccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 307 ERS---YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 307 ~~~---~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
... .......+++.|++||. ||||||+++|+|++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~ 228 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCC
Confidence 321 12223567889999994 9999999999999955554
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=288.22 Aligned_cols=186 Identities=18% Similarity=0.218 Sum_probs=157.8
Q ss_pred hcCCCcCceEeecCceEEEEEEECC---------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeee---------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSD---------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR--------- 211 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------- 211 (348)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++.+++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3567788999999999999999653 789999998644 35778999999999999887
Q ss_pred ------EeeEEEE-CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCC
Q 018991 212 ------LLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284 (348)
Q Consensus 212 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~N 284 (348)
+++++.. +...++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 67899999999 899999997541 24689999999999999999999999 99999999999
Q ss_pred EEECCCC--ceEEecccCcccccCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 285 ILLDRQW--NARVSDFGLAKLLCSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 285 ill~~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
||++.++ .+||+|||+++.+...... ......||+.|+|||. |||||||+||+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876543221 1233579999999994 99999999999999999996
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-36 Score=274.21 Aligned_cols=190 Identities=21% Similarity=0.312 Sum_probs=156.9
Q ss_pred HhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEE-EECCEEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC-VEGAYRMLVY 226 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~ 226 (348)
..++|.+.+.||+|+||.||+|+. .+++.||+|.+..... ...+..|+.++..++|++++..+..+ ...+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 346788999999999999999996 5789999998754322 23577899999999988766665554 6778899999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~ 303 (348)
||+ +++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 e~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 899999997432 4589999999999999999999999 99999999999999 7889999999999987
Q ss_pred ccCCCc------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERS------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... .......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcc
Confidence 654432 12234679999999995 999999999999999999964
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=305.08 Aligned_cols=183 Identities=27% Similarity=0.414 Sum_probs=153.6
Q ss_pred ceEeecCceEEEEEEEC---CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILS---DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|.+. +++.||||++.... ....+++.+|+++|++++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 46789999986543 2346789999999999999999999999965 457899999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCcc-
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY- 310 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~- 310 (348)
|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+......
T Consensus 454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 9999999754 4689999999999999999999999 9999999999999999999999999999877544322
Q ss_pred -cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 311 -VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 311 -~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
......+|+.|+|||+ |||||||+||||++ |+.||..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~ 575 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 575 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2223457788999994 99999999999998 9999964
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-36 Score=272.60 Aligned_cols=189 Identities=21% Similarity=0.313 Sum_probs=159.7
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEE-EECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC-VEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~-~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+. .+++.||+|.+..... .+.+.+|+.++..++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 45688889999999999999996 5789999998865432 24588899999999988766555544 67788899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~~ 304 (348)
|+ +++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 86 ~~-~~~L~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 899999997432 4689999999999999999999999 99999999999999 48889999999999876
Q ss_pred cCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ......||+.|+|||. |||||||++|+|++|+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 217 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 554321 1234679999999994 999999999999999999964
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=288.64 Aligned_cols=184 Identities=10% Similarity=-0.025 Sum_probs=140.1
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHH---HHHhcCCCCCeeeEe-------eEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEV---EVIGRVRHKNLVRLL-------GYCV 217 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~H~nIv~l~-------~~~~ 217 (348)
+|...+.||+|+||.||+|++. +++.||+|.+..... ...+.+.+|+ .+|.. +||||++++ +++.
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhee
Confidence 4667889999999999999965 789999999976543 2345677775 45555 799988755 5554
Q ss_pred EC-----------------CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 018991 218 EG-----------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR------MNIILGTAKGLAYLHEGLEPK 274 (348)
Q Consensus 218 ~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~aL~yLH~~~~~~ 274 (348)
.. ...|+||||++ |+|.+++.... ..+.+..+ ..++.|++.||.|||++ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ 214 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK---G 214 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---C
Confidence 43 33799999999 89999997531 12344444 67779999999999999 9
Q ss_pred ceecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhcc
Q 018991 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVR 342 (348)
Q Consensus 275 ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~ 342 (348)
|+||||||+|||++.++.+||+|||+++..... .....+|+.|+|||+ |||||||+||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999876422 223467799999994 9999999999999999
Q ss_pred CCCCC
Q 018991 343 YNSST 347 (348)
Q Consensus 343 ~Pf~~ 347 (348)
+||..
T Consensus 291 ~Pf~~ 295 (371)
T 3q60_A 291 LPFGL 295 (371)
T ss_dssp CSTTB
T ss_pred CCCCC
Confidence 99963
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-37 Score=282.44 Aligned_cols=196 Identities=25% Similarity=0.373 Sum_probs=160.7
Q ss_pred HhcCCCcCceEeecCceEEEEEEE------CCCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
..++|.+.+.||+|+||.||+|++ .++..||+|.+... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 345688889999999999999983 24678999998644 33445678899999999999999999999999989
Q ss_pred EEEEEeecCCCCHHHHHhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEE
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVG---DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARV 295 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl 295 (348)
.|+||||+++++|.+++..... ....+++..++.++.|++.||.|||++ +|+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999976432 124588999999999999999999999 9999999999999984 456999
Q ss_pred ecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 296 SDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 296 ~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+|||+++........ ......||+.|+|||. ||||||+++|+|++ |+.||..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 248 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPS 248 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999865433322 2233568899999994 99999999999998 9999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=282.29 Aligned_cols=189 Identities=23% Similarity=0.302 Sum_probs=160.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~~ 222 (348)
.++|.+.+.||+|+||.||+|+.. +|+.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 456788899999999999999965 68999999986443 23446788999999999999999999988754 678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999997 599999865 3589999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcc---------cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERSY---------VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~---------~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
........ ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 76532211 1223578999999993 999999999999999999963
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=284.42 Aligned_cols=197 Identities=18% Similarity=0.219 Sum_probs=151.3
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE-
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY- 221 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~- 221 (348)
.......++|.+.+.||+|+||.||+|+.. +++.||||.+..... .......|++.+..++||||+++++++...+.
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 344566788999999999999999999974 689999998865432 22345667888888999999999999976433
Q ss_pred ------EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCceecCCCCCCEEECC-CCc
Q 018991 222 ------RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH--EGLEPKVVHRDVKSSNILLDR-QWN 292 (348)
Q Consensus 222 ------~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH--~~~~~~ivHrdlkp~Nill~~-~~~ 292 (348)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| ++ +|+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence 7899999986 665554432223356889999999999999999999 77 9999999999999996 899
Q ss_pred eEEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 293 ARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 293 ~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+||+|||+++.+..... .....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 171 ~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp EEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 99999999987654332 234578999999994 999999999999999999964
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=284.86 Aligned_cols=184 Identities=24% Similarity=0.325 Sum_probs=156.5
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE----
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR---- 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~---- 222 (348)
.++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 456788899999999999999965 68999999986543 23356788999999999999999999999877654
Q ss_pred --EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 223 --MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 223 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
++||||+. ++|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999998 68988874 2489999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .....||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 9865432 234578999999993 999999999999999999964
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=276.52 Aligned_cols=188 Identities=29% Similarity=0.440 Sum_probs=151.7
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHH--HhcCCCCCeeeEeeEEEE-----CCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVRLLGYCVE-----GAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~l~~~~~~-----~~~~ 222 (348)
.++|++.+.||+|+||.||+|+. +++.||+|.+.... ...+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 45678889999999999999987 57899999986432 3334444444 556899999999986643 2367
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCceecCCCCCCEEECCCCceEEe
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL------EPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
++||||+++|+|.+++... ..++..+..++.|++.||.|||++. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999754 3588899999999999999999752 2389999999999999999999999
Q ss_pred cccCcccccCCCc-------ccccccccCCCccccee-----------------ccchHHHHHHHHHhccCCCC
Q 018991 297 DFGLAKLLCSERS-------YVTTRVMGTFGYAHFIV-----------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 297 DFGla~~~~~~~~-------~~~~~~~gt~~y~~pe~-----------------DiwSlG~il~el~~g~~Pf~ 346 (348)
|||+++.+..... .......||+.|+|||+ |||||||++|||++|+.||.
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 9999987654321 12223579999999993 99999999999999977763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=271.59 Aligned_cols=189 Identities=24% Similarity=0.322 Sum_probs=164.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+.... ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 456888999999999999999975 68999999986542 234677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC---CceEEecccCccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKL 303 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~---~~~kl~DFGla~~ 303 (348)
||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 999999999988643 3589999999999999999999999 99999999999999754 4699999999987
Q ss_pred ccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... .....||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 174 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 174 FQQNTK--MKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp BCCCSS--CSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ecCCCc--cccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 644322 233468899999984 999999999999999999963
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=276.25 Aligned_cols=187 Identities=22% Similarity=0.266 Sum_probs=160.4
Q ss_pred hcCCCcCceEeecCceEEEEEEE-C-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC------CeeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-S-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK------NLVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv~l~~~~~~~~~ 221 (348)
.++|++.+.||+|+||.||+|.. . +++.||+|.+... ....+.+.+|++++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35688889999999999999986 3 5889999988643 23456788899999888765 49999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC------------
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR------------ 289 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~------------ 289 (348)
.++||||+ +++|.+++.... ..++++..+..++.|++.||.|||++ +|+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 789999997642 24688999999999999999999999 9999999999999987
Q ss_pred -------CCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 290 -------QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 290 -------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++.+||+|||+++..... .....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 668999999999865432 234578999999994 999999999999999999964
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=276.99 Aligned_cols=191 Identities=27% Similarity=0.371 Sum_probs=158.8
Q ss_pred HhcCCCcCceEeecCceEEEEEEE--CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcC---CCCCeeeEeeEEE----
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGIL--SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRV---RHKNLVRLLGYCV---- 217 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~---- 217 (348)
..++|.+.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 346788889999999999999997 3578999998854321 1123455677766655 8999999999987
Q ss_pred -ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEe
Q 018991 218 -EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVS 296 (348)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~ 296 (348)
.....++||||+. |+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999998 69999997542 23589999999999999999999999 99999999999999999999999
Q ss_pred cccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 297 DFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 297 DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|||+++...... ......||+.|+|||+ |||||||++|+|++|+.||..
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 999998764322 2334678999999994 999999999999999999963
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=273.20 Aligned_cols=186 Identities=32% Similarity=0.414 Sum_probs=152.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-CEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-AYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-~~~~lv~e~ 228 (348)
.++|++.+.||+|+||.||++... ++.||+|.+.... ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 456788899999999999999874 7899999886433 456788999999999999999999997654 468999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+++++|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 171 (278)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc
Confidence 99999999996531 12378899999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....+++.|+|||. ||||||+++|+|++ |+.||..
T Consensus 172 ----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 217 (278)
T 1byg_A 172 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 217 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCC
Confidence 22467889999994 99999999999998 9999964
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=288.83 Aligned_cols=189 Identities=21% Similarity=0.290 Sum_probs=160.6
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC-CCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e 227 (348)
.++|.+.+.||+|+||.||+|+. .+++.||||.+..... ..++..|++++..++| +++..+..++...+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 35688899999999999999996 4689999998764432 2357789999999986 566677777788899999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE---CCCCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill---~~~~~~kl~DFGla~~~ 304 (348)
|+ +++|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||+++.+
T Consensus 84 ~~-g~sL~~ll~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 899999997432 4689999999999999999999999 99999999999999 68899999999999876
Q ss_pred cCCCcc------cccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSY------VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~------~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
...... ......||+.|++||. |||||||+||||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~ 215 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 544321 1224689999999995 999999999999999999974
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=278.28 Aligned_cols=196 Identities=20% Similarity=0.304 Sum_probs=161.4
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCC--CCCeeeEeeEEEE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVE 218 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~ 218 (348)
+..+....++|.+.+.||+|+||.||++...+++.||+|.+.... ....+.+.+|+.++.+++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 333444566788899999999999999998889999999986543 334567889999999997 5999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecc
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDF 298 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DF 298 (348)
.+..++||| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+++ +.+||+||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCC
T ss_pred CCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeec
Confidence 999999999 5678999999754 4688999999999999999999999 9999999999999965 89999999
Q ss_pred cCcccccCCCcc-cccccccCCCccccee---------------------ccchHHHHHHHHHhccCCCCC
Q 018991 299 GLAKLLCSERSY-VTTRVMGTFGYAHFIV---------------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 299 Gla~~~~~~~~~-~~~~~~gt~~y~~pe~---------------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+++........ ......||+.|+|||. ||||||+++|+|++|+.||..
T Consensus 171 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 171 GIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp SSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 999876543322 2234578999999983 999999999999999999964
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=303.84 Aligned_cols=194 Identities=21% Similarity=0.284 Sum_probs=160.9
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY 221 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~ 221 (348)
+...++|.+.+.||+|+||.||+|.+.. +..||+|.+.... ....+.+.+|+.++++++||||+++++++. ++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 3445678888999999999999999642 4579999886543 334467899999999999999999999985 456
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRK---FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTT---TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCC
Confidence 899999999999999997542 3589999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+..............+|+.|+|||+ |||||||++|||++ |+.||..
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 595 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 9876554444445667889999994 99999999999997 9999964
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=274.20 Aligned_cols=191 Identities=24% Similarity=0.345 Sum_probs=152.9
Q ss_pred hcCCCcCceEeecCceEEEEEEEC--CCc--EEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS--DGT--KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
.++|++.+.||+|+||.||+|++. ++. .||+|.+... .....+.+.+|++++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 456778899999999999999853 233 6899988654 2334567899999999999999999999998765 8
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
++|+||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhcc---CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 89999999999999997532 4588999999999999999999999 99999999999999999999999999998
Q ss_pred cccCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 303 LLCSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
........ ......+|..|+|||. ||||||+++|+|++ |+.||..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 227 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 227 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 77544322 2223567888999994 99999999999999 9999964
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-36 Score=272.12 Aligned_cols=184 Identities=26% Similarity=0.405 Sum_probs=151.7
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---------- 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~---------- 218 (348)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 345788899999999999999964 7899999998543 2345678899999999999999999998865
Q ss_pred ---CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 219 ---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 219 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
.+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSEN---LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSC---GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhccc---cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEE
Confidence 356799999999999999997532 4578899999999999999999999 9999999999999999999999
Q ss_pred ecccCcccccCCC-------------cccccccccCCCccccee-----------ccchHHHHHHHHHh
Q 018991 296 SDFGLAKLLCSER-------------SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLS 340 (348)
Q Consensus 296 ~DFGla~~~~~~~-------------~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~ 340 (348)
+|||+++...... ........||+.|+|||+ |||||||++|+|++
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 9999998764321 112234578999999994 99999999999997
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=277.41 Aligned_cols=191 Identities=30% Similarity=0.359 Sum_probs=155.8
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc------hHHHHHHHHHHHhcC----CCCCeeeEeeE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRV----RHKNLVRLLGY 215 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~H~nIv~l~~~ 215 (348)
+.-.++|.+.+.||+|+||.||+|+. .+++.||+|.+...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34467799999999999999999985 46889999998654321 122355688888888 89999999999
Q ss_pred EEECCEEEEEEee-cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCce
Q 018991 216 CVEGAYRMLVYEY-VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNA 293 (348)
Q Consensus 216 ~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~ 293 (348)
+.+.+..++|+|| +.+++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+||+++ .++.+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 179 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCA 179 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeE
Confidence 9999999999999 7899999999754 4589999999999999999999999 999999999999999 88999
Q ss_pred EEecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
||+|||+++...... .....||..|+|||. ||||||+++|+|++|+.||..
T Consensus 180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 241 (312)
T 2iwi_A 180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER 241 (312)
T ss_dssp EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence 999999998765432 234579999999993 999999999999999999963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-36 Score=280.61 Aligned_cols=183 Identities=24% Similarity=0.323 Sum_probs=155.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE------
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY------ 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~------ 221 (348)
++|...+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 46777899999999999999964 68999999986543 2334678899999999999999999999987653
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+. ++|.+++. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred EEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999998 58887764 2489999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... .....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 865432 234578999999993 999999999999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-36 Score=282.92 Aligned_cols=187 Identities=22% Similarity=0.278 Sum_probs=156.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC--------CCCeeeEeeEEE---
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--------HKNLVRLLGYCV--- 217 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~l~~~~~--- 217 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 356888899999999999999954 6889999998643 234567888999999885 788999999987
Q ss_pred -ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-----
Q 018991 218 -EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----- 291 (348)
Q Consensus 218 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----- 291 (348)
+....++||||+ +++|.+++.... ...+++..+..++.|++.||.|||++. +|+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSN--YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhh
Confidence 445789999999 557766665432 246899999999999999999999852 799999999999999775
Q ss_pred --------------------------------------------ceEEecccCcccccCCCcccccccccCCCccccee-
Q 018991 292 --------------------------------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV- 326 (348)
Q Consensus 292 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~- 326 (348)
.+||+|||+++..... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 233579999999994
Q ss_pred ---------ccchHHHHHHHHHhccCCCC
Q 018991 327 ---------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 327 ---------DiwSlG~il~el~~g~~Pf~ 346 (348)
|||||||+||||++|++||.
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~ 294 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFE 294 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999996
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-35 Score=273.23 Aligned_cols=185 Identities=22% Similarity=0.230 Sum_probs=138.6
Q ss_pred hcCCCcC-ceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEE
Q 018991 150 TSGLCEE-NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRM 223 (348)
Q Consensus 150 ~~~~~~~-~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~ 223 (348)
.++|.+. ++||+|+||.||+|+.. +++.||+|.+.... .. .......+..++||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-KA---RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-HH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-HH---HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 3456663 46999999999999976 68999999986432 11 2222334566799999999999976 44589
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccC
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGl 300 (348)
+||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERG--DQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence 9999999999999997542 24689999999999999999999999 9999999999999976 45599999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
++..... ......||+.|+|||+ |||||||++|+|++|+.||.
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 230 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFY 230 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 9865432 2234578999999995 99999999999999999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=269.28 Aligned_cols=170 Identities=13% Similarity=0.022 Sum_probs=147.6
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.++.+++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 45778899999999999999975 589999999865532 23467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++... .....+..++.|++.||.|||++ +|+||||||+|||++.++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~---- 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP---- 177 (286)
T ss_dssp ECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCT----
T ss_pred EecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccC----
Confidence 999999999999532 34556888999999999999999 99999999999999999999998664321
Q ss_pred CCcccccccccCCCcccceeccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~DiwSlG~il~el~~g~~Pf~~ 347 (348)
...+.+|||||||+||||++|+.||..
T Consensus 178 --------------~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 178 --------------DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp --------------TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred --------------CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 135678999999999999999999963
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=278.72 Aligned_cols=189 Identities=21% Similarity=0.234 Sum_probs=159.3
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CC-----CeeeEeeEEEECCEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HK-----NLVRLLGYCVEGAYR 222 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~-----nIv~l~~~~~~~~~~ 222 (348)
.++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....++..|+.++..++ |+ +|+++++++...+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 131 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHL 131 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEE
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCce
Confidence 567888999999999999999965 68899999986432 33456778888888875 55 499999999999999
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCceEEecccC
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGL 300 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~--~~~~~kl~DFGl 300 (348)
++||||+. ++|.+++.... ...+++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 132 ~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 132 CLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 99999996 59999997642 24589999999999999999999953 23899999999999994 578899999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
++..... .....||+.|+|||+ |||||||+||||++|++||..
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 234679999999994 999999999999999999973
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-36 Score=286.79 Aligned_cols=186 Identities=25% Similarity=0.295 Sum_probs=145.9
Q ss_pred CcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
...+.||+|+||+||.+...+|+.||||.+... ..+.+.+|+.++.++ +||||+++++++.+++..|+||||+. |
T Consensus 18 ~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 18 VSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred eccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 345789999999998776667999999998643 235677899999876 89999999999999999999999996 6
Q ss_pred CHHHHHhcCCCCCCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC-------------CceEEe
Q 018991 233 NLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ-------------WNARVS 296 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~-------------~~~kl~ 296 (348)
+|.+++......... .++..++.++.|++.||.|||++ +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999764321111 12334578999999999999999 99999999999999654 489999
Q ss_pred cccCcccccCCCcc---cccccccCCCcccce-----------------eccchHHHHHHHHHh-ccCCCC
Q 018991 297 DFGLAKLLCSERSY---VTTRVMGTFGYAHFI-----------------VQVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 297 DFGla~~~~~~~~~---~~~~~~gt~~y~~pe-----------------~DiwSlG~il~el~~-g~~Pf~ 346 (348)
|||+++.+...... ......||+.|+||| +|||||||++|||++ |+.||.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 99999987554322 123467999999999 499999999999999 999996
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=278.07 Aligned_cols=192 Identities=27% Similarity=0.348 Sum_probs=163.5
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc------hHHHHHHHHHHHhcCC--CCCeeeEeeEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ------AEKEFKVEVEVIGRVR--HKNLVRLLGYC 216 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--H~nIv~l~~~~ 216 (348)
.+...++|.+.+.||+|+||.||+|+. .+++.||+|.+...... ..+.+..|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 344566788899999999999999995 46889999998654221 2234667899999996 59999999999
Q ss_pred EECCEEEEEEeecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceE
Q 018991 217 VEGAYRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNAR 294 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~k 294 (348)
.+.+..++|+|++.+ ++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ +++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999986 8999998753 4689999999999999999999999 999999999999999 789999
Q ss_pred EecccCcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 295 VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 295 l~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+|||+++...... .....||+.|+|||. |||||||++|||++|+.||..
T Consensus 191 L~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 251 (320)
T 3a99_A 191 LIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 251 (320)
T ss_dssp ECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred EeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence 99999998765432 234579999999993 999999999999999999963
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=278.80 Aligned_cols=196 Identities=24% Similarity=0.319 Sum_probs=160.5
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA 220 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~ 220 (348)
..+++...++|.+.+.||+|+||.||+|+..+ .+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44455567889999999999999999999754 59999885432 223345778999999999999999999999999
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..+++|||+++++|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++ ++.+||+|||+
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~ 175 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK---IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGL 175 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC---CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred ceEEEeecccCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCC
Confidence 9999999999999999997532 4688999999999999999999999 999999999999998 67999999999
Q ss_pred cccccCCC----cccccccccCCCcccce-------------------eccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSER----SYVTTRVMGTFGYAHFI-------------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~----~~~~~~~~gt~~y~~pe-------------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
++...... ........||+.|+||| +||||||+++|+|++|+.||..
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 245 (319)
T 2y4i_B 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245 (319)
T ss_dssp CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSS
T ss_pred ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 87653211 11222346889999998 3999999999999999999964
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=273.33 Aligned_cols=187 Identities=22% Similarity=0.304 Sum_probs=158.6
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CC-cEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC------eeeEeeEEEECCE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DG-TKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN------LVRLLGYCVEGAY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~l~~~~~~~~~ 221 (348)
.++|.+.+.||+|+||.||+|... ++ ..||+|.+... ....+.+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 456888899999999999999964 34 68999988643 234567888999999987666 9999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEE--------------
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL-------------- 287 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill-------------- 287 (348)
.++||||+ +++|.+++.... ..++++..+..++.|++.||.|||++ +|+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeccccccccccccc
Confidence 99999999 567777776542 24689999999999999999999998 99999999999999
Q ss_pred -----CCCCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 288 -----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 288 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+.++.+||+|||+++..... .....||+.|+|||+ |||||||++|||++|+.||..
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 56789999999999865332 234579999999994 999999999999999999964
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=300.76 Aligned_cols=182 Identities=21% Similarity=0.297 Sum_probs=157.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC--CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCE-----
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS--DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAY----- 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~----- 221 (348)
.++|.+.+.||+|+||.||+|.+. +++.||||.+.... ......+.+|++++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367888999999999999999975 58999999886443 3445678899999999999999999999987654
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+||||+++++|.+++.. .+++..++.++.|++.||.|||++ +|+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccc
Confidence 7999999999999887642 589999999999999999999999 99999999999999986 9999999999
Q ss_pred ccccCCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~ 346 (348)
+..... ....||+.|++||. |||||||+||+|++|..||.
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~ 277 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEET
T ss_pred hhcccC-----CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCc
Confidence 876443 33579999999994 99999999999999988875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=284.70 Aligned_cols=182 Identities=19% Similarity=0.146 Sum_probs=152.2
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--------cchHHHHHHHHHHHhcCC---------CCCeeeE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--------GQAEKEFKVEVEVIGRVR---------HKNLVRL 212 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------H~nIv~l 212 (348)
.++|.+.+.||+|+||.||+|+. +|+.||||.+.... ....+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 34577789999999999999998 68999999996542 223467888999988885 7777777
Q ss_pred eeEEE------------------------------ECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHH
Q 018991 213 LGYCV------------------------------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262 (348)
Q Consensus 213 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~ 262 (348)
.+++. +.+..|+||||+++|++.+.+.+ ..+++..+..++.|++.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77643 26789999999999976666632 35899999999999999
Q ss_pred HHHHHH-hCCCCCceecCCCCCCEEECCCC--------------------ceEEecccCcccccCCCcccccccccCCCc
Q 018991 263 GLAYLH-EGLEPKVVHRDVKSSNILLDRQW--------------------NARVSDFGLAKLLCSERSYVTTRVMGTFGY 321 (348)
Q Consensus 263 aL~yLH-~~~~~~ivHrdlkp~Nill~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~y 321 (348)
||.||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876432 34799999
Q ss_pred cccee---------ccchHHHH-HHHHHhccCCCC
Q 018991 322 AHFIV---------QVSPLFIL-LYILLSVRYNSS 346 (348)
Q Consensus 322 ~~pe~---------DiwSlG~i-l~el~~g~~Pf~ 346 (348)
+|||+ ||||+|++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCCccceehhhhhCCCCcccccccCCCc
Confidence 99995 99998777 788999999984
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=283.61 Aligned_cols=187 Identities=25% Similarity=0.333 Sum_probs=149.9
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
..+|...+.||+|+||.|+.....+++.||||++...... .+.+|+++|+.+ +||||+++++++.+.+..|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4457778899999999976555567899999998654322 245799999999 799999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCceEEecccCccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKL 303 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-----~~~~kl~DFGla~~ 303 (348)
+. |+|.+++..... .+.+..+..++.|++.||.|||++ +|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF---AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSSC---CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcCC---CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 97 599999976532 234445678999999999999999 9999999999999953 33688999999987
Q ss_pred ccCCCc--ccccccccCCCccccee-------------ccchHHHHHHHHHh-ccCCCC
Q 018991 304 LCSERS--YVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~-g~~Pf~ 346 (348)
+..... .......||+.|+|||+ |||||||++|||++ |+.||.
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 654322 22334679999999994 99999999999999 999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=269.09 Aligned_cols=193 Identities=27% Similarity=0.358 Sum_probs=145.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHH-HHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVE-VIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|...+.||+|+||.||+|... +++.||+|.+.... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 466788899999999999999975 68999999997653 233445556665 677789999999999999999999999
Q ss_pred eecCCCCHHHHHhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDV-GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
||+++ +|.+++.... .....+++..+..++.|++.||.|||++ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99985 8887775210 1125689999999999999999999984 289999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee--------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV--------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~--------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 178 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 178 DSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred cccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 4322 223478999999984 999999999999999999963
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=264.16 Aligned_cols=172 Identities=24% Similarity=0.280 Sum_probs=147.2
Q ss_pred CCCcC-ceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHH-hcCCCCCeeeEeeEEEE----CCEEEE
Q 018991 152 GLCEE-NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVI-GRVRHKNLVRLLGYCVE----GAYRML 224 (348)
Q Consensus 152 ~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~l~~~~~~----~~~~~l 224 (348)
+|.+. +.||+|+||.||+|.. .+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. ....++
T Consensus 18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 45554 6799999999999996 46899999998532 3466788877 55699999999999987 677899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccCc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGLA 301 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGla 301 (348)
||||+++|+|.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||++
T Consensus 93 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EECCCCSCBHHHHHHHCT--TCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999997642 24689999999999999999999999 9999999999999998 788999999999
Q ss_pred ccccCCCcccccccccCCCcccceeccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~DiwSlG~il~el~~g~~Pf~ 346 (348)
+..... . ..+.+|||||||++|+|++|+.||.
T Consensus 168 ~~~~~~------------~-~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 168 KETTGE------------K-YDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp EECTTC------------G-GGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccccc------------c-CCchhhHHHHHHHHHHHHHCCCCCC
Confidence 865321 1 2467899999999999999999995
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-35 Score=267.26 Aligned_cols=189 Identities=23% Similarity=0.305 Sum_probs=144.1
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcc-h-HHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ-A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.++|++.+.||+|+||.||+|+.. +++.||+|.+...... . .+.+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 456778899999999999999975 6899999999765322 2 233444556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
||+ ++.+..+.... ...+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+++...
T Consensus 104 e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 45666665432 1468999999999999999999998 5 89999999999999999999999999998764
Q ss_pred CCCcccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....||+.|+|||. |||||||++|+|++|+.||..
T Consensus 177 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 177 DDKA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 4322 233578999999983 999999999999999999964
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=274.37 Aligned_cols=187 Identities=19% Similarity=0.238 Sum_probs=157.1
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-----------CCCeeeEeeEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----------HKNLVRLLGYCV 217 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~ 217 (348)
..+|.+.+.||+|+||.||+|+. .+++.||+|.+... ....+.+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 35688889999999999999996 46899999988643 234567888999988876 899999999998
Q ss_pred ECC----EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-----
Q 018991 218 EGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD----- 288 (348)
Q Consensus 218 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~----- 288 (348)
..+ ..+++|||+ +++|.+++.... ...+++..+..++.|++.||.|||++. +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 889999997642 245899999999999999999999842 899999999999994
Q ss_pred -CCCceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 289 -RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 289 -~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..+.+||+|||+++..... .....||+.|+|||+ |||||||++|||++|++||.
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 236 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE 236 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 4458999999999876432 233578999999994 99999999999999999996
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=291.68 Aligned_cols=190 Identities=23% Similarity=0.350 Sum_probs=161.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE------CCEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAYR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~~ 222 (348)
++|.+.+.||+|+||.||+|.. .+|+.||+|.+... .....+.+.+|++++.+++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 5688899999999999999996 46899999988654 33445678999999999999999999998755 6678
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCc---eEEeccc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFG 299 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~---~kl~DFG 299 (348)
++||||+++|+|.+++.... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997643 224588889999999999999999998 9999999999999987665 9999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+++...... ......||+.|+|||. |||||||++|+|++|+.||.
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~ 224 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL 224 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 998765433 2344689999999995 99999999999999999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-33 Score=266.46 Aligned_cols=188 Identities=19% Similarity=0.203 Sum_probs=143.1
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCC-CCee---------------
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRH-KNLV--------------- 210 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H-~nIv--------------- 210 (348)
.+|...+.||+|+||.||+|++ .+|+.||||++..... ...+.+.+|+.++..++| +|..
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 3466678999999999999995 4689999998863322 224678899999999987 2211
Q ss_pred ------eEeeEEEE-----CCEEEEEEeecCCCCHHHHHhcC---CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCce
Q 018991 211 ------RLLGYCVE-----GAYRMLVYEYVDNGNLDQWLHGD---VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276 (348)
Q Consensus 211 ------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~iv 276 (348)
.+..++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||.|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 11111111 12346777765 57999988411 11234678889999999999999999999 999
Q ss_pred ecCCCCCCEEECCCCceEEecccCcccccCCCcccccccccCCCcccce--------------------eccchHHHHHH
Q 018991 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI--------------------VQVSPLFILLY 336 (348)
Q Consensus 277 Hrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe--------------------~DiwSlG~il~ 336 (348)
||||||+|||++.++.+||+|||+++..... .....| +.|+||| +|||||||+||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999865432 334567 9999988 29999999999
Q ss_pred HHHhccCCCCC
Q 018991 337 ILLSVRYNSST 347 (348)
Q Consensus 337 el~~g~~Pf~~ 347 (348)
||++|+.||..
T Consensus 309 elltg~~Pf~~ 319 (413)
T 3dzo_A 309 WIWCADLPNTD 319 (413)
T ss_dssp HHHHSSCCCCT
T ss_pred HHHHCCCCCCC
Confidence 99999999964
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=7.9e-34 Score=280.63 Aligned_cols=174 Identities=17% Similarity=0.102 Sum_probs=128.6
Q ss_pred EeecCceEEEEEE-ECCCcEEEEEEEecCC----------cchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEEE
Q 018991 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----------GQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 159 lG~G~fg~V~~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
.+.|++|.+..++ .-.|+.+++|.+.... ....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5566666666554 3357889999986541 12345799999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||++|++|.++|... .+++.. .|+.||+.||+|+|++ |||||||||+|||++.++.+||+|||+|+....
T Consensus 322 Eyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999754 456654 4789999999999999 999999999999999999999999999997754
Q ss_pred CCcccccccccCCCccccee---------ccchHHHHHHHHHhccC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRY 343 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~ 343 (348)
... .....+||++|++||. |+||+|+++|+|.++..
T Consensus 392 ~~~-~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 392 DCS-WPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp --C-CSHHHHHHHHHHHHHHC-----------------CCCCTTHH
T ss_pred CCc-cccCceechhhccHHHhCCCCCCcccccccccchhhhccccc
Confidence 433 3345789999999994 99999999887765543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.6e-29 Score=244.09 Aligned_cols=174 Identities=17% Similarity=0.228 Sum_probs=138.1
Q ss_pred cCceEeecCceEEEEEEECCCcEEEEEEEecCCcc--------hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 155 EENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ--------AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 155 ~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..+.||+|+||.||+|.. .+..+++|........ ..+.+.+|++++++++||||+++..++...+..|+||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 356899999999999954 4678999987443211 1345789999999999999996666666777889999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++....
T Consensus 419 E~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 419 SYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp ECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred ECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 99999999999863 457999999999999999 9999999999999999 999999999998754
Q ss_pred CCccc------ccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERSYV------TTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~~~------~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
..... .....||+.|+|||+ |+|+..+-..+.+.++.++.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32221 235789999999995 99999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=193.48 Aligned_cols=145 Identities=14% Similarity=0.128 Sum_probs=116.2
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc------------------chHHHHHHHHHHHhc
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------------------QAEKEFKVEVEVIGR 203 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~ 203 (348)
.+..+......|.+.+.||+|+||.||+|...+|+.||+|.+..... .....+.+|+++|++
T Consensus 81 ~l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~ 160 (282)
T 1zar_A 81 SLHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK 160 (282)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence 34455555666777899999999999999997799999999854321 134568899999999
Q ss_pred CCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018991 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283 (348)
Q Consensus 204 l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~ 283 (348)
++ | +++.+++.. +..|+||||+++++|.+ +.. .....++.|++.||.|||++ +|+||||||+
T Consensus 161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~ 222 (282)
T 1zar_A 161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQY 222 (282)
T ss_dssp TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHH
Confidence 99 4 556665543 44699999999999988 421 12346999999999999998 9999999999
Q ss_pred CEEECCCCceEEecccCccccc
Q 018991 284 NILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 284 Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||++ ++.+||+|||+|+...
T Consensus 223 NILl~-~~~vkl~DFG~a~~~~ 243 (282)
T 1zar_A 223 NVLVS-EEGIWIIDFPQSVEVG 243 (282)
T ss_dssp SEEEE-TTEEEECCCTTCEETT
T ss_pred HEEEE-CCcEEEEECCCCeECC
Confidence 99999 9999999999998653
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=4.2e-22 Score=177.71 Aligned_cols=139 Identities=20% Similarity=0.163 Sum_probs=107.3
Q ss_pred CCcCceEeecCceEEEEEEE-CCCcE--EEEEEEecCCcc------------------------hHHHHHHHHHHHhcCC
Q 018991 153 LCEENVIGEGGYGIVYRGIL-SDGTK--VAVKNLLNNRGQ------------------------AEKEFKVEVEVIGRVR 205 (348)
Q Consensus 153 ~~~~~~lG~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 205 (348)
|.+.+.||+|+||.||+|.. .+|+. ||||.+...... ....+.+|+.+|..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 67888 999987443111 1135788999999998
Q ss_pred CCCe--eeEeeEEEECCEEEEEEeecCC-C----CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCcee
Q 018991 206 HKNL--VRLLGYCVEGAYRMLVYEYVDN-G----NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-EGLEPKVVH 277 (348)
Q Consensus 206 H~nI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH-~~~~~~ivH 277 (348)
|+++ +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| ++ +|+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---givH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEEe
Confidence 8764 344432 246899999942 3 77776532 223456789999999999999 88 9999
Q ss_pred cCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 278 rdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|||||+|||++. .++|+|||+|......
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 999999999998 9999999999876443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=2e-18 Score=160.96 Aligned_cols=148 Identities=14% Similarity=0.045 Sum_probs=105.5
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCc--------------chHH--------HHHHHHHH
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG--------------QAEK--------EFKVEVEV 200 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--------------~~~~--------~~~~E~~~ 200 (348)
+..+.....-|.+.+.||+|+||.||+|...+|+.||||+++.... .... ...+|...
T Consensus 87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~n 166 (397)
T 4gyi_A 87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAF 166 (397)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHH
Confidence 4444444445888999999999999999988899999998743210 0001 12346677
Q ss_pred HhcCCCCCeeeEeeEEEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018991 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (348)
Q Consensus 201 l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl 280 (348)
|.++.+.++.-..-+.... .+|||||++|++|.++.. . .....++.|++.+|.|||.+ +||||||
T Consensus 167 L~rL~~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~~--------~--~~~~~l~~qll~~l~~lH~~---gIVHrDL 231 (397)
T 4gyi_A 167 MKALYEEGFPVPEPIAQSR--HTIVMSLVDALPMRQVSS--------V--PDPASLYADLIALILRLAKH---GLIHGDF 231 (397)
T ss_dssp HHHHHHTTCSCCCEEEEET--TEEEEECCSCEEGGGCCC--------C--SCHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred HHHHHhcCCCCCeeeeccC--ceEEEEecCCccHhhhcc--------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCC
Confidence 7777555443222222233 379999999988866432 1 12356789999999999998 9999999
Q ss_pred CCCCEEECCCC----------ceEEecccCccccc
Q 018991 281 KSSNILLDRQW----------NARVSDFGLAKLLC 305 (348)
Q Consensus 281 kp~Nill~~~~----------~~kl~DFGla~~~~ 305 (348)
||.|||+++++ .+.|+||+-+-...
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 99999998776 38999999775543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=121.68 Aligned_cols=146 Identities=13% Similarity=0.031 Sum_probs=112.1
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~ 226 (348)
....+|.....++.|+.+.||++... +..+++|............+.+|+.++..+. +.+++++++++.+.+..|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 34456777778888889999999754 6789999886432122345788999999884 778889999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL----------------------------------- 271 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~----------------------------------- 271 (348)
||++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 90 e~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 99999999876421 1112467788899999999810
Q ss_pred ---------------------CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 272 ---------------------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 272 ---------------------~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13589999999999998765667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=3.4e-12 Score=112.66 Aligned_cols=129 Identities=19% Similarity=0.106 Sum_probs=94.8
Q ss_pred eecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC--eeeEeeEEEECCEEEEEEeecCCCCHHHH
Q 018991 160 GEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLLGYCVEGAYRMLVYEYVDNGNLDQW 237 (348)
Q Consensus 160 G~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 237 (348)
+.|..+.||++...+|..+++|..... ....+..|+.++..+.+.+ +++++++..+++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 355669999998767788999986543 2245677888888885444 567888888878889999999998874
Q ss_pred HhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 018991 238 LHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL---------------------------------------------- 271 (348)
Q Consensus 238 l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~---------------------------------------------- 271 (348)
... ... ..++.+++..|..||+..
T Consensus 104 ~~~-------~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 211 111 245667777777777641
Q ss_pred ---------CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 272 ---------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 272 ---------~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
.+.++|+|++|.|||+++++.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.17 E-value=4.1e-11 Score=111.34 Aligned_cols=141 Identities=13% Similarity=0.181 Sum_probs=104.5
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEe--cCC-cchHHHHHHHHHHHhcCC--CCCeeeEeeEEEEC---CEEEEEEe
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLL--NNR-GQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEG---AYRMLVYE 227 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~---~~~~lv~e 227 (348)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|..+++.+. +..+++++.++.+. +..|+|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4678999999999988654 578888664 222 122346788999999886 45688888888766 44799999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL------------------------------------ 271 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~------------------------------------ 271 (348)
|++|..+.+.. ...++......++.+++..|..||...
T Consensus 122 ~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 122 FVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp CCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred ecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99987764311 134677888889999999999999721
Q ss_pred -------------------CCCceecCCCCCCEEECCCCc--eEEecccCccc
Q 018991 272 -------------------EPKVVHRDVKSSNILLDRQWN--ARVSDFGLAKL 303 (348)
Q Consensus 272 -------------------~~~ivHrdlkp~Nill~~~~~--~kl~DFGla~~ 303 (348)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 68999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.17 E-value=3.1e-11 Score=109.64 Aligned_cols=178 Identities=16% Similarity=0.170 Sum_probs=117.9
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcC-CCCC--eeeEeeEEEECC---EEEEEEeec
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKN--LVRLLGYCVEGA---YRMLVYEYV 229 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~H~n--Iv~l~~~~~~~~---~~~lv~e~~ 229 (348)
.+.++.|....||+.. ..+++|..... .....+.+|.++|..+ .+.. +.+++......+ ..|+|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 3568999999999863 56888875322 3356788899999887 3333 445554433333 348999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG--------------------------------------- 270 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~--------------------------------------- 270 (348)
+|.+|.+... ..++..+...++.+++..|..||+.
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9987765332 1356666777777888777777751
Q ss_pred ----------------CCCCceecCCCCCCEEECC--CCceEEecccCcccccCCCc----------c---cccccccCC
Q 018991 271 ----------------LEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCSERS----------Y---VTTRVMGTF 319 (348)
Q Consensus 271 ----------------~~~~ivHrdlkp~Nill~~--~~~~kl~DFGla~~~~~~~~----------~---~~~~~~gt~ 319 (348)
..+.++|+|++|.||++++ ...+.|+||+.+........ . ....+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y 252 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHY 252 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHc
Confidence 0135799999999999998 45688999998865321100 0 000111111
Q ss_pred Cccc-ce--------eccchHHHHHHHHHhccCCC
Q 018991 320 GYAH-FI--------VQVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 320 ~y~~-pe--------~DiwSlG~il~el~~g~~Pf 345 (348)
++.. |+ .+.|+++.++|.+.+|+.||
T Consensus 253 ~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 253 KHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp TCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2222 33 38999999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=3.8e-07 Score=82.65 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=90.8
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCC---CeeeEeeEEE-ECCEEEEEEeecCCC
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHK---NLVRLLGYCV-EGAYRMLVYEYVDNG 232 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~---nIv~l~~~~~-~~~~~~lv~e~~~~g 232 (348)
+.++.|....||+. +..+++|... .......+..|.++|..+.+. .+.+++.+.. ..+..+++||+++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 46888888899987 5678888742 223456788999999998642 3566776664 345678999999998
Q ss_pred CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 018991 233 NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG------------------------------------------ 270 (348)
Q Consensus 233 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~------------------------------------------ 270 (348)
++.+... ..++......++.++...|..||+.
T Consensus 99 ~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 99 ILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp ECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 7765321 1123333334444444444444421
Q ss_pred ---------------CCCCceecCCCCCCEEECC---CCc-eEEecccCcccc
Q 018991 271 ---------------LEPKVVHRDVKSSNILLDR---QWN-ARVSDFGLAKLL 304 (348)
Q Consensus 271 ---------------~~~~ivHrdlkp~Nill~~---~~~-~kl~DFGla~~~ 304 (348)
..+.++|+|++|.|||++. ++. +.|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1335799999999999987 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=5.3e-07 Score=79.81 Aligned_cols=135 Identities=18% Similarity=0.107 Sum_probs=93.4
Q ss_pred eEeecCce-EEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 158 VIGEGGYG-IVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 158 ~lG~G~fg-~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
.+..|..+ .||+.... ++..+.+|.-.. ....++..|...|..+. +--+.++++++.+.+..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34555554 68987754 466788997542 23456788999888774 44477889999999999999999999887
Q ss_pred HHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------
Q 018991 235 DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG-------------------------------------------- 270 (348)
Q Consensus 235 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~-------------------------------------------- 270 (348)
.+..... ......+..+++..|.-||..
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 7654321 111223444555555555531
Q ss_pred -----------CCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 271 -----------LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 271 -----------~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012378999999999999877777999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=4.6e-07 Score=83.67 Aligned_cols=79 Identities=13% Similarity=0.014 Sum_probs=52.9
Q ss_pred ceE-eecCceEEEEEEEC-------CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCC-C--CCeeeEeeEEEEC---
Q 018991 157 NVI-GEGGYGIVYRGILS-------DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR-H--KNLVRLLGYCVEG--- 219 (348)
Q Consensus 157 ~~l-G~G~fg~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~--- 219 (348)
+.| +.|....+|+.... ++..+++|...... ......+..|..++..+. + ..+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 457 78888999988754 25678888654322 001235677888888774 2 3577788877654
Q ss_pred CEEEEEEeecCCCCHH
Q 018991 220 AYRMLVYEYVDNGNLD 235 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~ 235 (348)
+..|+||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3468999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.22 E-value=1.4e-05 Score=72.74 Aligned_cols=142 Identities=18% Similarity=0.272 Sum_probs=78.5
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-----CCCeeeEe-e--EEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----HKNLVRLL-G--YCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~l~-~--~~~~~~~~~lv~e~ 228 (348)
+.|+.|..+.||+....+| .+++|..... ...+..|..++..|. .|.++... + +....+..++++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3465677889999987554 5889987542 223334455544442 34443311 1 22456778999999
Q ss_pred cCCCCHH-----------H---HHhc---CCCCC-------CCCCHHHH-------------------------------
Q 018991 229 VDNGNLD-----------Q---WLHG---DVGDV-------SPLTWDIR------------------------------- 253 (348)
Q Consensus 229 ~~~g~L~-----------~---~l~~---~~~~~-------~~l~~~~~------------------------------- 253 (348)
++|..+. . .++. ..... ....|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9985431 1 1111 10000 00122110
Q ss_pred HHHHHHHHHHHHHHHh----------CCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 254 MNIILGTAKGLAYLHE----------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 254 ~~i~~~i~~aL~yLH~----------~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
..+..++..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 0111223345666653 0134899999999999998888999999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.14 E-value=6.6e-06 Score=77.11 Aligned_cols=75 Identities=13% Similarity=0.127 Sum_probs=48.8
Q ss_pred CceEeecCceEEEEEEEC-CCcEEEEEEEecCCc-------chHHHHHHHHHHHhcCCC--C-CeeeEeeEEEECCEEEE
Q 018991 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-------QAEKEFKVEVEVIGRVRH--K-NLVRLLGYCVEGAYRML 224 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~H--~-nIv~l~~~~~~~~~~~l 224 (348)
.+.||.|.++.||++... +++.+++|....... .....+..|.+++..+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 357899999999999753 467899997643211 122346678888887632 3 34566644 4555689
Q ss_pred EEeecCCC
Q 018991 225 VYEYVDNG 232 (348)
Q Consensus 225 v~e~~~~g 232 (348)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.5e-05 Score=68.77 Aligned_cols=74 Identities=24% Similarity=0.326 Sum_probs=54.2
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-C--CCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-H--KNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.+.+|.|..+.||+....||+.|.+|............+..|...|+.|. . -.+++++++ +. .++||||++++
T Consensus 20 v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~~ 95 (288)
T 3f7w_A 20 VAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDER 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCCC
T ss_pred EEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeeccc
Confidence 46799999999999999999999999765444444456788999888874 2 234555554 33 37899998865
Q ss_pred C
Q 018991 233 N 233 (348)
Q Consensus 233 ~ 233 (348)
.
T Consensus 96 ~ 96 (288)
T 3f7w_A 96 P 96 (288)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.92 E-value=6.3e-05 Score=68.15 Aligned_cols=139 Identities=14% Similarity=0.102 Sum_probs=90.4
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC---CCCeeeEeeEEEECCEEEEEEeecCCC
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR---HKNLVRLLGYCVEGAYRMLVYEYVDNG 232 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~l~~~~~~~~~~~lv~e~~~~g 232 (348)
.+.|+.|....+|+... ++..+++|..... ....+..|.+.|+.|. ...+++++++....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 35689999999999875 4678889976432 3556888988888873 366888998888888899999999986
Q ss_pred CHH--------HH---HhcCCC--CC----------------CCCCHHHHH---HHH----------------HHHHHHH
Q 018991 233 NLD--------QW---LHGDVG--DV----------------SPLTWDIRM---NII----------------LGTAKGL 264 (348)
Q Consensus 233 ~L~--------~~---l~~~~~--~~----------------~~l~~~~~~---~i~----------------~~i~~aL 264 (348)
.+. .. |+.... .. ..-+|.... ++. ..++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 531 11 222111 00 011343221 111 1111111
Q ss_pred -HHHHh-CCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 265 -AYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 265 -~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23321 1256899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00013 Score=68.92 Aligned_cols=73 Identities=10% Similarity=0.184 Sum_probs=44.6
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecC-----C--c--chHHHHHHHHHHHh-cCCCCCeeeEeeEEEECCEEEEE
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNN-----R--G--QAEKEFKVEVEVIG-RVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-----~--~--~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
.+.||.|....||++.. ++..+++|..... . . .....+..|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 35689999999999964 4678999943211 1 1 12223444433322 22234567777665 5667899
Q ss_pred Eeec-CC
Q 018991 226 YEYV-DN 231 (348)
Q Consensus 226 ~e~~-~~ 231 (348)
||++ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.0014 Score=59.05 Aligned_cols=144 Identities=13% Similarity=0.105 Sum_probs=77.1
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC--eeeEee------EEEECCEEEEEEee
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN--LVRLLG------YCVEGAYRMLVYEY 228 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~l~~------~~~~~~~~~lv~e~ 228 (348)
+.|+.|....+|+....+| .+++|...... ....+..|..++..+...+ +.+++. +....+..+++++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 3466687889999887655 68889775421 1224455666666553111 333332 12335677899999
Q ss_pred cCCCCHH-----H---------HHhcC---CCCCC--CC---CHHHHHH------------HHHHHHHHHHHHHhC----
Q 018991 229 VDNGNLD-----Q---------WLHGD---VGDVS--PL---TWDIRMN------------IILGTAKGLAYLHEG---- 270 (348)
Q Consensus 229 ~~~g~L~-----~---------~l~~~---~~~~~--~l---~~~~~~~------------i~~~i~~aL~yLH~~---- 270 (348)
++|..+. . .++.. ..... .. .|..... +...+...++++...
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 9875421 0 01110 00000 01 1221100 001133445555432
Q ss_pred CCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 271 ~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134789999999999999876668999988754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00044 Score=61.98 Aligned_cols=139 Identities=14% Similarity=0.113 Sum_probs=72.6
Q ss_pred CceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeec-CCCC
Q 018991 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYV-DNGN 233 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~-~~g~ 233 (348)
.+.|+.|....+|+. ..+++|........ ......|..++..+...++ .++++. +.+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 467888999999998 45888876433111 1122456666666532222 455544 343457899999 6543
Q ss_pred HHH---------------H---HhcCCCCC-CCCC-HHHHHHHHHH--------------HHHHHHH----HHh-CCCCC
Q 018991 234 LDQ---------------W---LHGDVGDV-SPLT-WDIRMNIILG--------------TAKGLAY----LHE-GLEPK 274 (348)
Q Consensus 234 L~~---------------~---l~~~~~~~-~~l~-~~~~~~i~~~--------------i~~aL~y----LH~-~~~~~ 274 (348)
+.. . ++...... ..+. +..+..+... +...+.. +.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 0 11111000 0011 1111111110 1111111 111 11345
Q ss_pred ceecCCCCCCEEECCCCceEEecccCccc
Q 018991 275 VVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 275 ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5567889999988764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.002 Score=58.25 Aligned_cols=143 Identities=14% Similarity=0.130 Sum_probs=79.7
Q ss_pred ceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC--CCeeeEeeE-----EEECCEEEEEEeec
Q 018991 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH--KNLVRLLGY-----CVEGAYRMLVYEYV 229 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~l~~~-----~~~~~~~~lv~e~~ 229 (348)
..++ |....||+....+|+.+++|...... .....+..|..++..+.. -.+++++.. ....+..++++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 77788998877667789999875332 234456667777776632 123444432 23356678999999
Q ss_pred CCCCHH-----HH---------Hhc---CCC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHhC-
Q 018991 230 DNGNLD-----QW---------LHG---DVG--DVSPLTWDIR----MNI---------------ILGTAKGLAYLHEG- 270 (348)
Q Consensus 230 ~~g~L~-----~~---------l~~---~~~--~~~~l~~~~~----~~i---------------~~~i~~aL~yLH~~- 270 (348)
+|..+. .. ++. ... ....+.+... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 874321 11 111 000 0011222111 000 00111122333221
Q ss_pred ---CCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 271 ---LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 271 ---~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 134689999999999999 4 899999987754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.00064 Score=64.34 Aligned_cols=69 Identities=19% Similarity=0.259 Sum_probs=46.0
Q ss_pred ceEeecCceEEEEEEECC--------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEEe
Q 018991 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e 227 (348)
+.|+.|-...+|++...+ +..+.+|+.... .....+..|..++..+...+ .+++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 467788889999998653 478999976331 11244557888888774333 356666543 3 38999
Q ss_pred ecCC
Q 018991 228 YVDN 231 (348)
Q Consensus 228 ~~~~ 231 (348)
|++|
T Consensus 153 ~l~G 156 (429)
T 1nw1_A 153 YIPS 156 (429)
T ss_dssp CCCE
T ss_pred EeCC
Confidence 9986
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0049 Score=55.82 Aligned_cols=32 Identities=38% Similarity=0.417 Sum_probs=27.5
Q ss_pred CCCceecCCCCCCEEECCC----CceEEecccCccc
Q 018991 272 EPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (348)
Q Consensus 272 ~~~ivHrdlkp~Nill~~~----~~~kl~DFGla~~ 303 (348)
...++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6799999998865
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.01 E-value=0.0013 Score=61.06 Aligned_cols=142 Identities=15% Similarity=0.125 Sum_probs=81.0
Q ss_pred ceEeecCceEEEEEEEC--------CCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEe
Q 018991 157 NVIGEGGYGIVYRGILS--------DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.|..|-...+|++... +++.+.+|+.-. .......+.+|..+++.+. +.-..++++.+. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 45666777889998864 246899987522 1223455668888888774 333356666553 3 28999
Q ss_pred ecCCCCHH--------------HH---HhcCCC-CCCCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 018991 228 YVDNGNLD--------------QW---LHGDVG-DVSPL--TWDIRMNIILGTAK-------------------GLAYLH 268 (348)
Q Consensus 228 ~~~~g~L~--------------~~---l~~~~~-~~~~l--~~~~~~~i~~~i~~-------------------aL~yLH 268 (348)
|++|..|. +. |+.-.. ...+. .+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 99875432 11 121111 01112 24555555544322 233332
Q ss_pred h----C-CCCCceecCCCCCCEEECCC----CceEEecccCccc
Q 018991 269 E----G-LEPKVVHRDVKSSNILLDRQ----WNARVSDFGLAKL 303 (348)
Q Consensus 269 ~----~-~~~~ivHrdlkp~Nill~~~----~~~kl~DFGla~~ 303 (348)
. . ....++|+|+.+.|||++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 1 1 12368999999999999876 7899999988754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0043 Score=59.08 Aligned_cols=72 Identities=13% Similarity=0.095 Sum_probs=44.8
Q ss_pred ceEeecCceEEEEEEECC-CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-eeEeeEEEECCEEEEEEeecCCCC
Q 018991 157 NVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-VRLLGYCVEGAYRMLVYEYVDNGN 233 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~l~~~~~~~~~~~lv~e~~~~g~ 233 (348)
+.|+.|-...+|++...+ +..+++|+........ -+...|..++..|...++ +++++.+ .+ .+|+||++|.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 467778888999998764 4788888763322111 112468888888764444 5677765 23 35999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0014 Score=60.42 Aligned_cols=72 Identities=15% Similarity=0.068 Sum_probs=41.3
Q ss_pred ceEeecCceEEEEEEECC---------CcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEE
Q 018991 157 NVIGEGGYGIVYRGILSD---------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~ 226 (348)
+.|+.|....+|+....+ +..+++|+....... ..+...|..++..+...+ .+++++.. .+ ++++
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 456777778899988653 267888865432211 112356777777764223 44666543 33 6899
Q ss_pred eecCCCC
Q 018991 227 EYVDNGN 233 (348)
Q Consensus 227 e~~~~g~ 233 (348)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998743
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.62 E-value=0.019 Score=52.23 Aligned_cols=31 Identities=19% Similarity=0.338 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 273 ~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4689999999999999888899999987764
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=96.41 E-value=0.0052 Score=36.49 Aligned_cols=32 Identities=31% Similarity=0.370 Sum_probs=19.2
Q ss_pred ccchhHHHHHHHHHHHHHHHHHHHHHHhhhhc
Q 018991 19 IFGLRLWVVIGILLGSLIVLALFLLSLCLTSR 50 (348)
Q Consensus 19 ~~~~~~~~~i~i~~~~~~~~~~~~~~~~~~~r 50 (348)
+++.+...++|++++.++.++++..+.++..|
T Consensus 5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~r 36 (38)
T 2k1k_A 5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRSR 36 (38)
T ss_dssp STTCCHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCceeeeehHHHHHHHHHHHHHHHHee
Confidence 34566778888888877655544443333333
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0096 Score=36.39 Aligned_cols=28 Identities=14% Similarity=0.222 Sum_probs=12.3
Q ss_pred HHHHHHHH-HHHHHHHHHHHHhhhhcccc
Q 018991 26 VVIGILLG-SLIVLALFLLSLCLTSRRKK 53 (348)
Q Consensus 26 ~~i~i~~~-~~~~~~~~~~~~~~~~r~~~ 53 (348)
.+++.+++ +++++++++.++++.|||++
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34444444 44444444444444444433
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=95.79 E-value=0.013 Score=35.81 Aligned_cols=29 Identities=31% Similarity=0.406 Sum_probs=13.8
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhhccc
Q 018991 24 LWVVIGILLGSLIVLALFLLSLCLTSRRK 52 (348)
Q Consensus 24 ~~~~i~i~~~~~~~~~~~~~~~~~~~r~~ 52 (348)
...++++++|+++++++.+.++++.|||+
T Consensus 11 ~~~Ia~~vVGvll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 11 LTSIISAVVGILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHC
T ss_pred ccchHHHHHHHHHHHHHHHHHHhheehhh
Confidence 44466666664444444344344444443
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.53 E-value=0.0092 Score=36.56 Aligned_cols=25 Identities=24% Similarity=0.243 Sum_probs=10.7
Q ss_pred HHHHHHHHHHHHHHHHHhhhhcccc
Q 018991 29 GILLGSLIVLALFLLSLCLTSRRKK 53 (348)
Q Consensus 29 ~i~~~~~~~~~~~~~~~~~~~r~~~ 53 (348)
+++.|++++++++++++++.|||++
T Consensus 16 gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 16 GMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred ehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 4444444444444444444444433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.017 Score=54.33 Aligned_cols=141 Identities=16% Similarity=0.176 Sum_probs=80.6
Q ss_pred ceEeecCceEEEEEEECC--------CcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEe
Q 018991 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.+..|-...+|+....+ +..+++|+....... .-+..+|..+++.+. +.-..++++.+ .+ ++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 457667778899998653 578899875332211 112346777777763 33345566533 33 78999
Q ss_pred ecCCCCHH--------------HHH---hcC-------CC--CCCCCCHHHHHHHHHHH-------------------HH
Q 018991 228 YVDNGNLD--------------QWL---HGD-------VG--DVSPLTWDIRMNIILGT-------------------AK 262 (348)
Q Consensus 228 ~~~~g~L~--------------~~l---~~~-------~~--~~~~l~~~~~~~i~~~i-------------------~~ 262 (348)
|++|..|. +.| +.. .. ...+..+.++..+..++ ..
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 99985431 111 110 00 11122344444443322 12
Q ss_pred HHHHHHhC---------------------CCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 263 GLAYLHEG---------------------LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 263 aL~yLH~~---------------------~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
.+.+|... ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 23333211 1235889999999999 7888999999988764
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.00 E-value=0.21 Score=31.79 Aligned_cols=26 Identities=31% Similarity=0.663 Sum_probs=17.7
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHh
Q 018991 21 GLRLWVVIGILLGSLIVLALFLLSLC 46 (348)
Q Consensus 21 ~~~~~~~i~i~~~~~~~~~~~~~~~~ 46 (348)
+..+|++++.++++++++++++.+++
T Consensus 6 ~vp~WiIi~svl~GLLLL~Lii~~Lw 31 (54)
T 2l8s_A 6 RVPLWVILLSAFAGLLLLMLLILALW 31 (54)
T ss_dssp CCCTHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 35678888888877777666555443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=91.61 E-value=0.34 Score=40.79 Aligned_cols=114 Identities=9% Similarity=0.029 Sum_probs=75.9
Q ss_pred CCCCCeeeEeeEEEECCEEEEEEeecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCC
Q 018991 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282 (348)
Q Consensus 204 l~H~nIv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp 282 (348)
-.||+.+.. .+-.+++.+.+.++.-+. -++.. + ..++....++++.+|+....+++. =+|--|.|
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P 107 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP 107 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence 368888866 455666665555554332 23332 2 346788889999998877766653 46888999
Q ss_pred CCEEECCCCceEEecccCcccccCCCcccccccccCCCcccceeccc-hHHHHHHHHHhccCCC
Q 018991 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS-PLFILLYILLSVRYNS 345 (348)
Q Consensus 283 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~Diw-SlG~il~el~~g~~Pf 345 (348)
+|++++.++.+++.-.|+-..+. +|---|-|.| .+=|++..+++++++|
T Consensus 108 ~NL~f~~~~~p~i~~RGik~~l~--------------P~~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 108 DELFFTRDGLPIAKTRGLQNVVD--------------PLPVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGEEECTTSCEEESCCEETTTBS--------------CCCCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred ceEEEcCCCCEEEEEccCccCCC--------------CCCCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999999887654332 1211122444 5667777888887776
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=91.46 E-value=0.33 Score=29.29 Aligned_cols=26 Identities=27% Similarity=0.701 Sum_probs=18.5
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHHh
Q 018991 21 GLRLWVVIGILLGSLIVLALFLLSLC 46 (348)
Q Consensus 21 ~~~~~~~i~i~~~~~~~~~~~~~~~~ 46 (348)
+..+|+++..+++++++++++..+++
T Consensus 7 ~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 7 AIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 46688888888887777766655544
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.84 E-value=0.22 Score=29.94 Aligned_cols=22 Identities=27% Similarity=0.460 Sum_probs=9.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH
Q 018991 24 LWVVIGILLGSLIVLALFLLSL 45 (348)
Q Consensus 24 ~~~~i~i~~~~~~~~~~~~~~~ 45 (348)
.++.++++.|+++++++++.++
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~ 34 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGF 34 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeehhHHHHHHHHHHHHhe
Confidence 3444455545444332333333
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.22 E-value=0.89 Score=38.33 Aligned_cols=112 Identities=10% Similarity=-0.017 Sum_probs=73.2
Q ss_pred CCCCeeeEeeEEEECCEEEEEEeecCCC-CHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCceecCCCC
Q 018991 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA-YLHEGLEPKVVHRDVKS 282 (348)
Q Consensus 205 ~H~nIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~-yLH~~~~~~ivHrdlkp 282 (348)
.||++ -...-.+++.+.+.++.-+++ ++.. ++ .++....++++.+++.-.. +++ .-+|--|.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~-i~-------~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAA-IR-------KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHH-HH-------TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHH-HH-------hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeC
Confidence 68887 334446677766666654333 4443 32 3677888888888776655 454 457888999
Q ss_pred CCEEECCCCceEEecccCcccccCCCcccccccccCCCcccceeccc-hHHHHHHHHHhccCCC
Q 018991 283 SNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS-PLFILLYILLSVRYNS 345 (348)
Q Consensus 283 ~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~Diw-SlG~il~el~~g~~Pf 345 (348)
+|++++.++.+++.-.|+-..+. +|---|.|.| .+=|++..++.+++.|
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~lp--------------P~e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKESLP--------------PDEWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp GGEEECTTCCEEESCCEETTTBS--------------SCSCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred ceEEEeCCCcEEEEEcCCcccCC--------------CCCCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999999999999888754332 1211122444 5667777777777765
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.78 E-value=0.49 Score=30.16 Aligned_cols=25 Identities=28% Similarity=0.743 Sum_probs=17.5
Q ss_pred chhHHHHHHHHHHHHHHHHHHHHHH
Q 018991 21 GLRLWVVIGILLGSLIVLALFLLSL 45 (348)
Q Consensus 21 ~~~~~~~i~i~~~~~~~~~~~~~~~ 45 (348)
+..+|++++.++++++++++++.++
T Consensus 9 ~vp~wiIi~svl~GLllL~li~~~L 33 (54)
T 2knc_A 9 AIPIWWVLVGVLGGLLLLTILVLAM 33 (54)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHHHHHHH
Confidence 4668888888887777766655544
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=88.71 E-value=1.3 Score=37.35 Aligned_cols=103 Identities=14% Similarity=0.063 Sum_probs=60.7
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
-+|.+.|.... .++++.+++.++.|.+.+|.-+-.+.. + ..+=+-|..|++..+|.+...+ ..+.. ......
T Consensus 33 vSL~eIL~~~~---~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~~--~~~~~~ 104 (229)
T 2yle_A 33 LSLEEILRLYN---QPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADDA--GEPPPV 104 (229)
T ss_dssp EEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHHcC---CCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-ccccc--cccCCC
Confidence 37899887542 689999999999999998877622101 1 1233456899999999998764 22110 000111
Q ss_pred ccccccCCCcccceeccchHHHHHHHHHhccCC
Q 018991 312 TTRVMGTFGYAHFIVQVSPLFILLYILLSVRYN 344 (348)
Q Consensus 312 ~~~~~gt~~y~~pe~DiwSlG~il~el~~g~~P 344 (348)
.++... .=...+.=|||||++||.-+--..|
T Consensus 105 ~pe~~~--~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 105 AGKLGY--SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --CCSS--SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred Chhhcc--ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 111100 0012334799999999987754444
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=88.01 E-value=0.061 Score=51.17 Aligned_cols=62 Identities=8% Similarity=0.014 Sum_probs=19.0
Q ss_pred CcCceEeecCceEEEEEEECC-CcEEEE------EEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE
Q 018991 154 CEENVIGEGGYGIVYRGILSD-GTKVAV------KNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~ 218 (348)
.+.+.|| ||.||+|.+.. ..+||+ |...... ......+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3446676 99999999754 467888 7654322 1223467788999999999999999887754
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=86.21 E-value=0.41 Score=27.51 Aligned_cols=8 Identities=25% Similarity=0.721 Sum_probs=3.7
Q ss_pred HHHHHHHH
Q 018991 26 VVIGILLG 33 (348)
Q Consensus 26 ~~i~i~~~ 33 (348)
.+++.++|
T Consensus 9 sIaagVvg 16 (35)
T 1iij_A 9 FIIATVVG 16 (35)
T ss_dssp HHHHHHHH
T ss_pred EeHHHHHH
Confidence 34444445
|
| >2l34_A TYRO protein tyrosine kinase-binding protein; immunoreceptor, transmembrane assembly, DAP12, protein bindi; NMR {Homo sapiens} PDB: 2l35_B | Back alignment and structure |
|---|
Probab=86.20 E-value=0.93 Score=25.74 Aligned_cols=26 Identities=27% Similarity=0.525 Sum_probs=17.1
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHhh
Q 018991 22 LRLWVVIGILLGSLIVLALFLLSLCL 47 (348)
Q Consensus 22 ~~~~~~i~i~~~~~~~~~~~~~~~~~ 47 (348)
.+...++||+++.++.++++.+..++
T Consensus 4 L~~gaIaGIVvgdi~~t~~i~~~vy~ 29 (33)
T 2l34_A 4 VSPGVLAGIVVGDLVLTVLIALAVYF 29 (33)
T ss_dssp CCTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCcceEEeEeHHHHHHHHHHHHHHhh
Confidence 34567888888887766655554444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=80.49 E-value=0.77 Score=42.49 Aligned_cols=29 Identities=28% Similarity=0.446 Sum_probs=24.6
Q ss_pred ceecCCCCCCEEE------CCCCceEEecccCccc
Q 018991 275 VVHRDVKSSNILL------DRQWNARVSDFGLAKL 303 (348)
Q Consensus 275 ivHrdlkp~Nill------~~~~~~kl~DFGla~~ 303 (348)
++|+|+.+.|||+ +++..+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567799999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 348 | ||||
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-48 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-47 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-46 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-44 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-43 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-43 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-42 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-41 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-39 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-39 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-38 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-36 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-36 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-34 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-34 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-32 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-32 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-32 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-31 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 8e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-29 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-29 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-29 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-28 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 8e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-17 |
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 1e-48
Identities = 44/165 (26%), Positives = 83/165 (50%), Gaps = 7/165 (4%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G V+ G + TKVAVK L + F E ++ +++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVK-SLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ ++ EY++NG+L +L G LT + +++ A+G+A++ E +
Sbjct: 78 TQE-PIYIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
HRD++++NIL+ + +++DFGLA+L+ +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 1e-47
Identities = 46/167 (27%), Positives = 77/167 (46%), Gaps = 8/167 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 13 GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+V ++ + +L LH ++I TA+G+ YLH +
Sbjct: 73 STAP-QLAIVTQWCEGSSLYHHLHIIET---KFEMIKLIDIARQTAQGMDYLH---AKSI 125
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGY 321
+HRD+KS+NI L ++ DFGLA + S+ ++ G+ +
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 2e-46
Identities = 39/166 (23%), Positives = 74/166 (44%), Gaps = 7/166 (4%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ ++ EY+ NG L +L + + + + YL + +
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
HRD+ + N L++ Q +VSDFGL++ + + + ++
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-44
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 11/167 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+ +G G G+V++ G +A K + L + + E++V+ +V G
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ E++D G+LDQ L + I + + KGL YL E + K
Sbjct: 72 AFYSDGEISICMEHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLRE--KHK 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++HRDVK SNIL++ + ++ DFG++ L +GT Y
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSY 169
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 2e-44
Identities = 51/198 (25%), Positives = 77/198 (38%), Gaps = 19/198 (9%)
Query: 155 EENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ IG G +G VY + + VA+K + + ++ EV + ++RH N +
Sbjct: 19 DLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ G + LV EY D PL + G +GLAYLH
Sbjct: 79 QYRGCYLREHTAWLVMEYCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH-- 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--------VMGTFGYA 322
++HRDVK+ NILL ++ DFG A ++ S+V T + G
Sbjct: 133 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQY 191
Query: 323 HFIVQVSPLFILLYILLS 340
V V L I L
Sbjct: 192 DGKVDVWSLGITCIELAE 209
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (383), Expect = 3e-44
Identities = 56/231 (24%), Positives = 97/231 (41%), Gaps = 34/231 (14%)
Query: 141 YTLRELEAATSGLCEE---------NVIGEGGYGIVYRGILSDGTK----VAVKNL-LNN 186
+T + A +E VIG G +G V G L K VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
+ ++F E ++G+ H N++ L G + M++ E+++NG+LD +L + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
T + ++ G A G+ YL + VHRD+ + NIL++ +VSDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 307 ERSYVTTR----VMGTFGY----------AHFIVQVSPLFILLYILLSVRY 343
+ S T + V I+++ ++S
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 4e-44
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 7/166 (4%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E +G+G +G V+ G + T+VA+K L + + F E +V+ ++RH+ LV+L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIK-TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E +V EY+ G+L +L G+ G L +++ A G+AY+
Sbjct: 81 VSEEPI-YIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER---MNY 134
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
VHRD++++NIL+ +V+DFGLA+L+ +
Sbjct: 135 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 8e-44
Identities = 47/165 (28%), Positives = 84/165 (50%), Gaps = 7/165 (4%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIK-TIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+E A LV+E++++G L +L + + + L +G+AYL E V+
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLE---EACVI 123
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
HRD+ + N L+ +VSDFG+ + + ++ +T +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKW 168
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-43
Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 144 RELEAATSGLCEENV-IGEGGYGIVYRGIL---SDGTKVAVKNLLNNRGQAE-KEFKVEV 198
++L L ++ +G G +G V +G+ VA+K L +A+ +E E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
+++ ++ + +VRL+G C + MLV E G L ++L G + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLH 116
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VM 316
+ G+ YL E VHRD+ + N+LL + A++SDFGL+K L ++ SY T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 317 GTFGY----------AHFIVQVSPLFILLYILLSVRY 343
+ V + ++ LS
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 4e-43
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 19/178 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 216 CVEG----AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ LV +Y ++G+L +L+ +T + + + L TA GLA+LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 272 -----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV---TTRVMGTFGY 321
+P + HRD+KS NIL+ + ++D GLA S + +GT Y
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 38/168 (22%), Positives = 73/168 (43%), Gaps = 8/168 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G +G VY+ A K + + +++ VE++++ H N+V+LL
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ E+ G +D + PLT + T L YLH + K+
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+HRD+K+ NIL + +++DFG++ + + GT +
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMA 178
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 146 bits (368), Expect = 4e-42
Identities = 47/210 (22%), Positives = 89/210 (42%), Gaps = 17/210 (8%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGR 203
+ E + + ++ +G G YG VY G+ VAVK L + + E EF E V+
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKE 69
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
++H NLV+LLG C ++ E++ GNL +L + ++ + + + +
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSA 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+ YL + +HRD+ + N L+ +V+DFGL++L+ + +
Sbjct: 128 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 324 FI----------VQVSPLFILLYILLSVRY 343
V +LL+ + +
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 4e-42
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 41/221 (18%)
Query: 158 VIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
V+G G +G V +VAVK L +E+E E++++ ++ H+N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-------------------DVGDVSPLTW 250
V LLG C L++EY G+L +L + D++ LT+
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+ +Y
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 311 VT-TRVMGTFGY----------AHFIVQVSPLFILLYILLS 340
V + V ILL+ + S
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 261
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-41
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 8/173 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG G YG + SDG + K + + ++ EV ++ ++H N+VR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 214 GYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
++ +V EY + G+L + + L + + ++ L H
Sbjct: 70 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129
Query: 272 E--PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+ V+HRD+K +N+ LD + N ++ DFGLA++L + S+ +GT Y
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYM 181
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-41
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 25/206 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD---GTKVAVKNLLN--NRGQAEKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G VAVK L N N + E E V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VR++G C ++ MLV E + G L+++L + + + ++ + G+ YL E
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEE 125
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR--VMGTFGY------ 321
VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + +
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 322 ----AHFIVQVSPLFILLYILLSVRY 343
V +L++ S
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (361), Expect = 6e-41
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 31/207 (14%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL-LNNRGQAEKEFK 195
L LE + + IGEG +G V++ T VAVK L + +F+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG--------------- 240
E ++ + N+V+LLG C G L++EY+ G+L+++L
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 241 -----DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295
PL+ ++ I A G+AYL E K VHRD+ + N L+ ++
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI 181
Query: 296 SDFGLAKLLCSERSY-VTTRVMGTFGY 321
+DFGL++ + S Y +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRW 208
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-41
Identities = 53/221 (23%), Positives = 85/221 (38%), Gaps = 36/221 (16%)
Query: 156 ENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHK 207
+G G +G V VAVK L + E+E E++V+ + H
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG--------------DVGDVSPLTWDIR 253
N+V LLG C G +++ EY G+L +L D L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VT 312
++ AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +Y V
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK 204
Query: 313 TRVMGTFGYAH----------FIVQVSPLFILLYILLSVRY 343
+ F V I L+ L S+
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-40
Identities = 50/187 (26%), Positives = 79/187 (42%), Gaps = 21/187 (11%)
Query: 139 RWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLN---NRGQAEKEF 194
R + L + E +G+G +G VY +A+K L + E +
Sbjct: 1 RQWALEDFE-------IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL 53
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
+ EVE+ +RH N++RL GY + L+ EY G + + L +S
Sbjct: 54 RREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA 109
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
I A L+Y H +V+HRD+K N+LL +++DFG + S R T
Sbjct: 110 TYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR---RTT 163
Query: 315 VMGTFGY 321
+ GT Y
Sbjct: 164 LCGTLDY 170
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 1e-40
Identities = 52/166 (31%), Positives = 74/166 (44%), Gaps = 13/166 (7%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + + F E V+ ++RH NLV+LLG
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 217 VEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
VE +V EY+ G+L +L S L D + L + + YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
VHRD+ + N+L+ A+VSDFGL K S + +
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKW 166
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 142 bits (359), Expect = 4e-40
Identities = 44/194 (22%), Positives = 84/194 (43%), Gaps = 17/194 (8%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +++YE++ G L + + + ++ D + + KGL ++HE V
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYV 146
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTF--------GYAHFIV 326
H D+K NI+ + + + DFGL L ++S T F +
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 327 QVSPLFILLYILLS 340
+ + +L YILLS
Sbjct: 207 DMWSVGVLSYILLS 220
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 4e-40
Identities = 48/168 (28%), Positives = 76/168 (45%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + + + K E+ + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G + G+ YLH
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVVYLH---GIG 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 25/205 (12%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRL 212
+ IG G + VY+G+ ++ +VA L + + + FK E E++ ++H N+VR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 213 LGYCVEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+LV E + +G L +L + + + KGL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH 129
Query: 269 EGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYA----- 322
P ++HRD+K NI + + ++ D GLA L R+ V+GT +
Sbjct: 130 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEMY 185
Query: 323 ----HFIVQVSPLFILLYILLSVRY 343
V V + + + + Y
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEY 210
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 2e-39
Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 156 ENVIGEGGYGIVYRGILSDG---TKVAVKNL-LNNRGQAEKEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + + A+K + ++F E+EV+ ++ H N++
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHG------------DVGDVSPLTWDIRMNIIL 258
LLG C Y L EY +GNL +L S L+ ++
Sbjct: 75 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 134
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++ T
Sbjct: 135 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTMGRLP 189
Query: 319 FGYAHFI----------VQVSPLFILLYILLS 340
+ V +LL+ ++S
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 5e-39
Identities = 42/200 (21%), Positives = 76/200 (38%), Gaps = 22/200 (11%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLV 210
IGEG +G V++GI VA+K N + +E F E + + H ++V
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L+G E ++ E G L +L L + + LAYL
Sbjct: 72 KLIGVITEN-PVWIIMELCTLGELRSFLQVRKY---SLDLASLILYAYQLSTALAYLES- 126
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA-------- 322
+ VHRD+ + N+L+ ++ DFGL++ + Y ++ +
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 323 --HFIVQVSPLFILLYILLS 340
V + ++ +L
Sbjct: 185 RFTSASDVWMFGVCMWEILM 204
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-38
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGT-----KVAVKNLLNNRGQAEK-EFKVEVEV 200
E S + + VIG G +G VY+G+L + VA+K L + ++ +F E +
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT 260
+G+ H N++RL G + M++ EY++NG LD++L G + + ++ G
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG---EFSVLQLVGMLRGI 119
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS--ERSYVTTRVMGT 318
A G+ YL VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 120 AAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 319 FGYA----------HFIVQVSPLFILLYILLSVRY 343
+ V I+++ +++
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 211
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 2e-38
Identities = 44/175 (25%), Positives = 75/175 (42%), Gaps = 16/175 (9%)
Query: 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNL 209
+G+G +G+V RG VAVK L + ++ +A +F EV + + H+NL
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+RL G + +M V E G+L L G + A+G+ YL
Sbjct: 74 IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG---HFLLGTLSRYAVQVAEGMGYLE- 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY--VTTRVMGTFGYA 322
+ +HRD+ + N+LL + ++ DFGL + L + + F +
Sbjct: 129 --SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-38
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 10/166 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G G VY + ++ G +VA++ + + ++ E+ V+ ++ N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ G +V EY+ G+L + + + + + L +LH +V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+HRD+KS NILL + +++DFG + E+S +T V GT +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYW 182
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-37
Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 14/172 (8%)
Query: 157 NVIGEGGYGIVYRGILSD-----GTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ VA+K L +A KE E V+ V + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RLLG C+ L+ + + G L ++ ++ +N + AKG+ YL +
Sbjct: 75 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG---SQYLLNWCVQIAKGMNYLED- 129
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGY 321
++VHRD+ + N+L+ + +++DFGLAKLL + E+ Y +
Sbjct: 130 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (340), Expect = 2e-37
Identities = 42/194 (21%), Positives = 81/194 (41%), Gaps = 17/194 (8%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G+V+R + + G K + + K E+ ++ ++ H L+ L
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +L+ E++ G L + + ++ +N + +GL ++H E +V
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY---KMSEAEVINYMRQACEGLKHMH---EHSIV 149
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTF--------GYAHFIV 326
H D+K NI+ + + + V DFGLA L + T F F
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 327 QVSPLFILLYILLS 340
+ + +L Y+LLS
Sbjct: 210 DMWAIGVLGYVLLS 223
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 2e-36
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLV 210
VIG G +G VY G L D AVK+L E +F E ++ H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 211 RLLGYCVEG-AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ ++V Y+ +G+L ++ + T + L AKG+ +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH---NPTVKDLIGFGLQVAKGMKFLAS 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTRVMGTFGY 321
K VHRD+ + N +LD ++ +V+DFGLA+ + + + T +
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 132 bits (332), Expect = 4e-36
Identities = 49/203 (24%), Positives = 75/203 (36%), Gaps = 28/203 (13%)
Query: 156 ENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVR---HKN 208
+IG GG+G VY +D G A+K L R Q E E ++ V
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 68
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V + + + ++ G+L L + GL ++H
Sbjct: 69 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGLEHMH 124
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQV 328
VV+RD+K +NILLD + R+SD GLA ++ +GT GY V
Sbjct: 125 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQ 178
Query: 329 S-----------PLFILLYILLS 340
L +L+ LL
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLR 201
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 9e-36
Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 12/171 (7%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE---KEFKVEVEVIGRVRHKNLVR 211
++GEG + V L+ + A+K L E E +V+ R+ H V+
Sbjct: 13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L + Y NG L +++ + L YLH
Sbjct: 73 LYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLH--- 125
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE-RSYVTTRVMGTFGY 321
++HRD+K NILL+ + +++DFG AK+L E + +GT Y
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 3e-35
Identities = 44/195 (22%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNL-LNNRGQAEKE 193
Y E E A + +G+G +G+VY G+ T+VA+K + + E
Sbjct: 10 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 69
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 70 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ + +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186
Query: 308 RSY-VTTRVMGTFGY 321
Y + + +
Sbjct: 187 DYYRKGGKGLLPVRW 201
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 25/188 (13%)
Query: 156 ENVIGEGGYGIVYRGI------LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGR-VRHK 207
+G G +G V + VAVK L +E + E++++ H
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 208 NLVRLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRM 254
N+V LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 78 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV-TT 313
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 138 CYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194
Query: 314 RVMGTFGY 321
+
Sbjct: 195 DARLPLKW 202
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 3e-34
Identities = 36/196 (18%), Positives = 79/196 (40%), Gaps = 22/196 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G +GIV+R + S K + +G + K E+ ++ RH+N++ L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++++E++ ++ + ++ L ++ + + L +LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAF---ELNEREIVSYVHQVCEALQFLH---SHNIG 124
Query: 277 HRDVKSSNILLDRQWNARV--SDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP---- 330
H D++ NI+ + ++ + +FG A+ L ++ Y V
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVST 182
Query: 331 ------LFILLYILLS 340
L L+Y+LLS
Sbjct: 183 ATDMWSLGTLVYVLLS 198
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 8e-34
Identities = 50/203 (24%), Positives = 80/203 (39%), Gaps = 25/203 (12%)
Query: 155 EENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L G VA+K +L + ++ E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIVRLR 79
Query: 214 GYCVEGA------YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ Y LV +YV H L + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI- 325
H + HRD+K N+LLD ++ DFG AK L V+ + I
Sbjct: 139 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 326 --------VQVSPLFILLYILLS 340
+ V +L LL
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLL 218
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 121 bits (304), Expect = 7e-33
Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 27/205 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
++G GG V+ L VAVK L L F+ E + + H +V
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 212 LLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ G +V EYVD L +H P+T + +I + L +
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNFS 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGYAH-- 323
H+ ++HRDVK +NI++ +V DFG+A+ + + V T V+GT Y
Sbjct: 128 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 324 --------FIVQVSPLFILLYILLS 340
V L +LY +L+
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLT 209
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 1e-32
Identities = 45/192 (23%), Positives = 81/192 (42%), Gaps = 26/192 (13%)
Query: 156 ENVIGEGGYGIVYRGIL--------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-R 205
+GEG +G V + TKVAVK L ++ + + + E+E++ + +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------------GDVGDVSPLTWDIR 253
HKN++ LLG C + ++ EY GNL ++L L+
Sbjct: 78 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++ A+G+ YL K +HRD+ + N+L+ +++DFGLA+ + Y T
Sbjct: 138 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194
Query: 314 RV-MGTFGYAHF 324
+
Sbjct: 195 TNGRLPVKWMAP 206
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (303), Expect = 1e-32
Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 9/173 (5%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG+VY+ + G A+K L E+ ++ ++H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+LV+E++D + L + +L G+AY H+ +
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHD---RR 120
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQ 327
V+HRD+K N+L++R+ +++DFGLA+ T ++ + A ++
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 1e-32
Identities = 38/171 (22%), Positives = 64/171 (37%), Gaps = 13/171 (7%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRV-RHKNLV 210
++G+G +G V+ A+K L + + + VE V+ H L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ V EY++ G+L + GL +LH
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHS- 121
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+RD+K NILLD+ + +++DFG+ K + T GT Y
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDY 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 120 bits (303), Expect = 2e-32
Identities = 42/198 (21%), Positives = 81/198 (40%), Gaps = 19/198 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G +G V+ +G A+K L + R + + E ++ V H ++R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
G + ++ +Y++ G L L +P+ + L
Sbjct: 70 WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-------CLALEYLHS 122
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLL-------CSERSYVTTRVMGTFGYAHFI 325
+++RD+K NILLD+ + +++DFG AK + C Y+ V+ T Y +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPY-NKS 181
Query: 326 VQVSPLFILLYILLSVRY 343
+ IL+Y +L+
Sbjct: 182 IDWWSFGILIYEMLAGYT 199
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-32
Identities = 41/169 (24%), Positives = 77/169 (45%), Gaps = 8/169 (4%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+ IGEG YG+V + +VA+K + Q + E++++ R RH+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ Y+ + L+ + L+ D + +GL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYIHS---AN 129
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT--TRVMGTFGY 321
V+HRD+K SN+LL+ + ++ DFGLA++ + + T + T Y
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 119 bits (299), Expect = 4e-32
Identities = 43/178 (24%), Positives = 74/178 (41%), Gaps = 20/178 (11%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNL---------LNNRGQAEKEFKVEVEVIGRVR 205
+ ++G G +V R I + AVK + + + EV+++ +V
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVS 67
Query: 206 -HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
H N+++L + LV++ + G L +L V L+ I+ + +
Sbjct: 68 GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV----TLSEKETRKIMRALLEVI 123
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
LH+ +VHRD+K NILLD N +++DFG + L V GT Y
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYL 176
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 7e-32
Identities = 43/172 (25%), Positives = 71/172 (41%), Gaps = 14/172 (8%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
+V+G G + V VA+K + + E + E+ V+ +++H N+V L
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 73
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G + L+ + V G L + T +I + YLH +
Sbjct: 74 DIYESGGHLYLIMQLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLH---DL 126
Query: 274 KVVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+VHRD+K N+L D +SDFGL+K+ + V + GT GY
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYV 176
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-31
Identities = 43/197 (21%), Positives = 80/197 (40%), Gaps = 19/197 (9%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+VY+ G VA+K L E+ ++ + H N+V+LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E++ + + + + + +GLA+ H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHS---H 121
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA----------H 323
+V+HRD+K N+L++ + +++DFGLA+ T V+ + A
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 324 FIVQVSPLFILLYILLS 340
V + L + +++
Sbjct: 182 TAVDIWSLGCIFAEMVT 198
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 3e-31
Identities = 43/172 (25%), Positives = 77/172 (44%), Gaps = 14/172 (8%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+ +GEG + VY+ + VA+K + + + E++++ + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL + LV+++++ LT +L T +GL YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+ ++HRD+K +N+LLD +++DFGLAK S T +V T Y
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYR 167
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 8e-31
Identities = 47/198 (23%), Positives = 74/198 (37%), Gaps = 22/198 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRL 212
++G+G +G V + G A+K L A+ E E V+ RH L L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
V EY + G L L + T + L YLH
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHS--- 123
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI------- 325
VV+RD+K N++LD+ + +++DFGL K S+ + GT Y
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDNDY 182
Query: 326 ---VQVSPLFILLYILLS 340
V L +++Y ++
Sbjct: 183 GRAVDWWGLGVVMYEMMC 200
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-29
Identities = 42/200 (21%), Positives = 79/200 (39%), Gaps = 20/200 (10%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG V++ VA+K L ++ E+ ++ ++HKN+VRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
LV+E+ D + + L +I + + KGL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHS---R 120
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI-------- 325
V+HRD+K N+L++R ++++FGLA+ + V+ + +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 326 --VQVSPLFILLYILLSVRY 343
+ + + L +
Sbjct: 181 TSIDMWSAGCIFAELANAGR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 3e-29
Identities = 40/175 (22%), Positives = 67/175 (38%), Gaps = 19/175 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
V+G G G V + K A+K +L + +A +E ++ + ++VR++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRAS---QCPHIVRIVD 72
Query: 215 YC----VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++V E +D G L + T I+ + + YLH
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ--AFTEREASEIMKSIGEAIQYLHS- 129
Query: 271 LEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+ HRDVK N+L + +++DFG AK S S T T Y
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYV 180
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 5e-29
Identities = 42/212 (19%), Positives = 88/212 (41%), Gaps = 32/212 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G +G V++ G KVA+K +L N + E++++ ++H+N+V L+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 214 GYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
C A LV+++ ++ + + T ++ GL
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS---YVTTRVMGTFGYA 322
Y+H K++HRD+K++N+L+ R +++DFGLA+ ++ T + T Y
Sbjct: 132 YIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 323 HFI-----------VQVSPLFILLYILLSVRY 343
+ + ++ + +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 110 bits (275), Expect = 1e-28
Identities = 38/178 (21%), Positives = 68/178 (38%), Gaps = 20/178 (11%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G +G +Y G ++ G +VA+K + +E ++ ++ + +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIPTIR 69
Query: 215 YC-VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+C EG Y ++V E + D + + + + + Y+H
Sbjct: 70 WCGAEGDYNVMVMELLGPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 274 KVVHRDVKSSNIL---LDRQWNARVSDFGLAKLLCSERSYV------TTRVMGTFGYA 322
+HRDVK N L + + DFGLAK R++ + GT YA
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-28
Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 24/201 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE------FKVEVEVIGRVR--HKN 208
++G GG+G VY GI +SD VA+K++ +R E +EV ++ +V
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + + G L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLL--------CSERSYVTTRVMGTF 319
V+HRD+K NIL+D ++ DFG LL R Y +
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 320 GYAHFIVQVSPLFILLYILLS 340
Y V L ILLY ++
Sbjct: 185 RYHGRSAAVWSLGILLYDMVC 205
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 110 bits (276), Expect = 3e-28
Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 19/194 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLL 213
+G G +G V G A+K L + K+ E ++ V LV+L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EYV G + L + + YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYLHS---L 160
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTRVMGTFGYAHFIV 326
+++RD+K N+L+D+Q +V+DFG AK + + ++ + GY + V
Sbjct: 161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGY-NKAV 219
Query: 327 QVSPLFILLYILLS 340
L +L+Y + +
Sbjct: 220 DWWALGVLIYEMAA 233
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 4e-28
Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 21/188 (11%)
Query: 152 GLCEEN-------VIGEGGYGIVYRG--ILSDGTKVAVKNLLNNRGQAEKEFKVEVEV-- 200
GLC + IGEG YG V++ + + G VA+K + G+ EV
Sbjct: 1 GLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV 60
Query: 201 ---IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQW--LHGDVGDVSPLTWDIRMN 255
+ H N+VRL C + ++DQ + D + + +
Sbjct: 61 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 120
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
++ +GL +LH +VVHRD+K NIL+ +++DFGLA++ + + T V
Sbjct: 121 MMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSV 175
Query: 316 MGTFGYAH 323
+ T Y
Sbjct: 176 VVTLWYRA 183
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-27
Identities = 40/199 (20%), Positives = 77/199 (38%), Gaps = 19/199 (9%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G KVA+K K E+ ++ +RH+N++ LL
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
++ G + L D ++ KGL Y+H
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAG 141
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQ------- 327
++HRD+K N+ ++ ++ DFGLA+ SE T V+ + A ++
Sbjct: 142 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGYVVTRWYRAPEVILNWMRYTQ 198
Query: 328 ---VSPLFILLYILLSVRY 343
+ + ++ +++ +
Sbjct: 199 TVDIWSVGCIMAEMITGKT 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 1e-27
Identities = 39/175 (22%), Positives = 74/175 (42%), Gaps = 20/175 (11%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + +V + S G + A K + + RG + ++ + EV ++ ++H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT + + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNAR----VSDFGLAKLLCSERSYVTTRVMGTFGY 321
++ H D+K NI+L + + + DFGLA + + + GT +
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEF 182
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 104 bits (261), Expect = 2e-26
Identities = 44/203 (21%), Positives = 84/203 (41%), Gaps = 31/203 (15%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLG 214
+G G Y V+ I +++ KV VK L + +K+ K E++++ +R N++ L
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 215 YCVEGAYRM--LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ R LV+E+V+N + Q LT + K L Y H
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCH---S 147
Query: 273 PKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQ---- 327
++HRDVK N+++D + R+ D+GLA+ + Y + + + +
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQ 205
Query: 328 -------VSPLFILLYILLSVRY 343
+ L +L ++ +
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 101 bits (251), Expect = 3e-25
Identities = 38/208 (18%), Positives = 67/208 (32%), Gaps = 32/208 (15%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLL 213
IGEG +G+++ G L + +VA+K R + + E + + +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVY 67
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ EG + +LV + + D + + +HE
Sbjct: 68 YFGQEGLHNVLVIDLLGPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 274 KVVHRDVKSSNILLDRQW-----NARVSDFGLAKLLCSERS------YVTTRVMGTFGY- 321
+V+RD+K N L+ R V DFG+ K + + GT Y
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 322 ---AHFIVQVSP------LFILLYILLS 340
H + S L + L
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLR 208
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-25
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 16/174 (9%)
Query: 157 NVIGEGGYGIVYRGIL----SDGTKVAVKNL----LNNRGQAEKEFKVEVEVIGRVRHK- 207
V+G G YG V+ G A+K L + + + + + E +V+ +R
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
LV L L+ +Y++ G L L T + L +L
Sbjct: 90 FLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHL 145
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
H+ +++RD+K NILLD + ++DFGL+K ++ + GT Y
Sbjct: 146 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.4 bits (244), Expect = 8e-24
Identities = 43/197 (21%), Positives = 81/197 (41%), Gaps = 13/197 (6%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ +G G YG V G +VAVK + K E+ ++ ++H+N++ LL
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ +L ++ LT D +I +GL Y+H
Sbjct: 84 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL-------CSERSYVTTRVMGTFGYAHFIV 326
++HRD+K SN+ ++ ++ DFGLA+ + R Y +M + + + V
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTV 200
Query: 327 QVSPLFILLYILLSVRY 343
+ + ++ LL+ R
Sbjct: 201 DIWSVGCIMAELLTGRT 217
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.0 bits (222), Expect = 6e-21
Identities = 41/173 (23%), Positives = 66/173 (38%), Gaps = 21/173 (12%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G GIV VA+K + K E+ ++ V HKN++ LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 215 YCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
E LV E +D + ++ G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHLH 136
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++HRD+K SNI++ ++ DFGLA+ + S++ T + T Y
Sbjct: 137 S---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYY 184
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 84.1 bits (207), Expect = 6e-20
Identities = 26/156 (16%), Positives = 50/156 (32%), Gaps = 21/156 (13%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVK----------NLLNNRGQAEKEFKVEVEVIGRVRH 206
++GEG V+ + VK + R + F V R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L +L G V VY + N L + + + ++ + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ +VH D+ N+L+ + + DF +
Sbjct: 119 FY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 80.1 bits (196), Expect = 2e-17
Identities = 27/181 (14%), Positives = 60/181 (33%), Gaps = 18/181 (9%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G + V+ + + T VA+K ++ + + E++++ RV + +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDS 76
Query: 215 YCVEGAYRMLVYEYVDNGNL------------DQWLHGDVGDVSPLTWDIRMNIILGTAK 262
++L + N + + + I
Sbjct: 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSYVT-TRVMGTFG 320
GL Y+H ++H D+K N+L++ + +A L + T + T
Sbjct: 137 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 321 Y 321
Y
Sbjct: 195 Y 195
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 348 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.67 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.07 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.69 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.19 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.31 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.06 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=356.66 Aligned_cols=190 Identities=27% Similarity=0.353 Sum_probs=166.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|+.+ +|+.||||.+.... ....+.+.+|+++|++++||||+++++++.+++..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 45788899999999999999975 68999999986543 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
|++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 85 ~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 9999999998643 4699999999999999999999999 99999999999999999999999999999875443
Q ss_pred c-ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 S-YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~-~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ......+||+.|+|||+ |||||||+||||++|++||..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 2 22345789999999994 999999999999999999953
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=353.93 Aligned_cols=188 Identities=23% Similarity=0.327 Sum_probs=169.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
++|++.+.||+|+||.||+|+. .+|+.||||.+........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 4688899999999999999995 469999999997665556678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++... ++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 100 AGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp TTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence 999999988643 589999999999999999999999 999999999999999999999999999998754433
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
......||+.|+|||+ |||||||+||+|++|++||..
T Consensus 172 -~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp -CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 3344689999999994 999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=348.20 Aligned_cols=187 Identities=27% Similarity=0.395 Sum_probs=167.0
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.+ +++.||+|.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 35788899999999999999975 6889999998643 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||++|+|.+++... .++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 999999999999754 4699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....||+.|+|||+ |||||||+||||++|++||..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 206 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCC
Confidence 32 234689999999995 999999999999999999963
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=351.77 Aligned_cols=190 Identities=23% Similarity=0.302 Sum_probs=168.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+.|++.+.||+|+||.||+|++. +++.||+|.+........+.+.+|+++|++++|||||++++++.+++..|+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45778899999999999999965 68999999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++.+.. .++++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~---~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE---RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 9999999976432 4699999999999999999999999 99999999999999999999999999998654322
Q ss_pred ccccccccCCCccccee---------------ccchHHHHHHHHHhccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV---------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~---------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......||+.|+|||+ |||||||+||||++|++||..
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 22334689999999993 999999999999999999964
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=350.35 Aligned_cols=192 Identities=29% Similarity=0.430 Sum_probs=162.2
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++..++|++.+.||+|+||.||+|+++ ..||||.+... .....+.|.+|+.+|.+++|||||++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 455778999999999999999999864 36999998644 33456789999999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||||++|+|.+++.... .++++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 81 v~Ey~~~g~L~~~l~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIE---TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHTSC---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 999999999999997542 4689999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCc-ccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERS-YVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~-~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... .......||+.|||||+ |||||||+||||+||+.||..
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~ 211 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSN 211 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCC
Confidence 54332 23345789999999994 999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-48 Score=350.71 Aligned_cols=189 Identities=22% Similarity=0.291 Sum_probs=164.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++|++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 45888899999999999999964 68999999986432 234467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 999999999998754 4699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCc-ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 307 ERS-YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 307 ~~~-~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
... ......+||+.|+|||+ |||||||+||||++|++||.
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCC
Confidence 332 23344689999999995 99999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=350.32 Aligned_cols=196 Identities=24% Similarity=0.334 Sum_probs=155.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--CCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--GAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--~~~~~lv 225 (348)
++|++.+.||+|+||.||+|+.+ +|+.||+|.+.... ....+.+.+|+++|++++|||||++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56888899999999999999964 68999999986553 2334678899999999999999999999865 4568999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL--EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~--~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
||||++|+|.+++.........+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998653333357999999999999999999999861 11499999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... ......||+.|+|||+ |||||||+||||++|++||..
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 754332 3345789999999995 999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=360.12 Aligned_cols=188 Identities=24% Similarity=0.342 Sum_probs=166.5
Q ss_pred HhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
..++|++.+.||+|+||.||+|+.. +|+.||+|.+... .....+.+.+|+.+|++++|||||++++++.+++..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567888999999999999999964 6899999998654 3344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999754 468999999999999999999996 5 79999999999999999999999999999764
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .....+||+.|+|||+ ||||+||++|||++|++||.
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 32 2234689999999995 99999999999999999995
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=340.14 Aligned_cols=186 Identities=25% Similarity=0.387 Sum_probs=159.7
Q ss_pred CcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE----CCEEEEEE
Q 018991 154 CEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVY 226 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~----~~~~~lv~ 226 (348)
+..+.||+|+||.||+|++. ++..||+|.+.... ....+.+.+|+++|++++|||||++++++.+ +...|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 34567999999999999965 68899999986543 2345678999999999999999999999875 35689999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC-CCCceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~-~~~~~kl~DFGla~~~~ 305 (348)
||+++|+|.+++... ..+++..+..++.|++.||+|||++ .++|+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999754 4689999999999999999999998 22399999999999996 57899999999998653
Q ss_pred CCCcccccccccCCCccccee---------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV---------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~---------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. ......||+.|+|||+ |||||||+||||++|++||..
T Consensus 167 ~~---~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 167 AS---FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp TT---SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CC---ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 32 2345689999999995 999999999999999999964
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-48 Score=346.39 Aligned_cols=195 Identities=26% Similarity=0.397 Sum_probs=168.8
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
++++..++|++.+.||+|+||.||+|+++++..||||.+.... ...+.|.+|+++|.+++|||||++++++.+ +..|+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEE
Confidence 3445667888999999999999999999888899999986543 345679999999999999999999998754 55799
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
||||+++|+|.+++.... ..++++..++.++.||+.||.|||++ +|+||||||+||||++++.+||+|||+|+.+
T Consensus 85 v~Ey~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEc
Confidence 999999999999876432 23589999999999999999999998 9999999999999999999999999999988
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhcc-CCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVR-YNSS 346 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~-~Pf~ 346 (348)
............||+.|+|||+ |||||||+||||+||. +||.
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 6655555556789999999994 9999999999999964 4543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=350.60 Aligned_cols=189 Identities=24% Similarity=0.248 Sum_probs=168.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+. .+|+.||+|.+.+.. ....+.+.+|+.+|++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 4688899999999999999996 479999999996542 234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 999999999999764 4689999999999999999999999 999999999999999999999999999997654
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... .....+||+.|+|||+ |||||||+||||++|++||..
T Consensus 158 ~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~ 207 (337)
T d1o6la_ 158 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp TTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCC
Confidence 332 3445789999999995 999999999999999999963
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=340.91 Aligned_cols=190 Identities=28% Similarity=0.457 Sum_probs=156.4
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||+|++.+++.||||++.... ...++|.+|++++++++||||+++++++.+++..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 35677889999999999999999888899999986543 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~g~L~~~l~~~~---~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TTCBHHHHHHTTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 9999999987542 4688999999999999999999999 999999999999999999999999999998765544
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
.......||+.|+|||+ |||||||+||||+| |++||.
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~ 204 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 204 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence 44445679999999994 99999999999999 466664
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.3e-48 Score=349.53 Aligned_cols=195 Identities=24% Similarity=0.395 Sum_probs=171.7
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++++..++|++.+.||+|+||.||+|+++ +++.||||.+..+. ...+++.+|+++|++++|||||++++++.+++..+
T Consensus 11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 34455677888999999999999999975 58899999886543 34567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|||||++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 90 iv~E~~~~g~l~~~l~~~~--~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEeecccCcchHHHhhhcc--ccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceee
Confidence 9999999999999997542 25789999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
.............||+.|+|||+ |||||||++|||++|..||
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~ 216 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 216 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCC
Confidence 76655554555678999999994 9999999999999977665
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.1e-47 Score=349.60 Aligned_cols=188 Identities=25% Similarity=0.368 Sum_probs=168.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
++|++.+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46888999999999999999964 68999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCceEEecccCcccccCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~--~~~~~kl~DFGla~~~~~~ 307 (348)
++|+|.+++.... .++++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 106 ~gg~L~~~l~~~~---~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTCTT---SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 9999999986432 4699999999999999999999999 999999999999995 4678999999999987544
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. .....||+.|+|||+ |||||||++|+|++|++||.
T Consensus 180 ~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 180 QS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp SC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 32 334689999999995 99999999999999999996
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-46 Score=348.76 Aligned_cols=189 Identities=21% Similarity=0.296 Sum_probs=168.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
+.|++.+.||+|+||.||+|+.. +|+.||||.+........+.+.+|+.+|++++|||||++++++.+++..|+|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 45888899999999999999964 79999999997766556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC--CCCceEEecccCcccccCC
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD--RQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~--~~~~~kl~DFGla~~~~~~ 307 (348)
++|+|.+++... ..++++.++..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999987643 24699999999999999999999999 999999999999997 6789999999999987554
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.. .....||+.|+|||+ |||||||+||+|++|++||..
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 230 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 230 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 32 334679999999994 999999999999999999964
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-47 Score=345.46 Aligned_cols=184 Identities=27% Similarity=0.324 Sum_probs=163.4
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.|+..+.||+|+||.||+|+.. +++.||||.+..... ...+.+.+|+++|++++|||||++++++.+++..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4777899999999999999964 688999999875532 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
||++|+|..++... .++++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp CCSEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred ecCCCchHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 99999998776543 4699999999999999999999999 9999999999999999999999999999875432
Q ss_pred CcccccccccCCCccccee-------------ccchHHHHHHHHHhccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-------------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-------------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....||+.|+|||+ |||||||++|||++|++||..
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 33579999999993 999999999999999999964
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.2e-46 Score=344.44 Aligned_cols=186 Identities=24% Similarity=0.308 Sum_probs=166.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+.+ +|+.||||++... .....+.+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 45888899999999999999964 6899999998643 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
|||+||+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 999999999998754 4578899999999999999999998 999999999999999999999999999998654
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. ....+||+.|+|||+ |||||||+||||++|++||..
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCC
Confidence 3 234689999999995 999999999999999999963
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-47 Score=345.28 Aligned_cols=189 Identities=25% Similarity=0.303 Sum_probs=150.8
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
.+.|++.+.||+|+||.||+|+.+ +++.||||.+.... ......+.+|+.+|++++||||+++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 355888899999999999999965 68999999986543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccCcccc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLL 304 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGla~~~ 304 (348)
||++|+|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||+. +++.+||+|||+|+..
T Consensus 88 ~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 88 LVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999754 4699999999999999999999999 999999999999994 5789999999999876
Q ss_pred cCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....+||+.|+|||+ |||||||+||||++|++||..
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 4332 2334689999999995 999999999999999999963
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=332.32 Aligned_cols=191 Identities=23% Similarity=0.345 Sum_probs=171.6
Q ss_pred hcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++|++.+.||+|+||.||+|++++++.||||.+..... ..+++.+|+.++++++||||+++++++.+++..++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 367889999999999999999998888999999876543 4568999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++.... ..+++..++.++.|+++||.|||++ +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 82 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 82 ANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TTEEHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCcHHHhhhccc---cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999976542 4588999999999999999999998 999999999999999999999999999998766555
Q ss_pred ccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.......||+.|+|||. |||||||++|||+| |+.||..
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 45555779999999995 99999999999998 8999974
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-46 Score=341.39 Aligned_cols=191 Identities=28% Similarity=0.421 Sum_probs=153.2
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CC---cEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DG---TKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|++.+.||+|+||.||+|+++ ++ ..||||.+... .....++|.+|+++|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999975 33 35899988654 334456799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
||||++|+|.+++.... ..+++.+++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+.
T Consensus 106 ~Ey~~~g~L~~~~~~~~---~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQND---GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHTTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecccc---CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 99999999999987542 4689999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCccc----ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 306 SERSYV----TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 306 ~~~~~~----~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... .....||+.|+|||. |||||||+||||+| |+.||..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~ 236 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 236 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCC
Confidence 433221 122457899999994 99999999999998 8999974
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-46 Score=335.44 Aligned_cols=191 Identities=26% Similarity=0.397 Sum_probs=162.9
Q ss_pred hcCCCcCce-EeecCceEEEEEEEC---CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 150 TSGLCEENV-IGEGGYGIVYRGILS---DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 150 ~~~~~~~~~-lG~G~fg~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.++|.+.+. ||+|+||.||+|.++ ++..||||.+.... ....++|.+|+++|++++|||||++++++.++ ..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEE
Confidence 345566664 999999999999864 35579999986553 33457899999999999999999999998754 5799
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
|||||++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 86 vmE~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTTCT---TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 999999999999986432 4689999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCccc--ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSYV--TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~~--~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
....... .....||+.|+|||+ |||||||+||||+| |+.||..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~ 215 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCC
Confidence 6544322 223578999999994 99999999999998 9999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-46 Score=333.09 Aligned_cols=183 Identities=27% Similarity=0.411 Sum_probs=156.1
Q ss_pred ceEeecCceEEEEEEECC---CcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeecCC
Q 018991 157 NVIGEGGYGIVYRGILSD---GTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~~~ 231 (348)
+.||+|+||.||+|.+++ ++.||||.+... .....+++.+|+++|++++|||||++++++.++ ..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence 579999999999998643 468999998643 233456799999999999999999999998654 57899999999
Q ss_pred CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCccc
Q 018991 232 GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311 (348)
Q Consensus 232 g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 311 (348)
|+|.+++... .++++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 9999999754 4699999999999999999999998 99999999999999999999999999999875543322
Q ss_pred --ccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 312 --TTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 312 --~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....||+.|+|||+ |||||||++|||++ |++||..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~ 213 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRG 213 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCC
Confidence 233678999999994 99999999999998 8999974
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=334.59 Aligned_cols=188 Identities=23% Similarity=0.324 Sum_probs=166.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC------cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR------GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
+.|++.+.||+|+||.||+|+.+ +|+.||||.+.... ....+.+.+|+.+|++++|||||++++++.+++..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46888899999999999999974 68999999986432 123578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC----ceEEeccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW----NARVSDFG 299 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~----~~kl~DFG 299 (348)
+|||||++|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchh
Confidence 999999999999999754 4699999999999999999999999 999999999999998776 49999999
Q ss_pred CcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+|+.+.... ......||+.|+|||+ |||||||+||||++|+.||..
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 218 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCC
Confidence 998875432 2334679999999995 999999999999999999963
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=343.91 Aligned_cols=198 Identities=26% Similarity=0.387 Sum_probs=165.9
Q ss_pred HHHhcCCCcCceEeecCceEEEEEEECC-C-----cEEEEEEEecC-CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEE
Q 018991 147 EAATSGLCEENVIGEGGYGIVYRGILSD-G-----TKVAVKNLLNN-RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVE 218 (348)
Q Consensus 147 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~ 218 (348)
++..++|++.++||+|+||.||+|++.. + ..||+|.+... .......+.+|+.+|.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 4566788999999999999999999642 2 36999988654 333446788999999998 89999999999999
Q ss_pred CCEEEEEEeecCCCCHHHHHhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecC
Q 018991 219 GAYRMLVYEYVDNGNLDQWLHGDVG-------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRD 279 (348)
Q Consensus 219 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrd 279 (348)
.+..|+|||||++|+|.++++.... ....+++..++.++.|++.||.|||++ +|+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecc
Confidence 9999999999999999999976432 123589999999999999999999999 999999
Q ss_pred CCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 280 VKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 280 lkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|||+|||++.++.+||+|||+|+........ ......||+.|||||+ |||||||+||||++ |++||..
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554433 2334678999999994 99999999999997 8999964
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-46 Score=343.50 Aligned_cols=186 Identities=22% Similarity=0.204 Sum_probs=166.5
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~ 226 (348)
++|++.+.||+|+||.||+|+++ +|+.||||++.... ....+.+.+|+++|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 35788899999999999999964 79999999986432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccC
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~ 306 (348)
||+.+|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999998754 4689999999999999999999999 999999999999999999999999999998754
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
. .....||+.|||||+ |||||||+||||++|++||..
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCC
Confidence 3 234689999999995 999999999999999999963
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.9e-45 Score=328.98 Aligned_cols=188 Identities=25% Similarity=0.342 Sum_probs=166.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc---------chHHHHHHHHHHHhcCC-CCCeeeEeeEEEEC
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG---------QAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEG 219 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~ 219 (348)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+.+|++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5688889999999999999996 4789999999865421 12346888999999997 99999999999999
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
+..|+|||||++|+|.++++.+ .++++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999999754 4699999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCcccccccccCCCcccce----------------eccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFI----------------VQVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe----------------~DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++.+.... ......||+.|++|| +||||+||+||||++|+.||..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 999875432 233467999999998 3999999999999999999974
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-45 Score=343.22 Aligned_cols=186 Identities=25% Similarity=0.274 Sum_probs=161.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc---chHHHHH---HHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG---QAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++|++.++||+|+||.||+|+.. +|+.||||.+..... .....+. .|+.+++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 56888999999999999999965 689999999854321 1122333 3577788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 999999999999999754 4688999999999999999999999 999999999999999999999999999997
Q ss_pred ccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.... .....||+.|+|||+ |||||||+||||++|++||.
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~ 207 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 207 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCC
Confidence 65432 234679999999994 99999999999999999996
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-46 Score=335.88 Aligned_cols=191 Identities=27% Similarity=0.388 Sum_probs=158.3
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+..++|++++.||+|+||.||+|+++++..||||.+.... ...+.|.+|+.+|++++|||||++++++.+ +..|+|||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 3456788999999999999999999888899999986543 345789999999999999999999999854 56899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++.... ...+++.+++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+...
T Consensus 92 y~~~g~l~~~~~~~~--~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 92 YMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CCTTCBHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred ecCCCchhhhhhhcc--cccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 999999999886432 24589999999999999999999998 9999999999999999999999999999987655
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
.........||+.|+|||. |||||||+||||++|..||
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~ 214 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 214 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCC
Confidence 4444455679999999994 9999999999999965554
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-45 Score=333.00 Aligned_cols=189 Identities=18% Similarity=0.242 Sum_probs=165.4
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+.... .....+.+|+++|+.++||||+++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 356888899999999999999965 68899999986543 3345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC--CCceEEecccCcccccC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR--QWNARVSDFGLAKLLCS 306 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~--~~~~kl~DFGla~~~~~ 306 (348)
|++|+|.+++.... .++++.++..++.||+.||+|||++ +|+||||||+|||++. ...+||+|||+++....
T Consensus 83 ~~gg~L~~~i~~~~---~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 83 ISGLDIFERINTSA---FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTSSS---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 99999999997542 3689999999999999999999998 9999999999999985 45899999999987654
Q ss_pred CCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 307 ERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 307 ~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
... .....||+.|++||. |||||||++|+|++|++||..
T Consensus 157 ~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 157 GDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp TCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 332 334679999999994 999999999999999999963
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=331.10 Aligned_cols=190 Identities=28% Similarity=0.469 Sum_probs=155.1
Q ss_pred hcCCCcCceEeecCceEEEEEEECCC-----cEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILSDG-----TKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
.+.|+..++||+|+||.||+|.+++. ..||||.+.... .....+|.+|+++|++++|||||++++++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 34577789999999999999996532 469999986543 334457899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+.++++.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKD---GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHHTT---TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEecccCcchhhhhccc---ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999999886542 4699999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHhccCCC
Q 018991 304 LCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNS 345 (348)
Q Consensus 304 ~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf 345 (348)
+..... .......||+.|+|||+ |||||||+||||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 754332 22334578999999994 9999999999999965554
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-45 Score=334.28 Aligned_cols=188 Identities=22% Similarity=0.291 Sum_probs=163.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC---cchHHHHHHHHHHHh-cCCCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR---GQAEKEFKVEVEVIG-RVRHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 46888899999999999999965 68999999996432 223445666776665 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccccc
Q 018991 226 YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~ 305 (348)
|||+++|+|.+++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 9999999999999754 4689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.... ......||+.|+|||+ |||||||++|||++|+.||.
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 155 LGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 4332 3344689999999994 99999999999999999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=330.68 Aligned_cols=193 Identities=21% Similarity=0.279 Sum_probs=153.5
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECC----CcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSD----GTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR 222 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~ 222 (348)
+..++|++.+.||+|+||.||+|++.. +..||||.+.... ....+.+.+|+++|++++||||+++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 456778899999999999999998642 3568999885443 334567999999999999999999999985 4668
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||+++|+|.+++.... .++++..++.++.|++.||.|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRK---YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTT---TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhccC---CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 99999999999999876542 4689999999999999999999999 99999999999999999999999999999
Q ss_pred cccCCCcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 303 LLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 303 ~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.+............||+.|+|||+ |||||||+||||++ |++||..
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 876555555556788999999995 99999999999998 8999964
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.9e-45 Score=326.98 Aligned_cols=190 Identities=25% Similarity=0.319 Sum_probs=157.8
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC---cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----EE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YR 222 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~ 222 (348)
++|++.+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+++|+.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 4588889999999999999996 479999999996543 233457899999999999999999999998653 47
Q ss_pred EEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 223 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+||||+++++|.+++... .++++.+++.++.|++.||+|||++ +|+||||||+|||++.++..+|+|||.++
T Consensus 87 ~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhh
Confidence 9999999999999988654 4699999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCCc--ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 303 LLCSERS--YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 303 ~~~~~~~--~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
....... .......||+.|+|||+ |||||||+||||++|++||..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~ 216 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCC
Confidence 6543322 23344689999999994 999999999999999999963
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=329.22 Aligned_cols=183 Identities=25% Similarity=0.284 Sum_probs=155.9
Q ss_pred CceEeecCceEEEEEEE-CCCcEEEEEEEecCCcc-----hHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEeec
Q 018991 156 ENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQ-----AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYV 229 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~~ 229 (348)
.++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999996 46899999998544221 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
.++++..+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~----~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp SEEHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred cchHHhhhhhcc----cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 987776665422 4688899999999999999999999 999999999999999999999999999987654432
Q ss_pred ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 310 YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.....+||+.|+|||+ |||||||++|||++|++||.
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCC
Confidence 2334679999999994 99999999999999999996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-44 Score=326.29 Aligned_cols=189 Identities=23% Similarity=0.382 Sum_probs=161.3
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++|++++||||+++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4788889999999999999996 5789999999854432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+.+ ++.+++... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9975 555554333 224699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ......||+.|+|||. |||||||++|+|++|++||.
T Consensus 156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCC
Confidence 32 3334579999999994 99999999999999999996
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-44 Score=327.97 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=170.4
Q ss_pred hHHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcCCCCCeeeEeeE
Q 018991 143 LRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (348)
Q Consensus 143 ~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~l~~~ 215 (348)
+.+++.++++|++.+.||+|+||.||+|+++ +++.||||++..... ...+++.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 4556778889999999999999999999964 357899999865433 345679999999999999999999999
Q ss_pred EEECCEEEEEEeecCCCCHHHHHhcCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 018991 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVG--------------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275 (348)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~i 275 (348)
+.+.+..+++|||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999964321 123588999999999999999999998 99
Q ss_pred eecCCCCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHhcc-C
Q 018991 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVR-Y 343 (348)
Q Consensus 276 vHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~-~ 343 (348)
+||||||+|||++.++.+||+|||+|+.+...... ......||+.|+|||. |||||||+||||++|. +
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999876543332 3334678999999994 9999999999999995 5
Q ss_pred CCCC
Q 018991 344 NSST 347 (348)
Q Consensus 344 Pf~~ 347 (348)
||..
T Consensus 242 p~~~ 245 (301)
T d1lufa_ 242 PYYG 245 (301)
T ss_dssp TTTT
T ss_pred CCCC
Confidence 6753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-44 Score=330.03 Aligned_cols=184 Identities=26% Similarity=0.271 Sum_probs=157.5
Q ss_pred cCCCcC-ceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhc-CCCCCeeeEeeEEEE----CCEEE
Q 018991 151 SGLCEE-NVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR-VRHKNLVRLLGYCVE----GAYRM 223 (348)
Q Consensus 151 ~~~~~~-~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~H~nIv~l~~~~~~----~~~~~ 223 (348)
++|.+. ++||+|+||.||+|+. .+++.||||.+... ..+.+|+.++.+ .+|||||++++++.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 467765 4699999999999996 57899999998532 356678888665 489999999999976 45689
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC---CCceEEecccC
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR---QWNARVSDFGL 300 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~---~~~~kl~DFGl 300 (348)
+|||||+||+|.+++.... ..++++.++..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~~--~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRG--DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSCS--CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhcC--CCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 9999999999999997542 24699999999999999999999999 9999999999999985 56799999999
Q ss_pred cccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
|+....... .....||+.|+|||+ |||||||+||+|++|++||.
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 987754432 334689999999995 99999999999999999994
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=322.06 Aligned_cols=187 Identities=27% Similarity=0.355 Sum_probs=160.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCc------chHHHHHHHHHHHhcCC--CCCeeeEeeEEEECCE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG------QAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAY 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~ 221 (348)
++|++.+.||+|+||.||+|+.. +|+.||||.+..... .....+.+|+.+|++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 45888899999999999999964 789999999864321 11234667999999986 9999999999999999
Q ss_pred EEEEEeecCC-CCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-CCceEEeccc
Q 018991 222 RMLVYEYVDN-GNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-QWNARVSDFG 299 (348)
Q Consensus 222 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-~~~~kl~DFG 299 (348)
.|+||||+.+ +++.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccc
Confidence 9999999976 6888888654 4689999999999999999999999 9999999999999985 4799999999
Q ss_pred CcccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+|+..... ......||+.|+|||. |||||||+||||++|++||..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCC
Confidence 99875432 2345689999999994 999999999999999999963
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-43 Score=324.57 Aligned_cols=190 Identities=26% Similarity=0.421 Sum_probs=157.9
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc----EEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT----KVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~l 224 (348)
.+|++.++||+|+||.||+|++. +|+ +||+|.+... .....+++.+|+.+|++++|||||++++++.+++ .++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-eeE
Confidence 35888899999999999999964 443 6899988644 3445678999999999999999999999998754 678
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
++||+.+|+|.+++.... ..+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+
T Consensus 88 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK---DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHHTS---SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccccc---cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 899999999999887542 5689999999999999999999998 9999999999999999999999999999987
Q ss_pred cCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 305 CSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 305 ~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
...... ......||+.|+|||+ |||||||+||||+| |++||..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~ 216 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 216 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCC
Confidence 654433 2334578999999994 99999999999998 8999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-43 Score=319.90 Aligned_cols=189 Identities=23% Similarity=0.306 Sum_probs=161.7
Q ss_pred cCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|++++|+.||||.+.... ....+.+.+|+.+|++++||||+++++++.+++..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 4678889999999999999999899999999996543 22356789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCC
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~ 308 (348)
+.++.+..+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHhhc----CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 9877666665433 5699999999999999999999998 99999999999999999999999999998765432
Q ss_pred cccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 309 SYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 309 ~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.......|++.|++||. |||||||++|||++|++||..
T Consensus 155 -~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 155 -RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred -cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 23334578999999984 999999999999999999963
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=325.07 Aligned_cols=203 Identities=24% Similarity=0.347 Sum_probs=159.8
Q ss_pred chHHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcC-CCCCeeeEe
Q 018991 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRV-RHKNLVRLL 213 (348)
Q Consensus 142 ~~~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~l~ 213 (348)
+..++++..++|++.+.||+|+||.||+|++. +++.||||.+.... ....+.+..|..++.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 45666777888999999999999999999953 24689999986543 33455677888887776 689999999
Q ss_pred eEEEEC-CEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCC
Q 018991 214 GYCVEG-AYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDV 280 (348)
Q Consensus 214 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdl 280 (348)
+++... +..++|||||++|+|.++++.... ....+++..++.++.|++.||.|||++ +|+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcC
Confidence 988764 468999999999999999975421 123589999999999999999999999 9999999
Q ss_pred CCCCEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHhc-cCCCCC
Q 018991 281 KSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSV-RYNSST 347 (348)
Q Consensus 281 kp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g-~~Pf~~ 347 (348)
||+|||++.++.+||+|||+|+........ ......||+.|+|||+ |||||||++|||++| ++||..
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999876544332 3345689999999994 999999999999986 567764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-43 Score=317.67 Aligned_cols=188 Identities=26% Similarity=0.361 Sum_probs=154.1
Q ss_pred CCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----EEEEEEe
Q 018991 152 GLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRMLVYE 227 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~lv~e 227 (348)
+|.+.+.||+|+||.||+|++ +|+.||||.+.... ......+.|+..+.+++||||+++++++.+++ ..|+|||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 455678899999999999997 57899999885432 11222334555666789999999999998654 6899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCceecCCCCCCEEECCCCceEEecccCcc
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~-----~~~ivHrdlkp~Nill~~~~~~kl~DFGla~ 302 (348)
|+++|+|.+++++. ++++..++.++.|++.||.|||+.. .++|+||||||+||||+.++.+||+|||+++
T Consensus 82 y~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp CCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999753 5899999999999999999999621 2489999999999999999999999999999
Q ss_pred cccCCCcc---cccccccCCCccccee----------------ccchHHHHHHHHHhccCCCC
Q 018991 303 LLCSERSY---VTTRVMGTFGYAHFIV----------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 303 ~~~~~~~~---~~~~~~gt~~y~~pe~----------------DiwSlG~il~el~~g~~Pf~ 346 (348)
........ ......||+.|+|||. |||||||+||||+||..||.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 87554322 2334689999999984 99999999999999998874
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-43 Score=316.75 Aligned_cols=190 Identities=24% Similarity=0.344 Sum_probs=152.4
Q ss_pred cCCCcCceEeecCceEEEEEEEC--CC--cEEEEEEEecC---CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS--DG--TKVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~ 223 (348)
++|++.+.||+|+||.||+|++. ++ ..||||.+... .....++|.+|+.+|++++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 45788899999999999999853 22 37899988654 23345689999999999999999999999976 4578
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
+||||+++|++.+++..+. .++++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~~---~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG---GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhccc---CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 9999999999999876532 4699999999999999999999998 999999999999999999999999999998
Q ss_pred ccCCCcc--cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 304 LCSERSY--VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 304 ~~~~~~~--~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
+...... ......|+..|+|||+ |||||||++|||++ |+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~ 217 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIG 217 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCC
Confidence 7554332 2233568889999994 99999999999998 8999963
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-44 Score=316.80 Aligned_cols=187 Identities=32% Similarity=0.409 Sum_probs=153.5
Q ss_pred HhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCEEEEEEe
Q 018991 149 ATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYE 227 (348)
Q Consensus 149 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e 227 (348)
..++|++.+.||+|+||.||+|+++ |..||||.++.. ...+.+.+|++++++++||||+++++++.+ .+..|+|||
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CHHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 3456778899999999999999985 788999998643 345679999999999999999999999865 456899999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
|+++|+|.+++.... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 y~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp CCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC
Confidence 999999999996431 13589999999999999999999998 9999999999999999999999999999875432
Q ss_pred CcccccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
.....+|..|+|||. |||||||++|||+| |++||..
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~ 203 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 203 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTT
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCC
Confidence 233568899999994 99999999999998 7888864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-43 Score=320.19 Aligned_cols=198 Identities=26% Similarity=0.371 Sum_probs=168.4
Q ss_pred HHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEE
Q 018991 146 LEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCV 217 (348)
Q Consensus 146 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 217 (348)
+++..++|++.++||+|+||.||+|++. +++.||||++..... .....+.+|+.+++++ +|||||++++++.
T Consensus 18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 3455678888999999999999999852 457899999976543 3445788999999999 6999999999999
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCC
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVG--------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~ 283 (348)
+.+..+++||||++|+|.++++.... ....+++..+..++.||+.||.|||++ +++||||||+
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~ 174 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAAR 174 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGG
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccc
Confidence 99999999999999999999975431 223689999999999999999999999 9999999999
Q ss_pred CEEECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCC
Q 018991 284 NILLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSS 346 (348)
Q Consensus 284 Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~ 346 (348)
|||++.++.+|++|||+++........ ......||+.|+|||+ |||||||++|||+| |.+||.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 999999999999999999987654433 3334789999999994 99999999999998 566664
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-42 Score=316.23 Aligned_cols=191 Identities=27% Similarity=0.447 Sum_probs=159.1
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCc--EEEEEEEecC-CcchHHHHHHHHHHHhcC-CCCCeeeEeeEEEECCEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGT--KVAVKNLLNN-RGQAEKEFKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~~~~~~~lv 225 (348)
++|+++++||+|+||.||+|+++ ++. .||||.+... .....+++.+|+++|.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56888899999999999999965 444 5788887544 333456799999999998 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCce
Q 018991 226 YEYVDNGNLDQWLHGDV------------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNA 293 (348)
Q Consensus 226 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~ 293 (348)
|||+++|+|.++++... .....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997541 2335799999999999999999999999 99999999999999999999
Q ss_pred EEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhcc-CCCC
Q 018991 294 RVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVR-YNSS 346 (348)
Q Consensus 294 kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~-~Pf~ 346 (348)
||+|||+++...... ......||..|++||. |||||||++|||++|. +||.
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~ 228 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 228 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC
Confidence 999999998654322 2234578999999994 9999999999999965 5675
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=319.63 Aligned_cols=201 Identities=22% Similarity=0.400 Sum_probs=170.1
Q ss_pred HHHHHHhcCCCcCceEeecCceEEEEEEEC------CCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEE
Q 018991 144 RELEAATSGLCEENVIGEGGYGIVYRGILS------DGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216 (348)
Q Consensus 144 ~~~~~~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~ 216 (348)
+++++..++|.+.+.||+|+||.||+|.++ ++..||||++.... ......+.+|+.++++++||||+++++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 92 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 445666788889999999999999999863 25789999986543 33345689999999999999999999999
Q ss_pred EECCEEEEEEeecCCCCHHHHHhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCC
Q 018991 217 VEGAYRMLVYEYVDNGNLDQWLHGDV------GDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ 290 (348)
Q Consensus 217 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~ 290 (348)
..++..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+|||++.+
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~ 169 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 169 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCC
Confidence 99999999999999999999985321 1224578999999999999999999998 99999999999999999
Q ss_pred CceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHhc-cCCCCC
Q 018991 291 WNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSV-RYNSST 347 (348)
Q Consensus 291 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g-~~Pf~~ 347 (348)
+++||+|||+|+.+...... ......||+.|++||. |||||||+||||+|| ++||..
T Consensus 170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~ 238 (308)
T d1p4oa_ 170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG 238 (308)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence 99999999999977554332 2334578999999994 999999999999998 577753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-42 Score=311.70 Aligned_cols=185 Identities=28% Similarity=0.430 Sum_probs=158.2
Q ss_pred CceEeecCceEEEEEEECC----CcEEEEEEEecC-CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE-CCEEEEEEeec
Q 018991 156 ENVIGEGGYGIVYRGILSD----GTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE-GAYRMLVYEYV 229 (348)
Q Consensus 156 ~~~lG~G~fg~V~~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~-~~~~~lv~e~~ 229 (348)
.++||+|+||+||+|++.+ ...||||.+... .....++|.+|+++|++++||||+++++++.+ ++..++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 4689999999999999643 235899998643 34455789999999999999999999999876 46899999999
Q ss_pred CCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCCCc
Q 018991 230 DNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309 (348)
Q Consensus 230 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~~~ 309 (348)
++|+|.+++.... ..+++..++.++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+++.+.....
T Consensus 112 ~~g~l~~~~~~~~---~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRNET---HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcccc---ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 9999999987542 4577888999999999999999998 999999999999999999999999999998754332
Q ss_pred c---cccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 310 Y---VTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 310 ~---~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
. ......||+.|++||. ||||||++||||++|+.||.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 2 2223578999999994 99999999999999888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=316.12 Aligned_cols=197 Identities=25% Similarity=0.363 Sum_probs=163.1
Q ss_pred HHhcCCCcCceEeecCceEEEEEEECC--------CcEEEEEEEecCCc-chHHHHHHHHHHHhcC-CCCCeeeEeeEEE
Q 018991 148 AATSGLCEENVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRG-QAEKEFKVEVEVIGRV-RHKNLVRLLGYCV 217 (348)
Q Consensus 148 ~~~~~~~~~~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~H~nIv~l~~~~~ 217 (348)
+..++|.+.+.||+|+||.||+|+... +..||||.+..... ....++.+|...+.++ +|||||++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 456778888999999999999998532 24799999866543 3456788899999888 8999999999999
Q ss_pred ECCEEEEEEeecCCCCHHHHHhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCE
Q 018991 218 EGAYRMLVYEYVDNGNLDQWLHGDVG------------DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI 285 (348)
Q Consensus 218 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Ni 285 (348)
+++..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++ +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975431 124689999999999999999999999 999999999999
Q ss_pred EECCCCceEEecccCcccccCCCcc-cccccccCCCccccee----------ccchHHHHHHHHHh-ccCCCCC
Q 018991 286 LLDRQWNARVSDFGLAKLLCSERSY-VTTRVMGTFGYAHFIV----------QVSPLFILLYILLS-VRYNSST 347 (348)
Q Consensus 286 ll~~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~-g~~Pf~~ 347 (348)
|++.++.+||+|||+++........ ......||+.|+|||. |||||||++|||++ |++||..
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999999999999999987654332 2334678999999994 99999999999998 7999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=317.14 Aligned_cols=189 Identities=24% Similarity=0.280 Sum_probs=165.8
Q ss_pred cCCCcCceEeecCceEEEEEEEC----CCcEEEEEEEecCC----cchHHHHHHHHHHHhcCCC-CCeeeEeeEEEECCE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS----DGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAY 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~ 221 (348)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 45888899999999999999852 47899999885432 2234567889999999976 899999999999999
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.+++|||+.+|+|.+++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999998754 3578889999999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee------------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV------------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~------------DiwSlG~il~el~~g~~Pf~ 346 (348)
+.+............|++.|++||. |||||||+||+|++|++||.
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 8876555555556789999999983 99999999999999999995
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-42 Score=311.13 Aligned_cols=189 Identities=25% Similarity=0.320 Sum_probs=155.1
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CC-CcEEEEEEEecCC--cchHHHHHHHHHHHhcC---CCCCeeeEeeEEEE----
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SD-GTKVAVKNLLNNR--GQAEKEFKVEVEVIGRV---RHKNLVRLLGYCVE---- 218 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~l~~~~~~---- 218 (348)
.++|++.+.||+|+||.||+|++ ++ ++.||||++.... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 35788899999999999999996 34 5679999985432 12223455677766655 89999999999863
Q ss_pred -CCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEec
Q 018991 219 -GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297 (348)
Q Consensus 219 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~D 297 (348)
....+++|||+.++++....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 24679999999987766554432 24689999999999999999999999 999999999999999999999999
Q ss_pred ccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 298 FGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 298 FGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
||+++...... ......||+.|+|||+ ||||+||++|||++|++||.
T Consensus 160 fg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~ 216 (305)
T d1blxa_ 160 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216 (305)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred hhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCC
Confidence 99998654332 3345689999999994 99999999999999999996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=316.20 Aligned_cols=186 Identities=26% Similarity=0.332 Sum_probs=152.8
Q ss_pred CCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCeeeEeeEEEEC------CEEEE
Q 018991 152 GLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG------AYRML 224 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~------~~~~l 224 (348)
+|...++||+|+||+||+|++. +|+.||||++...... ..+|+++|++++||||+++++++... ...|+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3566788999999999999975 6899999999755422 23699999999999999999998643 35789
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKL 303 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~ 303 (348)
|||||+++.+..+.. .......+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~~l~~-~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYRVARH-YSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHHHHHH-HHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCccHHHHHh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 999998654333322 111235699999999999999999999998 999999999999999775 899999999987
Q ss_pred ccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 304 LCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+..... .....||+.|+|||. ||||+||++|||++|++||..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~ 225 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPG 225 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCC
Confidence 754332 233579999999993 999999999999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=314.79 Aligned_cols=189 Identities=23% Similarity=0.318 Sum_probs=157.7
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC-cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC----EEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA----YRML 224 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~----~~~l 224 (348)
++|.+.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+++|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 4577889999999999999996 479999999996543 334567889999999999999999999987643 2345
Q ss_pred EEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccc
Q 018991 225 VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304 (348)
Q Consensus 225 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~ 304 (348)
+++|+.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+..
T Consensus 88 l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 55667789999999643 589999999999999999999999 9999999999999999999999999999876
Q ss_pred cCCCc--ccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 305 CSERS--YVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 305 ~~~~~--~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
..... ......+||+.|+|||+ ||||+||++|+|++|++||..
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCC
Confidence 44322 22344679999999994 999999999999999999963
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=310.42 Aligned_cols=190 Identities=22% Similarity=0.316 Sum_probs=156.5
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecC--CcchHHHHHHHHHHHhcCCCCCeeeEeeEEEE--------C
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE--------G 219 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~--------~ 219 (348)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+++.+|+++|++++||||+++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 5678889999999999999996 47999999988544 23345678899999999999999999998854 3
Q ss_pred CEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEeccc
Q 018991 220 AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299 (348)
Q Consensus 220 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFG 299 (348)
+..|++|||+.++.+..+... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecc
Confidence 457999999987766554432 24688999999999999999999999 99999999999999999999999999
Q ss_pred CcccccCCCcc---cccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 300 LAKLLCSERSY---VTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 300 la~~~~~~~~~---~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
+++.+...... ......||+.|+|||+ ||||+||++|||++|++||..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 99876533221 2223579999999994 999999999999999999963
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=314.10 Aligned_cols=185 Identities=24% Similarity=0.327 Sum_probs=155.2
Q ss_pred hcCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECC------
Q 018991 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGA------ 220 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~------ 220 (348)
.+.|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 457888899999999999999964 69999999986542 233467889999999999999999999997654
Q ss_pred EEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccC
Q 018991 221 YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300 (348)
Q Consensus 221 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGl 300 (348)
..|+||||+ +.+|..+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccc
Confidence 569999999 5688887754 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 301 AKLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 301 a~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
|+...... ....||+.|+|||+ ||||+||++|+|++|++||..
T Consensus 168 a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 168 ARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCC
Confidence 98765432 34679999999994 999999999999999999963
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-41 Score=302.25 Aligned_cols=188 Identities=22% Similarity=0.288 Sum_probs=163.4
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEECCEEEEEEe
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~~~~~lv~e 227 (348)
++|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+.+|+.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 4678889999999999999996 478899999986543 3446788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCcccccCC
Q 018991 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307 (348)
Q Consensus 228 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~~~~~ 307 (348)
++.+++|..++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 99999988887643 5688999999999999999999999 9999999999999999999999999999876543
Q ss_pred CcccccccccCCCcccce-----------eccchHHHHHHHHHhccCCCC
Q 018991 308 RSYVTTRVMGTFGYAHFI-----------VQVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 308 ~~~~~~~~~gt~~y~~pe-----------~DiwSlG~il~el~~g~~Pf~ 346 (348)
.. ......+++.|++|| +|||||||++|||++|+.||.
T Consensus 155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCC
Confidence 32 222345677778777 399999999999999999974
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-40 Score=301.78 Aligned_cols=187 Identities=19% Similarity=0.229 Sum_probs=159.7
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCCcchHHHHHHHHHHHhcCCC-CCeeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|++. +|+.||||.+.... ....+.+|++.++.++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 56888999999999999999964 68999999875432 22346778889999875 8999999999999999999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECC-----CCceEEecccCccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKL 303 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~-----~~~~kl~DFGla~~ 303 (348)
+ +++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++. ++.+||+|||+|+.
T Consensus 83 ~-~~~l~~~~~~~~---~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 83 L-GPSLEDLLDLCG---RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp C-CCBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred c-CCCHHHHHHhhc---cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9 589999987542 4689999999999999999999998 9999999999999974 57899999999987
Q ss_pred ccCCCc------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 304 LCSERS------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 304 ~~~~~~------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
...... .......||+.|||||+ |||||||++|||++|++||.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCC
Confidence 653321 12334689999999994 99999999999999999996
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.7e-41 Score=307.55 Aligned_cols=182 Identities=23% Similarity=0.291 Sum_probs=157.9
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEEC--CEEEEEE
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEG--AYRMLVY 226 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~--~~~~lv~ 226 (348)
++|++.+.||+|+||+||+|+. .+|+.||||++... ..+++.+|+++|.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 4688899999999999999996 46899999998643 3467889999999995 99999999999854 5689999
Q ss_pred eecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCC-ceEEecccCccccc
Q 018991 227 EYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQW-NARVSDFGLAKLLC 305 (348)
Q Consensus 227 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~-~~kl~DFGla~~~~ 305 (348)
|||.+++|..+. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 3589999999999999999999999 999999999999998655 69999999998765
Q ss_pred CCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .....||+.|+|||. ||||+||++|||++|+.||..
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCC
Confidence 4332 334578999999994 999999999999999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.9e-40 Score=296.59 Aligned_cols=188 Identities=21% Similarity=0.282 Sum_probs=155.3
Q ss_pred cCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCC-eeeEeeEEEECCEEEEEEee
Q 018991 151 SGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN-LVRLLGYCVEGAYRMLVYEY 228 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~l~~~~~~~~~~~lv~e~ 228 (348)
++|++.+.||+|+||.||+|++ .+|+.||||.+..... .+++..|+++++.++|+| |+.+.+++.+.+..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 4588889999999999999996 4689999998865432 235778999999998766 55556667888899999999
Q ss_pred cCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEEC---CCCceEEecccCccccc
Q 018991 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLC 305 (348)
Q Consensus 229 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~---~~~~~kl~DFGla~~~~ 305 (348)
+. ++|.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+.
T Consensus 85 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 LG-PSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CBHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred cC-Cchhhhhhhcc---CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 95 57766665432 4689999999999999999999999 999999999999986 35579999999999875
Q ss_pred CCCc------ccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 306 SERS------YVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 306 ~~~~------~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.... .......||+.|+|||+ |||||||++|||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccc
Confidence 4332 12334689999999994 999999999999999999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-40 Score=306.05 Aligned_cols=185 Identities=23% Similarity=0.308 Sum_probs=155.6
Q ss_pred hcCCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCc--chHHHHHHHHHHHhcCCCCCeeeEeeEEEEC-----CE
Q 018991 150 TSGLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRG--QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG-----AY 221 (348)
Q Consensus 150 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~~-----~~ 221 (348)
.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45688899999999999999996 4799999999865432 3345788999999999999999999998643 34
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.+++++|+.+|+|.+++.. .++++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 4677788889999999853 3599999999999999999999999 9999999999999999999999999999
Q ss_pred ccccCCCcccccccccCCCccccee-----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV-----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~-----------DiwSlG~il~el~~g~~Pf~ 346 (348)
..... ......||+.|+|||. |||||||++|+|++|++||.
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCC
Confidence 76532 2234578889999984 99999999999999999996
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-39 Score=301.42 Aligned_cols=184 Identities=24% Similarity=0.260 Sum_probs=148.3
Q ss_pred cCCCcCceEeecCceEEEEEEEC-CCcEEEEEEEecCC--cchHHHHHHHHHHHhcCCCCCeeeEeeEEEE------CCE
Q 018991 151 SGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNR--GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE------GAY 221 (348)
Q Consensus 151 ~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~l~~~~~~------~~~ 221 (348)
+.|++.+.||+|+||+||+|++. +|+.||||++.... ......+.+|+.+|++++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 56888899999999999999965 69999999997543 2334568899999999999999999999964 368
Q ss_pred EEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEEecccCc
Q 018991 222 RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301 (348)
Q Consensus 222 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl~DFGla 301 (348)
.|+|||||.+ ++.+.+. ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhh
Confidence 8999999976 4555553 3488999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCC
Q 018991 302 KLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSS 346 (348)
Q Consensus 302 ~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~ 346 (348)
+...... ......||+.|+|||+ ||||+||++|+|++|++||.
T Consensus 167 ~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred hcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCC
Confidence 8654322 3344679999999995 99999999999999999995
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-34 Score=263.97 Aligned_cols=186 Identities=18% Similarity=0.212 Sum_probs=148.0
Q ss_pred CCCcCceEeecCceEEEEEEE-CCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-----------CCCeeeEeeEEEE-
Q 018991 152 GLCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-----------HKNLVRLLGYCVE- 218 (348)
Q Consensus 152 ~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~l~~~~~~- 218 (348)
.|++.++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 388889999999999999996 479999999986543 23456778888888775 5789999988764
Q ss_pred -CCEEEEEEeecCCCC-HHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCceecCCCCCCEEECCCC----
Q 018991 219 -GAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE-GLEPKVVHRDVKSSNILLDRQW---- 291 (348)
Q Consensus 219 -~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~-~~~~~ivHrdlkp~Nill~~~~---- 291 (348)
....+++++++..+. ........ ....+++..+..++.|++.||+|||+ + +|+||||||+|||++.++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred cccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 456677777766543 33333222 23568899999999999999999997 5 899999999999998654
Q ss_pred --ceEEecccCcccccCCCcccccccccCCCccccee----------ccchHHHHHHHHHhccCCCCC
Q 018991 292 --NARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----------QVSPLFILLYILLSVRYNSST 347 (348)
Q Consensus 292 --~~kl~DFGla~~~~~~~~~~~~~~~gt~~y~~pe~----------DiwSlG~il~el~~g~~Pf~~ 347 (348)
.+|++|||.+...... .....||+.|+|||+ ||||+||++++|++|++||..
T Consensus 168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~ 231 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231 (362)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCC
Confidence 4999999999865332 234679999999994 999999999999999999963
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=9.1e-26 Score=190.38 Aligned_cols=162 Identities=14% Similarity=0.145 Sum_probs=116.9
Q ss_pred CcCceEeecCceEEEEEEECCCcEEEEEEEecCCc------------------chHHHHHHHHHHHhcCCCCCeeeEeeE
Q 018991 154 CEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG------------------QAEKEFKVEVEVIGRVRHKNLVRLLGY 215 (348)
Q Consensus 154 ~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~H~nIv~l~~~ 215 (348)
.+++.||+|+||.||+|+..+|+.||||.++.... ........|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 35688999999999999988899999998743210 011234568889999999999988765
Q ss_pred EEECCEEEEEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCceecCCCCCCEEECCCCceEE
Q 018991 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARV 295 (348)
Q Consensus 216 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~~~~~ivHrdlkp~Nill~~~~~~kl 295 (348)
. . .+++|||+++..+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++|
T Consensus 83 ~--~--~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 83 E--G--NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp E--T--TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEE
T ss_pred c--C--CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEE
Confidence 3 2 379999999865543 22333567899999999999999 99999999999999965 5899
Q ss_pred ecccCcccccCCCcccccc--cc--c---CCCcccceeccchHHHHH
Q 018991 296 SDFGLAKLLCSERSYVTTR--VM--G---TFGYAHFIVQVSPLFILL 335 (348)
Q Consensus 296 ~DFGla~~~~~~~~~~~~~--~~--g---t~~y~~pe~DiwSlG~il 335 (348)
+|||+|.....+....... .. . ...| +-++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y-~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWREILERDVRNIITYFSRTY-RTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHH-CCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcHHHHHHHHHHHHHHHcCCC-CCcccHHHHHHHH
Confidence 9999998775443211100 00 0 0112 3556999986433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.67 E-value=5e-08 Score=83.93 Aligned_cols=149 Identities=14% Similarity=0.078 Sum_probs=95.9
Q ss_pred HHHHHhcCCCcCceEeecCceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEE
Q 018991 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRM 223 (348)
Q Consensus 145 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~ 223 (348)
++..-.+.|...+..+-++.+.||+... ++..+.+|+...........+.+|...+..+. +--+.+++++..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 3444445555444433344578998764 45677888775443333345677888777663 444678888888899999
Q ss_pred EEEeecCCCCHHHHHhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------
Q 018991 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG--------------------------------- 270 (348)
Q Consensus 224 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~aL~yLH~~--------------------------------- 270 (348)
+||++++|.++.+..... .. ...++.+++..+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 999999998876543211 11 112333444444444431
Q ss_pred --------------------C---CCCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 271 --------------------L---EPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 271 --------------------~---~~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
. .+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 0 12378999999999999876667999988764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.07 E-value=7.3e-06 Score=69.50 Aligned_cols=73 Identities=18% Similarity=0.113 Sum_probs=51.0
Q ss_pred EeecC-ceEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCC--CCCeeeEeeEEEECCEEEEEEeecCCCCH
Q 018991 159 IGEGG-YGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR--HKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234 (348)
Q Consensus 159 lG~G~-fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--H~nIv~l~~~~~~~~~~~lv~e~~~~g~L 234 (348)
+..|. -+.||+....++..+.+|.-.... ...+..|...+..+. .-.+.+++++..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 34444 367899887777788889764332 224566777776653 33467788888888889999999987554
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.69 E-value=5.4e-05 Score=68.62 Aligned_cols=75 Identities=15% Similarity=0.167 Sum_probs=47.3
Q ss_pred ceEeecCceEEEEEEEC-CCcEEEEEEEecC-------CcchHHHHHHHHHHHhcCC-C--CCeeeEeeEEEECCEEEEE
Q 018991 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNN-------RGQAEKEFKVEVEVIGRVR-H--KNLVRLLGYCVEGAYRMLV 225 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-H--~nIv~l~~~~~~~~~~~lv 225 (348)
+.||.|....||+.... +++.+++|.-... ......+...|.+.|..+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 46899999999999854 4678999965321 1112234456777776552 2 346666654 45556899
Q ss_pred EeecCCCC
Q 018991 226 YEYVDNGN 233 (348)
Q Consensus 226 ~e~~~~g~ 233 (348)
||++.+..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997643
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.19 E-value=0.00086 Score=58.71 Aligned_cols=66 Identities=15% Similarity=0.129 Sum_probs=44.5
Q ss_pred eEEEEEEECCCcEEEEEEEecCCcchHHHHHHHHHHHhcCCCCCe-----eeE--eeEEEECCEEEEEEeecCC
Q 018991 165 GIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL-----VRL--LGYCVEGAYRMLVYEYVDN 231 (348)
Q Consensus 165 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~H~nI-----v~l--~~~~~~~~~~~lv~e~~~~ 231 (348)
-.||++..++|..+++|...... ...+++..|...+..|...++ +.. -..+...+..+.++++++|
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 47999998899999999765442 345667788888877642222 111 1233456778889999876
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.31 E-value=0.0066 Score=54.29 Aligned_cols=70 Identities=19% Similarity=0.221 Sum_probs=45.9
Q ss_pred ceEeecCceEEEEEEECC--------CcEEEEEEEecCCcchHHHHHHHHHHHhcCC-CCCeeeEeeEEEECCEEEEEEe
Q 018991 157 NVIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYE 227 (348)
Q Consensus 157 ~~lG~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~l~~~~~~~~~~~lv~e 227 (348)
+.|+.|--=.+|++...+ ...|.+++.- .. .......+|..+++.+. +.-.+++++++. + .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceEEE
Confidence 467777788999998643 2457776553 22 22345567888888774 444457777763 2 58899
Q ss_pred ecCCC
Q 018991 228 YVDNG 232 (348)
Q Consensus 228 ~~~~g 232 (348)
|++|.
T Consensus 122 fi~g~ 126 (395)
T d1nw1a_ 122 YIPSR 126 (395)
T ss_dssp CCCEE
T ss_pred Eeccc
Confidence 99864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.06 E-value=0.024 Score=48.59 Aligned_cols=31 Identities=23% Similarity=0.227 Sum_probs=27.4
Q ss_pred CCceecCCCCCCEEECCCCceEEecccCccc
Q 018991 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303 (348)
Q Consensus 273 ~~ivHrdlkp~Nill~~~~~~kl~DFGla~~ 303 (348)
.++||+|+.+.|++++.+...-|.||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998853
|